Clustering O 0 4.361647931716561e-09
of O 0 9.116077575969939e-14
missense O 0 4.430438025337935e-07
mutations O 0 4.331516720412765e-06
in O 0 1.039115928719303e-11
the O 0 1.3825265909872542e-07
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
gene O 0 0.0007506739930249751
in O 0 3.3386146494965296e-13
a O 0 1.2161286517750614e-12
sporadic B-Disease 0 2.1446052414830774e-05
T I-Disease 1 0.9817267656326294
- I-Disease 0 0.26768508553504944
cell I-Disease 0 0.008803345263004303
leukaemia I-Disease 1 0.64554762840271
. O 0 4.03977407081868e-11

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
telangiectasia I-Disease 1 1.0
( O 0 0.0477813258767128
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 2.491500929180379e-12
is O 0 1.2994567071954611e-14
a O 0 2.5390934065569817e-14
recessive B-Disease 0 5.516377754588575e-08
multi I-Disease 0 2.678516011656029e-06
- I-Disease 1 0.9997876286506653
system I-Disease 0 1.2196269381092861e-05
disorder I-Disease 0 0.0010574336629360914
caused O 0 1.4376475270666544e-12
by O 0 1.9671054827483667e-15
mutations O 0 1.3649871233312183e-09
in O 0 8.10285523980504e-15
the O 0 7.0306771235222835e-15
ATM O 0 2.3724273656711148e-09
gene O 0 1.3493881567683275e-09
at O 0 1.329399351018834e-11
11q22 O 0 4.1724351751426525e-10
- O 0 3.10082981513915e-08
q23 O 0 3.4310912444546204e-10
( O 0 1.6402250922493283e-14
ref O 0 3.588993635617044e-08
. O 0 1.2097359789256523e-13
3 O 0 2.2560872983169722e-13
) O 0 6.573294832707896e-14
. O 0 6.2567513019543e-13

The O 0 4.0733716399898867e-10
risk O 0 9.250791799253477e-10
of O 0 6.023509463567653e-14
cancer B-Disease 0 2.4953855245257728e-05
, O 0 1.9381237933990825e-11
especially O 0 3.078408014611789e-11
lymphoid B-Disease 0 8.464168786304072e-05
neoplasias I-Disease 0 0.00012594048166647553
, O 0 6.833170747982953e-12
is O 0 3.361257466479896e-14
substantially O 0 2.1626003765540247e-10
elevated O 0 1.5090670046902233e-07
in O 0 3.6261255109693025e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.5151046514511108
and O 0 7.159909998222247e-09
has O 0 9.810920076347429e-09
long O 0 1.910111478709009e-11
been O 0 2.9270208761096594e-13
associated O 0 1.4058996154753256e-11
with O 0 5.2289835655860983e-11
chromosomal O 1 1.0
instability O 1 0.9999998807907104
. O 0 4.870939762646742e-10

By O 0 7.469066055747209e-13
analysing O 0 4.933400354900641e-09
tumour B-Disease 1 0.9999969005584717
DNA O 0 1.9116471321467543e-06
from O 0 1.6021826191266512e-15
patients O 0 1.1728808300016241e-13
with O 0 1.562390557099773e-14
sporadic B-Disease 0 0.003591349348425865
T I-Disease 1 0.9997956156730652
- I-Disease 0 0.17357096076011658
cell I-Disease 0 0.1262664645910263
prolymphocytic I-Disease 0 0.0006094552809372544
leukaemia I-Disease 0 0.02266378328204155
( O 0 4.604228890509043e-12
T B-Disease 0 1.3761414265900385e-05
- I-Disease 0 4.1639097503320954e-07
PLL I-Disease 0 1.313983588602241e-08
) O 0 3.43338842057582e-14
, O 0 1.5153197080230779e-15
a O 0 1.0097446729933571e-14
rare O 0 3.394412843252953e-13
clonal B-Disease 0 1.8551912228659262e-09
malignancy I-Disease 0 2.051034698524745e-06
with O 0 1.4650171741427236e-14
similarities O 0 2.5599976999357565e-11
to O 0 6.857595546104489e-13
a O 0 6.7206270930320056e-12
mature B-Disease 0 2.450903924255954e-09
T I-Disease 0 0.0004004449874628335
- I-Disease 0 2.4472894438076764e-05
cell I-Disease 0 1.801885082386434e-05
leukaemia I-Disease 0 0.0009010487701743841
seen O 0 4.219439020403115e-09
in O 0 1.884627350012824e-11
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
, O 0 1.819501910249599e-10
we O 0 1.1123230158130437e-12
demonstrate O 0 1.5173435873714236e-16
a O 0 3.737065522713508e-18
high O 0 1.76670707610566e-17
frequency O 0 2.2281470610485124e-15
of O 0 2.0265223558389733e-16
ATM O 0 1.1710195479963659e-08
mutations O 0 1.850774289380297e-08
in O 0 1.867799751670285e-12
T B-Disease 0 7.932057633297518e-05
- I-Disease 0 1.2571183560794452e-06
PLL I-Disease 0 2.5527663183311233e-07
. O 0 1.5296040475898387e-11

In O 0 7.710073898770098e-12
marked O 0 1.3066557384699973e-12
contrast O 0 4.0362271901475677e-13
to O 0 2.0572326258965976e-14
the O 0 7.397884117365389e-15
ATM O 0 2.775786933639779e-09
mutation O 0 4.1846448528559677e-10
pattern O 0 1.6398201907463772e-08
in O 0 3.865116213197517e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
, O 0 3.7063345448284934e-11
the O 0 2.1390138898880607e-16
most O 0 7.302290890614024e-18
frequent O 0 7.591194823620712e-15
nucleotide O 0 8.543568955597658e-13
changes O 0 7.685476604082919e-13
in O 0 5.6819427499609984e-15
this O 0 7.216694283178685e-14
leukaemia B-Disease 0 4.2802918187589967e-07
were O 0 4.641010882891483e-13
missense O 0 2.970413675029704e-07
mutations O 0 3.1231897423822375e-07
. O 0 2.0566902347862737e-11

These O 0 1.543340316656483e-10
clustered O 0 1.4576130524801556e-08
in O 0 4.843528464588964e-13
the O 0 1.1299855230120434e-13
region O 0 3.597038682537357e-12
corresponding O 0 1.0688039605373685e-14
to O 0 3.213947933743827e-14
the O 0 3.065692815777091e-15
kinase O 0 3.3944587141121474e-09
domain O 0 1.4012642157723576e-09
, O 0 1.7551720493669265e-11
which O 0 2.896669178392014e-13
is O 0 9.794431492723423e-16
highly O 0 4.37456306598351e-16
conserved O 0 9.183989289549e-13
in O 0 5.2201861268971056e-14
ATM O 0 7.777644306372622e-09
- O 0 1.1123119092459888e-09
related O 0 8.696788948714396e-12
proteins O 0 3.695515282675643e-10
in O 0 2.9799290205551054e-12
mouse O 0 2.5086687855946366e-06
, O 0 3.8050045753079687e-11
yeast O 0 6.465306956471295e-09
and O 0 5.849292838283615e-12
Drosophila O 0 6.290765824923383e-11
. O 0 1.852455255163532e-12

The O 0 4.418024106278562e-12
resulting O 0 1.0909704400725168e-13
amino O 0 4.432066421766051e-13
- O 0 4.5342330584619006e-11
acid O 0 1.0157647292730054e-12
substitutions O 0 7.384072059314281e-14
are O 0 1.0842109604523322e-15
predicted O 0 4.125346765582183e-12
to O 0 2.9422777013182397e-14
interfere O 0 6.148232478686566e-10
with O 0 9.33715995146689e-13
ATP O 0 4.785265073081746e-09
binding O 0 2.665975253057784e-11
or O 0 1.950676599415946e-12
substrate O 0 1.362625923206906e-08
recognition O 0 8.191742423280246e-11
. O 0 8.198233203415839e-10

Two O 0 3.513661583909311e-11
of O 0 4.553498352574507e-15
seventeen O 0 7.365796861336094e-11
mutated O 0 1.4406265336219803e-07
T B-Disease 0 1.4803046724409796e-05
- I-Disease 0 3.157160932687475e-08
PLL I-Disease 0 4.530816255510217e-08
samples O 0 5.273738112876458e-10
had O 0 7.891137396298653e-12
a O 0 2.922761299883848e-15
previously O 0 3.854015023785351e-11
reported O 0 5.518355905564931e-08
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999986886978149
T I-Disease 1 0.9999996423721313
allele O 0 1.2605167398760386e-07
. O 0 1.0826679830433505e-10

In O 0 1.6459595839068974e-11
contrast O 0 3.8248251787997845e-11
, O 0 1.5954213861482658e-12
no O 0 8.125335257055943e-13
mutations O 0 1.2471584875939357e-10
were O 0 4.871145804427601e-13
detected O 0 9.638296383229772e-09
in O 0 2.959314583206134e-14
the O 0 1.7526033250538087e-14
p53 O 0 1.269366469575095e-11
gene O 0 4.148515905799677e-11
, O 0 2.9287210237007293e-15
suggesting O 0 5.480097170322551e-14
that O 0 1.6515239696646145e-13
this O 0 3.199941939029116e-13
tumour B-Disease 1 1.0
suppressor O 0 3.8451443629128335e-07
is O 0 3.115063762493264e-11
not O 0 6.451503914428613e-11
frequently O 0 7.56424423098423e-10
altered O 0 2.172849690396106e-06
in O 0 2.9945507878936795e-11
this O 0 9.931482025660188e-11
leukaemia B-Disease 0 0.0004994691116735339
. O 0 1.6528745386268362e-11

Occasional O 0 5.604914576906594e-07
missense O 0 2.0431707525858656e-06
mutations O 0 6.587584380213229e-07
in O 0 9.038961663572834e-14
ATM O 0 5.2760476876301254e-08
were O 0 1.0860951027424903e-10
also O 0 1.8942937496380097e-10
found O 0 2.8296625459445224e-11
in O 0 6.608433960643423e-13
tumour B-Disease 1 1.0
DNA O 0 2.0571995264617726e-05
from O 0 2.315960872514497e-15
patients O 0 8.133459726035464e-13
with O 0 1.1141448007234711e-12
B B-Disease 1 0.9221164584159851
- I-Disease 0 0.0014712673146277666
cell I-Disease 0 0.14561554789543152
non I-Disease 0 2.753674198174849e-05
- I-Disease 1 0.9934476017951965
Hodgkins I-Disease 1 0.9998455047607422
lymphomas I-Disease 1 0.9868587255477905
( O 0 2.1625210303022335e-11
B B-Disease 0 3.1839510484132916e-05
- I-Disease 0 5.002621961125442e-08
NHL I-Disease 0 1.856629339158644e-08
) O 0 6.170988741706351e-14
and O 0 4.886870530636245e-14
a O 0 5.419561826223995e-13
B B-Disease 0 6.244145879463758e-06
- I-Disease 0 1.1993384063657686e-08
NHL I-Disease 0 8.367139203713236e-10
cell O 0 1.3157239742156435e-08
line O 0 3.3757283635083013e-09
. O 0 5.987467899953858e-12

The O 0 9.83315750872904e-13
evidence O 0 2.565102806811187e-13
of O 0 2.8961882881417046e-17
a O 0 3.88897898259688e-15
significant O 0 2.0847274424194142e-15
proportion O 0 1.18188722697532e-11
of O 0 1.3663589269079842e-14
loss O 0 3.499033951470665e-08
- O 0 4.607047188187607e-09
of O 0 5.260957888406602e-14
- O 0 3.62415221388801e-07
function O 0 6.616351910793128e-10
mutations O 0 2.2950375822006208e-08
and O 0 2.7906466200378066e-12
a O 0 2.0110769874490814e-13
complete O 0 3.4256181224989746e-10
absence O 0 6.108550622795084e-13
of O 0 5.891939343532742e-17
the O 0 3.279332101008281e-14
normal O 0 1.5398133072427878e-12
copy O 0 5.388395025313075e-12
of O 0 1.5195561962483295e-16
ATM O 0 3.506902768179998e-09
in O 0 1.793471648319292e-13
the O 0 2.2490572975492583e-14
majority O 0 4.632363936885042e-12
of O 0 1.4054664550233742e-13
mutated O 0 0.19023172557353973
tumours B-Disease 1 1.0
establishes O 0 2.383180763843029e-09
somatic O 0 1.0886710977153768e-10
inactivation O 0 3.3637309115874814e-07
of O 0 1.249342759906857e-16
this O 0 2.8194582204278977e-15
gene O 0 2.1322983309590704e-11
in O 0 3.0648743701918064e-15
the O 0 1.6265258166351477e-15
pathogenesis O 0 1.6244898481954095e-10
of O 0 6.264981785577498e-16
sporadic B-Disease 0 5.8208552218275145e-05
T I-Disease 0 0.47542089223861694
- I-Disease 0 2.99061957775848e-06
PLL I-Disease 0 2.9509823207263253e-07
and O 0 2.16865483904094e-11
suggests O 0 7.177028069071945e-13
that O 0 7.018859743358665e-15
ATM O 0 9.968578913721604e-12
acts O 0 1.2943566032354303e-13
as O 0 1.6012915616419633e-14
a O 0 6.190953565771151e-12
tumour B-Disease 1 0.9999998807907104
suppressor O 0 1.0986527740897145e-05
. O 0 2.3630597478785376e-10

As O 0 5.01757435513589e-13
constitutional O 0 2.0590677600462737e-12
DNA O 0 1.1342939387759543e-06
was O 0 7.867441420561505e-11
not O 0 2.391850823305064e-13
available O 0 3.343173821275785e-15
, O 0 3.5554517128025005e-15
a O 0 5.286386156296355e-14
putative O 0 9.964924885252913e-09
hereditary O 0 0.00026525481371209025
predisposition O 0 0.000110510183731094
to O 0 4.4399608434275706e-09
T B-Disease 0 0.014618732035160065
- I-Disease 0 1.4696706784889102e-05
PLL I-Disease 0 1.6062097074609483e-07
will O 0 2.354967566439714e-12
require O 0 2.0012258756879012e-15
further O 0 2.745121296075792e-14
investigation O 0 8.630850483089259e-13
. O 0 9.409884845065428e-14
. O 0 1.747544925607969e-12

Myotonic B-Disease 1 0.9999843835830688
dystrophy I-Disease 1 0.9999972581863403
protein O 0 5.808794594486244e-05
kinase O 0 3.2409036521130474e-06
is O 0 3.256607494523528e-13
involved O 0 8.17747376026046e-15
in O 0 6.161664412440563e-17
the O 0 4.261471064984158e-17
modulation O 0 1.0502206505976722e-14
of O 0 2.2731053927493984e-17
the O 0 1.5260348865640816e-14
Ca2 O 0 5.8702354088779884e-09
+ O 0 8.796515515996362e-09
homeostasis O 0 2.691934639642568e-07
in O 0 8.484803137864816e-12
skeletal O 0 0.00035042825038544834
muscle O 0 2.162837290597963e-06
cells O 0 8.348874480645918e-09
. O 0 8.546979964052515e-12

Myotonic B-Disease 1 0.9999903440475464
dystrophy I-Disease 1 0.9999991655349731
( O 0 1.1120032894496035e-07
DM B-Disease 1 0.9999998807907104
) O 0 1.0014188089879639e-10
, O 0 1.0799150338075894e-13
the O 0 1.692429320975387e-15
most O 0 4.517125741379871e-14
prevalent O 0 4.037208327645203e-07
muscular B-Disease 0 0.0005872860201634467
disorder I-Disease 1 0.607437252998352
in O 0 8.69750278742476e-12
adults O 0 7.977465354969127e-10
, O 0 4.356038099673221e-12
is O 0 1.1276071222587891e-12
caused O 0 4.381954434723445e-12
by O 0 5.6731497009355515e-15
( O 0 7.205261201863235e-15
CTG O 0 1.818632133776532e-09
) O 0 4.102117544301301e-14
n O 0 1.5511342210672296e-10
- O 0 5.105124856186194e-08
repeat O 0 3.6489187227317643e-09
expansion O 0 2.4229042708788506e-13
in O 0 1.3596710512179958e-16
a O 0 1.0950298343549256e-16
gene O 0 2.1634253159004586e-14
encoding O 0 5.7724333972985434e-15
a O 0 2.506340505959142e-14
protein O 0 5.601874519811645e-10
kinase O 0 1.896714820759371e-07
( O 0 1.8100160042652802e-12
DM B-Disease 1 0.9999991655349731
protein O 0 3.3356302537868032e-06
kinase O 0 4.614797717295005e-07
; O 0 9.273832786774183e-13
DMPK O 0 1.2292742379571564e-09
) O 0 4.313436086311956e-15
and O 0 2.7426653663968755e-15
involves O 0 5.246585179247707e-15
changes O 0 1.2022722227500449e-12
in O 0 1.7086216474873975e-14
cytoarchitecture O 0 2.284581945843911e-08
and O 0 8.30943126806094e-12
ion O 0 1.1699049506930237e-09
homeostasis O 0 9.326231520390138e-06
. O 0 9.562569486254446e-11

To O 0 3.757640032464593e-12
obtain O 0 7.844910701951258e-13
clues O 0 1.4977945966831996e-11
to O 0 2.1679660562427816e-13
the O 0 3.820168058841014e-14
normal O 0 9.45595424878265e-12
biological O 0 7.303720996054697e-12
role O 0 1.1342372218314453e-13
of O 0 2.2481241742908274e-16
DMPK O 0 1.6486328746623258e-08
in O 0 8.544526170590691e-14
cellular O 0 1.2653157688280459e-10
ion O 0 2.579841062999577e-10
homeostasis O 0 6.328636459329573e-07
, O 0 6.629410215230891e-11
we O 0 4.6068693304590624e-10
have O 0 1.2415151643286465e-13
compared O 0 6.994750221064492e-15
the O 0 4.091550723581009e-15
resting O 0 2.947472127479145e-11
[ O 0 8.604809844259959e-14
Ca2 O 0 2.3269853925700357e-12
+ O 0 1.4394700709186026e-11
] O 0 6.13904274637811e-11
i O 0 2.7012894698863477e-10
, O 0 2.1406301346305404e-16
the O 0 6.0268991544266886e-18
amplitude O 0 4.868760203894295e-16
and O 0 8.133766013149191e-14
shape O 0 6.9083662401769885e-12
of O 0 1.2743823773166742e-16
depolarization O 0 1.6888139107648636e-12
- O 0 1.867987986514663e-09
induced O 0 4.035340672725596e-10
Ca2 O 0 4.792594793245897e-11
+ O 0 5.229689077623778e-12
transients O 0 9.119348609587519e-10
, O 0 2.625672032227633e-13
and O 0 1.6905364776239815e-14
the O 0 3.558828780223644e-16
content O 0 9.494034857869711e-15
of O 0 2.1068708755115567e-17
ATP O 0 5.110472808822486e-12
- O 0 3.771289270454448e-12
driven O 0 1.5176071120268086e-12
ion O 0 1.0114654773463183e-11
pumps O 0 2.3950444058562503e-11
in O 0 5.5319755666496245e-14
cultured O 0 5.474359160428932e-11
skeletal O 0 2.38236975746986e-06
muscle O 0 1.1755198592311444e-08
cells O 0 3.3410817515400204e-12
of O 0 7.75817394899364e-17
wild O 0 9.96142390796706e-10
- O 0 1.6527296509138978e-07
type O 0 4.8710658120398875e-06
and O 0 2.5475149767473226e-10
DMPK O 0 2.3106528601601894e-07
[ O 0 1.0750024134753566e-11
- O 0 1.0680594186851522e-08
/ O 0 1.1979126384176197e-06
- O 0 3.554536363026273e-07
] O 0 2.582781766236053e-09
knockout O 0 1.9696956954362577e-08
mice O 0 7.31331155634507e-08
. O 0 1.5620764230728224e-12

In O 0 1.9695171882272433e-10
vitro O 0 1.8202334217676253e-07
- O 0 1.6071671780082397e-06
differentiated O 0 5.913580292116194e-09
DMPK O 0 2.469313358233194e-07
[ O 0 7.36992897265587e-11
- O 0 2.993476044821364e-08
/ O 0 4.921992513118312e-06
- O 0 1.7558519971316855e-07
] O 0 6.58836665778928e-11
myotubes O 0 9.186556376716837e-11
exhibit O 0 6.254770464585169e-13
a O 0 2.889637314151816e-14
higher O 0 1.7298344018052553e-14
resting O 0 1.0871204977891402e-11
[ O 0 4.6249872556964125e-14
Ca2 O 0 5.634788642627786e-12
+ O 0 3.354755015450017e-11
] O 0 3.2543273631446823e-10
i O 0 3.746803312054681e-09
than O 0 1.0088360607508375e-14
do O 0 2.5398237332718843e-11
wild O 0 6.004889641086919e-11
- O 0 1.9109953619533826e-09
type O 0 4.485242843799142e-09
myotubes O 0 7.265688495294853e-09
because O 0 3.1863437669615857e-12
of O 0 9.436753533510145e-18
an O 0 2.0067756355583114e-15
altered O 0 3.6129435443399416e-07
open O 0 3.3695399803690407e-09
probability O 0 9.9988275309177e-14
of O 0 1.5128355192074586e-16
voltage O 0 1.6040588857180182e-09
- O 0 2.3138143845358172e-08
dependent O 0 9.054366978400452e-11
l O 0 4.937890984990645e-09
- O 0 1.8449534955333746e-10
type O 0 2.6479052284145155e-10
Ca2 O 0 3.9906689064395096e-11
+ O 0 3.392629926990409e-11
and O 0 6.4951221484532695e-12
Na O 0 2.7988454220917447e-08
+ O 0 4.230725145215608e-11
channels O 0 6.695722865046605e-10
. O 0 1.9463219230742013e-11

The O 0 2.160327819411556e-11
mutant O 0 1.5773028438914594e-09
myotubes O 0 1.0118530013869531e-08
exhibit O 0 1.401931765121489e-10
smaller O 0 8.171061917361389e-12
and O 0 2.761508903492693e-12
slower O 0 1.8800613843517056e-10
Ca2 O 0 1.0670589967176625e-09
+ O 0 2.110445845859843e-10
responses O 0 5.11379567164072e-13
upon O 0 1.117530801377593e-16
triggering O 0 9.136526814789141e-15
by O 0 2.8742541052747584e-16
acetylcholine O 0 2.50650833422128e-10
or O 0 1.0548804191268246e-10
high O 0 5.504852684801165e-10
external O 0 9.644534060271326e-08
K O 0 7.581799650324683e-07
+ O 0 3.6101928113652093e-09
. O 0 6.596024421101632e-11

In O 0 6.603258738413498e-12
addition O 0 1.050798770912964e-12
, O 0 7.342042555522066e-13
we O 0 3.8348507312366276e-13
observed O 0 3.3300384578462388e-15
that O 0 7.188154524460488e-16
these O 0 1.3006983939686649e-15
Ca2 O 0 1.942517674491384e-10
+ O 0 1.099256685677119e-09
transients O 0 2.8115374561821227e-07
partially O 0 4.500464356738121e-08
result O 0 3.4939434158387517e-13
from O 0 1.9293276412472575e-18
an O 0 6.245932858317974e-18
influx O 0 2.0199937964584516e-15
of O 0 1.527814833658508e-17
extracellular O 0 8.868318406018982e-12
Ca2 O 0 2.74324785110025e-10
+ O 0 7.265414398577308e-12
through O 0 2.22543846144143e-14
the O 0 1.3731360375189659e-14
l O 0 1.268285199085284e-10
- O 0 2.5699829417358266e-11
type O 0 5.679722317464275e-11
Ca2 O 0 7.893247860879526e-11
+ O 0 1.0429346969376141e-10
channel O 0 1.1485933981703056e-08
. O 0 2.3551303268698476e-11

Neither O 0 1.89588593713097e-08
the O 0 3.3349741696518664e-13
content O 0 1.8457787381853663e-12
nor O 0 2.1343491210523702e-11
the O 0 2.323881477604272e-15
activity O 0 7.526555333842166e-13
of O 0 6.230186201499884e-16
Na O 0 3.890076243351359e-07
+ O 0 1.6014810311215655e-10
/ O 0 7.34160998661082e-09
K O 0 1.1879967842798322e-10
+ O 0 3.752118407640559e-12
ATPase O 0 1.7611697655794956e-09
and O 0 1.0781359312261873e-11
sarcoplasmic O 0 6.0021814185518e-09
reticulum O 0 3.024663186579346e-08
Ca2 O 0 1.4180739915659046e-09
+ O 0 1.1903722452188958e-09
- O 0 1.1475116856729528e-08
ATPase O 0 3.48714124243088e-08
are O 0 1.0166640749750822e-12
affected O 0 1.409523539552815e-12
by O 0 1.0049680847972007e-14
DMPK O 0 5.535265046319182e-08
absence O 0 9.123479749462149e-12
. O 0 1.239149950184315e-12

In O 0 1.4342582677073779e-10
conclusion O 0 1.255829988611179e-11
, O 0 1.439384310526759e-12
our O 0 2.7319531524711872e-14
data O 0 4.456561869211652e-14
suggest O 0 3.900586722106053e-13
that O 0 3.8218733055704265e-14
DMPK O 0 1.683469008639804e-08
is O 0 1.677562092806061e-15
involved O 0 4.1651071705996905e-16
in O 0 1.483404830059516e-16
modulating O 0 2.2040478979672845e-13
the O 0 4.171453882594349e-15
initial O 0 1.115087534841238e-14
events O 0 1.6971617999308151e-15
of O 0 3.338073134451207e-17
excitation O 0 4.575215531953114e-13
- O 0 2.2249173525779042e-07
contraction O 0 3.36112304655245e-10
coupling O 0 1.6354270715446262e-10
in O 0 4.2420491490162415e-13
skeletal O 0 0.0010720177087932825
muscle O 0 3.656135504570557e-06
. O 0 9.147277119786468e-13
. O 0 1.7113108890035034e-12

Constitutional O 0 2.841669299868954e-07
RB1 O 0 0.00020963668066542596
- O 0 3.934145934181288e-05
gene O 0 1.2736192047668737e-06
mutations O 0 1.7838643771028728e-06
in O 0 2.06330490345151e-13
patients O 0 1.3013759340985143e-11
with O 0 1.8803094660718028e-13
isolated O 0 0.0013675387017428875
unilateral B-Disease 0 0.003333388129249215
retinoblastoma I-Disease 1 0.683089017868042
. O 0 1.7006245300876799e-09

In O 0 5.973004642972901e-12
most O 0 6.278242086366764e-14
patients O 0 4.450569687092232e-12
with O 0 2.5063704909254747e-13
isolated O 0 0.0027266235556453466
unilateral B-Disease 0 0.17398981750011444
retinoblastoma I-Disease 1 0.9982865452766418
, O 0 4.899597527696642e-08
tumor B-Disease 0 0.0011453982442617416
development O 0 1.6379038967131998e-12
is O 0 7.415006041361187e-15
initiated O 0 7.426488081180987e-14
by O 0 4.4356091275388215e-17
somatic O 0 4.776319314017674e-13
inactivation O 0 2.5537934433828013e-08
of O 0 8.00792690744749e-17
both O 0 1.4909807329738234e-13
alleles O 0 2.439872848029878e-13
of O 0 5.503072473148703e-16
the O 0 5.39735194472063e-13
RB1 O 0 3.9081817249098094e-07
gene O 0 1.9838561904350627e-09
. O 0 7.547403674257325e-12

However O 0 1.4107387480422062e-09
, O 0 6.997301907818096e-14
some O 0 1.0002665013685236e-16
of O 0 7.091274469373787e-17
these O 0 1.4431633514090658e-13
patients O 0 6.397971345425968e-13
can O 0 8.623293458421763e-14
transmit O 0 6.735635937893392e-10
retinoblastoma B-Disease 0 0.0010645670117810369
predisposition O 0 0.008571235463023186
to O 0 3.365138723232519e-10
their O 0 1.8207473723164114e-11
offspring O 0 3.40130090759061e-10
. O 0 2.0749007980519485e-12

To O 0 3.4239943779573734e-12
determine O 0 2.5036231226203964e-13
the O 0 1.3297870935641536e-15
frequency O 0 9.238633295882703e-12
and O 0 2.0486789348295176e-12
nature O 0 9.628447128137707e-13
of O 0 1.206418862378933e-15
constitutional O 0 6.730678236976928e-10
RB1 O 0 2.64342270384077e-06
- O 0 7.15460002354007e-09
gene O 0 1.307852670606735e-08
mutations O 0 2.5629134370319662e-08
in O 0 6.439384344757854e-14
patients O 0 2.128278673088624e-12
with O 0 5.348190762325712e-14
isolated O 0 6.234665488591418e-05
unilateral B-Disease 0 7.608121813973412e-05
retinoblastoma I-Disease 0 0.03557876497507095
, O 0 1.5114989815323554e-10
we O 0 1.5539428467950533e-12
analyzed O 0 2.667472904886725e-13
DNA O 0 2.347837549376841e-11
from O 0 1.7733521488385434e-16
peripheral O 0 7.445223104696197e-07
blood O 0 8.105570827865449e-07
and O 0 1.1554175394223876e-09
from O 0 2.281624975758456e-12
tumor B-Disease 0 3.579422991606407e-05
tissue O 0 5.644562406814657e-06
. O 0 1.6836697314115412e-10

The O 0 3.859192045790882e-12
analysis O 0 3.68620689528143e-11
of O 0 9.317057758986835e-13
tumors B-Disease 1 1.0
from O 0 1.0921374915540127e-11
54 O 0 2.319098690861665e-08
( O 0 4.223778716106602e-13
71 O 0 1.3242942742408559e-08
% O 0 6.5462903212065975e-15
) O 0 2.578896162374819e-14
of O 0 2.7596036960013566e-15
76 O 0 6.977118971462914e-08
informative O 0 1.47915230286344e-07
patients O 0 1.2226671231019282e-07
showed O 0 6.337451452509413e-09
loss O 0 3.9245606764382046e-11
of O 0 3.653077342171242e-16
constitutional O 0 2.547370536731819e-09
heterozygosity O 0 1.157272436103085e-05
( O 0 4.245436988070672e-11
LOH O 1 0.9999550580978394
) O 0 9.565920972010034e-12
at O 0 8.808960505479746e-12
intragenic O 0 5.936739455592033e-08
loci O 0 1.8344092911348753e-10
. O 0 1.6715290609981004e-11

Three O 0 6.061762758413636e-10
of O 0 4.4953288731415866e-14
13 O 0 2.1290063462187092e-11
uninformative O 0 1.8309001461602747e-06
patients O 0 1.6943991099083178e-08
had O 0 1.4086971866777986e-10
constitutional O 0 7.66324677325958e-12
deletions O 0 7.036374427116243e-06
. O 0 9.82443570940461e-10

For O 0 2.3317081772333825e-12
39 O 0 4.5614115262715416e-10
randomly O 0 1.4445102891613715e-09
selected O 0 3.3688351663840876e-07
tumors B-Disease 1 1.0
, O 0 3.6645209089414266e-09
SSCP O 0 0.00012296068598516285
, O 0 1.0531630255383728e-11
hetero O 0 2.7053296491885703e-08
- O 0 7.986177941177175e-09
duplex O 0 2.8579268018802395e-07
analysis O 0 1.3001471644083495e-12
, O 0 2.2895107334892646e-16
sequencing O 0 8.701791728588787e-14
, O 0 1.4391989322840547e-14
and O 0 7.543667974356863e-14
Southern O 0 1.3519328712074952e-10
blot O 0 2.4902908535295865e-06
analysis O 0 5.067548485872264e-13
were O 0 2.0066303694078573e-15
used O 0 1.3246540739037926e-14
to O 0 4.607527534961249e-14
identify O 0 3.8157168397168206e-11
mutations O 0 7.15545933616113e-09
. O 0 9.100729718436451e-12

Mutations O 0 8.88817976374412e-06
were O 0 4.7655473317531616e-12
detected O 0 5.45658052075737e-09
in O 0 5.622804197073783e-13
21 O 0 7.846030491975853e-10
( O 0 1.381369384113526e-13
91 O 0 4.633069039527982e-09
% O 0 2.6281860260150836e-14
) O 0 8.569007455645414e-14
of O 0 2.4646766832309153e-13
23 O 0 0.012580439448356628
tumors B-Disease 1 1.0
with O 0 1.4303524267234025e-06
LOH O 1 0.999997615814209
. O 0 4.875078118971032e-09

In O 0 7.593164985664203e-11
6 O 0 6.541236996504551e-11
( O 0 4.494789143747596e-14
38 O 0 1.1102511271454674e-10
% O 0 6.614139777864035e-15
) O 0 8.858892623381937e-14
of O 0 1.1573567625100534e-12
16 O 0 0.18399034440517426
tumors B-Disease 1 1.0
without O 0 1.0699478281139818e-07
LOH O 1 0.9999855756759644
, O 0 1.5821355727266284e-13
one O 0 6.868964557847808e-15
mutation O 0 3.86128059864585e-13
was O 0 2.2621759066671077e-13
detected O 0 1.5530238206551417e-09
, O 0 4.491228569603045e-12
and O 0 6.977175781575085e-11
in O 0 2.0582353096182393e-12
9 O 0 1.8091006470655202e-09
( O 0 9.07521687600098e-15
56 O 0 1.739980104442651e-10
% O 0 1.6204071682615379e-15
) O 0 3.055810609436417e-14
of O 0 1.1602553973469841e-14
the O 0 4.056740181113128e-06
tumors B-Disease 1 1.0
without O 0 6.950461539645403e-08
LOH O 1 0.9999963045120239
, O 0 5.5913012934893924e-12
both O 0 1.190411267823488e-12
mutations O 0 5.058384822120843e-09
were O 0 1.3518773774034987e-12
found O 0 7.738921482813854e-12
. O 0 3.236243738269362e-12

Thus O 0 1.3521036512642581e-09
, O 0 7.346847739550522e-13
a O 0 6.522613802155061e-14
total O 0 1.1247983440650349e-14
of O 0 1.4687935646589385e-15
45 O 0 1.3975560986256852e-10
mutations O 0 6.522793682961492e-08
were O 0 6.521028075162638e-12
identified O 0 3.570721673895605e-08
in O 0 9.362127961765054e-09
tumors B-Disease 1 1.0
of O 0 7.262362369461761e-13
36 O 0 1.233025415103839e-07
patients O 0 1.290562240408022e-10
. O 0 1.8347155392173242e-12

Thirty O 0 4.427977096099767e-09
- O 0 5.590085265794187e-07
nine O 0 3.329346520697385e-11
of O 0 1.0388595723766957e-16
the O 0 1.0479515340352727e-14
mutations O 0 1.1468585109364327e-10
- O 0 3.690500127717655e-10
including O 0 2.4178030996573063e-13
34 O 0 2.6821638660079472e-11
small O 0 8.004491709213968e-13
mutations O 0 4.858705793253648e-08
, O 0 2.7933129984406e-13
2 O 0 1.3244981012568852e-13
large O 0 2.1174948188103226e-13
structural O 0 6.313842391136859e-07
alterations O 0 6.601825589314103e-06
, O 0 3.936135445359312e-11
and O 0 6.517661410576636e-11
hypermethylation O 0 3.427829506108537e-05
in O 0 1.2222236556169719e-08
3 O 0 2.584284811746329e-05
tumors O 1 1.0
- O 0 0.00018705382535699755
were O 0 3.6824701621362976e-10
not O 0 3.849656704524307e-12
detected O 0 5.881280185082716e-11
in O 0 4.323301161411272e-16
the O 0 7.9966665308560305e-16
corresponding O 0 1.0305250169916416e-13
peripheral O 0 2.237601037791137e-08
blood O 0 3.0917983728784293e-09
DNA O 0 1.1219653828220544e-07
. O 0 2.8640060809048684e-11

In O 0 1.0569063679799484e-10
6 O 0 4.972252054535886e-10
( O 0 5.19312728670257e-13
17 O 0 4.378372317481727e-11
% O 0 1.7398628483842726e-15
) O 0 1.582628969418404e-15
of O 0 6.69541759194143e-17
the O 0 2.352615064565855e-12
36 O 0 3.79620779256129e-09
patients O 0 5.265759616540633e-13
, O 0 5.741356076101138e-16
a O 0 5.841769396778412e-15
mutation O 0 4.542488780956422e-12
was O 0 6.803307917024881e-13
detected O 0 7.233877385992571e-11
in O 0 9.175709923654415e-16
constitutional O 0 3.1665926391449828e-12
DNA O 0 2.939422665804159e-05
, O 0 1.425078804961899e-11
and O 0 1.6586286163966513e-11
1 O 0 2.635174522168382e-13
of O 0 5.18668449152554e-16
these O 0 1.4962632912188245e-12
mutations O 0 2.5292536953713807e-09
is O 0 3.0757040252356316e-14
known O 0 1.6464351312427822e-13
to O 0 3.3641833893302553e-13
be O 0 5.244510338162089e-13
associated O 0 1.4446851701044316e-11
with O 0 3.0526098142302782e-12
reduced O 0 7.573357052592655e-09
expressivity O 0 1.915971552080009e-05
. O 0 9.516044896518139e-11

The O 0 1.868284390041386e-12
presence O 0 3.719368563137593e-13
of O 0 2.8926770718775395e-17
a O 0 9.440513387031554e-15
constitutional O 0 6.898437984043104e-12
mutation O 0 2.2982780123470548e-09
was O 0 1.1543647149281355e-09
not O 0 3.202062313217846e-12
associated O 0 1.0395956664965844e-11
with O 0 1.3144683333064702e-14
an O 0 4.835335860279167e-15
early O 0 1.900286317191302e-10
age O 0 6.412157697172072e-12
at O 0 1.7347955754212774e-12
treatment O 0 2.1840218869528805e-11
. O 0 3.282806697920554e-13

In O 0 4.2144582268477393e-10
1 O 0 4.8208510100566926e-11
patient O 0 2.5054805452562334e-10
, O 0 2.4361421422356734e-14
somatic O 0 2.4153073638344402e-11
mosaicism O 0 1.032711679727072e-06
was O 0 3.074341822784099e-11
demonstrated O 0 9.777861198934524e-15
by O 0 2.4138708121315792e-18
molecular O 0 2.6169658887825742e-14
analysis O 0 1.0956995436016501e-14
of O 0 1.8423762350530308e-17
DNA O 0 1.0071705958125676e-07
and O 0 4.049421117435087e-13
RNA O 0 8.763060321825833e-08
from O 0 1.574599520594907e-14
peripheral O 0 5.094108018965926e-06
blood O 0 1.4583548590962891e-07
. O 0 7.932549755951257e-11

In O 0 6.079965420013878e-10
2 O 0 2.856032355058602e-10
patients O 0 1.0126662529363895e-11
without O 0 1.9869033108794835e-14
a O 0 1.166733810259446e-13
detectable O 0 3.264171510863889e-08
mutation O 0 4.097375594369623e-08
in O 0 3.8037546203073536e-12
peripheral O 0 0.0627165138721466
blood O 0 2.341652816539863e-06
, O 0 1.6326701275659605e-12
mosaicism O 0 2.755264105758215e-08
was O 0 3.6095352401455116e-11
suggested O 0 2.0420790058928162e-11
because O 0 4.5289038361553957e-13
1 O 0 2.422194897726184e-15
of O 0 1.4128845395530426e-17
the O 0 7.705512660230451e-13
patients O 0 8.175711496694049e-11
showed O 0 1.1906839070263686e-08
multifocal O 1 0.9999997615814209
tumors B-Disease 1 1.0
and O 0 1.102238570638292e-06
the O 0 4.8019808615573645e-12
other O 0 2.0905523406139492e-12
later O 0 9.298288805581478e-10
developed O 0 7.217741959664181e-10
bilateral B-Disease 0 1.1846010838922894e-09
retinoblastoma I-Disease 0 0.00037820174475200474
. O 0 4.2357090057620894e-10

In O 0 6.209607134044504e-11
conclusion O 0 1.1173780650741705e-11
, O 0 7.444591818006607e-12
our O 0 7.142163921912414e-13
results O 0 6.720941484556972e-14
emphasize O 0 7.475788786842977e-14
that O 0 1.0542144109439763e-14
the O 0 8.360409742280017e-17
manifestation O 0 2.1030999682101863e-14
and O 0 3.0210795480935596e-14
transmissibility O 0 8.759655500956143e-11
of O 0 3.329160296438173e-16
retinoblastoma B-Disease 0 1.254412751450218e-07
depend O 0 2.1317857201719193e-11
on O 0 2.9328510106618744e-12
the O 0 7.285080504614797e-15
nature O 0 2.4335982990071614e-13
of O 0 3.535161819409522e-17
the O 0 5.3243508506186504e-15
first O 0 6.555515949958207e-14
mutation O 0 2.903361958402767e-13
, O 0 7.827684728428218e-15
its O 0 1.860869975229022e-15
time O 0 1.919108535280989e-12
in O 0 4.098754823500701e-14
development O 0 6.326134277881423e-13
, O 0 6.053550130787066e-13
and O 0 8.991340658126568e-12
the O 0 1.2883240684664031e-14
number O 0 9.541339072993704e-12
and O 0 1.3839401846738042e-10
types O 0 1.465811083622981e-10
of O 0 3.799876198743411e-15
cells O 0 3.726128294800901e-09
that O 0 1.6311201521401753e-12
are O 0 6.732102668296353e-14
affected O 0 1.839078368759406e-11
. O 0 4.4577715000229667e-13
. O 0 1.8063394746983819e-12

Hereditary B-Disease 1 0.9999701976776123
deficiency I-Disease 1 0.9999819993972778
of I-Disease 0 7.468424750162184e-13
the I-Disease 0 6.897424905533134e-12
fifth I-Disease 0 3.3160141299504176e-10
component I-Disease 0 1.415513452979189e-11
of I-Disease 0 3.4632206245165846e-15
complement I-Disease 0 2.7084659515175247e-10
in O 0 2.4129162209951538e-12
man O 0 2.6131937147511053e-07
. O 0 1.6997731347445644e-11

I O 0 0.006634226534515619
. O 0 1.0248426551839884e-09

Clinical O 0 0.00040934773278422654
, O 0 1.658085474476323e-10
immunochemical O 0 1.1548402653716039e-05
, O 0 7.43927697222091e-10
and O 0 2.9735219841953153e-10
family O 0 2.6637858585587537e-10
studies O 0 3.876515428102856e-11
. O 0 1.327270433316985e-12

The O 0 2.1520789317275302e-10
first O 0 8.90020956240134e-12
recognized O 0 1.0831109229988978e-12
human O 0 1.28401326029981e-11
kindred O 0 1.1035726998898099e-07
with O 0 6.474651570442802e-08
hereditary B-Disease 1 0.9999927282333374
deficiency I-Disease 1 0.9999830722808838
of I-Disease 0 3.109200451354571e-14
the I-Disease 0 8.561256738259804e-12
fifth I-Disease 0 8.595543166123321e-10
component I-Disease 0 5.700125441099324e-11
of I-Disease 0 2.6888801718505904e-14
complement I-Disease 0 1.7404266472453855e-08
( O 0 2.1519578653761418e-12
C5 O 0 5.971874994514792e-09
) O 0 3.217543690248875e-13
is O 0 1.4087650046078898e-13
described O 0 9.139438511551745e-11
. O 0 3.255884103992024e-11

The O 0 2.1985625126008657e-11
proband O 0 7.010144464913992e-09
, O 0 4.0196481126270056e-13
a O 0 9.880604093150808e-14
20 O 0 1.0411468779128463e-12
- O 0 1.1541444466800499e-09
year O 0 1.4377098144814637e-13
- O 0 2.035320001425589e-08
old O 0 1.6912478528752217e-08
black O 0 7.286758869906595e-12
female O 0 2.971246859662102e-11
with O 0 1.2282494465942762e-10
systemic B-Disease 1 0.9999992847442627
lupus I-Disease 1 0.9914733171463013
erythematosus I-Disease 1 0.9999998807907104
since O 0 4.488746981223812e-06
age O 0 5.927020652052306e-08
11 O 0 8.328825823467056e-11
, O 0 1.4695019289953648e-12
lacked O 0 1.5781370876766232e-08
serum O 0 6.758107407023317e-09
hemolytic O 0 3.991786456936097e-08
complement O 0 3.915184842995245e-11
activity O 0 1.1258851628781485e-09
, O 0 1.360055189129905e-12
even O 0 4.943179546246235e-12
during O 0 2.6774346628677392e-12
remission O 0 3.0944516393738297e-10
. O 0 6.008618624354922e-13

C5 O 0 0.00023456549388356507
was O 0 4.9830902071335004e-08
undetectable O 0 9.764308828152934e-08
in O 0 7.430416416702446e-13
her O 0 6.49142128938962e-11
serum O 0 1.0845715298080094e-10
by O 0 9.780990138641681e-16
both O 0 7.0620701127233065e-12
immunodiffusion O 0 1.4669736629002728e-05
and O 0 1.4250232105439409e-09
hemolytic O 0 3.65053978157448e-07
assays O 0 1.2808256677487861e-08
. O 0 6.484356107616662e-11

Other O 0 3.457059671082424e-13
complement O 0 3.028020813689719e-13
components O 0 4.3203010613446224e-12
were O 0 1.478910201767325e-12
normal O 0 1.407120808760709e-10
during O 0 2.727164739695087e-13
remission O 0 2.9984870923011053e-12
of O 0 1.812216270389837e-16
lupus O 0 6.588853693756391e-07
, O 0 2.8914210435659893e-12
but O 0 5.19315479508009e-10
C1 O 0 2.540365429126723e-08
, O 0 4.420700188290799e-14
C4 O 0 1.782726144483604e-08
, O 0 2.507205033863702e-11
C2 O 0 5.056795515656631e-08
, O 0 1.3349837728326985e-12
and O 0 3.722402594497076e-11
C3 O 0 1.1355430160620017e-06
levels O 0 2.689121425536456e-10
fell O 0 1.8203286344942171e-06
during O 0 3.3988215020208656e-11
exacerbations O 0 0.0005663224146701396
. O 0 7.336017210368695e-11

A O 0 7.247404898436116e-09
younger O 0 6.172370170531849e-09
half O 0 1.2135671634272427e-10
- O 0 1.3274398042995017e-06
sister O 0 2.986541949212551e-05
, O 0 7.036433241625062e-11
who O 0 1.8937754475700785e-08
had O 0 2.983933882205747e-07
no O 0 1.1498269003595851e-09
underlying O 0 7.381443456466741e-09
disease O 0 0.005276919342577457
, O 0 4.074235794657849e-13
was O 0 1.4816180282650748e-08
also O 0 7.213162511732207e-09
found O 0 7.457944817268469e-10
to O 0 1.1657673090748055e-11
lack O 0 1.5640276573858358e-10
immunochemically O 0 1.9557828636607155e-05
detectable O 0 8.92111245320848e-07
C5 O 0 2.3298507301205973e-07
. O 0 3.5076351545537676e-11

By O 0 1.9430318465296637e-11
hemolytic O 0 1.2921789220854407e-06
assay O 0 2.410850896694683e-08
, O 0 2.5310961659918974e-10
she O 0 1.5561408162056978e-08
exhibited O 0 2.2852190625921587e-11
1 O 0 1.49088196215591e-12
- O 0 2.8884890923563944e-08
2 O 0 6.496125252303253e-12
% O 0 1.9300290242322535e-16
of O 0 6.08627583315697e-18
the O 0 1.1268260223561491e-13
normal O 0 5.156919891113887e-10
serum O 0 2.4004606635763537e-10
C5 O 0 2.2857825354716255e-10
level O 0 4.90067396385907e-11
and O 0 8.308381651937757e-13
normal O 0 2.6001022081917347e-12
concentrations O 0 3.122058861437793e-11
of O 0 9.035000016363142e-17
other O 0 4.670505789842322e-15
complement O 0 1.2990143899785367e-12
components O 0 4.137989256802754e-11
. O 0 1.8321739958526706e-11

C5 O 0 3.989407559856772e-06
levels O 0 7.0044641198308e-09
of O 0 1.1412171248354939e-15
other O 0 3.7744086285249057e-14
family O 0 7.686591163916234e-13
members O 0 6.526709804672055e-17
were O 0 2.2151139768473473e-14
either O 0 2.441083088704915e-13
normal O 0 4.725029048580076e-11
or O 0 1.663851890466861e-13
approximately O 0 3.1399971598539134e-12
half O 0 2.144495470091101e-09
- O 0 4.292745416023536e-06
normal O 0 3.197491338369218e-08
, O 0 1.2975806410256419e-12
consistent O 0 9.701008225893037e-12
with O 0 4.90870527818793e-13
autosomal O 0 3.1269080409401795e-06
codominant O 0 1.7429188403639273e-07
inheritance O 0 3.553886351870261e-11
of O 0 1.6954277117295488e-15
the O 0 3.1294067272431836e-13
gene O 0 1.0252933435594969e-07
determining O 0 4.302822560475761e-07
C5 B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999998807907104
. O 0 1.1281803963258952e-10

Normal O 0 2.2187221475178376e-05
hemolytic O 0 0.0004981397651135921
titers O 0 4.6408142225118354e-05
were O 0 6.989673284607534e-10
restored O 0 3.829880856898171e-09
to O 0 2.528864053927271e-12
both O 0 1.5197869351890603e-10
homozygous O 0 0.0038618184626102448
C5 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
deficient I-Disease 1 1.0
( O 0 3.486583182166214e-07
C5D B-Disease 1 1.0
) O 0 3.307951829123468e-11
sera O 0 2.166259172042828e-09
by O 0 1.3632858966693015e-16
addition O 0 1.3040568796045282e-15
of O 0 1.0357335575801843e-16
highly O 0 8.519354926378453e-13
purified O 0 6.163872745545973e-10
human O 0 1.8727282224961783e-10
C5 O 0 4.448074975016425e-08
. O 0 3.066652487504484e-11

In O 0 1.400752430713581e-11
specific O 0 6.130216993749382e-12
C5 O 0 4.35161018330632e-09
titrations O 0 5.589094342894896e-08
, O 0 1.5648742718310515e-11
however O 0 6.826110423435727e-12
, O 0 3.897344415509235e-13
it O 0 5.298788317842362e-12
was O 0 3.5913230722606215e-11
noted O 0 6.2076138500344324e-12
that O 0 3.110186533230447e-13
when O 0 8.018794504273397e-13
limited O 0 4.1173007792874236e-14
amounts O 0 3.4541429724208603e-15
of O 0 1.2137585087460098e-15
C5 O 0 1.1895392448835196e-09
were O 0 8.077526278058023e-13
assayed O 0 1.1822394452298823e-10
in O 0 4.876216634928975e-15
the O 0 4.724764602861064e-16
presence O 0 4.071848652524579e-14
of O 0 1.7007709543795065e-16
low O 0 5.041636379210512e-12
dilutions O 0 4.970310829577329e-09
of O 0 2.10484180676292e-14
either O 0 3.898556588666224e-09
C5D B-Disease 1 0.9999998807907104
serum O 0 3.6676490822173946e-07
, O 0 2.4316762457245698e-14
curving O 0 3.109353399755044e-11
rather O 0 1.763867126834749e-15
than O 0 8.934714624130684e-17
linear O 0 7.984607441370584e-13
dose O 0 6.9342409418637896e-12
- O 0 1.1640044483840484e-09
response O 0 1.3811830368651301e-12
plots O 0 9.773700071491476e-08
were O 0 6.353084724963765e-10
consistently O 0 1.4064151232506816e-10
obtained O 0 4.602378082861711e-15
, O 0 4.210714931725659e-17
suggesting O 0 1.7229020724066893e-15
some O 0 6.651148870791062e-17
inhibitory O 0 5.139563687833748e-12
effect O 0 3.5381610835605315e-11
. O 0 4.977579980136593e-12

Further O 0 1.5717431522954683e-10
studies O 0 3.1545540919025727e-12
suggested O 0 1.666466552426027e-12
that O 0 3.752801495666806e-14
low O 0 9.046128429668343e-12
dilutions O 0 2.047540192506858e-06
of O 0 8.684556546123545e-12
C5D B-Disease 1 1.0
serum O 0 5.387068995332811e-07
contain O 0 4.089206729306072e-13
a O 0 1.3519789332657427e-14
factor O 0 1.8226705680770422e-13
( O 0 2.3940028883844824e-15
or O 0 3.936151602682188e-14
factors O 0 8.813880072837399e-13
) O 0 5.131112565680317e-15
interfering O 0 6.334187731618646e-13
at O 0 2.7811724277737593e-12
some O 0 8.577927538437125e-16
step O 0 9.50042648717453e-12
in O 0 1.1310155658978815e-14
the O 0 2.8253058394342098e-14
hemolytic O 0 1.4763534839090653e-09
assay O 0 1.89791290322594e-11
of O 0 1.847741388063054e-15
C5 O 0 1.2599506993282716e-09
, O 0 1.7813417299387957e-13
rather O 0 1.131122927323946e-15
than O 0 3.408200117120024e-16
a O 0 5.963445256135019e-15
true O 0 1.836324874712053e-13
C5 O 0 3.0705579745493594e-10
inhibitor O 0 3.520572999793359e-10
or O 0 1.0233957778438274e-12
inactivator O 0 2.3464187961508287e-06
. O 0 9.334819028872232e-11

Of O 0 1.0478592819829213e-11
clinical O 0 8.614604212198174e-07
interest O 0 4.457195897089594e-12
are O 0 2.8974094174252785e-13
( O 0 5.909201350896148e-14
a O 0 5.0119471425727827e-14
) O 0 1.1760342659016161e-14
the O 0 1.3579301867531514e-15
documentation O 0 6.59706872463417e-11
of O 0 3.046349793516673e-13
membranous O 1 0.9999986886978149
glomerulonephritis B-Disease 1 1.0
, O 0 1.4119600564299617e-05
vasculitis B-Disease 1 1.0
, O 0 4.196919007881661e-07
and O 0 0.004410523921251297
arthritis B-Disease 1 1.0
in O 0 1.2366148903486529e-11
an O 0 2.1894668695253416e-13
individual O 0 3.8233405699229783e-13
lacking O 0 1.962134343891364e-10
C5 O 0 2.019838296618559e-09
( O 0 2.4694796649737082e-14
and O 0 4.167455632973424e-14
its O 0 3.4203910388133814e-16
biologic O 0 5.15785192334306e-11
functions O 0 1.5250354147913758e-12
) O 0 1.2812866815713891e-13
, O 0 1.3676327865336235e-12
and O 0 1.4517738400332547e-10
( O 0 1.2564331085956892e-12
b O 0 1.7078253478075567e-08
) O 0 1.3513518112474193e-15
a O 0 9.189861726620666e-16
remarkable O 0 4.529350798501003e-14
propensity O 0 1.3071928262053945e-10
to O 0 2.6747807524429845e-08
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 2.1787450316113066e-12
the O 0 7.063019467250589e-14
proband O 0 1.4803780423733315e-08
, O 0 6.873528710180793e-14
even O 0 6.00892491146865e-14
during O 0 1.3619513909669465e-14
periods O 0 3.6149745306565673e-13
of O 0 4.034972138782643e-17
low O 0 2.188065267166861e-12
- O 0 1.5347592988157466e-11
dose O 0 1.2960192272669369e-13
or O 0 6.685085245822806e-16
alternate O 0 1.0422132585121216e-13
- O 0 1.9930410100066354e-10
day O 0 9.800964022570885e-14
corticosteroid O 0 5.154530136053381e-10
therapy O 0 4.4988443526072786e-11
. O 0 1.4679738273484094e-14

Other O 0 1.2111194208977438e-12
observations O 0 1.3540043218573938e-11
indicate O 0 2.6646129747120995e-11
that O 0 3.6431464399064306e-13
the O 0 1.4476855044603942e-12
C5D B-Disease 1 1.0
state O 0 8.052271523173449e-12
is O 0 1.7418693847330233e-14
compatible O 0 5.049477004061276e-13
with O 0 2.2059784554606665e-13
normal O 0 2.468072135553001e-10
coagulation O 0 3.422148328602326e-11
function O 0 4.5106005042150343e-10
and O 0 1.774879375415761e-11
the O 0 1.641859018804582e-14
capacity O 0 1.3395479624351333e-14
to O 0 4.503608535497703e-15
mount O 0 1.6348773029806196e-11
a O 0 4.4193666087766204e-11
neutrophilic O 0 0.0009704465046525002
leukocytosis O 0 0.002443496137857437
during O 0 3.3577671754159155e-09
pyogenic B-Disease 0 0.037932779639959335
infection I-Disease 1 0.9788706302642822
. O 0 1.5915341960992535e-12
. O 0 1.1749867571964057e-11

Susceptibility O 0 0.0009730379097163677
to O 0 1.0676152442101738e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 2.2564847313333303e-05
twins O 0 0.0002304276276845485
: O 0 5.895548806089668e-13
the O 0 4.0718210498384103e-16
role O 0 2.7814613812052538e-14
of O 0 4.598723188633868e-17
genes O 0 1.015958931566141e-11
, O 0 2.131497933613013e-14
HLA O 0 3.7816630538145546e-07
, O 0 5.5518012062605315e-12
and O 0 1.6372207409243167e-11
the O 0 2.6321403823886813e-13
environment O 0 1.1217973217014787e-09
. O 0 5.389546014339386e-12

OBJECTIVE O 0 3.860986641512909e-09
To O 0 1.8728584221666678e-12
determine O 0 3.2071845179615366e-12
the O 0 7.50281201777241e-15
relative O 0 2.8877985072672807e-13
effects O 0 8.967141265636691e-12
of O 0 7.474326723272721e-16
genetic O 0 2.9320515793074264e-08
and O 0 4.531859371277591e-13
environmental O 0 1.7290171844177443e-13
factors O 0 5.381689898950083e-15
in O 0 3.3124405013340835e-15
susceptibility O 0 1.798807431896421e-07
to O 0 4.387256780091775e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 1.0960853842334473e-06
AS B-Disease 1 0.9999986886978149
) O 0 1.1060698364151467e-11
. O 0 3.822650095769431e-12

METHODS O 0 5.555908046517288e-06
Twins O 0 7.481639386242023e-06
with O 0 5.4182201260355445e-12
AS B-Disease 1 0.9999911785125732
were O 0 5.982293653505888e-13
identified O 0 4.352184845152207e-12
from O 0 9.21545376833077e-16
the O 0 1.190601436884542e-13
Royal O 0 1.8218235808831196e-08
National O 0 9.723848462539486e-12
Hospital O 0 1.5201689507193805e-07
for O 0 4.0068648269123153e-13
Rheumatic B-Disease 1 0.997602641582489
Diseases I-Disease 0 0.006882959045469761
database O 0 4.123891628182719e-08
. O 0 3.091212841255242e-10

Clinical O 0 4.43365061073564e-05
and O 0 3.8810135660760636e-11
radiographic O 0 6.839736670372076e-06
examinations O 0 6.857612788735423e-08
were O 0 8.817293141276383e-13
performed O 0 8.824301012122504e-11
to O 0 4.545552167089725e-14
establish O 0 2.0368985664820372e-10
diagnoses O 0 0.0005652228719554842
, O 0 3.2988300979752694e-10
and O 0 2.3988661723706173e-07
disease O 0 0.034513846039772034
severity O 0 8.277348584329047e-09
was O 0 4.83943961293587e-12
assessed O 0 1.4422877226295122e-14
using O 0 1.1761060942955433e-14
a O 0 1.5735165720311833e-13
combination O 0 1.5205305547646986e-12
of O 0 7.031075970161322e-16
validated O 0 2.460665449177668e-09
scoring O 0 1.21617632631299e-10
systems O 0 6.821782583266156e-10
. O 0 2.8300023782734662e-11

HLA O 0 4.083156909473473e-06
typing O 0 1.0392150073812445e-07
for O 0 6.377658004572823e-14
HLA O 0 7.787130584802071e-07
- O 0 7.074878283219732e-08
B27 O 0 5.021544846606218e-10
, O 0 4.962038606067844e-14
HLA O 0 3.5573348711182007e-09
- O 0 2.1733351229791253e-10
B60 O 0 2.4881588109315622e-11
, O 0 3.338038260516582e-15
and O 0 1.099778176649269e-14
HLA O 0 2.9187606997993498e-08
- O 0 2.395673881494531e-08
DR1 O 0 4.4061227526981384e-05
was O 0 2.899544970444423e-12
performed O 0 1.3992042388003695e-14
by O 0 6.3768536289988854e-18
polymerase O 0 1.7205567482900253e-12
chain O 0 1.4761239106042545e-11
reaction O 0 1.9173505556684123e-14
with O 0 4.363629723519029e-16
sequence O 0 1.6882674078178006e-11
- O 0 1.1739450557490816e-11
specific O 0 3.198218108396841e-15
primers O 0 2.3127795512056792e-10
, O 0 9.623246345841566e-14
and O 0 3.996095988834103e-13
zygosity O 0 6.618889325515909e-10
was O 0 3.1737259304984167e-13
assessed O 0 8.784361643781615e-16
using O 0 3.076601541346542e-14
microsatellite O 0 6.659074358594808e-08
markers O 0 1.2296064824113273e-06
. O 0 1.192082543788331e-10

Genetic O 0 0.00013066148676443845
and O 0 2.2310762178706645e-12
environmental O 0 3.192533585584523e-14
variance O 0 1.1969763084895314e-14
components O 0 4.634372399725528e-11
were O 0 3.733286683266224e-12
assessed O 0 4.0481853980089966e-13
with O 0 2.626236494983683e-14
the O 0 5.19629505440003e-14
program O 0 5.730427417305339e-12
Mx O 0 1.2773332391802228e-10
, O 0 5.048879179324411e-17
using O 0 1.1297209289775625e-16
data O 0 2.486262098164247e-14
from O 0 1.143177238484779e-16
this O 0 9.991412265684257e-14
and O 0 7.875052693284701e-11
previous O 0 6.794471235638255e-11
studies O 0 4.634750049026248e-12
of O 0 3.038876282062612e-16
twins O 0 9.993734238378238e-06
with O 0 1.4707617068676626e-11
AS B-Disease 1 0.9999984502792358
. O 0 2.670465515386411e-10

RESULTS O 0 1.982879211936961e-06
Six O 0 4.751091881027847e-11
of O 0 7.021992494714085e-15
8 O 0 1.0777032599662562e-09
monozygotic O 0 1.2575185337482253e-07
( O 0 1.6560553275923873e-11
MZ O 1 0.9973030090332031
) O 0 1.5921862717149793e-09
twin O 0 0.0018565517384558916
pairs O 0 1.3607732398668304e-05
were O 0 1.8771428855757222e-08
disease O 0 0.00032233877573162317
concordant O 0 1.5262512365055159e-09
, O 0 9.600357835093387e-12
compared O 0 1.3541359873692205e-11
with O 0 8.954015480455713e-12
4 O 0 5.587958984420993e-10
of O 0 6.317519004130946e-15
15 O 0 6.064326818489008e-11
B27 O 0 2.5810089621103316e-09
- O 0 4.484421722850129e-09
positive O 0 7.724609119670253e-14
dizygotic O 0 3.315316771113075e-11
( O 0 9.306675405101796e-15
DZ O 0 3.884448318558498e-08
) O 0 2.3427982644153023e-13
twin O 0 4.844159917638535e-08
pairs O 0 2.0090779734305286e-11
( O 0 1.6696942155172527e-14
27 O 0 3.8864581691777644e-11
% O 0 2.351373414215068e-15
) O 0 4.5891265912150966e-14
and O 0 7.781802112416525e-12
4 O 0 1.67619026297805e-11
of O 0 2.6953140647113447e-14
32 O 0 6.197197990331915e-07
DZ O 0 0.4771135449409485
twin O 0 7.532179006375372e-05
pairs O 0 4.0220471397844904e-10
overall O 0 4.490134306034399e-11
( O 0 1.528438833831025e-13
12 O 0 9.527118677299384e-12
. O 0 1.771732039508242e-13
5 O 0 2.2101910145816417e-12
% O 0 7.074394611512446e-15
) O 0 2.93427093603707e-13
. O 0 2.537140202790722e-12

Nonsignificant O 0 2.730737833189778e-06
increases O 0 4.818647147963873e-10
in O 0 4.6314203015242195e-15
similarity O 0 7.621669137827802e-13
with O 0 5.125810986463452e-15
regard O 0 1.0118388603114897e-13
to O 0 4.863480278227694e-12
age O 0 7.950802516365485e-11
at O 0 3.300088535773682e-10
disease O 0 1.703754605841823e-05
onset O 0 2.4230075723608024e-08
and O 0 8.925544331406243e-11
all O 0 1.1471958094848994e-13
of O 0 7.466205265495328e-16
the O 0 1.3602763013209618e-11
disease O 0 8.085998160822783e-06
severity O 0 6.342297242944994e-10
scores O 0 2.7764684995545963e-10
assessed O 0 3.9432094200118895e-13
were O 0 1.6055133568101954e-12
noted O 0 3.4490714728718785e-09
in O 0 1.503081881182311e-09
disease O 1 0.7624624371528625
- O 0 0.0006111911498010159
concordant O 0 0.003859431017190218
MZ O 1 0.9999538660049438
twins O 0 4.809466554434039e-05
compared O 0 1.4457877603457625e-11
with O 0 1.3659207445670951e-11
concordant O 0 9.295497875427827e-05
DZ O 1 0.7932102680206299
twins O 0 0.0004444951773621142
. O 0 3.666670786439674e-11

HLA O 0 0.00029660534346476197
- O 0 3.577791721909307e-05
B27 O 0 5.520314516616054e-08
and O 0 3.4628821077992145e-12
B60 O 0 4.2851701353985305e-11
were O 0 5.239028205402188e-14
associated O 0 4.128414732469665e-13
with O 0 6.597967614971334e-13
the O 0 5.788056492428417e-11
disease O 0 8.806124242255464e-05
in O 0 9.543381303310852e-15
probands O 0 3.1091806818039913e-07
, O 0 6.774668499798242e-12
and O 0 5.151635628503071e-12
the O 0 1.2638449856973433e-13
rate O 0 1.0136735895116544e-10
of O 0 1.7749570115757943e-15
disease O 0 1.382011305395281e-07
concordance O 0 1.373742591036231e-12
was O 0 1.1221594400229185e-12
significantly O 0 2.0766478814326916e-11
increased O 0 2.2856714351066065e-12
among O 0 5.556427713770962e-13
DZ O 1 0.7492080330848694
twin O 0 0.0017903493717312813
pairs O 0 1.8247579003372039e-09
in O 0 1.0683934206084933e-12
which O 0 9.206781864667946e-11
the O 0 1.4919032806023913e-12
co O 0 9.844447959039826e-06
- O 0 2.02157366402389e-06
twin O 0 1.2692649988821358e-06
was O 0 2.3434174739600522e-11
positive O 0 2.4840945832038707e-15
for O 0 6.253872137837258e-18
both O 0 1.2882656909556783e-13
B27 O 0 7.306852456423485e-09
and O 0 3.3960223522200295e-11
DR1 O 0 0.0014542926801368594
. O 0 8.504639353867915e-11

Additive O 0 9.05065911105396e-10
genetic O 0 8.762237158066455e-09
effects O 0 6.061343787999718e-11
were O 0 1.7166704933653867e-14
estimated O 0 2.191604916209483e-14
to O 0 1.8757817022742318e-13
contribute O 0 4.4075008399924176e-13
97 O 0 3.772660517320503e-10
% O 0 5.45660572796999e-15
of O 0 4.178090597494323e-17
the O 0 3.1637581823003996e-14
population O 0 6.454891146329828e-14
variance O 0 6.8529448608856125e-12
. O 0 1.6123637147646974e-11

CONCLUSION O 0 2.682227995265407e-09
Susceptibility O 0 2.1132127585588023e-06
to O 0 4.414712151401545e-09
AS B-Disease 1 0.9999994039535522
is O 0 3.5113351028875917e-12
largely O 0 1.8148003716120242e-12
genetically O 0 2.0543547418760966e-10
determined O 0 1.619032019561928e-08
, O 0 3.937634940331947e-12
and O 0 5.386822498482102e-12
the O 0 1.153402223177339e-14
environmental O 0 4.052397740289537e-12
trigger O 0 8.18702536320437e-11
for O 0 1.348414788030286e-14
the O 0 1.20866067154779e-10
disease O 0 0.00024512442178092897
is O 0 1.0561470860197264e-13
probably O 0 9.499773363785824e-12
ubiquitous O 0 3.401776194067452e-09
. O 0 2.8064761625756773e-10

HLA O 0 0.0003478489816188812
- O 0 1.9226836229790933e-05
B27 O 0 6.836453181335855e-09
accounts O 0 3.3469033751051813e-13
for O 0 1.327991886641787e-16
a O 0 6.3045183189400136e-15
minority O 0 2.7664853914644016e-12
of O 0 3.1861247543110954e-16
the O 0 6.313438677017433e-14
overall O 0 6.0740943524928426e-12
genetic O 0 9.801371519957414e-11
susceptibility O 0 3.778954649202859e-10
to O 0 2.9725225753063356e-11
AS B-Disease 1 0.9999983310699463
. O 0 8.465251832845411e-10

Cell O 0 0.001709161326289177
cycle O 0 1.1525814443302806e-05
- O 0 1.3488763670466142e-06
dependent O 0 3.024054617828398e-10
colocalization O 0 1.674275473817488e-08
of O 0 3.61849730680288e-14
BARD1 O 0 2.8696538265648996e-06
and O 0 2.6352071566537738e-11
BRCA1 O 0 6.976034749861526e-10
proteins O 0 6.790399405959269e-12
in O 0 8.793615478730368e-16
discrete O 0 3.027960521206907e-11
nuclear O 0 5.924979973315203e-07
domains O 0 3.5344903892564616e-08
. O 0 5.371322830960423e-11

Germ O 0 0.08480747044086456
- O 0 0.013122623786330223
line O 0 7.730054676358122e-07
mutations O 0 4.741932957408324e-10
of O 0 1.2839071304596508e-16
the O 0 9.938914518866152e-14
BRCA1 O 0 4.145435106295281e-09
gene O 0 3.681009663747403e-10
predispose O 0 4.014934218421473e-10
women O 0 9.914764322049852e-12
to O 0 1.633239306601461e-13
early O 0 2.5491251331999365e-09
- O 1 0.9139084815979004
onset O 1 0.9974168539047241
breast B-Disease 1 0.9999995231628418
and I-Disease 1 0.999998927116394
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.3382200688837227e-14
compromising O 0 9.944850498655455e-10
the O 0 3.2061736620660197e-13
genes O 0 2.478951488527059e-10
presumptive O 0 1.2419527906093464e-10
function O 0 2.3356074019265094e-12
as O 0 3.1359002851047424e-14
a O 0 7.64683075974576e-13
tumor B-Disease 0 8.699677067625089e-08
suppressor O 0 2.3030696638670634e-07
. O 0 3.306149520820867e-10

Although O 0 2.549206401525339e-10
the O 0 3.234691431808906e-14
biochemical O 0 3.326820069426972e-11
properties O 0 1.0282936828420741e-11
of O 0 1.976839585378213e-15
BRCA1 O 0 3.685136817921375e-08
polypeptides O 0 4.282200372074385e-09
are O 0 3.0468104168096533e-12
not O 0 2.4618834748579843e-11
understood O 0 3.518743456332185e-12
, O 0 7.729914934051854e-14
their O 0 2.1424663326535982e-14
expression O 0 3.598203278300932e-13
pattern O 0 2.5974740136547325e-09
and O 0 1.4105267518230158e-12
subcellular O 0 1.143986771978689e-08
localization O 0 7.763378134795218e-11
suggest O 0 4.3084103992785394e-12
a O 0 1.1417052910988202e-14
role O 0 8.320402201424104e-13
in O 0 6.544883992404271e-14
cell O 0 2.0490470831191487e-07
- O 0 4.736080427392153e-06
cycle O 0 5.5309165247763303e-08
regulation O 0 7.092029741251338e-10
. O 0 2.776524019379445e-12

When O 0 6.54887344353483e-08
resting O 0 2.3171078389339073e-09
cells O 0 2.2441284941443485e-11
are O 0 1.2004056907830799e-14
induced O 0 1.4675098913841111e-09
to O 0 2.987821307639388e-13
proliferate O 0 2.2116594777799037e-07
, O 0 7.240012083777059e-13
the O 0 9.07757687919862e-14
steady O 0 2.3166812218589072e-11
- O 0 9.062297440243228e-11
state O 0 7.780611007909832e-13
levels O 0 3.889070123342005e-14
of O 0 3.905951815559072e-18
BRCA1 O 0 5.569428165180801e-12
increase O 0 4.415134355970215e-16
in O 0 2.906837345173263e-16
late O 0 1.968725475611638e-13
G1 O 0 4.8267025792858576e-11
and O 0 1.0327701964029518e-13
reach O 0 1.2162944195109708e-14
a O 0 2.189622123253035e-16
maximum O 0 1.8720768563959067e-15
during O 0 3.489008669650684e-13
S O 0 1.7246630790168638e-09
phase O 0 4.141732096174522e-11
. O 0 2.0217237172576175e-12

Moreover O 0 4.575713141719007e-09
, O 0 3.168495847638564e-12
in O 0 2.839369364626698e-13
S O 0 5.065029640149987e-08
phase O 0 2.1476780423523856e-11
cells O 0 2.3626937212251065e-11
, O 0 3.901194552949003e-14
BRCA1 O 0 2.9992625050212496e-10
polypeptides O 0 2.8878580082825067e-10
are O 0 4.82181189507408e-13
hyperphosphorylated O 0 1.1952270995152503e-07
and O 0 5.019282905971423e-11
accumulate O 0 8.462858192004319e-11
into O 0 1.1928335381071464e-13
discrete O 0 9.246592935774345e-10
subnuclear O 0 3.4279235023859655e-06
foci O 0 9.185833249603093e-08
termed O 0 2.506452156936234e-09
" O 0 1.0601691052825046e-10
BRCA1 O 0 1.3931606979156186e-08
nuclear O 0 1.615540057287035e-08
dots O 0 4.237216444380465e-08
. O 0 3.0664842887162536e-10

" O 0 1.4320292507363774e-08
BRCA1 O 0 3.9149077224465145e-07
associates O 0 1.4490642463727e-08
in O 0 3.7783003722230424e-13
vivo O 0 1.7715582600885682e-07
with O 0 9.752685177456463e-14
a O 0 2.800579050350055e-13
structurally O 0 4.463634351026258e-09
related O 0 1.3807550935940327e-10
protein O 0 2.877352187624638e-07
termed O 0 3.6813295878346253e-07
BARD1 O 0 0.0004922949592582881
. O 0 3.7594433122123405e-10

Here O 0 5.2467816757939545e-09
we O 0 7.368831933529663e-11
show O 0 1.8494084302184133e-12
that O 0 2.8142590051427087e-14
the O 0 1.7281548413499684e-15
steady O 0 2.079084300554701e-12
- O 0 5.524813939672413e-11
state O 0 4.86872207047101e-13
levels O 0 1.0415018185990638e-13
of O 0 1.1979565466321643e-17
BARD1 O 0 3.996294406505285e-09
, O 0 4.7971397565556816e-15
unlike O 0 3.1651584971688004e-14
those O 0 1.9188192049198328e-16
of O 0 2.5218443932083817e-17
BRCA1 O 0 4.632901173806658e-09
, O 0 1.0293901148150653e-12
remain O 0 3.4676325396179597e-13
relatively O 0 1.1504315939280235e-14
constant O 0 4.41347370976064e-13
during O 0 3.861855225797267e-13
cell O 0 2.1830466323535802e-08
cycle O 0 2.161369749842379e-08
progression O 0 2.2450910464044682e-08
. O 0 9.234229700338936e-12

However O 0 1.9730347133872783e-08
, O 0 7.722319311787018e-12
immunostaining O 0 4.1043730902856623e-07
revealed O 0 2.1566082253343666e-09
that O 0 8.158786146683639e-13
BARD1 O 0 6.650290060861153e-07
resides O 0 3.3571764812556637e-10
within O 0 9.549977995904069e-14
BRCA1 O 0 1.9189567990185452e-10
nuclear O 0 8.744648061220772e-11
dots O 0 5.5973860962899025e-11
during O 0 3.86362556531461e-12
S O 0 3.0122435656920743e-09
phase O 0 6.744623848135844e-13
of O 0 7.716085675937961e-17
the O 0 4.1748387109548715e-14
cell O 0 2.5140900916653663e-08
cycle O 0 3.4286051775467286e-10
, O 0 2.2171500322943098e-15
but O 0 2.7005267054687476e-14
not O 0 3.567189471869077e-15
during O 0 2.0166051882134016e-16
the O 0 1.8721830266818891e-16
G1 O 0 5.7732048308611894e-11
phase O 0 6.92263781021385e-12
. O 0 1.949159150055335e-12

Nevertheless O 0 3.479318877452897e-07
, O 0 2.462216888710067e-11
BARD1 O 0 1.0921687731979546e-07
polypeptides O 0 1.1356450890787073e-08
are O 0 3.884566279754864e-12
found O 0 1.5291072444703624e-12
exclusively O 0 9.905393020571973e-15
in O 0 7.964522054024203e-15
the O 0 1.7097030756269807e-15
nuclear O 0 3.308303500940135e-12
fractions O 0 3.80823514338339e-15
of O 0 1.1486276308025645e-17
both O 0 2.933178195772476e-14
G1 O 0 1.5093007399435976e-10
- O 0 6.559083942647703e-09
and O 0 1.454237702480654e-10
S O 0 1.0113937243261262e-08
- O 0 3.1070723771620123e-10
phase O 0 3.547256238745078e-11
cells O 0 5.0128731027276885e-11
. O 0 1.7777515570749358e-12

Therefore O 0 7.498996423827009e-10
, O 0 6.714639694954672e-13
progression O 0 4.3183305820093665e-09
to O 0 3.3585737272898153e-13
S O 0 1.499781348002216e-07
phase O 0 1.2582090924695422e-10
is O 0 1.443945332225971e-13
accompanied O 0 1.131821741363892e-12
by O 0 5.345696927922406e-16
the O 0 9.492906821742205e-16
aggregation O 0 7.132063494473539e-13
of O 0 7.671800808222036e-16
nuclear O 0 1.2589591591449789e-08
BARD1 O 0 2.3943982352392368e-09
polypeptides O 0 2.7440066885375813e-10
into O 0 6.429167961896631e-12
BRCA1 O 0 6.193952017952142e-09
nuclear O 0 3.176063856358269e-09
dots O 0 9.416659452199383e-09
. O 0 1.435539048744161e-10

This O 0 4.233727951552524e-11
cell O 0 4.392599066704861e-07
cycle O 0 4.88409057197714e-07
- O 0 3.3365134299856436e-07
dependent O 0 1.3929654651967383e-10
colocalization O 0 3.92417724981442e-08
of O 0 4.18363125176055e-14
BARD1 O 0 8.985647582449019e-06
and O 0 1.1022415619121873e-10
BRCA1 O 0 5.983435968914819e-09
indicates O 0 2.952285497234003e-13
a O 0 8.713541219061683e-16
role O 0 3.3337723315436663e-13
for O 0 1.9045851338785795e-15
BARD1 O 0 1.117171350983881e-07
in O 0 1.3800691275531185e-12
BRCA1 O 0 9.888735803542659e-07
- O 0 1.8999170379174757e-06
mediated O 0 1.7674406649348384e-07
tumor B-Disease 0 2.8703661314466444e-07
suppression O 0 1.3240460949859312e-09
. O 0 6.73457886679607e-11

Ethnic O 0 2.0688712254468555e-07
differences O 0 2.393920794929727e-07
in O 0 8.847836200677472e-13
the O 0 3.5970917000235914e-13
HFE O 0 1.7475454114901368e-06
codon O 0 6.274690544927353e-09
282 O 0 1.9339482792979368e-10
( O 0 5.414240561961436e-13
Cys O 0 0.001860758988186717
/ O 0 6.959859319977113e-07
Tyr O 0 2.252437347749492e-09
) O 0 9.457387130373807e-14
polymorphism O 0 1.9476485701996893e-10
. O 0 1.5525986746256493e-11

Recent O 0 7.652785072309598e-09
studies O 0 3.1635594144319157e-10
have O 0 9.49781746306666e-12
shown O 0 8.395185588372378e-12
that O 0 1.738595223343964e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 5.623065746362954e-08
HH B-Disease 0 0.01754956692457199
) O 0 6.449799461877292e-13
is O 0 6.025486099653365e-14
likely O 0 3.5868716850850912e-12
to O 0 4.79492205489318e-13
be O 0 7.914375535142404e-13
caused O 0 1.8961198442520727e-13
by O 0 4.474119612834636e-16
homozygosity O 0 2.4166921797075247e-09
for O 0 1.1734479990279409e-15
a O 0 2.323072832190187e-13
Cys282Tyr O 0 1.3509336440620245e-06
mutation O 0 1.7393108064922558e-09
in O 0 4.9691228508255e-14
the O 0 9.508773569965115e-14
HFE O 0 7.490675670851488e-07
gene O 0 4.987005031154013e-09
located O 0 1.2752962019746406e-09
4 O 0 8.915697069511452e-10
. O 0 2.4248252711300822e-11

5 O 0 1.6207830633163667e-09
Mb O 0 1.2204652932723548e-07
telomeric O 0 2.3452901587006636e-05
to O 0 1.904644497674468e-10
HLA O 0 5.85092966502998e-05
- O 0 1.8098724467563443e-05
A O 0 8.142832519375531e-10
. O 0 1.5961891530746897e-11

Population O 0 6.298425669903907e-11
studies O 0 1.539516777948613e-12
of O 0 5.982050248794676e-18
this O 0 5.026992311188503e-16
polymorphism O 0 1.1135633214143237e-11
are O 0 4.5833333940756456e-15
facilitated O 0 1.6964264194785361e-12
by O 0 4.2720712323327924e-15
the O 0 1.151748984270888e-14
fact O 0 2.731782627798246e-13
that O 0 3.984601209638776e-14
the O 0 7.248212548552607e-15
Cys282Tyr O 0 9.756247720815736e-08
mutation O 0 1.7993875486843613e-11
creates O 0 1.7684099085264748e-13
a O 0 2.3368538549541074e-13
Rsal O 0 3.450046648367788e-08
restriction O 0 1.4166789963354631e-09
site O 0 8.721183220039563e-10
. O 0 1.923785956925439e-11

We O 0 1.8027949977295066e-07
have O 0 2.3194423812156195e-13
studied O 0 1.4712155105289781e-12
the O 0 4.7754489368423934e-15
codon O 0 1.0007467077244314e-10
282 O 0 2.4780802410084846e-11
( O 0 1.5402795412820108e-13
Cys O 0 0.00026097201043739915
/ O 0 1.6987880258056975e-07
Tyr O 0 7.393610723660515e-11
) O 0 1.4716931701956267e-15
polymorphism O 0 2.8329929548098765e-12
in O 0 5.114268044974744e-15
different O 0 1.0014281647040355e-14
ethnic O 0 7.238855782160103e-12
groups O 0 1.288525102588478e-11
. O 0 4.667369355587647e-12

In O 0 8.176393589964803e-12
agreement O 0 4.212565626188214e-12
with O 0 5.0518925387389377e-14
previous O 0 2.9989774769437205e-13
observations O 0 6.653712953871849e-13
the O 0 4.1203549259853384e-15
Tyr O 0 1.5187025248497577e-11
allele O 0 3.6298500555136115e-13
appeared O 0 1.2853959563408068e-10
to O 0 1.123345326806656e-13
be O 0 8.532832372534077e-14
rare O 0 5.322267366408839e-12
or O 0 2.8177274749574543e-11
absent O 0 2.771685381208755e-10
in O 0 9.139812387828905e-13
Asiatic O 0 5.5939439747021424e-09
( O 0 5.884959606758909e-15
Indian O 0 5.777820236141373e-11
, O 0 3.531125858293599e-13
Chinese O 0 1.6925546251003731e-12
) O 0 1.024131341255223e-13
populations O 0 1.7020603676476398e-11
. O 0 1.9483711519163727e-12

The O 0 1.1150845871665815e-12
highest O 0 7.72596115366066e-15
allele O 0 7.401161796058084e-14
frequency O 0 3.0084780153205593e-12
( O 0 9.246340401235925e-15
7 O 0 1.6266276520182643e-12
. O 0 1.9002825029680592e-14
5 O 0 1.5192463172913895e-12
% O 0 2.896036351606791e-15
) O 0 2.1713582876712635e-14
was O 0 6.10210562634883e-11
found O 0 9.484167791395937e-12
in O 0 7.904207887168835e-13
Swedes O 0 2.1549871235038154e-05
. O 0 3.3382362846223756e-11

Saamis O 0 3.1586662316840375e-06
( O 0 5.471934537426559e-12
2 O 0 5.067173677181236e-12
% O 0 6.167455682580059e-15
) O 0 1.667262892145454e-14
and O 0 1.8305105695115564e-12
Mordvinians O 0 4.6725719471396587e-07
( O 0 1.849402927892388e-14
1 O 0 4.027397041079031e-14
. O 0 3.304718017250671e-14
8 O 0 8.533178504077643e-13
% O 0 1.0361010242955048e-16
) O 0 1.3102948537445825e-15
had O 0 5.217563794207569e-12
significantly O 0 2.304534167663075e-12
lower O 0 1.3041675486942517e-13
frequencies O 0 1.2359297613118159e-13
of O 0 7.891422157764092e-16
the O 0 3.318247166297396e-14
Tyr O 0 3.8682820835411746e-10
allele O 0 8.686809084557101e-12
. O 0 5.556196995548657e-12

Comparisons O 0 2.07177885958032e-10
with O 0 5.569709529197088e-14
allele O 0 5.880062604358971e-13
frequencies O 0 2.2838748578966894e-13
based O 0 4.43680025173903e-14
on O 0 9.078273614619714e-13
prevalence O 0 1.339953712431452e-07
estimates O 0 3.587707908536686e-11
of O 0 2.5287699384024358e-14
HH B-Disease 1 0.9408549070358276
showed O 0 7.448824135281029e-07
some O 0 2.3078086886169427e-14
disagreements O 0 2.460514014757109e-10
with O 0 2.1012796944065368e-14
the O 0 3.401149414867079e-15
RFLP O 0 1.924777837114533e-10
data O 0 2.6357223153160303e-13
, O 0 7.165845370695704e-15
particularly O 0 1.6618528927113407e-14
in O 0 1.2207644834241749e-13
Finns O 0 8.452076372122974e-07
. O 0 1.8470123000491334e-11

The O 0 1.5176318535203848e-10
newly O 0 1.3966046374935814e-10
described O 0 3.909774934363064e-11
HFE O 0 1.073781135119134e-07
marker O 0 1.6052310591874175e-09
provides O 0 2.394131849150702e-14
a O 0 4.881276174481162e-16
new O 0 2.1272728485688137e-15
approach O 0 5.599376756530716e-13
to O 0 6.877954118517018e-16
the O 0 1.0652656921584505e-16
screening O 0 1.2540228404300802e-11
of O 0 4.2992709028721163e-17
HH B-Disease 0 4.322368567954982e-06
as O 0 9.562747295410734e-12
well O 0 2.5572731866124743e-12
as O 0 8.650936548061997e-14
studies O 0 3.2482390800551986e-13
of O 0 2.1075050335281704e-18
the O 0 1.1395640341598087e-15
relationship O 0 6.084921520647935e-13
between O 0 2.1811211894213166e-14
the O 0 1.5259534019945557e-14
HFE O 0 5.5505207541273194e-08
Tyr O 0 1.0073440692703883e-10
allele O 0 2.3660623807431058e-11
and O 0 4.4172093066618956e-11
different O 0 3.445484522690556e-11
disorders O 0 5.886007329536369e-06
including O 0 8.299916309795208e-11
cancer B-Disease 0 0.00457974337041378

Autosomal B-Disease 1 0.9999641180038452
dominant I-Disease 1 0.9999096393585205
neurohypophyseal I-Disease 1 0.9999845027923584
diabetes I-Disease 1 0.9999995231628418
insipidus I-Disease 1 0.9999337196350098
associated O 0 1.812766640796326e-06
with O 0 3.4010249044119645e-12
a O 0 1.0069319510142005e-12
missense O 0 1.2151438966157002e-07
mutation O 0 6.222126286425933e-11
encoding O 0 9.904652618908383e-12
Gly23 O 0 3.01532008961658e-06
- O 0 4.390343292470789e-06
- O 0 1.0578669389360584e-05
> O 0 6.143722419693631e-09
Val O 0 6.887610652484e-06
in O 0 1.979646264624324e-12
neurophysin O 0 1.335957335868443e-07
II O 0 2.0660871768996003e-07
. O 0 1.9798548217542233e-11

Autosomal B-Disease 1 0.9999706745147705
dominant I-Disease 1 0.9998795986175537
neurohypophyseal I-Disease 1 0.9999781847000122
diabetes I-Disease 1 0.9999983310699463
insipidus I-Disease 1 0.9999047517776489
( O 0 7.674199054008568e-09
ADNDI B-Disease 0 0.0008251497056335211
) O 0 6.156983950456052e-11
is O 0 6.728621132490176e-11
an O 0 8.946465790415914e-09
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.1014886780458255e-07
by O 0 1.9451692860605885e-13
progressive O 0 2.5328565911308942e-08
degeneration O 0 0.3492489755153656
of O 0 2.1061308215020516e-14
the O 0 4.474860152564597e-13
magnocellular O 0 2.255090691960504e-08
neurons O 0 1.2929052273236152e-10
of O 0 8.702446675639428e-16
the O 0 9.990930642750449e-15
hypothalamus O 0 1.7652405578938435e-11
leading O 0 3.523627917223493e-11
to O 0 2.8792736966355703e-13
decreased O 0 3.584784247223638e-09
ability O 0 4.4160546747162854e-11
to O 0 4.299140524913897e-13
produce O 0 1.04193758655724e-12
the O 0 1.3400341762875162e-13
hormone O 0 5.966954903270649e-13
arginine O 0 2.3412270386269363e-12
vasopressin O 0 1.4762462899244738e-13
( O 0 8.76030611983783e-15
AVP O 0 1.9810986184864987e-10
) O 0 4.595891267382413e-13
. O 0 2.793565075445703e-12

Affected O 0 3.659166338820796e-07
individuals O 0 3.4350343749989243e-13
are O 0 4.54081217071689e-14
not O 0 1.4483594445308112e-12
symptomatic O 0 3.2979491360052293e-10
at O 0 5.009109238507392e-10
birth O 0 1.0294113339526234e-09
, O 0 2.913216889943726e-11
but O 0 2.213384853178013e-08
usually O 0 6.847221811767668e-08
develop O 0 2.6134357540286146e-06
diabetes B-Disease 1 0.9971907734870911
insipidus I-Disease 1 0.8602812886238098
at O 0 7.312243610613223e-07
1 O 0 6.186184720036181e-08
- O 0 0.12763981521129608
6 O 0 2.5475562992482992e-08
yr O 0 2.9723908667733667e-08
of O 0 1.485427957666121e-14
age O 0 4.908925002600206e-11
. O 0 7.441393963698861e-13

The O 0 2.2692655046729904e-11
genetic O 0 1.1184261294872044e-09
locus O 0 7.463885412506421e-12
of O 0 2.479362337182503e-14
the O 0 1.912851432805951e-09
disease O 0 0.017141181975603104
is O 0 6.803798247457388e-14
the O 0 4.658550766824775e-14
AVP O 0 4.884975624008803e-07
- O 0 1.7717587752485997e-06
neurophysin O 0 1.4882506320645916e-06
II O 0 1.0438616016017477e-07
( O 0 1.0137895094263806e-14
NPII O 0 3.2779814973515897e-10
) O 0 2.6909925449661006e-15
gene O 0 2.468918298970113e-11
, O 0 2.894531673808959e-13
and O 0 2.6357789648795427e-12
mutations O 0 3.5965228573076047e-09
that O 0 2.6647742172591915e-12
cause O 0 2.5493850086544256e-11
ADNDI B-Disease 0 1.747887154124328e-06
have O 0 3.8275566049961185e-10
been O 0 1.6694205740019896e-10
found O 0 7.619652304946545e-12
in O 0 6.99515044413207e-15
both O 0 1.7733403856684885e-14
the O 0 2.1875683330537394e-16
signal O 0 3.1916123101994416e-15
peptide O 0 1.5423623995344739e-15
of O 0 2.1705754872838074e-18
the O 0 4.649210110998928e-15
prepro O 0 6.4700684809793074e-09
- O 0 2.644989116618035e-09
AVP O 0 1.0019796548021986e-08
- O 0 1.2350273026484615e-09
NPII O 0 1.3031631329596394e-09
precursor O 0 4.5345073182434525e-12
and O 0 1.157383217043062e-12
within O 0 1.261064278175461e-12
NPII O 0 4.024745408059971e-07
itself O 0 3.7320854739952836e-11
. O 0 6.5786699005032645e-12

An O 0 7.678286825796299e-12
affected O 0 1.702432306238677e-09
girl O 0 2.9358513984334422e-06
who O 0 1.2997591891661386e-10
presented O 0 2.213379355015324e-13
at O 0 2.7823821805578186e-12
9 O 0 5.246916442991356e-11
months O 0 2.21304989308016e-13
of O 0 2.7967382556836956e-15
age O 0 2.9723965511152528e-08
and O 0 7.467154117257735e-10
her O 0 2.8191495804463784e-09
similarly O 0 1.1987402737112518e-10
affected O 0 1.5888370619165926e-09
younger O 0 2.8559139497730257e-09
brother O 0 4.336524028758504e-08
and O 0 3.102074708216662e-10
father O 0 3.183789620830879e-10
were O 0 5.657702496601746e-13
all O 0 7.245723965753573e-15
found O 0 1.5031713937810331e-12
to O 0 6.014497710635225e-14
have O 0 4.87415717596168e-13
a O 0 1.737340130157465e-14
novel O 0 4.93526851330639e-11
missense O 0 4.4479815386466726e-08
mutation O 0 9.468000827794754e-10
( O 0 2.4245532068579295e-14
G1758 O 0 3.0248162308232907e-10
- O 0 8.071046408986149e-08
- O 0 2.480212515365565e-07
> O 0 7.981432875725503e-11
T O 0 3.959621172611172e-11
) O 0 1.2412757471573826e-17
encoding O 0 1.3302279212736403e-16
the O 0 4.5475918462495153e-17
amino O 0 5.413233405905833e-15
acid O 0 2.6860081795879827e-15
substitution O 0 1.0174040531221989e-14
Gly23 O 0 4.747244819469643e-10
- O 0 6.15980910723124e-09
- O 0 3.2095957891442595e-08
> O 0 1.529919940734814e-10
Val O 0 2.9087857456033817e-07
within O 0 7.406690712141728e-12
NPII O 0 1.0699193353502778e-07
. O 0 1.302548000015058e-11

The O 0 3.158631689537117e-11
mutation O 0 6.413497510848742e-10
was O 0 9.810974732279987e-13
confirmed O 0 7.542200235665861e-14
by O 0 1.1557440310484807e-16
restriction O 0 7.084563491410734e-11
endonuclease O 0 2.1327136892068665e-06
analysis O 0 1.4768491984895604e-09
. O 0 3.4420293004711056e-11

A O 0 4.955567206588185e-11
T1 O 0 3.65854280204303e-09
- O 0 5.7690546784172625e-11
weighted O 0 7.698343373364891e-13
magnetic O 0 1.2591480863608645e-13
resonance O 0 2.838834852955663e-12
imaging O 0 3.038912055330911e-08
of O 0 4.576565770233673e-14
the O 0 3.994583483435399e-11
fathers O 0 8.493947767362897e-09
pituitary O 0 8.502599735393801e-10
gland O 0 9.290253982774388e-11
demonstrates O 0 5.953850693712903e-12
an O 0 2.480956622595825e-14
attenuated O 0 0.0011748989345505834
posterior O 0 0.024020392447710037
pituitary O 0 0.0006620355416089296
bright O 0 1.5635839645256056e-07
spot O 0 1.9835752027574927e-06
. O 0 6.126693041785813e-10

This O 0 3.126230177508127e-11
mutation O 0 3.7139740172165148e-09
may O 0 6.345957613562714e-12
be O 0 4.913952588003864e-16
valuable O 0 5.969200527374257e-16
for O 0 3.0038504109024624e-16
developing O 0 3.7353167434139856e-12
models O 0 5.047193218921109e-10
of O 0 6.750982151776386e-13
dominantly B-Disease 1 0.8986062407493591
inherited I-Disease 1 0.9998923540115356
neurodegeneration I-Disease 1 1.0
, O 0 1.7964049692231754e-10
as O 0 2.3755367654530388e-14
the O 0 2.736812580489585e-15
early O 0 4.150278645059791e-12
age O 0 7.041312520029985e-13
of O 0 4.9871463593373336e-17
onset O 0 1.0556663987415504e-08
of O 0 3.304995166431013e-14
symptoms O 0 1.9410513232287485e-06
suggests O 0 7.538417725336602e-14
that O 0 2.41707204246119e-15
this O 0 1.1226972788393706e-15
mutation O 0 8.549506588795275e-12
may O 0 6.65326843098113e-13
be O 0 7.309576697449392e-15
particularly O 0 1.9287870251156504e-14
deleterious O 0 3.229647105307265e-11
to O 0 3.171210473038033e-12
the O 0 1.6970372860875688e-13
magnocellular O 0 3.7680397468875526e-08
neuron O 0 1.2416840000639695e-08
. O 0 3.1698619423758956e-12
. O 0 5.656918076329953e-12

Frequent O 0 2.21106887465794e-07
inactivation O 0 2.7824412427435163e-06
of O 0 3.758024978445934e-13
PTEN O 0 1.9257918211224023e-06
/ O 0 0.0005771970609202981
MMAC1 O 0 5.5318960221484303e-05
in O 0 2.3011981209464238e-10
primary O 0 0.015938324853777885
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 6.272438124454993e-10

Sporadic B-Disease 1 0.9994182586669922
prostate I-Disease 1 0.9999901056289673
carcinoma I-Disease 1 1.0
is O 0 4.393755403953037e-08
the O 0 9.945802861843767e-13
most O 0 2.6381165047634214e-13
common O 0 9.281062030019882e-11
male B-Disease 0 4.100813910667966e-09
cancer I-Disease 0 7.985096885931853e-07
in O 0 2.7179007742322847e-13
the O 0 3.590679142906339e-11
Western O 0 0.0016900933114811778
world O 0 1.9984712551490702e-08
, O 0 1.1271919812469444e-12
yet O 0 2.8001781665967784e-13
many O 0 6.472609545633127e-17
of O 0 1.4883004778353957e-18
the O 0 6.380315909258012e-16
major O 0 7.595137761990181e-14
genetic O 0 4.252309268593102e-11
events O 0 3.661311772967975e-14
involved O 0 1.5834215720284678e-13
in O 0 3.642991466758401e-14
the O 0 1.5450816082292207e-13
progression O 0 2.1239721093024855e-08
of O 0 1.7479714683185584e-16
this O 0 1.4009180968055368e-11
often O 0 6.99685287486318e-09
fatal O 0 2.5916124286595732e-05
cancer B-Disease 0 0.00613250071182847
remain O 0 1.1536421123947704e-10
to O 0 9.999905417612531e-12
be O 0 2.8318869818577674e-11
elucidated O 0 8.121734936139546e-06
. O 0 2.991045952582816e-11

Numerous O 0 1.1965776147704332e-09
cytogenetic O 0 9.13415351533331e-05
and O 0 2.706257218321184e-09
allelotype O 0 2.491153054506867e-06
studies O 0 1.0629253033300756e-09
have O 0 1.9403606325851808e-12
reported O 0 1.3737249185408196e-11
frequent O 0 1.7281856501405457e-10
loss O 0 2.766018802891068e-10
of O 0 1.1002854223297323e-15
heterozygosity O 0 1.0518556337046903e-06
on O 0 3.1700342351115296e-10
chromosomal O 1 0.9713267683982849
arm O 0 0.0031782432924956083
10q O 0 8.21002021922368e-09
in O 0 1.2274080189722536e-11
sporadic B-Disease 1 0.9918713569641113
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 2.5622901023147904e-10

Deletion O 0 4.8909856559475884e-05
mapping O 0 6.151904585749435e-07
studies O 0 1.1403312072388871e-08
have O 0 3.149830049564706e-11
unambiguously O 0 5.897967891854705e-09
identified O 0 2.93259816430691e-09
a O 0 7.987045269955417e-13
region O 0 4.244060658464832e-11
of O 0 2.5971588703439796e-15
chromosome O 0 7.86251405315852e-07
10q23 O 0 4.135987385911477e-10
to O 0 3.256576594761612e-13
be O 0 1.1262759252788843e-13
the O 0 2.9369891240571154e-15
minimal O 0 1.5729068048031536e-10
area O 0 1.3881979121777022e-08
of O 0 8.351242738796269e-14
loss O 0 8.87310704911215e-08
. O 0 1.9988646154933676e-11

A O 0 4.776050735455506e-11
new O 0 2.7309816734433223e-12
tumor B-Disease 0 3.5164675615817487e-09
suppressor O 0 7.59366125535621e-10
gene O 0 1.4377593560155333e-09
, O 0 5.27012027767837e-13
PTEN O 0 1.3568636347827123e-07
/ O 0 8.9882334577851e-05
MMAC1 O 0 1.4604047464672476e-05
, O 0 4.7081161885786926e-11
was O 0 4.858274893493331e-10
isolated O 0 3.94228300137911e-06
recently O 0 6.759656230315159e-07
at O 0 1.1684526957100871e-10
this O 0 1.031413385146722e-14
region O 0 3.58684414634991e-12
of O 0 1.4912863128150396e-15
chromosome O 0 2.0980817225790815e-06
10q23 O 0 8.212600044466001e-10
and O 0 8.424331544854002e-12
found O 0 3.980313474649666e-12
to O 0 3.286251004934633e-14
be O 0 4.477878215658959e-15
inactivated O 0 6.286427489676782e-10
by O 0 1.8820297052843816e-15
mutation O 0 6.754569820133227e-11
in O 0 3.755475964928312e-12
three O 0 1.5741545666969614e-06
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 0 3.309921567051788e-06
lines O 0 8.839735528454185e-06
. O 0 9.03442987087999e-10

We O 0 3.1513786780124065e-06
screened O 0 2.091636815748643e-05
80 O 0 1.1043812264688313e-07
prostate B-Disease 1 0.9963145852088928
tumors I-Disease 1 1.0
by O 0 1.6864664504311067e-13
microsatellite O 0 1.5343304085035925e-06
analysis O 0 1.2658166959056416e-08
and O 0 1.3812820331970954e-10
found O 0 7.206733126929876e-11
chromosome O 0 1.6921262613323051e-07
10q23 O 0 9.27681403917191e-11
to O 0 9.277088645898157e-13
be O 0 6.597602780940293e-13
deleted O 0 1.1017193379814216e-08
in O 0 3.6832672328790395e-12
23 O 0 1.9807321061104943e-10
cases O 0 1.1543363920979433e-12
. O 0 1.0726246280068352e-11

We O 0 2.1278704025462503e-06
then O 0 5.846619022253918e-11
proceeded O 0 3.5982738056522523e-12
with O 0 5.945448664742062e-17
sequence O 0 4.0326262836822e-13
analysis O 0 3.4289384482841245e-14
of O 0 3.4390986878957787e-17
the O 0 1.5913716199834893e-14
entire O 0 2.6171098274629934e-11
PTEN O 0 7.936707646649666e-08
/ O 0 1.0946504858111439e-07
MMAC1 O 0 2.8949751040840965e-08
coding O 0 4.042766704515088e-06
region O 0 2.926585862539355e-09
and O 0 2.3205286650562762e-11
tested O 0 7.375437066636792e-12
for O 0 1.8850015137623784e-18
homozygous O 0 1.2009193823842718e-13
deletion O 0 4.075077081333589e-12
with O 0 4.987817460894465e-15
new O 0 6.396067486411083e-13
intragenic O 0 3.464652920115441e-08
markers O 0 2.1334329858291312e-07
in O 0 2.3308086146908713e-13
these O 0 2.9428968485213647e-13
23 O 0 6.2742502165979985e-12
cases O 0 4.423593314025441e-14
with O 0 2.699549839311338e-13
10q23 O 0 4.8181192369156634e-08
loss O 0 7.687933623046206e-11
of O 0 1.1976247969139493e-14
heterozygosity O 0 1.5349451132351533e-06
. O 0 2.07557568354666e-10

The O 0 1.656552905916417e-13
identification O 0 6.827874311950144e-14
of O 0 8.950781780348914e-17
the O 0 2.9264781651596947e-14
second O 0 2.583005684342332e-11
mutational O 0 2.989556548982364e-07
event O 0 2.614575049519896e-11
in O 0 3.1116640297410014e-13
10 O 0 4.041506278945617e-12
( O 0 1.978282582236826e-13
43 O 0 1.9734448741814958e-08
% O 0 3.4460409786135626e-12
) O 0 1.5076651038725686e-08
tumors B-Disease 1 1.0
establishes O 0 2.2734357116860338e-06
PTEN O 0 1.1294258683847147e-06
/ O 0 1.2073842299287207e-05
MMAC1 O 0 3.417327221200139e-08
as O 0 2.3324617519533686e-14
a O 0 3.754531983978047e-15
main O 0 2.784581419612575e-11
inactivation O 0 6.182917644537156e-08
target O 0 1.4613076373959366e-11
of O 0 1.3006983939686649e-15
10q O 0 2.1836378039097326e-08
loss O 0 1.0196854471899996e-09
in O 0 2.5271007508820276e-11
sporadic B-Disease 1 0.9999392032623291
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.3640087283560707e-12
. O 0 2.4594230731839195e-12

Risk O 0 2.9044059601801564e-07
reversals O 0 5.882550557778643e-10
in O 0 2.5607593235016206e-15
predictive O 0 2.288625712554282e-11
testing O 0 2.2317947490080314e-09
for O 0 7.71392758697198e-12
Huntington B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
. O 0 8.760624864434519e-11

The O 0 6.382297034618345e-13
first O 0 3.619689844489319e-15
predictive O 0 1.320483002456574e-12
testing O 0 2.0259566246849658e-10
for O 0 1.0327096166065641e-12
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 8.620235330668996e-14
HD B-Disease 0 2.3445040824299213e-06
) O 0 2.0738492520488983e-11
was O 0 4.853178622865606e-11
based O 0 6.173245576291016e-15
on O 0 4.0562679896796044e-14
analysis O 0 4.9912077102658506e-14
of O 0 3.6862220391823234e-18
linked O 0 1.3332583734954051e-12
polymorphic O 0 5.384293271654128e-13
DNA O 0 4.743363923864763e-09
markers O 0 2.622162487142532e-10
to O 0 1.192086810801506e-14
estimate O 0 7.627195858402047e-13
the O 0 1.0779307405440336e-14
likelihood O 0 1.5882470035324947e-12
of O 0 3.6062366848858753e-16
inheriting O 0 7.465607992918066e-12
the O 0 1.7238892469550668e-14
mutation O 0 3.9492009922675875e-13
for O 0 6.017761455635938e-16
HD B-Disease 0 1.1975308211731317e-07
. O 0 1.612869143796658e-10

Limits O 0 1.562957124834341e-10
to O 0 7.204138544394945e-14
accuracy O 0 8.782470410639842e-12
included O 0 2.4868537930295516e-15
recombination O 0 3.06069324615757e-14
between O 0 3.840197508131558e-15
the O 0 7.800023173469735e-15
DNA O 0 1.8723262940056884e-08
markers O 0 1.4344189480652858e-07
and O 0 1.2326616116720146e-10
the O 0 2.991276659963099e-13
mutation O 0 1.8909553922696887e-09
, O 0 1.7538827378274502e-12
pedigree O 0 5.826741755754483e-09
structure O 0 1.0615024831350794e-10
, O 0 4.8148059839233856e-14
and O 0 2.8088732732025343e-15
whether O 0 7.06223418300519e-15
DNA O 0 2.5584173668491417e-10
samples O 0 3.2133486409929857e-13
were O 0 3.479787106657221e-15
available O 0 2.6951531708030137e-15
from O 0 5.126766439627955e-16
family O 0 3.4565408261327812e-12
members O 0 4.60534608630889e-15
. O 0 5.649141094146715e-13

With O 0 2.1398590364929415e-12
direct O 0 2.4617601793869293e-12
tests O 0 1.6503645672294454e-10
for O 0 1.996496195911666e-17
the O 0 7.34106514726357e-16
HD B-Disease 0 5.953530113345096e-09
mutation O 0 1.2319264497406834e-09
, O 0 3.058348930010113e-13
we O 0 1.0835785393958908e-11
have O 0 4.998448486712159e-14
assessed O 0 3.309939636557315e-15
the O 0 7.040255160331598e-16
accuracy O 0 5.260941460250024e-09
of O 0 3.4863905755140156e-15
results O 0 5.463424851415155e-12
obtained O 0 5.694590328292044e-16
by O 0 6.638243529746255e-18
linkage O 0 2.4831001838032662e-11
approaches O 0 1.338129477015948e-12
when O 0 9.463594187811286e-14
requested O 0 6.488490571655153e-14
to O 0 4.143199672235198e-12
do O 0 2.98420371747099e-10
so O 0 5.9327221005886846e-15
by O 0 6.381675926533947e-17
the O 0 2.17195476827272e-14
test O 0 9.286586777346173e-11
individuals O 0 4.706434809882481e-16
. O 0 1.5631730935702914e-12

For O 0 4.901849759431087e-12
six O 0 3.7378945967093957e-13
such O 0 1.6816434151832875e-15
individuals O 0 1.1703455291003852e-15
, O 0 7.964192049987953e-14
there O 0 1.1411883807724288e-12
was O 0 3.90182374257475e-12
significant O 0 7.021296233631442e-15
disparity O 0 7.178619244180284e-12
between O 0 2.8540459383850914e-13
the O 0 4.708524694273242e-13
tests O 0 5.212605347360011e-10
. O 0 1.440806431411354e-13

Three O 0 2.483827366006608e-09
went O 0 7.19476034305444e-10
from O 0 1.452284574879597e-16
a O 0 2.73762861203097e-14
decreased O 0 1.5336320657866054e-08
risk O 0 7.718022748681719e-11
to O 0 4.626663703305618e-14
an O 0 7.8713425005956e-15
increased O 0 2.840659041325466e-09
risk O 0 7.147946234908886e-08
, O 0 7.388588005308172e-12
while O 0 2.50086583386544e-12
in O 0 6.06787806578437e-15
another O 0 8.69157827307343e-13
three O 0 1.0612883049590169e-13
the O 0 4.901320573903224e-14
risk O 0 5.627141547864811e-12
was O 0 4.853796184423054e-12
decreased O 0 4.167529876752951e-09
. O 0 9.56586632822054e-12

Knowledge O 0 1.9886921970302396e-11
of O 0 3.0956817525768334e-16
the O 0 8.745910053745414e-16
potential O 0 3.846412082986444e-16
reasons O 0 3.2677837596845343e-16
for O 0 4.861907492284049e-18
these O 0 5.354962409574184e-16
changes O 0 4.049863309291135e-12
in O 0 1.0303133129649367e-12
results O 0 2.828212386507545e-10
and O 0 2.4169617696134793e-11
impact O 0 4.17902366357803e-13
of O 0 2.3220193286092926e-16
these O 0 2.826072709183336e-13
risk O 0 9.683896615370405e-14
reversals O 0 1.870198874237561e-12
on O 0 8.57520814339513e-13
both O 0 9.446832205384226e-12
patients O 0 2.7629799490003215e-11
and O 0 1.1699561946413445e-13
the O 0 1.1968849136345227e-14
counseling O 0 2.0338490006738263e-12
team O 0 9.505473529602612e-14
can O 0 3.5692583498427456e-15
assist O 0 7.457409357733685e-16
in O 0 4.147256692390135e-15
the O 0 2.70613135307414e-14
development O 0 2.5507138515603635e-14
of O 0 9.35432002238556e-18
strategies O 0 7.000492850336992e-14
for O 0 4.880433442873093e-18
the O 0 5.336795458679711e-15
prevention O 0 1.2757973566479563e-09
and O 0 6.766207060783513e-13
, O 0 1.8587257113230476e-13
where O 0 4.5636629891765423e-11
necessary O 0 3.162663273631461e-12
, O 0 3.9115066708620555e-14
management O 0 3.6412482729529516e-14
of O 0 6.93249628225459e-19
a O 0 2.396352091912045e-14
risk O 0 1.393170518185216e-13
reversal O 0 6.285754929795731e-14
in O 0 9.40746621130597e-17
any O 0 2.18644318213221e-15
predictive O 0 3.7056632068432904e-11
testing O 0 2.7750285402916575e-10
program O 0 2.0543055104238483e-12
. O 0 6.836836598158452e-15
. O 0 2.426645581525555e-13

A O 0 1.2837984841862493e-10
novel O 0 1.2189282916352795e-10
common O 0 4.3103502538055505e-12
missense O 0 1.952631123458559e-08
mutation O 0 1.4562534511597391e-09
G301C O 0 1.0311596715384397e-10
in O 0 1.0230472407266912e-14
the O 0 9.674906546481427e-14
N O 0 1.289817532779125e-06
- O 0 8.939917961470201e-07
acetylgalactosamine O 0 5.78143999518943e-06
- O 0 3.6594525454347604e-07
6 O 0 4.367514960801344e-10
- O 0 3.147214933107989e-09
sulfate O 0 5.432685412642968e-09
sulfatase O 0 7.836884208245465e-08
gene O 0 1.1836750468674495e-09
in O 0 5.869294308381845e-13
mucopolysaccharidosis B-Disease 0 1.496716663496045e-06
IVA I-Disease 1 0.7642733454704285
. O 0 1.6138699265866308e-09

Mucopolysaccharidosis B-Disease 1 0.7577391266822815
IVA I-Disease 1 0.9997606873512268
( O 0 0.0002290814882144332
MPS B-Disease 1 0.9999994039535522
IVA I-Disease 1 1.0
) O 0 4.561587996221306e-09
is O 0 2.7820757850238742e-11
an O 0 1.7394814755267163e-11
autosomal B-Disease 1 0.9999967813491821
recessive I-Disease 1 0.9999979734420776
lysosomal I-Disease 1 0.9999995231628418
storage I-Disease 1 0.9999830722808838
disorder I-Disease 1 0.9999957084655762
caused O 0 6.736268431950521e-09
by O 0 3.5527082577896385e-14
a O 0 2.327499304399794e-09
genetic B-Disease 1 1.0
defect I-Disease 1 0.9999998807907104
in O 0 1.1204598013292433e-11
N O 0 2.7252295694779605e-05
- O 0 2.3176313334261067e-05
acetylgalactosamine O 0 0.0002934290678240359
- O 0 8.958335092756897e-05
6 O 0 4.8759456916513955e-08
- O 0 2.359019617870217e-06
sulfate O 0 5.232952275946445e-07
sulfatase O 0 4.047964807796234e-07
( O 0 1.209230740713274e-13
GALNS O 0 3.1032243441586616e-09
) O 0 1.8087934578955855e-13
. O 0 3.90797366255774e-13

In O 0 5.094786745263313e-11
previous O 0 6.854242173837122e-11
studies O 0 4.2025442154036696e-11
, O 0 1.1227675690214656e-12
we O 0 1.445237124420018e-10
have O 0 3.57494470224623e-13
found O 0 3.341851264031942e-13
two O 0 8.872365190627785e-15
common O 0 4.583615456047081e-14
mutations O 0 2.1180624962258143e-11
in O 0 1.009132352875787e-14
Caucasians O 0 1.6471586761213075e-08
and O 0 4.642609213734161e-11
Japanese O 0 1.0247067905311269e-07
, O 0 1.2187572999422525e-12
respectively O 0 5.616847265077496e-12
. O 0 9.90782716286942e-12

To O 0 7.598754091231452e-12
characterize O 0 7.250885447618316e-10
the O 0 1.1919579093275928e-13
mutational O 0 1.7968548871039047e-09
spectrum O 0 1.0276069275019784e-12
in O 0 1.2906697356314108e-15
various O 0 1.1416524997703826e-15
ethnic O 0 1.462434166821236e-11
groups O 0 2.084221900969241e-12
, O 0 2.9122082349786194e-13
mutations O 0 3.1018070056898495e-11
in O 0 7.161114056410578e-16
the O 0 2.4886664435366758e-15
GALNS O 0 2.245595265293332e-09
gene O 0 1.1120611376203016e-10
in O 0 2.2604418608174887e-13
Colombian O 0 2.3310191110681444e-08
MPS B-Disease 1 0.9999984502792358
IVA I-Disease 1 1.0
patients O 0 3.16183013637783e-06
were O 0 2.6694274503531734e-13
investigated O 0 5.429585114846702e-10
, O 0 4.756929225524509e-12
and O 0 4.136111245167662e-11
genetic O 0 1.3976507950985706e-08
backgrounds O 0 4.199897374324024e-12
were O 0 1.1331749916936116e-14
extensively O 0 1.3342002849747736e-11
analyzed O 0 1.825292174351123e-11
to O 0 1.4359305709537792e-14
identify O 0 2.6958348205673166e-13
racial O 0 3.951242816008921e-13
origin O 0 1.632076974109921e-14
, O 0 1.1622748932998278e-15
based O 0 5.691919527530233e-16
on O 0 2.0479618502888992e-14
mitochondrial O 0 2.8212634450852647e-09
DNA O 0 1.9308615151203412e-08
( O 0 3.79447339908935e-15
mtDNA O 0 1.226869734277658e-11
) O 0 1.6498389162006646e-14
lineages O 0 6.61067242613278e-11
. O 0 3.4695067999135354e-12

Three O 0 4.586615809376582e-10
novel O 0 9.070948436828985e-10
missense O 0 1.6135501937242225e-05
mutations O 0 0.0010100982617586851
never O 0 2.7442820282885805e-06
identified O 0 1.7541029739831515e-09
previously O 0 2.694605094610836e-10
in O 0 1.2256101895088273e-13
other O 0 3.983214799663237e-12
populations O 0 9.683996040621423e-07
and O 0 1.1255615106620098e-08
found O 0 1.1020850898546541e-08
in O 0 2.1375906687076673e-12
16 O 0 2.92188113981684e-11
out O 0 5.892224208547958e-12
of O 0 8.907052248609032e-16
19 O 0 5.093642729825376e-10
Colombian O 0 3.943593451793959e-09
MPS B-Disease 1 0.9999536275863647
IVA I-Disease 1 0.9999997615814209
unrelated O 0 1.2250383818468435e-08
alleles O 0 1.0011227263850841e-10
account O 0 9.802857310614588e-13
for O 0 1.4026029585012274e-14
84 O 0 5.527286184303648e-09
. O 0 2.2991965969998418e-11

2 O 0 1.5697906308176357e-09
% O 0 6.32959532226654e-14
of O 0 1.5903322840874287e-16
the O 0 6.566954282877929e-14
alleles O 0 1.1470542397862271e-12
in O 0 6.237850134430817e-14
this O 0 2.6587806866633194e-14
study O 0 3.2141211350408816e-13
. O 0 6.667318606934369e-13

The O 0 7.179184330352584e-11
G301C O 0 7.0213714842282116e-09
and O 0 6.15311794571749e-12
S162F O 0 6.882988623502229e-10
mutations O 0 6.05318961621748e-10
account O 0 1.1359909866080764e-13
for O 0 1.0580337672064406e-14
68 O 0 4.2159900459637356e-08
. O 0 3.385274005562877e-11

4 O 0 2.9583073768435497e-08
% O 0 3.1605345510860028e-12
and O 0 2.3582994931881096e-11
10 O 0 9.683389506909279e-12
. O 0 4.671368326880643e-12

5 O 0 2.695849099509928e-10
% O 0 2.0875857127482765e-14
of O 0 2.6638741498850437e-16
mutations O 0 1.5430151378836854e-08
, O 0 3.1875231620848155e-12
respectively O 0 2.3791032078418484e-12
, O 0 6.071751174757667e-13
whereas O 0 2.4673835891109164e-11
the O 0 2.3832896919005753e-13
remaining O 0 2.2738202987149236e-10
F69V O 0 1.568722041156434e-06
is O 0 4.69552944703383e-13
limited O 0 2.025323675046084e-13
to O 0 1.4922004942991875e-14
a O 0 2.734977060092885e-14
single O 0 2.4397762456163097e-12
allele O 0 5.5930742676180145e-11
. O 0 3.724796165949229e-11

The O 0 5.416425294391125e-11
skewed O 0 4.6198418424125975e-09
prevalence O 0 7.345043400164286e-07
of O 0 7.070779474893565e-15
G301C O 0 3.6091671873350606e-09
in O 0 3.048353670181969e-14
only O 0 8.266393754403911e-14
Colombian O 0 2.902322696410331e-12
patients O 0 9.248268248223876e-14
and O 0 2.0695211893129498e-16
haplotype O 0 5.475317248204714e-12
analysis O 0 2.6515169979757875e-15
by O 0 9.458739167011192e-18
restriction O 0 1.853384850106221e-12
fragment O 0 1.1959494505831003e-10
length O 0 1.0897035357393392e-10
polymorphisms O 0 2.162824364049243e-09
in O 0 2.4894000164206453e-13
the O 0 7.911473396977203e-14
GALNS O 0 1.7514685168862343e-07
gene O 0 6.729882762179784e-10
suggest O 0 3.987349513068228e-12
that O 0 3.1048863431476156e-14
G301C O 0 1.728362765407443e-11
originated O 0 9.877500293381525e-13
from O 0 6.60384671289834e-17
a O 0 2.30745094425167e-15
common O 0 1.9790853661829158e-14
ancestor O 0 8.923475023139837e-13
. O 0 1.2045611903765963e-11

Investigation O 0 4.6222364824544115e-10
of O 0 1.430135192704489e-15
the O 0 5.856517934456004e-15
genetic O 0 1.894447966555024e-11
background O 0 8.983124574063472e-13
by O 0 7.318473190373522e-16
means O 0 4.9167865484871405e-15
of O 0 1.6443415863462005e-17
mtDNA O 0 2.1540502714856302e-10
lineages O 0 1.5678716658307223e-10
indicate O 0 1.2154992290458466e-10
that O 0 2.5800169292655717e-11
all O 0 2.288691285101674e-11
our O 0 1.8476465149519505e-11
patients O 0 5.42167059944948e-13
are O 0 6.338029906948709e-17
probably O 0 3.0218877530505117e-13
of O 0 7.980420174229897e-17
native O 0 1.181591890303535e-11
American O 0 6.684723330430131e-10
descent O 0 9.07987143250466e-08

Low O 0 6.249202932906428e-09
frequency O 0 2.032009283059466e-10
of O 0 1.5416549872630803e-13
BRCA1 O 0 4.7843002448644256e-08
germline O 0 2.8289528497538186e-09
mutations O 0 4.975103351512189e-08
in O 0 7.127058817245346e-13
45 O 0 2.737223114834819e-09
German O 1 0.9997392296791077
breast B-Disease 1 0.9999996423721313
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.764361682951801e-10
. O 0 1.6795152074644548e-11

In O 0 7.1266959347782155e-12
this O 0 2.5188054428109362e-14
study O 0 1.0146740489925393e-13
we O 0 1.2786451585033998e-13
investigated O 0 9.783212434610888e-12
45 O 0 3.849240023945377e-11
German O 1 0.5703220367431641
breast B-Disease 1 0.9999983310699463
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.272827313662631e-12
for O 0 1.3263352648975029e-14
germline O 0 3.2153678830582066e-08
mutations O 0 2.774708462993658e-08
in O 0 1.2447343977479812e-14
the O 0 2.8861231438602475e-14
BRCA1 O 0 9.338319451046573e-09
gene O 0 3.4060221310028282e-09
. O 0 8.637410231493448e-12

We O 0 2.9564629855372004e-08
identified O 0 9.462832600837245e-11
four O 0 1.287396160813345e-13
germline O 0 3.4320862818404407e-10
mutations O 0 5.373032152533597e-08
in O 0 1.925223869214676e-12
three O 0 6.73016842256402e-09
breast B-Disease 1 0.8495179414749146
cancer I-Disease 0 0.31686240434646606
families O 0 3.7286913140421873e-11
and O 0 3.8819876202467185e-09
in O 0 4.680445364613206e-09
one O 1 0.7480418682098389
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.1053075121836287e-09
. O 0 1.0333391145523046e-14
among O 0 2.805390326662984e-17
these O 0 4.476202255093698e-16
were O 0 1.790534815684572e-14
one O 0 3.7934766954203156e-14
frameshift O 0 1.3224913386622461e-09
mutation O 0 1.1661654281125422e-11
, O 0 4.350022403919185e-14
one O 0 3.3458500726946117e-13
nonsense O 0 6.128615837042162e-07
mutation O 0 3.379857949070697e-09
, O 0 3.8394106145235585e-13
one O 0 2.127790402640245e-13
novel O 0 1.0096812275151024e-10
splice O 0 2.0314306311775e-05
site O 0 4.0961967329167237e-07
mutation O 0 2.0496723607266176e-07
, O 0 5.345707817377976e-12
and O 0 1.3055769573083742e-12
one O 0 5.666179873388411e-13
missense O 0 1.6139762237799005e-07
mutation O 0 9.713168047653653e-09
. O 0 2.301082935307619e-11

The O 0 1.0733613650670826e-11
missense O 0 1.1561989765596081e-07
mutation O 0 2.438851254282781e-07
was O 0 1.7368939619899493e-09
also O 0 1.7540349728228932e-10
found O 0 7.245185701387769e-11
in O 0 7.027252044156107e-13
2 O 0 5.964885474440962e-09
. O 0 5.686789580905405e-11

8 O 0 1.1621991369281659e-08
% O 0 1.981621111776452e-13
of O 0 3.6401677659616985e-16
the O 0 1.1280216263018575e-13
general O 0 2.0046824443509248e-12
population O 0 1.9733155810341269e-13
, O 0 5.711805404736217e-14
suggesting O 0 2.5149209104124992e-11
that O 0 6.981698639357825e-12
it O 0 2.2578761776914646e-11
is O 0 8.93681656455314e-12
not O 0 3.3442426605745368e-09
disease O 0 4.717751096450229e-07
associated O 0 5.6078371113432723e-11
. O 0 6.052101875209104e-11

The O 0 7.858248080028218e-11
average O 0 2.1663987270770235e-10
age O 0 1.3913556071165623e-11
of O 0 5.464961707994653e-14
disease O 0 0.017066046595573425
onset O 0 1.3025969565205742e-06
in O 0 5.2392339598694715e-12
those O 0 1.6271242166132627e-12
families O 0 7.48427741222718e-14
harbouring O 0 1.7906622851171505e-09
causative O 0 5.1645344001371996e-08
mutations O 0 1.8615267549648706e-07
was O 0 1.0500785657674427e-10
between O 0 2.2024185860475276e-12
32 O 0 1.2288435158325228e-08
. O 0 3.582142221736362e-11

3 O 0 4.582781443218664e-08
and O 0 3.6099914724196935e-10
37 O 0 3.6827951799267566e-09
. O 0 2.7342407851738137e-11

4 O 0 1.1653667364441844e-08
years O 0 2.3512782432871804e-12
, O 0 1.408571474520101e-13
whereas O 0 1.827593848827136e-12
the O 0 6.512047574357832e-14
family O 0 1.215810980538523e-12
harbouring O 0 6.948652209182171e-10
the O 0 8.824097865161445e-15
missense O 0 1.3701231260654367e-09
mutation O 0 7.666646206772043e-10
had O 0 5.119167936773472e-11
an O 0 6.54289223678045e-16
average O 0 9.604904371851575e-11
age O 0 5.87393675366421e-11
of O 0 5.917669054566555e-15
onset O 0 4.592748723553086e-07
of O 0 1.5540043210582333e-13
51 O 0 3.8097343804111006e-06
. O 0 1.0573378977918324e-10

2 O 0 3.553715188786555e-08
years O 0 3.193147135593932e-11
. O 0 2.1447633599680493e-11

These O 0 2.3803117463194745e-11
findings O 0 5.60624359435824e-11
show O 0 3.1584104775994604e-10
that O 0 4.841452325848872e-12
BRCA1 O 0 1.4821274874066148e-07
is O 0 4.611345485149021e-13
implicated O 0 6.4087342203922315e-12
in O 0 7.595424059126353e-15
a O 0 3.5516292648697786e-15
small O 0 1.6402376283369477e-14
fraction O 0 7.624421927143743e-12
of O 0 2.7740667540854247e-09
breast B-Disease 1 0.9999995231628418
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.763210562798212e-12
suggesting O 0 2.457959833931933e-12
the O 0 6.610428820642996e-16
involvement O 0 4.542068151171079e-14
of O 0 9.211332754519032e-18
another O 0 2.4561951390421506e-14
susceptibility O 0 4.764815764168873e-10
gene O 0 2.260232179196464e-08
( O 0 3.337382800672195e-11
s O 0 9.305177854912472e-07
) O 0 6.53345932910554e-10

Paternal O 0 2.318964288861025e-05
transmission O 0 4.712697773356922e-05
of O 0 2.5580709772654586e-10
congenital B-Disease 1 0.999987006187439
myotonic I-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999997615814209
. O 0 1.8312968563805043e-07

We O 0 2.2648848130302213e-07
report O 0 4.804195236074449e-13
a O 0 1.9242665796827436e-15
rare O 0 2.7591945790878328e-14
case O 0 4.375306540682633e-12
of O 0 1.1938993630528083e-12
paternally O 1 0.9451367855072021
transmitted O 1 0.999285876750946
congenital B-Disease 1 0.9999953508377075
myotonic I-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999998807907104
( O 0 7.619798481073303e-08
DM B-Disease 1 0.9999998807907104
) O 0 4.530191777263326e-09
. O 0 1.0262896782409214e-10

The O 0 1.756893588944486e-11
proband O 0 2.6751223458632012e-08
is O 0 2.511040691783456e-13
a O 0 1.3834312655950504e-13
23 O 0 9.06965908625823e-12
year O 0 6.770137412243386e-15
old O 0 8.123810744109505e-07
, O 0 1.4006850790337921e-08
mentally B-Disease 1 0.9999998807907104
retarded I-Disease 1 0.9999994039535522
male O 0 5.189682269701734e-06
who O 0 2.301872825682949e-07
suffers O 0 0.016274474561214447
severe O 0 2.8423569347069133e-06
muscular B-Disease 0 0.00029127701418474317
weakness I-Disease 0 0.0002882720436900854
. O 0 7.54997397933721e-10

He O 0 5.017587056954653e-08
presented O 0 8.289738687161652e-12
with O 0 7.865179063593075e-10
respiratory O 1 0.9987558126449585
and O 0 1.6841346450746641e-07
feeding O 0 5.962533759884536e-05
difficulties O 0 9.395345834661839e-09
at O 0 3.4415106181517885e-11
birth O 0 9.829941027827971e-11
. O 0 2.520946775982913e-12

His O 0 3.991824826243828e-08
two O 0 2.533008525151814e-10
sibs O 0 0.008712990209460258
suffer O 0 1.4399743122339714e-06
from O 0 2.1590619916911358e-12
childhood O 0 2.6255484044668265e-05
onset O 0 0.18804246187210083
DM B-Disease 1 0.9999998807907104
. O 0 1.8025595238668757e-07

Their O 0 2.1196720767502342e-10
late O 0 3.3203668980963386e-11
father O 0 1.4830124975273584e-11
had O 0 3.5069512398233638e-12
the O 0 6.285972453150542e-17
adult O 0 1.9705474773624998e-13
type O 0 2.1347572320973285e-10
of O 0 4.9340844859293784e-14
DM B-Disease 1 1.0
, O 0 6.6104770546360214e-09
with O 0 3.429440759150637e-11
onset O 0 1.7889431092044106e-07
around O 0 3.8874813090838956e-11
30 O 0 1.6978840208792256e-11
years O 0 3.3563324103487446e-13
. O 0 8.287869088935418e-13

Only O 0 3.070686760420216e-10
six O 0 3.9218831632790996e-14
other O 0 1.8681666346740257e-16
cases O 0 3.609775323841708e-15
of O 0 1.9635809257152824e-16
paternal O 0 2.3952184164954815e-06
transmission O 0 0.007582575082778931
of O 0 2.235123891525248e-11
congenital B-Disease 1 0.9999990463256836
DM I-Disease 1 1.0
have O 0 0.0027313041500747204
been O 0 2.0969450620356156e-09
reported O 0 1.6176667783085463e-09
recently O 0 1.970499852177454e-08
. O 0 1.2099124653552895e-11

We O 0 1.2659584491814257e-09
review O 0 9.685011039678448e-13
the O 0 1.9335375670486788e-15
sex O 0 4.013106036718228e-13
related O 0 8.820719897767795e-14
effects O 0 3.0747758505977885e-11
on O 0 2.677828011415917e-12
transmission O 0 1.3486165926224203e-06
of O 0 9.016654610449759e-12
congenital B-Disease 1 0.9999895095825195
DM I-Disease 1 1.0
. O 0 3.50896613099394e-07

Decreased O 0 2.6503834305913188e-05
fertility O 0 1.5011035259249184e-07
of O 0 3.437055988534136e-15
males O 0 4.1162982310910534e-13
with O 0 1.229579047086482e-13
adult O 0 3.11009387132799e-08
onset O 0 0.0009586511878296733
DM B-Disease 1 1.0
and O 0 2.0287104973704118e-07
contraction O 0 4.8859184059724114e-11
of O 0 1.5907935199969882e-16
the O 0 5.1052433324382234e-15
repeat O 0 4.5413187099718755e-12
upon O 0 1.0982007816023108e-16
male O 0 6.285695298676244e-14
transmission O 0 1.7993746770361696e-10
contribute O 0 4.7430446750056435e-14
to O 0 1.3559833594509185e-12
the O 0 5.843892535682682e-13
almost O 0 4.679860665657287e-11
absent O 0 1.72161781358815e-11
occurrence O 0 1.9329478989638105e-11
of O 0 5.878744502508431e-15
paternal O 0 1.345865427992976e-07
transmission O 0 4.395034920889884e-06
of O 0 2.1691844501181556e-11
congenital B-Disease 1 0.9999792575836182
DM I-Disease 1 0.9999998807907104
. O 0 1.9120359695534717e-07

Also O 0 1.7134119900674705e-07
the O 0 3.1419723593717475e-13
fathers O 0 5.73674517178463e-13
of O 0 3.1518397061075485e-17
the O 0 3.239204423351877e-14
reported O 0 4.860019497954227e-09
congenitally O 0 1.1776426163123688e-06
affected O 0 3.0435408859830204e-08
children O 0 1.021660950284442e-10
showed O 0 2.8618467595720176e-09
, O 0 3.804069689458678e-14
on O 0 7.538120518416069e-13
average O 0 1.2923271393988633e-12
, O 0 9.29252063752023e-15
shorter O 0 9.974347042751575e-11
CTG O 0 9.483334650894903e-08
repeat O 0 4.3387910153569464e-08
lengths O 0 1.2114431235943357e-08
and O 0 5.400834727359305e-12
hence O 0 1.699927850394578e-12
less O 0 2.0484433376974365e-13
severe O 0 1.6652060708111094e-07
clinical O 0 2.7907378807867644e-06
symptoms O 0 1.2485055549404933e-06
than O 0 3.5842144952957095e-14
the O 0 1.5391094648764536e-11
mothers O 0 2.1857742282804793e-09
of O 0 2.6892684094019645e-15
children O 0 7.305117621925206e-11
with O 0 7.761812859108375e-10
congenital B-Disease 1 0.9999665021896362
DM I-Disease 1 0.9999998807907104
. O 0 1.8417212288568408e-07

We O 0 7.781621569336039e-09
conclude O 0 1.8145901448107793e-11
that O 0 3.595930655022131e-14
paternal O 0 2.71163069776037e-09
transmission O 0 1.5866656895013875e-06
of O 0 1.1863494128044882e-12
congenital B-Disease 1 0.9999885559082031
DM I-Disease 1 1.0
is O 0 1.953298323087438e-07
rare O 0 2.6917810203030967e-09
and O 0 4.6154770977357984e-11
preferentially O 0 3.91720350600977e-10
occurs O 0 5.698382737895358e-12
with O 0 2.6660882093058717e-14
onset O 0 3.057264219563649e-09
of O 0 8.069267503534386e-14
DM B-Disease 1 1.0
past O 0 6.193178705871105e-05
30 O 0 2.5616156418273306e-10
years O 0 5.12372161029246e-14
in O 0 1.781890505644663e-15
the O 0 2.184593516285291e-14
father O 0 1.2544797665936525e-11
. O 0 8.585132930082062e-15
. O 0 1.7077298234378924e-13

The O 0 1.7950040065439765e-10
RB1 O 0 4.608402832673164e-07
gene O 0 7.852872796476618e-10
mutation O 0 4.283766674717526e-10
in O 0 1.9418914718426217e-14
a O 0 9.952279451941326e-12
child O 0 5.542892722587567e-08
with O 0 9.67662838746719e-09
ectopic B-Disease 1 0.9999840259552002
intracranial I-Disease 1 0.9999626874923706
retinoblastoma I-Disease 1 0.9997871518135071
. O 0 4.5517344915424474e-07

The O 0 1.3558527911516904e-10
RB1 O 0 9.134046194958501e-07
gene O 0 2.825237599424213e-09
mutation O 0 8.392552763858419e-10
was O 0 2.2944200792768266e-12
investigated O 0 2.434891697988828e-11
in O 0 3.506693362336638e-14
a O 0 7.003187613152662e-11
child O 0 9.359256836205532e-08
with O 0 7.127287648955871e-10
ectopic B-Disease 1 0.999568521976471
intracranial I-Disease 0 0.2191542685031891
retinoblastoma I-Disease 0 1.9520821297192015e-06
using O 0 5.3914381639708076e-12
DNA O 0 1.389692556585942e-07
obtained O 0 2.320013213659433e-13
from O 0 2.2820377853121135e-16
both O 0 2.865992220022623e-13
the O 0 1.3914310513247347e-13
pineal B-Disease 0 2.155655778324217e-07
and I-Disease 0 2.5533598346783037e-08
retinal I-Disease 1 0.9889947772026062
tumours I-Disease 1 1.0
of O 0 1.90604541698558e-12
the O 0 7.078755637213163e-11
patient O 0 2.7355698151154684e-08
. O 0 1.1872033738036247e-11

A O 0 5.309729878000269e-10
nonsense O 0 3.739936360602769e-08
mutation O 0 1.4896583966361732e-10
in O 0 2.5614236090905048e-15
exon O 0 9.238325104909961e-10
17 O 0 4.236557493708659e-10
( O 0 1.9321819331682456e-14
codon O 0 1.852018018111412e-11
556 O 0 9.985929184247455e-13
) O 0 4.8587630975343264e-15
of O 0 4.419411938528298e-17
the O 0 7.795654177527797e-14
RB1 O 0 5.489612675546596e-08
gene O 0 4.402685160886932e-10
was O 0 7.109752023226612e-12
found O 0 1.581320930319277e-13
to O 0 1.897642131864878e-14
be O 0 2.034930519445935e-13
present O 0 1.8422244930709972e-14
homozygously O 0 3.164902651064949e-08
in O 0 9.715811461570231e-14
both O 0 1.4273360054647966e-12
the O 0 4.4222854951548804e-14
retinal B-Disease 0 2.897577928706596e-07
and I-Disease 0 3.933872338990341e-09
the I-Disease 0 4.257129718188146e-11
pineal I-Disease 0 0.0008760656346566975
tumours I-Disease 1 0.9999997615814209
. O 0 7.703936932834665e-10

The O 0 1.9325821325189008e-12
same O 0 1.5654988292030173e-14
mutation O 0 6.985308165230464e-12
was O 0 1.4445907577792516e-12
present O 0 3.818199215458416e-15
heterozygously O 0 3.7049319168147576e-09
in O 0 8.37989515289645e-15
the O 0 1.5975138794005039e-15
DNA O 0 1.9620904900818914e-09
from O 0 7.177984835137516e-17
the O 0 1.3843221452028193e-15
constitutional O 0 3.929846899286549e-12
cells O 0 1.4162587769206425e-11
of O 0 1.588700289826086e-17
the O 0 2.282864381471933e-13
patient O 0 4.650357321445142e-10
, O 0 3.793677188118931e-15
proving O 0 4.146205601074371e-11
it O 0 5.571128194187258e-12
to O 0 7.869875270124366e-14
be O 0 9.026190609013902e-15
of O 0 5.0868864741099976e-17
germline O 0 8.646863225436618e-10
origin O 0 1.0799758656809821e-11
. O 0 8.000023386800503e-12

The O 0 4.342317738020851e-12
initial O 0 5.226914279003736e-13
mutation O 0 6.926375271942842e-12
was O 0 6.720995288089782e-13
shown O 0 1.548267671838341e-13
to O 0 5.151846492273092e-14
have O 0 8.4452618509534e-12
occurred O 0 6.315390432831691e-10
in O 0 1.5722317246941522e-14
the O 0 1.0233503091152188e-13
paternally O 0 1.816794603648475e-09
derived O 0 2.2399623388763557e-12
RB1 O 0 1.3257803743726981e-08
allele O 0 2.1546008033279662e-10
. O 0 2.825283236529419e-11

The O 0 1.872666431645964e-11
mutation O 0 4.6352499616375553e-10
is O 0 6.277547519350016e-14
in O 0 6.887721467190044e-16
an O 0 1.3374742351978416e-15
area O 0 2.1628903112969056e-09
of O 0 1.2963342684661739e-15
the O 0 1.0733684178022146e-13
gene O 0 8.395237977021353e-11
that O 0 1.7318581329228352e-14
encodes O 0 9.774510167188596e-14
the O 0 1.1836359630867498e-14
protein O 0 5.006279765740196e-11
- O 0 1.2056243781088938e-09
binding O 0 8.747997118363493e-12
region O 0 2.0305233189299443e-12
known O 0 5.255595221173581e-13
as O 0 4.754051969799167e-13
the O 0 7.939791944570895e-13
pocket O 0 0.004243555478751659
region O 0 2.586358277767431e-05
and O 0 3.036918627685736e-08
has O 0 5.996514396144903e-10
been O 0 5.443077087143033e-13
detected O 0 2.537156075510527e-11
in O 0 2.1395525499029553e-16
other O 0 3.5640457090853426e-16
cases O 0 4.921965731443127e-15
of O 0 1.4227071108037628e-16
retinoblastoma B-Disease 0 1.7028314687195234e-06
. O 0 2.1705820734546633e-12
. O 0 1.3336049278778184e-11

Low O 0 1.2967296243004967e-05
levels O 0 1.903435048467017e-10
of O 0 1.6028734803742554e-15
beta O 0 8.912469828988023e-13
hexosaminidase O 0 4.332820324748354e-08
A O 0 3.581263063878737e-10
in O 0 2.7199922002230092e-12
healthy O 0 4.202447764778405e-11
individuals O 0 6.464174288618556e-16
with O 0 6.284558919274208e-13
apparent O 0 1.0153197393947266e-07
deficiency O 0 6.434273382183164e-05
of O 0 1.8749848528527288e-16
this O 0 3.680842523140493e-13
enzyme O 0 1.6337972086333252e-09
. O 0 7.2429991691824736e-12

Appreciable O 0 7.884261776780477e-08
beta O 0 9.79741399120826e-10
hexosaminidase O 0 2.4031871248553216e-07
A O 0 1.325371895566363e-10
( O 0 3.5589004074472463e-14
hex O 0 2.0656784616157609e-10
A O 0 5.242392457638356e-12
) O 0 3.1173533128784833e-14
activity O 0 3.828114908399627e-12
has O 0 6.316175338826058e-13
been O 0 5.197742464300298e-14
detected O 0 6.472333086149362e-11
in O 0 1.0772489129028118e-13
cultured O 0 5.716400153232826e-08
skin O 0 0.18055538833141327
fibroblasts O 0 0.0015150347026064992
and O 0 0.0021133210975676775
melanoma B-Disease 1 0.9999910593032837
tissue O 0 0.1353587955236435
from O 0 4.9349673653109605e-11
healthy O 0 6.559196741307005e-09
individuals O 0 5.5297787867009205e-15
previously O 0 2.0204910661236752e-11
reported O 0 3.121806146921813e-09
as O 0 8.512449078956763e-10
having O 0 5.871693815606704e-07
deficiency B-Disease 0 3.91300682167639e-06
of I-Disease 0 2.8441821195415156e-17
hex I-Disease 0 5.91184345921647e-09
A I-Disease 0 3.953953137125765e-11
activity O 0 3.409079962768402e-11
indistinguishable O 0 1.9739330341713573e-13
from O 0 2.4600369946172764e-16
that O 0 1.2372783055264805e-14
of O 0 3.1419496038316195e-16
patients O 0 8.449084487605063e-11
with O 0 2.2321522408219607e-09
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9996621608734131
( O 0 1.2443956184503974e-13
TSD B-Disease 0 5.608423236935778e-08
) O 0 2.7913493998860117e-12
. O 0 5.529766314987805e-12

Identification O 0 3.2614004830122667e-09
and O 0 3.337510476320027e-11
quantitation O 0 3.982129115343014e-08
of O 0 1.1322847600660473e-14
hex O 0 4.340344972320054e-09
A O 0 9.54538097869273e-12
, O 0 2.033711029171114e-14
amounting O 0 5.463742658176965e-14
to O 0 5.579622050846944e-13
3 O 0 2.70428457405103e-10
. O 0 2.5183050089694348e-11

5 O 0 1.8243829558173275e-08
% O 0 7.502966997696703e-12
- O 0 6.880376076878747e-06
6 O 0 5.874659869675725e-09
. O 0 2.2576265509832716e-11

9 O 0 2.101413265620522e-09
% O 0 5.429967388811789e-14
of O 0 4.4397419865769324e-16
total O 0 1.918287848446526e-13
beta O 0 4.323194580102552e-12
hexosaminidase O 0 3.238547492401267e-07
activity O 0 3.951539184754438e-08
, O 0 7.285354611252792e-12
has O 0 1.3140861012186922e-12
been O 0 6.5437437166506775e-15
obtained O 0 5.730678167009814e-16
by O 0 1.251059589811823e-16
cellulose O 0 9.26308348425664e-06
acetate O 0 0.0018533964175730944
gel O 0 0.0004995096242055297
electrophoresis O 0 8.237658555287908e-09
, O 0 2.086767607670237e-12
DEAE O 0 4.485670501708228e-09
- O 0 7.998791906604907e-11
cellulose O 0 1.362402883842151e-07
ion O 0 7.596224760320069e-10
- O 0 1.5166842004532555e-08
exchange O 0 6.3968396551983275e-12
chromatography O 0 6.973709804070083e-13
, O 0 4.927676851089989e-15
radial O 0 2.974212542916632e-11
immunodiffusion O 0 2.900091278235095e-09
, O 0 2.0682904174063044e-12
and O 0 5.575710032568182e-12
radioimmunoassay O 0 2.78677021015028e-07
. O 0 3.580222923682541e-11

Previous O 0 9.602021009413875e-07
family O 0 2.594977011050048e-10
studies O 0 1.3064094944725824e-11
suggested O 0 8.103470151843428e-12
that O 0 5.553460794525955e-13
these O 0 1.7268838472367896e-14
individuals O 0 3.839185039061793e-16
may O 0 4.0015798834225347e-13
be O 0 2.7788082622562165e-15
compound O 0 2.7070893270086938e-12
heterozygotes O 0 3.20274189113956e-11
for O 0 9.008401858330377e-16
the O 0 4.2842786711686214e-15
common O 0 3.341199387475735e-14
mutant O 0 2.106677610136387e-10
TSD B-Disease 0 4.270520381766119e-09
gene O 0 4.486537008574487e-08
and O 0 1.7133138657809965e-11
a O 0 7.057528931923851e-13
rare O 0 2.6000885472443613e-11
( O 0 2.0677764242613833e-13
allelic O 0 1.2854793618455318e-10
) O 0 5.265538439297446e-13
mutant O 0 1.7512445937839516e-09
gene O 0 3.944859727766925e-08
. O 0 8.478724666804993e-11

Thus O 0 4.1471412415283737e-10
, O 0 6.508921548444013e-13
the O 0 3.175581999914417e-15
postulated O 0 2.6990529602977098e-11
rate O 0 3.1381947821623735e-12
mutant O 0 6.580150053309142e-12
gene O 0 6.5663627313306e-11
appears O 0 1.0620846650072346e-12
to O 0 2.4050682621096166e-16
code O 0 1.273103309920717e-14
for O 0 4.477363219627028e-16
the O 0 2.4432477322236003e-14
expression O 0 2.2222965113082027e-13
of O 0 5.29689777164431e-16
low O 0 4.278220139264377e-11
amounts O 0 2.908077221413542e-14
of O 0 1.6269602386579708e-15
hex O 0 1.3451071367853729e-09
A O 0 1.568223849390815e-11
. O 0 3.0776785200220536e-12

Heterozygotes O 0 3.3054025294632083e-08
for O 0 2.11556507446857e-13
the O 0 3.978540858307761e-14
rare O 0 1.8882098575673245e-12
mutant O 0 3.464838371769474e-08
may O 0 7.465701390430013e-10
be O 0 1.8497910383888198e-14
indistinguishable O 0 2.1327434447399735e-13
from O 0 2.478764098987681e-16
heterozygotes O 0 2.355197807613063e-11
for O 0 7.280464175052261e-16
the O 0 2.210311130629826e-14
common O 0 3.9135158330129427e-13
TSD B-Disease 0 4.7074323106244265e-08
mutant O 0 3.242762858235437e-08
. O 0 4.2110894632463314e-11

However O 0 3.190001596209413e-10
, O 0 3.160422905367291e-14
direct O 0 2.787240924173595e-13
visualization O 0 1.3207525739744597e-08
and O 0 1.4593141972607526e-10
quantitation O 0 1.4499370593057392e-07
of O 0 5.3874823337598816e-15
hex O 0 6.359292537005956e-10
A O 0 1.3494035804115928e-13
by O 0 1.9235305940783634e-17
the O 0 1.5442984256843216e-16
methods O 0 5.53435639330524e-12
described O 0 2.2691184001222275e-11
may O 0 1.1900752735702347e-12
prevent O 0 1.4443262124491651e-12
false O 0 3.5775364875395566e-13
- O 0 1.2432717966248674e-08
positive O 0 1.2405163430772442e-13
prenatal O 0 6.881931824409548e-08
diagnosis O 0 3.199486968696874e-07
of O 0 1.2492854528340193e-16
TSD B-Disease 0 1.9279181628917286e-07
in O 0 1.2194949911004116e-11
fetuses O 0 1.0226562707771336e-08
having O 0 5.731859431534758e-12
the O 0 1.9375256946258836e-14
incomplete O 0 4.072897852314128e-10
hex B-Disease 0 5.571245509372602e-08
A I-Disease 0 2.215201000410616e-08
deficiency I-Disease 0 0.00016681954730302095
of O 0 6.164652850557594e-16
the O 0 2.403811741671924e-12
type O 0 0.0012046409538015723
described O 0 5.294000970934576e-08
in O 0 6.153790671481474e-11
the O 0 1.4576671814037212e-10
four O 0 2.7874749175538227e-09
healthy O 0 1.8543942770232746e-10
individuals O 0 1.4704264281878432e-13

The O 0 2.2585868938995723e-11
tumor B-Disease 0 1.503464019947387e-08
suppressor O 0 1.1329622573441611e-08
gene O 0 2.8130976659213047e-08
Smad4 O 0 1.6115365042423946e-06
/ O 0 2.9673039989575045e-06
Dpc4 O 0 2.7419122261562734e-07
is O 0 1.104384324875779e-13
required O 0 2.1161682466303098e-15
for O 0 2.678536058591444e-17
gastrulation O 0 1.2533002191617015e-08
and O 0 5.853607043526665e-10
later O 0 8.124665384912078e-10
for O 0 5.967214298640416e-14
anterior O 0 2.306572014276753e-06
development O 0 1.3060763581762558e-10
of O 0 1.9800320525564146e-15
the O 0 3.6352281861801172e-12
mouse O 0 5.44519821232825e-07
embryo O 0 6.924655515661016e-09
. O 0 9.322310978721049e-11

Mutations O 0 2.7826781661133282e-05
in O 0 1.3037852047981247e-12
the O 0 1.8565938716963437e-12
SMAD4 O 0 6.667123670922592e-05
/ O 0 3.556541196303442e-05
DPC4 O 0 1.79737889993703e-06
tumor B-Disease 0 3.819727822929053e-08
suppressor O 0 1.6511336742297544e-09
gene O 0 4.280338750106694e-09
, O 0 3.59167380624241e-14
a O 0 1.8642519660291715e-15
key O 0 2.7632356038725936e-13
signal O 0 5.688855961825945e-13
transducer O 0 2.7597288603659065e-12
in O 0 4.253503338392736e-14
most O 0 9.440014145812442e-14
TGFbeta O 0 3.038563227164559e-05
- O 0 6.163126613500935e-07
related O 0 1.3284190414353247e-10
pathways O 0 9.189276561905046e-10
, O 0 1.7634038421642483e-14
are O 0 2.1771786798622774e-16
involved O 0 1.3365492116919689e-14
in O 0 6.850098169497139e-15
50 O 0 1.4235533867153205e-13
% O 0 1.946533170041928e-15
of O 0 6.351639185312244e-15
pancreatic B-Disease 0 4.688911576522514e-05
cancers I-Disease 0 0.20441564917564392
. O 0 5.6236893614114436e-11

Homozygous O 0 4.92258436679549e-07
Smad4 O 0 7.478486622858327e-06
mutant O 0 3.2063153412309475e-06
mice O 0 0.0573856495320797
die O 0 4.934183380100876e-05
before O 0 6.521277007981441e-12
day O 0 1.783123995680036e-12
7 O 0 3.1174295783698014e-11
. O 0 1.3099471594252288e-12

5 O 0 6.236042238150219e-10
of O 0 1.2082209419148754e-13
embryogenesis O 0 4.465220371230316e-08
. O 0 5.227400179386166e-10

Mutant O 0 1.2235508606295298e-08
embryos O 0 8.674863605229177e-10
have O 0 1.299451258401918e-11
reduced O 0 3.4518696494928447e-12
size O 0 4.697444655477057e-10
, O 0 1.4482456345277228e-09
fail O 0 1.476353475027281e-07
to O 0 4.48697936444864e-13
gastrulate O 0 5.694612923434761e-07
or O 0 1.3810223581031678e-12
express O 0 1.2725431331513798e-13
a O 0 3.746920122397546e-15
mesodermal O 0 6.375125427560135e-11
marker O 0 5.233820843386638e-07
, O 0 1.42231452310293e-11
and O 0 1.1886291950702343e-10
show O 0 6.303410060581882e-08
abnormal O 0 1.7015500120010074e-08
visceral O 0 9.365462849686423e-10
endoderm O 0 4.971536782250041e-07
development O 0 1.2703801344216004e-09
. O 0 6.747642028459566e-11

Growth B-Disease 1 0.9999980926513672
retardation I-Disease 1 0.9999994039535522
of O 0 5.929764600350051e-13
the O 0 3.114664125572486e-12
Smad4 O 0 0.0025001121684908867
- O 0 0.0015184618532657623
deficient O 0 4.817057924810797e-05
embryos O 0 1.243181113608216e-09
results O 0 5.966411826402451e-12
from O 0 3.553511001501663e-16
reduced O 0 6.833483431889498e-12
cell O 0 5.283066073502596e-08
proliferation O 0 8.575438137370384e-09
rather O 0 2.1391454976322404e-15
than O 0 7.533955195781464e-16
increased O 0 1.2885267939438672e-12
apoptosis O 0 3.343528343080493e-09
. O 0 5.825202820108899e-11

Aggregation O 0 1.1071374039772763e-08
of O 0 2.804588158933363e-13
mutant O 0 2.4904510453893636e-08
Smad4 O 0 6.027462404745165e-06
ES O 0 1.1672820932062677e-08
cells O 0 1.3224603356842835e-10
with O 0 1.0164353083166877e-12
wild O 0 2.6581297163374984e-08
- O 0 7.377290330623509e-06
type O 0 1.0717897112044739e-06
tetraploid O 0 3.94933607594794e-07
morulae O 0 9.816611736823688e-07
rescues O 0 2.8558936548961356e-08
the O 0 4.2448499142783147e-13
gastrulation B-Disease 0 3.7552833731524515e-08
defect I-Disease 0 2.9160014491935726e-07
. O 0 1.5367627309581522e-11

These O 0 7.328189166599941e-10
results O 0 1.171711061509484e-10
indicate O 0 1.0198847842646241e-11
that O 0 1.0647859411674551e-13
Smad4 O 0 3.375485846390802e-07
is O 0 2.7059300980458723e-14
initially O 0 1.2437478076523373e-13
required O 0 6.4288853078491655e-16
for O 0 7.954307736652823e-18
the O 0 8.142387961519292e-16
differentiation O 0 1.2390696108033339e-12
of O 0 2.3562299305577097e-16
the O 0 3.8261548877122076e-14
visceral O 0 5.8286227407056135e-12
endoderm O 0 4.823872856718481e-09
and O 0 4.41762815564517e-12
that O 0 1.7583794121277252e-14
the O 0 4.07277073259096e-15
gastrulation B-Disease 0 1.289015560956841e-09
defect I-Disease 0 9.695972025269839e-09
in O 0 2.2515939918196955e-14
the O 0 3.023882685047885e-13
epiblast O 0 4.409876964928117e-06
is O 0 9.017880192585537e-11
secondary O 0 4.908818240778601e-09
and O 0 3.435963735753944e-10
non O 0 2.1518890835903193e-11
- O 0 6.1989690038899425e-06
cell O 0 3.7412819438031875e-06
autonomous O 0 2.0088815944063754e-08
. O 0 2.5365570754942723e-10

Rescued O 0 1.4208844731911086e-06
embryos O 0 6.084817538720699e-09
show O 0 1.2423873840816668e-06
severe O 0 1.4881988136039581e-05
anterior O 0 0.00011771864956244826
truncations O 0 4.541666203294881e-05
, O 0 5.799433377973173e-09
indicating O 0 4.447731072332317e-10
a O 0 6.16631225247577e-12
second O 0 7.019312214806561e-12
important O 0 5.266196109559012e-15
role O 0 1.09738639616358e-12
for O 0 1.3980597278820395e-14
Smad4 O 0 3.968901296502736e-07
in O 0 1.5713219570986925e-12
anterior O 0 4.1325613153730956e-08
patterning O 0 2.7197651775168197e-07
during O 0 2.3654397884875777e-11
embryogenesis O 0 7.525537526476e-09
. O 0 6.081528336476794e-11

Prevalence O 0 0.0005539909470826387
of O 0 8.062041702630585e-13
p16 O 0 1.3462268633190888e-08
and O 0 1.373518659919526e-10
CDK4 O 0 3.497740124203119e-07
germline O 0 1.0826545882025584e-08
mutations O 0 5.5471232940362825e-08
in O 0 6.088218579454463e-13
48 O 0 7.900700182972287e-08
melanoma B-Disease 1 0.9999425411224365
- O 1 0.9999668598175049
prone O 1 0.9999865293502808
families O 0 5.925435253573141e-09
in O 0 1.904001539765332e-10
France O 0 1.2941747627337463e-05
. O 0 3.24992775746491e-11

The O 0 7.901315157710087e-09
French O 0 1.758239341143053e-05
Familial B-Disease 0 0.04486245661973953
Melanoma I-Disease 1 0.9998900890350342
Study O 0 1.5370201111863935e-08
Group O 0 4.4031134294186813e-10
. O 0 1.364954503590976e-11

Germline O 0 1.5906163753243163e-05
mutations O 0 2.392366877757013e-05
in O 0 1.641199112376035e-13
the O 0 8.384947704426823e-15
p16 O 0 1.0991639542989873e-10
and O 0 2.898162612674504e-12
CDK4 O 0 7.643831168024917e-08
genes O 0 1.0468938604901723e-08
have O 0 4.723551411123239e-11
been O 0 3.763428371023059e-12
reported O 0 1.3630969616929e-11
in O 0 2.8776991470899193e-16
a O 0 1.8230893411661647e-15
subset O 0 3.065874637497856e-11
of O 0 1.5045732400850026e-13
melanoma B-Disease 1 0.9812954664230347
pedigrees O 0 1.0688723932616995e-06
, O 0 3.2598504451364363e-10
but O 0 1.155038620304083e-09
their O 0 1.529334818506367e-12
prevalence O 0 2.017711722146487e-06
is O 0 1.5882983947154705e-12
not O 0 2.369629015577801e-12
well O 0 2.529687884948034e-13
known O 0 6.159823519313878e-12
. O 0 8.651490981947951e-12

We O 0 8.759794001278465e-10
searched O 0 1.8907913429400125e-11
for O 0 6.384723127561694e-16
such O 0 3.588727402135386e-15
germline O 0 1.0294545216282813e-09
mutations O 0 1.1254885023959105e-08
in O 0 6.972047180038576e-13
48 O 0 2.295979726341102e-07
French O 0 7.176158396760002e-05
melanoma B-Disease 1 0.9999793767929077
- O 1 0.9605329632759094
prone O 0 0.31271153688430786
families O 0 1.7899251959080376e-12
selected O 0 2.0376444807715735e-14
according O 0 6.806127312776629e-16
to O 0 3.756423408549266e-15
two O 0 6.4350469431448485e-15
major O 0 8.968572954605458e-13
criteria O 0 3.6574632211738844e-12
families O 0 7.096094748588154e-16
with O 0 2.0860320849164227e-15
at O 0 1.0924619498961508e-12
least O 0 6.610359639227029e-14
three O 0 1.6780758098182413e-13
affected O 0 5.834392214146278e-13
members O 0 5.413227754607888e-17
( O 0 3.438997176291006e-15
n O 0 6.065778990205217e-09
= O 0 2.4461047587465146e-07
20 O 0 9.312935622327045e-13
) O 0 1.0886792498315118e-14
or O 0 1.3275077109624334e-13
families O 0 1.1427031806139805e-14
with O 0 1.2009721017149089e-13
two O 0 1.1211967769139686e-12
affected O 0 2.025135484653995e-12
members O 0 3.93735456946179e-17
, O 0 9.820358112447693e-16
one O 0 4.0543843472235885e-16
of O 0 5.440424274416259e-19
them O 0 6.726760007981546e-15
affected O 0 9.295651271293282e-13
before O 0 2.6478241460839956e-14
the O 0 4.5298988499937e-16
age O 0 7.152245409694589e-15
of O 0 5.772245192202492e-19
50 O 0 1.1344681568941847e-14
( O 0 9.57306218481559e-15
n O 0 2.845590643119067e-07
= O 0 9.712669998407364e-05
28 O 0 1.5186546464818207e-09
) O 0 9.62407169474537e-14
, O 0 1.7280610536268837e-13
and O 0 5.1580606647873284e-14
one O 0 1.8865367675967217e-15
additional O 0 1.5050941145255872e-15
minor O 0 6.744885466120065e-12
criterion O 0 3.576725138287884e-09
. O 0 1.4795937045009033e-11

Sixteen O 0 3.3116167585944822e-09
different O 0 4.5642005799817476e-12
p16 O 0 1.0993447263629719e-09
germline O 0 4.2697059221552536e-09
mutations O 0 1.319564688628816e-07
were O 0 4.20978616549883e-12
found O 0 3.5672378245754643e-11
in O 0 2.1789808726888765e-13
21 O 0 2.5706865525165767e-09
families O 0 1.6624211501749947e-13
, O 0 1.716759872281981e-13
while O 0 2.544839881359062e-13
one O 0 6.782224657104e-14
germline O 0 5.285529791621002e-10
mutation O 0 1.4839186823767392e-10
, O 0 1.7539912732411796e-14
Arg24His O 0 2.4424398503697375e-08
, O 0 3.787875232658805e-13
was O 0 7.304403609742494e-12
detected O 0 9.064324291152559e-10
in O 0 1.772819460405927e-14
the O 0 1.6790811362826785e-13
CDK4 O 0 5.462559897750907e-07
gene O 0 4.171394785146276e-09
. O 0 1.1361827277622805e-11

The O 0 1.4167787494405448e-13
frequency O 0 7.290535905014883e-13
of O 0 1.6455786845831103e-16
p16 O 0 1.6154789311828566e-11
gene O 0 9.868791200906557e-11
mutation O 0 2.8949433128477864e-11
in O 0 8.9533864331315e-15
our O 0 6.799075869369856e-14
sample O 0 5.609007724428905e-13
( O 0 1.6257442169830688e-15
44 O 0 8.793059054316987e-13
% O 0 3.128291991650532e-16
) O 0 8.716865823379656e-16
is O 0 1.3093506237666307e-15
among O 0 7.904286470650516e-16
the O 0 6.24113458938709e-14
highest O 0 2.4173200333793554e-12
rates O 0 2.051622427501343e-09
yet O 0 1.3116729057072174e-11
reported O 0 1.863737775220642e-10
and O 0 1.1416935105645898e-12
the O 0 1.3428146296995142e-14
CDK4 O 0 2.884491934196376e-08
mutation O 0 4.8688750947656345e-11
is O 0 4.6289588237794985e-14
the O 0 6.353481058456048e-15
second O 0 1.8814307750636416e-11
mutation O 0 3.35584303401415e-11
detected O 0 3.5678673349082146e-09
in O 0 8.714044568390589e-15
this O 0 1.225221553851968e-14
gene O 0 1.983514602565961e-10
worldwide O 0 4.09965811298818e-12
. O 0 1.0886394216647055e-11

In O 0 3.6097142636082324e-11
summary O 0 2.5284214189014165e-07
, O 0 9.842755083200316e-11
our O 0 3.141782407151128e-12
results O 0 7.217441705051342e-13
show O 0 9.8584530296153e-13
frequent O 0 1.0949150657316165e-12
involvement O 0 2.9677719700152427e-13
of O 0 1.6021573934266907e-16
the O 0 3.921604150626274e-15
p16 O 0 7.232286818037448e-12
gene O 0 5.963297911026899e-11
in O 0 2.7070400500199543e-14
familial B-Disease 0 2.303278961335309e-06
melanoma I-Disease 1 0.9974849224090576
and O 0 3.720622698821785e-10
confirm O 0 2.1632385482917016e-07
the O 0 1.623363173487019e-13
role O 0 1.1452272290213283e-11
of O 0 1.3158791831471524e-16
the O 0 3.6473855348755774e-14
CDK4 O 0 5.074464404231094e-09
gene O 0 1.6919937673165464e-11
as O 0 7.358788464651919e-15
a O 0 5.396208653529744e-13
melanoma B-Disease 0 0.008484753780066967
- O 0 3.667537384899333e-06
predisposing O 0 1.9247509897013515e-07
gene O 0 5.0408871743456984e-08
. O 0 1.409104386992932e-12
. O 0 4.909653412987769e-12

Progression O 0 1.3969518022349803e-06
of O 0 4.23481982445538e-14
somatic O 0 6.095009913442695e-11
CTG O 0 1.6744678532631951e-07
repeat O 0 3.8972352456312365e-08
length O 0 1.1802522847936814e-10
heterogeneity O 0 3.628936484645351e-09
in O 0 1.2765476609805093e-12
the O 0 4.394506948005722e-13
blood O 0 7.391956838298519e-12
cells O 0 1.0350924110891224e-11
of O 0 7.986419685301893e-13
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
patients O 0 6.031613793311408e-06
. O 0 6.442597757366775e-12

The O 0 9.347750004606858e-12
genetic O 0 1.5018518373377532e-10
basis O 0 2.7578492874796856e-13
of O 0 7.896763755052549e-13
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 0 1.495553014763118e-08
DM B-Disease 1 1.0
) O 0 1.5159566657541035e-10
is O 0 4.659972765736625e-14
the O 0 8.289120537763339e-16
expansion O 0 2.545053740237585e-13
of O 0 9.321020543338258e-17
an O 0 2.3842703527655884e-14
unstable O 0 1.1983121339653735e-07
CTG O 0 4.255082615145511e-07
repeat O 0 3.7675008002224786e-08
in O 0 6.858586371364869e-14
the O 0 3.207946197092762e-14
34 O 0 2.0736507129470727e-12
UTR O 0 2.0446523640860192e-10
of O 0 1.7433573886872886e-15
the O 0 5.6473233207843254e-12
DM B-Disease 1 0.9999996423721313
protein O 0 2.70062827212314e-07
kinase O 0 3.6613997167478374e-08
gene O 0 2.7545690173269577e-09
on O 0 1.0596348451463733e-11
chromosome O 0 6.574604753950553e-07
19 O 0 1.7234191851400738e-10
. O 0 6.387950932107422e-12

One O 0 5.161109040141554e-11
of O 0 7.147767993535403e-16
the O 0 1.99779348642739e-15
principal O 0 3.325038676468481e-14
features O 0 8.283617932217102e-13
of O 0 1.1007976655045843e-15
the O 0 4.1957440993778405e-11
DM B-Disease 1 1.0
mutation O 0 6.693576324323658e-07
is O 0 4.8250933684743785e-14
an O 0 3.14638752707964e-16
extraordinarily O 0 8.357242849144075e-12
high O 0 3.2295502383483665e-10
level O 0 6.348015429286091e-12
of O 0 2.7521278361484494e-16
somatic O 0 1.683688084785917e-11
mosaicism O 0 7.616267794219311e-08
, O 0 2.278567525632047e-12
due O 0 1.0960386786530718e-13
to O 0 1.8398228158523523e-14
an O 0 2.427494994635391e-15
extremely O 0 3.95026719668401e-11
high O 0 1.5638419378904977e-11
degree O 0 8.137773766479783e-13
of O 0 1.4208359620837189e-16
somatic O 0 2.487410277751678e-10
instability O 0 6.984967626522121e-07
both O 0 4.664301583856556e-11
within O 0 3.004282239649214e-11
and O 0 1.3330048002913042e-11
between O 0 6.719200933494318e-13
different O 0 5.797320631363567e-13
tissues O 0 9.599507855284628e-10
. O 0 5.184944921327039e-12

This O 0 1.4510180557092411e-10
instability O 0 1.3904927875785233e-08
appears O 0 1.7106786473486402e-11
to O 0 1.8130479349830544e-14
be O 0 1.5483222292304736e-15
biased O 0 2.2065066787591014e-11
towards O 0 1.2672042336628591e-14
further O 0 6.7994871038657475e-15
expansion O 0 1.4875897822591577e-12
and O 0 3.829938753294182e-13
continuous O 0 6.13404997368977e-13
throughout O 0 8.402459283907149e-12
the O 0 1.216717292239558e-13
life O 0 1.1441782037883291e-13
of O 0 4.802497312738959e-18
an O 0 7.463496480599789e-17
individual O 0 7.875718961015385e-17
, O 0 6.099952238881575e-15
features O 0 1.1281314771238726e-09
that O 0 3.620308497431779e-09
could O 0 2.1829637830705906e-07
be O 0 1.3161279791701341e-12
associated O 0 1.2524905591837499e-11
with O 0 1.335587239761904e-12
the O 0 5.544909149890476e-13
progressive O 0 1.1251053561034396e-10
nature O 0 2.331931696353262e-11
of O 0 4.917311708914438e-15
the O 0 1.6233252242425777e-10
disease O 0 7.864083272579592e-06
. O 0 1.145879940413208e-12

Although O 0 4.4397704263010596e-11
increasing O 0 4.3613566534303483e-13
measured O 0 5.342099592547944e-12
allele O 0 9.723496313673863e-12
size O 0 6.120969286982358e-10
between O 0 1.4046305230053235e-09
patients O 0 9.590324090424929e-09
clearly O 0 7.23330770280306e-12
correlates O 0 1.0685645077113115e-12
with O 0 1.2112562675407022e-15
an O 0 5.844307107488386e-16
increased O 0 1.5866035915634846e-11
severity O 0 1.3309774260505947e-07
of O 0 2.6020556694560104e-13
symptoms O 0 0.0005161645240150392
and O 0 4.0315014239282465e-14
an O 0 1.0375808437939173e-15
earlier O 0 8.38951186299397e-10
age O 0 2.041600916102837e-10
of O 0 8.459157107968719e-16
onset O 0 1.4362061762085432e-08
, O 0 1.2005666101023993e-13
this O 0 1.0201394824978856e-15
correlation O 0 3.1073182221730278e-12
is O 0 1.3151987636982054e-13
not O 0 7.79874754185117e-14
precise O 0 2.158112057115691e-11
and O 0 2.5500693136976116e-12
measured O 0 5.180138002575108e-13
allele O 0 1.4669758463536908e-12
length O 0 3.235694734371464e-08
cannot O 0 1.8106761956460105e-07
be O 0 1.2706125756579978e-13
used O 0 2.1986356962475084e-13
as O 0 1.7050112542530207e-14
an O 0 7.561912576996776e-16
accurate O 0 1.1120865339719899e-10
predictor O 0 1.1136727096072718e-09
of O 0 1.1178303122277421e-14
age O 0 3.280045679510124e-10
of O 0 1.727546057594953e-14
onset O 0 5.389587158788345e-07
. O 0 1.0528220656391696e-10

In O 0 7.197772759759413e-12
order O 0 2.7940643505461327e-13
to O 0 1.838516775750981e-15
further O 0 4.150374620668978e-15
characterize O 0 2.1477557579641093e-11
the O 0 1.2425852210509129e-14
dynamics O 0 1.321935182846401e-11
of O 0 9.752294187048011e-14
DM B-Disease 1 0.9999997615814209
CTG O 0 6.799007678637281e-05
repeat O 0 2.4294397604762707e-08
somatic O 0 1.7036365373979123e-10
instability O 0 5.771848421431969e-08
, O 0 1.7711957117985677e-12
we O 0 1.3836385162613318e-11
have O 0 1.8054386992046902e-14
studied O 0 5.678871544019526e-13
repeat O 0 3.6524139290262936e-13
length O 0 8.238094044822966e-14
changes O 0 8.8231430896233e-14
over O 0 1.6636137725647288e-13
time O 0 3.1196922757777135e-13
in O 0 1.9014219994513415e-13
111 O 0 1.9317479882374755e-07
myotonic B-Disease 1 0.9999994039535522
dystrophy I-Disease 1 0.9999997615814209
patients O 0 8.896997805152296e-09
with O 0 5.797432833582925e-16
varying O 0 1.8615996602317636e-13
clinical O 0 4.314479440381547e-08
severity O 0 6.641326599776676e-09
and O 0 8.491824864814701e-13
CTG O 0 5.9012339903574684e-08
repeat O 0 2.7898896526323824e-09
size O 0 4.000941071502506e-12
over O 0 4.7344472092758494e-11
time O 0 1.3527781325683996e-11
intervals O 0 5.776244760280491e-11
of O 0 3.1823348112677244e-16
1 O 0 1.8001804907852303e-11
- O 0 3.0112286708572356e-07
7 O 0 6.71394259632585e-11
years O 0 2.3201769281874784e-13
. O 0 4.03856852473905e-13

We O 0 1.785096401363262e-06
have O 0 1.550310335836358e-12
found O 0 8.28318262504485e-15
a O 0 2.9599550459933764e-16
direct O 0 3.129482824683165e-14
progression O 0 6.892388171308994e-08
of O 0 3.398592645915792e-16
the O 0 7.437714317050717e-14
size O 0 3.5110336946836407e-12
heterogeneity O 0 9.93213178368535e-10
over O 0 5.205824053083896e-12
time O 0 5.722088384715884e-14
related O 0 3.33252915822764e-15
to O 0 9.670062703869258e-16
initial O 0 3.77286643563784e-15
CTG O 0 4.465827013744317e-11
repeat O 0 7.731430773372239e-11
size O 0 8.137203584557273e-12
and O 0 1.8509277444067607e-10
the O 0 1.0888106415822899e-13
time O 0 1.7708182142861517e-11
interval O 0 5.943678882402992e-10
and O 0 6.383830638591326e-13
always O 0 7.979948624635413e-13
biased O 0 2.2192902897344435e-12
towards O 0 6.17706188323487e-15
further O 0 3.905229817909722e-14
expansion O 0 1.947272378066689e-11
. O 0 5.608369237769528e-12

Attempts O 0 9.131223777103514e-09
to O 0 1.730663409891392e-13
mathematically O 0 6.565682459519495e-12
model O 0 2.1503761271635113e-10
the O 0 1.1404696902573425e-13
dynamics O 0 8.41922371819237e-08
have O 0 9.697156428956077e-07
proved O 0 8.345756441485719e-07
only O 0 2.067653548376569e-10
partially O 0 6.022332854627166e-08
successful O 0 1.2757298472818035e-12
suggesting O 0 1.0897273751767078e-12
that O 0 4.0641284554301244e-14
individual O 0 5.4954544705793345e-17
specific O 0 6.191452549492247e-15
genetic O 0 2.0647143994523276e-09
and O 0 6.4595160817471076e-12
/ O 0 3.044817503905506e-06
or O 0 9.891738469991473e-12
environmental O 0 1.4532164534231118e-11
factors O 0 7.411146002445079e-11
also O 0 2.2379287312190854e-09
play O 0 5.232597688475948e-10
a O 0 1.0082742237969237e-14
role O 0 6.66176369710364e-13
in O 0 1.3438215824672101e-14
somatic O 0 5.678917405771422e-12
mosaicism O 0 3.774835555248046e-09
. O 0 4.2391375240820317e-13
. O 0 3.83393880878935e-12

Aspartylglucosaminuria B-Disease 1 0.9999732971191406
among O 0 4.758927973913529e-11
Palestinian O 0 8.793713313082208e-09
Arabs O 0 4.167921474618197e-08
. O 0 4.139364961908143e-10

Aspartylglucosaminuria B-Disease 1 0.9999978542327881
( O 0 3.1944196621225274e-07
AGU B-Disease 1 0.9999983310699463
) O 0 1.3154384699565203e-11
is O 0 8.176900996581526e-14
a O 0 4.5081508513213076e-13
rare O 0 2.490487815975939e-09
disorder B-Disease 0 0.0008203470497392118
of I-Disease 0 1.7302499561691782e-14
glycoprotein I-Disease 0 4.165171776548959e-05
metabolism I-Disease 0 0.05343163385987282
caused O 0 4.272378006930921e-09
by O 0 2.4065479969047343e-14
the O 0 1.244623015761448e-10
deficiency B-Disease 0 4.1305604099761695e-05
of I-Disease 0 2.644676677531117e-16
the I-Disease 0 4.592388969104633e-12
lysosomal I-Disease 0 0.023584388196468353
enzyme I-Disease 0 2.9011882816121215e-06
aspartylglucosaminidase I-Disease 0 2.663453813056549e-07
( O 0 5.934064004065043e-13
AGA O 0 3.2349525280750413e-09
) O 0 2.0017288607926398e-12
. O 0 7.754406491922161e-12

AGU B-Disease 1 0.999995231628418
is O 0 3.069307652481257e-08
inherited O 0 2.5741061904227536e-07
as O 0 1.4351789071401222e-12
an O 0 5.548082609649341e-13
autosomal O 1 0.9731709361076355
recessive O 1 0.9723289012908936
trait O 0 0.02346598543226719
and O 0 3.0000782658134995e-07
occurs O 0 2.5278396043049156e-10
with O 0 6.348199384513444e-15
a O 0 1.066434267282812e-13
high O 0 5.266786572838411e-12
frequency O 0 2.2866721016701064e-10
in O 0 1.6407071534718654e-10
Finland O 0 0.0020402914378792048
because O 0 2.0311877180212434e-10
of O 0 5.104536854020654e-17
a O 0 2.1249341058981498e-14
founder O 0 1.1869836710753923e-11
effect O 0 9.050580597469438e-12
. O 0 6.5186155084884234e-12

While O 0 5.4324265086336254e-09
very O 0 1.7948345717652692e-12
few O 0 1.4275482922501692e-12
patients O 0 6.523951517900528e-12
with O 0 4.412651233992593e-12
AGU B-Disease 1 1.0
have O 0 9.944859158395047e-08
been O 0 4.2032009817116744e-11
reported O 0 8.628950332045804e-11
from O 0 2.133701405122e-15
non O 0 5.561127513348252e-12
- O 0 3.1971811154107854e-07
Finnish O 0 1.8004996604759071e-07
origin O 0 5.469037028804635e-11
, O 0 1.0767615965523447e-10
we O 0 3.201017007015139e-09
diagnosed O 0 2.4830884015614174e-09
the O 0 9.486758844852797e-15
disorder O 0 9.75544764969527e-08
in O 0 1.0186351308077383e-14
8 O 0 3.949928231716804e-11
patients O 0 1.1120043010319144e-13
originating O 0 1.3542011242028643e-14
from O 0 3.573769901429706e-14
3 O 0 2.2884194539329883e-12
unrelated O 0 4.8528171064932124e-11
families O 0 7.550999213921938e-13
, O 0 1.0275456294216515e-13
all O 0 3.972844138221002e-15
Palestinian O 0 6.946259973467095e-12
Arabs O 0 7.35663873568937e-12
from O 0 1.9294705383524373e-15
the O 0 2.8469751445106377e-15
region O 0 4.3976261976559627e-13
of O 0 8.762302391206051e-17
Jerusalem O 0 7.802883601470967e-07
. O 0 5.238576933352945e-11

The O 0 3.9856964950679696e-10
clinical O 0 9.953797075468174e-08
diagnosis O 0 0.007543145678937435
of O 0 6.0308615740245486e-12
AGU B-Disease 1 1.0
is O 0 1.896273573720464e-07
often O 0 4.54928450466241e-09
difficult O 0 1.8503569787498009e-09
, O 0 7.219255033184824e-14
in O 0 2.1239241038118438e-15
particular O 0 1.8925861583213993e-13
early O 0 4.1733942690580506e-12
in O 0 3.162153563085121e-14
the O 0 1.0853712676880956e-12
course O 0 2.126088105569579e-08
of O 0 1.1877648675397883e-15
the O 0 1.4030367145867473e-10
disease O 0 0.006258596200495958
, O 0 5.728872237709126e-13
and O 0 4.128707792316888e-12
most O 0 1.692552924258215e-14
of O 0 4.048356913710486e-16
the O 0 2.4974766178742502e-12
patients O 0 5.979764426677914e-12
are O 0 6.223419572921624e-15
diagnosed O 0 1.3422885913882965e-08
after O 0 5.486427284706608e-13
the O 0 1.694892598665121e-13
age O 0 4.651437221503407e-11
of O 0 2.331854439918099e-16
5 O 0 4.4952246786023053e-11
years O 0 1.364552893422244e-12
. O 0 2.005183345754613e-12

However O 0 3.8637068655589246e-08
, O 0 2.8154215070408384e-12
since O 0 1.4612232864669172e-12
these O 0 2.93545061576337e-14
patients O 0 2.746776398454727e-14
excrete O 0 4.033641639016733e-13
early O 0 2.0399736519699334e-14
large O 0 3.051481720504532e-15
amounts O 0 6.688727127506996e-14
of O 0 6.169832033513581e-15
aspartylglucosamine O 0 2.102901589751127e-06
in O 0 1.4692525624956931e-12
urine O 0 2.6345726815424353e-12
, O 0 3.068628049637123e-16
biochemical O 0 4.866437656493583e-13
screening O 0 3.661401043464352e-11
is O 0 4.1878386338161516e-14
easy O 0 1.487999307103749e-11
by O 0 6.901796401916332e-15
urine O 0 5.6224855500552895e-12
chromatography O 0 6.950245500653152e-13
. O 0 2.0341272611613948e-13
. O 0 2.66158406078687e-12

Detection O 0 9.135822764960722e-09
of O 0 9.369726843629512e-15
heterozygous O 0 2.3217783251539004e-10
carriers O 0 2.843865420931735e-11
of O 0 4.7245353110422425e-14
the O 0 7.532109407293319e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.6974112180000454e-11
ATM O 0 5.19424447897876e-10
) O 0 2.4622072518468196e-15
gene O 0 7.64083552830773e-14
by O 0 1.7240123473120824e-16
G2 O 0 2.389059505780722e-10
phase O 0 9.72928421855146e-12
chromosomal O 0 6.602499070140766e-06
radiosensitivity O 0 3.075355721193773e-07
of O 0 2.4205209234531844e-13
peripheral O 0 0.0021762726828455925
blood O 0 9.008726920001209e-06
lymphocytes O 0 2.382015281909844e-06
. O 0 2.2592429316237173e-10

In O 0 4.507337962422753e-06
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 0 0.040409237146377563
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.3060770243100706e-09
patients O 0 3.489486199992342e-10
, O 0 5.0249555357635353e-14
mutations O 0 3.187410613225694e-10
in O 0 6.297836076019124e-15
a O 0 7.932506241497064e-14
single O 0 4.318115418185109e-13
gene O 0 6.305421462737826e-11
, O 0 2.6249545953213084e-14
ATM O 0 2.9960092740033417e-10
, O 0 1.5599860812842703e-12
result O 0 8.377346667927388e-13
in O 0 9.712745364931497e-12
an O 0 6.234208740352187e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 9.61522573561524e-07
embraces O 0 3.827237193831934e-09
a O 0 9.093697474725493e-13
variety O 0 2.0863089630462212e-13
of O 0 3.849699894310771e-16
clinical O 0 5.0224198133719256e-09
features O 0 1.746064848262563e-09
and O 0 3.936617698485634e-10
manifests O 0 6.459436319161682e-10
extreme O 0 5.668275293579939e-10
radiosensitivity O 0 7.182796366578259e-07
and O 0 8.159942339880377e-12
a O 0 7.207794338595294e-14
strong O 0 2.570009634793313e-13
pre O 0 4.254323282548711e-10
- O 0 8.195286227419274e-08
disposition O 0 2.383521824356194e-09
to O 0 6.048959510368546e-12
malignancy B-Disease 0 2.3859804514358984e-06
. O 0 1.088249022146437e-11

Heterozygotes O 0 6.012539799371552e-09
for O 0 1.4752356779744458e-13
the O 0 5.927361229065512e-15
ATM O 0 1.632513901839161e-09
gene O 0 4.453924162817202e-08
have O 0 1.6042599193522022e-10
no O 0 2.073444931374735e-12
clinical O 0 3.197395126441904e-11
expression O 0 2.1181844391546592e-14
of O 0 1.9988398685787806e-13
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 0.0001890121347969398
may O 0 2.7540070224318924e-09
be O 0 4.979934867255231e-12
cancer B-Disease 0 5.70697356039318e-09
prone O 0 8.255259587031105e-09
with O 0 5.820596283602486e-14
a O 0 4.326147513139533e-12
moderate O 0 1.4718135155078471e-08
increase O 0 7.353331832327115e-11
in O 0 8.712445695446824e-12
in O 0 4.134683567746933e-11
vitro O 0 8.383503313780238e-07
radiosensitivity O 0 2.9438930937430996e-07
. O 0 1.2854247180560385e-11

We O 0 2.6188448032371525e-07
performed O 0 7.544960489713759e-11
a O 0 1.1781026187148574e-13
blind O 0 6.183389737735023e-12
chromosomal O 0 1.798370021788287e-07
analysis O 0 1.672619681647447e-11
on O 0 1.3080146774729906e-12
G2 O 0 1.9955153973683082e-08
- O 0 5.961134661447431e-07
phase O 0 3.1398206257193806e-10
lymphocytes O 0 2.961884071339682e-10
from O 0 7.470368961826675e-15
7 O 0 2.9740140905509804e-11
unrelated O 0 1.9195372402691646e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.3765074931579875e-06
, O 0 8.062714179028069e-14
13 O 0 3.894186134580785e-13
obligate O 0 1.3012289912239794e-08
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
heterozygotes O 0 5.9582134781521745e-08
( O 0 6.064305958439209e-14
parents O 0 1.191425972636717e-13
of O 0 7.828000565838426e-18
the O 0 7.52271915550537e-14
patients O 0 4.663932001019999e-13
) O 0 5.591865348822595e-16
, O 0 5.498799657797926e-13
and O 0 5.708745698385087e-10
14 O 0 4.332937481033028e-11
normal O 0 5.5713302894722094e-12
controls O 0 3.0039004172977e-07
following O 0 1.6224994709313628e-13
X O 0 6.0803859724956055e-09
- O 0 7.382055383642339e-11
irradiation O 0 1.3340654102245164e-11
with O 0 1.2832635344975363e-12
1 O 0 3.651508349161725e-13
Gy O 0 1.1503599184337077e-09
in O 0 3.5328736260769635e-15
order O 0 1.628861467635554e-14
to O 0 8.841850299307356e-16
evaluate O 0 1.1780369058988095e-14
this O 0 9.646251912890225e-18
cytogenetic O 0 7.630487387777496e-12
method O 0 4.194353333620074e-14
as O 0 2.8767001776077513e-16
a O 0 8.562851278418285e-17
tool O 0 1.4002006205968837e-13
for O 0 8.461826883026571e-18
detection O 0 3.476632772902305e-13
of O 0 8.774947004921781e-17
ATM O 0 1.5280550158536244e-08
carriers O 0 5.278357195770411e-10
. O 0 2.876729583711768e-11

Both O 0 4.868135761171288e-07
A B-Disease 1 0.9999966621398926
- I-Disease 1 0.9999983310699463
T I-Disease 1 0.9999998807907104
homozygotes O 0 0.0001471604045946151
and O 0 3.736280382304891e-11
heterozygotes O 0 5.217299925419638e-10
showed O 0 2.2508588742864433e-11
significantly O 0 1.511240785290191e-12
increased O 0 5.946422689103933e-14
levels O 0 2.1260488012567365e-14
of O 0 2.470521641230284e-17
radiation O 0 1.9385666405469237e-08
- O 0 1.9186752524547046e-06
induced O 0 8.183912427739415e-07
chromatid O 0 5.065029995421355e-07
damage O 0 9.929468802738484e-08
relative O 0 6.2740346772061084e-12
to O 0 1.0211703851221651e-13
that O 0 5.5744064962962026e-14
of O 0 3.3884176626368997e-16
normal O 0 1.8474430318882185e-10
controls O 0 3.274302071076818e-05
. O 0 1.2032252971749813e-10

These O 0 1.3476077198593117e-10
results O 0 7.021334468698681e-12
show O 0 2.048428700968108e-12
that O 0 3.671575694706329e-15
the O 0 1.4369161149637333e-15
G2 O 0 7.64448004897389e-10
- O 0 6.790328854755501e-10
phase O 0 1.4412557952647731e-11
chromosomal O 0 1.3411887778147502e-07
radiosensitivity O 0 6.9461649765401035e-09
assay O 0 1.8248752509109067e-10
can O 0 3.203363572665263e-12
be O 0 2.539366659385766e-16
used O 0 8.859204945605413e-16
for O 0 4.601212423251224e-18
the O 0 1.5235495595479395e-16
detection O 0 9.262523907593856e-12
of O 0 4.216186454868501e-14
A B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
T I-Disease 1 0.9999997615814209
heterozygotes O 0 9.769347343535628e-06
. O 0 1.515502862092788e-10

In O 0 2.0263960648359003e-11
combination O 0 1.6695662213850326e-11
with O 0 2.4889192405197838e-14
molecular O 0 2.1001460293046392e-10
genetic O 0 4.1793050797878095e-08
analyses O 0 9.570858550134176e-10
, O 0 5.6547977156937504e-14
this O 0 5.2089371905443896e-14
test O 0 8.154540154237111e-09
may O 0 2.185137487620281e-12
be O 0 5.70655718859503e-14
of O 0 4.112765828415295e-17
value O 0 6.577358557975643e-14
in O 0 3.97635076991934e-13
studies O 0 7.918577252241654e-12
of O 0 4.281203293060488e-17
familial B-Disease 0 1.596848449025856e-07
and I-Disease 0 3.204896348307784e-09
sporadic I-Disease 0 7.936861948110163e-05
cancers I-Disease 1 0.9846166372299194
aimed O 0 6.341365765827334e-10
at O 0 6.884327552469927e-10
determination O 0 2.051556841076163e-12
of O 0 7.046965050937281e-18
the O 0 7.973516591011978e-16
potential O 0 6.891979395936773e-16
involvement O 0 5.10852821091097e-14
of O 0 5.647063839017198e-16
ATM O 0 1.0257035683025606e-06
mutations O 0 1.1633633221208584e-06
in O 0 1.0271077391377226e-11
tumor B-Disease 0 0.001515197567641735
risk O 0 6.548196651579019e-09
or O 0 2.677541782042381e-12
development O 0 3.9226746850751226e-11
. O 0 1.1075892807077548e-12
. O 0 6.193221283035122e-12

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
telangiectasia I-Disease 1 0.9999998807907104
: O 0 6.413888864464923e-10
identification O 0 5.8831507374068615e-12
and O 0 7.255380649572041e-14
detection O 0 5.338392054798913e-12
of O 0 2.2780011439228547e-17
founder O 0 1.7793062162541062e-11
- O 0 5.814776926627019e-08
effect O 0 4.136758297024201e-11
mutations O 0 9.349542251513299e-10
in O 0 1.2899560044942306e-15
the O 0 1.1616409950179264e-15
ATM O 0 2.795454701054467e-10
gene O 0 6.914525896295487e-11
in O 0 2.9812164835298777e-14
ethnic O 0 1.8078648300612343e-10
populations O 0 1.593651433040577e-08
. O 0 4.324466826299833e-11

To O 0 4.722945125268385e-12
facilitate O 0 7.077452231045445e-13
the O 0 3.088606115791504e-15
evaluation O 0 1.5541636648962708e-14
of O 0 3.81043768381788e-18
ATM O 0 3.0189871436103743e-11
heterozygotes O 0 1.2966040567607973e-11
for O 0 1.9525188077730392e-16
susceptibility O 0 9.022599334329584e-10
to O 0 1.3626783729181469e-11
other O 0 9.145192242376865e-11
diseases O 0 0.017011843621730804
, O 0 8.288101514776144e-14
such O 0 3.5055465474886915e-12
as O 0 2.136747667691452e-07
breast B-Disease 1 0.9650850296020508
cancer I-Disease 0 0.4373350739479065
, O 0 7.730925274951339e-12
we O 0 2.042243596456217e-10
have O 0 3.2560797591160706e-13
attempted O 0 2.3773896046241916e-11
to O 0 3.2082274120312504e-14
define O 0 2.7068724865741967e-12
the O 0 6.715888763620011e-15
most O 0 3.3624097277496932e-15
common O 0 5.120029224268789e-14
mutations O 0 1.291786122514793e-10
and O 0 8.667242271109821e-13
their O 0 7.477838945388511e-15
frequencies O 0 4.300038450311128e-11
in O 0 3.080603505623003e-08
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 0 2.2579182768822648e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 2.7104889513407393e-12
homozygotes O 0 2.12499934315602e-10
from O 0 2.446954094290901e-15
10 O 0 3.0404332344987836e-14
ethnic O 0 1.1295557371393539e-11
populations O 0 2.149812416973873e-08
. O 0 2.182785029114509e-11

Both O 0 4.8498281779441044e-11
genomic O 0 2.614135397038808e-08
mutations O 0 1.4200922123563942e-05
and O 0 1.0774519471068444e-10
their O 0 2.8547520928125583e-14
effects O 0 8.053070363334136e-12
on O 0 2.614667380176905e-13
cDNA O 0 1.23774338001148e-10
were O 0 2.4742298054131195e-12
characterized O 0 2.667823184587803e-10
. O 0 1.627565617001725e-11

Protein O 0 4.613741566572571e-08
- O 0 2.2699517820967685e-09
truncation O 0 1.3418048894209278e-08
testing O 0 4.3849537334494926e-09
of O 0 2.4782619010941878e-17
the O 0 4.905075153321047e-16
entire O 0 1.4608184995858198e-13
ATM O 0 5.7386335267084476e-11
cDNA O 0 2.9258796774289664e-11
detected O 0 3.5805884923689746e-09
92 O 0 7.064700213721409e-11
( O 0 2.497764636181371e-14
66 O 0 2.932350751105872e-10
% O 0 2.999500790839193e-15
) O 0 1.9100938550026952e-14
truncating O 0 5.214795706365294e-09
mutations O 0 4.774546269459279e-08
in O 0 9.561456139372312e-15
140 O 0 1.0647763053206472e-12
mutant O 0 3.036140894252526e-09
alleles O 0 9.741823320252863e-11
screened O 0 1.305062227174858e-07
. O 0 2.757967638988834e-11

The O 0 5.744565847315419e-12
haplotyping O 0 6.309325506492769e-09
of O 0 1.162501559316513e-14
patients O 0 9.660870020633539e-11
with O 0 5.049640718589321e-13
identical O 0 4.626581073807756e-07
mutations O 0 1.9218625311623327e-05
indicates O 0 2.9693407732622745e-09
that O 0 2.682513100538131e-10
almost O 0 3.980097362799029e-10
all O 0 1.0235850795431434e-12
of O 0 1.7629986268962377e-16
these O 0 9.777750237618434e-15
represent O 0 6.454862855429389e-15
common O 0 3.1092626303491633e-12
ancestry O 0 4.306163758904802e-10
and O 0 6.852284850644708e-10
that O 0 5.47700149122754e-11
very O 0 1.8624291345248345e-11
few O 0 8.721075077378071e-12
spontaneously O 0 8.587161363926565e-12
recurring O 0 5.8801306046518675e-09
ATM O 0 1.1998140507785138e-06
mutations O 0 7.730873221589718e-06
exist O 0 6.060193680212933e-09
. O 0 1.0808770545267521e-10

Assays O 0 6.5985852337746564e-09
requiring O 0 2.584433752075843e-12
minimal O 0 2.04678071366593e-12
amounts O 0 1.786979648998356e-14
of O 0 8.512759867500033e-17
genomic O 0 2.5849007379008526e-09
DNA O 0 3.6649391859100433e-06
were O 0 6.930957544004634e-13
designed O 0 1.1357039440829109e-11
to O 0 1.1872219617722456e-14
allow O 0 4.660828472301259e-13
rapid O 0 1.3106917894772918e-12
screening O 0 6.908009754502675e-12
for O 0 2.1659789190661054e-16
common O 0 1.0770989541898299e-13
ethnic O 0 3.2080029743752903e-09
mutations O 0 1.0185449355049059e-05
. O 0 4.3787484055313186e-11

These O 0 2.0695264946191116e-11
rapid O 0 1.0068062356038965e-10
assays O 0 2.146933603119905e-10
detected O 0 1.9341928059191105e-09
mutations O 0 5.5462314740850616e-09
in O 0 1.004280683679186e-13
76 O 0 6.397203211605529e-09
% O 0 2.649491106924192e-14
of O 0 3.938019225627589e-15
Costa O 0 1.1083881190643297e-06
Rican O 0 3.6656658264355713e-10
patients O 0 2.1864810309524252e-11
( O 0 1.0251563527653544e-15
3 O 0 4.909388325556596e-13
) O 0 5.4714594671396305e-14
, O 0 2.7860290571952995e-13
50 O 0 1.3820922488069765e-12
% O 0 1.5415074680049864e-14
of O 0 1.0670760133249697e-15
Norwegian O 0 0.1978590339422226
patients O 0 1.6768122446109146e-09
( O 0 1.367004768354442e-15
1 O 0 1.2216472950431212e-13
) O 0 5.686575342556122e-14
, O 0 3.553652055780787e-13
25 O 0 2.1597446866940956e-13
% O 0 6.363494893716726e-16
of O 0 1.9235681480781733e-16
Polish O 0 7.631890912307426e-05
patients O 0 3.3446556635396973e-10
( O 0 7.619825807787329e-16
4 O 0 1.0221862419002026e-12
) O 0 1.1986973100317627e-13
, O 0 2.8128343838168535e-12
and O 0 4.5479200960762967e-10
14 O 0 3.632256648233856e-11
% O 0 7.350032049801441e-16
of O 0 1.2022925943159428e-16
Italian O 0 8.437322662757651e-07
patients O 0 3.232994080781815e-11
( O 0 9.44670540963422e-16
1 O 0 1.2610901635023292e-13
) O 0 1.5161481824784578e-13
, O 0 4.830952803590305e-13
as O 0 1.7281763856329818e-13
well O 0 7.604520312065599e-13
as O 0 6.948982405122206e-14
in O 0 3.3417984091760333e-14
patients O 0 1.1766900388093804e-13
of O 0 6.083676004491716e-18
Amish O 0 4.225285738357343e-05
/ O 0 3.858338459394872e-05
Mennonite O 0 1.2860602964792633e-06
and O 0 6.575894051508158e-09
Irish O 0 3.2736033883651317e-09
English O 0 1.6397468105555646e-10
backgrounds O 0 2.9784702482160696e-11
. O 0 4.024084017395513e-12

Additional O 0 9.95461438973999e-12
mutations O 0 1.0207717338062139e-08
were O 0 1.0761445987800267e-12
observed O 0 4.3484256993797654e-12
in O 0 3.7019257322393976e-15
Japanese O 0 1.6614798425962363e-09
, O 0 5.371865587311354e-15
Utah O 0 1.300184460963083e-12
Mormon O 0 8.045539061363183e-14
, O 0 1.7866124432750624e-13
and O 0 1.6912605213872944e-12
African O 0 1.6775797873243292e-13
American O 0 8.612038491194463e-13
patients O 0 3.013687173078483e-12
. O 0 3.501134386747762e-13

These O 0 1.3377161791477965e-12
assays O 0 1.4602711401190405e-11
should O 0 9.218799124955952e-15
facilitate O 0 6.58179381306988e-16
screening O 0 5.712933164730982e-12
for O 0 3.197506346611263e-14
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
heterozygotes O 0 4.89715887397324e-07
in O 0 1.5214618844308636e-12
the O 0 2.1088212014304386e-13
populations O 0 5.4930084786297684e-11
studied O 0 2.20384006183183e-11
. O 0 1.7085760771148352e-14
. O 0 2.3350939237776203e-13

The O 0 1.3101745466315151e-08
von B-Disease 1 0.9961428046226501
Hippel I-Disease 1 0.9994058609008789
- I-Disease 1 0.9992613196372986
Lindau I-Disease 1 0.9962502121925354
tumor I-Disease 0 3.828836270258762e-05
suppressor O 0 3.102462642345927e-08
gene O 0 1.675332939043983e-08
is O 0 6.860928248057438e-14
required O 0 8.126814413751075e-15
for O 0 1.9872197623885778e-16
cell O 0 2.3254948189332936e-08
cycle O 0 1.3350169858483696e-08
exit O 0 1.4854251162432774e-10
upon O 0 1.4540655463544938e-14
serum O 0 6.057694346139897e-10
withdrawal O 0 1.130884830224943e-09
. O 0 1.4271243908847708e-11

The O 0 3.80257388077343e-11
inactivation O 0 5.032894137002586e-07
of O 0 1.63950274255191e-14
the O 0 2.941698967751094e-11
von B-Disease 1 0.9999233484268188
Hippel I-Disease 1 0.9999784231185913
- I-Disease 1 0.9999852180480957
Lindau I-Disease 1 0.9998610019683838
( I-Disease 0 1.827633877571344e-10
VHL I-Disease 0 2.4300494260387495e-05
) I-Disease 0 2.0238843153469466e-12
tumor I-Disease 0 1.1502282459829871e-09
suppressor O 0 1.9123040928548107e-09
gene O 0 3.548323945778975e-08
predisposes O 0 8.482293765155191e-07
affected O 0 5.241128087085656e-10
individuals O 0 4.758138124499357e-15
to O 0 2.526625826962392e-13
the O 0 8.115120381235741e-11
human O 0 2.1204614313319325e-05
VHL B-Disease 1 0.9999982118606567
cancer I-Disease 1 0.9999970197677612
syndrome I-Disease 1 0.9999995231628418
and O 0 7.586129641135031e-11
is O 0 1.1879751739621303e-12
associated O 0 1.8494678011293786e-09
with O 0 5.234966238276684e-09
sporadic B-Disease 1 0.9999673366546631
renal I-Disease 1 0.9999834299087524
cell I-Disease 1 0.9999780654907227
carcinomas I-Disease 1 1.0
( O 0 1.6849827488840674e-07
RCC B-Disease 0 0.24089105427265167
) O 0 3.9093702497439153e-08
and O 0 1.9173550924733718e-07
brain B-Disease 0 0.00011144364543724805
hemangioblastomas I-Disease 0 3.855444447253831e-05
. O 0 2.1039470166073215e-10

VHL O 0 0.007277730852365494
- O 0 0.0007801812025718391
negative O 0 1.9644804893914625e-08
786 O 0 1.2687099371078148e-08
- O 0 5.57916282559745e-05
0 O 0 1.1793011012173338e-09
RCC B-Disease 0 1.1464702964758544e-08
cells O 0 1.416492478867326e-09
are O 0 1.8910995816176501e-13
tumorigenic O 0 3.1650160963181406e-06
in O 0 1.2379517411176266e-09
nude O 1 0.9971014857292175
mice O 1 0.9863161444664001
which O 0 2.2588421411118276e-10
is O 0 2.253235033451706e-14
suppressed O 0 7.344237793870806e-14
by O 0 7.610033180474783e-17
the O 0 7.548713156700594e-16
reintroduction O 0 3.428433578700485e-11
of O 0 1.635236576409769e-14
VHL B-Disease 0 4.57390742667485e-05
. O 0 2.9062238726673684e-11

Remarkably O 0 1.772994835391728e-07
, O 0 2.6111801523093225e-12
this O 0 1.594303370420526e-14
occurs O 0 2.1563364971648874e-13
without O 0 1.6148165390514227e-15
affecting O 0 1.19052033856204e-12
the O 0 8.621406540065824e-13
growth O 0 1.0701239200328061e-10
rate O 0 6.255636286756072e-11
and O 0 1.6484910225073035e-12
cell O 0 1.2932765969253524e-08
cycle O 0 7.638198962212073e-10
profile O 0 5.173081147474834e-12
of O 0 2.9322856559801306e-16
these O 0 7.29412461420581e-13
cells O 0 1.3260716309748677e-11
in O 0 1.770241430927664e-14
culture O 0 4.146174029107108e-11
. O 0 6.1987875769886625e-12

The O 0 3.832749048693351e-11
786 O 0 4.5550213600975553e-10
- O 0 4.486486886889907e-06
0 O 0 2.5759039345985e-09
cell O 0 1.3152804001492768e-07
line O 0 8.102357895722889e-08
, O 0 2.0863685941657079e-13
like O 0 3.467867659701085e-11
many O 0 9.768850225272407e-13
cancer B-Disease 0 9.674450573982085e-09
cells O 0 1.0388583222831205e-11
, O 0 2.969862853904881e-12
fails O 0 5.2930690941366265e-09
to O 0 4.788969107339877e-14
exit O 0 1.7525368656290397e-10
the O 0 1.5693375825199737e-14
cell O 0 4.467910041938694e-09
cycle O 0 9.33989482976294e-11
upon O 0 3.0576807311290125e-15
serum O 0 1.5381212969955982e-10
withdrawal O 0 5.168154793011581e-10
. O 0 3.28455769527114e-11

Here O 0 1.5777368744807063e-08
, O 0 2.612480327554567e-12
it O 0 1.0747942791843046e-13
is O 0 6.858828114568016e-16
shown O 0 3.003886515681839e-15
that O 0 1.399357588821514e-16
reintroduction O 0 2.0964169799003035e-13
of O 0 4.0676738971193144e-17
the O 0 5.331395793047554e-14
wild O 0 3.152694327823724e-09
- O 0 1.5857837354360527e-07
type O 0 1.6989135431799696e-08
VHL B-Disease 0 1.430222766884981e-07
gene O 0 1.5312694445768216e-09
restores O 0 3.687267025043184e-08
the O 0 8.85102199323605e-14
ability O 0 9.742854309782722e-13
of O 0 8.983938911538963e-15
VHL O 0 0.00040779681876301765
- O 0 1.2498822798079345e-05
negative O 0 8.633662673673825e-10
RCC B-Disease 0 1.8583123164717108e-06
cancer I-Disease 0 8.123586212605005e-07
cells O 0 5.898161299644489e-12
to O 0 1.8282508211335535e-14
exit O 0 1.5965311017662742e-10
the O 0 2.561420009200479e-14
cell O 0 1.7310012978555278e-08
cycle O 0 3.233323830897916e-09
and O 0 8.624926402418798e-13
enter O 0 1.829397917874065e-11
G0 O 0 1.3082668282038412e-08
/ O 0 7.265996515570805e-08
quiescence O 0 1.3792345043839305e-09
in O 0 8.840650108678239e-13
low O 0 2.8448610134290675e-09
serum O 0 3.493512323871073e-08
. O 0 4.755369275438737e-12

Both O 0 3.4808067539415788e-09
VHL O 0 0.0001027509497362189
- O 0 6.901658343849704e-05
positive O 0 1.0006632189529796e-09
and O 0 5.869266878066881e-11
VHL O 0 1.188964961329475e-05
- O 0 1.182227038043493e-06
negative O 0 5.2126723076861836e-11
RCC B-Disease 0 1.6480417031061734e-08
cells O 0 1.656113912673618e-09
exit O 0 4.6281292687133657e-10
the O 0 7.183854985220225e-15
cell O 0 5.2974824527041164e-09
cycle O 0 4.402976594430896e-11
by O 0 8.218153999860005e-16
contact O 0 4.919021856508721e-10
inhibition O 0 1.9455927979805665e-09
. O 0 2.236919330322884e-11

The O 0 1.0278490558679465e-10
cyclin O 0 3.065574816218941e-08
- O 0 1.568551399877549e-09
dependent O 0 1.0440268441436196e-11
kinase O 0 1.65063618329242e-09
inhibitor O 0 3.997022157697927e-11
, O 0 1.0872800784575897e-15
p27 O 0 6.0342330091001095e-12
, O 0 3.642795209224522e-15
accumulates O 0 8.528151058603828e-13
upon O 0 1.866485538971522e-16
serum O 0 6.35289694114749e-12
withdrawal O 0 4.1750762569403577e-11
, O 0 1.43870551865162e-13
only O 0 2.2427913204999678e-13
in O 0 3.907343503926301e-15
the O 0 7.386463572137559e-15
presence O 0 5.080790389105916e-12
of O 0 4.752094650299816e-16
VHL B-Disease 0 1.0464425486134132e-06
, O 0 3.8909840789896205e-14
as O 0 7.297708071792464e-15
a O 0 4.4162420844828104e-14
result O 0 5.998987656456733e-13
of O 0 1.1749697764357445e-17
the O 0 2.0783829538862427e-15
stabilization O 0 3.321015879832745e-13
of O 0 8.999296254147394e-17
the O 0 2.92640565913941e-14
protein O 0 2.82878970248035e-10
. O 0 4.614049160106548e-12

We O 0 1.7588031031579021e-09
propose O 0 1.5245534001895322e-11
that O 0 4.750797736978452e-13
the O 0 4.408272182075505e-14
loss O 0 3.868580802923738e-12
of O 0 7.859726184877836e-16
wild O 0 4.400339150834043e-07
- O 0 9.084951307158917e-05
type O 0 1.2051777048327494e-05
VHL B-Disease 0 0.00018734921468421817
gene O 0 3.775338655032101e-06
results O 0 1.8951600705419125e-11
in O 0 6.112034237431871e-17
a O 0 1.176612514118883e-15
specific O 0 5.4991113659225155e-14
cellular O 0 7.741653007542482e-08
defect O 0 3.7416175473481417e-06
in O 0 4.329217973692012e-12
serum O 0 2.504363510524854e-05
- O 0 2.36333016800927e-05
dependent O 0 5.07141919570131e-08
growth O 0 5.106426836931632e-09
control O 0 5.525019332708325e-06
, O 0 2.717736409182936e-12
which O 0 1.4984108788820838e-12
may O 0 2.7666896009435893e-13
initiate O 0 2.8337172018610968e-12
tumor B-Disease 0 4.831386402059934e-09
formation O 0 2.661264221145987e-12
. O 0 3.238412663031376e-11

This O 0 3.184869035166571e-11
is O 0 1.406423805541679e-13
corrected O 0 2.1174950681768223e-09
by O 0 3.0209612705303873e-16
the O 0 2.672423888696392e-16
reintroduction O 0 4.038988588028758e-11
of O 0 1.5508856473903966e-14
wild O 0 1.109850018110592e-06
- O 0 0.00294771627523005
type O 0 1.915759639814496e-05
VHL B-Disease 0 0.0002549600030761212
, O 0 3.815663930650803e-12
implicating O 0 7.017756598060032e-09
VHL B-Disease 0 1.0354994628869463e-05
as O 0 1.0347208116365247e-12
the O 0 2.6450717125218928e-15
first O 0 3.8418991973225916e-14
tumor B-Disease 0 5.5228335793522376e-11
suppressor O 0 2.7470897084880264e-11
involved O 0 3.816865226657917e-12
in O 0 8.178975210862763e-14
the O 0 2.6099622815614967e-14
regulation O 0 7.581008737433947e-11
of O 0 1.315608132604031e-16
cell O 0 6.309737443643826e-08
cycle O 0 6.295597376748674e-09
exit O 0 3.3872669114032306e-09
, O 0 2.3627781588902996e-12
which O 0 1.4180509197436741e-11
is O 0 2.341185784734273e-13
consistent O 0 1.2085579932652468e-12
with O 0 2.2949245975111996e-15
its O 0 9.332770796140807e-15
gatekeeper O 0 3.494679390314559e-07
function O 0 1.7408506858274109e-09
in O 0 1.2528292205743474e-12
the O 0 2.8328268550370517e-11
kidney O 0 3.0444116561056944e-08
. O 0 7.298197826242567e-14
. O 0 8.149364863485609e-12

Piebaldism B-Disease 1 0.9999995231628418
with O 0 0.37777233123779297
deafness B-Disease 1 1.0
: O 0 4.3106174185680857e-10
molecular O 0 3.389307168255584e-10
evidence O 0 5.987205523028116e-12
for O 0 6.8233145641884846e-15
an O 0 5.9157596356274045e-12
expanded O 1 0.9635789394378662
syndrome O 1 0.9999935626983643
. O 0 1.395198956366528e-10

In O 0 8.496203740548935e-12
a O 0 1.5372699641025278e-11
South O 0 8.786089722434554e-08
African O 0 5.200405210625814e-12
girl O 0 4.6328546554619265e-10
of O 0 1.0131819538691388e-15
Xhosa O 0 1.063706577042467e-06
stock O 0 1.573987190583992e-10
with O 0 3.9959054403022887e-13
severe O 0 2.5968103223306116e-09
piebaldism B-Disease 0 3.91243202102487e-06
and O 0 8.93158080828016e-09
profound O 0 1.061493470899677e-08
congenital O 1 0.999987006187439
sensorineural B-Disease 1 0.9999966621398926
deafness I-Disease 1 1.0
we O 0 0.03103042207658291
identified O 0 5.935906766119103e-10
a O 0 9.260849228589444e-15
novel O 0 1.031241281604367e-12
missense O 0 5.562766358657711e-10
substitution O 0 4.8682507677866305e-12
at O 0 1.0786352280106604e-12
a O 0 3.2045685261606434e-15
highly O 0 3.9357966111739934e-15
conserved O 0 7.188264740387584e-12
residue O 0 2.8804438834129087e-09
in O 0 1.234713320355605e-14
the O 0 5.548965777022125e-15
intracellular O 0 1.1321833748301202e-10
kinase O 0 8.594202682843388e-09
domain O 0 2.921596992111475e-11
of O 0 5.344921363380076e-16
the O 0 1.93791854850682e-13
KIT O 0 8.846441090781809e-08
proto O 0 4.5979898999348734e-08
- O 0 8.72869243551122e-09
oncogene O 0 3.160744332930676e-09
, O 0 7.355456846901143e-13
R796G O 0 1.6227906796117963e-09
. O 0 3.560486107334615e-12

Though O 0 1.2253602577061429e-09
auditory B-Disease 0 1.2152407080634475e-08
anomalies I-Disease 0 0.00021902417938690633
have O 0 1.2386366377015179e-09
been O 0 2.816400411498332e-11
observed O 0 1.1230663621297765e-10
in O 0 8.434777941206117e-13
mice O 0 6.6630773289944045e-06
with O 0 1.6140152365659577e-12
dominant O 0 7.453328976225748e-07
white O 0 1.3645401253370437e-08
spotting O 0 4.78364836453693e-06
( O 0 8.21723453170442e-11
W O 1 0.9692338109016418
) O 0 7.110222783809905e-13
due O 0 9.692014985712705e-13
to O 0 1.4972518017075664e-11
KIT O 0 0.0017268024384975433
mutations O 0 0.026490962132811546
, O 0 2.1677115569218586e-07
deafness B-Disease 1 1.0
is O 0 1.0603849176504809e-07
not O 0 1.6040894168511954e-09
typical O 0 3.516398561220768e-10
in O 0 3.065019375456113e-12
human O 0 2.0122618848983365e-10
piebaldism B-Disease 0 1.8601688225317048e-06
. O 0 7.141898877849329e-11

Thus O 0 2.921307293290987e-11
, O 0 2.801293471819087e-14
the O 0 4.014630973426576e-16
occurrence O 0 4.055786609336032e-11
of O 0 2.946901620295983e-13
sensorineural B-Disease 1 0.9999967813491821
deafness I-Disease 1 1.0
in O 0 7.628815268390099e-08
this O 0 9.305181625229864e-12
patient O 0 4.768186540049513e-11
extends O 0 1.8690390489635444e-13
considerably O 0 2.9677042073794624e-13
the O 0 1.5043135736646923e-15
phenotypic O 0 2.3439796111024425e-12
range O 0 1.6522724161083246e-11
of O 0 6.15859232981999e-15
piebaldism B-Disease 0 2.711451543291332e-06
due O 0 2.4161735112659954e-11
to O 0 1.0312197059811345e-12
KIT O 0 6.670273222653123e-08
gene O 0 5.913185496808637e-09
mutation O 0 5.1925578420375373e-11
in O 0 1.4216533224080397e-14
humans O 0 2.303086332755555e-10
and O 0 8.345009579191487e-12
tightens O 0 0.021965233609080315
the O 0 2.0135103436999535e-13
clinical O 0 1.2341555555295258e-10
similarity O 0 2.762599394037779e-12
between O 0 4.65196511954119e-13
piebaldism B-Disease 0 7.259567951223289e-07
and O 0 1.7909302513219316e-11
the O 0 1.999592796165595e-15
various O 0 4.1624884623641355e-15
forms O 0 1.8526079975655918e-11
of O 0 6.101244509615356e-11
Waardenburg B-Disease 1 0.9999972581863403
syndrome I-Disease 1 0.9999843835830688
. O 0 3.7989817997137465e-13
. O 0 3.64921244264127e-12

Cycloheximide O 0 6.826018648098398e-07
facilitates O 0 8.974468390654522e-11
the O 0 5.339361121476944e-15
identification O 0 7.203876980620832e-14
of O 0 1.9871591465932899e-16
aberrant O 0 1.7889245640390072e-09
transcripts O 0 1.0234899150418642e-07
resulting O 0 6.03343000560308e-11
from O 0 7.932079845111416e-15
a O 0 5.214228029383483e-13
novel O 0 5.243347422911881e-10
splice O 0 0.00010363577894167975
- O 0 3.3833764518931275e-06
site O 0 9.529914635209025e-09
mutation O 0 5.916295786612125e-10
in O 0 1.424761594511284e-14
COL17A1 O 0 7.496930010120195e-08
in O 0 1.1229419866578324e-14
a O 0 2.8439167795886455e-13
patient O 0 9.722277843904337e-11
with O 0 6.002593170781334e-13
generalized O 0 8.911979421100114e-06
atrophic B-Disease 1 0.9999692440032959
benign I-Disease 1 0.9993078708648682
epidermolysis I-Disease 1 0.9976165294647217
bullosa I-Disease 1 0.987528920173645
. O 0 3.2613773015555125e-08

Patients O 0 1.0505633554203087e-06
with O 0 4.6174694623424273e-10
generalized O 0 0.0005381804658100009
atrophic B-Disease 1 0.9999517202377319
benign I-Disease 1 0.9998308420181274
epidermolysis I-Disease 1 0.9989854693412781
bullosa I-Disease 1 0.9951268434524536
often O 0 1.622041963855736e-05
show O 0 3.7217052550886365e-08
decreased O 0 2.1050247767107066e-08
expression O 0 8.617400196198055e-12
of O 0 4.3809889120312653e-14
type O 0 4.223351788823493e-05
XVII O 0 2.6415415049996227e-05
collagen O 0 0.006128689274191856
, O 0 2.8839611254660724e-10
a O 0 3.269723250834411e-12
transmembrane O 0 9.006231316277535e-10
hemidesmosomal O 0 8.055997535727499e-10
protein O 0 5.719965733702592e-12
encoded O 0 2.926701443044591e-14
by O 0 3.0328804111147065e-14
COL17A1 O 0 2.3497659640270285e-07
. O 0 2.9185168171075304e-11

This O 0 6.805858654423957e-11
report O 0 2.991323985387928e-12
documents O 0 5.459502750056189e-14
a O 0 3.246418162506509e-13
novel O 0 7.853977190830363e-11
splice O 0 1.922988121805247e-05
- O 0 8.325649105245247e-06
site O 0 1.2969672447127323e-08
mutation O 0 8.819038832541537e-10
in O 0 1.249977955207959e-14
COL17A1 O 0 4.244099471861773e-08
in O 0 5.007319970988522e-15
a O 0 7.962950502975186e-13
patient O 0 2.907023788356611e-10
with O 0 4.077479239666948e-12
generalized O 0 4.201314368401654e-05
atrophic B-Disease 1 0.9999836683273315
benign I-Disease 1 0.9995880722999573
epidermolysis I-Disease 1 0.9967429041862488
bullosa I-Disease 0 0.441145122051239
, O 0 1.8541229662716319e-09
and O 0 6.275180028381122e-13
applies O 0 5.199685896694478e-14
a O 0 4.488016776521119e-16
new O 0 1.559460288970394e-15
methodology O 0 1.0511349549015975e-13
to O 0 4.321604872055277e-15
define O 0 3.9198328610767774e-11
and O 0 1.5729171437550704e-12
characterize O 0 6.608813052366713e-09
the O 0 1.830038128414896e-13
resulting O 0 5.351295578534532e-13
mRNA O 0 5.1684091034731594e-11
splice O 0 4.2026144342344196e-07
variants O 0 8.034399456846586e-08
. O 0 9.75904496103297e-11

Mutational O 0 3.496670160529902e-06
analysis O 0 4.320692970072315e-10
of O 0 2.1452346057318147e-14
COL17A1 O 0 1.3223288988228887e-06
identified O 0 1.3236824969453664e-09
a O 0 2.2307229848028687e-12
maternally O 0 6.455550050077363e-08
inherited O 0 3.5449324968794826e-06
G O 0 7.433236987708369e-06
- O 0 3.3321347814307956e-07
to O 0 2.668705034736263e-09
- O 0 4.24422905780375e-05
T O 0 1.2849801578340703e-06
transversion O 0 3.0665265882134918e-09
at O 0 1.2374335063569664e-11
the O 0 6.729377339788562e-15
- O 0 4.494515037922753e-10
1 O 0 2.62135707698773e-14
position O 0 7.467907992301723e-14
of O 0 1.8602292742137628e-17
exon O 0 7.465986162635829e-10
32 O 0 8.225894410074375e-10
. O 0 6.1321342968712056e-12

This O 0 3.5796816899580364e-12
acceptor O 0 7.501706721091406e-12
splice O 0 1.6083056664228934e-08
- O 0 2.644183183519999e-08
site O 0 3.1300442793202876e-10
mutation O 0 1.1112914061195411e-10
led O 0 7.166495044966248e-13
to O 0 5.910539578249515e-15
the O 0 2.772064185930178e-15
formation O 0 4.269871911285247e-15
of O 0 1.4739109472969998e-17
aberrant O 0 2.2304052701982435e-11
transcripts O 0 3.786301050467955e-09
present O 0 1.631907391337617e-12
at O 0 3.331480924462227e-11
extremely O 0 1.6415766315724944e-11
low O 0 7.742506191732446e-09
levels O 0 1.6600219809870254e-10
. O 0 1.1027773312577427e-11

Based O 0 2.544640054225056e-10
on O 0 1.4924618832456993e-11
our O 0 1.3460540733249704e-13
recent O 0 3.838983709918142e-14
finding O 0 9.26947287102544e-15
that O 0 1.3607621567090014e-14
cycloheximide O 0 5.78720396049448e-08
stabilized O 0 5.212978635427135e-07
mutant O 0 6.055857482145655e-10
COL17A1 O 0 6.92182977601874e-09
transcripts O 0 3.1840688419215724e-10
in O 0 1.2419407983846418e-14
keratinocytes O 0 1.6586072792978968e-10
homozygous O 0 1.5591086364660778e-12
for O 0 1.6400138104685476e-16
a O 0 2.815955612136059e-14
frameshift O 0 1.7823377618242375e-07
mutation O 0 2.2410511224535412e-09
, O 0 9.891898769282675e-14
the O 0 3.399841172480045e-14
effects O 0 6.292593113244038e-10
of O 0 3.744291355645742e-15
the O 0 3.843308321333644e-13
splice O 0 1.2530092135421e-05
- O 0 1.6953594084156975e-08
site O 0 6.003583741254204e-11
mutation O 0 7.174523019952417e-13
on O 0 2.2506983603570925e-16
splicing O 0 1.864038003812629e-12
of O 0 9.552295610396654e-17
COL17A1 O 0 1.6618277587365782e-10
transcripts O 0 3.667396247797328e-12
were O 0 2.9567739078808445e-15
determined O 0 6.358863529319376e-15
using O 0 5.4224508184378545e-15
reverse O 0 1.2289179673885542e-09
transcriptase O 0 3.546368532170163e-08
polymerase O 0 6.987487255472047e-10
chain O 0 7.53857698487792e-10
reaction O 0 1.574526099779039e-12
of O 0 8.682513211063676e-17
total O 0 2.181362593811284e-14
RNA O 0 1.5343603720907595e-08
from O 0 1.3615357518997288e-14
keratinocytes O 0 3.3077092176370115e-09
incubated O 0 2.447791414006417e-10
for O 0 2.216592049340306e-15
2 O 0 5.0847845899093524e-12
. O 0 3.620731102091379e-12

5 O 0 8.830349784716418e-10
h O 0 2.567987600343713e-08
in O 0 3.246540406301457e-14
the O 0 3.8096319854167074e-14
presence O 0 5.462291730040647e-11
or O 0 2.6335277274885938e-12
absence O 0 1.879471404897526e-12
of O 0 4.399196372276441e-16
10 O 0 6.972220110285088e-13
microg O 0 7.79124498251349e-09
cycloheximide O 0 2.0530865896262185e-09
per O 0 8.409520638446438e-14
ml O 0 2.3944575211487518e-09
. O 0 2.176050832580767e-11

Using O 0 2.280128343079557e-12
this O 0 2.935836862787318e-14
approach O 0 5.556157964270447e-11
, O 0 4.872902211947028e-13
an O 0 4.3047833906458693e-14
abnormally O 0 1.0906324376946941e-07
spliced O 0 0.1662038415670395
transcript O 0 0.03796015679836273
was O 0 5.641704348136045e-08
identified O 0 4.734007075235525e-10
that O 0 7.322693849670572e-15
contains O 0 2.0156514820543524e-16
an O 0 1.6962279791936918e-17
extra O 0 2.9561158479841226e-14
264 O 0 3.100153326326266e-13
bases O 0 5.448569928567792e-10
upstream O 0 1.6367172374354144e-12
from O 0 8.229349260793645e-17
exon O 0 1.4604661230377403e-11
32 O 0 6.332542268339125e-10
, O 0 5.954207938328737e-14
resulting O 0 5.090699522623983e-14
in O 0 1.577690005006259e-14
a O 0 1.5318689242441175e-12
premature O 0 4.6750787269234095e-11
termination O 0 4.000208150833906e-12
codon O 0 9.477427176385333e-11
27 O 0 3.560433545213293e-11
bp O 0 5.761794253517083e-12
downstream O 0 1.4536351289340388e-11
from O 0 9.475071484246582e-16
the O 0 4.371462501880086e-15
cryptic O 0 4.564237876536481e-11
splice O 0 2.622050772060902e-07
site O 0 4.122222563296418e-09
. O 0 1.8406257420999772e-11

Three O 0 6.20361678693726e-11
other O 0 2.0920180667546688e-14
splice O 0 1.3592514669369393e-08
variants O 0 8.368735149311135e-10
, O 0 1.3794612153950059e-12
including O 0 7.22965575074416e-15
one O 0 1.758151221451735e-14
derived O 0 1.3262857769975596e-16
from O 0 4.4824196092754423e-17
the O 0 9.608614036966205e-17
skipping O 0 1.1559889330492457e-12
of O 0 4.193147269876258e-17
exon O 0 3.263470882419739e-10
32 O 0 6.426406962134479e-09
, O 0 6.649335487600438e-13
were O 0 4.0983500772771853e-13
also O 0 9.573148697372691e-12
identified O 0 1.0870448985400571e-09
. O 0 6.915115615541145e-12

These O 0 2.556334588454945e-10
results O 0 1.7267152985223078e-11
indicate O 0 9.125998567949267e-13
the O 0 1.1262276062844081e-15
usefulness O 0 6.387975651916955e-12
of O 0 2.3964409668440355e-16
cycloheximide O 0 4.216150841784838e-07
treatment O 0 2.1363578961430818e-10
in O 0 1.0071277329390795e-16
evaluating O 0 1.6286416117637648e-13
the O 0 4.868967303449899e-15
abnormal O 0 7.461565219857302e-12
processing O 0 3.113878512678303e-13
of O 0 7.81434083607497e-17
mRNA O 0 1.903797258728801e-11
due O 0 2.059877008547817e-12
to O 0 9.117903779004219e-14
splice O 0 7.514762728533242e-06
- O 0 3.402654726869514e-07
site O 0 3.6495662047997257e-09
mutations O 0 1.6379198441995868e-08
, O 0 6.590722976054786e-13
because O 0 1.1572734957832065e-11
( O 0 1.185722256057814e-13
i O 0 2.6138000652764504e-09
) O 0 6.154247474317049e-15
aberrant O 0 6.756418341469228e-13
splicing O 0 4.513732998479014e-10
often O 0 7.737323151971176e-13
generates O 0 1.4910254901947563e-14
a O 0 1.4665331937117193e-13
premature O 0 9.106198434194468e-12
termination O 0 2.4990968496008126e-12
codon O 0 4.558617372474316e-11
, O 0 1.8539564414915555e-13
( O 0 1.0001302561189578e-14
ii O 0 1.4725533292736515e-10
) O 0 2.0975237809118218e-14
transcripts O 0 1.6383672196695898e-11
with O 0 1.8884358324051248e-13
premature O 0 2.1402803140890825e-11
termination O 0 6.895763799384669e-13
codons O 0 1.484303652210528e-10
can O 0 4.2187367488288885e-10
occur O 0 1.6908396904824485e-10
at O 0 5.698552185684491e-10
low O 0 6.216429682126545e-08
or O 0 6.201797964067168e-10
undetectable O 0 3.8181042327778414e-07
levels O 0 2.0498132705104588e-11
due O 0 1.2131302093518898e-13
to O 0 5.332944372563042e-13
nonsense O 0 1.0517657500486166e-07
- O 0 4.705831724294285e-09
mediated O 0 4.798256930671485e-11
mRNA O 0 4.086430900693966e-13
decay O 0 8.825866426587226e-11
, O 0 4.7174754608334674e-14
and O 0 9.948264407351123e-14
( O 0 5.764706656874571e-16
iii O 0 2.8486104100555742e-11
) O 0 1.1544767691742258e-13
the O 0 1.9973448554268768e-14
levels O 0 1.4631217515759937e-13
of O 0 5.936810913913538e-18
these O 0 3.552686150229715e-15
transcripts O 0 1.965464180297971e-10
can O 0 1.8650445771095647e-12
be O 0 8.93734320559403e-16
increased O 0 4.8556870973863724e-15
by O 0 1.4440080465453857e-14
cycloheximide O 0 1.2993301652386435e-06
. O 0 1.0732001398672253e-10

A O 0 1.4898544897778976e-10
deletion O 0 2.6459138879886268e-08
mutation O 0 3.954817362483709e-09
in O 0 1.1146798409430655e-13
COL17A1 O 0 4.7925846047292e-06
in O 0 1.0787010390825302e-12
five O 0 1.0032536433557393e-11
Austrian O 0 0.0005735745071433485
families O 0 3.1438144188628003e-12
with O 0 1.3762426094576785e-11
generalized O 0 1.2809089639631566e-05
atrophic B-Disease 1 0.999947190284729
benign I-Disease 1 0.9977084398269653
epidermolysis I-Disease 1 0.9934206604957581
bullosa I-Disease 0 0.014371274039149284
represents O 0 2.6828799598588304e-11
propagation O 0 3.042659874052944e-11
of O 0 4.1560603293274226e-16
an O 0 2.526507428697025e-15
ancestral O 0 1.6340910846679435e-08
allele O 0 6.154395659763168e-09
. O 0 1.1122096299498452e-10

Patients O 0 3.849851964332629e-06
with O 0 1.0912432069076772e-09
generalized O 0 0.0007912388537079096
atrophic B-Disease 1 0.9999785423278809
benign I-Disease 1 0.9998173117637634
epidermolysis I-Disease 1 0.9988400340080261
bullosa I-Disease 1 0.9417606592178345
, O 0 2.2627187623580625e-10
a O 0 6.230742376038545e-13
usually O 0 2.2826204359831237e-13
nonlethal O 0 1.2747897182308066e-10
form O 0 2.844722547801215e-11
of O 0 4.403226481347611e-12
junctional B-Disease 1 0.9993789196014404
epidermolysis I-Disease 1 0.9969213008880615
bullosa I-Disease 0 0.1396743357181549
, O 0 1.2598275200836895e-10
have O 0 6.075310827330371e-12
generalized O 0 3.667162407072766e-10
blistering B-Disease 0 2.005616437372737e-07
, O 0 1.3764060724508198e-10
nail B-Disease 1 0.9986200332641602
dystrophy I-Disease 1 0.8633424043655396
, O 0 2.6012109133333183e-10
patchy B-Disease 0 0.015882128849625587
alopecia I-Disease 1 0.9999911785125732
, O 0 3.9099294468769585e-08
and O 0 3.6688867055545415e-08
dental B-Disease 1 0.9863666892051697
abnormalities I-Disease 1 0.9984669089317322
. O 0 1.8481374763901215e-10

Skin B-Disease 1 0.9999922513961792
fragility I-Disease 0 0.00016563347890041769
in O 0 1.7657742130451626e-13
most O 0 1.902008586707974e-14
cases O 0 1.5849998180259006e-12
is O 0 8.211804717120352e-13
due O 0 1.0723417596600338e-12
to O 0 6.148527867400055e-13
mutations O 0 3.02183472689066e-10
in O 0 2.8163733264339975e-15
the O 0 1.4608364312733131e-15
gene O 0 1.1133296541621096e-11
encoding O 0 2.5065881661956446e-11
type O 0 2.652249349921476e-05
XVII O 0 8.190696462406777e-06
collagen O 0 0.0005082323332317173
( O 0 9.534376760322871e-11
COL17A1 O 0 3.0019009500392713e-06
) O 0 9.170148147774615e-12
. O 0 8.036145533740768e-12

Recently O 0 7.123065188352484e-06
, O 0 1.7779196170852885e-10
we O 0 1.1451819353913706e-10
reported O 0 1.724562680160968e-11
five O 0 2.1602431486428958e-13
Austrian O 0 5.583517577179009e-06
families O 0 1.3377952174861707e-12
with O 0 3.33063437940595e-12
generalized O 0 1.5876155885052867e-05
atrophic B-Disease 1 0.999904990196228
benign I-Disease 1 0.9980265498161316
epidermolysis I-Disease 1 0.9856614470481873
bullosa I-Disease 1 0.8343493938446045
who O 0 7.596791419928195e-06
share O 0 3.481730962567875e-12
the O 0 6.396454682111932e-14
same O 0 1.2581116703991313e-12
COL17A1 O 0 2.2360872264926002e-07
mutation O 0 2.5492465915988305e-09
. O 0 7.598912818429504e-12

Affected O 0 9.336217772215605e-07
individuals O 0 7.726646471077625e-13
in O 0 3.3013365261999605e-13
three O 0 6.5526468799592674e-12
families O 0 1.2208219800206345e-14
are O 0 9.15616013853399e-17
homozygous O 0 2.6493698118061453e-14
for O 0 6.085930402533168e-17
4003delTC O 0 2.747886293508195e-11
, O 0 6.00812260186101e-14
whereas O 0 2.160203222897894e-12
those O 0 7.336730032639523e-15
in O 0 3.218063836241125e-14
two O 0 1.9884435894720887e-13
others O 0 3.4653500229943346e-14
are O 0 4.817989049035873e-16
compound O 0 1.6596388152656516e-10
heterozygotes O 0 6.395885598919904e-09
. O 0 1.5961496013794374e-11

To O 0 3.0889069080330955e-11
determine O 0 2.125654860463122e-11
if O 0 8.858914036374843e-13
the O 0 9.240906049604578e-16
occurrence O 0 3.0504620097265844e-12
of O 0 6.174066562975142e-16
4003delTC O 0 5.9366715987607677e-08
in O 0 1.581194214190368e-13
these O 0 1.2061296853307403e-14
unrelated O 0 3.1796110883108852e-12
families O 0 5.117683281818074e-15
signifies O 0 2.820382015735997e-16
propagation O 0 2.8227420401094605e-14
of O 0 9.921714637398959e-18
an O 0 9.336535804651793e-17
ancestral O 0 4.1389702776228887e-10
allele O 0 2.8209379276944446e-11
or O 0 5.111230991401705e-13
a O 0 4.370833393569501e-13
mutational O 0 1.4900798532835324e-06
hot O 0 7.983726959537307e-07
spot O 0 6.79307810003138e-09
, O 0 6.742126117380981e-14
haplotypes O 0 1.7157411602575223e-10
were O 0 4.745273184808552e-13
determined O 0 1.0321110285871349e-12
for O 0 7.584847846928258e-17
polymorphisms O 0 7.4010535477953e-09
both O 0 5.775550523945405e-11
within O 0 3.69206817896206e-11
and O 0 1.9410954787968393e-10
flanking O 0 0.00022238880046643317
COL17A1 O 0 0.0004875219310633838
. O 0 1.3488009320550276e-10

Five O 0 2.9872446183354384e-10
intragenic O 0 2.7974509375638945e-09
polymorphisms O 0 3.1075066964092457e-09
were O 0 2.4662153829541067e-12
chosen O 0 6.841157821442165e-14
based O 0 4.134567037697434e-14
on O 0 2.308986552304604e-12
their O 0 8.988747246529982e-13
informativeness O 0 9.020178026730719e-07
. O 0 2.5567478689758616e-11

One O 0 1.528289578223152e-10
of O 0 1.5915953425606828e-15
these O 0 8.706489712127438e-14
, O 0 6.74326100600503e-13
not O 0 2.3512155764016107e-12
previously O 0 3.5518601948503203e-11
reported O 0 1.189404824630813e-10
, O 0 4.870644360922827e-13
was O 0 1.624309367564969e-11
2988 O 0 3.029429207490608e-10
A O 0 4.1753548535305995e-11
or O 0 4.420932370186037e-12
C O 0 1.417904940126391e-07
that O 0 1.3891902764847502e-13
introduces O 0 6.256059038867168e-13
a O 0 3.538796927477113e-14
new O 0 4.4879098809631757e-14
restriction O 0 2.7531991443618953e-12
site O 0 2.450161601386114e-12
for O 0 4.229764477716282e-15
Eco0109 O 0 8.34330293741914e-09
I O 0 6.108321031206287e-07
. O 0 3.24310261805294e-12

All O 0 1.777870277212823e-12
the O 0 1.0300450034204326e-14
4003delTC O 0 8.307501908610959e-11
alleles O 0 6.02624720957845e-13
showed O 0 6.561901629703604e-12
the O 0 5.271597228382069e-17
same O 0 3.198033508153899e-16
haplotype O 0 9.320723880212878e-12
for O 0 8.740269608410088e-17
these O 0 6.019620692955161e-16
five O 0 4.765240495762085e-15
polymorphic O 0 2.9029886133846716e-11
markers O 0 6.075357532608905e-07
. O 0 1.7372607519217098e-10

Fourteen O 0 5.979405859335429e-10
microsatellite O 0 6.349211822964662e-09
polymorphisms O 0 1.095480817170369e-09
were O 0 3.2641276834222133e-12
selected O 0 2.5353524008421384e-14
based O 0 1.7261857226816626e-14
on O 0 1.0082931017896257e-11
their O 0 6.597351246036276e-13
high O 0 3.287219671813113e-12
heterozygosity O 0 5.474908082447882e-09
and O 0 1.381748326867438e-10
their O 0 1.2540375300142646e-14
location O 0 1.7453015421775575e-10
within O 0 3.77667385212388e-12
10q23 O 0 8.474157375815139e-09
- O 0 1.6455979690022104e-08
q25 O 0 4.3627963464132336e-09
near O 0 2.946053401231552e-09
COL17A1 O 0 4.106655637770018e-07
. O 0 1.3512540912585802e-11

Three O 0 2.3406592219998856e-09
families O 0 4.1776547499150496e-12
shared O 0 1.2376153053772487e-11
microsatellite O 0 9.444435278282981e-08
polymorphisms O 0 4.193398694951611e-07
covering O 0 1.934712656748161e-07
at O 0 6.7294623207203585e-09
most O 0 9.152757761768382e-13
19 O 0 1.5793881480430372e-10
cM O 0 1.1050840242887716e-09
, O 0 2.0387398366739085e-11
whereas O 0 4.662053521009568e-10
the O 0 2.8484783975990524e-12
others O 0 1.5849280221580386e-11
shared O 0 3.3479521238666266e-12
smaller O 0 1.3738873753943448e-11
regions O 0 4.937024122853018e-09
consistent O 0 5.8388432977452e-10
with O 0 1.9138365209021152e-13
cross O 0 1.110763772627088e-10
- O 0 3.9148101649288947e-08
over O 0 1.1355902884702118e-09
events O 0 1.2539414818990569e-11
during O 0 4.8010782903538246e-14
passage O 0 8.071357472628441e-15
of O 0 1.1561006286105523e-17
this O 0 1.981626380321384e-15
mutation O 0 2.594973118764249e-13
through O 0 1.3711044078191527e-15
several O 0 2.977227635974668e-14
generations O 0 2.568393848295658e-12
. O 0 9.93289218237381e-13

These O 0 7.853067085505927e-10
results O 0 4.341185050327212e-11
indicate O 0 6.767617282549265e-12
that O 0 2.7687062169844123e-13
4003delTC O 0 1.6867835483935778e-07
occurs O 0 1.6363372462580017e-11
on O 0 5.1597628621981306e-14
a O 0 7.263547233029698e-15
single O 0 1.211918342373594e-13
ancestral O 0 2.8280128239188684e-10
allele O 0 1.8197335999170505e-11
. O 0 6.63501968211494e-13
. O 0 1.2265416547002639e-12

The O 0 6.895099768922108e-11
haptoglobin O 0 6.452534506706797e-08
- O 0 4.457884728026329e-08
gene O 0 3.5664455833028796e-09
deletion O 0 3.283583849267302e-09
responsible O 0 5.846035894957469e-12
for O 0 3.144698924547641e-14
anhaptoglobinemia B-Disease 0 5.375258751882939e-06
. O 0 1.1813648670422339e-10

We O 0 4.0363076436733536e-07
have O 0 6.898618503704823e-13
found O 0 1.050400369813256e-15
an O 0 5.148829976999092e-18
allelic O 0 1.0479811463071087e-11
deletion O 0 5.4827687279157544e-08
of O 0 3.8039809204058056e-15
the O 0 7.493579866867106e-13
haptoglobin O 0 6.690775222750744e-08
( O 0 1.8625930943536213e-14
Hp O 0 9.921229419604383e-13
) O 0 3.667609293524221e-14
gene O 0 1.6943683955883415e-10
from O 0 3.095659782659764e-15
an O 0 9.223091040899689e-15
individual O 0 1.930170738138285e-14
with O 0 9.8880790708189e-12
anhaptoglobinemia B-Disease 0 0.00011062846897402778
. O 0 2.586734437759475e-10

The O 0 8.555314442992845e-12
Hp O 0 1.969964330550411e-10
gene O 0 1.7780764638430924e-09
cluster O 0 2.150360778330196e-09
consists O 0 8.22039268252861e-13
of O 0 1.858323370673102e-15
coding O 0 1.912647348945029e-05
regions O 0 1.1727141924211537e-07
of O 0 8.715046100147422e-14
the O 0 1.0239678029100308e-12
alpha O 0 3.4539293083599154e-13
chain O 0 2.0578234227741632e-08
and O 0 1.8808268744535672e-12
beta O 0 2.1699218891993097e-14
chain O 0 1.0321377086341954e-10
of O 0 2.695542594200514e-16
the O 0 4.1063211994119345e-14
haptoglobin O 0 4.056933955443043e-10
gene O 0 7.403799795469013e-11
( O 0 9.705985371162313e-16
Hp O 0 5.994995624057642e-13
) O 0 3.230475782711739e-13
and O 0 7.415639283192554e-12
of O 0 8.160921042405216e-16
the O 0 2.0169083688337947e-13
alpha O 0 3.701039854361182e-13
chain O 0 8.481971747187345e-08
and O 0 2.3622913521148536e-12
beta O 0 7.512309459396793e-14
chain O 0 1.2975620578004055e-10
of O 0 4.3880007142961075e-16
the O 0 9.271404444958359e-14
haptoglobin O 0 1.0437855024747478e-08
- O 0 7.642789179307385e-10
related O 0 2.0434777134314963e-11
gene O 0 2.6342952264002406e-09
( O 0 9.026293947033467e-15
Hpr O 0 1.1453441528530561e-09
) O 0 1.8440465625844948e-13
, O 0 1.6289180833177486e-13
in O 0 2.1324169643607838e-14
tandem O 0 2.2697284407513507e-07
from O 0 1.0382114682934776e-13
the O 0 3.865114391737867e-12
5 O 0 1.3688091771157929e-09
side O 0 5.141113490481075e-08
. O 0 3.542584281479577e-11

Southern O 0 4.8825064880020363e-08
blot O 0 1.1812086086138152e-05
and O 0 7.673451175686796e-13
PCR O 0 2.980528879259481e-10
analyses O 0 4.0537063289436404e-11
have O 0 2.59616113329475e-13
indicated O 0 1.0224441085449065e-11
that O 0 1.5068218753907375e-13
the O 0 2.427297085387265e-14
individual O 0 5.293625577489948e-16
with O 0 2.0363271751320036e-14
anhaptoglobinemia B-Disease 0 1.871605270764576e-08
was O 0 5.445842127943523e-12
homozygous O 0 3.20472306732187e-14
for O 0 4.095606793788495e-17
the O 0 3.8277493001804717e-16
gene O 0 3.424669228757615e-11
deletion O 0 8.603022183528708e-10
and O 0 5.79712113816383e-13
that O 0 1.4476785791190175e-14
the O 0 8.724983575387904e-16
gene O 0 1.764001965331996e-11
deletion O 0 2.618634198370273e-10
was O 0 2.3863215223296486e-11
included O 0 9.273633158049174e-14
at O 0 6.314179647887164e-12
least O 0 4.5739304813281756e-14
from O 0 5.710383257593601e-16
the O 0 8.080136969126732e-15
promoter O 0 8.906506643313605e-09
region O 0 9.917204210618813e-12
of O 0 1.1489742525664487e-16
Hp O 0 4.333043038956541e-12
to O 0 1.719127905351961e-14
Hpr O 0 1.1085646983710618e-10
alpha O 0 1.9990333309039335e-14
but O 0 9.613436349059645e-13
not O 0 2.1458904802835327e-13
to O 0 3.560380682225868e-14
Hpr O 0 2.2796459830942695e-08
beta O 0 8.190114385298042e-12
( O 0 1.2954557131877875e-13
Hpdel O 0 1.2112562330912624e-07
) O 0 2.08252122144148e-12
. O 0 1.6067916094875123e-11

In O 0 1.3087383824231247e-12
addition O 0 3.1802219278148636e-13
, O 0 1.081212550047006e-11
we O 0 1.679375249974413e-10
found O 0 5.579472973048227e-13
seven O 0 3.722657710656394e-15
individuals O 0 7.040704120880868e-18
with O 0 2.1381013177665126e-15
hypohaptoglobinemia B-Disease 0 2.7333280172570085e-07
in O 0 3.932906084136434e-12
three O 0 8.345964544465012e-12
families O 0 6.350298162750151e-14
, O 0 7.377934119765298e-14
and O 0 8.301823312996393e-13
the O 0 7.309967179638076e-15
genotypes O 0 2.9572071787858922e-12
of O 0 3.903811005959336e-16
six O 0 4.75899831695048e-12
of O 0 1.671607610005541e-16
the O 0 3.8607284686895116e-13
seven O 0 4.0550944763531604e-13
individuals O 0 3.115345490098444e-17
were O 0 5.915073745616168e-15
found O 0 5.441706655597012e-13
to O 0 1.199239275592734e-13
be O 0 1.3710019447846222e-12
Hp2 O 0 9.376672096550465e-06
/ O 0 3.893850134772947e-06
Hpdel O 0 1.2141515526309377e-06
. O 0 1.7450178455002963e-11

The O 0 1.0846480658077695e-10
phenotypes O 0 4.796315167254761e-08
and O 0 1.112447217677115e-10
genotypes O 0 1.3175565083400897e-09
in O 0 2.4794296932424686e-13
one O 0 7.900876675993873e-13
of O 0 1.2781457182315455e-16
these O 0 3.0069390445468247e-13
three O 0 2.945519262526064e-13
families O 0 1.6572758654775574e-14
showed O 0 1.1718183368092383e-10
the O 0 5.546616531142915e-15
father O 0 2.0973030603888e-11
to O 0 2.941004441391927e-14
be O 0 4.8700474398642377e-14
hypohaptoglobinemic B-Disease 0 6.006656838586366e-10
( O 0 3.853919018360604e-15
Hp2 O 0 2.6626343352376125e-09
) O 0 5.0929041799790964e-14
and O 0 3.873141499362298e-13
Hp2 O 0 1.5416421206282394e-07
/ O 0 2.901193951743153e-08
Hpdel O 0 8.930627792835821e-09
, O 0 1.7077394457321732e-13
the O 0 1.9202343640406343e-14
mother O 0 1.0794539706537876e-09
to O 0 2.937237177655719e-14
be O 0 2.050369456738175e-14
Hp2 O 0 9.951325985468884e-09
- O 0 4.251015983669504e-09
1 O 0 1.954030605941584e-13
and O 0 2.9813087762398105e-13
Hp1 O 0 3.054660524526298e-08
/ O 0 7.39158345641755e-10
Hp2 O 0 6.681969422217549e-10
, O 0 2.0714070446425405e-14
one O 0 2.2905689423381812e-15
of O 0 9.819336147344496e-18
the O 0 8.969868169625764e-14
two O 0 1.445434158649228e-12
children O 0 1.3891294256378195e-13
to O 0 8.188960374058175e-15
be O 0 3.3512197872417535e-14
hypohaptoglobinemic B-Disease 0 9.592131533509018e-10
( O 0 2.0406497536684318e-15
Hp2 O 0 3.308837093207728e-10
) O 0 1.0766567182880684e-14
and O 0 2.783341320009708e-13
Hp2 O 0 1.0617186063655026e-07
/ O 0 7.051745853914326e-08
Hpdel O 0 8.113399019293865e-08
, O 0 1.6191306108359615e-12
and O 0 5.088934915825627e-13
the O 0 8.028393208686624e-16
other O 0 5.249808563128483e-15
child O 0 9.679710375257167e-13
to O 0 4.798457316305136e-15
be O 0 7.255117730545213e-14
Hp1 O 0 5.222881327426876e-08
and O 0 1.2044946637312925e-11
Hp1 O 0 2.0312729702709476e-06
/ O 0 9.355915722153441e-07
Hpdel O 0 3.6285438653749225e-08
, O 0 7.27523848998747e-14
showing O 0 3.723946877861456e-13
an O 0 1.1188275558802801e-16
anomalous O 0 6.237415965670845e-12
inheritance O 0 2.730656256666464e-10
of O 0 7.957449667727809e-14
Hp O 0 2.5733566388908002e-08
phenotypes O 0 7.785163234075299e-07
in O 0 3.0037190183046514e-12
the O 0 4.665277712756488e-12
child O 0 4.786422369562615e-10
with O 0 1.2531828873230122e-12
Hp1 O 0 6.816963832534384e-06
. O 0 7.173928118220374e-11

The O 0 7.547637514981886e-11
Hp2 O 0 1.7513776811028947e-06
/ O 0 5.806801709695719e-06
Hpdel O 0 9.098383202399418e-07
individuals O 0 1.0882049384861037e-12
had O 0 1.8608367069461451e-09
an O 0 1.3265705706502501e-14
extremely O 0 1.0631868718746773e-09
low O 0 4.203456285267748e-07
level O 0 2.7323639878451544e-11
of O 0 7.307282429302414e-17
Hp O 0 1.9079958099577077e-11
( O 0 6.5011726877546236e-15
mean O 0 2.5370771022242833e-12
+ O 0 8.563721780319167e-12
/ O 0 1.024286646611472e-07
- O 0 1.6870811236913141e-07
SD O 0 9.821031881074305e-07
= O 0 4.817990628680491e-08
0 O 0 2.167428563015772e-13
. O 0 2.0739944497167386e-16
049 O 0 5.513013656699428e-11
+ O 0 2.787731200395993e-12
/ O 0 2.8361981652125223e-09
- O 0 2.181263836220637e-09
0 O 0 8.536825760185884e-13
. O 0 3.251854511018029e-16
043 O 0 1.1028719604233572e-11
mg O 0 5.669455790252576e-13
/ O 0 2.4207587323576973e-11
ml O 0 6.777938453550458e-12
; O 0 6.385947407807832e-14
n O 0 5.176491457703492e-10
= O 0 4.249054441629596e-09
6 O 0 3.8030995995648464e-13
) O 0 4.655099848718542e-16
, O 0 9.196245178669411e-16
compared O 0 6.876751331731917e-15
with O 0 3.0801259437961137e-13
the O 0 1.5044190936411295e-12
level O 0 2.340494985320074e-12
( O 0 3.0877913759753636e-16
1 O 0 7.077903869012921e-15
. O 0 3.706503945319307e-15
64 O 0 2.386478330489855e-13
+ O 0 6.106058042000539e-13
/ O 0 3.9701140153169945e-09
- O 0 1.3987354607891689e-09
1 O 0 2.6793541343939076e-13
. O 0 6.040510854775057e-15
07 O 0 5.348723850981396e-13
mg O 0 2.638564280260658e-13
/ O 0 1.2915859354256654e-11
ml O 0 1.9263652901568146e-13
) O 0 1.4934888896454764e-16
obtained O 0 1.769568823240073e-15
from O 0 2.3317400375306606e-15
52 O 0 6.061392499034923e-10
healthy O 0 1.5179583284785636e-11
volunteers O 0 3.9773041902047696e-14
having O 0 1.868818007245629e-13
phenotype O 0 1.2042718385008033e-11
Hp2 O 0 9.150187274542532e-10
, O 0 2.8308511947332943e-14
whereas O 0 4.605175290585406e-13
the O 0 1.3987025411857108e-14
serum O 0 6.388103934718004e-10
Hp O 0 2.0823830507166186e-11
level O 0 5.525465068129121e-12
of O 0 4.165597854139057e-17
an O 0 5.617098989716893e-14
individual O 0 6.976725783463394e-14
with O 0 1.969054259920444e-11
Hp1 O 0 0.0001567702420288697
/ O 0 4.628439273801632e-05
Hpdel O 0 3.6628325688070618e-06
was O 0 5.645791389952137e-09
0 O 0 9.788629629081669e-11
. O 0 1.2194059781020505e-12

50 O 0 2.382787370192041e-11
mg O 0 3.5786592439412956e-11
/ O 0 2.765882856081703e-09
ml O 0 1.1725140858231953e-09
, O 0 1.3080969684178823e-12
which O 0 5.169369706597982e-13
was O 0 1.5041157555573115e-11
approximately O 0 4.40584289158278e-14
half O 0 1.0868219518789246e-11
the O 0 3.0244825198998126e-13
level O 0 9.378993892292242e-14
of O 0 3.047290694125746e-17
Hp O 0 2.6206212547230656e-11
in O 0 3.919320380393887e-13
control O 0 5.351316303858766e-06
sera O 0 5.843795847226829e-08
from O 0 8.925452980596948e-16
the O 0 7.586418404831145e-15
Hp1 O 0 6.66993003051175e-08
phenotype O 0 3.366138270899377e-11
( O 0 3.1195688757827927e-16
1 O 0 2.5027850004597472e-15
. O 0 3.370525785692047e-15
26 O 0 7.620361590007785e-13
+ O 0 7.452814407282737e-13
/ O 0 9.519250276923685e-09
- O 0 5.702969652077172e-09
0 O 0 2.8106071072939165e-13
. O 0 1.531842409148253e-16
33 O 0 1.8681150715433616e-14
mg O 0 7.138891935281125e-14
/ O 0 1.750458111793307e-11
ml O 0 9.224019117959337e-12
; O 0 2.0245242114691475e-13
n O 0 2.6172621847564415e-09
= O 0 2.039673034914813e-07
9 O 0 1.5056598329232784e-11
) O 0 3.0457830945936418e-15
, O 0 7.918772322235341e-16
showing O 0 1.6566096910052008e-13
a O 0 9.92998408109666e-15
gene O 0 1.0383913173761528e-10
- O 0 2.573114832316037e-09
dosage O 0 2.789946884629302e-10
effect O 0 1.0195269108115301e-11
. O 0 9.560846038481063e-13

The O 0 5.332713003819434e-12
other O 0 1.9919119861031877e-14
allele O 0 1.380177114089498e-12
( O 0 1.219625800092522e-14
Hp2 O 0 5.3284305856493575e-09
) O 0 8.925525825430412e-15
of O 0 2.8939241293690244e-17
individuals O 0 3.975677516369127e-16
with O 0 1.0224118643722968e-13
Hp2 O 0 1.3727411896979902e-05
/ O 0 1.700796246950631e-06
Hpdel O 0 1.4247011392853892e-07
was O 0 1.2594959797329608e-10
found O 0 9.650068287861413e-13
to O 0 1.5014083184182458e-13
have O 0 2.2621264236799554e-11
, O 0 1.7751348080265877e-13
in O 0 2.937360505652839e-14
all O 0 4.4701492941251475e-14
exons O 0 1.2939946891776799e-08
, O 0 1.451290693524343e-12
no O 0 1.5425757459580636e-13
mutation O 0 1.4626439572311065e-14
, O 0 1.7588395958635456e-17
by O 0 1.515150698480321e-17
DNA O 0 4.424106220257684e-11
sequencing O 0 6.88201370890873e-11
. O 0 5.8116272211306e-12

On O 0 4.862520386339497e-10
the O 0 2.6797054497791108e-14
basis O 0 2.921200853436769e-15
of O 0 3.626652296497072e-17
the O 0 2.4621895912098693e-14
present O 0 1.776136441427375e-14
study O 0 5.824527194104104e-14
, O 0 1.459032145216543e-15
the O 0 6.597278634136873e-16
mechanism O 0 3.1641277597159456e-13
of O 0 6.466784870631773e-17
anhaptoglobinemia B-Disease 0 9.772823972298283e-08
and O 0 7.606743360200063e-12
the O 0 3.2240521897716236e-15
mechanism O 0 9.130503563501216e-14
of O 0 2.805292677991672e-18
anomalous O 0 3.0748387776918795e-12
inheritance O 0 5.5613954413891165e-11
of O 0 1.134282063755673e-14
Hp O 0 5.705504513286996e-09
phenotypes O 0 2.2104954666701815e-07
were O 0 3.3952729516784075e-10
well O 0 6.718579859121832e-11
explained O 0 1.0831131547206496e-08
. O 0 5.63021200841729e-12

However O 0 1.3438410384480903e-08
, O 0 1.0204758045528894e-12
the O 0 1.2272282596073082e-14
mechanism O 0 3.042077874326754e-12
of O 0 2.103580278242927e-15
hypohaptoglobinemia B-Disease 0 7.167740477598272e-06
remains O 0 2.5692028060575467e-08
unknown O 0 4.9703681170854e-09

ATM O 0 1.6566066278755898e-06
mutations O 0 6.930704694241285e-05
and O 0 3.828923844650944e-09
phenotypes O 0 2.9495766284526326e-05
in O 0 1.3319551328550006e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 2.3685372525505954e-06
in O 0 1.7161682231564557e-12
the O 0 1.0573529898860734e-12
British O 0 1.1445950320876364e-07
Isles O 0 8.218139413429526e-08
: O 0 6.73335754760771e-15
expression O 0 7.385755134956299e-16
of O 0 2.818153061770187e-18
mutant O 0 2.729580884236471e-12
ATM O 0 5.2983260140360144e-11
and O 0 5.928735150387276e-13
the O 0 1.9678084777429404e-14
risk O 0 4.776558489016924e-12
of O 0 1.0718908027070474e-14
leukemia B-Disease 1 0.9378005266189575
, O 0 1.1297274795651902e-06
lymphoma B-Disease 1 1.0
, O 0 8.474401624880556e-07
and O 0 6.137560558272526e-05
breast B-Disease 1 0.9953680038452148
cancer I-Disease 0 0.005824300926178694
. O 0 1.4605086584573712e-10

We O 0 1.645193137278511e-08
report O 0 2.1948355676329467e-13
the O 0 6.920930187980537e-17
spectrum O 0 5.223938906369916e-15
of O 0 5.09117940914025e-16
59 O 0 5.242257739013212e-10
ATM O 0 6.370004967948262e-08
mutations O 0 1.7017001141539367e-07
observed O 0 1.2585792408259522e-09
in O 0 3.1368712072321614e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.019803984090685844
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.3638777607294372e-10
patients O 0 1.2395216797411734e-11
in O 0 1.2027244223003649e-15
the O 0 4.287487519964023e-13
British O 0 4.0418311186840583e-07
Isles O 0 4.265200914232992e-06
. O 0 2.332728107901083e-11

Of O 0 1.0033301446610299e-11
51 O 0 2.6045448464628862e-08
ATM O 0 3.9220669378892126e-08
mutations O 0 4.174134815571051e-08
identified O 0 1.8522909595031223e-10
in O 0 1.018806146759789e-14
families O 0 4.326553238533136e-15
native O 0 1.7478374433541055e-13
to O 0 2.7396200542526006e-13
the O 0 5.813541922167209e-13
British O 0 1.615955056877283e-06
Isles O 0 4.126766725676134e-06
, O 0 8.043107846411601e-12
11 O 0 6.557694383173274e-13
were O 0 7.94222221762184e-15
founder O 0 1.6454941792823363e-12
mutations O 0 7.724082706772606e-09
, O 0 2.6176077364686856e-12
and O 0 1.348100537451602e-11
2 O 0 3.0842073686643268e-12
of O 0 1.915718137890596e-16
these O 0 6.288944517061912e-14
11 O 0 2.9077831315742556e-14
conferred O 0 1.7210234592087976e-15
a O 0 4.594572250736289e-15
milder O 0 4.8756731985122315e-09
clinical O 0 2.2456520198943508e-08
phenotype O 0 1.0363453845085857e-10
with O 0 3.846290893747516e-14
respect O 0 1.1428039775347038e-13
to O 0 4.377050805137728e-12
both O 0 1.8449016758737002e-09
cerebellar B-Disease 0 0.0025103085208684206
degeneration I-Disease 1 0.9974986910820007
and O 0 7.481738562020723e-10
cellular O 0 1.2957906392330187e-07
features O 0 1.4200824125509826e-06
. O 0 5.408543835017099e-09

We O 0 5.146574153513939e-07
report O 0 1.4216472617178955e-11
, O 0 5.533305747189993e-14
in O 0 2.31652753755621e-14
two O 0 1.9800899808686268e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
families O 0 1.5920245677314426e-10
, O 0 8.726984690725793e-15
an O 0 1.6209689363940247e-16
ATM O 0 5.380154100009804e-10
mutation O 0 4.160996894264635e-11
( O 0 5.126296865737821e-16
7271T O 0 1.1446288361582901e-11
- O 0 1.1717116166209962e-09
- O 0 9.02031516147872e-09
> O 0 1.2068977761625632e-11
G O 0 3.3762368456535796e-09
) O 0 4.440692622241548e-15
that O 0 3.460721292869451e-13
may O 0 2.0001641402173087e-12
be O 0 3.2685709709298887e-15
associated O 0 4.6279345915396786e-14
with O 0 1.5556932158165989e-15
an O 0 4.4721082272222625e-15
increased O 0 1.2819882933001736e-09
risk O 0 2.353494998885708e-08
of O 0 1.277475738040157e-12
breast B-Disease 1 0.996891438961029
cancer I-Disease 0 0.06494878232479095
in O 0 4.593472954436684e-13
both O 0 5.093018715096598e-11
homozygotes O 0 1.072779582500516e-06
and O 0 5.486408636429241e-12
heterozygotes O 0 1.0848363873883216e-10
( O 0 4.781612795599563e-14
relative O 0 2.1411501044399373e-11
risk O 0 1.5332500546971772e-10
12 O 0 3.912799446427473e-13
. O 0 1.228530488060417e-14
7 O 0 3.4055962910839455e-11
; O 0 2.7754716927508305e-11
P O 0 8.182672900147736e-05
= O 0 3.0427054298343137e-07
. O 0 7.617508918566704e-14
0025 O 0 1.901341306620452e-10
) O 0 1.679208428393992e-14
, O 0 1.2990056621510482e-14
although O 0 1.830875945643684e-13
there O 0 2.831520689574804e-14
is O 0 4.087851148365198e-16
a O 0 7.93419361583129e-16
less O 0 2.5327376101339644e-14
severe O 0 2.9759772246507055e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.1672513210214674e-05
in O 0 2.4272000154115098e-14
terms O 0 1.6402398094467869e-15
of O 0 8.433983983608036e-18
the O 0 3.5471207202497808e-15
degree O 0 2.1091509344161458e-13
of O 0 5.765347119661814e-15
cerebellar B-Disease 0 0.00011859522783197463
degeneration I-Disease 1 0.8843578100204468
. O 0 2.82311396482271e-10

This O 0 1.2150975538249842e-11
mutation O 0 2.539073118423829e-11
( O 0 6.423324007154849e-15
7271T O 0 5.158166949126297e-11
- O 0 1.3699591683291601e-08
- O 0 5.907743272359767e-08
> O 0 5.516589962617502e-11
G O 0 2.3879356270128937e-09
) O 0 7.623663925829575e-16
also O 0 2.9541582701397232e-15
allows O 0 2.9881145504457272e-15
expression O 0 7.272585074576902e-15
of O 0 8.285860916754288e-17
full O 0 9.278020788715952e-14
- O 0 2.0266445466265992e-10
length O 0 3.642161659073162e-12
ATM O 0 3.020185143642884e-11
protein O 0 1.9613326587841762e-11
at O 0 3.4983309109802574e-13
a O 0 1.9121899227339707e-14
level O 0 2.507277663211984e-14
comparable O 0 3.7223045826206835e-14
with O 0 2.1792427075135318e-13
that O 0 2.203226490138377e-11
in O 0 2.919300435069716e-12
unaffected O 0 4.7208655473696126e-07
individuals O 0 3.722091807944333e-14
. O 0 1.8020072196575643e-12

In O 0 3.193273553567244e-12
addition O 0 5.802320429681984e-13
, O 0 3.158286783142006e-12
we O 0 5.566892780084487e-11
have O 0 1.462583309672083e-13
studied O 0 2.7302812788398967e-10
18 O 0 7.459652340280343e-10
A B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 1.7307695088675246e-05
, O 0 7.176877364969969e-13
in O 0 2.2882612688360227e-13
15 O 0 8.171061917361389e-12
families O 0 8.95628921504174e-15
, O 0 3.049657694344926e-13
who O 0 6.256259954540155e-10
developed O 0 1.4095189726504032e-07
leukemia B-Disease 0 0.010298721492290497
, O 0 2.5560934702184568e-08
lymphoma B-Disease 1 1.0
, O 0 1.2619324474272275e-09
preleukemic O 0 0.001195654971525073
T O 0 0.01558703277260065
- O 0 4.979099230695283e-06
cell O 0 6.540062167914584e-05
proliferation O 0 0.0026006163097918034
, O 0 3.481656518644627e-09
or O 0 2.4806624878692674e-06
Hodgkin B-Disease 1 0.9999998807907104
lymphoma I-Disease 1 1.0
, O 0 5.290475169061892e-09
mostly O 0 1.690535732234988e-11
in O 0 2.0494313190955182e-10
childhood O 0 1.148813225881895e-05
. O 0 7.27339022343898e-11

A O 0 8.325558575883463e-10
wide O 0 4.770051367786188e-11
variety O 0 2.934193903472715e-12
of O 0 4.396463949867717e-15
ATM O 0 4.104016326778037e-08
mutation O 0 6.083050729799311e-10
types O 0 1.1869746505133172e-11
, O 0 8.088371823439938e-15
including O 0 2.005690162836405e-14
missense O 0 3.922688449620182e-07
mutations O 0 2.252354079246288e-06
and O 0 4.115880136712491e-10
in O 0 9.291963899704658e-13
- O 0 3.6910921608068747e-06
frame O 0 7.070871106407139e-07
deletions O 0 4.1016136265170644e-08
, O 0 1.0767733926719814e-11
were O 0 5.138963256670626e-13
seen O 0 3.3080527900297696e-11
in O 0 3.9614050429716274e-14
these O 0 2.1267354739264166e-13
patients O 0 6.96392650576666e-13
. O 0 1.3068619266181497e-13

We O 0 1.8766547782433918e-07
also O 0 4.244622773923179e-13
show O 0 3.4201174878289997e-12
that O 0 6.67691067907962e-14
25 O 0 2.5236962110483825e-14
% O 0 2.855139946552128e-17
of O 0 1.1727039633018392e-17
all O 0 6.078501590955909e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 3.978827010087116e-07
carried O 0 4.8246778100446974e-11
in O 0 2.3194543752021526e-14
- O 0 8.925927552638768e-09
frame O 0 4.756694238494674e-08
deletions O 0 1.1793219734101967e-08
or O 0 1.4548493703150922e-12
missense O 0 2.1338230737910635e-08
mutations O 0 3.7945810049677675e-08
, O 0 1.1058830310913328e-13
many O 0 1.9993181457324477e-15
of O 0 3.4652687501830455e-15
which O 0 1.3460619285865505e-09
were O 0 7.320333922367084e-11
also O 0 2.7127686763606107e-09
associated O 0 1.7035324539893537e-10
with O 0 1.1866068295052906e-13
expression O 0 7.807781656453405e-14
of O 0 2.398709162258105e-16
mutant O 0 3.3624697470813203e-10
ATM O 0 2.9039382010154213e-09
protein O 0 6.497461679799699e-09
. O 0 7.818594729980255e-12

The O 0 1.601135023177047e-11
DMPK O 0 7.426847137281811e-09
gene O 0 5.301684646852323e-10
of O 0 8.539670300110672e-14
severely O 0 0.14388468861579895
affected O 0 7.767011993564665e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.1246793292229995e-05
is O 0 1.3899431193682699e-13
hypermethylated O 0 5.129230373768223e-09
proximal O 0 2.998009895893716e-10
to O 0 2.976465601767231e-11
the O 0 1.4897755067338342e-13
largely O 0 3.787942182142956e-12
expanded O 0 1.8183650141168073e-09
CTG O 0 3.7847544263058808e-06
repeat O 0 7.97969406107768e-08
. O 0 1.0522714644078945e-11

Using O 0 4.91867241381172e-11
methylation O 0 2.7494211352063758e-08
- O 0 2.2685419764911785e-08
sensitive O 0 5.123246271665494e-09
restriction O 0 2.1683645101688853e-08
enzymes O 0 4.783795581886352e-09
, O 0 2.071985026044429e-13
we O 0 4.4906095443726646e-13
characterized O 0 3.821258698463899e-15
the O 0 2.6729223146462918e-17
methylation O 0 3.853319052726789e-10
pattern O 0 7.309155591883609e-08
on O 0 4.761325014812634e-11
the O 0 8.746657911840039e-13
5 O 0 5.8170756406239477e-11
side O 0 1.4898572653354591e-10
of O 0 2.0114948002146e-17
the O 0 1.0939495735326227e-14
CTG O 0 1.502755964111202e-08
repeat O 0 1.4531895131675299e-10
in O 0 1.062895693972033e-15
the O 0 1.7576341290132598e-15
DMPK O 0 3.069007492584319e-09
gene O 0 1.468601212861742e-10
of O 0 1.0587355975307119e-15
normal O 0 2.2210243366682647e-10
individuals O 0 2.1232191606414914e-15
and O 0 1.7686191595457645e-13
of O 0 2.1832428798992465e-15
patients O 0 1.9173104770509042e-10
affected O 0 6.31425536856689e-11
with O 0 4.370825479327323e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 5.290305520044836e-12
showing O 0 3.70785303502319e-12
expansions O 0 8.300565096375223e-11
of O 0 1.4769404334247487e-15
the O 0 1.390505142669432e-13
repetitive O 0 2.211253331552143e-06
sequence O 0 4.14508924961865e-08
. O 0 2.3517503916492544e-11

The O 0 4.825273427350174e-12
gene O 0 3.7157985022240325e-11
segment O 0 2.268512461212069e-11
analyzed O 0 5.213266450476706e-12
corresponds O 0 8.829742492721948e-14
to O 0 2.4673610661660357e-14
the O 0 2.2728052214782482e-14
genomic O 0 1.1824869261545246e-07
SacI O 0 9.56770236371085e-06
- O 0 2.1397066518602514e-07
HindIII O 0 2.6591184365543086e-08
fragment O 0 6.467955060429631e-10
carrying O 0 3.1464780867601627e-12
exons O 0 2.7507518485236915e-09
11 O 0 3.486193278501304e-10
- O 0 6.114429140779976e-08
15 O 0 4.055438623806751e-11
. O 0 1.919375899536724e-12

There O 0 2.0065884717701543e-11
is O 0 7.562436360995534e-15
constitutive O 0 1.4390521109811094e-12
methylation O 0 5.330263164182725e-08
in O 0 5.491536045343359e-13
intron O 0 3.1481791666010395e-05
12 O 0 6.071503022564428e-11
at O 0 4.78217827479515e-14
restriction O 0 1.831973808763543e-12
sites O 0 4.410808523980236e-12
of O 0 1.1639830411170845e-15
SacII O 0 6.704514134980855e-07
and O 0 6.1396248328404734e-12
HhaI O 0 6.763497761852477e-09
, O 0 2.2917806229692285e-14
localized O 0 1.5363765815123998e-10
1 O 0 3.6343825084855785e-12
, O 0 2.1886652375440602e-13
159 O 0 5.851281958957344e-11
- O 0 8.062950307419214e-09
1 O 0 2.0170697794322234e-13
, O 0 5.542788365737799e-15
232 O 0 3.459300852498223e-14
bp O 0 2.8813282597524303e-13
upstream O 0 1.474777195980756e-13
of O 0 2.245037831076494e-17
the O 0 2.0650980891415063e-15
CTG O 0 1.3569296797300012e-09
repeat O 0 6.006974084815653e-11
, O 0 3.1551513534684066e-15
whereas O 0 1.3563414917572812e-14
most O 0 2.942325113987462e-16
, O 0 1.0666031317711766e-13
if O 0 3.576018994810859e-11
not O 0 7.513248703738817e-12
all O 0 1.206497805849617e-14
, O 0 1.8027581787398092e-14
of O 0 2.5011205823727538e-18
the O 0 1.8117946068007819e-16
other O 0 5.035319042106707e-17
sites O 0 7.183573939688326e-13
of O 0 1.4155936222336028e-16
SacII O 0 1.462667853502353e-08
, O 0 8.52728464554274e-14
HhaI O 0 2.0041426296302234e-09
, O 0 2.1174220417394946e-13
and O 0 4.755402885706084e-13
HpaII O 0 2.3832864570749734e-08
in O 0 4.849774892117832e-14
this O 0 9.433565175765227e-15
region O 0 3.880441974690729e-12
are O 0 5.6950713371269664e-15
unmethylated O 0 8.815431584707767e-08
, O 0 9.748226531547388e-13
in O 0 1.7030092071788905e-14
normal O 0 2.5868920894289715e-10
individuals O 0 1.7929978604402453e-15
and O 0 7.106504105883552e-14
most O 0 1.1973409985249718e-15
of O 0 9.901756919887647e-17
the O 0 6.794982870643451e-13
patients O 0 3.99348436264102e-12
. O 0 3.800206677118112e-13

In O 0 2.007636461590079e-12
a O 0 6.474644632286156e-14
number O 0 1.0791428785728724e-13
of O 0 1.231914045871519e-14
young O 0 2.4533546305605114e-09
and O 0 1.630902346505536e-08
severely O 1 0.9753173589706421
affected O 0 1.1344807404611856e-07
patients O 0 1.1033444158314865e-09
, O 0 7.871285410574955e-14
however O 0 2.4280822578243155e-12
, O 0 1.999254406503167e-14
complete O 0 1.2135096801122597e-13
methylation O 0 6.720916045921399e-10
of O 0 3.743204030039264e-16
these O 0 1.6952895183042042e-14
restriction O 0 2.992466691109641e-11
sites O 0 6.649574224582011e-10
was O 0 1.0256209215242507e-09
found O 0 7.642792106653251e-13
in O 0 7.613260243654924e-16
the O 0 9.3913405833446e-15
mutated O 0 1.1866589932907345e-09
allele O 0 8.354712061064973e-11
. O 0 2.5134965289663747e-11

In O 0 3.828180827891714e-12
most O 0 3.373254502331627e-14
of O 0 1.37464937305231e-16
these O 0 4.4521610248308974e-14
patients O 0 1.9219795568438391e-13
, O 0 8.086855422706116e-16
the O 0 2.1175744060260467e-14
onset O 0 2.1878681089049223e-09
of O 0 3.981325055605386e-15
the O 0 1.970716922983229e-09
disease O 0 0.4998047947883606
was O 0 3.883233645751716e-08
congenital O 1 0.9948034882545471
. O 0 7.24212245728495e-10

Preliminary O 0 1.8241503596527764e-07
in O 0 4.85676863309914e-12
vivo O 0 8.984894606101079e-08
footprinting O 0 7.126953391889401e-07
data O 0 6.334928241702453e-12
gave O 0 9.617796197045753e-14
evidence O 0 1.1372498977962626e-14
for O 0 4.312575937588909e-17
protein O 0 4.1329727834549246e-11
- O 0 4.3737969690482714e-07
DNA O 0 3.2246378395939246e-05
contact O 0 8.49489154575167e-08
in O 0 2.2880833512595178e-12
normal O 0 1.6032666305676457e-09
genes O 0 4.1341891021673405e-10
at O 0 1.0697983297836e-12
an O 0 1.015031026792995e-15
Sp1 O 0 4.696965660855312e-08
consensus O 0 3.822558724631345e-14
binding O 0 2.1261362895957925e-12
site O 0 3.470527684679148e-11
upstream O 0 2.2335926511130033e-12
of O 0 4.049575185316654e-17
the O 0 3.9889106591645216e-15
CTG O 0 1.000320182242831e-08
repeat O 0 7.585453376535156e-10
and O 0 1.8921520031139547e-14
for O 0 3.534364500017082e-18
a O 0 1.028755991328279e-16
significant O 0 4.0684519762907063e-16
reduction O 0 5.224601675769824e-13
of O 0 1.3671813217843852e-16
this O 0 1.1923285709453113e-13
interaction O 0 1.428024229898836e-13
in O 0 7.731035050421303e-14
cells O 0 1.5895661523157578e-11
with O 0 8.766055779483792e-15
a O 0 6.240137529964218e-13
hypermethylated O 0 4.25500132905654e-08
DMPK O 0 1.0478947487513324e-08
gene O 0 5.348221865375535e-10
. O 0 1.880987499005421e-13
. O 0 1.5316467712189752e-12

The O 0 4.776975703890685e-09
hemochromatosis B-Disease 1 0.9999915361404419
gene O 0 1.156138750957325e-06
product O 0 7.862921251600152e-12
complexes O 0 5.2646900727815193e-11
with O 0 6.079315382264555e-14
the O 0 2.3975042261269e-14
transferrin O 0 1.3063061743423532e-09
receptor O 0 4.7919640477900316e-11
and O 0 8.03248439984472e-12
lowers O 0 3.9325875889062445e-10
its O 0 7.635447477614862e-17
affinity O 0 9.505554082435896e-16
for O 0 1.1223792047327868e-17
ligand O 0 1.2245259873363418e-13
binding O 0 2.4743583917907763e-11
. O 0 6.516564197978081e-12

We O 0 2.990075529396563e-07
recently O 0 4.265324760055478e-10
reported O 0 2.0820404861982e-12
the O 0 1.985431596427585e-16
positional O 0 1.486277594053842e-11
cloning O 0 2.642153718035445e-10
of O 0 5.703653183780971e-17
a O 0 1.492405476272423e-14
candidate O 0 1.8215975602919876e-12
gene O 0 2.4337889481529373e-09
for O 0 9.838869302614128e-11
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 0.000584007182624191
HFE O 0 0.028946364298462868
. O 0 1.058823806410203e-09

The O 0 1.6766282806557342e-11
gene O 0 8.158860809182045e-10
product O 0 2.5270813219790966e-11
, O 0 1.3214398379788467e-13
a O 0 4.1996045990798717e-14
member O 0 2.992405449949928e-14
of O 0 3.842450152550111e-17
the O 0 4.8577805393155114e-15
major O 0 7.310750854520875e-14
histocompatibility O 0 4.5371397611182473e-11
complex O 0 1.2000105353848767e-09
class O 0 3.742919574278858e-08
I O 0 0.0005703564384020865
- O 0 1.3518000940848651e-08
like O 0 5.486822662881252e-10
family O 0 1.0248207144014643e-10
, O 0 7.25956092657333e-14
was O 0 3.791441119394001e-12
found O 0 9.217502656326884e-14
to O 0 1.856868168069719e-14
have O 0 1.924459262737585e-13
a O 0 8.877985254232817e-15
mutation O 0 5.850383654089353e-13
, O 0 2.305406672585119e-14
Cys O 0 6.138979642855702e-06
- O 0 1.0799672267580718e-08
282 O 0 1.1249170484006754e-09
- O 0 8.599815259913157e-08
- O 0 8.866576450827779e-08
> O 0 1.8514705393823938e-11
Tyr O 0 1.0710954692627617e-11
( O 0 5.712387549305041e-16
C282Y O 0 1.897389851571868e-13
) O 0 4.457033370101741e-16
, O 0 1.1540925550293513e-15
in O 0 1.8378435963161506e-15
85 O 0 1.220543848282074e-12
% O 0 1.410564919974652e-15
of O 0 1.0829337406469911e-15
patient O 0 7.06142078144012e-09
chromosomes O 0 2.078533256621995e-08
. O 0 6.7409529347362e-11

This O 0 2.365065435161462e-11
mutation O 0 1.2140903560275973e-10
eliminates O 0 5.570506833585398e-10
the O 0 6.917367611873615e-13
ability O 0 3.796462710176085e-12
of O 0 5.552456611555997e-16
HFE O 0 3.9522738006780855e-06
to O 0 3.82257723738344e-12
associate O 0 1.295407617979416e-11
with O 0 4.54149901279316e-13
beta2 O 0 3.207144118277938e-06
- O 0 4.724545306089567e-06
microglobulin O 0 1.5715146446382278e-06
( O 0 2.7488111071193033e-13
beta2m O 0 2.539115406818837e-08
) O 0 6.907624429050574e-13
and O 0 4.36837496514339e-13
prevents O 0 8.380008492681057e-11
cell O 0 1.6614607147857896e-06
- O 0 0.00011937525414396077
surface O 0 1.3434203083306784e-06
expression O 0 1.50763856954228e-09
. O 0 6.796674334452746e-11

A O 0 4.5297401940480597e-10
second O 0 7.606250698732886e-12
mutation O 0 5.2651220189270376e-11
that O 0 6.70230526893939e-13
has O 0 6.657972090318154e-11
no O 0 7.883720586077114e-12
effect O 0 1.7095500362551697e-11
on O 0 4.849227269732026e-11
beta2m O 0 1.8935388652607799e-06
association O 0 1.506979355756291e-14
, O 0 3.637102300786026e-15
H63D O 0 5.6358180344773245e-09
, O 0 2.185153100131565e-13
was O 0 1.1359471696614776e-10
found O 0 4.494435726365431e-11
in O 0 1.700552811631853e-13
eight O 0 7.878748348177922e-11
out O 0 1.8963904058200143e-10
of O 0 8.960557202304718e-16
nine O 0 4.919573082240447e-11
patients O 0 3.654460631677403e-14
heterozygous O 0 3.5945181428792897e-14
for O 0 2.7033364222808865e-17
the O 0 7.084198170843967e-15
C282Y O 0 7.171455651544534e-10
mutant O 0 3.799946135529808e-09
. O 0 2.071113940071978e-11

In O 0 1.287539866390297e-11
this O 0 2.011713820700145e-13
report O 0 4.076647439760217e-12
, O 0 8.913315506682562e-14
we O 0 4.471646143644481e-12
demonstrate O 0 2.964025780458762e-14
in O 0 3.012826101407161e-15
cultured O 0 7.163751796629425e-12
293 O 0 6.113262673856923e-12
cells O 0 1.0791975819934851e-11
overexpressing O 0 9.972948689096484e-09
wild O 0 1.4810069837167816e-09
- O 0 3.1315644832830003e-07
type O 0 2.613577635202091e-06
or O 0 7.249384252616675e-12
mutant O 0 7.131952250993834e-10
HFE O 0 1.498914414810315e-08
proteins O 0 4.917024010175908e-10
that O 0 7.356316077122838e-12
both O 0 3.8048701017125153e-13
the O 0 8.476964789838615e-14
wild O 0 8.26048829338788e-09
- O 0 7.476687073904031e-07
type O 0 5.061339379608398e-06
and O 0 5.927503821112623e-09
H63D O 0 1.640881600906141e-05
HFE O 0 2.242257323814556e-06
proteins O 0 4.6446976398328843e-07
form O 0 4.661484531709448e-10
stable O 0 3.31560306987555e-10
complexes O 0 3.268099124653645e-10
with O 0 1.43252272023775e-13
the O 0 1.5935350098934126e-13
transferrin O 0 8.790154160109864e-10
receptor O 0 1.6635201896542107e-11
( O 0 5.228287150004646e-14
TfR O 0 7.506402255330613e-08
) O 0 7.421380133695865e-13
. O 0 3.500382058860274e-12

The O 0 3.501285025797607e-11
C282Y O 0 1.5218770244018742e-08
mutation O 0 1.72925886943176e-08
nearly O 0 5.651269729955999e-11
completely O 0 2.326369354932467e-07
prevents O 0 3.4064981946357875e-08
the O 0 4.652499739632443e-12
association O 0 3.206398498491539e-14
of O 0 6.594733829525965e-17
the O 0 2.2060403905097697e-14
mutant O 0 2.871862747610976e-10
HFE O 0 7.234919330301182e-09
protein O 0 3.013742033708411e-10
with O 0 3.8791872817266204e-14
the O 0 7.649529881054162e-13
TfR O 0 4.1918530769180506e-05
. O 0 1.443010728269245e-11

Studies O 0 1.8569091153608497e-08
on O 0 6.9189944572334294e-12
cell O 0 1.2234901980434643e-08
- O 0 1.0190603205728621e-07
associated O 0 1.3679758714690848e-10
transferrin O 0 7.164346893517859e-10
at O 0 1.1864133807326649e-11
37 O 0 8.436101643638505e-12
degrees O 0 2.8830408546620667e-11
C O 0 8.481259783366113e-08
suggest O 0 1.3372115914567217e-11
that O 0 2.8135412294232054e-13
the O 0 2.6016422157337966e-14
overexpressed O 0 2.6665188670449425e-06
wild O 0 7.003090729540418e-08
- O 0 9.942201586454757e-07
type O 0 1.2481407907216635e-07
HFE O 0 1.5718384815954778e-07
protein O 0 6.562762777662101e-09
decreases O 0 1.696356249913933e-11
the O 0 5.603225648832051e-16
affinity O 0 3.2153931837100797e-15
of O 0 2.5821407313436996e-17
the O 0 1.8282962220995264e-14
TfR O 0 8.269648077430247e-09
for O 0 2.5734112428765213e-15
transferrin O 0 2.292341427789779e-09
. O 0 5.418613474583722e-12

The O 0 5.859714796718762e-11
overexpressed O 0 8.469618819617608e-07
H63D O 0 1.7839072086189844e-07
protein O 0 3.0243214599323665e-09
does O 0 6.669084173793749e-10
not O 0 2.1841541162498368e-12
have O 0 1.0146241485875507e-12
this O 0 2.1971619605632396e-15
effect O 0 4.77878858446551e-13
, O 0 3.512061518343157e-14
providing O 0 1.5239979840841718e-15
the O 0 2.036854410790022e-15
first O 0 9.119637824853838e-15
direct O 0 5.338689424349771e-15
evidence O 0 5.598151716496025e-12
for O 0 1.2418689911665383e-15
a O 0 4.0604268536879873e-13
functional O 0 8.076044277771643e-10
consequence O 0 4.648330765438802e-12
of O 0 3.6925022260033975e-16
the O 0 1.402539515733478e-13
H63D O 0 2.836313342413632e-06
mutation O 0 5.060563079695157e-10
. O 0 2.084106758698523e-12

Addition O 0 7.002453478177628e-11
of O 0 4.879391568525168e-14
soluble O 0 3.68906079017961e-08
wild O 0 1.4296990968887258e-07
- O 0 1.9667317246785387e-05
type O 0 1.196043194795493e-05
HFE O 0 0.0028718847315758467
/ O 0 0.0017235291888937354
beta2m O 0 1.0156717280551675e-06
heterodimers O 0 6.459969448258107e-09
to O 0 2.5735134509541346e-12
cultured O 0 2.3224340506278196e-10
cells O 0 1.1120022680444208e-09
also O 0 2.5998952990491375e-11
decreased O 0 2.6439234135366974e-10
the O 0 2.8165344744522126e-15
apparent O 0 4.9745946836647625e-14
affinity O 0 5.927609833235531e-15
of O 0 8.228972066434321e-17
the O 0 9.545820758198945e-15
TfR O 0 6.734329094371105e-09
for O 0 1.2560943569590251e-17
its O 0 9.684449459216699e-18
ligand O 0 1.2104853828554061e-14
under O 0 5.073213035647686e-14
steady O 0 1.530134309188358e-12
- O 0 1.8375820309834978e-10
state O 0 3.282885421840298e-11
conditions O 0 5.0139131957394056e-08
, O 0 2.2045303001714048e-14
both O 0 2.6952727295035186e-14
in O 0 1.7262844867233125e-14
293 O 0 3.2809620905543957e-12
cells O 0 1.746462870155785e-11
and O 0 5.213631718188616e-13
in O 0 4.3945486897893626e-13
HeLa O 0 1.0215956081083277e-06
cells O 0 7.69656394172813e-10
. O 0 1.0670146407057435e-12

Furthermore O 0 6.637236094064747e-09
, O 0 4.15152938068597e-12
at O 0 4.517449782304173e-12
4 O 0 9.1718100128646e-12
degrees O 0 5.2404907080472185e-09
C O 0 7.106018892955035e-05
, O 0 1.5614046167122808e-10
the O 0 9.896343293458454e-12
added O 0 1.6590082907441683e-07
soluble O 0 6.505728733507965e-10
complex O 0 6.17528077284657e-12
of O 0 1.2427322659705562e-14
HFE O 0 1.0416751138109248e-05
/ O 0 6.248013164622535e-07
beta2m O 0 7.155701586825103e-10
inhibited O 0 1.472419842302175e-12
binding O 0 2.4459766352104284e-13
of O 0 2.2026240789933886e-16
transferrin O 0 1.7666459961596104e-10
to O 0 1.007963786221755e-12
HeLa O 0 3.970487796323141e-07
cell O 0 5.24448296346236e-07
TfR O 0 2.576102588136564e-06
in O 0 1.0041446840691748e-13
a O 0 1.0509731106222997e-12
concentration O 0 1.5036454215078265e-06
- O 0 2.3581806090078317e-06
dependent O 0 7.356548148429454e-10
manner O 0 6.969145815993727e-10
. O 0 8.454738645302662e-12

Scatchard O 0 0.00011784837988670915
plots O 0 3.9639877513764077e-07
of O 0 1.08228225372594e-13
these O 0 7.264464230898396e-14
data O 0 1.0298888478144086e-12
indicate O 0 3.785414256357589e-12
that O 0 6.654487074223003e-13
the O 0 6.158456990895678e-13
added O 0 1.2230748858144125e-08
heterodimer O 0 1.6610166020392114e-10
substantially O 0 4.429318023468909e-10
reduced O 0 4.890922736255909e-12
the O 0 1.1590250396394499e-15
affinity O 0 2.5767868809295665e-14
of O 0 5.346226852910032e-16
TfR O 0 6.302400379354367e-08
for O 0 4.9085593174704595e-15
transferrin O 0 1.827042406254975e-09
. O 0 1.8535764936822297e-11

These O 0 5.500699007399135e-09
results O 0 7.316090788744845e-11
establish O 0 2.912492946469114e-12
a O 0 2.504304746973711e-14
molecular O 0 5.6728254038684867e-11
link O 0 6.054107757336169e-07
between O 0 1.6272280745077694e-10
HFE O 0 0.00023974213399924338
and O 0 9.994266525481521e-11
a O 0 4.985043004475734e-14
key O 0 4.549286294897037e-12
protein O 0 1.887296395552962e-11
involved O 0 1.8090703631304383e-12
in O 0 6.473981507132409e-13
iron O 0 1.5678471072533284e-06
transport O 0 1.5259717933702177e-09
, O 0 4.4247515807588345e-13
the O 0 3.1421327535306395e-14
TfR O 0 9.586951819073875e-07
, O 0 1.119273727520631e-12
and O 0 6.129208468888536e-13
raise O 0 9.746046472029063e-14
the O 0 2.7579501288696386e-16
possibility O 0 9.510563858802432e-15
that O 0 8.151502205438338e-14
alterations O 0 2.600398785190805e-09
in O 0 2.9408568882525153e-15
this O 0 3.3884324857134766e-15
regulatory O 0 2.5717332777230872e-11
mechanism O 0 7.515976035987748e-11
may O 0 2.5482813775790092e-11
play O 0 6.991639905917779e-12
a O 0 1.6274505648553126e-15
role O 0 3.017383706175464e-13
in O 0 1.5319813966669857e-14
the O 0 2.4608234964725376e-14
pathogenesis O 0 2.0551249590994303e-08
of O 0 4.470579722387624e-12
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.6982202311055516e-08
. O 0 1.770747437568332e-11

Genomic O 0 9.464268941883347e-07
organization O 0 1.550539696637543e-10
of O 0 1.1724686807101491e-14
the O 0 3.774007473721086e-13
UBE3A O 0 3.388173865914723e-07
/ O 0 4.515063665166963e-07
E6 O 0 4.421554677946915e-09
- O 0 1.8606691583045176e-06
AP O 0 0.00011550248018465936
gene O 0 1.8854919847655083e-09
and O 0 2.923232673718995e-13
related O 0 5.820609836129642e-13
pseudogenes O 0 8.314326116476423e-09
. O 0 4.7380700057830794e-11

The O 0 1.8346392113843812e-11
UBE3A O 0 1.485627887376495e-08
gene O 0 8.870860296328331e-11
encodes O 0 3.825516726313483e-12
the O 0 1.6597439839605849e-13
E6 O 0 1.148888539859172e-09
- O 0 1.416711484125699e-06
AP O 0 3.644891330623068e-05
ubiquitin O 0 3.1044212339681465e-12
- O 0 1.77852246818766e-11
protein O 0 2.922843824609833e-12
ligase O 0 4.755266818333437e-13
and O 0 1.5960918350876874e-11
has O 0 1.6768425190050174e-11
recently O 0 4.364273178958378e-11
been O 0 1.0819087460775187e-13
shown O 0 3.445523141633127e-15
to O 0 5.518775934595206e-16
be O 0 2.9926280502084665e-14
mutated O 0 4.82029747672641e-07
in O 0 2.642349045345327e-06
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.57374011880529e-07
who O 0 1.600994510575493e-11
lack O 0 1.2710592127429532e-12
15q11 O 0 2.435237789200073e-09
- O 0 2.1989180254422536e-08
q13 O 0 1.5375147821572455e-09
deletions O 0 1.593998000259944e-08
or O 0 2.2506710384284645e-10
chromosome O 0 2.6104837161256e-05
15 O 0 4.069939107953502e-10
paternal O 0 1.298809706895554e-06
uniparental B-Disease 0 0.020916402339935303
disomy I-Disease 0 0.0013624465791508555
. O 0 3.0272706563749807e-09

Previous O 0 7.255284706353393e-10
UBE3A O 0 1.4677290494091721e-08
cDNA O 0 2.604085280744073e-10
analysis O 0 1.1935294419451736e-10
has O 0 1.911014315542081e-12
shown O 0 2.2646311841306548e-14
a O 0 3.444392987923253e-15
coding O 0 1.2936166058352683e-06
region O 0 7.390554834785235e-10
of O 0 1.8917902776938297e-15
approximately O 0 2.1224057233926175e-11
2 O 0 1.011983830068175e-09
. O 0 3.6810918896401645e-11

6 O 0 4.205557502245938e-08
kb O 0 1.3334387176655582e-06
and O 0 2.8030162635417355e-09
a O 0 1.784503794732828e-10
3 O 0 1.0491050517202893e-07
- O 0 0.04483060538768768
untranslated O 1 0.9887285232543945
region O 0 1.3703383046959061e-05
( O 0 2.875706129387007e-13
UTR O 0 7.035738658345281e-10
) O 0 2.249369259783732e-15
of O 0 2.6041007222457573e-17
< O 0 6.399328983386354e-12
50 O 0 1.8393710762409227e-13
bp O 0 1.2673480971267526e-12
, O 0 3.0553020508548856e-15
whereas O 0 4.598440904316284e-14
Northern O 0 1.0476738920850437e-10
analysis O 0 3.398217254466096e-12
has O 0 6.01476388226857e-13
indicated O 0 2.4735066967741803e-13
mRNA O 0 7.280971208974488e-14
sizes O 0 7.307134064493681e-12
of O 0 1.7466334368415604e-14
5 O 0 8.873606294201863e-10
- O 0 3.458177843640442e-06
8 O 0 3.444546592401565e-10
kb O 0 2.0368506170598266e-07
. O 0 2.69733940044814e-11

We O 0 9.695898306461004e-09
have O 0 4.803972771341182e-14
analyzed O 0 5.1198828569755037e-14
additional O 0 5.843594011625917e-16
cDNA O 0 1.8963497439017374e-11
clones O 0 1.3881370719559527e-08
and O 0 3.189888891225179e-12
provide O 0 1.2819117749458039e-14
evidence O 0 6.225108726025039e-14
for O 0 2.0403364375047314e-17
an O 0 3.6216354791691625e-16
additional O 0 9.155725223114475e-13
0 O 0 6.96730424465386e-08
. O 0 5.325336699391059e-11

5 O 0 1.506753055657839e-09
kb O 0 6.791860851507181e-09
of O 0 1.159481717452962e-13
5 O 0 2.0614081275294183e-10
- O 0 5.696546736544406e-07
UTR O 0 2.397830712652649e-06
and O 0 2.7679714076356277e-10
> O 0 4.414993717838378e-11
2 O 0 2.2082823850771982e-12
kb O 0 8.082443159196373e-09
of O 0 1.0147844343262255e-13
3 O 0 3.6450025220347015e-09
- O 0 1.5201297856037854e-06
UTR O 0 5.948078523942968e-06
. O 0 3.483187349662131e-11

We O 0 1.123051333706826e-05
have O 0 6.681580202311244e-12
established O 0 5.022550301006512e-14
the O 0 6.0642889754286165e-16
genomic O 0 4.6856841323661413e-11
organization O 0 1.7798066351878278e-13
of O 0 1.3194883375958438e-16
UBE3A O 0 3.813116489226331e-09
and O 0 6.087289960293729e-13
the O 0 6.776825796153143e-16
sequence O 0 8.837008815681946e-13
of O 0 3.239386450732242e-16
intron O 0 1.2251362022652756e-06
- O 0 1.2644923685911635e-07
exon O 0 2.5988779128738315e-08
borders O 0 8.408485427935375e-07
. O 0 2.6518676143894027e-10

We O 0 9.68458152783569e-06
have O 0 2.4625140815359714e-10
also O 0 1.2121184264635154e-11
mapped O 0 5.991967366725248e-09
two O 0 5.080553084355413e-14
highly O 0 5.0882116174513076e-15
homologous O 0 2.925530640223578e-13
processed O 0 6.493945138574819e-12
pseudogenes O 0 1.4586852559173025e-10
, O 0 2.7323625133302e-12
UBE3AP1 O 0 3.35153664821064e-08
and O 0 2.7990533068428247e-12
UBE3AP2 O 0 2.7233759691824844e-09
, O 0 6.942279325190814e-14
to O 0 2.1105635143216228e-13
chromosomes O 0 1.5367407346644768e-09
2 O 0 6.274277625228919e-11
and O 0 1.7715193756373537e-09
21 O 0 1.1674508026970898e-09
, O 0 7.732204633514872e-13
respectively O 0 1.790206177743059e-11
, O 0 1.3470647340640962e-11
and O 0 1.4467126108197448e-10
determined O 0 3.659964831204121e-10
their O 0 4.1751971752981495e-14
genomic O 0 4.331933478596284e-09
organization O 0 8.23792856846639e-12
. O 0 2.110105709954291e-12

These O 0 2.9106201893114303e-09
results O 0 1.0069757250263933e-09
will O 0 3.682355809164761e-11
form O 0 2.0502805182787132e-13
the O 0 2.2018282650696636e-14
basis O 0 3.143061779267188e-14
for O 0 6.632302387714654e-16
studies O 0 7.058780101230899e-13
of O 0 1.9769734099664344e-17
mutation O 0 5.620887869733915e-12
and O 0 1.2233120874789727e-13
imprinting O 0 1.994266307647763e-09
of O 0 4.253032726887242e-14
UBE3A O 0 3.5944924547948176e-06
. O 0 4.7322895602164294e-11

Mutation O 0 5.100842415117768e-08
spectrum O 0 6.172952426997114e-11
and O 0 3.9502125528945164e-12
genotype O 0 6.834272592293189e-10
- O 0 1.055698589880194e-06
phenotype O 0 1.0950117967922779e-07
analyses O 0 4.571011569254324e-09
in O 0 1.512394159561281e-12
Cowden B-Disease 1 0.9988651275634766
disease I-Disease 1 0.9996910095214844
and O 0 9.28409793488072e-09
Bannayan B-Disease 1 0.9998955726623535
- I-Disease 1 0.999995231628418
Zonana I-Disease 1 0.999997615814209
syndrome I-Disease 1 0.9999990463256836
, O 0 2.1967977784087545e-11
two O 0 7.725209361097995e-11
hamartoma B-Disease 0 0.1914263367652893
syndromes I-Disease 0 0.010330765508115292
with O 0 1.346404671781487e-11
germline O 0 6.306889190454967e-06
PTEN O 0 1.8737053324002773e-05
mutation O 0 8.208002100218437e-07
. O 0 1.227851154084192e-10

The O 0 3.479348009705063e-08
tumour B-Disease 1 0.9999912977218628
suppressor O 0 5.016921022615861e-06
gene O 0 3.3304946356338405e-08
PTEN O 0 1.4113988200392669e-08
, O 0 3.694475714938195e-12
which O 0 4.0818721016092074e-14
maps O 0 5.388012702667311e-09
to O 0 1.808878047349083e-11
10q23 O 0 1.1019236723086578e-07
. O 0 5.730965701999935e-11

3 O 0 2.5400187508850536e-10
and O 0 1.9827059915752954e-13
encodes O 0 2.6272148519190797e-13
a O 0 1.000263748511445e-14
403 O 0 7.140202600182388e-13
amino O 0 2.0370517338913485e-12
acid O 0 1.4850185968071083e-12
dual O 0 1.1818968026489074e-10
specificity O 0 5.657369239742138e-09
phosphatase O 0 0.0011955063091591
( O 0 8.048029473753382e-13
protein O 0 1.3160245115884095e-09
tyrosine O 0 8.871516143926783e-08
phosphatase O 0 1.1421352610341273e-05
; O 0 4.009160191331684e-12
PTPase O 0 3.561598793666576e-09
) O 0 1.943610609912369e-14
, O 0 5.268489366560408e-14
was O 0 1.1597040168453976e-11
shown O 0 4.569522711606044e-12
recently O 0 9.822243018930976e-10
to O 0 1.0506144565436415e-12
play O 0 1.661212972736692e-10
a O 0 4.728528563168778e-14
broad O 0 4.504165269925142e-12
role O 0 3.337064652386701e-11
in O 0 2.8059648788519853e-12
human O 0 3.846614415881078e-10
malignancy B-Disease 0 1.922982482938096e-05
. O 0 2.3040475777280633e-11

Somatic O 0 8.333238810109833e-08
PTEN O 0 6.032517774201551e-08
deletions O 0 2.0006380907489074e-07
and O 0 8.161101794357251e-10
mutations O 0 1.3947720312046386e-08
were O 0 3.9346450360008833e-13
observed O 0 7.2412865634308154e-12
in O 0 5.041969988218986e-13
sporadic B-Disease 1 0.8615602254867554
breast I-Disease 1 0.9999921321868896
, I-Disease 0 9.636220283937291e-07
brain I-Disease 0 0.39046818017959595
, I-Disease 0 1.3725777137096884e-07
prostate I-Disease 1 0.9969627261161804
and I-Disease 0 4.1898394556483254e-05
kidney I-Disease 0 0.0001905655226437375
cancer I-Disease 0 1.1543272194103338e-05
cell O 0 4.214645741740242e-06
lines O 0 0.4655360281467438
and O 0 4.1326723021484213e-07
in O 0 3.920279031954799e-12
several O 0 3.7015234627402194e-11
primary O 0 1.5459602309420006e-06
tumours B-Disease 1 1.0
such O 0 4.787074382728296e-12
as O 0 4.438193457190209e-08
endometrial B-Disease 1 0.9604533314704895
carcinomas I-Disease 1 1.0
, O 1 0.9998188614845276
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9995187520980835
thyroid B-Disease 1 0.9999947547912598
tumours I-Disease 1 1.0
. O 0 3.18101243124147e-08

In O 0 5.909737109399682e-12
addition O 0 5.156292602094548e-13
, O 0 1.2984613926604605e-13
PTEN O 0 1.4031685813264971e-09
was O 0 2.6048030919711973e-12
identified O 0 4.791630417097514e-13
as O 0 3.4282414460476526e-16
the O 0 2.6119417657954945e-16
susceptibility O 0 1.693724674400876e-11
gene O 0 1.2183494491058156e-10
for O 0 9.096468424427823e-14
two O 0 3.9847631860823185e-09
hamartoma B-Disease 1 0.9997058510780334
syndromes I-Disease 1 0.9999550580978394
Cowden B-Disease 1 0.9999749660491943
disease I-Disease 1 0.9999980926513672
( O 0 4.667387136503276e-12
CD B-Disease 0 3.531101100406886e-08
; O 0 3.5235150908086155e-10
MIM O 0 0.004684142768383026
158350 O 0 1.0120619009512666e-07
) O 0 7.941654603903225e-13
and O 0 1.6456865384317787e-11
Bannayan B-Disease 0 0.0003965300275012851
- I-Disease 0 4.7096335038077086e-05
Zonana I-Disease 0 0.0059556202031672
( I-Disease 0 5.703012389592088e-13
BZS I-Disease 0 9.77300640414569e-09
) I-Disease 0 1.1935611563494968e-14
or I-Disease 0 1.432522110374028e-14
Ruvalcaba I-Disease 0 1.9514341147441883e-06
- I-Disease 0 5.111612153996248e-06
Riley I-Disease 0 7.898612238932401e-06
- I-Disease 1 0.9944604635238647
Smith I-Disease 0 0.006071504671126604
syndrome I-Disease 1 0.8705723285675049
( O 0 4.0634074609854215e-14
MIM O 0 1.87727200682275e-05
153480 O 0 8.52862314104641e-09
) O 0 6.234831444532074e-13
. O 0 1.039319455151122e-12

Constitutive O 0 2.5473886888782715e-10
DNA O 0 1.338009383289318e-06
from O 0 1.4254689009035593e-13
37 O 0 8.49377790324013e-11
CD B-Disease 0 6.728149704038344e-10
families O 0 1.5176165879537962e-11
and O 0 2.8315466291117808e-11
seven O 0 5.941972174711152e-12
BZS B-Disease 0 1.2962529183369043e-07
families O 0 7.498351711678758e-14
was O 0 3.3053247638914485e-13
screened O 0 3.5652310964584544e-11
for O 0 3.047828679161261e-15
germline O 0 1.812154515334896e-08
PTEN O 0 2.3064875165346166e-07
mutations O 0 3.0860911692798254e-07
. O 0 5.850389617201301e-11

PTEN O 0 1.4919281738912105e-06
mutations O 0 9.05216711544199e-06
were O 0 2.925096796724258e-12
identified O 0 5.609922942850787e-11
in O 0 2.6109931206583052e-14
30 O 0 1.0228536767575847e-11
of O 0 1.652328875428237e-15
37 O 0 1.839403651615612e-08
( O 0 1.539096134610743e-13
81 O 0 3.990085206684313e-10
% O 0 3.7359163173797654e-15
) O 0 6.954813464634399e-15
CD B-Disease 0 2.0760499222505224e-11
families O 0 1.0548566143839255e-13
, O 0 8.071880938989844e-15
including O 0 1.4617850658225906e-14
missense O 0 4.282333421201656e-08
and O 0 9.670788475579783e-11
nonsense O 0 4.029130451499441e-08
point O 0 1.1424913098911915e-11
mutations O 0 1.8427062653536552e-10
, O 0 1.73592575454214e-14
deletions O 0 5.861897078851541e-10
, O 0 2.447507528677978e-13
insertions O 0 9.710903192683418e-10
, O 0 2.4052691804422877e-13
a O 0 1.0593246115367383e-13
deletion O 0 1.816882111427276e-08
/ O 0 2.673006633813202e-07
insertion O 0 4.4400264020971747e-10
and O 0 9.409019396944274e-11
splice O 0 6.681107333861291e-05
site O 0 9.741334849877603e-08
mutations O 0 2.0680860757238406e-07
. O 0 2.0526380942187394e-11

These O 0 1.5677093304078404e-11
mutations O 0 5.065913244450826e-10
were O 0 8.244113399759334e-14
scattered O 0 5.5633896794970994e-11
over O 0 2.0644574938444293e-10
the O 0 9.524462381976795e-13
entire O 0 2.1725838142416798e-11
length O 0 1.4225505322318366e-11
of O 0 4.0604185305304893e-17
PTEN O 0 1.5640753969758947e-10
, O 0 5.992797404152927e-14
with O 0 1.9559714464149457e-15
the O 0 1.4643291716313163e-15
exception O 0 4.345878312165402e-13
of O 0 4.402503771237673e-16
the O 0 1.5027327255820455e-12
first O 0 1.3377991769925046e-10
, O 0 4.5696908063108665e-11
fourth O 0 2.409121346858001e-09
and O 0 5.2321333030014294e-12
last O 0 2.243161559278839e-11
exons O 0 1.1973229163686483e-07
. O 0 1.3035179879938852e-10

A O 0 1.2825900341795204e-09
hot O 0 4.566343392298222e-08
spot O 0 3.883118271374997e-10
for O 0 2.1957376746624315e-15
PTEN O 0 9.859450145199844e-09
mutation O 0 2.716786795531334e-09
in O 0 1.3125416721646455e-14
CD B-Disease 0 1.4101918244247003e-10
was O 0 1.7625668979892595e-10
identified O 0 7.88543449287138e-12
in O 0 1.2865406617717829e-15
exon O 0 4.2752388296207755e-09
5 O 0 4.4550074740357104e-10
that O 0 1.2219368312332834e-12
contains O 0 1.4587004564317607e-12
the O 0 1.3416460867624047e-12
PTPase O 0 1.1411628264568208e-07
core O 0 1.6734247321181783e-10
motif O 0 1.287433804009197e-08
, O 0 1.7538124815266731e-12
with O 0 9.904680835269922e-14
13 O 0 7.85053879542863e-13
of O 0 2.468685730404335e-16
30 O 0 1.227770923123428e-11
( O 0 1.0279454967353913e-13
43 O 0 3.038978235725409e-10
% O 0 4.335888388644826e-15
) O 0 1.2967134215891886e-14
CD B-Disease 0 1.9019607069847844e-11
mutations O 0 5.899778887652474e-09
identified O 0 6.181069545085904e-11
in O 0 2.6177587116212042e-15
this O 0 5.796684374094908e-15
exon O 0 4.29928235234911e-08
. O 0 2.5525245805901875e-10

Seven O 0 1.3077167126951394e-10
of O 0 7.534012370505403e-16
30 O 0 1.1299192918118317e-12
( O 0 1.0036272316416971e-14
23 O 0 5.416154070375656e-12
% O 0 3.1720693013425943e-16
) O 0 4.247614850046719e-15
were O 0 3.580538372304626e-14
within O 0 6.294213061993834e-14
the O 0 4.579157098129208e-15
core O 0 1.3806220706610861e-12
motif O 0 1.8060521134177776e-10
, O 0 6.046612456610603e-14
the O 0 6.262236975311921e-15
majority O 0 2.1378842706559764e-12
( O 0 7.424292571781704e-14
five O 0 3.534724054253535e-13
of O 0 4.697770721623254e-16
seven O 0 1.1778403773143875e-12
) O 0 3.549597656345789e-15
of O 0 2.3354231948656734e-17
which O 0 7.165265017601563e-13
were O 0 5.537045973634525e-13
missense O 0 1.6861877227825062e-08
mutations O 0 2.9423472547307483e-09
, O 0 1.454501090695972e-14
possibly O 0 9.900392815677742e-14
pointing O 0 3.847230867215501e-10
to O 0 4.971631179656599e-12
the O 0 6.235315811852632e-14
functional O 0 1.3233536488854725e-10
significance O 0 1.945266864256112e-12
of O 0 3.78917944316901e-15
this O 0 6.601240821330068e-13
region O 0 1.3593181025228773e-09
. O 0 6.948092101666248e-11

Germline O 0 1.4510144865198527e-05
PTEN O 0 4.0212387375504477e-07
mutations O 0 3.226824901503278e-06
were O 0 1.1413783113090048e-11
identified O 0 5.036576711248131e-10
in O 0 9.698227464161047e-13
four O 0 6.698504251279047e-11
of O 0 1.2701007475292899e-14
seven O 0 3.5050418123461213e-10
( O 0 1.7783000007438876e-13
57 O 0 1.064314969489999e-09
% O 0 4.4302723382211306e-14
) O 0 1.225021928515091e-12
BZS B-Disease 0 1.4648227306679473e-06
families O 0 4.070843055009599e-12
studied O 0 7.443491933933899e-10
. O 0 5.934066606150257e-12

Interestingly O 0 6.296452426113319e-08
, O 0 5.3824812662472965e-11
none O 0 3.773937325840526e-12
of O 0 1.1880814990433838e-16
these O 0 6.077912695703902e-14
mutations O 0 4.9811110791608826e-09
was O 0 1.7664404661221766e-10
observed O 0 6.2236899661671785e-12
in O 0 1.6353488929785748e-14
the O 0 1.4427285863378991e-13
PTPase O 0 4.6060830527494545e-07
core O 0 1.5170769085415259e-09
motif O 0 3.5060526215602295e-07
. O 0 4.389551916395007e-11

It O 0 1.0612930978481927e-08
is O 0 3.5914085832859655e-13
also O 0 2.7768084598193965e-13
worthy O 0 8.560574056809371e-15
of O 0 6.581614745010874e-17
note O 0 1.0473196962457187e-11
that O 0 6.253216667346725e-14
a O 0 1.5969176529089316e-14
single O 0 8.212682378778979e-13
nonsense O 0 5.977264905254742e-09
point O 0 1.7451241840493736e-11
mutation O 0 8.60580356976115e-12
, O 0 1.773272623032708e-14
R233X O 0 2.998975026646811e-11
, O 0 2.5287999233687686e-13
was O 0 5.0967476766805575e-12
observed O 0 4.043501373573316e-13
in O 0 9.055673708325456e-16
the O 0 4.03175850901565e-16
germline O 0 3.1640933362969692e-12
DNA O 0 1.8705845761246565e-08
from O 0 1.9798651341262463e-16
two O 0 8.853431463157809e-15
unrelated O 0 4.93133268594792e-12
CD B-Disease 0 3.912613344425608e-09
families O 0 1.7887795411564156e-11
and O 0 7.715370009542255e-12
one O 0 3.319617801131325e-12
BZS B-Disease 0 2.1349401322368067e-06
family O 0 2.2285608081151764e-10
. O 0 8.284206653996762e-12

Genotype O 0 1.1368888408469502e-06
- O 0 8.397543751925696e-06
phenotype O 0 2.3846058638810064e-07
studies O 0 1.719288877932712e-10
were O 0 1.3019681090620933e-13
not O 0 4.446072850161631e-12
performed O 0 2.3220407818769218e-09
on O 0 7.2110603079045266e-12
this O 0 2.0666133463808495e-13
small O 0 9.117461126362247e-12
group O 0 2.4281899407840868e-11
of O 0 3.496086138144762e-15
BZS B-Disease 0 6.06031653660466e-06
families O 0 7.101985666224664e-12
. O 0 2.73876971448872e-12

However O 0 1.3452347569220535e-10
, O 0 6.211409831575684e-14
genotype O 0 1.2534033706768088e-11
- O 0 1.953156214540286e-08
phenotype O 0 1.5593429880667031e-09
analysis O 0 1.2551971181190558e-12
inthe O 0 3.3241137620265704e-10
group O 0 7.304277842290485e-12
of O 0 2.3191335932371156e-16
CD B-Disease 0 8.207656776448857e-09
families O 0 1.8217930636277302e-11
revealed O 0 1.7371390992337865e-09
two O 0 1.9109112079154777e-13
possible O 0 1.261364466651968e-13
associations O 0 1.2181046347983717e-15
worthy O 0 6.273953558554816e-15
of O 0 1.402136121586304e-16
follow O 0 3.8952543968129305e-10
- O 0 7.741859775478588e-08
up O 0 1.9142776253033844e-10
in O 0 6.356077637955856e-14
independent O 0 2.6578403106852777e-12
analyses O 0 8.095553671871869e-10
. O 0 5.475032319873785e-13

The O 0 1.0111728121486863e-10
first O 0 9.661897150403664e-12
was O 0 1.3816711663672265e-11
an O 0 2.460930137920597e-15
association O 0 5.5553014987642924e-14
noted O 0 1.1154648316136218e-09
in O 0 2.9897438691417477e-12
the O 0 2.1632747676525454e-12
group O 0 1.2016583908480705e-11
of O 0 9.896847437516023e-17
CD B-Disease 0 6.560222143292549e-09
families O 0 1.2291064867275825e-11
with O 0 2.3833717222032647e-09
breast B-Disease 1 0.7102377414703369
disease I-Disease 0 0.18266065418720245
. O 0 4.427018474029154e-11

A O 0 1.0046098675164927e-10
correlation O 0 1.9631600511882397e-10
was O 0 3.800492906491648e-11
observed O 0 4.749332004061468e-12
between O 0 3.326358014987124e-14
the O 0 3.019317041936913e-14
presence O 0 4.672237041702942e-10
/ O 0 1.868218714662362e-05
absence O 0 6.932610410216589e-13
of O 0 3.858060953224396e-18
a O 0 3.8837011203025386e-15
PTEN O 0 4.3846926089941007e-10
mutation O 0 1.429593388113659e-10
and O 0 1.1271979037013116e-13
the O 0 1.3988626304127418e-14
type O 0 1.015399107018311e-07
of O 0 8.053342606499647e-13
breast O 0 0.02229810692369938
involvement O 0 1.328257468458105e-07
( O 0 4.374440740195773e-11
unaffected O 0 3.0873206924297847e-06
versus O 0 4.7488590837474476e-09
benign O 0 0.00019568104471545666
versus O 0 1.679328853754214e-08
malignant O 1 0.5976468920707703
) O 0 2.0387602717164555e-10
. O 0 4.648412904595389e-11

Specifically O 0 5.278560699650825e-09
and O 0 1.4481778623509634e-11
more O 0 6.896819130439147e-16
directly O 0 1.0213963735124926e-13
, O 0 1.2447925719707986e-12
an O 0 2.983411992929161e-14
association O 0 7.108270135697259e-13
was O 0 5.295189176024451e-09
also O 0 2.351742689477021e-10
observed O 0 1.0867804919878488e-11
between O 0 5.904976350555244e-14
the O 0 1.5279446282227848e-15
presence O 0 5.4445905656131874e-14
of O 0 1.9584033706507414e-17
a O 0 1.6441818880778142e-13
PTEN O 0 2.894915382967156e-07
mutation O 0 7.010641525084793e-07
and O 0 8.36207405541245e-08
malignant B-Disease 1 0.9999209642410278
breast I-Disease 1 0.9999690055847168
disease I-Disease 1 0.9999819993972778
. O 0 6.562287158118352e-09

Secondly O 0 5.483846689458005e-05
, O 0 1.4891008565109942e-11
there O 0 2.9623781726273446e-12
appeared O 0 5.8898512733662756e-09
to O 0 3.3707496429474793e-12
be O 0 3.877859838796738e-12
an O 0 1.364371957020315e-14
interdependent O 0 1.3723962410949753e-06
association O 0 7.072274189889871e-12
between O 0 6.977012717568343e-12
mutations O 0 1.7057784873486526e-07
upstream O 0 5.449692364045688e-10
and O 0 1.92692199002531e-11
within O 0 3.1474006885988393e-13
the O 0 3.204570262578185e-14
PTPase O 0 1.141403949134201e-08
core O 0 3.64219106263608e-11
motif O 0 4.15171763634703e-09
, O 0 2.699765866594206e-13
the O 0 1.9243178251760525e-15
core O 0 2.2698401318244077e-12
motif O 0 5.497046151603513e-10
containing O 0 1.1229854394480265e-13
the O 0 7.102086659657031e-14
majority O 0 1.2523250665641417e-12
of O 0 5.136358558360018e-16
missense O 0 3.388535674275772e-07
mutations O 0 7.641323236384778e-07
, O 0 2.828225934697892e-12
and O 0 1.70107287630894e-12
the O 0 8.654051765835408e-15
involvement O 0 3.056425772196558e-12
of O 0 4.56645520381042e-16
all O 0 2.5431452733634674e-14
major O 0 2.1888907515959372e-13
organ O 0 9.168683867688543e-11
systems O 0 3.425833783321508e-10
( O 0 1.2071567974825809e-13
central O 0 1.5650012397117052e-09
nervous O 0 1.0127452014785376e-06
system O 0 7.19307280405701e-10
, O 0 5.485415073558375e-12
thyroid O 0 1.2547684491437394e-06
, O 0 9.65299173927292e-10
breast O 1 0.9612249135971069
, O 0 0.0003258487267885357
skin O 1 0.9999997615814209
and O 1 0.7646868824958801
gastrointestinal O 1 0.9999724626541138
tract O 1 0.9889340996742249
) O 0 9.239876641586875e-10
. O 0 3.013454485945033e-10

However O 0 9.15333409068353e-09
, O 0 3.4192088179882396e-13
these O 0 9.074070205148635e-16
observations O 0 2.3184748391968935e-12
would O 0 1.4560132613472554e-11
need O 0 1.2858826416856095e-12
to O 0 3.8023452659033397e-13
be O 0 4.4029469198174354e-13
confirmed O 0 6.581606353667224e-12
by O 0 8.098273559184002e-17
studying O 0 2.191972697915181e-14
a O 0 4.176755885327687e-15
larger O 0 5.6114875658479224e-14
number O 0 2.36297635104743e-12
of O 0 2.052610282400136e-15
CD B-Disease 0 1.4082742971766038e-08
families O 0 3.2194132776330875e-11
. O 0 1.0296576959112347e-11

Molecular O 0 0.0004928041598759592
defects O 1 0.9912514090538025
leading O 0 3.620060029518868e-09
to O 0 2.2200819741607924e-12
human O 0 1.28685798128636e-10
complement B-Disease 0 3.3714965752551507e-07
component I-Disease 1 0.5233339071273804
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 9.63135387416214e-12
an O 0 4.953464396474649e-13
African O 0 2.4098589443410923e-11
- O 0 6.130041185770096e-08
American O 0 3.412827312421207e-11
family O 0 4.4137814930733654e-11
. O 0 4.500901821385961e-12

Complement B-Disease 0 2.040451181528624e-05
component I-Disease 0 0.010823113843798637
C6 I-Disease 1 0.9999994039535522
deficiency I-Disease 1 1.0
( O 0 1.6890411291825558e-10
C6D B-Disease 0 7.779755105730146e-05
) O 0 1.4726937724862665e-10
was O 0 4.7383480250573484e-08
diagnosed O 0 1.4788020962441806e-05
in O 0 3.758496606390965e-14
a O 0 3.6295421529386473e-11
16 O 0 7.824539904888184e-10
- O 0 2.7287430981459693e-08
year O 0 3.1722674075258805e-13
- O 0 2.5630244593344287e-09
old O 0 1.126941029383488e-07
African O 0 4.2252852150252707e-13
- O 0 1.515882905311905e-12
American O 0 2.288427151768413e-13
male O 0 1.2927190784842169e-12
with O 0 1.6241909076356031e-12
meningococcal B-Disease 1 0.9999994039535522
meningitis I-Disease 1 0.9999998807907104
. O 0 3.8037437088966897e-10

The O 0 1.321412090860008e-09
patients O 0 1.1783100717366324e-08
father O 0 3.884705890300211e-09
and O 0 2.0296075931014457e-10
two O 0 3.8430335302930274e-11
brothers O 0 1.77987317329098e-07
also O 0 3.378580193391656e-10
had O 0 2.343321314768332e-09
C6D B-Disease 0 2.2565190604950658e-08
, O 0 3.565411041493022e-13
but O 0 1.1478202286210881e-12
gave O 0 1.7399061358336354e-11
no O 0 3.3365664831724873e-12
history O 0 1.71238755597089e-13
of O 0 2.846645309880977e-14
meningitis B-Disease 1 1.0
or O 0 7.320027223256531e-11
other O 0 3.764749362950015e-12
neisserial B-Disease 0 0.007014053408056498
infection I-Disease 0 0.004368475638329983
. O 0 1.420140480906662e-11

By O 0 9.854437212531049e-15
using O 0 7.199217621784576e-15
exon O 0 8.640903097212327e-12
- O 0 5.680039216748867e-10
specific O 0 4.835820871344765e-13
polymerase O 0 3.1561461777407374e-10
chain O 0 7.966148574123366e-11
reaction O 0 8.75059166837236e-14
( O 0 1.222199986158787e-16
PCR O 0 1.4782116503075926e-11
) O 0 2.0214276114799163e-15
/ O 0 2.1741964131849478e-11
single O 0 3.7855477894076575e-14
- O 0 1.7787597783591735e-11
strand O 0 1.847552388856144e-10
conformation O 0 3.7244439845575406e-13
polymorphism O 0 1.695856318871189e-13
as O 0 1.2143923276185725e-16
a O 0 1.2942139332409596e-16
screening O 0 1.0153856054573307e-11
step O 0 3.091638544564651e-13
and O 0 3.211358659903189e-16
nucleotide O 0 5.645946814318006e-15
sequencing O 0 6.985763625010598e-15
of O 0 4.467122723643622e-18
target O 0 2.294726474810771e-12
exons O 0 6.314438416588075e-10
, O 0 3.195566034008834e-11
we O 0 2.4626771108482437e-11
determined O 0 2.3835848659420344e-13
that O 0 6.406048346679124e-15
the O 0 2.078985617828214e-15
proband O 0 6.112549133518996e-09
was O 0 2.2315315827831084e-12
a O 0 8.370434641908567e-16
compound O 0 1.1149654333478254e-12
heterozygote O 0 4.342466490558916e-12
for O 0 3.670902091755025e-16
two O 0 1.3860408046989514e-13
C6 O 0 4.220189708803446e-08
gene O 0 2.2813509303887258e-08
mutations O 0 9.690152324992596e-08
. O 0 4.336509276670064e-11

The O 0 4.852956231315986e-11
first O 0 8.656206719297177e-13
, O 0 2.4338012819826414e-14
1195delC O 0 1.445347314055212e-10
located O 0 1.1874456279370449e-11
in O 0 1.1312573091010279e-14
exon O 0 4.897464656039574e-09
7 O 0 6.7170109474545825e-09
, O 0 7.612966246989261e-13
is O 0 6.295098042017125e-15
a O 0 5.260894953858621e-15
novel O 0 8.925777651713762e-12
mutation O 0 4.910723216955404e-11
, O 0 4.3240994010255995e-13
while O 0 7.632260166749727e-13
the O 0 5.946456570421824e-14
second O 0 1.3256164395347714e-11
, O 0 3.4483849695003677e-14
1936delG O 0 4.4397704263010596e-11
in O 0 5.98041683178268e-15
exon O 0 3.434718620631827e-10
12 O 0 1.1414594269787415e-10
, O 0 3.984155128207434e-13
has O 0 4.902466453626797e-12
been O 0 2.589638030923991e-13
described O 0 4.603682344193893e-13
before O 0 9.114426200535972e-14
to O 0 6.770928625719416e-14
cause O 0 1.680536569279023e-12
C6D B-Disease 0 7.662939793817714e-08
in O 0 1.733060750301347e-14
an O 0 5.4715507772913445e-15
unrelated O 0 8.58739857001467e-10
African O 0 4.4031722712389865e-10
- O 0 9.63010435839351e-08
American O 0 3.421665381586614e-11
individual O 0 1.1138637755203629e-13
. O 0 1.6754413611694274e-12

Both O 0 6.386791540080594e-09
mutations O 0 7.449243071278033e-07
result O 0 3.1462513150337656e-11
in O 0 4.240973349410593e-13
premature O 0 6.951091369167273e-10
termination O 0 1.9698176423332825e-10
codons O 0 3.000026538302336e-08
and O 0 4.2181255710538323e-10
C6 O 0 6.562617272720672e-06
null O 0 5.350865421860362e-07
alleles O 0 1.3647848184916711e-08
. O 0 9.744374196429817e-10

Allele O 0 6.595121671004733e-10
- O 0 1.334167915034712e-10
specific O 0 1.6176234071858808e-13
PCR O 0 2.763731465904584e-09
indicated O 0 4.0870296036388254e-10
that O 0 7.94798458276201e-14
the O 0 1.4347862294420387e-14
probands O 0 4.269203373041819e-07
two O 0 1.542507510610136e-10
brothers O 0 1.8630753118031862e-07
also O 0 1.2590083142693942e-10
inherited O 0 1.6843257899523678e-09
the O 0 2.833442734387066e-15
1195delC O 0 1.2958685235986422e-09
mutation O 0 1.0863810545602703e-10
from O 0 6.850542438277974e-15
their O 0 5.656688225469386e-13
heterozygous O 0 6.033298305396784e-09
mother O 0 6.253080186979787e-08
and O 0 1.2800262965458747e-13
the O 0 1.0800251353852383e-15
1936delG O 0 4.097199524100148e-10
mutation O 0 3.040194485048886e-11
from O 0 5.146813062511504e-16
their O 0 7.922493126214392e-15
homozygous O 0 1.70083998968229e-11
father O 0 5.7652046331346796e-11
. O 0 3.3835778010795833e-14
. O 0 9.678548110528262e-13

PAX6 O 0 0.00034399188007228076
mutations O 0 1.2729544323519804e-05
reviewed O 0 1.3974593571219884e-07
. O 0 9.271016732093074e-10

Mutations O 0 0.00014821421063970774
in O 0 9.851328737139897e-13
PAX6 O 0 9.533498968039567e-08
are O 0 9.910689348184565e-14
responsible O 0 1.269150257977858e-12
for O 0 2.1900253691694432e-14
human O 0 2.7901505550431693e-09
aniridia B-Disease 1 1.0
and O 0 1.349393369309837e-05
have O 0 1.4291450689540852e-08
also O 0 7.428964388100923e-11
been O 0 7.030151634446202e-12
found O 0 6.368288600448746e-13
in O 0 2.0678976177354765e-14
patients O 0 8.383516320389917e-13
with O 0 6.56977564798128e-13
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 2.678538102429684e-08
with O 0 1.1181582948438518e-07
congenital B-Disease 1 0.9999991655349731
cataracts I-Disease 1 0.9999990463256836
, O 0 4.0206398210784755e-08
with O 0 3.280299054608804e-08
autosomal B-Disease 1 0.9992677569389343
dominant I-Disease 0 0.054355427622795105
keratitis I-Disease 1 0.9994580149650574
, O 0 3.8702830806869315e-07
and O 0 8.798042294699826e-09
with O 0 1.2968360607601426e-08
isolated B-Disease 1 0.9999334812164307
foveal I-Disease 1 0.9999997615814209
hypoplasia I-Disease 1 0.9999998807907104
. O 0 2.3253351244534315e-08

No O 0 1.1508383135350186e-09
locus O 0 1.8237191271031072e-11
other O 0 1.0367589761955259e-13
than O 0 1.5971986645595126e-13
chromosome O 0 1.3660417607752606e-05
11p13 O 0 3.3839878454955397e-08
has O 0 3.9175027111149063e-10
been O 0 4.866124864166821e-12
implicated O 0 3.75856672174546e-11
in O 0 3.3174214243703037e-12
aniridia B-Disease 1 1.0
, O 0 1.4166107176194487e-10
and O 0 2.6643676414445094e-12
PAX6 O 0 2.0145303381013946e-07
is O 0 5.624072388354939e-12
clearly O 0 5.630383746041412e-12
the O 0 2.2691051274547572e-15
major O 0 6.54167963288349e-13
, O 0 1.6479385564482918e-11
if O 0 8.271457963004991e-10
not O 0 1.039464781610322e-11
only O 0 5.6664044387633866e-14
, O 0 1.2732514559831917e-14
gene O 0 1.9150361851849595e-11
responsible O 0 1.4009047394347718e-11
. O 0 7.038080621774023e-12

Twenty O 0 7.782749555929058e-09
- O 0 1.5473247003683355e-06
eight O 0 6.011960373975e-11
percent O 0 9.451147546871153e-14
of O 0 3.281861248744554e-17
identified O 0 1.9602406503560488e-11
PAX6 O 0 8.895237613160134e-08
mutations O 0 3.231266632042207e-08
are O 0 5.802674421691301e-13
C O 0 1.0314919563825242e-05
- O 0 0.0002277899329783395
T O 0 2.6728010197984986e-05
changes O 0 8.22931098265478e-11
at O 0 8.540619925688497e-13
CpG O 0 7.44213313197406e-09
dinucleotides O 0 6.076765202145396e-10
, O 0 6.65579109838596e-14
20 O 0 1.0448300482180511e-14
% O 0 2.28478931890171e-17
are O 0 7.719585311673551e-18
splicing O 0 9.206873596845355e-10
errors O 0 1.2013024388579652e-06
, O 0 2.4405057510480666e-13
and O 0 6.070567225985313e-14
more O 0 1.4403122935657494e-16
than O 0 5.3681166194868065e-15
30 O 0 5.621538933138492e-13
% O 0 2.534324960465031e-16
are O 0 9.446699718631605e-17
deletion O 0 5.7659497836037854e-12
or O 0 5.8907545826675494e-15
insertion O 0 6.989039989108159e-12
events O 0 1.1221414075723857e-10
. O 0 2.73267769523855e-10

There O 0 1.9854535793228933e-09
is O 0 1.9295277723686832e-13
a O 0 1.5770648946911853e-13
noticeably O 0 2.2601717830639245e-08
elevated O 0 2.0339972195415612e-07
level O 0 1.1464096165425541e-11
of O 0 2.2439602132616845e-16
mutation O 0 4.3313369557651527e-10
in O 0 2.6961931155040052e-14
the O 0 3.0770842146012056e-13
paired O 0 4.357440630542442e-09
domain O 0 2.892078763971906e-11
compared O 0 2.9440826946475207e-12
with O 0 1.1709882195842791e-12
the O 0 2.099879731903842e-12
rest O 0 3.419941413396188e-12
of O 0 1.7363867707525287e-17
the O 0 4.438795691956172e-15
gene O 0 8.613838808901875e-11
. O 0 1.6229273784237885e-12

Increased O 0 5.975155925597164e-09
mutation O 0 8.976669185756236e-09
in O 0 4.861555087535066e-14
the O 0 2.7019436221829146e-14
homeodomain O 0 2.6814211295800305e-08
is O 0 6.073682951978493e-14
accounted O 0 1.3880257620363379e-12
for O 0 2.3700208511663163e-17
by O 0 6.466023996817122e-16
the O 0 3.724051164557922e-14
hypermutable O 0 4.7560952509684284e-08
CpG O 0 1.9539720952366224e-08
dinucleotide O 0 1.1406287026005657e-09
in O 0 8.218617030420622e-14
codon O 0 1.3219508820938586e-10
240 O 0 7.945537457143548e-12
. O 0 6.211783257908943e-12

Very O 0 1.0475605938253807e-09
nearly O 0 1.336568334307786e-12
all O 0 8.844238275768079e-14
mutations O 0 2.0644901344013533e-09
appear O 0 3.1158898378125244e-11
to O 0 2.6667737462737762e-11
cause O 0 6.141976705009711e-09
loss O 0 1.903299029493155e-08
of O 0 1.3659987049713406e-15
function O 0 2.969892734516755e-11
of O 0 3.805183283674433e-16
the O 0 2.1298235188828805e-14
mutant O 0 1.9132619100137305e-11
allele O 0 1.2010292933795075e-13
, O 0 6.688714252606198e-14
and O 0 2.8468120906682912e-15
more O 0 2.608334770288202e-18
than O 0 1.9414969238957906e-16
80 O 0 9.434866218372209e-14
% O 0 5.947992939957377e-16
of O 0 1.175683318975745e-16
exonic O 0 1.622204024442908e-07
substitutions O 0 1.8991776207233357e-10
result O 0 3.478962777581085e-12
in O 0 9.770931622393036e-14
nonsense O 0 3.4803569803898426e-08
codons O 0 2.941909382769836e-09
. O 0 1.2638340894655098e-11

In O 0 3.487859306927632e-12
a O 0 4.824136898870339e-14
gene O 0 5.922838608451997e-12
with O 0 2.0740505921192738e-15
such O 0 1.670582117804212e-15
extraordinarily O 0 3.72296160913721e-12
high O 0 3.0701036331237663e-12
sequence O 0 7.452679445796306e-11
conservation O 0 1.8169607528609188e-13
throughout O 0 4.8407272249884406e-14
evolution O 0 8.459137795617522e-13
, O 0 9.8659714295804e-14
there O 0 7.630338418398996e-13
are O 0 4.1701990032829914e-14
presumed O 0 1.4346249188612603e-10
undiscovered O 0 3.1468530559131125e-10
missense O 0 5.781091871881472e-08
mutations O 0 6.725865659973351e-07
, O 0 1.4938165721761765e-12
these O 0 2.1390324610854293e-14
are O 0 1.860749273034038e-15
hypothesized O 0 1.0706669578697259e-10
to O 0 3.5426651195935577e-11
exist O 0 1.578208674857251e-09
in O 0 1.4411967441934487e-13
as O 0 1.9110589846715875e-11
- O 0 1.411703919984575e-06
yet O 0 3.381679311575958e-11
unidentified O 0 1.1086090379031077e-10
phenotypes O 0 2.7345339881357233e-10
. O 0 5.988501253044454e-14
. O 0 8.195203413455254e-13

Genetic O 0 3.8352165574906394e-05
heterogeneity O 0 1.488311482944482e-07
and O 0 1.1219637718884456e-10
penetrance O 0 1.0648336967733485e-07
analysis O 0 1.1368807804890135e-11
of O 0 1.5039233032342449e-15
the O 0 9.853527499145698e-13
BRCA1 O 0 9.29130783333676e-06
and O 0 1.4797252312348519e-09
BRCA2 O 0 1.1848387657664716e-06
genes O 0 1.499970210261381e-07
in O 0 3.863970032824682e-09
breast B-Disease 1 0.9863016605377197
cancer I-Disease 0 0.0209663063287735
families O 0 4.6537180359296215e-11
. O 0 9.604849554589734e-11

The O 0 2.203134135925211e-05
Breast B-Disease 1 0.9999997615814209
Cancer I-Disease 1 0.9999990463256836
Linkage O 0 0.0007486327085644007
Consortium O 0 1.6379322786974626e-08
. O 0 2.4025297376550903e-11

The O 0 6.334235436514235e-13
contribution O 0 9.541707566207078e-15
of O 0 1.7290252735823906e-15
BRCA1 O 0 7.255117679960676e-07
and O 0 4.266970332622577e-09
BRCA2 O 0 0.010877616703510284
to O 0 0.00036338999052532017
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 5.049942686241593e-08
assessed O 0 2.0443267304687263e-12
by O 0 4.35960573468442e-15
linkage O 0 3.290733729954809e-07
and O 0 2.5191407987401604e-11
mutation O 0 2.5591483793219183e-11
analysis O 0 4.5193427992973323e-13
in O 0 2.5037686174697463e-15
237 O 0 1.1535969662163081e-12
families O 0 6.561082650487562e-14
, O 0 9.464966381185838e-14
each O 0 1.1405810825014447e-16
with O 0 2.6263567736621932e-14
at O 0 2.002836481732051e-12
least O 0 5.1531827714506803e-14
four O 0 3.0974701969999074e-13
cases O 0 5.056679033832445e-12
of O 0 2.9573765311652345e-12
breast B-Disease 1 0.9999539852142334
cancer I-Disease 0 0.014198584482073784
, O 0 8.074471673962316e-14
collected O 0 1.3339801268816287e-13
by O 0 8.648401005756368e-13
the O 0 1.6015366099964012e-06
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 3.457329876255244e-05
Consortium O 0 8.417208596789294e-10
. O 0 1.7920774456406385e-12

Families O 0 2.701598666998706e-10
were O 0 2.62302413947188e-13
included O 0 2.834282016982853e-14
without O 0 6.148474944781511e-15
regard O 0 3.0743240815096122e-15
to O 0 6.704728257506988e-15
the O 0 2.9866559597105553e-15
occurrence O 0 1.5686771881462391e-09
of O 0 4.040150158868272e-12
ovarian B-Disease 0 0.004421557299792767
or I-Disease 0 4.996282901292837e-11
other I-Disease 0 1.342143896021497e-10
cancers I-Disease 0 0.029969215393066406
. O 0 5.73021144423258e-11

Overall O 0 8.684147906024009e-05
, O 0 1.4572718498584436e-07
disease O 0 0.08850045502185822
was O 0 8.335055562413984e-11
linked O 0 8.821550601112449e-09
to O 0 9.912798012989832e-12
BRCA1 O 0 1.2349836708835937e-07
in O 0 1.1931832949517267e-14
an O 0 6.080967054160054e-16
estimated O 0 2.1212916406082583e-12
52 O 0 2.3181023767193665e-09
% O 0 3.885256696310171e-15
of O 0 1.5280721860906854e-16
families O 0 8.356202015058489e-13
, O 0 2.549076130297506e-13
to O 0 1.6575421048735384e-13
BRCA2 O 0 8.155589398262109e-11
in O 0 1.7784688313509343e-14
32 O 0 8.708043834626533e-12
% O 0 4.283966010131966e-16
of O 0 1.246567271166721e-16
families O 0 6.85245751200908e-13
, O 0 2.7789504638414675e-12
and O 0 4.9085670424109384e-12
to O 0 2.0288303914477168e-13
neither O 0 1.5538577369245132e-11
gene O 0 4.380653131907941e-11
in O 0 3.282104270438055e-14
16 O 0 3.766356530040399e-13
% O 0 5.211095584018715e-17
( O 0 6.341830437903921e-16
95 O 0 4.302329603689259e-10
% O 0 1.829781638706951e-11
confidence O 0 2.560364009696059e-06
interval O 0 3.2404940952801553e-07
[ O 0 1.2539923266441377e-10
CI O 0 0.00018423829169478267
] O 0 3.734144937705963e-10
6 O 0 1.998132735658853e-11
% O 0 1.322599663252863e-13
- O 0 1.1726538104994688e-05
28 O 0 1.72043890245277e-08
% O 0 2.0640426860892274e-15
) O 0 4.298618938965637e-15
, O 0 4.5238229767839266e-15
suggesting O 0 7.670876195527143e-13
other O 0 4.796318642816613e-14
predisposition O 0 6.1600444745124605e-09
genes O 0 8.672944584731113e-10
. O 0 2.6475351425081506e-11

The O 0 4.295743274984609e-11
majority O 0 2.1577540101902493e-11
( O 0 3.2557691351936535e-13
81 O 0 1.1574174951789473e-10
% O 0 1.6573032881692248e-15
) O 0 4.111499620038268e-15
of O 0 4.5706579695364586e-15
the O 0 1.1241293123021023e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.7972256712364687e-12
were O 0 2.3183232135230714e-13
due O 0 9.116981529531248e-14
to O 0 2.7500644448306966e-13
BRCA1 O 0 5.781364720292004e-09
, O 0 4.909144922168873e-13
with O 0 1.584524341163157e-13
most O 0 1.551158561406002e-13
others O 0 8.648388429011167e-12
( O 0 8.278069256548864e-14
14 O 0 1.1269023908466735e-11
% O 0 1.6978351911238823e-15
) O 0 1.112423700925418e-14
due O 0 2.0166081803572877e-13
to O 0 1.6902456864698046e-11
BRCA2 O 0 1.0811789934450644e-06
. O 0 4.471350026347132e-11

Conversely O 0 6.950461539645403e-08
, O 0 8.505056034446845e-12
the O 0 1.7766141680096263e-14
majority O 0 4.397718354840624e-13
of O 0 9.372188744890706e-16
families O 0 1.6171328057028311e-13
with O 0 2.475948265856509e-12
male B-Disease 0 1.9564410536077048e-08
and I-Disease 0 7.974578331015891e-09
female I-Disease 0 9.959437363704637e-08
breast I-Disease 0 0.005419175606220961
cancer I-Disease 0 0.009333276189863682
were O 0 3.0141656531812444e-11
due O 0 2.0717866311414923e-10
to O 0 4.3915560077323335e-10
BRCA2 O 0 1.821909108912223e-06
( O 0 1.22104680966989e-12
76 O 0 1.6188250739901378e-08
% O 0 1.3954045167616225e-13
) O 0 2.017778956073246e-12
. O 0 1.742343769262078e-11

The O 0 1.2379741329282545e-11
largest O 0 2.1781717055024963e-12
proportion O 0 2.983724031735413e-11
( O 0 5.374873723179574e-13
67 O 0 1.4614436771864803e-08
% O 0 1.0630868269565809e-14
) O 0 3.213641307816921e-14
of O 0 1.1103880901707527e-15
families O 0 2.2222172019192854e-12
due O 0 8.709600423685571e-13
to O 0 2.0123778945307924e-13
other O 0 1.7613231904326128e-14
genes O 0 3.795554148755542e-10
was O 0 4.821159471646297e-09
found O 0 2.1193527488527764e-10
in O 0 3.5983957241865483e-13
families O 0 1.1397869139392197e-13
with O 0 3.388164315082376e-13
four O 0 2.1785871717749927e-12
or O 0 9.03410104970831e-14
five O 0 1.3366511944588183e-14
cases O 0 4.3939512266296873e-14
of O 0 6.82471047448556e-14
female O 0 3.2086586543300655e-06
breast B-Disease 0 0.06009693816304207
cancer I-Disease 0 0.0024828175082802773
only O 0 2.783239194670273e-10
. O 0 3.313207208588409e-10

These O 0 2.1331362023979672e-11
estimates O 0 1.2471942922864798e-10
were O 0 3.4875401178080523e-12
not O 0 1.3948037603378483e-12
substantially O 0 3.260111347547223e-10
affected O 0 6.784703441425899e-12
either O 0 3.681170629822941e-14
by O 0 3.6318197798104745e-15
changing O 0 3.0839854975317493e-11
the O 0 2.5503391241844982e-14
assumed O 0 2.169332205190222e-12
penetrance O 0 8.02330424320985e-10
model O 0 1.9418461630338335e-11
for O 0 1.5803123343076635e-15
BRCA1 O 0 4.718621493537967e-09
or O 0 1.0732211018320281e-13
by O 0 3.579594269381616e-15
including O 0 3.067526701400203e-13
or O 0 5.629560012598844e-11
excluding O 0 1.1853136250294938e-08
BRCA1 O 0 2.8225408641446847e-06
mutation O 0 7.426319004188997e-10
data O 0 4.456738797453674e-11
. O 0 9.797740743722194e-12

Among O 0 2.5562066352513568e-11
those O 0 1.2988607585306955e-12
families O 0 7.807920434331483e-13
with O 0 4.132389222477606e-11
disease O 0 0.0002641705796122551
due O 0 6.321743801183943e-13
to O 0 1.3247665768198469e-12
BRCA1 O 0 1.610525600881374e-06
that O 0 2.435357471242128e-10
were O 0 1.239684830484089e-11
tested O 0 2.1892560680969453e-11
by O 0 1.2358376963743365e-17
one O 0 1.7197108757779087e-15
of O 0 2.801592285521416e-18
the O 0 1.1938331174530365e-16
standard O 0 5.410933880860627e-14
screening O 0 1.7191813023089558e-13
methods O 0 5.590338305119791e-13
, O 0 8.249221686057635e-15
mutations O 0 6.33137682906626e-12
were O 0 1.0089360953419082e-14
detected O 0 4.9131025636750536e-11
in O 0 8.4943068576974045e-16
the O 0 8.64893653386694e-15
coding O 0 1.5126980201785045e-07
sequence O 0 7.700649895525657e-09
or O 0 7.050501675542886e-14
splice O 0 2.7729202045634338e-08
sites O 0 1.3705674373198917e-09
in O 0 6.154904771884118e-15
an O 0 5.226347868071907e-16
estimated O 0 1.4220342568413424e-12
63 O 0 4.035866307816605e-09
% O 0 4.770678447283457e-15
( O 0 1.1910369134633843e-14
95 O 0 5.272923209176383e-10
% O 0 5.904329542644193e-12
CI O 1 0.9925203323364258
51 O 0 2.0580296222760808e-06
% O 0 6.666457316728547e-12
- O 0 7.353156433964614e-06
77 O 0 3.256417002717171e-08
% O 0 3.630048803324355e-14
) O 0 7.460632318097987e-14
. O 0 6.953971361418898e-13

The O 0 6.34060620847976e-13
estimated O 0 1.0989232662956053e-13
sensitivity O 0 5.302025832265578e-11
was O 0 1.2415074523985936e-10
identical O 0 1.0662558076052209e-12
for O 0 1.188112683752477e-17
direct O 0 9.511720482291907e-16
sequencing O 0 8.3720478466498e-12
and O 0 5.407890322074553e-14
other O 0 1.2923053562525588e-15
techniques O 0 5.034117567248586e-10
. O 0 5.99479276983117e-12

The O 0 1.8157682302177847e-10
penetrance O 0 1.8369448184785142e-07
of O 0 7.777890880184338e-14
BRCA2 O 0 1.509218705564308e-08
was O 0 9.785241193716043e-13
estimated O 0 4.411497672950738e-16
by O 0 4.788779184024257e-17
maximizing O 0 1.533620127593116e-12
the O 0 1.1399918552548738e-12
LOD O 0 0.05358128622174263
score O 0 6.212363956592526e-08
in O 0 4.289088547759605e-14
BRCA2 O 0 5.876385600345202e-09
- O 0 1.0605828215659585e-08
mutation O 0 3.3405306298917026e-10
families O 0 2.3638395792646358e-14
, O 0 7.73241808581758e-15
over O 0 3.849023150984815e-13
all O 0 8.038467352693146e-14
possible O 0 2.4805084744040917e-13
penetrance O 0 7.076899510849444e-09
functions O 0 1.890687606476149e-10
. O 0 1.9891019387152653e-11

The O 0 8.968469955399072e-13
estimated O 0 8.641009321920176e-14
cumulative O 0 9.877033219085618e-12
risk O 0 1.5654341156690066e-09
of O 0 1.2131816818500285e-12
breast B-Disease 1 0.9999128580093384
cancer I-Disease 1 0.9978237152099609
reached O 0 2.118518160898475e-08
28 O 0 6.440663002926783e-10
% O 0 1.71190322253165e-14
( O 0 1.2765415013569169e-14
95 O 0 7.48779149795098e-10
% O 0 1.3787483524665967e-12
CI O 1 0.9884911775588989
9 O 0 4.1111984927511e-09
% O 0 2.519604533693376e-13
- O 0 2.8247056249597335e-08
44 O 0 7.659446861485453e-12
% O 0 3.531711483638441e-17
) O 0 1.580702611355556e-17
by O 0 1.695102517252252e-17
age O 0 8.359450149241984e-14
50 O 0 2.423707190350212e-14
years O 0 3.2655193653308157e-14
and O 0 8.934970818774701e-13
84 O 0 2.5884936555309324e-12
% O 0 3.265254572243592e-16
( O 0 6.005240720488743e-16
95 O 0 2.783848498943975e-11
% O 0 2.7835324106426085e-13
CI O 0 0.06391339749097824
43 O 0 6.547060227291013e-09
% O 0 9.886712217140048e-14
- O 0 1.8918473898565935e-08
95 O 0 2.780130292645566e-10
% O 0 2.8154600131586206e-15
) O 0 4.641534616068265e-16
by O 0 9.446524356341744e-16
age O 0 1.6703043028559739e-12
70 O 0 1.478648041682018e-12
years O 0 9.88105674755782e-14
. O 0 8.764911539616005e-13

The O 0 7.235115617731935e-08
corresponding O 0 0.0021649091504514217
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 2.866687464120332e-05
were O 0 2.872240778550861e-10
0 O 0 1.7047661060587416e-08
. O 0 1.1846902799039771e-11

4 O 0 1.994025916607356e-10
% O 0 3.400347020556145e-14
( O 0 7.709297474489327e-15
95 O 0 6.64652777260244e-11
% O 0 5.178764860523655e-13
CI O 1 0.8156186938285828
0 O 0 3.876452936424357e-09
% O 0 2.565259202974568e-13
- O 0 3.431991402180756e-08
1 O 0 1.5239189033941503e-12
% O 0 2.138255266004676e-16
) O 0 1.5234731280593396e-17
by O 0 1.4800635166931692e-17
age O 0 3.251386451199288e-14
50 O 0 9.812948691741586e-15
years O 0 1.5299781637467293e-14
and O 0 8.080485065786736e-13
27 O 0 4.9384107914107744e-12
% O 0 1.3151416027385512e-16
( O 0 2.611712537504144e-16
95 O 0 1.0581685701283039e-11
% O 0 2.098373016144739e-13
CI O 0 0.21880120038986206
0 O 0 1.4284547988907548e-09
% O 0 1.4908298933465763e-13
- O 0 1.0961087326677443e-07
47 O 0 1.2427975981665895e-08
% O 0 9.642289552319974e-16
) O 0 1.9163321044284574e-16
by O 0 1.1298162731236878e-15
age O 0 5.733269761720727e-12
70 O 0 3.26604563706534e-12
years O 0 7.022157242622326e-14
. O 0 5.549352752494408e-13

The O 0 9.070494355611913e-11
lifetime O 0 4.303503386982044e-10
risk O 0 9.8370545043025e-10
of O 0 2.236076585395222e-13
breast B-Disease 1 0.6873641014099121
cancer I-Disease 0 0.0007053544977679849
appears O 0 2.4931137015959948e-11
similar O 0 3.837536300017874e-13
to O 0 8.627217863710346e-12
the O 0 5.4952587619228055e-12
risk O 0 4.096979006051882e-11
in O 0 3.8851677578507094e-15
BRCA1 O 0 1.2528836856873227e-09
carriers O 0 7.939008825341709e-12
, O 0 1.5699618254733094e-12
but O 0 6.550350539757943e-11
there O 0 2.8332780457711315e-13
was O 0 1.2702109329632005e-12
some O 0 1.1581272376549195e-16
suggestion O 0 1.8991756951802774e-12
of O 0 6.569925690338765e-17
a O 0 1.0533915319882459e-12
lower O 0 1.3349398253481581e-09
risk O 0 1.3213258265309946e-10
in O 0 5.2687705814988967e-14
BRCA2 O 0 8.633136427960153e-10
carriers O 0 5.641097940330131e-13
< O 0 2.150447788590304e-12
50 O 0 8.093441281747937e-13
years O 0 2.6256706769749172e-14
of O 0 3.5708384898058484e-15
age O 0 7.70337474365057e-11
. O 0 4.705151632894422e-12

Eye B-Disease 1 0.9690316915512085
movement I-Disease 0 9.06361237866804e-05
abnormalities I-Disease 0 0.38403546810150146
correlate O 0 1.792952986079399e-08
with O 0 1.380991414973165e-11
genotype O 0 4.818760057645477e-09
in O 0 6.582136918842352e-11
autosomal O 1 0.9975823163986206
dominant O 1 0.9991095662117004
cerebellar B-Disease 1 0.9997934699058533
ataxia I-Disease 1 0.999998927116394
type I-Disease 1 0.9999988079071045
I I-Disease 1 0.999911904335022
. O 0 6.455150303175117e-10

We O 0 5.274930359178143e-08
compared O 0 6.571675148503431e-11
horizontal O 0 2.1816201751789777e-06
eye O 0 0.13455864787101746
movements O 0 0.00011174617247888818
( O 0 8.158653613810074e-11
visually O 0 7.755183162316825e-10
guided O 0 1.0666438843287551e-09
saccades O 0 7.917789730527147e-07
, O 0 1.470209197440564e-11
antisaccades O 0 4.582939183706003e-08
, O 0 1.5660805985362458e-11
and O 0 2.8508334581900385e-11
smooth O 0 1.1768809260459534e-09
pursuit O 0 1.7784579364743536e-11
) O 0 2.3154850094047295e-14
in O 0 5.959124117554601e-15
control O 0 1.6291575377636036e-07
subjects O 0 7.906074683816655e-10
( O 0 3.9728482548011257e-13
n O 0 2.4776923623903713e-07
= O 0 9.577489436196629e-06
14 O 0 6.410914160648318e-11
) O 0 8.527821325618121e-14
and O 0 1.279905435108697e-11
patients O 0 2.7925847398413417e-12
with O 0 9.26940172025787e-15
three O 0 4.4686081007369594e-13
forms O 0 3.7934304135400776e-12
of O 0 1.3707613603225477e-12
autosomal O 1 0.9981663823127747
dominant O 0 0.1099514588713646
cerebellar B-Disease 0 0.008811642415821552
ataxias I-Disease 0 0.002327489899471402
type I-Disease 1 0.9789035320281982
I I-Disease 0 0.017224814742803574
spinocerebellar B-Disease 1 0.994056224822998
ataxias I-Disease 0 7.67413730500266e-05
1 I-Disease 0 6.241123173822416e-10
and I-Disease 0 1.1151749662596799e-10
2 I-Disease 0 4.445742385339457e-12
( O 0 1.3413606976455522e-14
SCA1 B-Disease 0 1.1632370622294275e-08
, O 0 2.1134608819972645e-12
n O 0 3.2848948450237e-08
= O 0 1.5598412517192628e-07
11 O 0 1.2795338790241861e-12
; O 0 6.183309174737344e-15
SCA2 B-Disease 0 8.248455807269295e-10
, O 0 1.6887486960041886e-13
n O 0 1.0837765351823236e-08
= O 0 3.3315373570985685e-07
10 O 0 1.5126935077811043e-13
) O 0 2.95337112242184e-14
and O 0 5.4628856993588215e-11
SCA3 B-Disease 1 0.9999998807907104
/ O 0 0.00019566740957088768
Machado B-Disease 0 7.362506693198156e-08
- I-Disease 0 3.330057154471433e-07
Joseph I-Disease 0 4.48800210506306e-06
disease I-Disease 0 0.00011459238885436207
( O 0 2.4017881799609335e-14
MJD B-Disease 1 0.9999997615814209
) O 0 2.1499434177396637e-12
( O 0 1.1573760613087236e-13
n O 0 1.3456703129577363e-07
= O 0 3.873550667776726e-06
16 O 0 1.2776419679172424e-11
) O 0 1.2887228176966525e-13
. O 0 6.976610044881482e-13

In O 0 8.58865149139243e-12
SCA1 B-Disease 0 1.1497046870090344e-08
, O 0 1.6453293127894827e-14
saccade O 0 1.403397276861229e-11
amplitude O 0 6.75600254993608e-14
was O 0 3.975222928609412e-12
significantly O 0 2.1039860825800005e-11
increased O 0 1.609727282025908e-11
, O 0 6.2736521706796555e-12
resulting O 0 4.570316347596304e-12
in O 0 3.904459221215628e-12
hypermetria B-Disease 0 3.9329381252173334e-05
. O 0 1.4052434216260679e-10

The O 0 1.0278902035087967e-10
smooth O 0 4.076559978472005e-09
pursuit O 0 5.13047049288673e-10
gain O 0 1.0980449188791042e-10
was O 0 1.1750910244856527e-09
decreased O 0 6.387816853248296e-08
. O 0 6.45906383933692e-11

In O 0 2.3097719917264392e-11
SCA2 B-Disease 0 1.281145767251246e-08
, O 0 9.89665435106174e-14
saccade O 0 4.3905759583573456e-10
velocity O 0 9.765841607611847e-11
was O 0 8.904153109279278e-11
markedly O 0 3.765597256233377e-08
decreased O 0 2.611783713746263e-07
. O 0 2.4367372009059807e-10

The O 0 6.871769819838391e-11
percentage O 0 1.582873762617787e-11
of O 0 4.826876965751412e-15
errors O 0 1.500436610513134e-07
in O 0 2.284911897274672e-13
antisaccades O 0 4.09774975196342e-06
was O 0 3.3483005257295417e-10
greatly O 0 6.49462601753914e-12
increased O 0 5.83859557923283e-11
and O 0 8.804395407180365e-11
was O 0 3.6638674733024956e-11
significantly O 0 2.3106530577798878e-11
correlated O 0 1.325687302988765e-11
with O 0 2.588183833918123e-11
age O 0 1.7347617786711567e-09
at O 0 2.6779496398177116e-09
disease O 0 1.850407716119662e-05
onset O 0 2.5988581953129142e-08
. O 0 3.839048176579318e-11

In O 0 2.7620722549415166e-12
addition O 0 1.260775202771222e-13
, O 0 1.5803222445931464e-14
a O 0 1.9156677129604548e-15
correlation O 0 9.97544494923952e-12
between O 0 2.167487543613955e-12
smooth O 0 1.915261726992412e-08
pursuit O 0 4.657503271943142e-10
gain O 0 1.6238918543187708e-10
and O 0 9.113427026918863e-12
the O 0 6.7853395360642325e-15
number O 0 2.632923718458302e-13
of O 0 3.3216901011181004e-15
trinucleotide O 0 1.3249837138573639e-05
repeats O 0 1.0751767121064404e-07
was O 0 8.723620784079067e-12
found O 0 7.275005793096201e-13
. O 0 3.8286897523914787e-13

In O 0 3.2484128720255967e-09
SCA3 B-Disease 1 0.999997615814209
, O 0 6.560081922124539e-10
gaze B-Disease 0 6.332475663839432e-07
- I-Disease 0 4.78385345559218e-06
evoked I-Disease 0 5.69539304606792e-09
nystagmus I-Disease 0 1.2979070334040443e-06
was O 0 5.891601095875387e-10
often O 0 2.918663845764141e-13
present O 0 6.691412581938795e-16
as O 0 2.7255813471254667e-15
was O 0 5.680030556141913e-13
saccade O 0 1.1886795991955523e-09
hypometria O 0 5.38403924110753e-07
and O 0 6.942078162319731e-11
smooth O 0 7.454559747266387e-10
pursuit O 0 1.217123068997239e-10
gain O 0 4.04187829039504e-11
was O 0 3.7524514051590074e-10
markedly O 0 8.68702585421488e-08
decreased O 0 9.972477243991307e-08
. O 0 3.787857527637328e-11

Three O 0 1.1997489113291238e-10
major O 0 3.932621155805505e-12
criteria O 0 2.5725599493535423e-13
, O 0 4.093656235729646e-16
saccade O 0 8.011261792839619e-12
amplitude O 0 2.655982767431949e-14
, O 0 1.4544364620820965e-15
saccade O 0 8.602045291350446e-12
velocity O 0 3.170007008626574e-12
, O 0 1.3448453234279206e-13
and O 0 1.2204943815579544e-13
presence O 0 1.3586628566999992e-12
of O 0 1.630030034289586e-14
gaze B-Disease 0 8.367321129298944e-07
- I-Disease 0 2.1085816115373746e-07
evoked I-Disease 0 1.3325580916490054e-10
nystagmus I-Disease 0 2.979346769294011e-10
, O 0 3.379383632737959e-15
permitted O 0 1.8128541338447227e-14
the O 0 4.007592659030485e-16
correct O 0 5.186168335058472e-13
assignment O 0 3.876703645599999e-13
of O 0 5.012816668876998e-18
90 O 0 1.1383769090139023e-13
% O 0 4.754597103263361e-16
of O 0 4.0602018092100004e-17
the O 0 7.835784565689632e-14
SCA1 B-Disease 0 4.7165904959456384e-08
, O 0 6.250975079355112e-14
90 O 0 6.047119998752598e-14
% O 0 1.3984716452982452e-16
of O 0 1.817289666871645e-17
the O 0 4.894687628299865e-14
SCA2 B-Disease 0 5.983238793305645e-07
, O 0 9.835257608337145e-13
and O 0 1.7953481583343756e-12
93 O 0 8.255498715192822e-12
% O 0 2.1373662784567531e-16
of O 0 7.146915765893901e-18
the O 0 2.3534798242186294e-13
patients O 0 4.4950336855476e-12
with O 0 6.816686429732266e-13
SCA3 B-Disease 1 1.0
to O 0 4.3028797191979606e-10
their O 0 2.3074971837802605e-13
genetically O 0 4.473120096548655e-09
confirmed O 0 2.760046129424154e-07
patient O 0 7.606308827234898e-08
group O 0 4.11593112023545e-12
and O 0 2.9693150715992545e-11
, O 0 5.276660618863671e-12
therefore O 0 5.006678231722628e-12
, O 0 2.1717831526213427e-12
may O 0 3.306009285775069e-11
help O 0 4.0719906830091745e-13
orient O 0 1.552189488052136e-08
diagnoses O 0 2.04283969651442e-06
of O 0 1.0063908672145274e-15
SCA1 B-Disease 0 6.683389415229612e-07
, O 0 4.28072182735717e-13
SCA2 B-Disease 0 5.0089905556660597e-08
, O 0 3.471320453307669e-12
and O 0 4.0003189649695514e-10
SCA3 B-Disease 1 1.0
at O 0 8.086910585625162e-10
early O 0 6.360620363743408e-12
clinical O 0 3.994922614936058e-09
stages O 0 4.6395994685033415e-11
of O 0 4.4205270441684686e-16
the O 0 1.2564248252910915e-10
diseases O 0 0.013170450925827026
. O 0 5.888176773417853e-13
. O 0 1.0290569611715039e-11

Genetic O 0 4.453008841664996e-06
basis O 0 3.5544809283416523e-12
and O 0 7.072459480041149e-13
molecular O 0 2.223195405548495e-09
mechanism O 0 8.257482875251299e-08
for O 0 1.5109713480399023e-10
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999871253967285
fibrillation I-Disease 1 1.0
. O 0 2.2964595700614154e-05

Ventricular B-Disease 0 0.0003400182176847011
fibrillation I-Disease 0 0.0002349193673580885
causes O 0 1.0917601045434822e-08
more O 0 6.4374038123205836e-15
than O 0 6.1554917657165656e-15
300 O 0 4.094808666406033e-14
, O 0 4.3671646567057174e-14
000 O 0 1.2976170702186374e-13
sudden O 0 4.806214020519617e-12
deaths O 0 3.546270499477089e-10
each O 0 1.963699182102631e-14
year O 0 1.6386335173414375e-14
in O 0 3.322363746421052e-14
the O 0 6.781930702789984e-13
USA O 0 1.1528605625699129e-07
alone O 0 7.316467570683827e-11
. O 0 8.730024082109766e-13

In O 0 2.8217545487707607e-12
approximately O 0 6.495948527349138e-13
5 O 0 1.1964013113541228e-10
- O 0 1.3321321148396237e-06
12 O 0 4.349489518551408e-11
% O 0 2.9580359869722534e-16
of O 0 4.2948921395815056e-18
these O 0 3.804357850067334e-15
cases O 0 2.5026430377377874e-14
, O 0 7.215235353630334e-14
there O 0 2.474360777035556e-13
are O 0 2.101844834788945e-14
no O 0 1.655517736787182e-12
demonstrable O 0 3.5902399986298406e-07
cardiac O 0 0.00013660777767654508
or O 0 1.575446856305618e-10
non O 0 1.456773723873539e-08
- O 1 0.8169813752174377
cardiac O 1 0.8165265321731567
causes O 0 4.296675726322974e-08
to O 0 3.904317841252336e-12
account O 0 5.342748812808829e-13
for O 0 8.181404840168667e-15
the O 0 3.5873349646733943e-13
episode O 0 1.1828519497214529e-08
, O 0 5.249699286391518e-11
which O 0 2.1077124420787463e-12
is O 0 1.2127039315508546e-14
therefore O 0 4.714956723661512e-14
classified O 0 1.336404764629151e-09
as O 0 1.7180065015054424e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.999972939491272
fibrillation I-Disease 1 1.0
( O 0 6.035273145243991e-06
IVF B-Disease 1 0.9999998807907104
) O 0 2.4825000388695173e-10
. O 0 2.1242485201411476e-11

A O 0 9.383570309662304e-11
distinct O 0 7.505510427573137e-13
group O 0 9.213083421166779e-12
of O 0 1.7962334839471093e-14
IVF B-Disease 1 1.0
patients O 0 3.565849340247951e-07
has O 0 3.2141041130667736e-12
been O 0 2.207840030590824e-12
found O 0 3.958471137682773e-12
to O 0 1.3165090220236542e-13
present O 0 3.6744780531000956e-14
with O 0 3.0217653059676566e-14
a O 0 9.506367047718012e-13
characteristic O 0 1.0230694069690571e-09
electrocardiographic O 0 2.0935385691700503e-06
pattern O 0 7.530809398303973e-07
. O 0 6.012475933792061e-11

Because O 0 5.165220695602102e-09
of O 0 1.5472418387062507e-15
the O 0 1.0799103412450616e-14
small O 0 1.7313700386573094e-13
size O 0 2.36650473522948e-11
of O 0 7.942127667569102e-16
most O 0 2.3075579668645554e-14
pedigrees O 0 5.35905597676134e-10
and O 0 4.664367850293338e-13
the O 0 2.9561534562469807e-15
high O 0 4.958200191564066e-13
incidence O 0 2.0104997133785218e-07
of O 0 8.735315937388397e-14
sudden B-Disease 0 1.869589851821729e-07
death I-Disease 0 3.2770095970136026e-08
, O 0 3.632670553255224e-12
however O 0 9.82573289225186e-13
, O 0 2.759351068424838e-15
molecular O 0 4.367827280415959e-12
genetic O 0 3.968287642930335e-10
studies O 0 4.73689934932936e-13
of O 0 2.8547506952081953e-15
IVF B-Disease 1 1.0
have O 0 6.145527642331672e-09
not O 0 4.690555235886684e-12
yet O 0 7.138991004254636e-13
been O 0 1.9335543637120228e-13
done O 0 5.811475259354104e-11
. O 0 5.354215334985035e-13

Because O 0 1.8541722113241121e-07
IVF B-Disease 1 0.9999934434890747
causes O 0 5.511854510587e-07
cardiac O 0 0.0059532527811825275
rhythm O 0 0.0010815061395987868
disturbance O 0 7.02740294400428e-07
, O 0 7.176442599898802e-12
we O 0 3.199809341103421e-12
investigated O 0 1.5229599265725868e-12
whether O 0 2.8305164473125394e-14
malfunction O 0 4.491252258986833e-09
of O 0 2.1134878241036134e-17
ion O 0 2.112012370547589e-10
channels O 0 1.1241731954214629e-05
could O 0 2.24542964133434e-05
cause O 0 2.1313000253542214e-09
the O 0 1.0039197771705144e-11
disorder O 0 2.77520683766852e-07
by O 0 1.4589257102327647e-16
studying O 0 9.16996947125659e-13
mutations O 0 1.090386003710364e-09
in O 0 7.17629521616598e-15
the O 0 5.569337512326654e-14
cardiac O 0 1.109691272205282e-08
sodium O 0 1.1973691482758397e-10
channel O 0 5.401618707878697e-08
gene O 0 1.3273735532948194e-07
SCN5A O 0 1.4567148127753171e-06
. O 0 1.6479951084336086e-11

We O 0 2.567759293015115e-05
have O 0 3.294577805013077e-11
now O 0 2.6756515839748696e-13
identified O 0 6.97458746572871e-13
a O 0 3.208545557606239e-14
missense O 0 1.885614011598591e-07
mutation O 0 2.6167579214586567e-09
, O 0 3.6402552115255907e-14
a O 0 1.3096609131110337e-14
splice O 0 3.127251329715364e-05
- O 0 7.604895472468343e-06
donor O 0 2.062421761150901e-11
mutation O 0 2.2897621299033943e-10
, O 0 6.180341340696754e-14
and O 0 6.664073047731034e-14
a O 0 5.863092943005771e-14
frameshift O 0 1.910398594873186e-08
mutation O 0 3.6149711696298326e-11
in O 0 9.16941223369158e-16
the O 0 2.0705222340258386e-14
coding O 0 6.830146617176069e-07
region O 0 4.1675676798469397e-10
of O 0 1.3522027617220546e-15
SCN5A O 0 3.287286460817995e-07
in O 0 1.8224029056657098e-13
three O 0 5.655644789298586e-12
IVF B-Disease 1 0.9999974966049194
families O 0 1.164786583157662e-12
. O 0 7.280600276306226e-13

We O 0 2.708994362166095e-09
show O 0 2.438142190312048e-13
that O 0 3.969767079281864e-16
sodium O 0 8.978753206429282e-14
channels O 0 1.9864734857044652e-12
with O 0 1.376279885005995e-14
the O 0 1.5397678317379156e-14
missense O 0 1.4563625860830598e-08
mutation O 0 1.265337418177026e-10
recover O 0 2.197643109158598e-12
from O 0 9.318034090454697e-17
inactivation O 0 6.959559151198391e-09
more O 0 1.9511488643297534e-16
rapidly O 0 5.109702591599152e-12
than O 0 1.3383629633419245e-14
normal O 0 2.71580646860059e-10
and O 0 1.6908251057948243e-12
that O 0 3.8872605221534906e-14
the O 0 1.3099906630373997e-14
frameshift O 0 5.7505303630023263e-08
mutation O 0 3.928230310479286e-11
causes O 0 6.176758730143048e-14
the O 0 3.72159066090109e-16
sodium O 0 2.16092543164903e-11
channel O 0 9.579341053722601e-08
to O 0 7.29194829518498e-11
be O 0 4.419153411261423e-12
non O 0 7.866727560167097e-13
- O 0 3.4114918889827095e-08
functional O 0 2.6467313674061188e-08
. O 0 4.692346858292673e-11

Our O 0 5.945612358004837e-08
results O 0 1.6199538932504254e-10
indicate O 0 1.3963642742087501e-11
that O 0 2.1864372020796025e-13
mutations O 0 3.444611818004262e-10
in O 0 1.3330026847418151e-14
cardiac O 0 7.205764873674525e-09
ion O 0 4.107259671259911e-11
- O 0 6.06925823376514e-06
channel O 0 2.2899835983025696e-07
genes O 0 8.966517528463669e-10
contribute O 0 1.5518035261733593e-13
to O 0 1.7121514031851956e-14
the O 0 2.8188667796724774e-15
risk O 0 2.3895832822239463e-14
of O 0 5.4189892330104426e-18
developing O 0 2.854212005631851e-11
IVF B-Disease 1 0.999998927116394
. O 0 2.9802229477640663e-13
. O 0 4.195651801246897e-13

Molecular O 0 5.424963234190727e-08
heterogeneity O 0 1.242167826376317e-07
in O 0 3.005256460353323e-11
mucopolysaccharidosis B-Disease 0 8.056536898948252e-05
IVA I-Disease 1 0.9587060809135437
in O 0 2.5692811433941642e-08
Australia O 0 4.420904224389233e-05
and O 0 2.8022197895438694e-09
Northern O 0 0.0002542402653489262
Ireland O 0 1.3702559954253957e-05
: O 0 3.2030211816191922e-12
nine O 0 2.781908275788225e-13
novel O 0 8.611649587875192e-12
mutations O 0 5.734453537020734e-11
including O 0 6.66860907857017e-15
T312S O 0 1.1484958817309376e-10
, O 0 5.129645081099199e-15
a O 0 1.2426699666972857e-15
common O 0 3.9481425398966985e-15
allele O 0 5.3575426836897574e-14
that O 0 3.84164983082292e-14
confers O 0 1.0307345255089473e-11
a O 0 7.153824407857279e-12
mild O 0 2.6532921637567597e-08
phenotype O 0 8.173727650273577e-08
. O 0 3.143168711416955e-11

Mucopolysaccharidosis B-Disease 1 0.6598514318466187
IVA I-Disease 1 0.9997476935386658
( O 0 0.00044640747364610434
MPS B-Disease 1 0.9999996423721313
IVA I-Disease 1 1.0
) O 0 1.1113900022508005e-08
is O 0 7.123356765559308e-11
an O 0 6.720540790539076e-11
autosomal B-Disease 1 0.9999983310699463
recessive I-Disease 1 0.9999984502792358
lysosomal I-Disease 1 0.9999996423721313
storage I-Disease 1 0.9999892711639404
disorder I-Disease 1 0.9999935626983643
caused O 0 3.981397878050075e-09
by O 0 1.3030031494423201e-14
a O 0 9.523076771600358e-10
genetic B-Disease 1 1.0
defect I-Disease 1 0.9999998807907104
in O 0 8.775605242483664e-12
N O 0 1.4451647075475194e-05
- O 0 2.141353616025299e-05
acetylgalactosamine O 0 0.00010133313480764627
- O 0 5.030244210502133e-05
6 O 0 3.762466960210986e-08
- O 0 4.752254881168483e-06
sulfate O 0 5.722257583329338e-07
sulfatase O 0 8.026432283259055e-07
( O 0 3.8077161324152897e-13
GALNS O 0 4.281220267188246e-09
) O 0 3.8605002441322034e-13
. O 0 7.18195739424915e-13

Previous O 0 8.714569510459569e-09
studies O 0 2.7657744150477725e-11
of O 0 5.699393005102976e-16
patients O 0 1.1908382266390127e-12
from O 0 1.6551480393047158e-16
a O 0 8.546454017578642e-13
British O 0 6.599496373382863e-06
- O 0 0.0011061790864914656
Irish O 0 3.8686771119955665e-08
population O 0 1.5513568348782952e-13
showed O 0 2.3717645902809892e-11
that O 0 4.373480557876919e-15
the O 0 8.589322249160064e-16
I113F O 0 2.808375754170811e-11
mutation O 0 5.217255013428845e-12
is O 0 3.663543493025753e-16
the O 0 3.156917602451889e-17
most O 0 1.2284166785960415e-16
common O 0 6.909620021733646e-15
single O 0 5.328663400284983e-13
mutation O 0 2.8205318081120367e-09
among O 0 2.482291594496644e-10
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 1.0
patients O 1 0.7568339705467224
and O 0 4.847685586284456e-10
produces O 0 9.839338371842032e-11
a O 0 8.720201782885795e-10
severe O 0 3.081919658143306e-06
clinical O 0 5.785564667348808e-07
phenotype O 0 4.9247443456579276e-08
. O 0 2.4207587323576973e-11

We O 0 3.055575916732778e-07
studied O 0 3.2837010888187024e-10
mutations O 0 3.0576827181327815e-10
in O 0 1.6827470991135599e-15
the O 0 3.1919291005217147e-15
GALNS O 0 2.5747448617607915e-09
gene O 0 1.5719581886175504e-11
from O 0 1.0014085135396592e-15
23 O 0 6.978047154861111e-13
additional O 0 1.671783154619244e-12
MPS B-Disease 1 0.9999997615814209
IVA I-Disease 1 1.0
patients O 0 1.0744304745458066e-05
( O 0 6.177548842476246e-14
15 O 0 1.959708870874488e-12
from O 0 1.1186025521657539e-14
Australia O 0 1.2404909099927863e-08
, O 0 7.752401964735561e-14
8 O 0 1.4962690374903387e-12
from O 0 6.747161643549113e-16
Northern O 0 1.0342649829908623e-06
Ireland O 0 5.67681759378047e-08
) O 0 1.053736006735367e-14
, O 0 4.4372022112241496e-16
with O 0 9.828641035880656e-16
various O 0 5.410738046843222e-14
clinical O 0 1.7120848738727545e-08
phenotypes O 0 1.6397819768698696e-09
( O 0 1.0170092849468015e-12
severe O 0 1.2241301305948582e-07
, O 0 3.5942132516758596e-12
16 O 0 5.248535547147659e-12
cases O 0 9.552971478102301e-13
; O 0 1.2429224587485327e-13
intermediate O 0 1.682994715812569e-11
, O 0 3.4728020155763706e-13
4 O 0 1.1057259274860343e-11
cases O 0 7.220850306577375e-11
; O 0 1.0181036014245137e-09
mild O 0 1.3177236724004615e-07
, O 0 1.921527000015022e-11
3 O 0 3.51478741944522e-11
cases O 0 4.6001739743839476e-12
) O 0 4.004269572172037e-12
. O 0 1.425513873609674e-11

We O 0 1.1831925803562626e-06
found O 0 1.0899441071909877e-11
two O 0 2.8645864841433596e-14
common O 0 1.1126153167187458e-13
mutations O 0 2.484102257227505e-09
that O 0 3.357802230707918e-11
together O 0 2.2215148123838624e-11
accounted O 0 3.379134194680944e-10
for O 0 1.184114706108538e-14
32 O 0 2.691451228553632e-10
% O 0 1.358754138052593e-15
of O 0 2.5943045876874144e-17
the O 0 5.598850850714425e-14
44 O 0 8.163693679397177e-12
unrelated O 0 2.1035157123094894e-12
alleles O 0 2.1608585146909443e-12
in O 0 1.3509615789334545e-13
these O 0 9.0654518397279e-13
patients O 0 5.750507708901509e-12
. O 0 2.6569265993044155e-13

One O 0 2.1283334816768473e-10
is O 0 3.3959995731323855e-13
the O 0 1.879605751099224e-14
T312S O 0 1.4281333893251258e-09
mutation O 0 1.5200826708472448e-10
, O 0 5.1973230135848175e-15
a O 0 3.0816977150736977e-15
novel O 0 2.1457249171907833e-11
mutation O 0 3.597042108616222e-10
found O 0 7.108066847789918e-13
exclusively O 0 5.330379353510849e-14
in O 0 3.808565604817432e-13
milder O 0 9.508572134109272e-07
patients O 0 4.190893410083163e-09
. O 0 2.2262348214896477e-12

The O 0 1.1591098220131713e-10
other O 0 1.899403079480902e-13
is O 0 7.18909456162535e-14
the O 0 1.8599198583720868e-14
previously O 0 9.131352618485522e-11
described O 0 5.417024120935032e-11
I113F O 0 5.387722490368674e-10
that O 0 6.13870526676788e-14
produces O 0 3.1600205308360274e-13
a O 0 9.534044560777222e-12
severe O 0 4.280716581206434e-08
phenotype O 0 5.085978571628402e-08
. O 0 6.939814001238886e-11

The O 0 1.6731087348897944e-10
I113F O 0 8.641180215818167e-09
and O 0 8.484446652190503e-12
T312S O 0 4.2116457543706076e-10
mutations O 0 3.213635468846121e-10
accounted O 0 8.916946174497564e-12
for O 0 4.281533860903044e-15
8 O 0 4.576546780432622e-11
( O 0 6.181861934243665e-14
18 O 0 9.111550056117856e-12
% O 0 3.2254176068825975e-15
) O 0 1.3147373001485413e-13
and O 0 2.0872314987485652e-10
6 O 0 5.400583313885932e-10
( O 0 1.0074750820925071e-13
14 O 0 3.4737180579919036e-12
% O 0 2.284241394463955e-16
) O 0 3.071602723468762e-16
of O 0 5.4852935493708556e-18
44 O 0 8.346772166663297e-13
unrelated O 0 1.3677632160549735e-12
alleles O 0 1.4889466612780233e-12
, O 0 4.655701822328662e-13
respectively O 0 3.1227063036071145e-12
. O 0 8.024643449733304e-12

The O 0 8.287304870124856e-12
relatively O 0 1.208599518208453e-12
high O 0 6.066171870378056e-13
residual O 0 8.665966277909831e-10
GALNS O 0 4.77458286241017e-07
activity O 0 7.637906973556596e-10
seen O 0 3.6262621377902704e-11
when O 0 1.1087130698120631e-13
the O 0 1.959801967630446e-16
T312S O 0 1.1128026668541513e-12
mutant O 0 5.726753164563003e-13
cDNA O 0 1.9082934017700115e-12
is O 0 9.137628804653519e-14
overexpressed O 0 2.732022830187475e-09
in O 0 6.696910143403831e-14
mutant O 0 2.985463432025881e-09
cells O 0 1.6270039135402037e-11
provides O 0 8.384335511364195e-16
an O 0 5.348791791097049e-18
explanation O 0 5.729788253019605e-14
for O 0 2.308877347734846e-15
the O 0 1.2167805825413769e-12
mild O 0 2.2579570213565603e-08
phenotype O 0 1.7750851455389238e-08
in O 0 4.403803981634785e-13
patients O 0 1.4224041215704641e-11
with O 0 2.9584777146542465e-15
this O 0 1.241496190790628e-13
mutation O 0 4.0837724868403313e-10
. O 0 9.8072756513079e-12

The O 0 3.684412584054053e-12
distribution O 0 6.522172558975914e-12
and O 0 2.474713312148203e-14
relative O 0 3.313792577676138e-15
frequencies O 0 1.7072501317392033e-14
of O 0 1.2337091786785028e-16
the O 0 3.870611920168618e-15
I113F O 0 2.5099131106820494e-11
and O 0 4.9668582235377207e-14
T312S O 0 3.885277950060884e-12
mutations O 0 2.3005826410571473e-11
in O 0 2.595831781473869e-15
Australia O 0 3.3186999155720986e-12
corresponded O 0 3.8721128625511525e-14
to O 0 4.758827609318422e-15
those O 0 1.6110255636866473e-16
observed O 0 4.510387018302059e-13
in O 0 9.390946713024127e-15
Northern O 0 3.962652954214718e-06
Ireland O 0 3.259817162870604e-07
and O 0 1.048197032643694e-11
are O 0 6.014410910933955e-16
unique O 0 2.8528876991802687e-16
to O 0 5.403116444383828e-14
these O 0 1.2273359174949042e-14
two O 0 2.588171647485704e-13
populations O 0 1.0003993466956018e-10
, O 0 1.5966466023658102e-14
suggesting O 0 2.8465760564672093e-13
that O 0 5.058931382530621e-14
both O 0 2.250220104379249e-14
mutations O 0 2.3061358378484442e-11
were O 0 5.105381991731689e-14
probably O 0 1.6579445065098564e-12
introduced O 0 1.481999419017388e-12
to O 0 2.0015991902128105e-12
Australia O 0 2.2606956584514393e-10
by O 0 4.602446163134847e-16
Irish O 0 7.102631742299248e-13
migrants O 0 8.441420576866393e-14
during O 0 3.27457389342708e-15
the O 0 4.98190051224142e-16
19th O 0 1.466573910924307e-11
century O 0 1.4460429520468665e-09
. O 0 3.59750007561388e-11

Haplotype O 0 9.98459881884628e-07
analysis O 0 2.3951188254933697e-10
using O 0 2.442295064103428e-12
6 O 0 1.649554971783207e-11
RFLPs O 0 7.777970267852652e-09
provides O 0 1.4333503391898532e-14
additional O 0 1.0476712296572026e-15
data O 0 9.585604879291942e-13
that O 0 1.758112020766936e-13
the O 0 2.681279914621467e-14
I113F O 0 1.0917137194255133e-09
mutation O 0 4.7093804550479845e-12
originated O 0 4.051218995687611e-14
from O 0 2.5034414443764244e-17
a O 0 1.7347663570197618e-15
common O 0 6.78500699092914e-14
ancestor O 0 5.920489359184655e-12
. O 0 2.9668358048073884e-11

The O 0 6.807715502432643e-11
other O 0 1.2653867753967263e-12
9 O 0 2.6178337275695185e-11
novel O 0 4.986217168323481e-12
mutations O 0 7.307479510387793e-09
identified O 0 1.8621184594280749e-09
in O 0 2.729605549835895e-13
these O 0 4.449856715743605e-12
23 O 0 7.415221769946356e-10
patients O 0 7.096447561527608e-12
were O 0 4.5125212702785966e-13
each O 0 4.486256218540251e-15
limited O 0 9.860737920641682e-11
to O 0 8.598453546393436e-12
a O 0 2.0098865280426814e-11
single O 0 1.5588731416826818e-09
family O 0 3.2761331425490425e-09
. O 0 6.105598665540057e-11

These O 0 1.3411401329765926e-11
data O 0 7.157997610439393e-13
provide O 0 1.32076627737919e-14
further O 0 5.122351280390392e-15
evidence O 0 7.769198797486204e-15
for O 0 1.4018260281182702e-16
extensive O 0 3.689365132841793e-11
allelic O 0 5.1845665538508e-09
heterogeneity O 0 1.3989343869980075e-06
in O 0 1.2219276257496858e-08
MPS B-Disease 1 0.9999995231628418
IVA I-Disease 1 1.0
in O 0 2.91667778817839e-09
British O 0 4.379488746053539e-05
- O 0 0.00025751712382771075
Irish O 0 2.7272134772715617e-08
patients O 0 2.36131062619771e-11
and O 0 4.872253156010535e-16
provide O 0 6.913067339949853e-17
evidence O 0 3.393360735158839e-15
for O 0 4.694311187603761e-17
their O 0 9.03717662633979e-16
transmission O 0 4.733178737836852e-09
to O 0 4.701201992800275e-13
Australia O 0 1.3615644722797526e-10
by O 0 6.244917692639412e-15
British O 0 5.261636104592071e-08
- O 0 1.125312962813041e-07
Irish O 0 2.176528228481356e-11
migrants O 0 2.440412780711776e-13
. O 0 1.2763485260757087e-15
. O 0 5.4694872356252436e-14

Identification O 0 1.6406884184583248e-10
of O 0 2.1677995634466693e-14
constitutional O 0 1.7249515704698126e-10
WT1 O 0 7.436500891344622e-05
mutations O 0 5.078716640127823e-06
, O 0 3.31759061411932e-13
in O 0 2.721556670076588e-14
patients O 0 3.1694265267834254e-12
with O 0 7.285420639165097e-13
isolated O 1 0.8038868308067322
diffuse B-Disease 1 0.9999343156814575
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.0207883149870867e-10
and O 0 9.188435196082548e-14
analysis O 0 6.593637175969155e-14
of O 0 1.76219169566508e-16
genotype O 0 2.0993531912871788e-10
/ O 0 3.620052439146093e-06
phenotype O 0 2.214578964654379e-09
correlations O 0 8.898630964038201e-12
by O 0 1.3866634501481486e-15
use O 0 8.292090972195076e-13
of O 0 1.0166974582375993e-15
a O 0 5.320529173485911e-13
computerized O 0 2.135252152868361e-08
mutation O 0 3.5231677575353615e-09
database O 0 1.622403655865412e-09
. O 0 2.7782630362960248e-11

Constitutional O 0 1.1872844929428084e-08
mutations O 0 4.4085712858077386e-08
of O 0 4.710387912647317e-15
the O 0 2.0236005050995078e-14
WT1 O 0 8.321212163764358e-09
gene O 0 1.1378071228251851e-11
, O 0 4.365078149858834e-16
encoding O 0 1.9238306965280866e-14
a O 0 1.0622063124909875e-12
zinc O 0 6.119936415416305e-07
- O 0 2.3142519012253615e-07
finger O 0 4.6810504272798426e-07
transcription O 0 7.766259635388906e-09
factor O 0 8.650154377509711e-12
involved O 0 7.0685787952051715e-12
in O 0 2.0741183076600223e-11
renal O 0 0.0003989178512711078
and O 0 1.0808863137867775e-08
gonadal O 0 0.01740659587085247
development O 0 1.0740757616645169e-08
, O 0 8.95210208046171e-12
are O 0 4.0466318040584606e-14
found O 0 4.628890586805268e-13
in O 0 5.818258726777948e-16
most O 0 2.5232147575211632e-14
patients O 0 4.884497212080674e-13
with O 0 9.042380559598495e-13
Denys B-Disease 1 0.9999978542327881
- I-Disease 1 0.9999995231628418
Drash I-Disease 1 0.9999953508377075
syndrome I-Disease 1 0.9999990463256836
( O 0 1.549869824493677e-12
DDS B-Disease 1 1.0
) O 0 1.5907861139474733e-10
, O 0 4.203568049199191e-12
or O 0 2.2886313677528136e-10
diffuse B-Disease 1 0.9971485733985901
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 2.453404979174678e-10
DMS B-Disease 0 0.002925248583778739
) O 0 5.206416894831811e-13
associated O 0 1.1467841259937828e-10
with O 0 1.8570358584213409e-09
pseudohermaphroditism B-Disease 1 1.0
and O 0 0.00020242917526047677
/ O 1 0.6471189260482788
or O 0 3.905902712375564e-09
Wilms B-Disease 1 0.763384222984314
tumor I-Disease 0 0.21870125830173492
( O 0 1.0082480406126137e-09
WT B-Disease 1 0.999997615814209
) O 0 2.6933601182665967e-11
. O 0 8.41753750036034e-12

Most O 0 2.445158138464354e-11
mutations O 0 1.3043504054621735e-07
in O 0 1.6835083674338058e-11
DDS B-Disease 1 1.0
patients O 0 0.24698147177696228
lie O 0 3.166442468227615e-07
in O 0 1.1868642597586201e-14
exon O 0 1.17351428574608e-09
8 O 0 2.5223537147844866e-10
or O 0 6.878368317628225e-14
exon O 0 1.1848896863675407e-10
9 O 0 8.962135894519108e-11
, O 0 1.7988802925006896e-14
encoding O 0 1.310937469689577e-11
zinc O 0 0.0006827533361501992
finger O 1 0.6471931338310242
2 O 0 4.112876705875124e-09
or O 0 2.3268856286229322e-10
zinc O 0 0.0007366152130998671
finger O 1 0.9640834927558899
3 O 0 3.3740610305699192e-09
, O 0 5.524221271396845e-12
respectively O 0 6.902122970386948e-12
, O 0 2.87027563175557e-13
with O 0 1.2498571513690215e-13
a O 0 2.215869501775991e-11
hot O 0 4.598332168370689e-07
spot O 0 2.0609384421277355e-08
( O 0 1.880179531217694e-14
R394W O 0 6.687955744766327e-12
) O 0 2.0737657772907595e-15
in O 0 1.3593035447980058e-15
exon O 0 5.838464711693803e-10
9 O 0 2.2124002629908546e-09
. O 0 1.1168795055471747e-11

We O 0 5.869343056019716e-08
analyzed O 0 4.8187641377150925e-11
a O 0 1.4462385553460494e-13
series O 0 5.7569199407581095e-11
of O 0 2.945382924102874e-14
24 O 0 1.1949178535530791e-08
patients O 0 5.761969894269026e-12
, O 0 4.5406214188971686e-14
10 O 0 3.538893353707828e-13
with O 0 8.773278110940641e-12
isolated B-Disease 1 0.9428607821464539
DMS I-Disease 1 0.9893689751625061
( O 0 7.754342957674853e-13
IDMS B-Disease 0 5.190902356844163e-07
) O 0 1.5649979955619647e-13
, O 0 1.0691960690293115e-13
10 O 0 1.451671899008189e-13
with O 0 2.869910472463877e-12
DDS B-Disease 1 1.0
, O 0 2.4975866708132344e-08
and O 0 1.4490958433199808e-10
4 O 0 3.8943612223896196e-11
with O 0 2.436562887217497e-12
urogenital B-Disease 1 0.6529423594474792
abnormalities I-Disease 1 0.9997425675392151
and O 0 2.017036493384694e-08
/ O 1 0.9826149940490723
or O 0 4.487894784688251e-06
WT B-Disease 1 0.9999998807907104
. O 0 5.583484230520241e-10

We O 0 1.1440701541687304e-07
report O 0 5.422772300645029e-11
WT1 O 0 2.994156034219486e-07
heterozygous O 0 1.224117363030075e-09
mutations O 0 8.4839300029671e-08
in O 0 2.0134768418528237e-12
16 O 0 1.7912736849368116e-09
patients O 0 1.1529981414071244e-09
, O 0 5.59074618197708e-12
4 O 0 4.892383165255865e-10
of O 0 3.4190379883834374e-14
whom O 0 6.823761000696038e-10
presented O 0 4.9317464174969405e-12
with O 0 9.846242744748768e-12
IDMS B-Disease 0 0.0015854729572311044
. O 0 1.2676756866447647e-10

One O 0 4.902567241060751e-09
male O 0 2.1002124483970874e-08
and O 0 2.916958688481408e-11
two O 0 1.4446354702768449e-11
female O 0 1.3921639396841101e-09
IDMS B-Disease 0 0.0010240244446322322
patients O 0 2.419662248343002e-09
with O 0 5.630362495678831e-12
WT1 O 0 0.18995095789432526
mutations O 0 0.0007631835178472102
underwent O 0 6.112212759035174e-06
normal O 0 7.55963611709376e-08
puberty O 0 2.0252289687050506e-05
. O 0 2.7993496409806085e-10

Two O 0 7.0871655211135476e-09
mutations O 0 8.182555006897019e-07
associated O 0 6.325384105387855e-10
with O 0 4.985057071998922e-12
IDMS B-Disease 0 0.00664410088211298
are O 0 7.830200788976061e-13
different O 0 2.1518734805658045e-14
from O 0 3.022115299981462e-15
those O 0 6.71340399246924e-15
described O 0 5.369046353342899e-12
in O 0 5.61132217080651e-12
DDS B-Disease 1 1.0
patients O 0 1.795753814803902e-05
. O 0 5.364000042751282e-12

No O 0 3.9441654386962455e-09
WT1 O 0 2.3411341487644677e-07
mutations O 0 4.491640481774084e-08
were O 0 6.975093246042174e-13
detected O 0 1.3743237659014085e-09
in O 0 1.9865926191944307e-14
the O 0 5.462005088670285e-13
six O 0 5.254775781171617e-12
other O 0 4.361148757663774e-13
IDMS B-Disease 0 0.004287342540919781
patients O 0 1.531116899933238e-10
, O 0 6.571786859951899e-15
suggesting O 0 7.795781381547684e-12
genetic O 0 3.4825647921010727e-10
heterogeneity O 0 5.069566988424867e-10
of O 0 3.406227800902342e-14
this O 0 1.4334986531139293e-09
disease O 0 0.00037592113949358463
. O 0 5.327457225368093e-12

We O 0 8.403048923355527e-09
analyzed O 0 6.308528144316483e-10
genotype O 0 2.84499007685568e-10
/ O 0 3.4988678976333176e-07
phenotype O 0 8.844137644459238e-10
correlations O 0 2.1800193594767592e-10
, O 0 6.4391825205234454e-12
on O 0 8.903062315157584e-12
the O 0 2.3544485249784274e-14
basis O 0 2.1647007781124342e-14
of O 0 1.0485582981461044e-16
the O 0 2.384121546017415e-13
constitution O 0 3.375242099701303e-11
of O 0 9.51135347879773e-17
a O 0 1.7863909949813322e-13
WT1 O 0 1.129904774188617e-07
mutation O 0 3.045411839375234e-11
database O 0 1.1559211920975088e-11
of O 0 1.6456234449804168e-15
84 O 0 8.194465661581773e-10
germ O 0 0.00010054472659248859
- O 0 1.3419424249150325e-05
line O 0 3.671519550607627e-07
mutations O 0 1.4252189428631823e-09
, O 0 7.309047301857358e-15
to O 0 4.789058215205928e-15
compare O 0 2.3851461170704136e-12
the O 0 1.9358550491923665e-15
distribution O 0 3.680446225562406e-11
and O 0 6.613699171653664e-11
type O 0 9.612575624373676e-09
of O 0 1.616381961817067e-15
mutations O 0 2.557020017945888e-08
, O 0 2.5707927675750267e-14
according O 0 2.8383960242439317e-16
to O 0 1.1287872763235396e-14
the O 0 4.022698379914022e-14
different O 0 2.1679434289434418e-11
symptoms O 0 4.883046855752582e-08
. O 0 5.224193473651884e-13

This O 0 2.9196400071901385e-12
demonstrated O 0 3.7079784772145463e-13
( O 0 5.704660173606359e-15
1 O 0 1.339891061600748e-13
) O 0 3.5068486742978466e-13
the O 0 1.3539745767707917e-13
association O 0 2.3164302981738653e-14
between O 0 2.2498177637293032e-13
mutations O 0 3.6073020126536903e-09
in O 0 2.2649638986723362e-14
exons O 0 2.0555953383905035e-08
8 O 0 1.9639625481460143e-09
and O 0 4.0015532554171784e-11
9 O 0 3.9388406425366895e-10
and O 0 2.4426691572210224e-11
DMS B-Disease 0 0.00015608799003530294
; O 0 8.891771867414189e-13
( O 0 1.1827377693494814e-14
2 O 0 1.1047452015688908e-12
) O 0 2.5331773896401788e-14
among O 0 4.630713876046209e-15
patients O 0 1.8918716690897314e-13
with O 0 1.2981355899076286e-15
DMS B-Disease 0 2.0898880848108092e-06
, O 0 9.727186605832088e-16
a O 0 1.1002554982438926e-16
higher O 0 6.5122857600226e-17
frequency O 0 8.14832735654544e-15
of O 0 4.17890355060034e-17
exon O 0 4.9160515658286386e-09
8 O 0 9.05976127452135e-10
mutations O 0 8.842421905796982e-09
among O 0 1.0609867612297944e-13
46 O 0 5.8316338424901915e-09
, O 0 2.3260235751387803e-11
XY O 0 1.6685469745425507e-05
patients O 0 1.9184764887825168e-11
with O 0 4.758466773282892e-14
female O 0 7.230580023609434e-11
phenotype O 0 3.2932330473745e-11
than O 0 9.494216122920424e-15
among O 0 8.10904349311109e-14
46 O 0 2.946628008260177e-08
, O 0 6.773663574488609e-11
XY O 0 2.568334821262397e-05
patients O 0 1.584492780037916e-11
with O 0 7.579447323675242e-15
sexual O 0 2.0167487471689505e-11
ambiguity O 0 1.0876441969287498e-09
or O 0 2.2495551255108381e-10
male O 0 1.440899954907593e-09
phenotype O 0 3.5927862906959263e-09
; O 0 1.7493265516699275e-11
and O 0 6.299966659462086e-10
( O 0 8.955786958385337e-13
3 O 0 1.5071482256656665e-11
) O 0 2.385407579200572e-14
statistically O 0 3.8363799984009184e-13
significant O 0 3.731531481921714e-14
evidence O 0 4.4026324252932625e-11
that O 0 1.2950222491592278e-11
mutations O 0 4.28005275665555e-09
in O 0 1.1904599993230094e-14
exons O 0 3.0830670993964304e-07
8 O 0 1.3415565547347796e-08
and O 0 3.081327901166553e-11
9 O 0 4.656861007923396e-11
preferentially O 0 2.051652736589915e-10
affect O 0 5.5698241158141926e-11
amino O 0 1.0857134635777754e-11
acids O 0 3.0627854852999237e-13
with O 0 2.0938842391561476e-16
different O 0 1.5135627764020153e-16
functions O 0 3.7834056092027335e-13
. O 0 2.8603456951083184e-13
. O 0 1.9916557552485115e-12

The O 0 8.993369243759375e-11
185delAG O 0 3.322253050441759e-08
BRCA1 O 0 1.0905737646282887e-08
mutation O 0 1.7636015911537406e-11
originated O 0 2.948183418314404e-13
before O 0 3.1595351724869212e-15
the O 0 1.574822349817039e-17
dispersion O 0 1.0129284563897833e-12
of O 0 1.1983411856170015e-16
Jews O 0 4.163132338863562e-11
in O 0 2.413485806606469e-13
the O 0 6.59615320263568e-14
diaspora O 0 4.3657031115196254e-12
and O 0 1.45636315507236e-11
is O 0 1.661900326556387e-14
not O 0 8.813287014249049e-14
limited O 0 2.6393899002150056e-13
to O 0 2.2499036867514727e-13
Ashkenazim O 0 9.894979946523108e-09
. O 0 3.836030885301378e-12

The O 0 1.536469562690712e-11
185delAG O 0 2.4377158069910365e-08
mutation O 0 8.319319677596582e-10
in O 0 4.380804936475122e-14
BRCA1 O 0 1.2413216232687319e-08
is O 0 8.99421257415621e-14
detected O 0 4.305613088284588e-10
in O 0 6.924554906659634e-15
Ashkenazi O 0 8.640882676047568e-09
Jews O 0 8.092052418764983e-13
both O 0 3.606668728863699e-13
in O 0 1.1999955716601729e-11
familial B-Disease 1 0.9995591044425964
breast I-Disease 1 0.9999997615814209
and I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.6187076568030534e-08
in O 0 2.373732070279355e-12
the O 0 2.068024842084154e-13
general O 0 2.60940271126775e-12
population O 0 4.756564066232816e-13
. O 0 3.5669501206869736e-12

All O 0 3.103761414546824e-10
tested O 0 3.3321054249135784e-10
Ashkenazi O 0 6.366416283043463e-10
mutation O 0 1.0854298362894532e-11
carriers O 0 7.584559065867968e-13
share O 0 4.538361873807073e-14
the O 0 1.2730814564706778e-14
same O 0 1.2284677398596844e-13
allelic O 0 2.0241218423588947e-10
pattern O 0 1.4519034152726817e-07
at O 0 2.2622948653294728e-11
the O 0 2.0149395932138325e-13
BRCA1 O 0 2.406982346769837e-08
locus O 0 1.0526217675277394e-09
. O 0 1.1160601609550014e-10

Our O 0 4.895652772063386e-09
previous O 0 1.0172271011632539e-11
study O 0 5.565411412972177e-13
showed O 0 8.852972174788754e-12
that O 0 2.899341474166977e-15
this O 0 1.6950913337703704e-15
Ashkenazi O 0 3.056414499269522e-08
mutation O 0 2.53500109792526e-09
also O 0 3.2704125518812077e-10
occurs O 0 1.0696902348270032e-12
in O 0 2.848452369970649e-15
Iraqi O 0 2.301020485262484e-12
Jews O 0 2.1188279809066651e-13
with O 0 6.643392695972173e-16
a O 0 4.6888393944691676e-15
similar O 0 3.230899095897459e-14
allelic O 0 2.298539830691837e-10
pattern O 0 1.7792689277484897e-07
. O 0 4.9753517278317005e-11

We O 0 2.1317815424026776e-07
extended O 0 2.1022048685148675e-11
our O 0 2.4832054950707852e-14
analysis O 0 1.5058529713430323e-14
to O 0 1.5776018288764498e-15
other O 0 1.6341879707968917e-15
non O 0 4.0726197913197593e-13
- O 0 1.0758676616262619e-08
Ashkenazi O 0 8.55175397163066e-09
subsets O 0 1.2121368145323608e-11
354 O 0 6.588447777795825e-13
of O 0 3.544521599651131e-16
Moroccan O 0 6.742216784871857e-10
origin O 0 3.1001876819826066e-14
, O 0 5.049866859445579e-15
200 O 0 4.865959489454199e-15
Yemenites O 0 6.937524860139987e-11
and O 0 8.832011693987642e-15
150 O 0 6.882341325667321e-15
Iranian O 0 6.928921954425793e-13
Jews O 0 5.625467539710494e-12
. O 0 1.3956393549521828e-12

Heteroduplex O 0 1.0438909612275893e-06
analysis O 0 3.752392147005068e-11
complemented O 0 6.581514847003866e-13
by O 0 1.9747207324606565e-16
direct O 0 2.0486531985804482e-14
DNA O 0 8.827925057630637e-10
sequencing O 0 1.6155993209920894e-11
of O 0 7.057302227790683e-16
abnormally O 0 1.4872672537968867e-11
migrating O 0 2.577856114335808e-12
bands O 0 1.2133391080054734e-12
were O 0 2.6859802359710527e-13
employed O 0 1.8543722113406602e-11
. O 0 2.7996565569315957e-12

Four O 0 3.898009692804294e-11
of O 0 5.548899602573121e-16
Moroccan O 0 2.3063713161519672e-09
origin O 0 3.8335986132526784e-14
( O 0 7.179878483170221e-16
1 O 0 2.045622260585288e-15
. O 0 1.1124486036940672e-15
1 O 0 1.2371177927829758e-14
% O 0 5.248384488985912e-16
) O 0 2.5575975189161097e-14
and O 0 1.2987499964367544e-11
none O 0 5.1146270378665815e-12
of O 0 8.890342009095379e-18
the O 0 2.972198801366819e-15
Yemenites O 0 1.1976523939249972e-10
or O 0 3.092461174492695e-15
Iranians O 0 1.892166402674058e-14
was O 0 3.92168868451441e-14
a O 0 1.8038156887865444e-16
carrier O 0 1.5088580070706653e-13
of O 0 5.013986054108964e-17
the O 0 6.120537426488812e-14
185delAG O 0 1.0855391252562185e-08
mutation O 0 5.264602087606818e-10
. O 0 2.342450886039238e-12

BRCA1 O 0 7.242998663059552e-07
allelic O 0 6.2729315075671366e-09
patterns O 0 3.9176520658656955e-06
were O 0 2.5582489685677112e-12
determined O 0 1.9889957736385355e-11
for O 0 1.6899197741109093e-15
four O 0 4.0216113317108337e-13
of O 0 2.409071551576577e-16
these O 0 2.573944204477263e-13
individuals O 0 6.781144605392956e-16
and O 0 2.5308702074171296e-13
for O 0 6.186490948124586e-16
12 O 0 9.027435239226597e-14
additional O 0 5.021953735701761e-15
non O 0 4.957455453091786e-12
- O 0 1.3138581778093794e-08
Ashkenazi O 0 5.966161609194387e-08
185delAG O 0 3.111158275448389e-10
mutation O 0 1.100371616741258e-11
carriers O 0 5.341060059504965e-12
who O 0 2.9651655353291062e-08
had O 0 0.0007395711145363748
breast B-Disease 1 0.9999901056289673
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.662756292184156e-10

Six O 0 6.906442706622329e-08
non O 0 4.918487284122364e-10
- O 0 6.662795931333676e-05
Ashkenazi O 0 2.316173049621284e-05
individuals O 0 2.2434074183844827e-13
shared O 0 2.8453056425715995e-13
the O 0 3.357641567531362e-15
common O 0 3.7228016215541324e-14
Ashkenazi O 0 3.3994071446663554e-10
haplotype O 0 9.626717201172141e-10
, O 0 1.0529696689229318e-12
four O 0 1.425991811611349e-12
had O 0 7.070038304801685e-11
a O 0 2.8751768947312328e-15
closely O 0 8.833171173672216e-12
related O 0 2.9121930561482046e-12
pattern O 0 2.7068890062764694e-07
, O 0 6.270090696647301e-11
and O 0 7.447847893971016e-11
the O 0 2.898824572310915e-13
rest O 0 2.2490908441197277e-11
( O 0 4.8415027683549466e-14
n O 0 1.862654386286522e-07
= O 0 1.3464265066431835e-05
6 O 0 9.41647107510768e-11
) O 0 4.3152974412135475e-14
displayed O 0 9.172850467479426e-14
a O 0 1.4188800687760933e-13
distinct O 0 5.4903165347397476e-11
BRCA1 O 0 1.2935115023537946e-07
allelic O 0 4.128619668364308e-09
pattern O 0 8.074709398897539e-07
. O 0 1.3987853930697014e-10

We O 0 2.293926115726208e-08
conclude O 0 5.247146814268966e-11
that O 0 2.9257859698351985e-14
the O 0 1.4729575998034643e-14
185delAG O 0 1.8109657773379695e-08
BRCA1 O 0 4.3916273284594354e-08
mutation O 0 3.6924363566726015e-10
occurs O 0 6.376967096738406e-13
in O 0 1.3387605606073657e-15
some O 0 7.887874042627162e-15
non O 0 2.53935539262784e-10
- O 0 6.0219981605769135e-06
Ashkenazi O 0 8.096592864603736e-06
populations O 0 6.558734000350341e-09
at O 0 7.776475643983538e-12
rates O 0 2.7453493037926657e-12
comparable O 0 9.633906043724524e-16
with O 0 3.9898369955714626e-16
that O 0 1.5224909007127696e-14
of O 0 1.9228503405949345e-15
Ashkenazim O 0 1.9718876842489408e-07
. O 0 3.6380928651602584e-12

The O 0 1.783546574318784e-11
majority O 0 1.1493318232899674e-12
of O 0 6.42528171205419e-16
Jewish O 0 3.3297722218383896e-11
185delAG O 0 5.056879803788661e-09
mutation O 0 1.807853519664171e-11
carriers O 0 6.463197490223782e-13
have O 0 8.421045707539959e-14
a O 0 6.078535434326723e-15
common O 0 3.187653659368801e-14
allelic O 0 1.2208891016218804e-11
pattern O 0 2.3556870587526646e-07
, O 0 1.1166382488797533e-12
supporting O 0 6.153760769185557e-13
the O 0 1.3292146686983992e-14
founder O 0 1.2024602234067538e-12
effect O 0 4.338705772693324e-13
notion O 0 6.257694557844362e-13
, O 0 6.046153161465284e-13
but O 0 4.91730733822443e-13
dating O 0 3.003743434537576e-11
the O 0 2.2932616600775026e-15
mutations O 0 3.3796982139983056e-12
origin O 0 1.1975785912666766e-15
to O 0 5.300761406554092e-15
an O 0 8.920547336343365e-17
earlier O 0 8.571370176124748e-12
date O 0 6.575987671064709e-11
than O 0 1.8130824939273024e-14
currently O 0 1.9366188340474988e-12
estimated O 0 5.579604053090881e-12
. O 0 4.356829480522961e-11

However O 0 7.315704153576519e-10
, O 0 7.944892573691353e-14
the O 0 3.6860007187376287e-16
different O 0 2.0066991908348217e-15
allelic O 0 3.5028348277510446e-11
pattern O 0 2.3529075576789182e-07
at O 0 3.29930666120859e-11
the O 0 6.743900820812068e-14
BRCA1 O 0 4.7781876233443654e-09
locus O 0 1.9587009097987718e-11
even O 0 2.997293732653894e-11
in O 0 1.9940853879425475e-15
some O 0 9.5672519623139e-16
Jewish O 0 2.2575531721802378e-11
mutation O 0 5.921099114486461e-12
carriers O 0 4.1185205744941056e-13
, O 0 7.988671302163602e-14
might O 0 1.1741644982687927e-11
suggest O 0 8.766537842874733e-12
that O 0 2.6244704651699757e-13
the O 0 1.208164936096403e-14
mutation O 0 4.082506901981198e-12
arose O 0 3.688367360555993e-14
independently O 0 9.288349169661592e-13
. O 0 8.671967359702784e-14
. O 0 6.000592817773098e-12

Crystal O 0 1.7130081459981739e-06
structure O 0 6.40324238077028e-10
of O 0 7.718861323496775e-15
the O 0 3.913017913165229e-12
hemochromatosis B-Disease 1 1.0
protein O 0 4.200761395622976e-06
HFE O 0 2.0958680124749662e-06
and O 0 4.597173770132246e-12
characterization O 0 3.11530884422595e-10
of O 0 6.832896200887825e-16
its O 0 7.403022219223433e-15
interaction O 0 7.78505948942354e-14
with O 0 3.209935369266094e-14
transferrin O 0 1.1547919287480113e-09
receptor O 0 1.0370018732608344e-10
. O 0 1.1170733608956152e-11

HFE O 0 3.771728734136559e-05
is O 0 3.3758922740600994e-11
an O 0 7.01018019674815e-14
MHC O 0 2.429243917134727e-09
- O 0 7.088953424272404e-08
related O 0 3.563050965382786e-10
protein O 0 6.965561460958725e-09
that O 0 5.322234081402144e-13
is O 0 1.8393525431600367e-14
mutated O 0 1.9485923985484987e-10
in O 0 2.785965089267123e-13
the O 0 4.7705697031608096e-11
iron B-Disease 1 0.9928643703460693
- I-Disease 1 0.9999898672103882
overload I-Disease 1 0.9998488426208496
disease I-Disease 1 0.9999945163726807
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.4298860833150684e-06

HFE O 0 3.986183401138987e-06
binds O 0 1.1846017500261041e-08
to O 0 1.1301807580077483e-11
transferrin O 0 3.460576714076069e-09
receptor O 0 5.447028939009613e-11
( O 0 9.136740436498439e-14
TfR O 0 1.3016949651500909e-07
) O 0 2.397866790109643e-13
and O 0 6.958483268759696e-13
reduces O 0 1.174066052711531e-11
its O 0 9.136382183913398e-16
affinity O 0 6.870851323737817e-15
for O 0 4.309850172329755e-15
iron O 0 3.0098615155793595e-08
- O 0 4.840102540981661e-09
loaded O 0 1.046048057201654e-11
transferrin O 0 5.7740416614660006e-11
, O 0 5.921229218747159e-14
implicating O 0 1.1268089794569391e-09
HFE O 0 1.6281538819384878e-06
in O 0 6.402503527347392e-12
iron O 0 4.6266654862847645e-06
metabolism O 0 9.78395837591961e-06
. O 0 2.6447795342665614e-11

The O 0 2.717366054394432e-10
2 O 0 1.005129757203349e-09
. O 0 5.774934003222043e-11

6 O 0 2.9789245559186384e-07
A O 0 8.2273382551179e-10
crystal O 0 3.351709949583892e-07
structure O 0 1.7383555706018683e-09
of O 0 5.30456416097079e-15
HFE O 0 6.216350357135525e-06
reveals O 0 3.0988397958786607e-10
the O 0 8.728078951414527e-16
locations O 0 1.651116222911586e-11
of O 0 8.735166181963322e-14
hemochromatosis B-Disease 1 1.0
mutations O 1 0.9922769069671631
and O 0 8.846331445155897e-10
a O 0 1.1411622515000719e-12
patch O 0 1.722040178719908e-05
of O 0 8.424576140864115e-15
histidines O 0 2.2150079530547373e-06
that O 0 5.128706487278478e-11
could O 0 3.5436537038080473e-10
be O 0 6.574135089391572e-14
involved O 0 3.298296423308311e-13
in O 0 1.0484209854444426e-11
pH O 0 7.000779760346632e-07
- O 0 1.4602044018374727e-07
dependent O 0 3.744958232410056e-10
interactions O 0 6.211999664662571e-11
. O 0 1.0217967964798458e-11

We O 0 4.770358827954624e-07
also O 0 6.680204132913925e-12
demonstrate O 0 6.684750951564677e-13
that O 0 7.539659001298826e-13
soluble O 0 6.329118917847154e-08
TfR O 0 0.00044618238462135196
and O 0 3.414220642317112e-11
HFE O 0 3.7450872696354054e-06
bind O 0 3.5308652002186136e-08
tightly O 0 1.9085126723439316e-07
at O 0 7.692891462740548e-11
the O 0 5.361710932823196e-15
basic O 0 8.810943294412787e-12
pH O 0 3.640302295715436e-11
of O 0 8.340150434717368e-17
the O 0 3.010863314310136e-14
cell O 0 1.9964026876095886e-08
surface O 0 5.002841518830792e-08
, O 0 8.058909442554274e-12
but O 0 1.8848654581571367e-10
not O 0 1.1249846540439812e-11
at O 0 3.538883075471233e-11
the O 0 1.0966122758124253e-12
acidic O 0 7.704293203403267e-09
pH O 0 3.0371355430602875e-10
of O 0 8.992749748256302e-15
intracellular O 0 9.223156638427099e-08
vesicles O 0 1.4080452501730178e-06
. O 0 1.51943413406741e-09

TfR O 0 0.005617513787001371
HFE O 0 1.845305996539537e-05
stoichiometry O 0 1.3801961529225082e-07
( O 0 3.6242290418764256e-11
2 O 0 1.288761024981211e-11
1 O 0 2.0693744027383554e-13
) O 0 4.704749637833919e-15
differs O 0 3.8014605569305915e-13
from O 0 3.28416887089534e-15
TfR O 0 4.988548880646704e-07
transferrin O 0 8.39691996490366e-11
stoichiometry O 0 6.542958536082111e-11
( O 0 7.41515003696222e-14
2 O 0 4.437253516009765e-12
2 O 0 1.723249798066262e-12
) O 0 7.67968096748858e-15
, O 0 9.364398159358335e-16
implying O 0 2.3683388488738612e-14
a O 0 3.1329972596725296e-16
different O 0 5.910173712955861e-17
mode O 0 3.742187156398173e-14
of O 0 1.4507548532291904e-18
binding O 0 3.466314962927847e-14
for O 0 3.0029340271326517e-16
HFE O 0 4.1682074680693404e-08
and O 0 4.916616159339471e-12
transferrin O 0 1.7085957648710348e-10
to O 0 1.5271632699750959e-12
TfR O 0 5.78911931370385e-06
, O 0 5.882971193527098e-12
consistent O 0 2.3155592027146454e-11
with O 0 1.491518226200833e-13
our O 0 6.243599116450421e-14
demonstration O 0 1.1492572301805004e-12
that O 0 3.3395747782829013e-14
HFE O 0 3.0614950574658906e-09
, O 0 9.578289902759454e-14
transferrin O 0 1.0319723547924653e-10
, O 0 1.827994786790521e-12
and O 0 3.472984400065826e-11
TfR O 0 3.566094528650865e-05
form O 0 7.140039427755429e-13
a O 0 2.2271041347915466e-13
ternary O 0 1.5203269754238136e-09
complex O 0 5.911000755531859e-08
. O 0 5.144482617680524e-10

Identification O 0 1.398932220064708e-10
of O 0 1.1183592843033024e-14
three O 0 3.6496004243886937e-13
novel O 0 9.200439889112122e-12
mutations O 0 9.254519817147866e-09
and O 0 1.9460906410667667e-12
a O 0 6.7334862966156924e-15
high O 0 1.1366991569739578e-14
frequency O 0 6.571690213492618e-14
of O 0 2.3258135068174e-16
the O 0 6.674936753499339e-14
Arg778Leu O 0 2.762974702363863e-07
mutation O 0 3.255860858697446e-10
in O 0 2.772564079364659e-13
Korean O 0 1.8361672005084984e-07
patients O 0 9.862763383772233e-12
with O 0 7.812225259057337e-13
Wilson B-Disease 0 6.716624920954928e-05
disease I-Disease 0 0.010936358012259007
. O 0 1.2662566307997114e-11

Four O 0 4.785730478573669e-09
mutations O 0 2.499355105101131e-07
- O 0 1.9062620140175568e-06
- O 0 1.2233242614456685e-06
R778L O 0 4.648497142767383e-09
, O 0 4.058427246068745e-14
A874V O 0 5.03804116480655e-12
, O 0 7.932044799123224e-16
L1083F O 0 5.71717044366149e-13
, O 0 1.5958388717473085e-15
and O 0 8.391154761864302e-15
2304delC O 0 2.0827128216494017e-11
- O 0 2.0942658718325902e-10
- O 0 9.207803963739991e-10
in O 0 7.564632378614586e-14
the O 0 6.7292231797921615e-15
copper O 0 2.7434228933725935e-12
- O 0 4.0455841259466607e-13
transporting O 0 2.5293921688054888e-14
enzyme O 0 3.530669463389091e-12
, O 0 7.003374287016962e-15
P O 0 3.170678652963943e-08
- O 0 2.4784418961587562e-09
type O 0 2.505462726176688e-09
ATPase O 0 4.135145115213845e-09
( O 0 5.555258808303751e-14
ATP7B O 0 1.2293750462077924e-09
) O 0 4.255448210742927e-15
, O 0 4.977477729707332e-15
were O 0 4.7559057691668686e-15
identified O 0 3.244414285841213e-12
in O 0 1.6576402251701483e-13
Korean O 0 5.285848487801559e-07
Patients O 0 1.0807918796040816e-11
with O 0 1.8863875034507566e-13
Wilson B-Disease 0 4.420457480591722e-05
disease I-Disease 0 8.698884630575776e-05
. O 0 9.230619740785428e-12

Arg778Leu O 0 5.755419351771707e-06
, O 0 1.1493543963791986e-11
the O 0 5.246448214020136e-14
most O 0 3.3020950526745562e-15
frequently O 0 2.592561582082098e-11
reported O 0 2.2701226315424705e-11
mutation O 0 2.6949978707002664e-12
of O 0 6.310716816712514e-18
this O 0 3.3006216388628074e-15
enzyme O 0 7.68432279613096e-12
, O 0 2.9862372882653865e-13
was O 0 3.6772360711978536e-09
found O 0 1.3048021552108935e-09
in O 0 8.838222580014043e-13
six O 0 9.753624991004628e-12
of O 0 3.290073166993735e-16
eight O 0 1.0423594279385107e-11
unrelated O 0 4.0831885095293785e-10
patients O 0 5.1888922845966245e-12
studied O 0 1.8234600027838832e-13
, O 0 3.701935989278993e-17
an O 0 7.080104077625264e-19
allele O 0 3.667572616997605e-15
frequency O 0 3.351975814969155e-13
of O 0 1.9128357006529574e-14
37 O 0 1.040005770391872e-08
. O 0 3.0327809708019515e-11

5 O 0 2.207982463531266e-09
% O 0 3.22892320520074e-13
, O 0 1.2227738353104423e-12
which O 0 4.221612209115433e-13
is O 0 3.2473932414244e-15
considerably O 0 1.325909781274559e-11
higher O 0 2.4805402211989548e-14
than O 0 1.663124458571759e-14
those O 0 1.0130395464548816e-14
in O 0 1.1623064876287604e-14
other O 0 2.7111494473042175e-13
Asian O 0 1.0956056201161246e-10
populations O 0 9.698903485899635e-11
. O 0 2.0838125062289103e-12

The O 0 3.763722840333106e-12
novel O 0 5.750924476216612e-12
single O 0 1.4853973628360662e-13
nucleotide O 0 1.0802045889712897e-11
deletion O 0 2.9415486713091354e-10
, O 0 8.93752370831509e-14
2304delC O 0 1.4256186231520473e-09
, O 0 6.743392736568987e-12
was O 0 2.3279478345017424e-09
found O 0 1.544446862067339e-11
in O 0 9.792013256010659e-14
one O 0 8.345618640603902e-11
patient O 0 1.0185774446114237e-09
. O 0 2.1941753969301203e-12

Since O 0 6.323909451655396e-11
a O 0 7.8171552618609e-14
mutation O 0 2.355057338379596e-12
at O 0 4.822986289314789e-14
cDNA O 0 1.6242451827963578e-10
nucleotide O 0 1.6306932471010782e-09
2302 O 0 3.3578848501747416e-07
( O 0 3.639116460431302e-14
2302insC O 0 6.303332300561237e-10
) O 0 4.885522325234759e-13
had O 0 1.7400805241152284e-09
been O 0 6.613128013949199e-12
previously O 0 5.7343661069575447e-11
described O 0 1.9088876312967074e-11
, O 0 2.2092753787419234e-13
this O 0 3.091106472348504e-14
region O 0 6.131970799183595e-12
of O 0 1.47467086158214e-16
the O 0 3.040189627823153e-14
ATP7B O 0 6.234930793880267e-08
gene O 0 1.0159799224140897e-08
may O 0 6.26055110530821e-12
be O 0 1.729933165846905e-14
susceptible O 0 3.0285943024288553e-12
to O 0 1.7763473526312412e-13
gene O 0 1.41582674473284e-07
rearrangements O 0 0.002030087634921074
causing O 0 5.48287462152075e-05
Wilson B-Disease 0 0.03139965608716011
disease I-Disease 1 0.7679139971733093
. O 0 1.23567239773692e-10

Disruption O 0 7.619432196293019e-09
of O 0 3.800702479383458e-15
splicing O 0 2.6630697647078705e-10
regulated O 0 2.413796593159212e-11
by O 0 8.529635013740605e-16
a O 0 2.1861940697424226e-14
CUG O 0 3.2754162049286606e-08
- O 0 1.8332908524598679e-09
binding O 0 9.457198045514925e-12
protein O 0 3.433849204981243e-09
in O 0 9.700346081942257e-11
myotonic B-Disease 1 0.9999972581863403
dystrophy I-Disease 1 0.9999969005584717
. O 0 2.9190250216970526e-10

Myotonic B-Disease 1 0.9999966621398926
dystrophy I-Disease 1 0.9999997615814209
( O 0 6.269052619245485e-07
DM B-Disease 1 1.0
) O 0 8.141112672888084e-09
is O 0 2.7535298260245034e-12
caused O 0 2.478097805083679e-12
by O 0 4.2419780575409785e-16
a O 0 1.751223338976142e-14
CTG O 0 9.086329910701352e-09
expansion O 0 8.660806100069252e-11
in O 0 8.164670111873717e-13
the O 0 7.123716221947574e-13
3 O 0 2.6496974753209557e-11
untranslated O 0 4.582817041409726e-07
region O 0 4.012362109229173e-10
of O 0 3.750581422312053e-15
the O 0 4.373971237287e-12
DM B-Disease 1 0.9999994039535522
gene O 0 4.61598602896629e-07
. O 0 1.3102075847870598e-11

One O 0 2.088265844968351e-11
model O 0 1.479267125459316e-10
of O 0 2.2577274251533996e-13
DM B-Disease 1 0.9999998807907104
pathogenesis O 0 0.0010244834702461958
suggests O 0 3.482604482574203e-10
that O 0 1.297450594363184e-14
RNAs O 0 1.553746686866475e-09
from O 0 8.830188243810441e-16
the O 0 2.658291143971454e-16
expanded O 0 1.1776067317462169e-12
allele O 0 2.1869418981908945e-13
create O 0 3.954022642616538e-14
a O 0 1.1240846849256553e-13
gain O 0 3.864303408512848e-12
- O 0 2.1577243103365618e-08
of O 0 7.508298588984955e-14
- O 0 6.704200927742932e-08
function O 0 1.017308546430451e-11
mutation O 0 2.186929429865911e-13
by O 0 1.51497732142393e-17
the O 0 1.2039403380961484e-16
inappropriate O 0 1.2757365151251643e-13
binding O 0 1.2319099462320543e-13
of O 0 8.779968983856713e-17
proteins O 0 6.537407420958985e-11
to O 0 9.757788110506538e-13
the O 0 3.3902847434812144e-13
CUG O 0 2.22397648030892e-06
repeats O 0 1.5887628990185476e-07
. O 0 1.75625711890115e-11

Data O 0 3.506189116819769e-08
presented O 0 2.4028229059225303e-11
here O 0 2.6080843214260074e-12
indicate O 0 1.6298302984996127e-11
that O 0 1.0519693839985966e-13
the O 0 6.6679987913316734e-15
conserved O 0 9.276142354242012e-11
heterogeneous O 0 5.861570256948667e-11
nuclear O 0 3.994465647139123e-09
ribonucleoprotein O 0 4.666715347489969e-10
, O 0 8.006140780718318e-13
CUG O 0 7.035785642983683e-08
- O 0 2.8920046357683304e-09
binding O 0 1.7886634881558727e-11
protein O 0 2.5229648925595427e-10
( O 0 1.0389478279158437e-14
CUG O 0 5.713890249836595e-09
- O 0 1.8794528156007573e-09
BP O 0 6.565398225077956e-11
) O 0 3.681477086343258e-15
, O 0 2.1413753542175347e-14
may O 0 4.652994569503965e-13
mediate O 0 5.802592087378322e-11
the O 0 3.028845484967166e-14
trans O 0 8.033196885470772e-10
- O 0 2.3902972046130344e-08
dominant O 0 4.41052083743898e-09
effect O 0 2.187631152616998e-12
of O 0 3.105817031186323e-17
the O 0 1.4591434241699886e-15
RNA O 0 4.083252402864446e-09
. O 0 1.065708827609202e-12

CUG O 0 4.447686478670221e-06
- O 0 1.020322997646872e-06
BP O 0 1.1397028210069493e-08
was O 0 9.996129791967068e-12
found O 0 5.863246340672519e-15
to O 0 2.906005664698178e-16
bind O 0 7.48592767635392e-12
to O 0 4.674215455338117e-14
the O 0 8.423776541761907e-14
human O 0 7.641473565023205e-11
cardiac O 0 1.081723553397751e-06
troponin O 0 6.034291004652914e-07
T O 0 8.444309855804022e-07
( O 0 2.4073284530623344e-14
cTNT O 0 2.0701464847894258e-11
) O 0 1.77725469432434e-14
pre O 0 3.861768977514446e-12
- O 0 7.166437443473228e-10
messenger O 0 1.3919661430439323e-11
RNA O 0 1.415890182876467e-09
and O 0 2.3344648154670355e-14
regulate O 0 2.7940643505461327e-13
its O 0 3.3905917844542647e-15
alternative O 0 2.8936969736614165e-14
splicing O 0 7.356281694903544e-10
. O 0 6.383444987878573e-12

Splicing O 0 3.429169392887843e-09
of O 0 5.864144619113082e-14
cTNT O 0 4.9732977736027806e-09
was O 0 3.924478103600748e-11
disrupted O 0 4.7103424094530055e-07
in O 0 4.1357802599284454e-11
DM B-Disease 1 0.9999998807907104
striated O 1 0.9994876384735107
muscle O 1 0.9986345171928406
and O 0 8.901394288329811e-09
in O 0 6.051380100138837e-13
normal O 0 8.50790438100546e-10
cells O 0 1.4999616132493898e-11
expressing O 0 2.5005808089727547e-15
transcripts O 0 1.9200321887957728e-11
that O 0 1.9266444722162296e-13
contain O 0 1.8013070202105297e-11
CUG O 0 8.102100764517672e-06
repeats O 0 1.0948880344585632e-06
. O 0 2.9324331157765116e-11

Altered O 0 2.9063032343401574e-05
expression O 0 2.6606936098794165e-10
of O 0 5.3150389092097156e-14
genes O 0 3.33157168519449e-10
regulated O 0 1.346285305459105e-09
posttranscriptionally O 0 1.703091445648397e-09
by O 0 1.0816503163253114e-14
CUG O 0 1.5548361886885687e-07
- O 0 5.9588501244434156e-08
BP O 0 6.487390069587207e-10
therefore O 0 2.2343543302442287e-13
may O 0 1.2989932107667235e-14
contribute O 0 2.8140107397858685e-15
to O 0 1.6936785090723716e-12
DM B-Disease 1 0.9999998807907104
pathogenesis O 0 0.0003230937581975013
. O 0 3.155505154048277e-12
. O 0 4.312554219981779e-12

Identification O 0 2.625936412758989e-10
of O 0 3.0667687593783407e-15
a O 0 1.781385775652053e-13
novel O 0 8.123576811236433e-11
nonsense O 0 7.177825267490334e-08
mutation O 0 4.5563769424106226e-10
and O 0 2.8273598943313015e-14
a O 0 3.327382850737919e-16
missense O 0 1.3254850342314661e-11
substitution O 0 6.216494739764641e-14
in O 0 4.2302461218259144e-16
the O 0 6.850460487840327e-16
vasopressin O 0 1.1158796461721923e-13
- O 0 3.2338174360546645e-09
neurophysin O 0 1.4181018137549017e-08
II O 0 1.1104174468812289e-08
gene O 0 2.341390414883904e-10
in O 0 7.231148053390632e-14
two O 0 5.394963447334644e-13
Spanish O 0 1.1967657767564255e-11
kindreds O 0 2.2983192593528656e-07
with O 0 3.2527185805930614e-11
familial B-Disease 0 0.05897931754589081
neurohypophyseal I-Disease 1 0.9992306232452393
diabetes I-Disease 1 0.9999680519104004
insipidus I-Disease 1 0.9974775910377502
. O 0 1.0067535249902448e-08

Familial B-Disease 1 0.999749481678009
neurohypophyseal I-Disease 1 0.9998487234115601
diabetes I-Disease 1 0.9999978542327881
insipidus I-Disease 1 0.9999488592147827
( O 0 4.41956899521756e-06
FNDI B-Disease 1 1.0
) O 0 3.2727279219990635e-10
is O 0 9.721118224628733e-13
an O 0 7.628271929058239e-13
autosomal B-Disease 1 0.999994158744812
dominant I-Disease 1 0.9999988079071045
disease I-Disease 1 0.9999997615814209
caused O 0 1.1183891501787002e-06
by O 0 9.518936749941531e-10
deficiency O 0 0.13615822792053223
in O 0 2.2526431945908004e-13
the O 0 1.271859570786682e-12
antidiuretic O 0 1.061857979323122e-08
hormone O 0 4.85482400808257e-12
arginine O 0 2.2558476354267443e-12
vasopressin O 0 1.0126459810662694e-13
( O 0 4.87541417709057e-16
AVP O 0 1.7696457363727824e-12
) O 0 1.246286691502943e-16
encoded O 0 1.453004949931457e-16
by O 0 1.2926252170692657e-16
the O 0 7.546039497202586e-15
AVP O 0 3.0871444067770426e-08
- O 0 2.9462748329933675e-07
neurophysin O 0 4.241299791374331e-07
II O 0 8.095313575040564e-08
( O 0 5.594965002365601e-14
AVP O 0 7.314675087854994e-09
- O 0 3.699496531339719e-08
NPII O 0 2.987885849847771e-08
) O 0 1.0084281296834398e-14
gene O 0 2.8802088752194477e-12
on O 0 1.0047237564494993e-12
chromosome O 0 2.6249733764416305e-07
20p13 O 0 1.1461205318141765e-08
. O 0 3.333438733377214e-11

In O 0 5.192637292372737e-11
this O 0 1.5651054671023124e-13
study O 0 8.835205245368016e-13
, O 0 6.415188475925038e-13
we O 0 2.7479804889929405e-11
analyzed O 0 4.864408355287342e-12
two O 0 4.764024664669596e-14
families O 0 3.1753033260747705e-15
with O 0 6.958263429828566e-15
FNDI B-Disease 1 0.9999939203262329
using O 0 1.3577651847350262e-14
direct O 0 1.2966415931952614e-14
automated O 0 3.2490072372944045e-13
fluorescent O 0 3.9695026779473785e-12
, O 0 2.2083244521214906e-12
solid O 0 5.199803088107302e-11
phase O 0 2.0607033440755984e-11
, O 0 3.433198685195635e-14
single O 0 1.1789972210324295e-13
- O 0 7.231876902880074e-11
stranded O 0 1.555831960660392e-12
DNA O 0 6.579306327178513e-13
sequencing O 0 8.662011334440757e-15
of O 0 6.703976264303394e-18
PCR O 0 4.987867896488751e-10
- O 0 5.492222648895151e-11
amplified O 0 5.5034636570194806e-11
AVP O 0 1.6596397589552225e-09
- O 0 1.7422224773966377e-09
NPII O 0 6.998107426881006e-09
DNA O 0 9.558785762919797e-09
. O 0 1.993677792300197e-12

In O 0 1.4031429663996509e-11
one O 0 7.048179314489422e-13
of O 0 2.6362764929745185e-16
the O 0 2.593785375284291e-13
families O 0 1.1046645233747307e-13
, O 0 7.33863721202356e-14
affected O 0 7.899309461753545e-13
individuals O 0 7.575160569338527e-17
presented O 0 4.660965657757397e-15
a O 0 1.3779898751199119e-14
novel O 0 4.097744712994178e-11
nonsense O 0 1.0775907277604801e-08
mutation O 0 1.4308747763036589e-11
in O 0 9.17591956430886e-16
exon O 0 1.1048684883663284e-10
3 O 0 2.0899473124336154e-11
of O 0 2.563543361980568e-16
the O 0 4.1143805484984697e-14
gene O 0 3.4265523751741966e-10
, O 0 5.7058382270294e-14
consisting O 0 2.499854425280925e-16
in O 0 4.81312326827037e-15
a O 0 3.981875864190326e-13
G O 0 4.371974569039594e-07
to O 0 8.702762469003922e-12
T O 0 1.7435506549645652e-07
transition O 0 6.304070980511778e-12
at O 0 1.697102961634167e-12
nucleotide O 0 8.317613958697123e-12
2101 O 0 4.993294111521607e-10
, O 0 2.0835411304251372e-13
which O 0 1.3895526371795856e-14
produces O 0 2.845943458380882e-15
a O 0 2.3027113713953084e-15
stop O 0 2.6618089676855305e-11
signal O 0 2.7421255370529973e-12
in O 0 8.26179131618171e-14
codon O 0 3.2853439968505427e-09
82 O 0 1.3674887888726062e-09
( O 0 1.3888539027607366e-13
Glu O 0 8.788721572727809e-08
) O 0 2.2454278291329094e-13
of O 0 3.328382762544241e-14
NPII O 0 1.083430561266141e-05
. O 0 8.646545979207332e-11

The O 0 2.568424466165009e-11
premature O 0 2.397390341801753e-10
termination O 0 1.2295731273426203e-11
eliminates O 0 6.961994869492116e-11
part O 0 8.577842212573183e-13
of O 0 5.088134113936634e-15
the O 0 1.6810175213627376e-12
C O 0 2.6616942250257125e-07
- O 0 3.052368358069657e-10
terminal O 0 2.737435556010581e-10
domain O 0 3.52295406388925e-12
of O 0 1.544056888945456e-16
NPII O 0 6.242754646557103e-10
, O 0 4.342822094471931e-16
including O 0 1.212711380808579e-17
a O 0 1.1138705602542704e-16
cysteine O 0 7.937649086739614e-15
residue O 0 3.409396896747463e-12
in O 0 4.272218192549141e-15
position O 0 1.6373177119666238e-11
85 O 0 1.5970898648715037e-12
, O 0 2.0898732776882673e-13
which O 0 5.947233157332921e-12
could O 0 3.4159941542100114e-10
be O 0 4.696019777466337e-14
involved O 0 7.952712720673584e-15
in O 0 1.3889644575010122e-14
the O 0 3.66782803131252e-13
correct O 0 1.9911432502794923e-08
folding O 0 9.804638523291942e-08
of O 0 8.268944848234452e-15
the O 0 1.0228258127617518e-12
prohormone O 0 2.483796208707645e-07
. O 0 5.0750403879362693e-11

In O 0 1.792151010926446e-10
the O 0 4.33522532108932e-12
second O 0 5.788762871827835e-11
family O 0 2.689784430343761e-13
, O 0 9.362969850051027e-16
a O 0 1.4437337772770648e-16
G279A O 0 3.3683312757916417e-13
substitution O 0 1.5372499415989074e-14
at O 0 6.910510033132644e-13
position O 0 6.145728891071567e-12
- O 0 1.694433066079526e-10
1 O 0 1.235443547459433e-14
of O 0 1.0790639333154782e-18
the O 0 1.099122856374736e-16
signal O 0 1.2450620300919792e-14
peptide O 0 3.358046872796623e-14
was O 0 1.2354701951159536e-13
observed O 0 1.1382358272062076e-13
in O 0 1.0359005421848016e-14
all O 0 9.913109829534639e-14
affected O 0 1.6918452749870028e-11
individuals O 0 1.7537136158410696e-14
. O 0 3.0048823672357283e-12

This O 0 9.826505928400842e-12
missense O 0 6.89717509771981e-08
mutation O 0 6.849834477407057e-08
, O 0 3.3957355156932767e-12
which O 0 1.1200794632071354e-11
replaces O 0 9.129972511345841e-08
Ala O 0 5.099256839002919e-08
with O 0 2.2077979635465317e-12
Thr O 0 0.0001407646486768499
, O 0 5.181514505653295e-12
is O 0 4.750375491054245e-15
frequent O 0 2.0665918629148017e-11
among O 0 2.222623994574402e-12
FNDI B-Disease 1 1.0
patients O 0 9.235432116838638e-06
and O 0 2.2790588860566174e-12
is O 0 8.235893792039178e-14
thought O 0 2.6153782264892733e-11
to O 0 1.381097300190209e-14
reduce O 0 1.0955501913642585e-12
the O 0 1.707591210731239e-15
efficiency O 0 4.494797614077069e-14
of O 0 7.635472623905484e-18
cleavage O 0 1.1131534062569504e-11
by O 0 3.0820604039938e-16
signal O 0 3.140115392100823e-13
peptidases O 0 1.1914073894114807e-10
. O 0 1.6489934417940333e-13
. O 0 1.1343438124575278e-12

Genetic O 0 7.808220630067808e-07
heterogeneity O 0 8.28080626291694e-09
of O 0 2.60980581763548e-12
Saethre B-Disease 1 0.9990267753601074
- I-Disease 1 0.9999914169311523
Chotzen I-Disease 1 0.9999836683273315
syndrome I-Disease 1 0.9999990463256836
, O 0 7.009341024266647e-13
due O 0 4.909592020039752e-14
to O 0 1.4192129188430463e-13
TWIST O 0 3.674714434964699e-07
and O 0 1.1187034631987558e-09
FGFR O 0 9.441998372494709e-06
mutations O 0 1.0052437460217334e-07
. O 0 1.539420674268044e-11

Thirty O 0 7.197234808131725e-09
- O 0 1.047682872012956e-06
two O 0 2.5374158069829678e-12
unrelated O 0 6.227517113099879e-11
patients O 0 6.5891428598086055e-12
with O 0 8.727646435215835e-16
features O 0 2.2470937610652442e-10
of O 0 1.4365702637880728e-12
Saethre B-Disease 1 0.9999301433563232
- I-Disease 1 0.9999520778656006
Chotzen I-Disease 1 0.9998456239700317
syndrome I-Disease 1 0.999970555305481
, O 0 1.0447184939788978e-14
a O 0 6.500866061827718e-14
common O 0 6.969860105732195e-11
autosomal B-Disease 0 0.2375224232673645
dominant I-Disease 0 0.2523914873600006
condition I-Disease 1 0.9578582048416138
of O 0 5.124323274735554e-12
craniosynostosis B-Disease 1 0.9999879598617554
and O 0 3.0373296340258094e-06
limb B-Disease 1 0.9995083808898926
anomalies I-Disease 0 0.030165672302246094
, O 0 2.3318961345220046e-11
were O 0 6.483100189504098e-13
screened O 0 6.512536288028059e-09
for O 0 1.0925484116312747e-14
mutations O 0 2.9870639295381807e-09
in O 0 1.3368073195716562e-13
TWIST O 0 1.187083356057883e-07
, O 0 4.687737611280829e-12
FGFR2 O 0 4.7495227306626475e-08
, O 0 2.092322219345369e-13
and O 0 5.711854600409794e-12
FGFR3 O 0 1.8724210804066388e-06
. O 0 3.448495655700157e-11

Nine O 0 1.1870082694542816e-08
novel O 0 9.883903695495633e-10
and O 0 5.847432954508847e-11
three O 0 1.8043492047703502e-12
recurrent O 0 2.3521317871200154e-06
TWIST O 0 5.3900989769317675e-06
mutations O 0 1.9033490389119834e-05
were O 0 2.414801691941193e-10
found O 0 2.6449320511545693e-10
in O 0 1.29177994256241e-12
12 O 0 2.75970024610217e-10
families O 0 6.088078717374212e-13
. O 0 6.475318545251518e-12

Seven O 0 1.538318583627074e-09
families O 0 3.807897465228638e-13
were O 0 4.419621068315997e-14
found O 0 2.6414647921226e-13
to O 0 4.0593640645084084e-14
have O 0 8.397215214839271e-13
the O 0 1.5688915349699496e-14
FGFR3 O 0 1.2906398616507886e-08
P250R O 0 1.7307875618821633e-11
mutation O 0 4.251579296954411e-11
, O 0 1.9225293828705609e-13
and O 0 5.5455991361530454e-12
one O 0 3.3557898213715243e-12
individual O 0 9.709914757004626e-15
was O 0 5.69419511542435e-10
found O 0 5.3171154978937096e-11
to O 0 4.420230186649027e-13
have O 0 1.059327105201735e-12
an O 0 3.771382698612046e-16
FGFR2 O 0 6.09233410386878e-08
VV269 O 0 1.0638111225258484e-10
- O 0 1.923445708262861e-10
270 O 0 3.4718632049152154e-12
deletion O 0 5.106330025483885e-09
. O 0 9.774147637087172e-12

To O 0 1.3501393059112132e-10
date O 0 7.465996570976685e-11
, O 0 4.7048506041612315e-14
our O 0 1.2492480245656626e-15
detection O 0 1.728631343969611e-13
rate O 0 4.9273410872296974e-14
for O 0 1.2747123727502461e-17
TWIST O 0 3.2403744132381007e-09
or O 0 2.851141631815546e-12
FGFR O 0 8.203948596019472e-07
mutations O 0 1.543077701171569e-07
is O 0 2.7020545089601056e-12
68 O 0 4.411547127602944e-09
% O 0 1.6649875922425394e-14
in O 0 3.188628018308687e-13
our O 0 4.203365655541802e-09
Saethre B-Disease 1 0.9792042970657349
- I-Disease 1 0.9990082383155823
Chotzen I-Disease 1 0.9999006986618042
syndrome I-Disease 1 0.9999935626983643
patients O 0 1.4377675716659155e-09
, O 0 2.556100303478543e-14
including O 0 1.4515564314768192e-12
our O 0 2.0087685681513534e-10
five O 0 3.1631983274035824e-13
patients O 0 3.946631094305618e-14
elsewhere O 0 2.3861721111387638e-14
reported O 0 1.301752650985366e-12
with O 0 7.352016266832032e-14
TWIST O 0 2.805339818223729e-07
mutations O 0 3.276497864135308e-07
. O 0 6.743315975055175e-12

More O 0 5.354427296509756e-14
than O 0 2.776466851431769e-15
35 O 0 5.883573793094565e-13
different O 0 5.766579129083595e-15
TWIST O 0 3.035482265545397e-08
mutations O 0 9.461599859150738e-08
are O 0 2.819655045473851e-13
now O 0 3.0243935827956037e-11
known O 0 8.893841067260377e-13
in O 0 2.1529038114428446e-14
the O 0 2.829242509759869e-14
literature O 0 4.867154856230682e-12
. O 0 4.083931977316713e-12

The O 0 3.677553053749172e-12
most O 0 3.1591737011766804e-15
common O 0 6.0136112059526285e-15
phenotypic O 0 1.493984731933129e-12
features O 0 4.733260006162254e-09
, O 0 3.6918518242501364e-10
present O 0 4.03844519674193e-13
in O 0 9.380097915035693e-15
more O 0 2.6942884560429855e-16
than O 0 2.193164642678557e-14
a O 0 3.5405287642648053e-12
third O 0 1.425705664637178e-09
of O 0 2.709885191338134e-15
our O 0 4.518873469860907e-11
patients O 0 1.5202398259521466e-13
with O 0 1.1478754390756231e-15
TWIST O 0 1.069366017958373e-08
mutations O 0 7.570645266241627e-08
, O 0 1.6580575074812837e-13
are O 0 3.4542219582431918e-15
coronal B-Disease 0 7.1405854562556215e-09
synostosis I-Disease 0 4.2734805560940003e-07
, O 0 1.1534582967584472e-12
brachycephaly B-Disease 0 1.1933967414279323e-07
, O 0 2.800364384825116e-10
low B-Disease 0 1.7283942725043744e-05
frontal I-Disease 1 0.9999911785125732
hairline I-Disease 1 0.9999998807907104
, O 0 2.1136456780368462e-05
facial B-Disease 1 0.9999531507492065
asymmetry I-Disease 1 0.6657505035400391
, O 0 9.063484895932561e-08
ptosis B-Disease 1 0.9652184247970581
, O 0 5.576545336616334e-10
hypertelorism B-Disease 0 0.0008919502724893391
, O 0 1.1992880466493716e-08
broad B-Disease 0 1.8333485058974475e-05
great I-Disease 0 4.0060372157313395e-06
toes I-Disease 0 0.00669096177443862
, O 0 1.0174871362123028e-11
and O 0 2.7298998131475294e-11
clinodactyly B-Disease 0 1.13634246190486e-06
. O 0 4.2255154236725545e-11

Significant O 0 3.1243063691732686e-10
intra O 0 9.388019250877733e-09
- O 0 9.899929136736318e-05
and O 0 3.2873859190374333e-10
interfamilial O 0 3.222502087396606e-08
phenotypic O 0 2.686871003465541e-10
variability O 0 3.0446771770442638e-09
is O 0 1.9517389074808107e-14
present O 0 1.1725441089941021e-15
for O 0 1.4161228854767387e-16
either O 0 1.9570417335301737e-12
TWIST O 0 4.1261429828409746e-07
mutations O 0 2.1005733685797168e-07
or O 0 6.247739305076383e-12
FGFR O 0 5.579322987614432e-06
mutations O 0 3.3597169135646254e-07
. O 0 3.8787046491295385e-11

The O 0 5.6814775106772686e-11
overlap O 0 2.2302213409375327e-08
in O 0 1.0438113047517295e-12
clinical O 0 3.015872351852522e-08
features O 0 7.763859777298876e-09
and O 0 1.1082228468239919e-09
the O 0 3.548280918218294e-13
presence O 0 6.401761759589064e-11
, O 0 2.0677656635548214e-12
in O 0 1.8994998445247963e-14
the O 0 8.271846783111745e-15
same O 0 4.6113080124114345e-14
genes O 0 1.6053970219170877e-12
, O 0 1.3802144589251096e-15
of O 0 8.89871803997809e-19
mutations O 0 2.8619459233047984e-12
for O 0 1.3844104186090685e-17
more O 0 1.27869135965081e-17
than O 0 4.9074361517824e-15
one O 0 3.697640717920114e-12
craniosynostotic B-Disease 0 1.3256282727525104e-05
condition I-Disease 0 4.3368760316297994e-07
- O 0 4.2737917371749035e-11
such O 0 1.5801262411691518e-14
as O 0 1.0090217507016663e-12
Saethre B-Disease 0 4.865471510129282e-07
- I-Disease 0 4.034126810381622e-09
Chotzen I-Disease 0 7.316238281873666e-09
, I-Disease 0 8.47124359049968e-14
Crouzon I-Disease 0 5.204670028291503e-09
, I-Disease 0 8.979853536109084e-13
and I-Disease 0 1.1222655443843266e-10
Pfeiffer I-Disease 1 0.9967879056930542
syndromes I-Disease 0 0.0010095143225044012
- O 0 6.175679079234442e-09
support O 0 1.0562478490591318e-13
the O 0 1.7070376747002083e-15
hypothesis O 0 9.685324374106297e-13
that O 0 1.6070435929801778e-14
TWIST O 0 3.8092398679800965e-10
and O 0 1.154994936497511e-12
FGFRs O 0 2.97410784888541e-09
are O 0 2.3449061059045446e-15
components O 0 5.140159131666877e-13
of O 0 1.1373920034550322e-16
the O 0 2.2668124210247767e-15
same O 0 7.376608343796255e-15
molecular O 0 3.4102340634549477e-13
pathway O 0 1.539307418509106e-13
involved O 0 1.1706179560720458e-15
in O 0 2.7509732243622233e-16
the O 0 1.8252535103463995e-15
modulation O 0 7.1340260088259555e-12
of O 0 1.3060470131602553e-13
craniofacial O 1 0.6756376624107361
and O 0 1.3683418842447281e-07
limb O 1 0.9932782053947449
development O 0 1.3394848563663686e-09
in O 0 1.0369928657091854e-12
humans O 0 8.05699257311332e-11
. O 0 8.225406846525812e-14
. O 0 3.479699601377506e-12

Mutation O 0 2.4744849724811502e-08
analysis O 0 4.1660952465605305e-11
of O 0 9.29782645190183e-14
UBE3A O 0 0.0018786848522722721
in O 0 9.181607310893014e-06
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 4.932452156936051e-06
. O 0 1.744338874731799e-11

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.739907010138268e-06
AS B-Disease 1 1.0
) O 0 1.0789161231095079e-10
is O 0 6.716048615677817e-13
caused O 0 4.912725608263724e-12
by O 0 8.568794680969063e-14
chromosome O 0 2.0730078176711686e-05
15q11 O 0 3.200786480306306e-08
- O 0 2.0502465503113854e-08
q13 O 0 3.5687638955117507e-10
deletions O 0 9.436684766939152e-10
of O 0 5.3900135223161616e-14
maternal O 0 3.5809915033269135e-09
origin O 0 3.6998239893873755e-14
, O 0 1.7285809624499084e-14
by O 0 1.4684693416225532e-14
paternal O 0 2.282656730301369e-08
uniparental B-Disease 0 7.731297955615446e-05
disomy I-Disease 0 0.00034799546119756997
( O 0 4.337570580492667e-10
UPD B-Disease 1 0.9999996423721313
) O 0 9.274302159578696e-11
15 O 0 1.2588894770376724e-12
, O 0 3.309977329523468e-15
by O 0 5.455023893940992e-15
imprinting O 0 0.0033533701207488775
defects O 1 0.9998912811279297
, O 0 7.2181748425603764e-12
and O 0 2.2675075792705224e-12
by O 0 1.0522939331426666e-14
mutations O 0 4.162810984809084e-09
in O 0 7.214065770536765e-14
the O 0 3.5751626268828995e-13
UBE3A O 0 1.7905338722812303e-07
gene O 0 8.259070760630038e-09
. O 0 1.6062737945299332e-11

UBE3A O 0 3.4439042337908177e-06
encodes O 0 9.01021701693594e-10
a O 0 2.808079506769201e-12
ubiquitin O 0 1.1644607153526998e-11
- O 0 2.829508849444551e-09
protein O 0 2.089800832383304e-10
ligase O 0 2.6740011246917383e-11
and O 0 2.7811272729216796e-10
shows O 0 4.253370633477971e-08
brain O 0 1.8893756532634143e-06
- O 0 6.693095411236527e-09
specific O 0 8.811980550631204e-13
imprinting O 0 1.0366289870944456e-06
. O 0 3.834313422323987e-11

Here O 0 3.110253743443536e-08
we O 0 5.467639188627693e-11
describe O 0 1.1923819570602845e-11
UBE3A O 0 1.1788635134735159e-07
coding O 0 0.0003280264791101217
- O 0 0.0001382549962727353
region O 0 2.300792267817542e-08
mutations O 0 2.4802861986472635e-09
detected O 0 3.7857269402641336e-11
by O 0 1.1326897794576888e-16
SSCP O 0 4.151194943347036e-09
analysis O 0 2.630339956261052e-12
in O 0 1.8018378943832764e-13
13 O 0 2.361376205683996e-09
AS B-Disease 1 0.9999998807907104
individuals O 0 6.564724892160756e-14
or O 0 4.978824210549737e-12
families O 0 1.9350976983995016e-12
. O 0 4.041128542908723e-12

Two O 0 5.9461115142767085e-08
identical O 0 5.596118057837884e-07
de O 0 2.0084870655523446e-08
novo O 0 3.0946317508551147e-08
5 O 0 7.204117944553667e-12
- O 0 1.304764851717266e-09
bp O 0 2.5448232063296494e-11
duplications O 0 1.81081205585798e-10
in O 0 2.711070571596169e-14
exon O 0 2.652161268379416e-10
16 O 0 1.4971440753797083e-10
were O 0 2.8315004963093415e-13
found O 0 4.207266045969105e-12
. O 0 3.961288328607759e-12

Among O 0 2.110062471971652e-11
the O 0 1.6055186965058948e-13
other O 0 3.1182691249010547e-14
11 O 0 4.0731477977777597e-13
unique O 0 2.4203197785392e-15
mutations O 0 1.4309581297666796e-09
, O 0 4.794236297019083e-13
8 O 0 3.740813648428487e-12
were O 0 4.303691395770269e-14
small O 0 8.234071654763045e-14
deletions O 0 1.177366559801385e-08
or O 0 4.7814898741782574e-12
insertions O 0 1.6459439677873888e-07
predicted O 0 3.335221947509126e-07
to O 0 4.381371654371691e-11
cause O 0 2.967533163644731e-10
frameshifts O 0 1.781375249265693e-05
, O 0 1.1282858675132346e-10
1 O 0 1.556654219588005e-12
was O 0 7.714119273916076e-12
a O 0 5.946408035433946e-15
mutation O 0 1.30978713118457e-12
to O 0 1.4403845031245028e-15
a O 0 1.0791691874162141e-14
stop O 0 4.743748449609342e-11
codon O 0 1.837160458484366e-11
, O 0 2.3263659946451583e-14
1 O 0 3.5234658428900468e-15
was O 0 6.101794281431969e-14
a O 0 4.01996585162618e-15
missense O 0 2.2017372369731447e-09
mutation O 0 6.139010411132517e-10
, O 0 7.740748146634058e-13
and O 0 8.880641014230584e-12
1 O 0 1.6952265329342464e-12
was O 0 8.827449188286707e-11
predicted O 0 1.333356480781589e-10
to O 0 4.115393261090207e-14
cause O 0 7.306610557474696e-14
insertion O 0 3.1287160362492017e-12
of O 0 8.517121266615225e-15
an O 0 2.122777214424998e-12
isoleucine O 1 0.861980676651001
in O 0 2.089998313303809e-12
the O 0 3.296169421933802e-14
hect O 0 2.2560102674873406e-09
domain O 0 7.127878582507963e-12
of O 0 4.776703604395514e-16
the O 0 1.7095801499705104e-14
UBE3A O 0 1.3386165509388093e-09
protein O 0 6.423866993898741e-10
, O 0 1.5405233512455485e-13
which O 0 5.295425946019337e-15
functions O 0 3.122119736679273e-14
in O 0 3.7833442331953755e-15
E2 O 0 6.76231709517694e-11
binding O 0 5.42367745767075e-13
and O 0 1.449704004302492e-14
ubiquitin O 0 4.566114196816184e-13
transfer O 0 1.4130417756025304e-12
. O 0 7.445458312382858e-12

Eight O 0 2.2253496267943262e-10
of O 0 3.5289928387499995e-16
the O 0 1.0794161822236335e-14
cases O 0 6.116898979523222e-13
were O 0 7.254875953460749e-12
familial O 0 8.788417176219809e-07
, O 0 8.380907634553125e-10
and O 0 4.4666700893536415e-11
five O 0 5.443253812097149e-13
were O 0 1.7371421954983507e-13
sporadic O 0 4.9202281360294364e-08
. O 0 1.1668714605672648e-10

In O 0 2.7946589487015672e-11
two O 0 3.2091590127479586e-13
familial O 0 2.5506389889073944e-08
cases O 0 3.03969738268961e-10
and O 0 5.831202274514391e-12
one O 0 1.3450505086890635e-13
sporadic O 0 2.5199037523293555e-08
case O 0 1.6900048027679304e-10
, O 0 5.364373496189595e-14
mosaicism O 0 6.809459107692817e-10
for O 0 1.5831361303955726e-15
UBE3A O 0 1.481815914416984e-08
mutations O 0 6.090274951020547e-09
was O 0 9.264926499608084e-12
detected O 0 4.0631156217330044e-09
in O 0 3.994759845181786e-14
the O 0 9.153931085359446e-12
mother O 0 2.8208032176735287e-07
of O 0 1.2548408772372643e-15
three O 0 6.649219508325643e-10
AS B-Disease 1 1.0
sons O 0 5.842090899932373e-08
, O 0 1.9678507955089852e-13
in O 0 1.3748683045993956e-14
the O 0 7.340344830445225e-14
maternal O 0 1.0639557013192302e-09
grandfather O 0 7.952864755633726e-11
of O 0 6.002947643481848e-17
two O 0 6.782671646554661e-12
AS B-Disease 1 1.0
first O 0 6.469297320066403e-11
cousins O 0 6.514799366641455e-08
, O 0 8.796641193242749e-11
and O 0 6.022760068447042e-11
in O 0 5.942059995087123e-13
the O 0 1.8732130430132443e-11
mother O 0 2.0761241614764003e-08
of O 0 3.643291861699189e-17
an O 0 3.2315664900972596e-13
AS B-Disease 1 0.9999998807907104
daughter O 0 0.00035422371001914144
. O 0 1.528671494943623e-10

The O 0 3.79823532651799e-13
frequencies O 0 1.2354542302389637e-12
with O 0 3.902447213034038e-13
which O 0 7.015761669532106e-13
we O 0 1.961440124903513e-12
detected O 0 2.456489525681782e-11
mutations O 0 3.6908431172433254e-11
were O 0 1.1003116549401087e-13
5 O 0 5.836952015475516e-13
( O 0 1.3999917253314318e-14
14 O 0 4.475767412942533e-12
% O 0 2.762498695796394e-16
) O 0 1.9968333745816772e-15
of O 0 6.736511263028574e-17
35 O 0 3.59767840518721e-11
in O 0 1.0236875129315207e-14
sporadic O 0 1.6983992168206896e-07
cases O 0 1.2517473280126978e-08
and O 0 6.203477731503426e-10
8 O 0 1.1885656348020746e-10
( O 0 4.455608025409749e-15
80 O 0 4.632503148443989e-13
% O 0 1.781917610698975e-15
) O 0 1.501722669285631e-14
of O 0 3.3647817376393605e-16
10 O 0 6.125632228022593e-13
in O 0 1.0951228835711594e-14
familial O 0 7.837090088003151e-09
cases O 0 4.668401949736722e-12
. O 0 1.836752185893284e-13
. O 0 3.462155692343649e-12

The O 0 6.177902078796649e-10
hemochromatosis B-Disease 1 0.9999898672103882
845 O 0 1.4575678619621613e-07
G O 0 1.4999945960880723e-06
- O 0 1.4103654244479458e-08
- O 0 1.2176466945845732e-08
> O 0 5.743919662820618e-12
A O 0 1.1114720255278598e-13
and O 0 2.0558949914662936e-14
187 O 0 2.212743009655238e-12
C O 0 1.046867925680317e-08
- O 0 1.0980963693896229e-08
- O 0 9.698842973193678e-08
> O 0 1.332729038239222e-09
G O 0 1.4537199604092166e-06
mutations O 0 1.4949655735563283e-08
: O 0 1.743725064513868e-13
prevalence O 0 7.4473303079969355e-09
in O 0 8.417255065694407e-14
non O 0 1.0745437872827779e-10
- O 0 6.317543920886237e-06
Caucasian O 0 1.1922758858418092e-05
populations O 0 1.3143676369509194e-07
. O 0 1.098899183454849e-11

Hemochromatosis B-Disease 1 0.9764865040779114
, O 0 3.474434606687282e-07
the O 0 1.5833644795293367e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 2.0000611410109226e-12
iron I-Disease 0 0.007787471637129784
metabolism I-Disease 0 0.0004476329777389765
, O 0 7.471409602111123e-11
leads O 0 2.5409953252619744e-08
, O 0 2.53325867227705e-11
if O 0 9.43715217083252e-10
untreated O 0 2.2693598111800384e-08
, O 0 2.593891440749946e-15
to O 0 9.141342197094282e-14
progressive O 0 9.350671348329342e-09
iron B-Disease 0 0.20635443925857544
overload I-Disease 0 0.032879311591386795
and O 0 1.0783534953873186e-08
premature B-Disease 0 6.698267718263651e-09
death I-Disease 0 1.3016452360403719e-09
. O 0 1.5576144540840886e-11

The O 0 2.103045293466721e-09
hemochromatosis B-Disease 1 0.9999974966049194
gene O 0 5.1905073632951826e-05
, O 0 1.9260365871631713e-11
HFE O 0 4.320394054957433e-06
, O 0 1.472516830691717e-10
recently O 0 4.0042696269892986e-08
has O 0 2.824799838485603e-10
been O 0 3.5819063643957594e-13
identified O 0 3.575341628661577e-12
, O 0 4.494171826135637e-14
and O 0 2.8116140600616124e-14
characterization O 0 4.120803698270947e-11
of O 0 5.216286969543098e-17
this O 0 1.993478150022661e-14
gene O 0 2.9454296779363176e-09
has O 0 2.174296992452085e-10
shown O 0 1.4698270812268932e-12
that O 0 3.7164607329109867e-13
it O 0 6.14986468867873e-13
contains O 0 2.8835167218375923e-13
two O 0 1.2174886749802272e-12
mutations O 0 2.5792372682076348e-09
that O 0 1.6343058633835894e-12
result O 0 6.23138368162357e-13
in O 0 2.2661466531282348e-15
amino O 0 4.203245282212442e-13
acid O 0 2.201798788323099e-14
substitutions O 0 4.932265652081739e-15
- O 0 1.865282884747077e-12
cDNA O 0 2.3841590594125828e-12
nucleotides O 0 5.016387695858104e-13
845 O 0 5.70645039468104e-13
G O 0 1.0822968077306427e-09
- O 0 1.226494239503495e-09
- O 0 5.027027127901817e-10
> O 0 1.022681505452594e-12
A O 0 8.344013820811222e-14
( O 0 2.3953625880230624e-16
C282Y O 0 2.2719049948619063e-13
) O 0 1.2750388278507963e-16
and O 0 1.3398487861863507e-15
187 O 0 6.909231758771284e-13
C O 0 7.092737508429536e-09
- O 0 1.8727265072016053e-08
- O 0 1.8756867348201922e-07
> O 0 1.8847000349264675e-10
G O 0 1.0814142470394472e-08
( O 0 6.8720045590955035e-15
H63D O 0 5.172454686785954e-10
) O 0 1.3943960732159394e-13
. O 0 7.342896906833984e-13

Although O 0 2.5501068989797204e-07
hemochromatosis B-Disease 1 0.9999998807907104
is O 0 1.5758586102698757e-10
common O 0 5.499963548830089e-13
in O 0 9.209906126042729e-15
Caucasians O 0 6.3754113099889764e-09
, O 0 1.4927563850818115e-13
affecting O 0 7.024471976313507e-11
> O 0 3.303325668557733e-10
= O 0 1.3792115005628602e-08
1 O 0 8.223352283408952e-14
/ O 0 7.764285325784215e-10
300 O 0 3.324935719613742e-15
individuals O 0 1.38285407828655e-16
of O 0 1.4902336361500597e-16
northern O 0 2.3110726488084765e-06
European O 0 1.5620101878610626e-09
origin O 0 8.24271410133047e-14
, O 0 2.6146375646171616e-13
it O 0 1.890628062092836e-12
has O 0 3.169065357355727e-11
not O 0 2.1427996096251567e-12
been O 0 3.5454194376345616e-13
recognized O 0 3.634591695130364e-15
in O 0 1.3369641096053577e-15
other O 0 2.5377327328305124e-14
populations O 0 1.669892002453821e-10
. O 0 3.109654244173865e-12

The O 0 5.126180729897456e-12
present O 0 5.695505865028908e-15
study O 0 1.163841057219301e-15
used O 0 2.1824684800272193e-15
PCR O 0 1.3958064704056028e-09
and O 0 2.328800130166342e-13
restriction O 0 6.08683173308755e-11
- O 0 5.182151929794543e-10
enzyme O 0 5.0610015310537104e-12
digestion O 0 1.3630058887104113e-11
to O 0 2.2857057026715207e-16
analyze O 0 4.5207867871844935e-15
the O 0 4.9072625497328826e-17
frequency O 0 5.8126937203144876e-15
of O 0 9.154304441547788e-18
the O 0 9.425072188161345e-16
845 O 0 6.200463861967542e-13
G O 0 1.9935741946142116e-09
- O 0 4.236983333627542e-11
- O 0 6.058015200594014e-11
> O 0 1.9219832160261713e-13
A O 0 3.755859284606394e-14
and O 0 1.2417038832692948e-14
187 O 0 6.264691998665584e-13
C O 0 9.38309319131747e-10
- O 0 1.3965248402136865e-10
- O 0 7.041538463425923e-10
> O 0 8.748396972124706e-12
G O 0 6.134527330559081e-10
mutations O 0 4.308492364962779e-12
in O 0 9.106248986814826e-16
HLA O 0 4.799259212262541e-09
- O 0 1.2144818484216557e-10
typed O 0 3.3866687232375625e-11
samples O 0 1.050217746968729e-12
from O 0 6.412349768880883e-17
non O 0 2.554308218931378e-13
- O 0 4.153224608671735e-08
Caucasian O 0 1.7635928770687315e-06
populations O 0 1.7764062221203858e-08
, O 0 9.56327980130775e-15
comprising O 0 6.939178083461032e-15
Australian O 0 1.5928916172192054e-12
Aboriginal O 0 2.383553153028489e-13
, O 0 1.6971488826783695e-15
Chinese O 0 1.4990040323381235e-14
, O 0 5.602886200378439e-15
and O 0 2.9587850182075104e-13
Pacific O 0 6.984418599031983e-11
Islanders O 0 8.188696248856431e-11
. O 0 1.481953394635166e-13

Results O 0 6.588055612155586e-07
showed O 0 4.835661870927765e-10
that O 0 1.6699457843025872e-14
the O 0 4.237176863037704e-15
845 O 0 3.288356392738834e-11
G O 0 4.764748240404515e-08
- O 0 1.6617525133710842e-09
- O 0 4.0998340833375835e-10
> O 0 6.152070497998652e-13
A O 0 9.602857246361618e-14
mutation O 0 5.029668521949748e-12
was O 0 1.3930756504951236e-12
present O 0 1.4383530004796318e-15
in O 0 5.601368740853433e-15
these O 0 9.699179461431125e-15
populations O 0 2.3993171815658854e-13
( O 0 7.295497256243126e-18
allele O 0 1.1384212808348442e-15
frequency O 0 1.1023660825316972e-13
0 O 0 1.4819590866965715e-13
. O 0 6.042143828418245e-16
32 O 0 6.371396059400361e-14
% O 0 5.2276213291685446e-17
) O 0 2.067699539080761e-15
, O 0 2.5837128660513575e-13
and O 0 4.787497134839391e-11
, O 0 1.5298601144589363e-12
furthermore O 0 2.1872777894449413e-11
, O 0 7.212625136900075e-13
it O 0 9.172859520567567e-12
was O 0 1.2641439006699784e-09
always O 0 7.838966281648041e-11
seen O 0 4.4489122130210446e-13
in O 0 9.101764741452503e-17
conjunction O 0 6.971175600076511e-15
with O 0 3.959758410922165e-14
HLA O 0 5.723468916585261e-07
haplotypes O 0 1.2228976054018403e-08
common O 0 1.729906322356367e-11
in O 0 3.460112310061693e-14
Caucasians O 0 7.002163293634567e-10
, O 0 7.491371990786793e-15
suggesting O 0 1.0146140790598737e-13
that O 0 1.5426279231876144e-14
845 O 0 4.2141646075521955e-12
G O 0 4.4090423756415476e-08
- O 0 5.346837195219223e-09
- O 0 7.567162008115247e-09
> O 0 9.393469509177965e-12
A O 0 2.2524048598482338e-11
may O 0 1.721562128964571e-11
have O 0 2.782820902966915e-13
been O 0 2.8393316886012043e-13
introduced O 0 6.274749600118645e-13
into O 0 4.044070037612785e-14
these O 0 8.671897055968162e-15
populations O 0 8.242938666705446e-13
by O 0 2.6301603327601912e-15
Caucasian O 0 8.597236700325084e-09
admixture O 0 7.284407299579243e-09
. O 0 9.930496702725833e-11

187 O 0 5.866933605602753e-09
C O 0 1.122428102462436e-06
- O 0 5.4541175131817e-08
- O 0 1.4194742448125908e-07
> O 0 2.545562372002763e-10
G O 0 3.292748473882057e-08
was O 0 4.562039765051984e-13
present O 0 1.520298276519463e-16
at O 0 6.151404196471353e-16
an O 0 6.647768824692533e-19
allele O 0 4.785150005187297e-15
frequency O 0 5.928226659568381e-13
of O 0 7.403699845581237e-15
2 O 0 3.1355296137292044e-10
. O 0 3.3504452684463004e-11

68 O 0 1.5118979717954062e-05
% O 0 1.3275895140163474e-12
in O 0 1.4123074996812146e-14
the O 0 1.8285797409676313e-13
two O 0 1.000033931532196e-12
populations O 0 1.0687042223400667e-10
analyzed O 0 9.112632176622171e-11
( O 0 1.4698649131064494e-14
Australian O 0 1.6291661075751307e-10
Aboriginal O 0 2.8049990108414136e-10
and O 0 1.0454376947466315e-11
Chinese O 0 5.2701228797635835e-12
) O 0 1.3179762186135702e-13
. O 0 5.375232594098667e-13

In O 0 1.3687289149300064e-12
the O 0 4.246726397188344e-14
Australian O 0 5.717748323419425e-13
Aboriginal O 0 4.922327736384124e-13
samples O 0 1.2866842465618367e-13
, O 0 1.13888542842016e-16
187 O 0 7.86945446415617e-14
C O 0 5.456047280638643e-10
- O 0 1.4009595705744005e-09
- O 0 5.979842399028712e-09
> O 0 1.7335924362704702e-11
G O 0 2.1371874936448876e-08
was O 0 1.5350803310790195e-12
found O 0 5.3310905223733634e-14
to O 0 2.8342101462372786e-15
be O 0 3.3431992322642025e-15
associated O 0 5.965985084427361e-14
with O 0 2.560809467852098e-14
HLA O 0 5.439133474283153e-06
haplotypes O 0 1.93562197381425e-08
common O 0 2.3327947212825606e-11
in O 0 8.155079394981182e-14
Caucasians O 0 1.420408146657337e-08
, O 0 7.74517873881192e-13
suggesting O 0 1.7625860840309038e-11
that O 0 2.100993424375419e-12
it O 0 2.531460284449505e-12
was O 0 8.605339748071761e-13
introduced O 0 1.3591279760438637e-14
by O 0 4.125527173859069e-16
recent O 0 1.872215490278384e-12
admixture O 0 3.828091621471685e-09
. O 0 1.1514855041694361e-10

In O 0 1.562050315484509e-11
the O 0 9.07293717152674e-14
Chinese O 0 3.729325469313885e-14
samples O 0 2.4161803200556387e-13
analyzed O 0 4.797599356632862e-14
, O 0 2.0729819806469737e-16
187 O 0 1.3521060898517845e-13
C O 0 4.90312623835365e-10
- O 0 2.971174972721258e-10
- O 0 2.130023935009717e-09
> O 0 1.9527473388292194e-11
G O 0 1.0703989516969159e-07
was O 0 2.0542215151131415e-10
present O 0 6.914897121698335e-14
in O 0 8.201078705027953e-14
association O 0 2.9775778840983574e-15
with O 0 3.827473802714377e-15
a O 0 1.212669830004398e-13
wide O 0 3.906246853757622e-12
variety O 0 1.0316898160431243e-12
of O 0 7.677425318750042e-15
HLA O 0 1.0213296263827942e-05
haplotypes O 0 7.26146254237392e-09
, O 0 1.582334659350551e-13
showing O 0 1.0002552171956003e-12
this O 0 1.3658424273925722e-15
mutation O 0 2.814373083540045e-13
to O 0 7.109646428711276e-15
be O 0 1.3310134278651884e-14
widespread O 0 1.8125578078384552e-13
and O 0 2.0437788961213954e-10
likely O 0 9.017979071823667e-12
to O 0 1.8608212708345548e-14
predate O 0 8.047827404489283e-10
the O 0 4.653095874644457e-15
more O 0 6.845337129649521e-17
genetically O 0 2.617687750589015e-12
restricted O 0 6.9579684895682e-12
845 O 0 6.37788571955511e-11
G O 0 2.1097855551488465e-06
- O 0 8.602768275522976e-08
- O 0 4.5387910319050206e-08
> O 0 1.3491165649914816e-11
A O 0 8.950799628391903e-13
mutation O 0 2.2047565162441884e-11
. O 0 2.1761025869714706e-13

Genotype O 0 1.435080139344791e-05
- O 0 0.0006838157423771918
phenotype O 0 4.93542165713734e-06
correlations O 0 3.7527991025854135e-07
in O 0 4.575134993078933e-10
attenuated B-Disease 1 0.9968094229698181
adenomatous I-Disease 1 0.9999984502792358
polyposis I-Disease 1 0.9999741315841675
coli I-Disease 1 0.9999988079071045
. O 0 1.5588003066113743e-07

Germ O 0 0.02327181026339531
- O 0 0.01649070344865322
line O 0 2.6048933250422124e-06
mutations O 0 2.6309809886271296e-09
of O 0 4.4395220227084423e-16
the O 0 2.5572656514073755e-14
tumor B-Disease 0 8.728505695998479e-10
suppressor O 0 3.8635189492097766e-10
APC O 0 1.326213999730541e-10
are O 0 1.2130307338025642e-13
implicated O 0 1.5540074782549596e-09
in O 0 5.344051312583531e-10
attenuated B-Disease 1 0.999963641166687
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999969005584717
coli I-Disease 1 1.0
( O 0 9.488308023719583e-07
AAPC B-Disease 1 0.9999995231628418
) O 0 4.103673303945676e-11
, O 0 1.217590346038952e-13
a O 0 2.0134259114557712e-13
variant O 0 7.872149581089616e-06
of O 0 4.899127326041253e-09
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999920129776001
polyposis I-Disease 1 0.9999997615814209
( O 0 2.203762283770061e-09
FAP B-Disease 0 1.852908297905742e-07
) O 0 3.486969740729151e-11
. O 0 2.2346933331585106e-11

AAPC B-Disease 1 0.9999898672103882
is O 0 6.771729843535468e-10
recognized O 0 7.685693037941602e-14
by O 0 8.005639786141006e-16
the O 0 1.9246481680254817e-15
occurrence O 0 4.238123046951259e-11
of O 0 5.900785146828935e-15
< O 0 1.1568867641642555e-08
100 O 0 1.2514105420316501e-12
colonic B-Disease 0 9.018879154609749e-07
adenomas I-Disease 0 1.1597720686040702e-06
and O 0 5.985632822724796e-11
a O 0 8.621998514452001e-13
later O 0 1.8196417705951262e-09
onset O 0 3.6510275549517246e-06
of O 0 2.2123591847389434e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.8323584717069323e-11
age O 0 8.159821429654102e-11
> O 0 1.3919448059451778e-11
40 O 0 3.53387839824304e-11
years O 0 3.6164157063943436e-13
) O 0 1.3841518534639385e-13
. O 0 1.0333993860286994e-12

The O 0 4.1431542224801277e-11
aim O 0 4.345981907682983e-11
of O 0 1.5731719259716486e-16
this O 0 1.5662924567229472e-15
study O 0 7.307290555524752e-15
was O 0 3.6705417215876154e-14
to O 0 3.715152998743721e-15
assess O 0 1.1373253901159064e-11
genotype O 0 1.516277034485647e-11
- O 0 9.641775733371105e-08
phenotype O 0 9.988808002958649e-09
correlations O 0 3.7064515900908646e-09
in O 0 3.651541846672046e-10
AAPC B-Disease 1 0.9999996423721313
families O 0 3.2934124316597035e-09
. O 0 2.7531428525850998e-11

By O 0 2.0198968365969794e-12
protein O 0 4.219799232263455e-10
- O 0 1.0750553336436042e-08
truncation O 0 9.4295023700397e-07
test O 0 1.0148976770096851e-07
( O 0 1.492413184272243e-15
PTT O 0 5.115056381926886e-12
) O 0 7.228879339168882e-16
assay O 0 4.55060082226854e-14
, O 0 2.1481396111035418e-16
the O 0 8.554296907395506e-17
entire O 0 2.903926827734632e-13
coding O 0 7.263807333401928e-08
region O 0 1.8823064634743147e-11
of O 0 5.867759861611082e-17
the O 0 1.5847192349739908e-15
APC B-Disease 0 5.841399412787052e-12
gene O 0 2.8847091382289136e-10
was O 0 2.1030271274424805e-11
screened O 0 4.230761518897452e-09
in O 0 5.671053633204276e-14
affected O 0 5.0894257558331546e-11
individuals O 0 3.706419242024582e-15
from O 0 1.152782432229174e-13
11 O 0 5.799046576271394e-09
AAPC B-Disease 1 0.9999997615814209
kindreds O 0 5.767661423305981e-05
, O 0 5.61198865156598e-11
and O 0 2.8102442248267856e-12
their O 0 6.8282354020955584e-15
phenotypic O 0 1.3553504672747518e-11
differences O 0 7.242840771581882e-10
were O 0 2.0276447187939084e-11
examined O 0 2.5310697537861415e-08
. O 0 1.1660053131357095e-11

Five O 0 4.1362080427376213e-10
novel O 0 7.048495120898224e-11
germ O 0 3.3804790291469544e-05
- O 0 0.0001848432293627411
line O 0 8.463256335744518e-07
APC B-Disease 0 7.308381677617604e-10
mutations O 0 1.4953847937704268e-08
were O 0 4.3283239947906893e-13
identified O 0 1.106952515761428e-10
in O 0 3.478794943084784e-13
seven O 0 6.32841001824147e-11
kindreds O 0 1.658609471633099e-05
. O 0 6.675329733418778e-11

Mutations O 0 4.123051985516213e-05
were O 0 4.522124341654887e-11
located O 0 1.7704096869075592e-11
in O 0 1.3987994248142177e-13
three O 0 4.2170089577416026e-13
different O 0 3.5276487033418253e-15
regions O 0 8.101028528550991e-12
of O 0 1.7360232745041484e-16
the O 0 1.0023492283308798e-14
APC B-Disease 0 2.414025576658041e-12
gene O 0 1.5504472705707428e-11
( O 0 1.0846287594535654e-15
1 O 0 7.930294299658604e-15
) O 0 8.343086489140568e-15
at O 0 2.0231201696557788e-12
the O 0 5.711849450449474e-14
5 O 0 2.3962826514734026e-11
end O 0 7.0916848782243136e-12
spanning O 0 3.2769797292386826e-11
exons O 0 4.278602006024812e-08
4 O 0 2.410223409743395e-10
and O 0 2.5008195167486313e-11
5 O 0 1.189485250747968e-12
, O 0 1.2155065094634349e-13
( O 0 1.8669135553076813e-15
2 O 0 5.2939338974827485e-14
) O 0 9.381202234240676e-16
within O 0 1.3267571508327066e-15
exon O 0 4.0991363081666066e-11
9 O 0 1.5688237375854897e-09
, O 0 7.078167804479285e-13
and O 0 2.6677963657628645e-11
( O 0 2.5185076260266816e-14
3 O 0 5.947922276233752e-13
) O 0 2.1808923211189685e-14
at O 0 1.4668388031990887e-12
the O 0 1.3981211377707154e-14
3 O 0 2.460680530863568e-12
distal O 0 4.687802576675004e-11
end O 0 1.57764190600318e-10
of O 0 3.7572668945460533e-16
the O 0 5.396154511183755e-14
gene O 0 3.8470546193103416e-10
. O 0 3.098629859643598e-12

Variability O 0 5.967543984297663e-06
in O 0 4.778615112117912e-13
the O 0 5.47115724578405e-14
number O 0 8.579744553705027e-12
of O 0 2.7093338683670254e-10
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 2.151305125153158e-06
most O 0 1.3486932924633432e-13
apparent O 0 1.2662325181433953e-11
in O 0 7.330313249844303e-14
individuals O 0 3.5458622410483977e-15
with O 0 8.982593857100041e-13
mutations O 0 2.1229965341262869e-07
in O 0 3.738495624183713e-12
region O 0 8.642696336380595e-09
1 O 0 4.0846818982753774e-11
, O 0 3.8768630666874415e-11
and O 0 6.174170952277791e-09
upper O 0 0.05329088494181633
- O 1 0.9952374696731567
gastrointestinal O 0 0.329036682844162
manifestations O 0 2.823418476793904e-08
were O 0 1.5920327556262492e-11
more O 0 6.507763620523799e-14
severe O 0 8.799804440684511e-09
in O 0 1.61413769720134e-13
them O 0 3.1685986300045155e-12
. O 0 1.0788662498095736e-11

In O 0 5.7110375456526086e-12
individuals O 0 1.2557704747210522e-14
with O 0 3.847694461222434e-13
mutations O 0 2.2505272312400848e-08
in O 0 3.3046818320031646e-13
either O 0 1.1896685858658884e-09
region O 0 3.444365859195386e-08
2 O 0 4.0959963198972105e-10
or O 0 3.26417920470945e-11
region O 0 5.1288386870851355e-09
3 O 0 1.939558583186063e-11
, O 0 6.100842487449798e-13
the O 0 1.0008935175077286e-14
average O 0 5.681233478452286e-13
number O 0 2.1212612016322657e-14
of O 0 8.542073163175443e-16
adenomas B-Disease 0 1.334463632929328e-07
tended O 0 7.317168524423323e-07
to O 0 2.2318646930585828e-11
be O 0 2.2978713116322824e-12
lower O 0 3.40759582009853e-12
than O 0 4.035057336003456e-13
those O 0 5.284450855418468e-14
in O 0 1.9570584437961572e-14
individuals O 0 4.396445103384641e-16
with O 0 1.561914524583416e-13
mutations O 0 4.6062236691568614e-08
in O 0 8.315927699058256e-13
region O 0 4.172691969728248e-09
1 O 0 1.1235136085363528e-11
, O 0 4.995677265959286e-13
although O 0 3.497847497757611e-11
age O 0 3.594679241769594e-12
at O 0 1.3257018096138329e-12
diagnosis O 0 1.6929995183545543e-07
was O 0 7.582924631092947e-13
similar O 0 5.363987249165647e-13
. O 0 2.031806667357472e-11

In O 0 5.91995286125524e-10
all O 0 8.109447002802028e-10
AAPC B-Disease 1 0.9999926090240479
kindreds O 0 0.00014748000830877572
, O 0 1.8989694799270707e-12
a O 0 1.1790753682921432e-14
predominance O 0 3.7312686274049156e-10
of O 0 3.4545416115368266e-13
right O 0 0.003544954815879464
- O 1 0.9999901056289673
sided O 1 0.9999991655349731
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 2.1626168745569885e-05
rectal B-Disease 1 0.9916701316833496
polyp I-Disease 0 3.968344390159473e-05
sparing O 0 3.387071179083989e-10
was O 0 2.457081205164968e-10
observed O 0 1.718226672053902e-10
. O 0 7.264222643549312e-12

No O 0 2.9617927793879062e-05
desmoid B-Disease 1 0.9970390796661377
tumors I-Disease 1 1.0
were O 0 8.366843928797607e-08
found O 0 2.2319979198215378e-10
in O 0 1.2138802062047066e-13
these O 0 3.0362984262261028e-12
kindreds O 0 0.0001179150422103703
. O 0 6.214393583059419e-11

Our O 0 1.1437020080995453e-10
data O 0 2.975470347540976e-12
suggest O 0 6.295588182714251e-12
that O 0 6.457627943663724e-13
, O 0 1.0114959000592783e-12
in O 0 6.952145456540215e-12
AAPC B-Disease 1 1.0
families O 0 5.211677964189754e-11
, O 0 4.791086435598129e-15
the O 0 4.373893512908485e-17
location O 0 7.517688186374494e-13
of O 0 1.1767197431960494e-16
the O 0 1.0470889156817889e-13
APC B-Disease 0 6.178744627050037e-08
mutation O 0 1.9662654437979654e-07
may O 0 2.523143083354995e-10
partially O 0 8.184223077023489e-09
predict O 0 9.632460801212162e-11
specific O 0 3.5431821864516377e-13
phenotypic O 0 1.384571901574816e-09
expression O 0 4.41520064953238e-09
. O 0 9.463648753538223e-10

This O 0 5.721692564186753e-11
should O 0 5.8169424138609926e-11
help O 0 4.864263898900385e-14
in O 0 3.3956251189246457e-16
the O 0 1.996071680203859e-15
design O 0 2.6291288590662987e-10
of O 0 5.588179167315263e-15
tailored O 0 1.1401569963709335e-06
clinical O 0 1.2372544006211683e-05
- O 0 4.3517761696421076e-06
management O 0 1.0849915410560129e-10
protocols O 0 1.4498555134245805e-11
in O 0 9.983419366332434e-16
this O 0 1.858953430836961e-16
subset O 0 6.042302617449702e-13
of O 0 1.4921798266952745e-15
FAP B-Disease 0 1.0767011282553085e-08
patients O 0 8.224634862052937e-11
. O 0 4.127782642603106e-14
. O 0 4.6597907824019735e-12

Wilms B-Disease 0 0.15897957980632782
' I-Disease 0 3.994047801825218e-06
tumor I-Disease 0 0.0010316206607967615
1 O 0 2.049970748707608e-10
and O 0 3.700346695723056e-10
Dax O 0 0.047855596989393234
- O 0 3.147319205254462e-07
1 O 0 1.544578592631296e-12
modulate O 0 1.583683878481068e-10
the O 0 7.997559049472552e-14
orphan O 0 5.864757290918732e-11
nuclear O 0 3.396514666742512e-11
receptor O 0 7.785776689160639e-13
SF O 0 3.169518822687678e-05
- O 0 2.604565452202223e-07
1 O 0 5.39881344924914e-13
in O 0 1.6700724157282017e-15
sex O 0 6.603511140679252e-12
- O 0 5.9771532341657e-12
specific O 0 1.4517738140124026e-14
gene O 0 2.710009647244327e-11
expression O 0 1.861430280747367e-12
. O 0 5.972500597382913e-13

Products O 0 2.9704965154309093e-09
of O 0 2.2925238096771494e-14
steroidogenic O 0 6.160762922036156e-08
factor O 0 1.2577866526086723e-10
1 O 0 2.8098369984908e-12
( O 0 1.6013624074776717e-13
SF O 1 0.6753109693527222
- O 0 3.891637607011944e-05
1 O 0 5.7148216714431044e-11
) O 0 6.199257687050652e-13
and O 0 4.1344629109207887e-11
Wilms B-Disease 0 6.794936780352145e-05
tumor I-Disease 0 1.9554136088117957e-05
1 O 0 1.5644347796384128e-12
( O 0 2.298394933847748e-14
WT1 O 0 2.573125890137362e-08
) O 0 5.90583219264515e-14
genes O 0 2.647528897503637e-12
are O 0 9.758777758391121e-16
essential O 0 5.700005304044723e-15
for O 0 1.096768965049206e-16
mammalian O 0 4.302522314120205e-12
gonadogenesis O 0 6.796262996822122e-10
prior O 0 7.639552781612408e-14
to O 0 2.4753082680903545e-14
sexual O 0 2.2952694432587517e-12
differentiation O 0 7.154882797344442e-10
. O 0 9.045649645988973e-11

In O 0 9.296364893163211e-12
males O 0 7.660177180068839e-12
, O 0 2.4542496940976877e-12
SF O 1 0.9711391925811768
- O 0 0.00023256639542523772
1 O 0 3.2822342066474164e-11
participates O 0 9.266128662976936e-12
in O 0 1.7704213746069786e-13
sexual O 0 9.143874893369208e-13
development O 0 2.9373364075654896e-15
by O 0 3.212484287280751e-17
regulating O 0 2.6686450358553993e-12
expression O 0 4.1382771775316796e-13
of O 0 9.794202926176562e-17
the O 0 5.328071696949349e-14
polypeptide O 0 1.1943846800477331e-08
hormone O 0 3.9275466559574035e-12
Mullerian O 0 1.609946065350698e-10
inhibiting O 0 8.284432168048639e-11
substance O 0 6.797326035368201e-10
( O 0 2.213826723936746e-13
MIS O 0 9.109505299420562e-06
) O 0 4.2434737906708875e-13
. O 0 1.4731754227961802e-12

Here O 0 9.931151012665396e-09
, O 0 3.971759553189624e-12
we O 0 3.74538291006421e-12
show O 0 2.294131464658511e-12
that O 0 7.303893953406262e-14
WT1 O 0 5.833873046867666e-07
- O 0 3.0450213017729766e-08
KTS O 0 6.554259357471892e-08
isoforms O 0 4.4259773797350466e-12
associate O 0 1.7468559584954413e-11
and O 0 9.23034638631269e-14
synergize O 0 2.457224290708382e-08
with O 0 3.347615587512287e-11
SF O 1 0.99683678150177
- O 0 0.0006060334853827953
1 O 0 1.7405775432077775e-10
to O 0 1.933998100556167e-12
promote O 0 4.841990697279641e-11
MIS O 0 6.445118197007105e-05
expression O 0 3.644401100344474e-11
. O 0 2.6749945574583434e-12

In O 0 2.175071581178578e-11
contrast O 0 4.834976863321572e-11
, O 0 2.7003336632719366e-12
WT1 O 0 5.2561572374543175e-06
missense O 0 1.3672126897290582e-06
mutations O 0 1.8748370393950609e-06
, O 0 2.310730003608069e-13
associated O 0 6.641303826326883e-12
with O 0 3.613833884918982e-11
male B-Disease 0 2.1608045699395007e-06
pseudohermaphroditism I-Disease 1 1.0
in O 0 6.266272833954645e-08
Denys B-Disease 1 0.9999957084655762
- I-Disease 1 0.999995231628418
Drash I-Disease 1 0.9999769926071167
syndrome I-Disease 1 0.9999985694885254
, O 0 2.7631171656272713e-11
fail O 0 4.213873250336064e-09
to O 0 7.851643732967664e-14
synergize O 0 1.1875696372953826e-06
with O 0 4.774241002536428e-10
SF O 1 0.9998346567153931
- O 0 0.0008110664202831686
1 O 0 6.647216110877707e-10
. O 0 2.1721653989392742e-11

Additionally O 0 3.2283449247216822e-09
, O 0 2.4394830773488696e-12
the O 0 2.846912701241766e-13
X O 0 0.000659689016174525
- O 0 1.83932866093528e-06
linked O 0 5.121837602928281e-07
, O 0 1.987302331160276e-13
candidate O 0 2.551576300507258e-13
dosage O 0 1.4709048215544307e-11
- O 0 2.900153424703622e-12
sensitive O 0 4.482407500727703e-11
sex O 0 6.427209459092253e-11
- O 0 2.4658027356072587e-11
reversal O 0 1.879571802018698e-12
gene O 0 1.178407198210163e-11
, O 0 2.470120191288422e-14
Dax O 0 5.464779633257422e-07
- O 0 2.0015336055223543e-09
1 O 0 1.635942358142739e-13
, O 0 1.3602120088097597e-14
antagonizes O 0 6.652390860395485e-10
synergy O 0 3.925112838920608e-12
between O 0 2.1686454715341696e-12
SF O 0 0.18276004493236542
- O 0 3.4958100059157005e-06
1 O 0 9.103212107730574e-12
and O 0 6.274223219963904e-13
WT1 O 0 1.4259864400401057e-08
, O 0 9.077022580837937e-14
most O 0 1.4796923375912595e-15
likely O 0 1.2860905103471293e-13
through O 0 2.6346981000168693e-16
a O 0 5.533172847720568e-16
direct O 0 3.814204946892344e-14
interaction O 0 1.6839570102927803e-12
with O 0 1.9379870971891755e-11
SF O 1 0.999647855758667
- O 0 0.000142242934089154
1 O 0 2.6486426940586227e-10
. O 0 6.385356653149099e-12

We O 0 1.1883327655226594e-09
propose O 0 3.777410675920301e-11
that O 0 2.120517981043027e-13
WT1 O 0 4.3748860889536445e-07
and O 0 4.218214111340046e-10
Dax O 0 0.0004709907225333154
- O 0 1.0545799966621416e-07
1 O 0 1.0685029250279143e-13
functionally O 0 9.33235368323626e-13
oppose O 0 1.408179996220671e-12
each O 0 8.516406370807743e-15
other O 0 5.589245158279382e-15
in O 0 2.0172160112002374e-13
testis O 0 3.250482052408188e-07
development O 0 2.1390773538316338e-14
by O 0 1.1393293001543008e-15
modulating O 0 3.450049690378876e-10
SF O 0 0.3968895375728607
- O 0 3.798716079472797e-06
1 O 0 1.5772629036181485e-10
- O 0 3.316491969940216e-08
mediated O 0 3.0623124036566196e-09
transactivation O 0 2.4369674278545972e-08
. O 0 1.9436125885813338e-12
. O 0 3.354587007481369e-12

A O 0 2.6532792629652135e-10
mouse O 0 5.713217632319356e-08
model O 0 2.5597916675224042e-08
for O 0 1.4587470120730472e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999997615814209
imprinting O 0 0.01500924862921238
- O 0 0.032033808529376984
centre O 0 7.427667242154712e-06
mutations O 0 4.8958138876287194e-08
. O 0 6.172866471448879e-12

Imprinting O 0 3.6431981698115123e-06
in O 0 2.9828006384291506e-12
the O 0 1.0003600595456796e-12
15q11 O 0 1.143805672398912e-08
- O 0 3.964863992678147e-08
q13 O 0 1.3226326700532809e-09
region O 0 4.6907608006185875e-12
involves O 0 6.349304762509611e-14
an O 0 2.3265411610586505e-16
imprinting O 0 8.616036240027825e-08
centre O 0 3.301817130818563e-08
( O 0 2.1397248681681623e-15
IC O 0 1.0487464846206662e-12
) O 0 5.797546230118739e-15
, O 0 2.092024843018247e-15
mapping O 0 2.435234089034899e-12
in O 0 8.978867725283751e-15
part O 0 1.4855589089597665e-13
to O 0 1.7423619513325106e-13
the O 0 1.989147185860055e-15
promoter O 0 2.250902797484855e-10
and O 0 1.2235694228646121e-12
first O 0 1.252259269044799e-14
exon O 0 1.6954441323102643e-11
of O 0 8.851377069447539e-14
SNRPN O 0 0.00017508355085738003
. O 0 1.3520720654192075e-10

Deletion O 0 2.2168541136124986e-07
of O 0 5.025559300848338e-14
this O 0 1.2147486521448675e-13
IC O 0 1.942715099900738e-09
abolishes O 0 1.0842938280575254e-07
local O 0 8.340076025625809e-12
paternally O 0 6.425766585493875e-10
derived O 0 3.7333607342746045e-14
gene O 0 7.952045966153065e-11
expression O 0 7.821473503588638e-12
and O 0 9.123136274213905e-11
results O 0 2.822867495311243e-09
in O 0 4.3717452058444906e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 7.934429779865582e-10
PWS B-Disease 1 0.999997615814209
) O 0 8.95166302194994e-11
. O 0 1.543395619640897e-11

We O 0 5.73575789530878e-07
have O 0 9.885396537803737e-13
created O 0 2.8770981772138424e-14
two O 0 6.11900802379925e-14
deletion O 0 1.8896610942675807e-09
mutations O 0 1.1965553881054802e-08
in O 0 5.385474509921051e-13
mice O 0 6.962002953514457e-05
to O 0 1.4701931339011765e-10
understand O 0 1.950911752146567e-07
PWS B-Disease 1 1.0
and O 0 1.8495770470750017e-09
the O 0 2.019605728313667e-14
mechanism O 0 4.0901196275353047e-13
of O 0 8.348390642543499e-18
this O 0 5.488273748768986e-15
IC O 0 4.731452452055862e-10
. O 0 4.0479715933405824e-12

Mice O 0 8.133948722388595e-05
harbouring O 0 1.6491643606286743e-08
an O 0 5.068184031633248e-14
intragenic O 0 3.087015443270502e-07
deletion O 0 4.0107315726345405e-06
in O 0 6.938712625303989e-12
Snrpn O 0 0.0006304678390733898
are O 0 3.849113302395457e-12
phenotypically O 0 1.0841858966159634e-08
normal O 0 1.6369194888454786e-09
, O 0 4.398655647618738e-14
suggesting O 0 2.423418453759152e-12
that O 0 1.2774336981009188e-13
mutations O 0 1.9993652566885345e-10
of O 0 2.32063787081188e-16
SNRPN O 0 8.986006037048355e-07
are O 0 2.521521199846423e-14
not O 0 7.317740570401618e-14
sufficient O 0 1.3315136855238368e-14
to O 0 2.436422374615943e-13
induce O 0 4.502602379830023e-08
PWS B-Disease 1 0.9999985694885254
. O 0 4.265822806104325e-09

Mice O 0 0.0005338602350093424
with O 0 7.399299001200482e-14
a O 0 6.3257424234993646e-15
larger O 0 4.379660086743613e-14
deletion O 0 9.147220758620733e-10
involving O 0 2.5634264676221985e-12
both O 0 1.1666214869143765e-11
Snrpn O 0 4.575860657496378e-06
and O 0 1.1616167229500096e-11
the O 0 2.631568194692152e-13
putative O 0 3.2342324374212694e-08
PWS O 1 0.9999969005584717
- O 0 4.756189446197823e-05
IC O 0 1.6809822867003277e-08
lack O 0 2.2575575089889277e-11
expression O 0 3.38725981941998e-13
of O 0 3.7492063172617446e-16
the O 0 1.4775420470458656e-13
imprinted O 0 1.579368080761867e-09
genes O 0 1.570772956149824e-09
Zfp127 O 0 3.866176356837059e-08
( O 0 7.457473901644265e-14
mouse O 0 3.5697919620325536e-10
homologue O 0 1.9781951077213478e-10
of O 0 5.02572226998739e-14
ZNF127 O 0 2.7843418592965463e-06
) O 0 5.048340760184511e-13
, O 0 1.840055207811761e-13
Ndn O 0 1.3451159475152963e-07
and O 0 6.687161132994113e-13
Ipw O 0 2.4968102252387325e-08
, O 0 1.7242304806153186e-11
and O 0 4.2644070241161514e-13
manifest O 0 3.06384285346864e-13
several O 0 1.7487801571430817e-14
phenotypes O 0 2.488553807467042e-10
common O 0 2.916202002101187e-11
to O 0 7.44939043784143e-09
PWS B-Disease 1 1.0
infants O 0 0.005603753961622715
. O 0 9.295500480455132e-11

These O 0 3.015872057296476e-12
data O 0 1.5554871030543788e-13
demonstrate O 0 1.667265941464064e-14
that O 0 6.896036747281592e-14
both O 0 3.1490939413417185e-13
the O 0 2.3351118131134663e-13
position O 0 2.3746888136444433e-11
of O 0 4.4458410208438574e-17
the O 0 9.194460480249547e-15
IC O 0 1.250490249543601e-11
and O 0 4.613773555914302e-13
its O 0 2.0398948355541914e-15
role O 0 2.320151449436425e-12
in O 0 2.4182675447629448e-14
the O 0 4.647437271040325e-15
coordinate O 0 2.015071269567681e-12
expression O 0 2.7365113755735415e-14
of O 0 1.0794644789834947e-16
genes O 0 1.7653989381472002e-11
is O 0 6.562042169410212e-15
conserved O 0 1.2723253440399818e-12
between O 0 1.2437015826927134e-11
mouse O 0 9.434154344489798e-05
and O 0 2.359918482852663e-08
human O 0 2.226488549084138e-09
, O 0 1.5084884730232062e-11
and O 0 3.3215638572947626e-11
indicate O 0 1.5606603509521477e-10
that O 0 1.107424481977537e-12
the O 0 3.089491349924679e-14
mouse O 0 1.0454870746912093e-08
is O 0 7.761616158542383e-15
a O 0 1.686635192099694e-15
suitable O 0 6.128694014957692e-13
model O 0 1.3663208342507005e-09
system O 0 1.6143771042198551e-10
in O 0 3.9090451931173345e-14
which O 0 3.5610498924643075e-12
to O 0 6.718249275037419e-14
investigate O 0 5.195098908353235e-13
the O 0 1.0076892628435499e-15
molecular O 0 2.922442452965579e-12
mechanisms O 0 2.540587965699226e-12
of O 0 1.5763678871607575e-16
imprinting O 0 1.4283302540718523e-08
in O 0 8.3561543101629e-13
this O 0 1.3363663203379977e-13
region O 0 2.0064965314259275e-11
of O 0 3.7366127902206453e-16
the O 0 2.6729874620678475e-14
genome O 0 4.1523767931039846e-12
. O 0 4.5797882223782074e-14
. O 0 8.270119615169658e-13

Mutations O 0 1.6726467038097326e-06
of O 0 9.489654003466512e-15
the O 0 1.2216512252759965e-14
ATM O 0 7.069597129927274e-10
gene O 0 2.7793561896416463e-10
detected O 0 1.610591993106425e-09
in O 0 5.413241469659491e-12
Japanese O 1 0.5757777690887451
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.8725022077560425
: O 0 7.612168274190312e-13
possible O 0 1.1384963067781473e-13
preponderance O 0 6.451716383359951e-10
of O 0 3.596936845460174e-15
the O 0 2.3377900635300486e-13
two O 0 1.1085545052443371e-13
founder O 0 1.6202929623010398e-11
mutations O 0 7.264465140544019e-10
4612del165 O 0 7.837904630880743e-11
and O 0 9.392639660835145e-13
7883del5 O 0 2.5436075468121544e-09
. O 0 2.750160342512853e-12

The O 0 2.1115199866361678e-11
ATM O 0 2.0158672953130008e-08
( O 0 1.704131280533261e-09
A O 1 0.9999997615814209
- O 1 0.9999998807907104
T O 1 1.0
, O 0 6.551654219144609e-10
mutated O 0 4.211157644817831e-09
) O 0 1.2371743745838524e-14
gene O 0 7.782944427825456e-12
on O 0 5.256286942159627e-13
human O 0 3.8444560035433284e-11
chromosome O 0 6.239926619855396e-07
11q22 O 0 1.1521215981247224e-08
. O 0 1.0040729532534431e-11

3 O 0 1.614140614947246e-06
has O 0 3.5610754345327678e-09
recently O 0 4.472829662205413e-09
been O 0 1.1936762342457108e-12
identified O 0 3.367587892572077e-12
as O 0 3.830393101767089e-16
the O 0 1.1843799650638825e-16
gene O 0 1.877357644342048e-12
responsible O 0 2.3006976776181534e-14
for O 0 2.0213880126896322e-16
the O 0 1.384054979999827e-12
human O 0 3.484921990093426e-06
recessive B-Disease 1 0.9999972581863403
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.16114193201065063
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 1.4846152085468134e-10
. O 0 1.604369415098006e-11

In O 0 4.338120574570725e-12
order O 0 6.754717770361685e-13
to O 0 1.4496294654031336e-14
define O 0 1.0912525223727432e-11
the O 0 4.452458163988794e-14
types O 0 4.880108539495609e-10
of O 0 7.556963952173867e-13
disease O 0 0.10428766906261444
- O 0 1.327447421317629e-06
causing O 0 3.735920905967305e-09
ATM O 0 1.5232659222874645e-07
mutations O 0 1.1541654032498627e-07
in O 0 4.2924382581341347e-13
Japanese O 0 1.899095695989672e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 9.363217259306111e-07
as O 0 1.4335395663502698e-13
well O 0 9.592642029017731e-14
as O 0 7.190764232970978e-15
to O 0 8.222579958767646e-15
look O 0 7.361491516193197e-13
for O 0 1.1936640582794429e-17
possible O 0 7.051197343702466e-15
mutational O 0 1.6120847712297603e-10
hotspots O 0 1.8011798649797406e-11
, O 0 8.126202618793932e-13
reverse O 0 1.98945020457586e-08
- O 0 5.548853043713109e-10
transcribed O 0 1.8207725605012826e-10
RNA O 0 1.5690692078962343e-09
derived O 0 2.127029326596478e-15
from O 0 8.80237102007812e-17
ten O 0 1.4766962338260553e-14
patients O 0 5.741665349006005e-15
belonging O 0 8.965959154925832e-16
to O 0 6.555828335709155e-14
eight O 0 7.34006822336597e-13
unrelated O 0 3.280068924804702e-11
Japanese O 0 0.00013615442730952054
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 4.046109669531006e-09
was O 0 4.689045332573194e-11
analyzed O 0 1.7375937928082452e-12
for O 0 8.386245736096376e-18
mutations O 0 1.081205302155483e-13
by O 0 4.62788113979024e-18
the O 0 7.015560311801093e-17
restriction O 0 6.817739732142836e-13
endonuclease O 0 3.1538835432165513e-10
fingerprinting O 0 5.753596488133894e-10
method O 0 2.4259308104013222e-11
. O 0 1.6813027749543186e-12

As O 0 2.1420305529318284e-09
has O 0 1.2071078858699735e-10
been O 0 1.1953980828208893e-13
reported O 0 4.175884085137055e-13
by O 0 3.020569253094486e-16
others O 0 7.404437441871706e-14
, O 0 1.3377198112250743e-14
mutations O 0 5.425099952605095e-11
that O 0 3.4697945742751674e-14
lead O 0 1.7969728136058016e-11
to O 0 1.1683471666195755e-15
exon O 0 5.341888389964744e-11
skipping O 0 4.913475848411508e-08
or O 0 1.551495182328111e-10
premature O 0 6.470889102327959e-11
protein O 0 2.8906851912147147e-10
truncation O 0 2.2334997140660562e-07
were O 0 5.98394009898584e-08
also O 0 1.8487703812297696e-08
predominant O 0 1.0309408793318653e-07
in O 0 9.066995418360868e-12
our O 0 4.828136154766405e-12
mutants O 0 5.608939007695213e-11
. O 0 2.85432891515211e-13

Six O 0 4.3168046914843217e-10
different O 0 2.5318102784633104e-14
mutations O 0 5.624207211063492e-10
were O 0 2.0883791115693107e-13
identified O 0 3.0503605197296224e-10
on O 0 6.10285016966472e-11
12 O 0 6.004061397363314e-12
of O 0 6.312814794900133e-17
the O 0 1.2455116690616996e-13
16 O 0 5.934632993365163e-12
alleles O 0 1.7796717875426249e-12
examined O 0 2.922803554739062e-09
. O 0 7.722805034360292e-12

Four O 0 8.59681770215559e-11
were O 0 4.371481475418104e-14
deletions O 0 8.314508803675125e-11
involving O 0 9.309815071634198e-12
a O 0 9.296080398513151e-12
loss O 0 2.3467017218337105e-10
of O 0 2.3864142474181372e-17
a O 0 2.5604918304968777e-14
single O 0 1.963785240650072e-14
exon O 0 1.1937086735747116e-11
exon O 0 5.910197220515556e-09
7 O 0 7.305497318199627e-10
, O 0 1.6362139507869466e-13
exon O 0 1.411198241596523e-10
16 O 0 4.67060452813417e-11
, O 0 1.7160257318859368e-14
exon O 0 1.629498619371006e-10
33 O 0 1.380345060475463e-09
or O 0 1.1509457937489836e-13
exon O 0 3.6222149724096653e-09
35 O 0 6.3471046196639236e-09
. O 0 6.20418508234799e-11

The O 0 6.879673913884332e-12
others O 0 1.7715630394946058e-13
were O 0 1.4848104706475726e-14
minute O 0 4.6817015325259503e-14
deletions O 0 1.5217246907006654e-10
, O 0 1.5334759015991212e-13
4649delA O 0 1.3471297688472106e-10
in O 0 1.7607344813584474e-15
exon O 0 3.4607597343416785e-10
33 O 0 3.929822689485718e-09
and O 0 6.821317057210952e-13
7883del5 O 0 6.509560945833215e-11
in O 0 7.083008513069549e-15
exon O 0 5.566927474554006e-10
55 O 0 3.877022258791385e-09
. O 0 3.0689402408246025e-11

The O 0 4.1532818850775755e-11
mutations O 0 5.042922968101493e-09
4612del165 O 0 2.654418074232723e-10
and O 0 3.1020523064313743e-13
7883del5 O 0 1.4966236583369152e-11
were O 0 1.666249468046041e-13
found O 0 9.329251374244965e-14
in O 0 4.2280824158668227e-17
more O 0 1.9040528067584547e-17
than O 0 4.981919570482734e-16
two O 0 7.977932279645134e-15
unrelated O 0 7.941519078631665e-13
families O 0 1.55423481566384e-14
; O 0 5.456064473916694e-15
44 O 0 1.0737288472619302e-13
% O 0 2.6267598131143204e-16
( O 0 1.9845086216826536e-15
7 O 0 8.01996524746329e-11
of O 0 1.0703870651157868e-14
16 O 0 5.122764989984319e-10
) O 0 5.9593519694174125e-15
of O 0 9.445037747344864e-18
the O 0 2.2094164097276412e-15
mutant O 0 9.348998138147824e-12
alleles O 0 1.755551812861883e-13
had O 0 5.65146951458928e-09
one O 0 3.176195336471524e-14
of O 0 4.425991994865035e-17
the O 0 4.2780584847204595e-14
two O 0 3.290199059383103e-12
mutations O 0 1.771235491609957e-09
. O 0 2.247340117819685e-12

The O 0 1.1177212801138925e-11
4612del165 O 0 1.860428588962293e-09
mutations O 0 1.1057740501030366e-08
in O 0 9.800940305648362e-15
three O 0 1.143086801835792e-14
different O 0 9.391406863672722e-16
families O 0 3.937959086288334e-15
were O 0 6.205071992251149e-15
all O 0 3.147622408472508e-17
ascribed O 0 7.363003978223814e-14
to O 0 1.7091954276058675e-14
the O 0 4.318622045531521e-15
same O 0 4.021956379052227e-13
T O 0 1.8854139582913376e-08
- O 0 4.0515826804643496e-10
- O 0 4.762768998634037e-11
> O 0 3.1117811913382656e-14
A O 0 1.183288256061902e-14
substitution O 0 1.354624810083081e-14
at O 0 2.7518840071266704e-14
the O 0 6.841554995191132e-16
splice O 0 9.966008462924947e-09
donor O 0 9.079623988425545e-13
site O 0 6.412512448122909e-12
in O 0 5.72515599923766e-14
intron O 0 5.745416274294257e-06
33 O 0 7.89653942234736e-09
. O 0 1.3628629474959908e-11

Microsatellite O 0 8.673083016219607e-07
genotyping O 0 2.9102610099585036e-08
around O 0 4.852937496302445e-11
the O 0 1.868208685624692e-13
ATM O 0 2.0372881159858025e-09
locus O 0 2.26287419358151e-10
also O 0 2.3117431580121917e-10
indicated O 0 1.5500221939301895e-10
that O 0 1.522819041276536e-14
a O 0 8.877985254232817e-15
common O 0 8.716259728954248e-14
haplotype O 0 5.2965763330803384e-08
was O 0 3.852592911357533e-09
shared O 0 7.142569413524924e-14
by O 0 3.1440597746614667e-16
the O 0 3.3002690613985128e-15
mutant O 0 9.765990099941391e-11
alleles O 0 3.5014151951104355e-13
in O 0 6.254374053165854e-14
both O 0 1.0016971627169191e-11
mutations O 0 5.0475158275276044e-08
. O 0 2.568855718421137e-11

This O 0 5.2132388683734376e-11
suggests O 0 4.225611874297819e-11
that O 0 6.328426823375144e-13
these O 0 3.998327547955621e-14
two O 0 1.3779117278601982e-13
founder O 0 2.939832544068821e-10
mutations O 0 1.591749025919853e-07
may O 0 1.146842603522158e-11
be O 0 4.3911170543881745e-15
predominant O 0 9.540734088181457e-13
among O 0 3.762345862916468e-15
Japanese O 0 9.664776617901438e-11
ATM O 0 8.537831552857256e-10
mutant O 0 1.5380604567738487e-09
alleles O 0 2.334006321547122e-10
. O 0 1.798310111933432e-11

W474C O 0 1.7192251178244078e-08
amino O 0 1.1145583067584397e-10
acid O 0 1.9384149233664383e-12
substitution O 0 6.423731853518952e-14
affects O 0 3.6022684943466665e-13
early O 0 4.7366079022328686e-14
processing O 0 2.5562722511668357e-13
of O 0 1.1615555538780945e-17
the O 0 1.3205608930653046e-16
alpha O 0 3.203185850753369e-16
- O 0 1.5108560561492845e-14
subunit O 0 1.6495526190644927e-14
of O 0 4.5646943017224167e-17
beta O 0 9.439905725595193e-14
- O 0 7.45714393013408e-11
hexosaminidase O 0 6.673919750177504e-10
A O 0 1.219985917844113e-11
and O 0 6.215999394897087e-13
is O 0 8.400763503617955e-15
associated O 0 5.879717719647903e-12
with O 0 1.4691768851840536e-12
subacute O 1 0.7664027810096741
G B-Disease 0 0.00018384886789135635
( I-Disease 0 4.682194844514431e-13
M2 I-Disease 0 1.7715650812988315e-07
) I-Disease 0 8.581893529147067e-11
gangliosidosis I-Disease 0 1.7842386341726524e-06
. O 0 2.454448588817826e-10

Mutations O 0 0.00023099911049939692
in O 0 1.1444623460726833e-12
the O 0 1.191346419302311e-13
HEXA O 0 8.131463147265094e-08
gene O 0 3.789049976554715e-11
, O 0 8.833287855001799e-16
encoding O 0 8.93338967931272e-16
the O 0 7.825168299421044e-17
alpha O 0 4.845026870107822e-16
- O 0 1.3428512045821767e-13
subunit O 0 5.077830720462938e-14
of O 0 7.771681477524385e-17
beta O 0 1.2970405457134182e-13
- O 0 3.472297172013583e-10
hexosaminidase O 0 2.521435005231609e-10
A O 0 4.627380835280082e-13
( O 0 3.240152750851711e-16
Hex O 0 2.64481340474243e-12
A O 0 1.0019349445163778e-13
) O 0 1.845684368550647e-15
, O 0 3.859448714138076e-16
that O 0 8.736173410016726e-16
abolish O 0 1.933048443536478e-10
Hex O 0 1.7280933628516237e-10
A O 0 1.3865617638428307e-13
enzyme O 0 5.779514453824186e-12
activity O 0 1.7478432590145587e-10
cause O 0 7.585143521282589e-06
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9926653504371643
( O 0 2.808327148709792e-15
TSD B-Disease 0 3.783269253432309e-09
) O 0 2.1819254302640756e-13
, O 0 1.0272556053405116e-13
the O 0 4.442628719330405e-13
fatal O 0 4.605776211974444e-06
infantile B-Disease 0 5.89299997955095e-05
form I-Disease 0 4.0920605792749143e-10
of I-Disease 0 3.26522798599696e-13
G I-Disease 0 0.0002265367074869573
( I-Disease 0 5.682140955670656e-14
M2 I-Disease 0 2.9160228010027822e-08
) I-Disease 0 3.296166291300029e-12
gangliosidosis I-Disease 0 3.9423174058583754e-08
, I-Disease 0 1.9755507993379773e-11
Type I-Disease 0 1.2100803132852889e-06
1 I-Disease 0 2.259462755782593e-10
. O 0 3.4352735933662615e-11

Less O 0 5.077327447366997e-10
severe O 0 1.3275816854729783e-06
, O 0 4.758889463052363e-12
subacute O 0 0.008189165033400059
( O 0 2.1217430590247943e-10
juvenile O 0 0.013721376657485962
- O 1 0.9873364567756653
onset O 1 0.9954882264137268
) O 0 1.853324782530308e-08
and O 0 1.386613348586252e-07
chronic O 0 0.00830348301678896
( O 0 2.2686583514563985e-12
adult O 0 5.732952672587999e-07
- O 0 0.018717734143137932
onset O 0 1.5231919860525522e-05
) O 0 2.5140119478371525e-13
variants O 0 5.7723346935656394e-11
are O 0 1.7822040772417364e-14
characterized O 0 1.3944838935919107e-13
by O 0 4.475687351705996e-17
a O 0 3.777071530704484e-15
broad O 0 4.0426086957146e-12
spectrum O 0 1.8524480994291936e-12
of O 0 3.171332859134516e-15
clinical O 0 2.6658574014959413e-08
manifestations O 0 2.919956276770108e-09
and O 0 1.7255538664606718e-10
are O 0 1.5381562668524695e-14
associated O 0 3.697339309716163e-11
with O 0 4.701614531726905e-13
residual O 0 6.641759000558523e-07
levels O 0 2.5064270103847264e-10
of O 0 3.2432690380042187e-16
Hex O 0 2.6048960766189566e-09
A O 0 2.102829412334306e-12
enzyme O 0 1.631096126220033e-11
activity O 0 2.331736019545172e-11
. O 0 9.557295059525739e-12

We O 0 1.76865722067987e-08
identified O 0 2.140456041577199e-11
a O 0 8.385655315750959e-14
1422 O 0 2.1368440350499895e-09
G O 0 2.3140026428336569e-07
- O 0 1.8476110597021034e-07
- O 0 3.1650537835048453e-07
> O 0 2.558549205833316e-10
C O 0 7.411164459902864e-10
( O 0 3.1374584763265996e-16
amino O 0 5.321794505183837e-14
acid O 0 1.8883439123896888e-15
W474C O 0 2.499493430426717e-15
) O 0 2.157285383177071e-18
substitution O 0 1.5485813683727742e-16
in O 0 1.1097819719225433e-16
the O 0 4.2036894154680055e-15
first O 0 2.324065690329641e-13
position O 0 3.384728207347226e-13
of O 0 5.313406658853255e-18
exon O 0 3.279244653597857e-10
13 O 0 2.902396031845278e-11
of O 0 7.12797283355807e-16
HEXA O 0 6.808569651184371e-06
of O 0 6.774503443570008e-15
a O 0 1.4887593111426178e-12
non O 0 8.265441282795383e-12
- O 0 5.746737130607471e-08
Jewish O 0 1.8350121422372467e-09
proband O 0 1.751016952766804e-06
who O 0 5.257615523501791e-11
manifested O 0 2.2010736603576136e-13
a O 0 4.1169926287012125e-15
subacute O 0 2.956379603347159e-07
variant O 0 9.493901984569675e-07
of O 0 7.720562470586723e-13
G B-Disease 0 0.0073916069231927395
( I-Disease 0 1.3809854952293033e-12
M2 I-Disease 0 4.4596285420084314e-07
) I-Disease 0 2.2148564926549597e-10
gangliosidosis I-Disease 0 2.2388021534425206e-06
. O 0 4.932664277035315e-10

On O 0 2.0168162695455294e-09
the O 0 6.1421666364136485e-12
second O 0 3.661536074339722e-10
maternally O 0 2.1176900233399465e-08
inherited O 0 2.5208844789403884e-08
allele O 0 5.37027818048319e-11
, O 0 3.137632298075288e-12
we O 0 2.5978665833120695e-12
identified O 0 3.9585093015992445e-12
the O 0 1.7662660342556563e-13
common O 0 5.656667578790575e-09
infantile O 1 0.9998316764831543
disease O 1 0.9999986886978149
- O 0 0.06332732737064362
causing O 0 2.284483116454794e-06
4 O 0 1.274812366780509e-09
- O 0 4.985055479522771e-09
bp O 0 7.234190677052332e-12
insertion O 0 5.383913258792672e-13
, O 0 5.217548127486177e-14
+ O 0 4.41617098792535e-12
TATC O 0 8.151487818075509e-10
1278 O 0 4.4657076647691696e-11
, O 0 2.873780179752858e-14
in O 0 1.29755134893226e-15
exon O 0 2.2369683883027847e-09
11 O 0 1.0668921301970613e-09
. O 0 4.680170747478618e-12

Pulse O 0 5.415294253907632e-06
- O 0 1.3747131788477418e-07
chase O 0 6.077136571747133e-10
analysis O 0 3.0132312118548443e-13
using O 0 3.1609608051701155e-13
proband O 0 1.5967428268481854e-08
fibroblasts O 0 1.5431329103421376e-08
revealed O 0 1.0444706433077044e-08
that O 0 2.005967657606189e-12
the O 0 1.816703390370225e-14
W474C O 0 2.6315005730026542e-11
- O 0 2.730450631219239e-12
containing O 0 1.4982657584212966e-15
alpha O 0 5.818169788318487e-16
- O 0 1.4818878681663664e-14
subunit O 0 1.7403682729438992e-14
precursor O 0 1.6381031730725026e-13
was O 0 2.5582539558977047e-12
normally O 0 6.440056719511384e-15
synthesized O 0 4.1374621963111494e-14
, O 0 9.525923954267941e-15
but O 0 4.0741559702728997e-14
not O 0 3.574286337417647e-15
phosphorylated O 0 4.102080545902165e-13
or O 0 9.734948815760727e-15
secreted O 0 3.644022204211256e-13
, O 0 3.721087240421417e-12
and O 0 2.4569533907392582e-11
the O 0 1.0031875368387774e-13
mature O 0 5.057843792226346e-13
lysosomal O 0 7.406341512306014e-11
alpha O 0 8.8716198016342e-15
- O 0 5.7913665182929286e-12
subunit O 0 8.09769178794495e-12
was O 0 6.62310414845102e-11
not O 0 4.860575375346954e-13
detected O 0 2.050068587111653e-10
. O 0 6.928354374588497e-13

When O 0 2.517476449526157e-09
the O 0 3.3900826753013175e-14
W474C O 0 2.0890586135968725e-11
- O 0 4.0279233941287185e-12
containing O 0 1.030414479192025e-14
alpha O 0 1.1424372122685426e-14
- O 0 1.0454930107414717e-12
subunit O 0 2.537561090074081e-12
was O 0 2.7239809366474965e-11
transiently O 0 5.771431943468741e-11
co O 0 5.027959826264805e-09
- O 0 7.437602755899775e-10
expressed O 0 9.07947215776975e-16
with O 0 4.2013307992868167e-16
the O 0 2.152527109421421e-17
beta O 0 1.9806355370615537e-16
- O 0 4.7084145799900987e-14
subunit O 0 3.940335606628445e-14
to O 0 1.5853790312882546e-14
produce O 0 8.03195095882333e-15
Hex O 0 2.3015834030304383e-11
A O 0 3.15496164349921e-13
( O 0 1.9135497070758454e-15
alphabeta O 0 2.955309885699364e-10
) O 0 7.217672098012995e-14
in O 0 2.06337957787614e-13
COS O 0 1.0557756468188018e-05
- O 0 5.510593155122478e-07
7 O 0 5.98255125994207e-11
cells O 0 6.18004085406465e-12
, O 0 1.0920691603897182e-14
the O 0 4.215297313795856e-16
mature O 0 2.9146335952384694e-15
alpha O 0 1.3866620042364378e-17
- O 0 1.0797909943027935e-14
subunit O 0 6.828264624732239e-14
was O 0 1.163173116852656e-11
present O 0 3.744005482026044e-15
, O 0 9.564670968220321e-14
but O 0 1.6965753888570356e-12
its O 0 2.1835759756057543e-15
level O 0 1.0103963293209978e-13
was O 0 2.0742981713794267e-13
much O 0 2.3372359684572727e-14
lower O 0 1.6712092864093475e-12
than O 0 3.7842971452610365e-15
that O 0 5.6422897495682356e-14
from O 0 2.0840030704308342e-16
normal O 0 3.2362652190249044e-14
alpha O 0 3.016964863206123e-16
- O 0 9.503062535021548e-14
subunit O 0 5.679066158309487e-13
transfections O 0 3.950433036248313e-11
, O 0 4.514737277875203e-15
although O 0 3.794705062600424e-15
higher O 0 3.400109893682561e-16
than O 0 2.5087593355949686e-15
in O 0 2.130771416513494e-13
those O 0 2.1132058505412415e-13
cells O 0 2.498429631583865e-12
transfected O 0 3.96388824541738e-12
with O 0 1.9867497914517496e-16
an O 0 1.036598672695629e-17
alpha O 0 6.831335966198983e-15
- O 0 6.830346011010846e-11
subunit O 0 6.710882544114227e-11
associated O 0 7.612749541863195e-09
with O 0 5.7903640215961616e-11
infantile O 0 0.00016033591236919165
TSD B-Disease 0 6.962163297430379e-06
. O 0 9.196900185859391e-11

Furthermore O 0 1.1614923245417685e-08
, O 0 5.866485140552935e-13
the O 0 2.478396380809454e-15
precursor O 0 6.520850482846785e-13
level O 0 4.935678059835025e-13
of O 0 2.4758048438026602e-17
the O 0 1.296492557748192e-15
W474C O 0 2.2251338683935973e-13
alpha O 0 1.0969363202307378e-16
- O 0 8.257785189154376e-15
subunit O 0 8.788157918396267e-14
was O 0 5.217135751189872e-12
found O 0 1.4879068842895554e-13
to O 0 1.8823286232114676e-14
accumulate O 0 7.1319313302287135e-12
in O 0 8.588666328021534e-16
comparison O 0 4.682194844514431e-13
to O 0 7.070081689151617e-14
the O 0 6.062950028097244e-15
normal O 0 4.0664100233768485e-13
alpha O 0 1.78881012954902e-15
- O 0 1.8902988983132696e-13
subunit O 0 8.465061334186896e-13
precursor O 0 2.562111547227408e-12
levels O 0 4.6422882898911055e-12
. O 0 4.066255253516726e-13

We O 0 3.0052380139977686e-08
conclude O 0 7.687200181960563e-11
that O 0 5.176846500304713e-14
the O 0 7.251171234637366e-15
1422 O 0 2.4513246987822868e-09
G O 0 2.932539189259842e-07
- O 0 6.530599705456552e-08
- O 0 2.317281939667737e-07
> O 0 3.172677676133162e-10
C O 0 1.707486596558283e-08
mutation O 0 2.0129979280691934e-11
is O 0 1.6963503423673455e-14
the O 0 2.2420875292944236e-15
cause O 0 8.03609620254192e-13
of O 0 2.1913102334471333e-16
Hex B-Disease 0 4.982894097338431e-06
A I-Disease 0 1.0324859431420919e-05
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.259286778927977e-13
the O 0 1.1151674202125594e-12
proband O 0 5.049551418778719e-06
. O 0 9.596005240419814e-11

The O 0 1.9296023112680416e-12
resulting O 0 4.195283714609338e-13
W474C O 0 6.052390533195506e-11
substitution O 0 3.786295495883385e-12
clearly O 0 7.939625519537419e-13
interferes O 0 6.369737636652273e-12
with O 0 2.3674917629870477e-16
alpha O 0 2.3952254745647256e-16
- O 0 2.1368057808736872e-14
subunit O 0 3.683474220626294e-14
processing O 0 3.187808740937048e-12
, O 0 3.304048098892688e-15
but O 0 6.293201111731749e-15
because O 0 8.203772836253505e-17
the O 0 1.3652725611618885e-18
base O 0 3.7132135474043926e-14
substitution O 0 8.112400454087648e-14
falls O 0 5.788302059883677e-10
at O 0 7.820141019118654e-13
the O 0 2.553863458871434e-14
first O 0 9.771868644120607e-13
position O 0 9.71568637174458e-13
of O 0 2.4256227738892732e-17
exon O 0 6.475397995586718e-10
13 O 0 1.3062002868213796e-11
, O 0 7.272196286454112e-15
aberrant O 0 3.0941651150973026e-12
splicing O 0 3.7410782027791356e-08
may O 0 2.0066863726242445e-09
also O 0 1.892709947104443e-12
contribute O 0 1.442469157086814e-14
to O 0 3.462219931322369e-13
Hex B-Disease 0 4.813599844055716e-06
A I-Disease 0 3.610580563417898e-07
deficiency I-Disease 0 0.00011666698264889419
in O 0 4.1833093792405934e-15
this O 0 1.3039933987202962e-13
proband O 0 2.0037695946939493e-07
. O 0 1.8432807363799597e-12
. O 0 2.226400270741169e-12

Two O 0 1.0291201918422033e-10
frequent O 0 1.1388618936791772e-08
missense O 0 0.00015884643653407693
mutations O 0 0.02639564871788025
in O 0 1.0551851801210432e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 9.082755658695874e-10

Pendred B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
is O 0 1.2182761111034779e-06
an O 0 1.4008999642101116e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.054173797369003296
by O 0 4.606497475134752e-11
early O 0 3.3106666705862153e-06
childhood O 1 0.9995445609092712
deafness B-Disease 1 1.0
and O 0 0.027026526629924774
goiter B-Disease 1 1.0
. O 0 1.3568165257993314e-08

A O 0 1.1272625055624985e-09
century O 0 1.7393164686296814e-10
after O 0 2.184578066404333e-13
its O 0 2.2872758899974933e-16
recognition O 0 4.560486797905829e-15
as O 0 8.020782931057735e-13
a O 0 2.4611240823091407e-10
syndrome O 0 0.17235371470451355
by O 0 1.3394815550520685e-14
Vaughan O 0 2.4468280912515183e-07
Pendred O 0 6.000410053275118e-07
, O 0 8.629176366514724e-12
the O 0 3.1248632154090572e-12
disease O 0 1.1026022548321635e-06
gene O 0 5.96912741457345e-10
( O 0 1.3276570598116932e-13
PDS O 0 1.1993770385743119e-06
) O 0 4.059598252177665e-13
was O 0 1.1831237378689963e-10
mapped O 0 1.1604652172536589e-07
to O 0 2.004866932192595e-11
chromosome O 0 2.2601456294069067e-05
7q22 O 0 4.3198731702887017e-08
- O 0 5.798164011139306e-07
q31 O 0 3.103557588701733e-08
. O 0 2.740851122451371e-11

1 O 0 1.0066401934238911e-08
and O 0 1.913730951486059e-09
, O 0 3.636060419767717e-12
recently O 0 3.4861087350179787e-09
, O 0 1.556080568218543e-13
found O 0 1.8799069560152676e-14
to O 0 6.190501252083142e-17
encode O 0 5.689124572914178e-14
a O 0 4.0980844477449263e-13
putative O 0 1.7097172289037843e-10
sulfate O 0 8.434843046245533e-09
transporter O 0 3.5701606293514487e-07
. O 0 1.0573923681089781e-10

We O 0 1.9817392171717074e-08
performed O 0 6.949069791817308e-12
mutation O 0 1.690056921450564e-13
analysis O 0 8.607891858341838e-15
of O 0 8.656943900276804e-18
the O 0 1.4112437957060527e-14
PDS B-Disease 0 8.905743698051083e-07
gene O 0 8.11079647888846e-09
in O 0 2.566644271249918e-13
patients O 0 2.9280777021772897e-12
from O 0 5.543102720840349e-16
14 O 0 3.3881014313563718e-12
Pendred B-Disease 0 1.682680021986016e-07
families O 0 2.9398826309565834e-14
originating O 0 4.710608530848759e-13
from O 0 4.036733377036847e-14
seven O 0 4.662217660544865e-12
countries O 0 1.0028469618313454e-13
and O 0 5.806826373910834e-13
identified O 0 3.4692238665146036e-11
all O 0 1.1728226896601246e-13
mutations O 0 5.357676524653243e-10
. O 0 1.7655898444657314e-12

The O 0 1.858866012505178e-11
mutations O 0 1.2303954521897253e-09
include O 0 1.4352109995244278e-13
three O 0 5.8563673658793e-13
single O 0 1.5713219570986925e-12
base O 0 1.710904612428621e-10
deletions O 0 1.0062834832069711e-07
, O 0 1.7726464393574837e-11
one O 0 9.710864111531908e-14
splice O 0 1.5639478760931524e-06
site O 0 6.964047116753136e-09
mutation O 0 2.231420159759523e-09
and O 0 2.1245837120847932e-12
10 O 0 4.151305763987895e-13
missense O 0 1.3995013148360158e-07
mutations O 0 8.761236927057325e-07
. O 0 3.973155138226048e-11

One O 0 5.800478500295192e-11
missense O 0 7.693973458344772e-08
mutation O 0 5.582858619845865e-09
( O 0 3.710233007869594e-14
L236P O 0 1.5854609292098587e-10
) O 0 8.364972126431724e-13
was O 0 2.4212956639679817e-10
found O 0 4.959214896377295e-12
in O 0 1.5650501770266803e-15
a O 0 2.2674318138674564e-14
homozygous O 0 1.464594764910565e-11
state O 0 9.833475179965578e-13
in O 0 1.0997955069433699e-13
two O 0 7.439534556973049e-13
consanguineous O 0 1.5590613244853557e-08
families O 0 3.4764224918909514e-12
and O 0 1.769561385443763e-12
in O 0 2.5042463440519977e-15
a O 0 1.5776688291825776e-14
heterozygous O 0 1.7242459630223417e-12
state O 0 7.396504470100901e-14
in O 0 5.3333357526066504e-15
five O 0 3.852640422126723e-15
additional O 0 4.544128050595507e-15
non O 0 3.518610749986273e-11
- O 0 8.024687758734217e-07
consanguineous O 0 2.2962344701227266e-06
families O 0 7.748259672757385e-11
. O 0 6.0412577718160776e-12

Another O 0 1.496339024908977e-10
missense O 0 1.4160346495373233e-07
mutation O 0 1.6953747294934374e-09
( O 0 2.0214556482704704e-14
T416P O 0 5.397305519183604e-11
) O 0 1.7619725936526137e-13
was O 0 5.590237300845402e-11
found O 0 2.2719927068176604e-12
in O 0 1.6007714622365255e-15
a O 0 1.481859577265928e-14
homozygous O 0 4.886335260023689e-12
state O 0 2.2016206132485783e-12
in O 0 2.2686141702178697e-13
one O 0 6.148768993963216e-11
family O 0 1.4767159717266054e-10
and O 0 1.5612610163029395e-11
in O 0 1.8522863550997836e-15
a O 0 8.92055628312887e-15
heterozygous O 0 2.3810235467297547e-12
state O 0 1.4878728674463937e-13
in O 0 7.221279103115583e-14
four O 0 2.3941341530803184e-12
families O 0 1.965539954103604e-13
. O 0 2.728357687345473e-12

Pendred B-Disease 0 0.0015060300938785076
patients O 0 1.5906163753243163e-05
in O 0 5.471601036838303e-12
three O 0 9.919644966549512e-12
non O 0 2.5163123321125802e-11
- O 0 1.0989197107846849e-06
consanguineous O 0 6.577251383532712e-07
families O 0 2.119314272686079e-12
were O 0 2.061392235293974e-14
shown O 0 2.3844431474868283e-14
to O 0 8.034581843157501e-16
be O 0 3.37004842968671e-16
compound O 0 8.165075061385141e-13
heterozygotes O 0 2.2691442475020196e-11
for O 0 2.7568995433172473e-15
L236P O 0 7.275655078409216e-10
and O 0 4.465977501005858e-12
T416P O 0 2.9379505495086278e-09
. O 0 4.960444815321763e-12

In O 0 1.3092207873377504e-11
total O 0 3.9063866616277643e-13
, O 0 1.0624453790700206e-12
one O 0 2.1640302397263333e-12
or O 0 2.376391184527593e-12
both O 0 2.148357013120883e-12
of O 0 2.9326437920981416e-16
these O 0 1.1373893363600396e-13
mutations O 0 6.325770463000424e-10
were O 0 3.0650135207643814e-12
found O 0 2.1514098835773154e-10
in O 0 3.279352429799015e-13
nine O 0 1.57924062715864e-10
of O 0 7.541574786537608e-16
the O 0 3.2533498464659694e-12
14 O 0 1.311143277282767e-10
families O 0 4.5536396376701094e-14
analyzed O 0 1.6643335321031572e-10
. O 0 1.9908846706634398e-12

The O 0 2.4413251368399225e-13
identification O 0 9.907722022363744e-14
of O 0 2.176564051579926e-16
two O 0 1.271228266966698e-13
frequent O 0 1.0448685250352696e-09
PDS B-Disease 0 8.10075580375269e-05
mutations O 0 8.569308533878939e-07
will O 0 2.675927242377224e-13
facilitate O 0 2.872717322810643e-14
the O 0 6.146364138676953e-15
molecular O 0 4.611003134868952e-09
diagnosis O 0 0.0004916150355711579
of O 0 1.9819262897513568e-10
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.0078327061791015e-09

Insertional O 0 3.003704932780238e-06
mutation O 0 2.437522683695903e-10
by O 0 1.647080553407931e-15
transposable O 0 1.3935773646167604e-09
element O 0 5.744046349676069e-10
, O 0 2.5339641843147298e-11
L1 O 0 1.1196821958492365e-07
, O 0 1.289591480477248e-12
in O 0 6.170141031132739e-14
the O 0 3.0763462523925034e-12
DMD B-Disease 1 1.0
gene O 0 0.000162614494911395
results O 0 2.1399060301519057e-10
in O 0 3.1052326508740347e-12
X B-Disease 1 0.9999821186065674
- I-Disease 1 0.999966025352478
linked I-Disease 1 0.9999744892120361
dilated I-Disease 1 0.9999260902404785
cardiomyopathy I-Disease 1 1.0
. O 0 6.290723941759779e-09

X B-Disease 1 0.9999699592590332
- I-Disease 1 0.9999908208847046
linked I-Disease 1 0.9999916553497314
dilated I-Disease 1 0.999994158744812
cardiomyopathy I-Disease 1 1.0
( O 0 4.262277197852882e-09
XLDCM B-Disease 0 7.34859422664158e-05
) O 0 1.3940670449616444e-12
is O 0 2.752072895473908e-14
a O 0 2.647568037202064e-13
clinical O 0 3.300268147654606e-08
phenotype O 0 5.262376312487049e-09
of O 0 2.279395307214476e-14
dystrophinopathy B-Disease 0 0.003868156112730503
which O 0 1.9289676800315902e-10
is O 0 5.1657893322112555e-14
characterized O 0 4.302883136603208e-12
by O 0 3.089815594136888e-14
preferential O 0 1.4303148887506723e-08
myocardial B-Disease 0 0.0023177689872682095
involvement I-Disease 0 1.1686381862219264e-09
without O 0 6.421101172472687e-13
any O 0 3.4664670900451736e-14
overt O 0 2.689024281021801e-10
clinical O 0 4.35532029996466e-07
signs O 0 3.549044669259871e-10
of O 0 3.8818484017488775e-12
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 1.5731910707472707e-07

To O 0 3.2184138687441077e-10
date O 0 5.179343065542241e-11
, O 0 4.188589105007419e-14
several O 0 1.6154088903672613e-14
mutations O 0 5.774738465191831e-10
in O 0 8.579604854255102e-14
the O 0 4.063869032955303e-12
Duchenne B-Disease 0 0.0027222614735364914
muscular I-Disease 0 6.760049586773675e-07
dystrophy I-Disease 0 1.5741301467642188e-05
gene O 0 1.3699130931854597e-06
, O 0 1.8236816223815566e-10
DMD O 1 1.0
, O 0 4.871933967365294e-10
have O 0 3.417438901309744e-11
been O 0 2.6182719187195502e-12
identified O 0 2.423217737579364e-10
in O 0 1.687924295777285e-13
patients O 0 1.3597860684666507e-11
with O 0 4.1417258213544486e-14
XLDCM B-Disease 0 5.908648745389655e-05
, O 0 6.6362635872674325e-12
but O 0 1.0094620180988584e-13
a O 0 2.6722608348540454e-16
pathogenic O 0 8.735982721724475e-14
correlation O 0 9.655223669191582e-13
of O 0 1.4412420181044794e-15
these O 0 7.337366391552136e-13
cardiospecific O 0 5.971296559437178e-07
mutations O 0 1.0893788271459925e-07
in O 0 1.4266418992339713e-12
DMD O 1 1.0
with O 0 2.8520135905707455e-11
the O 0 2.423714224111806e-12
XLDCM B-Disease 0 8.290092955576256e-05
phenotype O 0 7.207718795143592e-07
has O 0 3.7991632062528424e-09
remained O 0 1.868146436156959e-11
to O 0 5.097024148234541e-14
be O 0 3.159670875635401e-13
elucidated O 0 8.790498640109945e-08
. O 0 1.4751640881049966e-11

We O 0 2.1867340365133714e-06
report O 0 1.6647455983176407e-11
here O 0 9.809617311160035e-15
the O 0 1.7735812778682206e-17
identification O 0 7.382435083440417e-15
of O 0 2.6105260958079468e-17
a O 0 1.2028404531086445e-13
unique O 0 5.564063207570691e-13
de O 0 4.9588198131056416e-11
novo O 0 7.548822122949161e-10
L1 O 0 1.8074743091123224e-11
insertion O 0 3.940412991558506e-13
in O 0 1.3118533731917067e-14
the O 0 2.3313721287700206e-14
muscle O 0 1.2782910840947181e-10
exon O 0 3.0665428529808025e-10
1 O 0 2.5454350432996264e-11
in O 0 1.0351161768007433e-11
DMD O 1 1.0
in O 0 2.346500493910497e-10
three O 0 8.539076563895964e-12
XLDCM B-Disease 0 1.3074507023702608e-06
patients O 0 2.0687727572687997e-11
from O 0 2.62793113394892e-17
two O 0 6.6319261992069545e-15
unrelated O 0 8.876344104180589e-11
Japanese O 0 2.040795834545861e-07
families O 0 1.8027669201198249e-12
. O 0 4.563121148298821e-12

The O 0 1.5919258099239553e-12
insertion O 0 5.3739873662195237e-11
was O 0 3.852890576028223e-11
a O 0 7.35563546920906e-14
5 O 0 2.565143193342112e-12
- O 0 4.01680511075142e-09
truncated O 0 2.5892346044997794e-08
form O 0 1.1336485222779302e-10
of O 0 8.275003674906162e-15
human O 0 3.1335413864380657e-12
L1 O 0 3.331113995752588e-10
inversely O 0 9.038608403399984e-12
integrated O 0 8.938133566616102e-11
in O 0 3.853814836696223e-12
the O 0 3.911130100342497e-12
5 O 0 1.1984110925844504e-10
- O 0 4.793717423012822e-08
untranslated O 0 7.296741387108341e-06
region O 0 1.9241852555751393e-08
in O 0 2.622088744047568e-13
the O 0 6.479904113965542e-15
muscle O 0 1.2482691963411341e-11
exon O 0 2.598738715539617e-12
1 O 0 1.6949313588927872e-13
, O 0 4.158348673537725e-14
which O 0 2.853271818033937e-14
affected O 0 4.5821121419722943e-14
the O 0 6.895109182676877e-16
transcription O 0 8.907737741870037e-11
or O 0 1.6434616254695777e-12
the O 0 1.744693121528626e-13
stability O 0 1.6875655386994204e-11
of O 0 1.419183718440981e-16
the O 0 1.2927775982964768e-13
muscle O 0 9.488519969735876e-10
form O 0 1.5281611086682793e-14
of O 0 2.967267587306141e-17
dystrophin O 0 1.313692155058277e-09
transcripts O 0 6.27420893017927e-10
but O 0 3.252717106078107e-12
not O 0 5.260054951284829e-14
that O 0 1.7325244725666165e-15
of O 0 8.032156681950394e-17
the O 0 1.2765452757357298e-12
brain O 0 3.612433374655666e-08
or O 0 1.961989191988714e-13
Purkinje O 0 6.035234605406004e-07
cell O 0 0.015434223227202892
form O 0 1.0318262155806224e-07
, O 0 9.618737806249555e-09
probably O 0 6.063768864805752e-07
due O 0 3.803110604216897e-11
to O 0 1.363197640706637e-12
its O 0 4.213225735904668e-15
unique O 0 5.693789776277771e-15
site O 0 2.0257738195250674e-11
of O 0 1.7630331170190587e-15
integration O 0 1.3360804129725068e-10
. O 0 1.0536089362078727e-11

We O 0 2.9234045739734427e-10
speculate O 0 3.606904054945237e-12
that O 0 3.2653679158398466e-15
this O 0 4.602757183045167e-18
insertion O 0 3.1005366595568754e-14
of O 0 1.2644885858152132e-17
an O 0 1.2272557670022703e-15
L1 O 0 1.5507533817071817e-06
sequence O 0 1.4631752947025234e-06
in O 0 1.230692908693598e-10
DMD O 1 1.0
is O 0 4.624968116817563e-11
responsible O 0 1.650661215785859e-13
for O 0 3.8188215729164114e-17
some O 0 7.471301756859839e-17
of O 0 4.309763523506229e-17
the O 0 2.435110625512507e-14
population O 0 4.557721235333044e-15
of O 0 5.356022590421681e-17
Japanese O 0 1.7606978985895694e-07
patients O 0 1.5807065942632925e-12
with O 0 2.618257825785374e-15
XLDCM B-Disease 0 2.0112017296014528e-07
. O 0 4.631849374533981e-13
. O 0 4.8724305840019966e-12

Severe O 0 0.0007192721241153777
early O 0 2.565804777532321e-07
- O 1 0.999871015548706
onset O 1 0.9999431371688843
obesity B-Disease 1 1.0
, O 0 1.2811655324185267e-05
adrenal B-Disease 1 0.9999991655349731
insufficiency I-Disease 1 0.9999998807907104
and O 0 4.0607321238894656e-07
red O 0 1.4002972648086143e-06
hair O 1 0.9993247985839844
pigmentation O 0 0.21197305619716644
caused O 0 1.2766258272733921e-08
by O 0 1.8738435553656424e-13
POMC O 0 9.056121598405298e-06
mutations O 0 1.2940209614953346e-07
in O 0 6.683246621050354e-13
humans O 0 5.194620844584108e-10
. O 0 1.205735858378354e-11

Sequential O 0 1.6144680259344568e-08
cleavage O 0 2.717115421546623e-07
of O 0 2.3121663343173872e-14
the O 0 4.668243364840206e-15
precursor O 0 1.748161728223896e-12
protein O 0 2.6638316552585195e-10
pre O 0 2.014989952670021e-09
- O 0 1.3470098565449007e-06
pro O 0 6.284741971285257e-08
- O 0 1.866192405941547e-06
opiomelanocortin O 0 3.353435928943327e-08
( O 0 1.0117302876283107e-14
POMC O 0 1.504254221185164e-10
) O 0 1.5798361959121882e-15
generates O 0 4.6128359751449865e-15
the O 0 3.027942674900335e-15
melanocortin O 0 1.0255701843320253e-09
peptides O 0 4.9559266412924075e-11
adrenocorticotrophin O 0 1.519037118313804e-09
( O 0 3.111686323648173e-14
ACTH O 0 7.690162395768141e-11
) O 0 1.4148041292932467e-14
, O 0 5.2969740681370336e-14
melanocyte O 0 1.410198713358568e-08
- O 0 6.9877719397482e-06
stimulating O 0 1.247534964221586e-09
hormones O 0 1.351971451457601e-10
( O 0 1.9509786107073553e-15
MSH O 0 1.2741115107406387e-10
) O 0 8.261341562862542e-16
alpha O 0 2.854498914664624e-16
, O 0 8.819781517611136e-17
beta O 0 2.6070739733267425e-16
and O 0 2.6690823437194736e-16
gamma O 0 1.0931225543857253e-16
as O 0 4.516374169045772e-15
well O 0 1.7082948833521704e-15
as O 0 5.613127861032148e-17
the O 0 8.562650273529434e-18
opioid O 0 2.4263470532336247e-15
- O 0 2.7854124172096983e-13
receptor O 0 3.778728750665787e-15
ligand O 0 3.272664935273853e-14
beta O 0 3.87252079361855e-13
- O 0 2.007869426279285e-09
endorphin O 0 4.4433942747446054e-08
. O 0 1.3455291568431615e-11

While O 0 2.9055476774564326e-11
a O 0 5.0873988046351223e-14
few O 0 2.6392474292732775e-14
cases O 0 4.258495750583853e-14
of O 0 3.5527353628439506e-14
isolated O 1 0.9998557567596436
ACTH B-Disease 1 0.9974561333656311
deficiency I-Disease 1 0.9938424825668335
have O 0 6.421708304005236e-11
been O 0 1.0709937103836609e-10
reported O 0 7.188921014034122e-09
( O 0 7.400022435100073e-13
OMIM O 0 3.925915734726004e-05
201400 O 0 5.80927572713108e-09
) O 0 4.109690696476112e-14
, O 0 3.019489497844974e-14
an O 0 1.905450759199026e-14
inherited O 0 0.0001625879667699337
POMC O 1 0.5799863338470459
defect O 1 0.7063261270523071
has O 0 7.011939828771574e-08
not O 0 5.838283329007155e-11
been O 0 2.059281044297645e-11
described O 0 2.708392191075326e-11
so O 0 2.633386998046605e-12
far O 0 7.111230007628144e-12
. O 0 7.796168224882827e-12

Recent O 0 8.535332796100192e-08
studies O 0 2.4847501833846763e-10
in O 0 1.9285185156713708e-14
animal O 0 3.377573221108321e-11
models O 0 9.974303501192328e-12
elucidated O 0 1.2399929694151268e-10
a O 0 1.3121638107668754e-14
central O 0 2.4824443173830646e-13
role O 0 9.290115063950027e-14
of O 0 2.391271286538926e-17
alpha O 0 4.7437683799557775e-14
- O 0 2.616147853906625e-10
MSH O 0 1.4641137191517828e-08
in O 0 1.5749088570272442e-14
the O 0 3.515343855717062e-15
regulation O 0 4.155038292597002e-12
of O 0 4.403811643047793e-17
food O 0 1.4646162971657106e-12
intake O 0 9.872032797350952e-14
by O 0 2.2318695706739868e-18
activation O 0 1.9800244292598893e-15
of O 0 1.671435424089232e-16
the O 0 9.844115540086351e-13
brain O 0 1.3459085401734683e-08
melanocortin O 0 6.914872008323414e-10
- O 0 5.460589314054687e-09
4 O 0 1.1282681386393101e-11
- O 0 1.8312419636234978e-10
receptor O 0 1.7752974383524606e-13
( O 0 8.99031029336821e-16
MC4 O 0 2.284030603538767e-10
- O 0 2.0668085298769512e-11
R O 0 1.298990914833098e-10
; O 0 3.1997879145579874e-14
refs O 0 7.230828436011194e-11
3 O 0 1.1846535037662864e-12
- O 0 1.2408613025982618e-10
5 O 0 1.363969430023121e-13
) O 0 2.1183732851502496e-15
and O 0 7.115344419347455e-15
the O 0 4.347844735151353e-16
linkage O 0 2.095649431765878e-09
of O 0 8.633279129836944e-15
human O 0 1.0224967184058187e-07
obesity B-Disease 1 1.0
to O 0 7.20246307039929e-10
chromosome O 0 6.831867722212337e-06
2 O 0 2.0901228664493843e-11
in O 0 1.4552669778868793e-14
close O 0 1.736656998763131e-11
proximity O 0 3.849976171199643e-10
to O 0 9.710554842862207e-13
the O 0 2.0391178098800276e-14
POMC O 0 4.0803564971270134e-09
locus O 0 5.0821573512049856e-12
, O 0 3.403580043671861e-13
led O 0 3.44487784652292e-12
to O 0 2.938026951175739e-14
the O 0 4.168892454961852e-15
proposal O 0 7.348445311451679e-13
of O 0 8.545099982472897e-17
an O 0 6.182248265970908e-15
association O 0 5.1808935390233995e-15
of O 0 1.694023939907932e-16
POMC O 0 4.3735704821301624e-05
with O 0 2.0962642732769154e-10
human O 0 6.769281526430859e-07
obesity B-Disease 1 1.0
. O 0 6.003392227782456e-10

The O 0 4.859817409608169e-12
dual O 0 7.771008142531954e-11
role O 0 2.4461275019427298e-12
of O 0 1.8064125329841484e-15
alpha O 0 2.4612013815872302e-12
- O 0 1.0561135077580275e-08
MSH O 0 1.9824771868570679e-07
in O 0 5.717295787597025e-15
regulating O 0 4.352344526448171e-11
food O 0 1.9941513718091386e-10
intake O 0 2.6045271495078737e-10
and O 0 4.885084307557075e-13
influencing O 0 5.710844297457385e-11
hair O 0 0.006241974886506796
pigmentation O 0 7.378838290605927e-06
predicts O 0 5.573804084946232e-09
that O 0 5.783944829161614e-13
the O 0 9.437632627977942e-15
phenotype O 0 7.440763283295126e-11
associated O 0 5.3733389265842035e-12
with O 0 1.7717016818474124e-13
a O 0 1.2259130342806568e-11
defect O 0 5.563445597545069e-07
in O 0 5.714181162746676e-14
POMC O 0 6.853415470686741e-06
function O 0 1.001251193066821e-09
would O 0 4.9852025285623824e-11
include O 0 6.180872480499033e-10
obesity B-Disease 1 1.0
, O 0 5.222056467801828e-11
alteration O 0 1.5317353074806306e-07
in O 0 5.7498089622853854e-11
pigmentation O 1 0.837114155292511
and O 0 1.05057306427625e-05
ACTH B-Disease 0 0.0050577688962221146
deficiency I-Disease 0 0.011836661957204342
. O 0 1.764240836754638e-11

The O 0 1.2739287055807402e-11
observation O 0 1.4576270856991869e-08
of O 0 2.6134593417875308e-14
these O 0 1.0322775273463591e-10
symptoms O 0 9.910602329910034e-07
in O 0 3.0855205865228932e-15
two O 0 5.3495680378979477e-14
probands O 0 5.3441460146075315e-09
prompted O 0 1.738780668926465e-12
us O 0 2.9179390566118346e-14
to O 0 2.1768227936755325e-15
search O 0 8.294238099072412e-14
for O 0 2.5276257239456373e-15
mutations O 0 4.101523565225307e-10
within O 0 6.268170661336003e-13
their O 0 3.647645065770616e-13
POMC O 0 8.803667128631787e-07
genes O 0 5.33123634127719e-09
. O 0 1.4460304481600517e-11

Patient O 0 0.000500583671964705
1 O 0 6.121573387085633e-11
was O 0 8.793017702846129e-11
found O 0 6.191848249403886e-13
to O 0 9.597487226882615e-15
be O 0 3.530879710519127e-15
a O 0 1.2671787591469704e-16
compound O 0 3.4561715468728327e-12
heterozygote O 0 4.270823278362812e-12
for O 0 7.541747369500611e-16
two O 0 2.1601142641096416e-14
mutations O 0 3.410628029998364e-11
in O 0 2.739287822519699e-15
exon O 0 2.151062439281759e-09
3 O 0 8.866681694419398e-11
( O 0 3.979292007125386e-14
G7013T O 0 1.7062543045121004e-10
, O 0 1.6936129690510449e-13
C7133delta O 0 5.400235369990014e-09
) O 0 1.3703260904197444e-14
which O 0 1.25053598051361e-14
interfere O 0 4.2854456962226894e-12
with O 0 5.3176525140717634e-15
appropriate O 0 3.094254766758506e-15
synthesis O 0 5.111491132160466e-14
of O 0 4.684814293903815e-16
ACTH O 0 4.1005693285356415e-10
and O 0 2.590344388639365e-13
alpha O 0 1.1565270225874502e-12
- O 0 2.8996391066016258e-08
MSH O 0 1.7959893057195586e-06
. O 0 7.084343962154849e-12

Patient O 0 0.00991096068173647
2 O 0 1.7813954478196337e-10
was O 0 1.3933892017634064e-12
homozygous O 0 5.082426450184196e-13
for O 0 3.0350648984977635e-16
a O 0 5.393808229919861e-14
mutation O 0 8.181183161481975e-12
in O 0 1.0311142978130464e-14
exon O 0 3.962293959602903e-08
2 O 0 5.820788295807233e-09
( O 0 2.705585863856108e-13
C3804A O 0 2.730026205099989e-10
) O 0 3.4799366079724114e-13
which O 0 3.897098843717167e-13
abolishes O 0 3.675464483876567e-07
POMC O 0 4.632136096915929e-06
translation O 0 5.167368755110147e-09
. O 0 4.566554079321605e-11

These O 0 1.8357242809186047e-11
findings O 0 2.383290613472422e-12
represent O 0 3.923474822890285e-15
the O 0 1.506625804204107e-14
first O 0 4.9024708446455956e-14
examples O 0 2.5893107712744896e-14
of O 0 4.328548530519512e-16
a O 0 2.4783048946375175e-09
genetic B-Disease 1 1.0
defect I-Disease 1 0.9999997615814209
within O 0 8.577842212573183e-13
the O 0 1.9097079467919262e-14
POMC O 0 2.1420402163130348e-07
gene O 0 2.3799873183349973e-09
and O 0 2.23826992639016e-13
define O 0 8.036560132651527e-12
a O 0 3.590655333826631e-13
new O 0 1.1581926390169528e-10
monogenic B-Disease 0 0.0068069384433329105
endocrine I-Disease 0 0.0011329730041325092
disorder I-Disease 0 0.00721603911370039
resulting O 0 1.0072814977946098e-12
in O 0 4.620167096125449e-13
early O 0 3.642766728262359e-07
- O 1 0.9999853372573853
onset O 1 0.9999750852584839
obesity B-Disease 1 1.0
, O 0 0.00016265898011624813
adrenal B-Disease 1 0.9999997615814209
insufficiency I-Disease 1 0.9999998807907104
and O 0 1.9081994651060086e-07
red O 0 1.6756276011165028e-07
hair O 0 0.0715179592370987
pigmentation O 0 2.389680958003737e-05
. O 0 5.903316030453354e-12
. O 0 4.354152455254834e-12

A O 0 3.6027429928253696e-09
European O 0 3.739948795100645e-09
multicenter O 0 4.165705149716814e-07
study O 0 5.627426302723393e-10
of O 0 8.122290340306648e-11
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
: O 0 1.0547319684306444e-09
classification O 0 1.084045209154283e-08
of O 0 4.183164324848376e-16
105 O 0 4.540630649252364e-10
mutations O 0 5.946229748587939e-07
and O 0 1.98028832915087e-12
a O 0 7.461681791919635e-15
general O 0 1.2054673055659874e-14
system O 0 2.1507736929870895e-14
for O 0 9.92894667749451e-18
genotype O 0 1.9790600907197697e-13
- O 0 2.383519076554208e-11
based O 0 4.0581331562294584e-14
prediction O 0 1.4655510138794625e-10
of O 0 1.2124072794369024e-15
metabolic O 0 8.048247082115267e-07
phenotype O 0 8.104150595045212e-08
. O 0 1.9080868829401965e-11

Phenylketonuria B-Disease 0 0.00029807662940584123
( O 0 2.2958297589414922e-12
PKU B-Disease 0 5.680955439402169e-08
) O 0 4.1104944968617385e-12
and O 0 8.50272907637617e-10
mild B-Disease 0 0.0001306749472860247
hyperphenylalaninemia I-Disease 1 1.0
( O 0 1.5217064230910182e-07
MHP B-Disease 1 1.0
) O 0 2.2969457447175046e-09
are O 0 2.5125044406104635e-11
allelic B-Disease 0 3.671789090731181e-05
disorders I-Disease 1 0.9741937518119812
caused O 0 1.928489312685855e-10
by O 0 3.02208819492715e-14
mutations O 0 2.903474616289259e-08
in O 0 1.905356399728702e-14
the O 0 6.537110940453908e-14
gene O 0 5.244680689742154e-09
encoding O 0 5.2694071328573955e-09
phenylalanine O 0 0.005086804274469614
hydroxylase O 0 0.0023261471651494503
( O 0 5.774292068799758e-12
PAH O 0 3.053716568501841e-08
) O 0 1.0076447055223925e-12
. O 0 1.8833326825146157e-12

Previous O 0 3.94141501658396e-08
studies O 0 1.6754175824473805e-10
have O 0 8.343318440642844e-13
suggested O 0 2.4779466673008343e-12
that O 0 7.799963881163427e-15
the O 0 2.8481590848126624e-15
highly O 0 1.1585493848997874e-12
variable O 0 6.764917070967158e-09
metabolic O 0 0.00355915236286819
phenotypes O 0 4.152243127464317e-05
of O 0 3.998290032392049e-10
PAH B-Disease 1 0.9998155236244202
deficiency I-Disease 1 0.9982343912124634
correlate O 0 1.0795201887958683e-06
with O 0 3.125810055237821e-09
PAH O 0 0.0017208877252414823
genotypes O 0 3.111154910584446e-06
. O 0 2.0472278039473935e-10

We O 0 2.0086096341742632e-08
identified O 0 1.8305705909438252e-11
both O 0 7.122815249942238e-14
causative O 0 1.8617853925206873e-08
mutations O 0 9.832992020619713e-08
in O 0 3.025682731704754e-13
686 O 0 4.42903314024079e-09
patients O 0 2.108162888703191e-08
from O 0 1.417019306797565e-13
seven O 0 3.3135735821865353e-10
European O 0 1.7518084205470075e-10
centers O 0 2.1032779962126824e-09
. O 0 9.882819389239739e-12

On O 0 1.2441245256233913e-10
the O 0 2.8760654322929026e-15
basis O 0 5.716572950855662e-16
of O 0 3.4442694352638783e-18
the O 0 7.354463620302357e-16
phenotypic O 0 1.9995346524359636e-12
characteristics O 0 2.270477729438003e-11
of O 0 1.081451644747533e-15
297 O 0 4.352454785472304e-10
functionally O 0 5.772101729917267e-08
hemizygous O 0 1.1046336112485733e-05
patients O 0 6.467578828051046e-08
, O 0 2.4334578948258245e-14
105 O 0 2.456624096855431e-12
of O 0 1.4649933778108616e-16
the O 0 5.624495959038675e-14
mutations O 0 4.611370174600893e-10
were O 0 3.7653772244281014e-14
assigned O 0 2.2170846159397933e-13
to O 0 9.096463850449907e-15
one O 0 4.434513940407801e-15
of O 0 2.2019256738585978e-17
four O 0 5.1316149409213335e-14
arbitrary O 0 2.258816189648627e-10
phenotype O 0 2.577566426964495e-08
categories O 0 1.0541688633125545e-09
. O 0 1.0454242332924579e-10

We O 0 1.3328695480652186e-08
proposed O 0 2.487317643518061e-12
and O 0 1.0809053305194105e-11
tested O 0 1.8409839624977664e-11
a O 0 5.295584341180474e-16
simple O 0 9.813397619203631e-15
model O 0 1.562398214277616e-12
for O 0 4.344079276654114e-17
correlation O 0 1.699182352980777e-12
between O 0 2.489285904141991e-13
genotype O 0 4.157956097483595e-12
and O 0 2.8886910767057794e-13
phenotypic O 0 1.1255840010049312e-10
outcome O 0 3.026610628786841e-10
. O 0 2.3438554916377363e-11

The O 0 2.9157167132087825e-12
observed O 0 4.019468438642981e-11
phenotype O 0 2.350410699403227e-10
matched O 0 1.7707819932599733e-10
the O 0 4.170469376199755e-14
predicted O 0 1.2516947478502516e-08
phenotype O 0 2.1704748220940928e-08
in O 0 4.0305345866409326e-13
79 O 0 1.5813702347600156e-08
% O 0 5.406629513532565e-15
of O 0 3.5185599736433377e-17
the O 0 1.0892701671205707e-12
cases O 0 2.2129477417198729e-10
, O 0 2.9638166920697984e-10
and O 0 2.668545662221078e-10
in O 0 8.472120032430863e-13
only O 0 2.0983112816730376e-11
5 O 0 5.943077247775458e-14
of O 0 4.774366968057562e-18
184 O 0 2.359376799834778e-13
patients O 0 8.930234481584198e-13
was O 0 1.4246562913752814e-13
the O 0 1.8318521087637473e-15
observed O 0 3.4048219972604432e-12
phenotype O 0 9.82700682980453e-13
more O 0 3.0315689685313184e-17
than O 0 5.39976558204449e-15
one O 0 2.985225348167697e-12
category O 0 1.754923495411731e-08
away O 0 1.1027347923686648e-08
from O 0 6.2393217694733764e-15
that O 0 3.946949375405878e-13
expected O 0 2.0322086027868558e-12
. O 0 2.898997448347318e-12

Among O 0 5.520958690219402e-11
the O 0 3.8676714283515656e-13
seven O 0 9.015029255867932e-14
contributing O 0 5.387402627959545e-14
centers O 0 4.966752356616588e-11
, O 0 1.2238464636247365e-13
the O 0 1.5816090358707915e-15
proportion O 0 5.704456546885839e-14
of O 0 6.050975073335657e-17
patients O 0 3.93333742041823e-14
for O 0 2.3143409253115956e-18
whom O 0 4.6556105460582656e-14
the O 0 6.75506816671614e-16
observed O 0 1.0775515679392611e-12
phenotype O 0 5.880345689546207e-12
did O 0 1.8061321327422775e-09
not O 0 2.9964707798368906e-11
match O 0 3.80012521450368e-10
the O 0 1.4368737590812058e-13
predicted O 0 1.5301520051025364e-08
phenotype O 0 3.90404819583523e-09
was O 0 3.6260581204317077e-09
4 O 0 2.290271965132984e-11
% O 0 1.0170863988263196e-13
- O 0 1.3131202649674378e-05
23 O 0 6.02303051877584e-09
% O 0 1.798386302885851e-14
( O 0 5.760689370188157e-14
P O 0 3.069712306569272e-07
< O 0 1.303805761271315e-11
. O 0 4.0376346200927254e-14
0001 O 0 1.7799553497788168e-10
) O 0 8.240851306472868e-16
, O 0 3.1991807084018364e-16
suggesting O 0 1.256580966666962e-13
that O 0 1.3356706691190767e-13
differences O 0 3.516809239656471e-13
in O 0 1.8993084296370956e-17
methods O 0 2.539745918387899e-15
used O 0 1.369937884632106e-16
for O 0 1.187174268027051e-18
mutation O 0 3.2644856463219865e-14
detection O 0 7.248195533354762e-12
or O 0 1.0411553563738352e-11
phenotype O 0 4.068107045895886e-06
classification O 0 0.0015369860921055079
may O 0 4.9095949528066285e-09
account O 0 5.068921085822631e-13
for O 0 3.761484853925584e-15
a O 0 2.0032174703754624e-13
considerable O 0 4.5291176950339185e-14
proportion O 0 2.248694936854423e-12
of O 0 1.71311100681114e-15
genotype O 0 2.0599026651080266e-10
- O 0 9.751631750987144e-07
phenotype O 0 3.246054802730214e-08
inconsistencies O 0 1.9206284562756082e-08
. O 0 6.580153782964615e-11

Our O 0 2.381048691546539e-10
data O 0 1.0510257594797956e-11
indicate O 0 4.0280001556425304e-12
that O 0 1.2503793302403449e-13
the O 0 4.184668697714347e-14
PAH O 0 1.080659561836228e-08
- O 0 1.9243897586562753e-09
mutation O 0 4.850827378666267e-11
genotype O 0 1.910251606418792e-13
is O 0 8.415096042239327e-16
the O 0 2.0510272506136117e-17
main O 0 8.944826758623681e-13
determinant O 0 6.021703274905477e-11
of O 0 1.9810567506643555e-14
metabolic O 0 2.194982698711101e-05
phenotype O 0 1.2390248826932293e-08
in O 0 1.2921686832513546e-13
most O 0 2.4884992070456358e-12
patients O 0 1.2442841201831811e-09
with O 0 7.514775468564494e-10
PAH B-Disease 1 0.9994184970855713
deficiency I-Disease 1 0.7757500410079956
. O 0 2.2006476502189898e-11

In O 0 9.210381762825293e-11
the O 0 3.601073161451501e-13
present O 0 3.3410082968428345e-14
study O 0 2.7314478126148553e-14
, O 0 4.03925745051637e-15
the O 0 3.0780673318617658e-15
classification O 0 1.0539466868686453e-11
of O 0 2.0468310295405792e-16
105 O 0 1.485933154299346e-09
PAH O 0 6.981351674539837e-08
mutations O 0 3.344199583921181e-08
may O 0 5.00503338860675e-13
allow O 0 7.281999168159276e-14
the O 0 1.047699711140054e-14
prediction O 0 1.6660804680324048e-10
of O 0 3.0234265334535914e-17
the O 0 2.1568989270418643e-14
biochemical O 0 3.263846304335516e-09
phenotype O 0 8.79719422308689e-11
in O 0 1.7745179308717614e-14
> O 0 1.4894304539714298e-11
10 O 0 5.753368159493177e-13
, O 0 7.668239415843658e-14
000 O 0 2.0817416258693544e-13
genotypes O 0 6.081565806503875e-10
, O 0 4.1156561665645075e-12
which O 0 4.078546875230238e-11
may O 0 1.8681570179701623e-11
be O 0 3.542712125517559e-15
useful O 0 6.030748800057951e-15
for O 0 3.268856315153995e-16
the O 0 2.293166538277526e-14
management O 0 6.531758207223293e-12
of O 0 2.181261458077382e-15
hyperphenylalaninemia B-Disease 1 1.0
in O 0 5.355173526844226e-10
newborns O 0 3.2898292090521863e-08
. O 0 6.662691774163287e-13

Somatic O 0 1.2780733982253878e-07
instability O 0 6.294735754863723e-08
of O 0 3.695944578488951e-14
the O 0 1.6074030398816747e-13
CTG O 0 1.3456859733196325e-06
repeat O 0 3.682895055590052e-08
in O 0 7.180351148730613e-14
mice O 0 8.234120607575335e-10
transgenic O 0 7.526505113597537e-11
for O 0 3.6687287322673123e-14
the O 0 5.337773625879727e-11
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 2.153308514607488e-06
is O 0 1.6014840842348832e-10
age O 0 5.1713251736362764e-12
dependent O 0 1.2991376637655483e-13
but O 0 3.2820072614486717e-12
not O 0 5.389736034322641e-14
correlated O 0 1.744367047725251e-13
to O 0 1.0295344119598277e-14
the O 0 4.753203310548654e-15
relative O 0 1.5033060516908558e-12
intertissue O 0 6.543564801120283e-09
transcription O 0 8.241827487154296e-08
levels O 0 8.488324487743171e-10
and O 0 5.404433844891088e-11
proliferative O 0 0.00028624047990888357
capacities O 0 1.7425199416720716e-07
. O 0 8.491315289793633e-11

A O 0 4.927614427607807e-10
( O 0 1.9887775237412142e-13
CTG O 0 1.6443797434817498e-09
) O 0 1.626558588339877e-13
nexpansion O 0 8.387180727709165e-09
in O 0 6.34810888751336e-13
the O 0 5.658817598536148e-12
3 O 0 1.699069152039101e-08
- O 0 0.0009025373728945851
untranslated O 0 0.07570585608482361
region O 0 4.923584242533252e-07
( O 0 6.625177972419474e-14
UTR O 0 2.956330458214751e-10
) O 0 1.0918644325263668e-15
of O 0 2.8227806409890537e-17
the O 0 6.18464806277641e-13
DM O 1 0.9999997615814209
protein O 0 5.904835688852472e-06
kinase O 0 1.361907038699428e-06
gene O 0 5.464290353529577e-08
( O 0 1.0096449772154653e-13
DMPK O 0 7.3149957202645055e-09
) O 0 6.08150428480685e-15
is O 0 1.8509079413270253e-16
responsible O 0 1.0590679944350381e-13
for O 0 4.3648160037495706e-14
causing O 0 8.049981943258899e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
( O 0 2.1067279476483236e-08
DM B-Disease 1 0.9999997615814209
) O 0 2.0989738835908156e-09
. O 0 2.877355124997205e-11

Major O 0 3.959989669510833e-08
instability O 0 7.290307166840648e-06
, O 0 2.939887222552784e-11
with O 0 3.784950326247982e-13
very O 0 8.302895453419709e-14
large O 0 1.6686786230134948e-14
expansions O 0 2.430578849299536e-09
between O 0 1.1643673872296922e-11
generations O 0 1.0274604951565625e-11
and O 0 2.525528397523402e-12
high O 0 3.1445460384887935e-12
levels O 0 4.806612464818005e-14
of O 0 8.906295014389077e-18
somatic O 0 2.9749540504664385e-12
mosaicism O 0 3.3310666225361274e-08
, O 0 2.6531842044555387e-13
is O 0 1.6473454206105374e-14
observed O 0 2.263376985833787e-12
in O 0 2.5006594559819073e-13
patients O 0 7.388281653142315e-11
. O 0 1.5864031008977486e-12

There O 0 1.2670244409207498e-08
is O 0 2.064674928421717e-13
a O 0 6.229265963730163e-14
good O 0 2.546801745190175e-13
correlation O 0 1.3817338115687527e-12
between O 0 9.40129593098027e-13
repeat O 0 1.6045554218635516e-08
size O 0 4.6086596344752095e-11
( O 0 3.0127601260108994e-13
at O 0 1.872137861402834e-11
least O 0 5.846445289697799e-13
in O 0 1.5911356704857021e-13
leucocytes O 0 8.22890569907031e-07
) O 0 9.542586447593149e-14
, O 0 3.74632203243349e-14
clinical O 0 1.3286420574853963e-10
severity O 0 1.2755833056488086e-09
and O 0 1.0419564516750413e-10
age O 0 2.3235493390449946e-11
of O 0 4.36341568888117e-15
onset O 0 1.1358642382219841e-07
. O 0 3.159782852035775e-11

The O 0 4.672068287803199e-10
trinucleotide O 0 1.977440479095094e-05
repeat O 0 4.972973783878842e-07
instability O 0 4.632070726984239e-09
mechanisms O 0 5.884231296660047e-11
involved O 0 4.0460164515629393e-13
in O 0 7.786924750841084e-12
DM B-Disease 1 1.0
and O 0 4.0546680679653946e-07
other O 0 3.3985250724732907e-10
human O 0 5.195545782044064e-06
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 6.124814197483452e-13
unknown O 0 2.487097194858734e-10
. O 0 1.6178162975943877e-11

We O 0 2.5352731469752143e-08
studied O 0 2.6468636310506e-11
somatic O 0 1.003180871705922e-11
instability O 0 3.4942000681770224e-11
by O 0 1.3967717295824446e-15
measuring O 0 4.4874656768278953e-10
the O 0 1.182690962308816e-13
CTG O 0 9.083889551675384e-08
repeat O 0 1.5199741909555087e-08
length O 0 1.204343569316535e-10
at O 0 6.092321959416669e-12
several O 0 1.2002414849759252e-13
ages O 0 1.2545568750521596e-10
in O 0 2.3769824812874124e-14
various O 0 1.4442262761139163e-13
tissues O 0 2.478054428323162e-09
of O 0 7.307760341173123e-16
transgenic O 0 1.0288488994092404e-07
mice O 0 4.184641397841915e-07
carrying O 0 1.1110100198771095e-13
a O 0 1.0190961708409288e-13
( O 0 2.358723161450041e-14
CTG O 0 3.603485287939634e-09
) O 0 9.512909801253147e-14
55expansion O 0 1.9760908187560489e-10
surrounded O 0 1.4824639779642546e-11
by O 0 7.35268914980533e-14
45 O 0 1.289198023508853e-12
kb O 0 1.0891887392006083e-09
of O 0 3.597883828295205e-15
the O 0 1.7241407954116106e-12
human O 0 7.643697230719226e-09
DM B-Disease 1 1.0
region O 0 1.69249663173332e-08
, O 0 5.243786836499863e-14
using O 0 1.214180564087803e-14
small O 0 1.2636678162203374e-11
- O 0 3.0437145142059308e-06
pool O 0 1.9682750984628683e-09
PCR O 0 1.580079067586837e-09
. O 0 1.1895215715207463e-12

These O 0 8.973720100335925e-10
mice O 0 1.0930039024970029e-06
have O 0 1.0037469987123071e-12
been O 0 2.739294725838219e-14
shown O 0 2.0708856111602107e-14
to O 0 4.100021307163436e-14
reproduce O 0 4.9469527141354774e-08
the O 0 3.5732725236830784e-14
intergenerational O 0 5.0333757994902584e-11
and O 0 9.031176956449116e-13
somatic O 0 2.5961923583173174e-12
instability O 0 6.471644886651973e-10
of O 0 1.4435136810596766e-16
the O 0 1.6786736117910955e-14
55 O 0 2.95967872605829e-12
CTG O 0 4.910671869140515e-09
repeat O 0 2.782303901160965e-11
suggesting O 0 1.2362173459380676e-13
that O 0 1.1453123173772316e-15
surrounding O 0 1.4007589847157137e-13
sequences O 0 3.8652768097335866e-08
and O 0 4.887661109176378e-11
the O 0 1.2026057741602782e-14
chromatin O 0 1.0272581896231259e-08
environment O 0 5.027553928727002e-10
are O 0 8.785032387996722e-16
involved O 0 3.099507683932551e-14
in O 0 2.4343642878420224e-13
instability O 0 4.7576648398717225e-08
mechanisms O 0 8.690729802474095e-10
. O 0 4.8431150583005955e-12

As O 0 3.08198015719352e-11
observed O 0 1.3362581006981511e-11
in O 0 5.357782499892949e-16
some O 0 3.494524421148262e-16
of O 0 2.3932436821659465e-16
the O 0 1.4195160888755276e-13
tissues O 0 2.8422184050747035e-10
of O 0 2.0236120247475904e-14
DM B-Disease 1 1.0
patients O 0 6.193616172822658e-06
, O 0 1.2181245866594442e-13
there O 0 1.5542355271715158e-13
is O 0 2.996870330021495e-15
a O 0 1.6640944807029545e-15
tendency O 0 6.543017863624989e-12
for O 0 1.7067706475635863e-15
repeat O 0 2.111075092514625e-09
length O 0 2.4615877045053303e-11
and O 0 4.166821781278335e-13
somatic O 0 1.9322125279983005e-13
mosaicism O 0 2.5658258850924653e-10
to O 0 1.7559194590423093e-14
increase O 0 1.1805065998631188e-14
with O 0 1.2151525445591727e-12
the O 0 1.447216912281446e-11
age O 0 5.5927332209826375e-11
of O 0 9.04479449656026e-17
the O 0 2.383798724820557e-13
mouse O 0 2.1196221666741621e-07
. O 0 1.3624996964001213e-10

Furthermore O 0 3.964108827858581e-07
, O 0 1.1206249123096867e-10
we O 0 5.136793074234092e-11
observed O 0 8.00095070491863e-13
no O 0 1.771163510994045e-14
correlation O 0 1.4648502408894787e-13
between O 0 5.038149005653263e-15
the O 0 1.1597813341822296e-15
somatic O 0 1.9295405551122968e-11
mutation O 0 1.0461055133248465e-08
rate O 0 6.768427596171023e-09
and O 0 2.6368876526738916e-10
tissue O 0 5.247552508080844e-06
proliferation O 0 1.4035209460416809e-05
capacity O 0 4.917471638221649e-11
. O 0 1.465612006756878e-11

The O 0 1.3903945269427842e-12
somatic O 0 6.257378643015343e-11
mutation O 0 3.2587890164137434e-09
rates O 0 5.296874050486622e-10
in O 0 1.4525437669614567e-14
different O 0 2.9564385336557086e-13
tissues O 0 2.4988159097460994e-08
were O 0 2.1948587045073076e-11
also O 0 2.082943366399359e-11
not O 0 1.5789188804061355e-13
correlated O 0 5.601256763097806e-13
to O 0 3.9096587837843255e-13
the O 0 2.8751152934131108e-12
relative O 0 7.85072007403187e-09
inter O 0 5.525556389329722e-06
- O 0 0.01265442930161953
tissue O 0 8.68401002662722e-06
difference O 0 4.455960882394916e-13
in O 0 9.685674182831645e-17
transcriptional O 0 5.686016761596857e-12
levels O 0 1.4213963664931606e-13
of O 0 1.4255855669865493e-17
the O 0 2.6025405788776546e-14
three O 0 5.724207999963093e-13
genes O 0 4.078490583453442e-12
( O 0 4.044484490833876e-15
DMAHP O 0 1.6548699077745255e-09
, O 0 6.159256047896799e-13
DMPK O 0 8.613472601837202e-08
and O 0 3.971428047533365e-11
59 O 0 9.801034289713684e-11
) O 0 3.4789244036004426e-15
surrounding O 0 1.181275780318125e-12
the O 0 1.210454262864924e-12
repeat O 0 1.1385903775362749e-08
. O 0 1.3715557281492735e-13
. O 0 1.8182582176007323e-12

A O 0 3.0248162308232907e-10
novel O 0 5.939202463167703e-10
missense O 0 2.644365508785995e-07
mutation O 0 1.3608952542654151e-07
in O 0 2.0166351498863283e-13
patients O 0 1.6648788250805957e-11
from O 0 1.3673698395547085e-15
a O 0 1.0273016812223368e-11
retinoblastoma B-Disease 0 0.01204871479421854
pedigree O 0 3.3434171200497076e-05
showing O 0 6.9785937029109846e-09
only O 0 1.3589908365307934e-10
mild O 0 2.359474837732023e-10
expression O 0 1.4120657225967503e-13
of O 0 5.47823058499251e-16
the O 0 1.16355644737276e-12
tumor B-Disease 0 6.053259085092577e-07
phenotype O 0 5.547490911084196e-09
. O 0 4.659995479772139e-12

We O 0 3.06670955296795e-08
have O 0 4.877167937632036e-14
used O 0 4.1209364141036285e-15
single O 0 2.6225874770469115e-14
strand O 0 5.392006632853885e-11
conformation O 0 3.445368990107056e-13
polymorphism O 0 1.3078426145882172e-12
analysis O 0 1.567771411824237e-12
to O 0 2.656129642945003e-14
study O 0 1.5173458193032396e-13
the O 0 2.3746216310568252e-14
27 O 0 3.286763569643192e-11
exons O 0 1.7991137746253827e-10
of O 0 7.532891110641475e-16
the O 0 7.501598897185352e-14
RB1 O 0 2.7369997823711856e-08
gene O 0 3.796662151334118e-10
in O 0 1.8353154147268333e-14
individuals O 0 1.7282660408940751e-16
from O 0 5.227244664204812e-16
a O 0 2.3453882065649356e-12
family O 0 5.845417483385518e-10
showing O 0 3.0565605158017206e-08
mild O 0 1.4375756141049578e-09
expression O 0 4.610903469475826e-14
of O 0 2.6864269315012815e-16
the O 0 1.3687281288834313e-13
retinoblastoma B-Disease 0 3.4926545140478993e-06
phenotype O 0 7.769967425019786e-08
. O 0 6.867664856941014e-12

In O 0 2.5179447069034744e-11
this O 0 5.762659230010292e-13
family O 0 1.4245598624340605e-11
affected O 0 5.766345734237177e-12
individuals O 0 9.87826170823847e-15
developed O 0 8.67497149670271e-08
unilateral B-Disease 1 0.999972939491272
tumors I-Disease 1 1.0
and O 0 3.0008018256921787e-06
, O 0 9.851145073291878e-12
as O 0 3.470489141291916e-14
a O 0 4.9074107407939827e-14
result O 0 6.520822158065029e-14
of O 0 1.5207907467689526e-17
linkage O 0 5.2969397756896797e-08
analysis O 0 2.2019911935511338e-11
, O 0 7.742856242233184e-14
unaffected O 0 8.460135370036426e-10
mutation O 0 2.0211578938278407e-11
carriers O 0 1.2420777080468515e-11
were O 0 9.262064205872722e-12
also O 0 8.166115561536458e-10
identified O 0 2.3115989122857172e-09
within O 0 3.866316555106719e-12
the O 0 4.7151414717117035e-12
pedigree O 0 3.6021063465341285e-07
. O 0 1.8295512674293413e-11

A O 0 1.941558441798108e-10
single O 0 7.827603040570785e-13
band O 0 1.353574370643873e-13
shift O 0 2.1667671996905558e-13
using O 0 3.7844578274111307e-14
SSCP O 0 2.1386718174198904e-08
was O 0 4.813241385320799e-12
identified O 0 4.7884352732951996e-12
in O 0 7.157458050451992e-15
exon O 0 5.7653895879639094e-08
21 O 0 1.305617445268581e-07
which O 0 2.4695243679845325e-12
resulted O 0 1.6496863554024688e-12
in O 0 6.817797838603017e-15
a O 0 5.73906292497886e-14
missense O 0 8.543146634565346e-09
mutation O 0 4.069034605785893e-12
converting O 0 6.75925109069539e-14
a O 0 1.0927114654736211e-13
cys O 0 9.296129064750858e-06
- O 0 1.9688904728809575e-07
- O 0 1.7214563996503784e-08
> O 0 2.8090171248079665e-12
arg O 0 2.1390181292879618e-12
at O 0 2.1611445949866817e-14
nucleotide O 0 3.573390227381429e-13
position O 0 2.2720794429914593e-12
28 O 0 1.0116767720867031e-13
in O 0 5.563330264667476e-17
the O 0 1.2279815683589488e-15
exon O 0 5.5646158791944345e-09
. O 0 1.1483907574882934e-10

The O 0 4.957438973218764e-11
mutation O 0 3.3134284205260656e-10
destroyed O 0 8.926229755346071e-10
an O 0 6.880293623517334e-15
NdeI O 0 1.072197619578219e-06
restriction O 0 1.2036375451884851e-08
enzyme O 0 8.58664472858095e-10
site O 0 5.725516727395075e-10
. O 0 1.8349261346473078e-11

Analysis O 0 2.0052819404980937e-09
of O 0 8.550553657043353e-15
all O 0 1.8624911454680898e-13
family O 0 3.332990079676218e-13
members O 0 7.551156449706728e-17
demonstrated O 0 4.723199285974538e-15
that O 0 4.2063984385915616e-16
the O 0 1.6244424332222574e-15
missense O 0 4.110095019882465e-08
mutation O 0 5.580197193211234e-09
co O 0 8.634263792828278e-08
- O 0 1.2968934015589184e-07
segregated O 0 4.0893894492910476e-07
with O 0 7.725681205883461e-11
patients O 0 1.60883661948219e-08
with O 0 6.463422863589585e-08
tumors B-Disease 1 1.0
or O 0 2.0980596673325635e-06
who O 0 9.563984804117354e-07
, O 0 8.140878921501782e-13
as O 0 7.676829007555175e-14
a O 0 1.3662190140057567e-13
result O 0 1.8844851352138592e-13
of O 0 3.289969438544921e-18
linkage O 0 9.665690470228583e-09
analysis O 0 1.2367257391787678e-11
had O 0 3.3620400907707904e-10
been O 0 5.972716353615237e-13
predicted O 0 4.360402230257909e-12
to O 0 1.386700507839591e-15
carry O 0 2.0401848342243428e-13
the O 0 2.1541730056110105e-14
predisposing O 0 3.613080679087943e-08
mutation O 0 3.245669510931748e-09
. O 0 1.0618158262365451e-11

These O 0 4.573210733715971e-12
observations O 0 3.1870795065558344e-12
point O 0 6.522085389121246e-12
to O 0 7.967226630224786e-15
another O 0 1.8913051734546077e-13
region O 0 1.5765042049586953e-11
of O 0 1.3343452954906842e-15
the O 0 2.0079417458167964e-13
RB1 O 0 3.132053905119392e-08
gene O 0 3.317543462166839e-11
where O 0 4.024496664742361e-13
mutations O 0 8.93981763616658e-12
only O 0 3.4525838812264967e-14
modify O 0 1.7306099608926928e-10
the O 0 4.753879039552655e-13
function O 0 3.91349582948286e-12
of O 0 5.1638034846422415e-16
the O 0 1.7620497075321317e-13
gene O 0 1.3480974558888192e-08
and O 0 1.5021317523178368e-11
raise O 0 8.299697057010877e-14
important O 0 2.190834836205487e-15
questions O 0 5.998008859064204e-15
for O 0 7.68392290848843e-17
genetic O 0 1.506976626819423e-10
counseling O 0 1.3351815584140142e-13
in O 0 1.1098968110613452e-15
families O 0 5.9080154200666975e-15
with O 0 4.689834404072307e-14
these O 0 1.6561295249680613e-13
distinctive O 0 5.3546903022727577e-11
phenotypes O 0 6.432244514797958e-09
. O 0 5.222449534457441e-13
. O 0 1.949850871041381e-12

Maternal B-Disease 0 0.006179443560540676
disomy I-Disease 0 0.0559433288872242
and O 0 0.04603959992527962
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 1.9874589085588923e-08
with O 0 6.809497085126515e-14
gamete O 0 9.854688176602622e-10
complementation O 0 4.924002183770426e-08
in O 0 7.78480368547347e-15
a O 0 1.8327128212930997e-14
case O 0 2.5580000357489086e-12
of O 0 4.860095056843884e-16
familial O 0 1.949992878280682e-07
translocation O 0 1.8160595800509327e-06
( O 0 1.3850320629976709e-12
3 O 0 2.3561819162409847e-11
; O 0 2.1402346041254905e-12
15 O 0 8.213183280182668e-13
) O 0 4.748835585156137e-15
( O 0 2.5085952759009973e-16
p25 O 0 5.962916250178141e-13
; O 0 1.882734521399792e-14
q11 O 0 1.617850298174517e-11
. O 0 2.9812107237058363e-14
2 O 0 4.053168933294826e-13
) O 0 8.487642825984881e-14
. O 0 1.623131750533302e-12

Maternal B-Disease 0 0.012093552388250828
uniparental I-Disease 0 0.033453308045864105
disomy I-Disease 0 0.11200594156980515
( I-Disease 0 2.560665812723073e-08
UPD I-Disease 1 0.9999992847442627
) I-Disease 0 9.542896473035967e-10
for I-Disease 0 2.711128576412397e-13
chromosome I-Disease 0 0.21854078769683838
15 I-Disease 0 4.772056083623966e-10
is O 0 3.370013415462253e-14
responsible O 0 1.0564936241391071e-13
for O 0 1.8617069496600276e-16
an O 0 7.214939823835037e-16
estimated O 0 3.588035034016168e-12
30 O 0 4.6383231457058915e-12
% O 0 1.2610792748937922e-15
of O 0 1.9680793985841417e-17
cases O 0 1.2706115673499774e-11
of O 0 7.33241134476259e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.8389024464559043e-10
PWS B-Disease 1 0.9999970197677612
) O 0 5.255680612936686e-11
. O 0 1.489453178848965e-11

We O 0 4.5212945565253904e-07
report O 0 3.0420720196350226e-12
on O 0 7.792197541949171e-16
an O 0 4.457232952239938e-18
unusual O 0 2.292318150077556e-14
case O 0 3.1629286863232853e-12
of O 0 3.3383184166638864e-15
maternal B-Disease 0 3.017915730652021e-07
disomy I-Disease 0 3.150405291307834e-06
15 I-Disease 0 1.02957968539652e-10
in O 0 6.214177176305791e-12
PWS B-Disease 1 1.0
that O 0 3.7029184163372975e-09
is O 0 1.0214761978974418e-13
most O 0 2.0947158666916738e-15
consistent O 0 3.320629361758254e-13
with O 0 1.7014994556537044e-14
adjacent O 0 7.288357295465175e-08
- O 0 4.354005341156153e-06
1 O 0 9.360984210005086e-13
segregation O 0 5.820440796000526e-10
of O 0 1.6114057358961766e-17
a O 0 9.329519036656297e-14
paternal O 0 2.376372210122213e-09
t O 0 1.2831975482185953e-08
( O 0 1.8564466844751652e-14
3 O 0 5.952541519589627e-13
; O 0 1.2451884412890274e-13
15 O 0 7.222313160937591e-14
) O 0 3.5198369419857725e-16
( O 0 3.136355546785046e-17
p25 O 0 1.0243364587537301e-13
; O 0 3.1746612751007517e-15
q11 O 0 9.41559981024187e-13
. O 0 6.55226190348474e-15
2 O 0 1.322715046080938e-14
) O 0 1.9222919076546775e-16
with O 0 1.1133869044413882e-15
simultaneous O 0 3.4291201822522765e-11
maternal O 0 4.439141676471081e-08
meiotic O 0 7.708115035143237e-09
nondisjunction O 0 1.2021970974274154e-07
for O 0 6.571818284874242e-13
chromosome O 0 2.274279268021928e-06
15 O 0 1.9872067880122302e-10
. O 0 1.962934502441893e-11

The O 0 4.995828195575314e-10
patient O 0 6.16128970065688e-09
( O 0 5.731560516995804e-13
J O 0 3.184971501468681e-05
. O 0 5.71411286343082e-11
B O 0 3.0196024454198778e-05
. O 0 1.5757630389325733e-13
) O 0 2.8230636161678856e-15
, O 0 5.794539263155986e-15
a O 0 2.5912784288109614e-13
17 O 0 6.378628181202828e-11
- O 0 9.186981730913146e-10
year O 0 6.541276987301683e-14
- O 0 2.37516335488408e-08
old O 0 7.50799813431513e-07
white O 0 2.0334942063549022e-10
male O 0 4.704909638969523e-12
with O 0 1.1826345837958468e-13
PWS B-Disease 1 0.9999997615814209
, O 0 7.939660214006938e-12
was O 0 2.1850719150728892e-11
found O 0 3.4532129759845542e-12
to O 0 1.4554654139894985e-12
have O 0 7.524183498475168e-10
47 O 0 1.1719942705212816e-07
chromosomes O 0 6.077602865417475e-09
with O 0 2.7150617908436314e-13
a O 0 1.871729984545545e-12
supernumerary O 0 2.871290917028091e-06
, O 0 5.929162716356018e-10
paternal O 0 1.9812334528523934e-07
der O 0 0.004595752339810133
( O 0 4.787620495362577e-13
15 O 0 6.589843145991814e-13
) O 0 1.3137332781148429e-15
consisting O 0 7.677890445717203e-16
of O 0 1.269559980519939e-15
the O 0 1.5673246034353383e-10
short O 0 4.866348035648116e-07
arm O 0 0.0020746488589793444
and O 0 2.0114253318492814e-10
the O 0 1.043398698062463e-13
proximal O 0 2.4324942060616195e-09
long O 0 2.717581764954957e-06
arm O 0 5.512054485734552e-05
of O 0 1.2361979150022576e-14
chromosome O 0 0.00011496997467475012
15 O 0 4.5977571749844515e-10
, O 0 1.170972498652778e-12
and O 0 3.845108606514991e-11
distal O 0 1.910467108245939e-05
chromosome O 1 0.9987844824790955
arm O 0 0.07567289471626282
3p O 0 2.2254072973737493e-05
. O 0 3.4628130918257227e-10

The O 0 1.312670305786412e-09
t O 0 5.902224486931118e-08
( O 0 1.2411504658228767e-13
3 O 0 4.399891095994285e-13
; O 0 7.203561206738096e-14
15 O 0 7.213364427256438e-14
) O 0 2.9579248138979263e-15
was O 0 3.3025409663933747e-12
present O 0 3.7680067535095577e-14
in O 0 6.989431955298567e-14
the O 0 1.643680309047768e-13
balanced O 0 1.0231497723708904e-12
state O 0 7.104447780938161e-13
in O 0 5.618687481424856e-13
the O 0 3.3043873626931175e-12
patients O 0 1.929828657987187e-10
father O 0 1.6669761057630517e-11
and O 0 9.267043512770079e-13
a O 0 1.0839975835355564e-12
sister O 0 2.0565187242027605e-06
. O 0 1.7357629222836124e-11

Fluorescent O 0 4.557282995421019e-09
in O 0 1.7356782515149521e-13
situ O 0 5.3945034203528586e-12
hybridization O 0 1.177714501442162e-12
analysis O 0 1.8567096373833109e-13
demonstrated O 0 1.9117596299967655e-14
that O 0 1.7922327779306378e-14
the O 0 2.973471891886542e-13
PWS B-Disease 1 0.9999998807907104
critical O 0 1.6409896774760568e-09
region O 0 1.8058936290810124e-10
resided O 0 7.692116943402993e-10
on O 0 9.264214829302064e-13
the O 0 1.384950643649682e-15
derivative O 0 3.71955504591126e-12
chromosome O 0 4.033451617146966e-08
3 O 0 2.794131245820175e-11
and O 0 1.0166373819175956e-11
that O 0 1.2560048487375575e-11
there O 0 1.5653339735521854e-11
was O 0 1.5252639429252923e-10
no O 0 2.8028553328111883e-13
deletion O 0 9.078069893031504e-12
of O 0 1.7807208060840638e-16
the O 0 1.0508234039863229e-11
PWS B-Disease 1 1.0
region O 0 2.4741641624359545e-08
on O 0 1.4226218814084035e-10
the O 0 1.980026521431269e-13
normal O 0 7.387126327307314e-11
pair O 0 4.9010011327066394e-11
of O 0 2.7398508876713863e-16
15s O 0 1.7401541362385697e-12
present O 0 1.4086575330675422e-13
in O 0 1.2036740961590686e-12
J O 0 0.0001378222368657589
. O 0 3.018048658209871e-11

B O 0 0.010494714602828026
. O 0 2.1246435721877788e-09

Methylation O 0 3.678395188444483e-08
analysis O 0 2.1502357186453658e-11
at O 0 5.560029297862687e-14
exon O 0 3.836153129096326e-13
alpha O 0 8.703882883528968e-14
of O 0 2.8684709878273797e-16
the O 0 8.078939264539314e-14
small O 0 7.063376793181586e-12
nuclear O 0 7.673865098922761e-08
ribonucleoprotein O 0 3.256918512661855e-09
- O 0 8.315646482515149e-08
associated O 0 1.0522784865685253e-09
polypeptide O 0 3.33733716217921e-08
N O 0 7.696039361348994e-09
( O 0 6.332647012568908e-15
SNRPN O 0 5.31031468797849e-11
) O 0 2.5860667621414478e-15
gene O 0 1.602693325275517e-11
showed O 0 2.1385339679658166e-11
a O 0 2.1737121922316832e-14
pattern O 0 1.0174071363167059e-08
characteristic O 0 1.6267759361809908e-09
of O 0 2.6700067531264596e-14
only O 0 1.0964089636189556e-09
the O 0 8.046222542412718e-12
maternal O 0 2.963696204005828e-07
chromosome O 0 1.0564625881670509e-05
15 O 0 2.41465458739043e-10
in O 0 2.0180261975366598e-11
J O 0 0.011867163702845573
. O 0 1.736889798653607e-10

B O 0 0.005139323882758617
. O 0 1.4326431152511532e-09

Maternal B-Disease 0 0.00014272850239649415
disomy I-Disease 0 1.3995722838444635e-06
was O 0 5.006986492084309e-11
confirmed O 0 4.887199585995594e-13
by O 0 8.932908061672868e-17
polymerase O 0 2.5397911551650054e-10
chain O 0 4.745027148977954e-10
reaction O 0 1.863223117459789e-13
analysis O 0 2.865061839033359e-14
of O 0 9.165455663385616e-17
microsatellite O 0 7.075037444792542e-09
repeats O 0 2.3465473120154456e-08
at O 0 2.883703475661803e-13
the O 0 3.122330732586434e-16
gamma O 0 1.8986749021968063e-13
- O 0 1.5750938331393627e-08
aminobutyric O 0 7.0034493759862926e-09
acid O 0 9.26209976770398e-12
receptor O 0 3.0815478749453284e-13
beta3 O 0 5.6177184432071314e-11
subunit O 0 1.6419992102112424e-11
( O 0 1.8227888816391147e-13
GABRB3 O 0 3.433751061265866e-09
) O 0 9.895484090341813e-14
locus O 0 4.9503432603126285e-11
. O 0 1.7477191568970873e-11

A O 0 8.272909024498176e-10
niece O 0 2.503143150534015e-07
( O 0 1.9571798608869484e-12
B O 0 2.3896170660009375e-06
. O 0 5.854870624780184e-13
B O 0 1.1427462709434622e-07
. O 0 4.890784754588802e-15
) O 0 1.353353561860018e-15
with O 0 2.5084352184377018e-14
45 O 0 1.233333574157669e-11
chromosomes O 0 5.680136916375034e-10
and O 0 4.368451780867311e-12
the O 0 5.904725544099562e-15
derivative O 0 1.614609487776697e-12
3 O 0 1.2375108533399515e-12
but O 0 1.9694973082962086e-11
without O 0 1.115700820576368e-13
the O 0 3.1589284004351556e-14
der O 0 0.0003948465164285153
( O 0 1.9111070758142008e-14
15 O 0 8.803928316621426e-14
) O 0 2.716467907887721e-15
demonstrated O 0 1.3101805678241742e-14
a O 0 4.7770364459921374e-14
phenotype O 0 7.1890440267452504e-09
consistent O 0 1.865497166464447e-11
with O 0 3.801690882129609e-14
that O 0 2.5147995665053546e-12
reported O 0 3.5541386500526073e-10
for O 0 7.986483606643258e-16
haploinsufficiency O 0 2.3199923759875674e-08
of O 0 1.8663725130126227e-15
distal O 0 1.6415640402556164e-07
3 O 0 2.9604763085444574e-07
p O 0 0.0001378287997795269
. O 0 2.1732853017208953e-10

Uniparental B-Disease 1 0.9999648332595825
disomy I-Disease 1 0.9999849796295166
associated O 0 7.530026095992071e-07
with O 0 3.423271388580673e-11
unbalanced O 0 8.71829797688406e-06
segregation O 0 1.2103238987037912e-05
of O 0 5.452062073834328e-14
non O 0 1.6074822029032987e-10
- O 0 5.481524567585438e-07
Robertsonian O 0 3.6026740417582914e-06
translocations O 0 4.407051528687589e-05
has O 0 2.600626825000063e-09
been O 0 2.321204860267212e-12
reported O 0 2.171771790182575e-11
previously O 0 4.9510891914072985e-11
but O 0 1.1202018479483655e-10
has O 0 1.0515557175017065e-10
not O 0 1.3289455473575185e-11
, O 0 6.655895994946148e-13
to O 0 7.882302666475938e-13
our O 0 8.687596134019163e-14
knowledge O 0 1.1340436028051972e-15
, O 0 3.5524017589176745e-15
been O 0 7.563636945494973e-14
observed O 0 9.873068210425676e-14
in O 0 1.0314516075084668e-16
a O 0 4.777781242062658e-15
case O 0 9.612372746728437e-13
of O 0 1.0431897858563521e-13
PWS B-Disease 1 0.9999998807907104
. O 0 1.8614793040327982e-09

Furthermore O 0 2.7132389277539914e-06
, O 0 2.600694937182624e-10
our O 0 2.5386793361947824e-12
findings O 0 2.1967839873571204e-12
are O 0 2.8786338479472144e-15
best O 0 1.2148853971438722e-13
interpreted O 0 1.7278260866873153e-14
as O 0 2.8026563478312193e-14
true O 0 3.0464834214344316e-13
gamete O 0 1.450348452447514e-10
complementation O 0 1.7936677920715738e-08
resulting O 0 1.484634290505049e-11
in O 0 6.070993013862491e-11
maternal B-Disease 0 0.0005063083954155445
UPD I-Disease 1 0.9999997615814209
15 I-Disease 0 4.263261416781461e-06
and O 0 1.0240621151069718e-07
PWS B-Disease 1 0.9999963045120239

Schwartz B-Disease 1 0.9948057532310486
- I-Disease 1 0.9997554421424866
Jampel I-Disease 1 0.999671220779419
syndrome I-Disease 1 0.9999958276748657
type I-Disease 0 0.0011518164537847042
2 I-Disease 0 6.049800216345602e-09
and O 0 1.8053649242233405e-08
Stuve B-Disease 1 0.9999309778213501
- I-Disease 1 0.9999955892562866
Wiedemann I-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999985694885254
: O 0 3.50521512043709e-14
a O 0 9.153964470316029e-16
case O 0 4.846753423951022e-13
for O 0 1.4363461676693496e-15
" O 0 5.974539981669358e-13
lumping O 0 1.1078149508847446e-09
" O 0 1.043815815032767e-11
. O 0 3.109593474642097e-13

Recent O 0 1.2198993815104586e-08
studies O 0 2.559462086715314e-10
demonstrated O 0 2.8151636837642213e-12
the O 0 4.074666815843389e-15
existence O 0 1.1120487533209863e-13
of O 0 9.40215637351787e-17
a O 0 2.6208787744230744e-13
genetically O 0 7.018097214483987e-11
distinct O 0 1.9213710483745317e-13
, O 0 3.5219307396687494e-13
usually O 0 1.325801549437438e-14
lethal O 0 3.014638370749459e-14
form O 0 5.001688472438702e-15
of O 0 1.4863000416127903e-15
the O 0 2.508861451921973e-10
Schwartz B-Disease 1 0.999991774559021
- I-Disease 1 0.9999704360961914
Jampel I-Disease 1 0.9998880624771118
syndrome I-Disease 1 0.9999481439590454
( O 0 1.451687924871551e-14
SJS B-Disease 0 7.018380074441666e-06
) O 0 7.896849542549447e-14
of O 0 1.5463920529019178e-15
myotonia B-Disease 1 0.9760348796844482
and O 0 5.6032590123322734e-08
skeletal B-Disease 1 0.9889034628868103
dysplasia I-Disease 1 0.9999860525131226
, O 0 2.161801626598958e-09
which O 0 8.913226406948027e-11
we O 0 1.9153147123862624e-10
called O 0 2.6644400227815446e-11
SJS B-Disease 0 0.005556968972086906
type I-Disease 0 1.8889613784267567e-06
2 I-Disease 0 1.0058753135977483e-10
. O 0 8.823775043964588e-12

This O 0 6.976956345994267e-09
disorder O 0 0.00011381482909200713
is O 0 7.427323594480159e-14
reminiscent O 0 2.3925651390643843e-11
of O 0 2.6443654988021195e-15
another O 0 1.0639891745434227e-11
rare O 0 5.194650265494261e-10
condition O 0 2.3192409059902275e-07
, O 0 1.350392237267628e-13
the O 0 2.532237657407177e-12
Stuve B-Disease 1 0.9997778534889221
- I-Disease 1 0.9999977350234985
Wiedemann I-Disease 1 0.9999994039535522
syndrome I-Disease 1 0.9999994039535522
( O 0 1.1905521056856938e-12
SWS B-Disease 0 9.810391020437237e-06
) O 0 7.169297707582123e-13
, O 0 3.8275507980092827e-13
which O 0 3.6185751660713916e-13
comprises O 0 1.0801097863333275e-11
campomelia B-Disease 0 1.3146157584742468e-07
at O 0 2.2488377479645827e-11
birth O 0 2.490271704125302e-11
with O 0 6.841200240852163e-13
skeletal B-Disease 0 0.06696458905935287
dysplasia I-Disease 1 0.9998446702957153
, O 0 3.198738773857457e-10
contractures B-Disease 0 0.00022759517014492303
, O 0 1.6185462969886544e-09
and O 0 3.003653437083642e-10
early B-Disease 0 4.253438989909597e-10
death I-Disease 0 3.7391054141799884e-10
. O 0 6.984602132775741e-12

To O 0 4.389351035416489e-11
test O 0 6.769217564955854e-12
for O 0 2.0574923288452037e-17
possible O 0 4.1680438126519975e-14
nosologic O 0 1.1297711921542941e-07
identity O 0 4.6475731596551384e-10
between O 0 1.1057165183459006e-09
these O 0 7.060770856881504e-10
disorders O 0 5.214579505263828e-05
, O 0 2.1684291460957045e-13
we O 0 3.4999496356658e-11
reviewed O 0 2.4633489692504895e-11
the O 0 1.335789677248166e-14
literature O 0 1.323208469877768e-12
and O 0 8.016042257058542e-13
obtained O 0 2.984151960911882e-14
a O 0 3.783661870550596e-15
follow O 0 2.2913064674778827e-12
- O 0 3.6205832776303737e-10
up O 0 7.624904874159455e-11
of O 0 2.0246059437958105e-16
the O 0 2.4816522060521103e-14
only O 0 6.307752063727801e-12
two O 0 1.059703106515153e-12
surviving O 0 1.0343316203531572e-09
patients O 0 2.5123723631018113e-13
, O 0 1.368579852589641e-16
one O 0 3.847896190589152e-15
with O 0 5.6387389874533456e-14
SJS B-Disease 0 0.0002043139684246853
type I-Disease 0 2.94777862563933e-07
2 I-Disease 0 5.070937419970889e-11
at O 0 8.572424436970039e-10
age O 0 2.425446510301299e-10
10 O 0 1.2760578455440347e-13
years O 0 1.8424950353943502e-14
and O 0 3.074595089701086e-14
another O 0 1.36770247362826e-13
with O 0 9.690462408201705e-13
SWS B-Disease 0 8.63670211401768e-05
at O 0 2.7858737539077083e-10
age O 0 1.5108697279386796e-11
7 O 0 9.833123898461693e-12
years O 0 3.5834098817584537e-13
. O 0 9.539606517922072e-13

Patients O 0 5.6813296396285295e-06
reported O 0 8.038070209437365e-10
as O 0 3.2323017960106393e-12
having O 0 1.3797600562082124e-10
either O 0 5.251223900160085e-10
neonatal O 1 0.9999719858169556
SJS B-Disease 1 0.999735414981842
or O 0 1.609554045600703e-09
SWS B-Disease 0 5.415007035480812e-05
presented O 0 1.0511249937941378e-13
a O 0 7.11594157757527e-15
combination O 0 8.721831172868108e-14
of O 0 1.4827598938795206e-16
a O 0 2.5014192106542765e-12
severe O 0 1.6568153515805761e-09
, O 0 5.259325960849104e-13
prenatal O 0 0.013411082327365875
- O 0 0.05930972099304199
onset O 0 0.0005769036943092942
neuromuscular B-Disease 1 0.999991774559021
disorder I-Disease 1 0.9998959302902222
( O 0 2.0161708674110157e-12
with O 0 1.3754612726568638e-10
congenital B-Disease 1 0.9999798536300659
joint I-Disease 0 7.725365867372602e-05
contractures I-Disease 1 0.999942421913147
, O 0 1.6089681594166905e-05
respiratory O 1 0.9999986886978149
and O 0 3.9335634482995374e-07
feeding O 0 2.7685038730851375e-05
difficulties O 0 2.77308820351152e-09
, O 0 1.4963760279159723e-14
tendency O 0 3.791833166899572e-11
to O 0 5.655725724990762e-14
hyperthermia B-Disease 0 1.472639723942848e-06
, O 0 1.3281421969157936e-11
and O 0 2.7266994218066998e-11
frequent O 0 3.8949757197315193e-08
death O 0 1.1141022469018935e-06
in O 0 2.3133089888105474e-10
infancy O 0 9.228559605389819e-08
) O 0 4.203032117900936e-15
with O 0 1.4267785070136386e-15
a O 0 1.8274151723091103e-13
distinct O 0 3.853537280940067e-11
campomelic B-Disease 0 8.09442499303259e-05
- I-Disease 0 0.0008400992373935878
metaphyseal I-Disease 0 0.00022615860507357866
skeletal I-Disease 0 0.22252607345581055
dysplasia I-Disease 1 0.9981375932693481
. O 0 3.2186673326606297e-09

The O 0 1.0792257929340132e-12
similarity O 0 5.19358557896088e-12
of O 0 6.910196957049845e-16
the O 0 2.6387553708935585e-13
clinical O 0 5.938423974782836e-09
and O 0 2.3026008183490987e-12
radiographic O 0 2.74313788395375e-05
findings O 0 4.402477049580966e-09
is O 0 3.822749950789517e-13
so O 0 2.37271248655635e-13
extensive O 0 2.819944000531649e-10
that O 0 3.3605478400033917e-09
these O 0 5.772888833632805e-10
disorders O 0 4.12446115660714e-06
appear O 0 5.551599544656449e-12
to O 0 8.896407915903737e-12
be O 0 1.5112935208838607e-11
a O 0 3.0680549246986377e-12
single O 0 2.5773819190000324e-10
entity O 0 5.26001073808402e-08
. O 0 2.214697092384199e-09

The O 0 5.2424647956073045e-11
follow O 0 2.3528585330057084e-11
- O 0 1.2429706153227471e-08
up O 0 6.732973900636097e-11
observation O 0 9.250015753359264e-10
of O 0 5.5399713459134683e-17
an O 0 5.2512506367211834e-15
identical O 0 4.868453196138489e-09
and O 0 5.069458047790576e-11
unique O 0 3.021472774668993e-13
pattern O 0 2.3885380784349763e-08
of O 0 3.884458875977152e-14
progressive O 0 1.2406859468683251e-06
bone B-Disease 1 0.7002348899841309
dysplasia I-Disease 1 0.9999830722808838
in O 0 6.321633216899158e-10
the O 0 1.1142139294539888e-10
two O 0 1.3660887976385538e-09
patients O 0 3.669484993640282e-10
( O 0 8.424217528290071e-16
one O 0 2.2537552810879095e-14
with O 0 6.579594724956395e-13
SJS B-Disease 0 0.09580910950899124
type I-Disease 0 3.139448745059781e-05
2 I-Disease 0 3.097124987028188e-11
, O 0 4.3492780991277735e-13
one O 0 9.465801623434467e-13
with O 0 7.587847884737986e-12
SWS B-Disease 0 0.00012593629071488976
) O 0 1.6945184404953961e-12
surviving O 0 1.3855037950261107e-10
beyond O 0 1.090100058831478e-11
infancy O 0 1.2929527448690692e-09
adds O 0 2.585640590524463e-09
to O 0 1.3704810127457973e-13
the O 0 4.240895761192624e-15
evidence O 0 1.8652900404814154e-12
in O 0 3.1286036468355623e-15
favor O 0 9.495597803063985e-14
of O 0 8.009759939684908e-17
identity O 0 4.857037515237916e-12
. O 0 2.3236900684869832e-12

The O 0 1.461101378774643e-11
hypothesis O 0 1.2449220820887064e-10
that O 0 1.5489736229779005e-13
SWS B-Disease 0 3.895283953170292e-06
and O 0 2.6306311729645815e-12
SJS B-Disease 0 0.00019368482753634453
type I-Disease 0 1.3582268366008066e-05
2 I-Disease 0 8.477915591775798e-11
are O 0 1.3969969387024606e-13
the O 0 4.752231594351564e-12
same O 0 1.8772754017959414e-08
disorder O 0 0.00031462687184102833
should O 0 8.384975873354517e-12
be O 0 4.063349132179091e-16
testable O 0 6.92278545483282e-15
by O 0 1.606483349506996e-17
molecular O 0 1.812481642635838e-13
methods O 0 1.4096023827347981e-11
. O 0 3.514549220227925e-13
. O 0 2.9927393029038907e-12

A O 0 2.1739073041704415e-10
mouse O 0 1.0042433729040567e-07
model O 0 1.216720413310668e-08
of O 0 1.8301027360223543e-11
severe O 1 0.9994828701019287
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9976027607917786
defects O 1 0.9999964237213135
in O 0 4.069219183833184e-09
hemostasis O 1 0.9977080821990967
and O 0 1.3007397683395538e-06
thrombosis B-Disease 0 0.00011965903104282916
. O 0 9.760478536513517e-11

von B-Disease 1 0.7780352234840393
Willebrand I-Disease 0 0.34051454067230225
factor I-Disease 0 2.5286292384407716e-06
( I-Disease 0 9.064549111315046e-10
vWf I-Disease 0 0.0017817297484725714
) I-Disease 0 1.3437275811156724e-05
deficiency I-Disease 1 0.9990456700325012
causes O 0 0.0074510881677269936
severe O 1 0.9999953508377075
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 4.833407274418278e-06
humans O 0 2.0443194443942048e-05
. O 0 2.8508401195281863e-10

We O 0 5.244237821777631e-10
generated O 0 1.1585614161557702e-14
a O 0 4.672611174936017e-14
mouse O 0 2.1702917241128716e-09
model O 0 7.04333813494884e-10
for O 0 1.965074085982614e-14
this O 0 1.7015141465931416e-12
disease O 0 1.7423497311597202e-08
by O 0 6.988978862816702e-18
using O 0 2.0880395530014154e-14
gene O 0 5.589579354925434e-10
targeting O 0 1.3686584310335093e-08
. O 0 7.996747708460816e-11

vWf B-Disease 0 0.0003882896271534264
- I-Disease 1 0.9938082098960876
deficient I-Disease 1 0.9509717226028442
mice O 0 0.2731723189353943
appeared O 0 3.628620675044658e-07
normal O 0 6.085223880347712e-09
at O 0 2.6658380364308343e-11
birth O 0 1.8181517055793073e-11
; O 0 1.6350191599928676e-13
they O 0 2.970389776160709e-12
were O 0 8.430096898326411e-13
viable O 0 4.954593679773467e-11
and O 0 2.231247651918178e-11
fertile O 0 2.160795542494043e-09
. O 0 1.774951435828953e-10

Neither O 0 6.538058983096562e-07
vWf O 0 2.66651240963256e-05
nor O 0 1.3113054819768877e-06
vWf O 0 4.059898492414504e-05
propolypeptide O 0 0.0007373642292805016
( O 0 3.827804739842122e-10
von B-Disease 0 0.01549651101231575
Willebrand I-Disease 0 0.07408688217401505
antigen O 0 1.1482644367788453e-05
II O 0 0.0004095635667908937
) O 0 2.0421607113685347e-11
were O 0 1.7759122297733576e-11
detectable O 0 8.71036132110703e-10
in O 0 9.949251031328085e-14
plasma O 0 1.8558221626108207e-08
, O 0 4.850013446411339e-11
platelets O 0 2.815436328518217e-09
, O 0 3.269251189208511e-11
or O 0 3.2133625187807935e-12
endothelial O 0 8.651700232967241e-13
cells O 0 3.603040175242933e-12
of O 0 7.27990539800487e-17
the O 0 5.952004975039518e-14
homozygous O 0 3.087471112106499e-10
mutant O 0 3.019181704644325e-08
mice O 0 5.150367542228196e-06
. O 0 2.099720571024921e-11

The O 0 4.941258860413633e-11
mutant O 0 2.0952454349298932e-07
mice O 0 0.00012004611926386133
exhibited O 0 1.1762357132738543e-07
defects O 0 0.31760215759277344
in O 0 1.2942190721898506e-12
hemostasis O 0 0.00017166300676763058
with O 0 1.9707223700149434e-11
a O 0 2.954124792009516e-11
highly O 0 9.538583256585298e-10
prolonged O 0 5.456579856399912e-06
bleeding O 1 0.5390642881393433
time O 0 2.670288656858588e-09
and O 0 1.679666683518377e-10
spontaneous O 0 5.400786415310499e-11
bleeding O 0 3.047655445698183e-05
events O 0 8.954574278255412e-13
in O 0 5.487721822100555e-14
approximately O 0 1.2593889689785365e-12
10 O 0 8.039928857221657e-13
% O 0 2.313770868829371e-15
of O 0 2.912232892107714e-15
neonates O 0 1.3278095138957724e-06
. O 0 5.830682464624815e-11

As O 0 1.3689233080427243e-10
in O 0 1.5363040429660496e-13
the O 0 8.629731044346167e-13
human O 0 1.1363524704544048e-10
disease O 0 3.040065166715067e-06
, O 0 1.625626373524282e-15
the O 0 6.851741095777457e-16
factor O 0 4.158043267338263e-12
VIII O 0 3.453422323218547e-06
level O 0 6.026064092168326e-09
in O 0 3.3630435675863213e-12
these O 0 8.442733491487164e-12
mice O 0 7.670245395274833e-06
was O 0 1.707667340866692e-10
reduced O 0 2.3988560703819273e-12
strongly O 0 8.424395729622614e-12
as O 0 7.41212809445696e-13
a O 0 8.462365465485011e-13
result O 0 1.9708049428524e-11
of O 0 7.136815857527404e-16
the O 0 7.069006838222869e-13
lack O 0 1.2103642740846077e-12
of O 0 3.297635913898185e-17
protection O 0 3.8585641301026874e-13
provided O 0 1.5386023144024936e-14
by O 0 6.442218771109251e-15
vWf O 0 2.018183309360211e-08
. O 0 1.5321509339027983e-10

Defective O 0 0.0012158110039308667
thrombosis B-Disease 0 0.0007654918008483946
in O 0 1.3331421036544278e-11
mutant O 0 2.7289831905363826e-06
mice O 1 0.5769214630126953
was O 0 2.5959357685678697e-07
also O 0 8.712686683232107e-10
evident O 0 9.838677615670033e-12
in O 0 4.998693787453684e-15
an O 0 9.932516921367187e-16
in O 0 6.675306737490699e-14
vivo O 0 6.605574309759277e-09
model O 0 3.3235917490381794e-11
of O 0 2.1317703394088498e-14
vascular B-Disease 0 0.4544152617454529
injury I-Disease 0 0.03211104869842529
. O 0 7.212096198028206e-11

In O 0 1.4085748626518901e-12
this O 0 1.54016441256382e-14
model O 0 1.533114954432868e-11
, O 0 1.1065054986636111e-13
the O 0 3.7575716464125636e-14
exteriorized O 0 7.613638786096999e-08
mesentery O 0 2.50488572106633e-08
was O 0 2.592551694158285e-11
superfused O 0 1.982954911383672e-10
with O 0 5.531163431459797e-14
ferric O 0 3.7132870112088767e-09
chloride O 0 3.055801167661798e-09
and O 0 8.244571136906131e-10
the O 0 1.4126286945748134e-13
accumulation O 0 3.3663630910618636e-11
of O 0 5.20434661078345e-15
fluorescently O 0 5.391530066845007e-07
labeled O 0 1.664954396574103e-08
platelets O 0 2.6232593874908616e-09
was O 0 6.476454355447414e-12
observed O 0 1.2578568015734343e-13
by O 0 1.2599588620628116e-15
intravital O 0 9.432761238770127e-10
microscopy O 0 3.558323913299688e-10
. O 0 2.7851498884956527e-11

We O 0 1.287424879592436e-06
conclude O 0 7.992208006513124e-10
that O 0 4.5337697355055107e-13
these O 0 6.429725458653723e-14
mice O 0 2.987960101563658e-08
very O 0 3.734993813796911e-13
closely O 0 1.2701184548546962e-09
mimic O 0 1.3698013390239794e-05
severe O 0 0.0011121088173240423
human O 1 0.6557115912437439
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9996089339256287
will O 0 2.7445753403299022e-06
be O 0 9.971298092770198e-12
very O 0 1.3696153450737034e-14
useful O 0 5.045474040702e-16
for O 0 6.146820490912176e-19
investigating O 0 7.340481541562912e-15
the O 0 3.171536994074804e-16
role O 0 4.965844494506447e-14
of O 0 4.766889668910389e-17
vWf O 0 3.381803448387899e-10
in O 0 1.1839945690539366e-11
normal O 0 1.0087047286333473e-07
physiology O 0 1.7859261447483732e-07
and O 0 3.090587785692378e-10
in O 0 2.8940542670663483e-11
disease O 0 1.2648154552152846e-05
models O 0 2.676394349199196e-11
. O 0 1.6161685705007311e-12
. O 0 4.0580150351132716e-11

Oral O 0 4.461684511625208e-06
contraceptives O 0 0.0009998540626838803
and O 0 3.980826224214695e-10
the O 0 1.5783296978405525e-12
risk O 0 2.6321154145136916e-09
of O 0 2.8432308590842226e-11
hereditary B-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 3.943757265201242e-10

Hereditary B-Disease 1 0.9999954700469971
Ovarian I-Disease 1 0.9999979734420776
Cancer I-Disease 1 0.9999185800552368
Clinical O 0 0.08582503348588943
Study O 0 1.351836154128705e-08
Group O 0 7.315065886359662e-09
. O 0 7.290446024654784e-11

BACKGROUND O 0 0.0010796418646350503
Women O 0 1.5139637810079876e-07
with O 0 8.048705473807927e-13
mutations O 0 4.352323834666549e-09
in O 0 3.546729560434739e-14
either O 0 1.4538182289969281e-11
the O 0 1.563909700526278e-12
BRCA1 O 0 2.9297549986040394e-07
or O 0 1.962300764588032e-12
the O 0 1.1850350074057298e-13
BRCA2 O 0 2.0223400731822494e-09
gene O 0 3.907636991762331e-10
have O 0 1.4684540475956576e-12
a O 0 3.396237555509246e-14
high O 0 2.2936589693517417e-12
lifetime O 0 6.345669822938049e-11
risk O 0 1.2019490291947932e-08
of O 0 4.926723917719755e-09
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 1.7004905816797589e-10

Oral O 0 2.1497859052033164e-05
contraceptives O 1 0.889538049697876
protect O 0 0.029700879007577896
against O 1 0.9993122816085815
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.1262104450285877e-12
general O 0 7.781194091838195e-12
, O 0 1.6093504306979867e-10
but O 0 1.36489342050794e-09
it O 0 7.910954009926474e-12
is O 0 1.4519481333929475e-14
not O 0 6.518704999213367e-15
known O 0 7.171205395185929e-15
whether O 0 4.217748925724324e-13
they O 0 2.1998923516175495e-11
also O 0 2.5464887143389348e-11
protect O 0 3.5077288296214704e-11
against O 0 2.8716545807938587e-10
hereditary B-Disease 0 0.00011093746434198692
forms I-Disease 0 1.313022011117937e-07
of I-Disease 0 1.1063795000154641e-06
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 1.444603325850835e-10

METHODS O 0 1.3715356850241278e-08
We O 0 3.772564899362507e-11
enrolled O 0 8.594973148999541e-13
207 O 0 2.7282420766994164e-09
women O 0 6.259497364879962e-09
with O 0 5.477918421092909e-07
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.131925355314706e-09
161 O 0 6.531270191345584e-09
of O 0 4.600100682317088e-13
their O 0 4.298673417224563e-09
sisters O 0 1.7551229802847956e-06
as O 0 4.4709871113539357e-13
controls O 0 2.104342797792924e-07
in O 0 1.9061561682374994e-14
a O 0 5.0887191595933023e-14
case O 0 6.607734498453866e-11
- O 0 4.3554243234211754e-07
control O 0 4.970674467585923e-07
study O 0 2.3564244305829263e-11
. O 0 1.057607126875304e-12

All O 0 2.4119466840444304e-11
the O 0 7.819496460927111e-14
patients O 0 3.3087752373053836e-13
carried O 0 2.1910461455148383e-13
a O 0 1.8432076442128752e-15
pathogenic O 0 2.2762619913963e-11
mutation O 0 1.8861133488368154e-10
in O 0 3.704993262057879e-14
either O 0 3.5151562216562127e-11
BRCA1 O 0 1.5536710407104692e-07
( O 0 1.986760365599305e-13
179 O 0 5.380523249165492e-10
women O 0 1.2690238859747183e-09
) O 0 1.8027128401154613e-11
or O 0 3.3638550278602963e-10
BRCA2 O 0 7.596059731440619e-06
( O 0 6.583442818675067e-11
28 O 0 1.234336082234222e-07
women O 0 4.851163359909094e-10
) O 0 2.2337589677262626e-12
. O 0 1.1483813899815232e-11

The O 0 7.925168854505671e-11
control O 0 4.025707767141284e-06
women O 0 1.0898885266508174e-10
were O 0 4.477641469950201e-14
enrolled O 0 2.844023912315814e-14
regardless O 0 4.1389595811553055e-15
of O 0 2.4165242007414962e-18
whether O 0 4.047940368318015e-12
or O 0 7.968924999046667e-12
not O 0 3.086835231869145e-10
they O 0 9.70574575570593e-12
had O 0 8.694886477478292e-11
either O 0 6.567445155411522e-13
mutation O 0 9.673371131890818e-11
. O 0 2.196779867388865e-12

Lifetime O 0 9.859844496418191e-09
histories O 0 1.1353499251853805e-09
of O 0 3.7669270406116926e-15
oral O 0 3.7923775231263335e-10
- O 0 1.5761388860724423e-09
contraceptive O 0 3.6783532664230734e-08
use O 0 7.034802428085296e-13
were O 0 4.5925679166732014e-14
obtained O 0 1.1397776135174589e-14
by O 0 8.627775956778633e-16
interview O 0 1.1356472207069146e-08
or O 0 2.5971603950032847e-14
by O 0 3.704692618301163e-16
written O 0 1.3058254293412536e-13
questionnaire O 0 1.4990848731626094e-13
and O 0 1.0393878615319423e-14
were O 0 4.3013747606595286e-15
compared O 0 2.761832409092172e-14
between O 0 8.230010097899643e-13
patients O 0 4.95739449490884e-10
and O 0 1.1353709639116971e-10
control O 1 0.6521458625793457
women O 0 3.802512527073532e-09
, O 0 2.7639785534112893e-13
after O 0 9.098325120648204e-14
adjustment O 0 1.1162890273599957e-12
for O 0 4.185077295820191e-17
year O 0 3.4881849089336554e-16
of O 0 1.7505738447000992e-16
birth O 0 3.240162582685002e-10
and O 0 1.1466609779742232e-11
parity O 0 1.171117203213612e-09
. O 0 1.0568513945929947e-11

RESULTS O 0 2.1565193719652598e-07
The O 0 1.9970193033957973e-12
adjusted O 0 1.3698363332537156e-08
odds O 0 4.458928287931485e-06
ratio O 0 4.7029548113641795e-06
for O 0 2.6783193334267708e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 3.098646450538922e-09
with O 0 4.1501578649377757e-13
any O 0 4.429091371004751e-13
past O 0 1.902628402050688e-11
use O 0 1.0568322340301015e-13
of O 0 7.24502908109947e-16
oral O 0 2.6889228621485017e-09
contraceptives O 0 2.5820258088060655e-05
was O 0 4.594673530533555e-09
0 O 0 5.08906861096392e-10
. O 0 3.8862637066761074e-12

5 O 0 7.05845104587155e-11
( O 0 1.7032244213101289e-13
95 O 0 6.142653052876312e-10
percent O 0 4.273184472936009e-09
confidence O 0 7.536456791967794e-08
interval O 0 1.7079807568265437e-09
, O 0 3.568389209335568e-14
0 O 0 8.102461843823017e-13
. O 0 1.9767265064797547e-15
3 O 0 1.2565714798979527e-13
to O 0 2.205613513009408e-12
0 O 0 1.2218051570478394e-10
. O 0 7.90527379342966e-14
8 O 0 3.6083768351763412e-12
) O 0 1.1126619374121627e-13
. O 0 1.0588666445390804e-12

The O 0 1.0249463500144884e-09
risk O 0 6.370728389271108e-10
decreased O 0 2.6788418705514516e-10
with O 0 8.322171551606965e-15
increasing O 0 5.3837664849235717e-14
duration O 0 6.186173535233097e-12
of O 0 1.1363635201686083e-17
use O 0 4.0924525595599504e-13
( O 0 1.7941856970938273e-14
P O 0 7.20329129677566e-09
for O 0 4.991678978221879e-16
trend O 0 4.3752440559430283e-10
, O 0 6.290444781818089e-14
< O 0 6.5742541618951655e-12
0 O 0 1.0397576896692406e-12
. O 0 8.173660153234125e-17
001 O 0 1.5139975319440613e-14
) O 0 4.616120699431267e-18
; O 0 2.4847258626319528e-18
use O 0 3.72240010676131e-16
for O 0 4.584048078124891e-16
six O 0 4.0574309320348667e-13
or O 0 3.812874088725618e-14
more O 0 4.542395021185424e-15
years O 0 3.548477429862057e-13
was O 0 3.7531202104479355e-12
associated O 0 8.044561111003601e-13
with O 0 1.1575542092781901e-14
a O 0 1.1468853210877539e-13
60 O 0 3.029507200658088e-12
percent O 0 5.667422911179165e-13
reduction O 0 2.841630142996765e-12
in O 0 2.3583745633465325e-12
risk O 0 6.673016028635459e-10
. O 0 3.0645399412554397e-12

Oral O 0 5.990003870692817e-08
- O 0 3.275916071743268e-08
contraceptive O 0 1.2141099432483315e-06
use O 0 5.563629112970148e-09
protected O 0 0.38739973306655884
against O 1 0.9993370175361633
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 4.751332248649487e-13
for O 0 3.89658025626554e-16
carriers O 0 6.350131466666131e-13
of O 0 5.723424918003357e-16
the O 0 3.7603787271522915e-12
BRCA1 O 0 3.802173509370732e-08
mutation O 0 9.782004373182218e-11
( O 0 8.173917915947886e-15
odds O 0 1.6348843112634626e-10
ratio O 0 1.53245697381843e-11
, O 0 1.9362263799661134e-13
0 O 0 9.718151847484813e-13
. O 0 2.5366864353824166e-15
5 O 0 3.0066965898360026e-14
; O 0 1.2042171696391348e-14
95 O 0 7.932458162551725e-11
percent O 0 7.890272324395653e-10
confidence O 0 1.0269859629374878e-08
interval O 0 1.0298074892833853e-10
, O 0 5.358173299718988e-15
0 O 0 4.9567886958607615e-14
. O 0 2.3846134752246093e-16
3 O 0 1.62412113244954e-14
to O 0 6.655600685379418e-14
0 O 0 8.493254710639775e-12
. O 0 4.3365688102113553e-14
9 O 0 1.6446532720773566e-12
) O 0 1.2348916631426494e-15
and O 0 6.771144110901198e-15
for O 0 3.598291912887324e-17
carriers O 0 4.885941369374425e-13
of O 0 1.0084314754635814e-15
the O 0 4.417855404420523e-12
BRCA2 O 0 1.2456121467607773e-08
mutation O 0 4.728659738079122e-12
( O 0 1.719606055450686e-15
odds O 0 9.767928133008752e-11
ratio O 0 1.3035422567753141e-11
, O 0 5.637752634526927e-13
0 O 0 4.460367838965418e-12
. O 0 4.316085605370968e-15
4 O 0 4.792946638534912e-13
; O 0 6.380565699274157e-14
95 O 0 2.3756774325534025e-10
percent O 0 9.825747993019718e-10
confidence O 0 1.7263852569726623e-08
interval O 0 3.841489348843652e-10
, O 0 5.0221864156523716e-14
0 O 0 9.53229465847083e-13
. O 0 1.1609233463533652e-15
2 O 0 2.6196077845450604e-14
to O 0 1.5333705984631185e-13
1 O 0 4.085238549354775e-13
. O 0 6.344317432516178e-14
1 O 0 1.9826683155498015e-13
) O 0 9.328646253907447e-14
. O 0 7.708717019751232e-13

CONCLUSIONS O 0 1.5869632719045512e-08
Oral O 0 2.002262800004928e-09
- O 0 1.3932165643382177e-08
contraceptive O 0 3.3922668762897956e-07
use O 0 2.9351025082613447e-11
may O 0 4.9409292629531976e-11
reduce O 0 4.080259047301027e-11
the O 0 5.00795802396703e-12
risk O 0 1.508025349039599e-07
of O 0 4.976657308475296e-09
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.8708251614540927e-10
women O 0 1.2648355973698955e-10
with O 0 3.546810875597675e-14
pathogenic O 0 5.972794481223787e-10
mutations O 0 6.092125204304466e-08
in O 0 9.371626738530203e-14
the O 0 6.089147740716283e-13
BRCA1 O 0 6.235607656890352e-07
or O 0 1.0370374697865614e-10
BRCA2 O 0 1.294520075134642e-06
gene O 0 6.795866624997871e-07

A O 0 1.4377099510909375e-09
Japanese O 0 7.76514941236428e-09
family O 0 3.422892871918215e-11
with O 0 2.061464931049639e-12
adrenoleukodystrophy B-Disease 1 0.9999994039535522
with O 0 5.786648287278706e-13
a O 0 5.741307223475905e-14
codon O 0 1.240593738849327e-10
291 O 0 1.1613331823978612e-11
deletion O 0 6.550557429818582e-09
: O 0 5.117961718488495e-13
a O 0 1.948258720151086e-13
clinical O 0 6.305427735497915e-09
, O 0 1.7428970051046322e-13
biochemical O 0 1.2893138112701763e-08
, O 0 2.6167343031985313e-12
pathological O 0 1.610937658824696e-07
, O 0 3.101440285147028e-11
and O 0 4.647953966152585e-10
genetic O 0 3.1995602967072045e-07
report O 0 6.408957392567416e-11
. O 0 7.1439798521311104e-12

We O 0 9.865642880413361e-08
report O 0 6.824752351794472e-13
a O 0 1.3144257275492233e-14
Japanese O 0 1.2210998878714463e-09
family O 0 1.1446053826968949e-10
with O 0 1.6473808983619165e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 0 3.218471045229876e-09
ALD B-Disease 1 0.9999998807907104
) O 0 1.235209200547982e-12
with O 0 7.431657015038312e-15
a O 0 1.0601189251533555e-13
three O 0 4.325996754827449e-13
base O 0 1.4686412086462042e-09
pair O 0 1.6920221668215163e-08
deletion O 0 3.313247010083842e-09
( O 0 1.381086796981663e-14
delGAG O 0 5.018632037723236e-11
291 O 0 2.611638336147415e-12
) O 0 3.912790095183735e-14
in O 0 2.622027080049008e-14
the O 0 8.84854949728675e-12
ALD B-Disease 1 0.9999990463256836
gene O 0 9.606014828023035e-07
. O 0 2.087541077500088e-11

A O 0 1.160341892014749e-10
variety O 0 2.383472542596965e-12
of O 0 2.916157195752343e-15
phenotypes O 0 4.276030196592728e-09
were O 0 2.7904445247528553e-12
observed O 0 2.839360040488015e-12
within O 0 1.9395898461557065e-13
this O 0 1.242391470734558e-13
family O 0 1.0528461436010161e-10
. O 0 1.1154467106921917e-11

While O 0 3.351424693320837e-10
the O 0 1.8446234936655287e-13
proband O 0 5.796284199277579e-07
( O 0 5.178155647322935e-12
patient O 0 3.9895262204936444e-08
1 O 0 1.8695997441170453e-12
) O 0 3.0247595335548827e-13
was O 0 3.410847342413814e-12
classified O 0 1.0250376936138395e-10
as O 0 3.005415361023722e-12
having O 0 2.547123753235403e-12
a O 0 1.6480735936594683e-15
rare O 0 3.459432650824816e-14
intermediate O 0 1.3335839594078025e-12
type O 0 2.7563046955947357e-08
of O 0 7.373938834759688e-14
adult O 0 8.211406566260848e-06
cerebral O 0 0.012484218925237656
and O 0 5.5199983250986406e-08
cerebello O 1 0.6759606003761292
- O 1 0.9808670878410339
brain O 0 0.02674735151231289
stem O 0 1.579470332302435e-09
forms O 0 3.50488665867843e-11
, O 0 2.7714566752656822e-11
his O 0 6.876345326478628e-11
younger O 0 5.912551004350064e-10
brother O 0 6.460323387358358e-10
( O 0 7.02379099977099e-14
patient O 0 8.95778284881743e-10
2 O 0 1.3310941758548633e-11
) O 0 1.288409570004978e-11
and O 0 7.797726908620461e-09
nephew O 0 0.00021184977958910167
( O 0 2.930180056925913e-11
patient O 0 1.0858502008659343e-07
3 O 0 2.795654549872517e-12
) O 0 1.0986073162300158e-12
had O 0 1.8186641526085623e-08
a O 0 1.9125184769208659e-10
childhood O 0 0.00015043838357087225
ALD B-Disease 1 0.9999997615814209
type O 0 0.001492842799052596
. O 0 3.5487807137357663e-10

Another O 0 5.165181615751635e-09
nephew O 0 1.835641796787968e-06
( O 0 2.56524714664641e-11
patient O 0 2.5981796625274e-07
4 O 0 3.3302055557626886e-10
) O 0 4.231804143217666e-12
of O 0 3.904768015546879e-14
patient O 0 4.5364818106463645e-06
1 O 0 7.73760829714254e-12
was O 0 1.1368531810385107e-10
classified O 0 7.424180159532057e-10
as O 0 1.8274945445817536e-10
having O 0 6.099548643945241e-10
an O 0 1.6110402671198204e-13
adolescent O 0 3.4848281416088867e-07
form O 0 2.4050295088784424e-10
. O 0 8.155496417083796e-11

The O 0 5.828634016408207e-12
tau O 0 1.1806435169792184e-11
level O 0 1.4108557204461913e-11
in O 0 3.035334096156313e-14
the O 0 8.984980294501899e-12
cerebrospinal O 0 0.0016343970783054829
fluid O 0 3.22871642310929e-07
( O 0 5.729085608696671e-11
CSF O 0 0.00029672388336621225
) O 0 7.239021448252059e-12
in O 0 3.1075079575532127e-12
patient O 0 1.2823245754134405e-07
1 O 0 5.363782877056134e-13
was O 0 3.924053304515951e-10
as O 0 3.044438616137124e-13
high O 0 7.452615456184086e-13
as O 0 1.6793886431238497e-13
that O 0 5.526621369746076e-13
of O 0 7.419504633344055e-15
patients O 0 3.451682273336587e-10
with O 0 6.813937608596277e-11
Alzheimers B-Disease 1 0.9999983310699463
disease I-Disease 1 0.9975466132164001
( O 0 5.578373659807963e-14
AD B-Disease 0 1.2441204733093514e-09
) O 0 1.5343669043654806e-11
. O 0 1.5960887125854306e-11

His O 0 1.753008294080871e-10
brain O 0 2.9608390739177537e-10
magnetic O 0 4.876354094823787e-12
resonance O 0 7.579172706106974e-11
image O 0 9.225942232404805e-11
( O 0 1.3925321602748474e-14
MRI O 0 1.3621919592310405e-08
) O 0 4.226867120205036e-12
showed O 0 4.591776203710651e-08
abnormalities B-Disease 0 0.003897702321410179
in I-Disease 0 3.074404879982451e-12
the I-Disease 0 4.3126735516096915e-10
bilateral I-Disease 0 9.17747547646286e-06
cerebellar I-Disease 1 0.8181091547012329
hemispheres I-Disease 1 0.7683075070381165
and O 0 3.055162096643471e-07
brain O 0 9.047937510331394e-07
stem O 0 6.047047584889498e-11
, O 0 2.717133701195251e-13
but O 0 3.848843466158769e-11
not O 0 5.923414536646021e-12
in O 0 5.781736444861532e-14
the O 0 2.001068581669596e-12
cerebral O 0 6.921423789663095e-08
white O 0 1.2812861882594007e-10
matter O 0 3.757625720995916e-12
, O 0 5.45847208036597e-14
where O 0 3.606075399224806e-14
marked O 0 3.1461130884047296e-15
reductions O 0 6.243542466886909e-13
of O 0 7.132270466974201e-16
the O 0 1.4803784934014352e-11
cerebral O 0 1.5304185581044294e-05
blood O 0 2.7806248414918855e-09
flow O 0 1.0375821313246547e-09
and O 0 8.70008287634505e-10
oxygen O 0 3.724341321453828e-11
metabolism O 0 2.383945663098075e-08
were O 0 6.7948272876317e-13
clearly O 0 9.912226204764063e-13
demonstrated O 0 5.995215026766804e-16
by O 0 1.6070525945250397e-18
positron O 0 5.569828994723969e-13
emission O 0 3.4637326644035293e-13
tomography O 0 3.4664693338015695e-09
( O 0 6.550893725046358e-13
PET O 0 4.566366840208502e-09
) O 0 8.48554299742732e-13
. O 0 1.6928645985014867e-12

In O 0 3.130050385546923e-10
patients O 0 2.3333143417403335e-08
2 O 0 4.82537010348949e-10
and O 0 1.4788279489863498e-09
3 O 0 9.339984341494301e-11
, O 0 2.165288212402014e-13
the O 0 9.916130010211369e-15
autopsy O 0 5.496589778886118e-07
findings O 0 1.50836183820946e-11
showed O 0 4.966998340405482e-11
massive O 0 3.6548777893052886e-11
demyelination B-Disease 1 1.0
of I-Disease 0 1.602292777624914e-11
the I-Disease 0 1.2657140613381301e-10
cerebral I-Disease 0 2.7432042770669796e-07
white I-Disease 0 2.1298430033511728e-11
matter I-Disease 0 6.297454826489565e-14
with O 0 4.398088876697906e-16
sparing O 0 1.2013408659788255e-13
of O 0 1.0461816163403375e-15
the O 0 8.446014612521757e-13
U O 0 1.3427539670374244e-05
- O 0 1.0091624744745786e-06
fibers O 0 2.6585712475934997e-07
, O 0 2.2553443487782765e-12
compatible O 0 1.5874291898337889e-12
with O 0 8.022997142944494e-14
the O 0 3.950147975102618e-14
findings O 0 9.902460795796486e-12
of O 0 3.685174723971202e-14
childhood O 0 1.2489052096498199e-05
ALD B-Disease 1 0.9999982118606567
. O 0 2.5528798519580675e-10

Oleic O 0 0.0003990475961472839
and O 0 2.65668886889614e-09
erucic O 0 1.5929365417832742e-06
acids O 0 1.7045376221602737e-09
( O 0 2.2175740993393527e-14
Lorenzos O 0 2.3429995721357955e-09
Oil O 0 2.2682862532708015e-12
) O 0 2.6190070264272202e-15
were O 0 1.266879862395708e-15
administered O 0 6.535452788756363e-14
to O 0 2.847906643583392e-13
patients O 0 6.901622502664129e-12
1 O 0 3.533234631519083e-13
and O 0 2.4011164168058485e-09
4 O 0 6.137265695649319e-10
, O 0 4.97504598281906e-12
but O 0 3.068101762232489e-12
sufficient O 0 2.5267641643833376e-14
effectiveness O 0 8.610823642660193e-13
was O 0 2.1849416807079303e-12
not O 0 1.1940899928997856e-13
obtained O 0 3.8672510289591844e-13
. O 0 2.0370905483291235e-12

The O 0 8.994072153711841e-11
findings O 0 3.996160694019757e-11
in O 0 2.7142833675651047e-14
this O 0 4.5460549658472155e-14
family O 0 2.2875160966828734e-12
suggest O 0 6.24636930721123e-12
that O 0 1.0907541417391059e-13
delGAG291 O 0 1.499090740431086e-09
is O 0 3.396224341795269e-14
part O 0 8.423868868353158e-15
of O 0 8.205963210515546e-17
the O 0 5.258068828430107e-14
cause O 0 1.0327845349766829e-12
of O 0 1.3116751998112517e-15
Japanese O 0 2.8304766601650044e-06
ALD B-Disease 1 0.9999994039535522
with O 0 2.0517680436593633e-12
phenotypic O 0 6.420547982166624e-10
variations O 0 1.0803900352129858e-07
. O 0 4.3242132097276453e-10

Moreover O 0 7.059508533302505e-09
, O 0 1.3815704223013592e-12
although O 0 2.02651385798093e-13
the O 0 1.2714604048162225e-14
scale O 0 7.287728642779712e-09
of O 0 8.624127785874808e-15
the O 0 5.3102110382508005e-12
study O 0 2.1898241900353277e-11
is O 0 6.509700276654401e-14
limited O 0 7.753903422114128e-12
, O 0 7.248222855249509e-12
there O 0 2.7070893270086938e-12
is O 0 3.901475259667723e-15
a O 0 4.538253241831588e-16
possibility O 0 2.9356352689458715e-14
that O 0 3.049878871588113e-13
PET O 0 4.153586807831289e-09
can O 0 1.0242979424715526e-12
detect O 0 5.905523032395665e-12
an O 0 1.7314649402287198e-14
insidious B-Disease 0 7.532365270890296e-05
lesion I-Disease 1 0.9999983310699463
which O 0 3.1830825264478335e-07
is O 0 2.342018766421372e-11
undetectable O 0 1.6828510807087582e-10
by O 0 2.5691824838269134e-16
computed O 0 8.547306092065998e-12
tomogram O 0 8.675034024463457e-09
( O 0 8.594013223501076e-15
CT O 0 1.877200901390097e-07
) O 0 4.539764221554547e-14
or O 0 1.418108320117191e-14
MRI O 0 3.7121450358057473e-10
analysis O 0 7.491507956515486e-13
, O 0 4.197410444933304e-14
and O 0 6.5578824922502e-13
that O 0 1.3658132784477583e-12
the O 0 1.8930482994974213e-13
higher O 0 7.713875518162647e-14
level O 0 7.566883453375209e-14
of O 0 6.2941277095277634e-18
tau O 0 2.7279438067186537e-14
reflects O 0 6.3983064655412196e-15
the O 0 1.520141840122017e-16
process O 0 4.469532823546136e-15
of O 0 6.8277075946903e-17
neuronal B-Disease 0 1.1231086460838924e-07
degeneration I-Disease 0 0.20069362223148346
in O 0 1.900091639583934e-09
ALD B-Disease 1 0.9999995231628418
. O 0 1.1535832289411019e-09

Lorenzos O 0 1.0844856888070353e-06
Oil O 0 2.40094111259026e-10
should O 0 1.0352938124846833e-11
be O 0 2.014898893280717e-15
given O 0 2.42802970403568e-17
in O 0 8.65450487552263e-17
the O 0 5.6383277529574536e-15
early O 0 9.050407992483578e-12
stage O 0 7.233632581815641e-10
. O 0 9.694504856001818e-14
. O 0 6.480417873329369e-13

Nonsense O 0 1.3704815273740678e-06
mutation O 0 5.680204751001838e-09
in O 0 2.5154733846030272e-14
exon O 0 1.0608574019244088e-09
4 O 0 1.1271206190599514e-09
of O 0 1.5435728731435713e-14
human O 0 1.315561964920775e-10
complement O 0 4.331799641210665e-10
C9 O 0 5.8050115825381e-09
gene O 0 6.556059872764308e-08
is O 0 3.9359810441279286e-13
the O 0 1.0598146116263954e-15
major O 0 5.450328773373703e-13
cause O 0 4.768238321545271e-12
of O 0 5.329206890505259e-15
Japanese O 0 4.0359250306210015e-06
complement B-Disease 0 1.8388710998351598e-07
C9 I-Disease 0 7.186972652561963e-05
deficiency I-Disease 0 0.04942450299859047
. O 0 4.48251678830669e-12

Deficiency B-Disease 1 0.9999332427978516
of I-Disease 0 4.3268549008469714e-13
the I-Disease 0 1.6481389820618975e-12
ninth I-Disease 0 7.34674654445655e-10
component I-Disease 0 2.0713984347220382e-11
of I-Disease 0 1.7928893978713493e-14
human I-Disease 0 5.581887174699318e-10
complement I-Disease 0 1.9686420549280825e-10
( O 0 1.8397315057006383e-14
C9 O 0 2.783896377311912e-11
) O 0 1.5175244077298387e-14
is O 0 5.45470900944285e-16
the O 0 3.138356066552893e-16
most O 0 4.888268812625572e-14
common O 0 2.9768940645880093e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.8122482521349994e-12
Japan O 0 1.0282195944455452e-05
but O 0 5.260898383596668e-10
is O 0 2.803468991240815e-14
rare O 0 9.44711024903136e-14
in O 0 3.635217398368501e-14
other O 0 1.4338348759170005e-13
countries O 0 1.511833870983595e-13
. O 0 1.3761211137622298e-12

We O 0 9.292499925095399e-08
studied O 0 1.5447268464363617e-11
the O 0 6.373504705570903e-16
molecular O 0 3.16439908130961e-13
basis O 0 7.805891078915134e-14
of O 0 5.0312083329801666e-14
C9 B-Disease 0 0.015136945992708206
deficiency I-Disease 1 0.9851378202438354
in O 0 8.329674840504286e-13
four O 0 2.1939755567856878e-11
Japanese O 0 5.6475503384945114e-08
C9 B-Disease 0 6.075954388506943e-07
- I-Disease 0 1.699879067018628e-05
deficient I-Disease 0 0.0009538106969557703
patients O 0 6.58522267826811e-08
who O 0 2.800162768323844e-09
had O 0 8.168490950311025e-08
suffered O 0 4.1070157408285013e-07
from O 0 3.251358817596417e-12
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.6956910037512216e-09

Direct O 0 3.909191113177224e-12
sequencing O 0 3.0381190618822274e-11
of O 0 1.918512684872045e-15
amplified O 0 4.694907310143215e-11
C9 O 0 2.9464844453208627e-10
cDNA O 0 6.663244955795733e-11
and O 0 5.406751001774124e-12
DNA O 0 3.4194180820179554e-09
revealed O 0 1.3227870404933229e-12
a O 0 7.059564335155444e-16
nonsense O 0 6.154597231161629e-12
substitution O 0 1.5539857879773473e-14
( O 0 1.0051625503270005e-16
CGA O 0 5.410723084853242e-12
- O 0 1.0778389292198653e-09
- O 0 2.279040289820955e-09
> O 0 9.547433373405245e-13
TGA O 0 4.828381028332274e-10
) O 0 2.415965817432076e-15
at O 0 2.4123926089440837e-15
codon O 0 6.447778780078323e-14
95 O 0 3.669680797300026e-14
in O 0 5.645017725053986e-16
exon O 0 2.2087982831653363e-10
4 O 0 1.0231474556476883e-09
in O 0 4.441273195564255e-13
the O 0 3.2169683583660458e-12
four O 0 3.2568902436080904e-11
C9 B-Disease 0 1.4445612350755255e-07
- I-Disease 0 9.132946615864057e-06
deficient I-Disease 0 5.342759777704487e-06
individuals O 0 4.721472101091792e-14
. O 0 1.7364407437978069e-12

An O 0 1.2161396835321664e-13
allele O 0 3.7972450704637506e-12
- O 0 1.5016513033039303e-10
specific O 0 1.2224304955874704e-13
polymerase O 0 1.2256897718998516e-09
chain O 0 6.271038688332453e-10
reaction O 0 9.006577493357593e-13
system O 0 2.485837924393053e-12
designed O 0 4.7373015232832216e-11
to O 0 1.204566909543056e-13
detect O 0 1.1495653040594078e-10
exclusively O 0 9.149854539401009e-14
only O 0 2.0838414327428723e-11
one O 0 2.985445549628929e-13
of O 0 1.6598395430413205e-16
the O 0 1.0200548766119491e-13
normal O 0 2.2519108106022756e-11
and O 0 4.037349678209269e-14
mutant O 0 2.360395299355611e-12
alleles O 0 7.727821068606242e-14
indicated O 0 3.543625115565163e-11
that O 0 5.218566464376684e-13
all O 0 8.957405265653043e-14
the O 0 3.602493466297457e-14
four O 0 2.2129782002115045e-13
patients O 0 1.7257479760545216e-14
were O 0 4.7216812705841606e-17
homozygous O 0 2.188371960856403e-14
for O 0 1.6328350738916694e-16
the O 0 2.187461103976573e-15
mutation O 0 3.912478251533874e-13
in O 0 1.1802628026050753e-15
exon O 0 2.579616076303637e-09
4 O 0 8.635400661205495e-08
and O 0 2.5238660050774797e-09
that O 0 1.3480472293991852e-10
the O 0 1.9858067013683867e-12
parents O 0 8.78273842541688e-12
of O 0 3.9944361197772574e-16
patient O 0 2.752109928838564e-10
2 O 0 1.8207560025657044e-13
were O 0 2.32321025481555e-13
heterozygous O 0 8.032537412994145e-10
. O 0 7.161196548949311e-12

The O 0 2.9551096812630018e-12
common O 0 1.002573471833336e-13
mutation O 0 9.97428051610627e-13
at O 0 3.872762706228286e-14
codon O 0 1.1449514296726915e-12
95 O 0 1.2835646174408355e-12
in O 0 3.6386841348150234e-15
exon O 0 1.2109094171819379e-08
4 O 0 2.1391491245026373e-08
might O 0 2.417153144307349e-09
be O 0 6.674059227365983e-14
responsible O 0 1.0982605477176735e-14
for O 0 2.5912299573505547e-16
most O 0 2.4234390197191112e-14
Japanese O 0 3.963640153870074e-07
C9 B-Disease 0 4.616325895767659e-05
deficiency I-Disease 0 0.0008115689270198345
. O 0 4.923864864014166e-14
. O 0 3.061145954774691e-12

BRCA1 O 0 4.556168846647779e-07
required O 0 8.465594219554673e-13
for O 0 2.8059391510732454e-15
transcription O 0 1.9546058993569204e-08
- O 0 7.88132911111461e-06
coupled O 0 2.0480372953102233e-09
repair O 0 4.395286801184284e-09
of O 0 3.018426789133525e-16
oxidative O 0 1.8355842887340934e-11
DNA O 0 3.245640698423813e-07
damage O 0 1.8529783929466248e-08
. O 0 3.1452195015102546e-11

The O 0 8.585382147430209e-07
breast B-Disease 1 0.9999582767486572
and I-Disease 1 0.9998993873596191
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
susceptibility O 0 3.62268510798458e-05
gene O 0 1.4293460708358907e-06
BRCA1 O 0 9.958067721527186e-07
encodes O 0 6.507243077713554e-10
a O 0 3.043376661793218e-09
zinc O 0 0.01837012730538845
finger O 0 0.19577771425247192
protein O 0 2.307676368218381e-06
of O 0 2.205863530030383e-14
unknown O 0 3.1569530323238837e-10
function O 0 3.24207272139887e-10
. O 0 1.0111067365314863e-11

Association O 0 4.5408711513150735e-11
of O 0 2.159272906283134e-15
the O 0 2.2257610115877444e-14
BRCA1 O 0 8.958529057467857e-11
protein O 0 5.3424461035622706e-12
with O 0 3.6774769732498495e-15
the O 0 1.9683000956655268e-14
DNA O 0 2.694597256436282e-08
repair O 0 3.867731024342902e-09
protein O 0 4.359514485519078e-11
Rad51 O 0 1.1794078602633817e-07
and O 0 9.447931152706257e-12
changes O 0 6.809136587904163e-13
in O 0 9.459723247242334e-16
the O 0 1.7192705509942345e-16
phosphorylation O 0 1.8283922553069543e-12
and O 0 2.606958702730533e-13
cellular O 0 2.340360977931555e-12
localization O 0 2.5007561126055844e-12
of O 0 8.51691760813097e-17
the O 0 8.304982712008333e-15
protein O 0 4.569481598659664e-11
after O 0 2.636833622542828e-13
exposure O 0 1.0584486846015873e-12
to O 0 4.228822831188819e-14
DNA O 0 1.764164835549309e-06
- O 0 2.7455328677206126e-08
damaging O 0 3.7560171639583473e-10
agents O 0 3.169452547635565e-11
are O 0 2.0540604875091302e-14
consistent O 0 1.3291291353113854e-13
with O 0 1.5029589826935755e-16
a O 0 2.456380194565302e-16
role O 0 3.196231731432235e-14
for O 0 3.0784298090236314e-16
BRCA1 O 0 5.020048959858414e-11
in O 0 3.8420750413624416e-14
DNA O 0 1.9589808175624057e-07
repair O 0 2.5956981062336126e-06
. O 0 4.712896045644399e-11

Here O 0 3.5443740387108846e-08
, O 0 2.4899140908807293e-12
it O 0 8.251696038703155e-14
is O 0 2.7492226719580447e-15
shown O 0 1.0447229832535182e-13
that O 0 6.307985817716188e-14
mouse O 0 6.70151649728723e-08
embryonic O 0 1.1833319879528403e-09
stem O 0 4.1111984927511e-09
cells O 0 1.871391042129744e-08
deficient B-Disease 0 2.912637910412741e-06
in I-Disease 0 5.646587798030511e-13
BRCA1 I-Disease 0 1.0692643570564542e-07
are O 0 2.849737590002177e-13
defective O 0 2.1514972026182022e-09
in O 0 8.284755802397126e-13
the O 0 4.841376323276581e-13
ability O 0 1.729015541851453e-11
to O 0 3.1371681240201926e-14
carry O 0 1.0206763819547993e-12
out O 0 1.6687894122124902e-11
transcription O 0 1.2645425151447398e-08
- O 0 1.9130384387722188e-08
coupled O 0 4.896833979972648e-11
repair O 0 4.318526092284003e-10
of O 0 2.4608523961779067e-17
oxidative O 0 1.3580649625699603e-11
DNA O 0 3.334876510052709e-06
damage O 0 1.908914327941602e-06
, O 0 1.803073836070812e-11
and O 0 4.373312476046998e-12
are O 0 4.121376447719727e-15
hypersensitive O 0 3.8421121839604666e-10
to O 0 7.682493963906412e-15
ionizing O 0 3.7095933963504635e-12
radiation O 0 5.790430634977639e-11
and O 0 3.1077655775419225e-14
hydrogen O 0 3.377892041599162e-13
peroxide O 0 4.483839965985226e-09
. O 0 1.5096800545788547e-11

These O 0 2.0623096563809895e-09
results O 0 1.8562945625077987e-10
suggest O 0 7.310469590793289e-11
that O 0 3.727409440129614e-12
BRCA1 O 0 8.348050073436752e-08
participates O 0 1.44023352272038e-11
, O 0 7.811629489963556e-13
directly O 0 4.4501598586710323e-13
or O 0 1.3014671805533506e-12
indirectly O 0 3.682370033897264e-11
, O 0 6.100237502637551e-13
in O 0 2.052493984776478e-14
transcription O 0 1.0021481244848474e-07
- O 0 1.4783485084990389e-06
coupled O 0 2.921977104719531e-10
repair O 0 1.0234791902874463e-09
of O 0 4.878146784787751e-17
oxidative O 0 2.5061708350954115e-12
DNA O 0 1.7359334947286698e-07
damage O 0 2.0992551696963346e-08
. O 0 1.3630805468720086e-12
. O 0 8.078438959446821e-12

Truncation O 0 4.51392861577915e-06
mutations O 0 2.9263164833537303e-05
in O 0 3.345078120747802e-13
the O 0 2.4192976723520776e-13
transactivation O 0 3.832481070276117e-06
region O 0 1.0771442626733574e-09
of O 0 6.632397403635512e-14
PAX6 O 0 1.6755646356614307e-05
result O 0 1.900619939210202e-10
in O 0 5.911343327813165e-14
dominant O 0 8.384397176541825e-09
- O 0 2.255096433145809e-06
negative O 0 8.244534915879953e-11
mutants O 0 7.535414514592276e-10
. O 0 6.408034367889892e-13

PAX6 O 0 1.7057212744475692e-06
is O 0 2.303180649670944e-12
a O 0 2.3229209422420856e-14
transcription O 0 2.994379397214253e-11
factor O 0 4.795022343594135e-13
with O 0 1.2092161886872402e-14
two O 0 6.495139441477921e-14
DNA O 0 4.5831836104071044e-08
- O 0 6.270957531029353e-09
binding O 0 3.0372617615403996e-11
domains O 0 4.760975613748997e-09
( O 0 8.559880235181616e-13
paired O 0 3.520086266917133e-08
box O 0 5.474409547900905e-08
and O 0 9.827972463627432e-11
homeobox O 0 1.7967314303035664e-09
) O 0 4.4011672019513004e-13
and O 0 6.16455400181265e-14
a O 0 2.580626904795944e-15
proline O 0 3.064893616677722e-10
- O 0 1.7002603491800272e-10
serine O 0 1.941043575870438e-10
- O 0 8.200012197034923e-11
threonine O 0 2.0529768995913855e-09
( O 0 2.8772616545726624e-15
PST O 0 6.106742889144812e-10
) O 0 8.133610836713254e-14
- O 0 1.798695220545099e-10
rich O 0 3.002252743286582e-12
transactivation O 0 1.6587385687216738e-08
domain O 0 1.2487991751797267e-09
. O 0 4.820839040464708e-12

PAX6 O 0 0.000911746290512383
regulates O 0 7.876874587964267e-05
eye O 0 0.08451896905899048
development O 0 2.2790307141473676e-10
in O 0 1.8698947555281786e-13
animals O 0 2.558297757665473e-12
ranging O 0 2.2489971582100032e-14
from O 0 3.5758255551014858e-16
jellyfish O 0 1.1382189678624255e-12
to O 0 4.811544822373162e-15
Drosophila O 0 5.930431926787216e-13
to O 0 2.8273866605724347e-14
humans O 0 3.3424775534168782e-12
. O 0 4.955184483221298e-13

Heterozygous O 0 1.2081293334631482e-06
mutations O 0 2.1656712760886876e-06
in O 0 1.1834379776056586e-13
the O 0 1.8272827641187955e-13
human O 0 3.538057867513711e-12
PAX6 O 0 9.883569873636588e-07
gene O 0 1.731581278363592e-06
result O 0 3.371420156939031e-11
in O 0 7.501151833195791e-15
various O 0 5.493523658976068e-14
phenotypes O 0 3.951167837357161e-09
, O 0 1.6586173623781009e-13
including O 0 1.723339526638057e-11
aniridia B-Disease 1 1.0
, O 0 8.666055464345845e-07
Peters B-Disease 1 1.0
anomaly I-Disease 1 0.9999985694885254
, O 0 2.320650560605486e-09
autosomal B-Disease 0 0.0007613247144035995
dominant I-Disease 0 3.00456777040381e-05
keratitis I-Disease 1 0.9386588335037231
, O 0 7.185523287489559e-08
and O 0 2.7455694606715042e-08
familial B-Disease 0 0.28826409578323364
foveal I-Disease 0 0.35684138536453247
dysplasia I-Disease 1 0.9992425441741943
. O 0 4.9473936059030166e-09

It O 0 1.0444839437795395e-09
is O 0 3.952770727920496e-14
believed O 0 2.8228512734783384e-13
that O 0 3.4592065353795465e-15
the O 0 2.2717207651958785e-15
mutated O 0 4.180823742760964e-10
allele O 0 1.3471796378103362e-12
of O 0 1.2867859836891314e-15
PAX6 O 0 1.8438056770264666e-07
produces O 0 2.643129205087691e-12
an O 0 4.965605292402142e-15
inactive O 0 2.9478955387851613e-10
protein O 0 6.506628551505855e-07
and O 0 1.1259785281936274e-07
aniridia B-Disease 1 1.0
is O 0 1.4372090184622266e-08
caused O 0 1.7134494934012423e-09
due O 0 2.3431569184939605e-12
to O 0 2.4504048963536196e-12
genetic O 0 6.861785806222542e-08
haploinsufficiency O 0 4.7841908781265374e-06
. O 0 1.1952859535480087e-10

However O 0 3.333454845488859e-09
, O 0 3.714998754044026e-14
several O 0 5.493112000963703e-15
truncation O 0 4.218948301826231e-09
mutations O 0 7.95140238096792e-07
have O 0 3.992694022625365e-11
been O 0 5.625432303139888e-13
found O 0 1.233961175427234e-12
to O 0 1.6451011559948103e-13
occur O 0 1.8758909356431097e-11
in O 0 2.422662629319658e-14
the O 0 4.681230446682005e-13
C O 0 1.096125060939812e-06
- O 0 1.1836824853617145e-08
terminal O 0 1.8345650332207697e-08
half O 0 1.5565970550284608e-13
of O 0 5.141923763346826e-17
PAX6 O 0 1.1027810664643312e-08
in O 0 1.0088422610320114e-13
patients O 0 2.4267209335765427e-12
with O 0 8.275859516996067e-14
Aniridia B-Disease 1 1.0
resulting O 0 3.4278056088021813e-11
in O 0 1.6409042432664368e-14
mutant O 0 1.5857815061082192e-10
proteins O 0 8.804144219221044e-11
that O 0 8.172102317766106e-13
retain O 0 1.0274212036698316e-11
the O 0 1.616706544842455e-14
DNA O 0 2.8637701987577202e-08
- O 0 5.003103487055682e-10
binding O 0 6.6339477314270034e-12
domains O 0 3.63274565984284e-09
but O 0 1.8360282183493837e-08
have O 0 1.0473947265055017e-09
lost O 0 1.2304711916044653e-08
most O 0 1.718550123002815e-15
of O 0 3.662829206023201e-17
the O 0 3.8087598802942144e-14
transactivation O 0 1.3435411894135996e-08
domain O 0 9.938971867740065e-10
. O 0 1.6860502577431546e-11

It O 0 4.913904838588223e-09
is O 0 5.084200747039469e-13
not O 0 6.69775243296658e-14
clear O 0 1.758298943997736e-14
whether O 0 1.9363573397300883e-15
such O 0 3.966302502769357e-15
mutants O 0 2.4376973328799068e-08
really O 0 3.711325691213574e-09
behave O 0 1.7319819623634602e-12
as O 0 3.7403243615405715e-14
loss O 0 1.4896462535718413e-11
- O 0 6.733224644506208e-09
of O 0 3.382764649450219e-14
- O 0 3.374018149315816e-07
function O 0 1.3388552419502098e-11
mutants O 0 6.280715964673833e-12
as O 0 2.99857392503666e-15
predicted O 0 7.40607987263775e-13
by O 0 5.0836329808549244e-15
haploinsufficiency O 0 1.298340066568926e-07
. O 0 1.9594780659160094e-11

Contrary O 0 1.7861161438759154e-08
to O 0 2.206274008972886e-12
this O 0 7.283440648828913e-15
theory O 0 2.3727768881653954e-12
, O 0 2.831273627004749e-13
our O 0 3.395602619611984e-14
data O 0 4.593184014557716e-13
showed O 0 2.7256906801054193e-11
that O 0 1.0301472402971662e-14
these O 0 7.173800492378079e-16
mutants O 0 2.7560521139585736e-12
are O 0 5.50521387831848e-16
dominant O 0 1.0985728299273134e-10
- O 0 6.41991704242173e-08
negative O 0 1.4006930381185723e-12
in O 0 1.4947264312511945e-15
transient O 0 2.1463980224255275e-13
transfection O 0 5.860664731294207e-11
assays O 0 4.521555005410072e-11
when O 0 1.9007124433395584e-12
they O 0 8.265541978072152e-14
are O 0 5.352838474458944e-16
coexpressed O 0 1.144138894737523e-09
with O 0 6.496221204195518e-13
wild O 0 1.2743097244083401e-08
- O 0 5.767044967797119e-06
type O 0 1.4446771956500015e-06
PAX6 O 0 3.7291847547749057e-06
. O 0 5.6485219279700516e-11

We O 0 8.382129834672014e-08
found O 0 9.153560071376021e-13
that O 0 5.5672426304415046e-15
the O 0 9.269856576950546e-16
dominant O 0 5.208828368630236e-10
- O 0 4.136982454383542e-07
negative O 0 5.115936840827118e-11
effects O 0 2.1300849972760716e-09
result O 0 1.6280049140379727e-13
from O 0 9.272040366854911e-18
the O 0 5.848987493917558e-17
enhanced O 0 5.3434904070948086e-14
DNA O 0 2.503421636657066e-10
binding O 0 1.8134742297247486e-13
ability O 0 1.1878387542237773e-13
of O 0 4.256304825750397e-17
these O 0 1.5330716974766914e-14
mutants O 0 2.423065081913478e-10
. O 0 1.4783687512023858e-12

Kinetic O 0 9.836810255237083e-10
studies O 0 2.1544240003112947e-10
of O 0 5.582934445184983e-16
binding O 0 1.2618650568896328e-09
and O 0 2.680201338645105e-10
dissociation O 0 3.498868555995571e-11
revealed O 0 5.732548116754721e-12
that O 0 1.4223007732170972e-15
various O 0 1.1657510635758003e-16
truncation O 0 4.185539137502303e-10
mutants O 0 1.4485446619971754e-08
have O 0 1.830299245497713e-10
3 O 0 4.128621489823958e-12
- O 0 7.780807464996542e-08
5 O 0 6.301817401244136e-10
- O 0 5.1036156634154395e-08
fold O 0 6.832565069281316e-10
higher O 0 4.514513661177128e-15
affinity O 0 3.6385573445707313e-16
to O 0 1.5197417494033374e-16
various O 0 1.8172757702373542e-17
DNA O 0 4.153345029012101e-11
- O 0 9.771080700191753e-14
binding O 0 3.701459440601934e-15
sites O 0 3.5652072114845945e-13
when O 0 3.2190781073734853e-13
compared O 0 9.839744579027976e-16
with O 0 2.102240907395081e-15
the O 0 2.1418995320866135e-13
wild O 0 6.026307630691008e-08
- O 0 5.876802902093914e-07
type O 0 1.8414221258922225e-08
PAX6 O 0 5.008694756725163e-07
. O 0 2.055474540574309e-11

These O 0 8.513439397894729e-10
results O 0 9.45339292957037e-12
provide O 0 6.395890304059177e-15
a O 0 2.2658698851127194e-15
new O 0 3.051628977182412e-14
insight O 0 6.578007046400061e-15
into O 0 3.510371984074916e-15
the O 0 7.259082945881195e-16
role O 0 4.3615122364421e-14
of O 0 1.9395573507954763e-16
mutant O 0 3.9228112425071515e-10
PAX6 O 0 2.6910534245416784e-08
in O 0 9.881853365104054e-13
causing O 0 3.476348098274684e-09
aniridia B-Disease 1 0.9999994039535522
. O 0 3.659655911647519e-11
. O 0 9.957082901246306e-12

Reversal O 0 7.461195394853348e-08
of O 0 1.9302141482380186e-11
severe O 0 2.887319351430051e-05
hypertrophic B-Disease 1 0.9999833106994629
cardiomyopathy I-Disease 1 1.0
and O 0 1.187691964332771e-06
excellent O 0 1.1679546219056647e-08
neuropsychologic O 0 1.6658599633956328e-05
outcome O 0 1.9255792516048587e-09
in O 0 2.3661242236350244e-12
very B-Disease 0 8.348297608762323e-10
- I-Disease 0 2.4958184440038167e-05
long I-Disease 0 5.125868440813974e-08
- I-Disease 0 3.0310278020806436e-07
chain I-Disease 0 5.7286683841084596e-08
acyl I-Disease 0 3.1021799712371845e-11
- I-Disease 0 3.9459671641317584e-11
coenzyme I-Disease 0 1.6130304557326891e-12
A I-Disease 0 2.061402047323635e-12
dehydrogenase I-Disease 0 1.2079179612101143e-07
deficiency I-Disease 0 4.469117266125977e-05
. O 0 3.75617115536131e-12

Very B-Disease 0 1.1070808625390782e-07
- I-Disease 0 9.712400787975639e-05
long I-Disease 0 2.671095273854007e-07
- I-Disease 0 9.640824600865017e-07
chain I-Disease 0 1.4248628588120482e-07
acyl I-Disease 0 1.0724716253962541e-10
- I-Disease 0 4.314983093056668e-11
coenzyme I-Disease 0 2.0981408613545555e-13
A I-Disease 0 9.471643541909044e-15
dehydrogenase I-Disease 0 2.9656910607855913e-12
( I-Disease 0 2.65090158618796e-14
VLCAD I-Disease 0 8.502802018028888e-08
) I-Disease 0 1.3325039856237897e-11
deficiency I-Disease 0 5.117833552503726e-07
is O 0 6.52623571503752e-14
a O 0 1.046796590381538e-11
disorder O 0 2.107844193233177e-05
of O 0 1.0470639070340212e-15
fatty O 0 2.2270672417334936e-08
acid O 0 4.0499097131441175e-12
beta O 0 9.709096099661104e-16
oxidation O 0 4.124589396154593e-13
that O 0 2.5149771588212078e-12
reportedly O 0 3.8638468424778694e-08
has O 0 5.587322160494068e-09
high O 0 3.70024601237251e-11
rates O 0 8.657573546955177e-10
of O 0 1.738894943835445e-14
morbidity O 1 0.9891874194145203
and O 0 6.45359321538308e-08
mortality O 0 2.2103356968727894e-05
. O 0 3.496933645430467e-11

We O 0 1.1589887938256993e-09
describe O 0 2.729293028559676e-13
the O 0 6.966469908538039e-15
outcome O 0 3.8025680694497854e-14
of O 0 2.132714810261796e-17
a O 0 9.577522829722421e-14
5 O 0 4.6013848113701794e-12
- O 0 2.6034656652740296e-09
year O 0 7.041564461509817e-14
- O 0 2.8500167559286638e-08
old O 0 2.793619160001981e-06
girl O 0 5.305150239109935e-07
with O 0 2.1944203398849282e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 2.180443325894288e-10
was O 0 6.303926998463272e-12
first O 0 1.0894733601602216e-13
seen O 0 1.2533371562817308e-10
at O 0 4.798027947172656e-11
5 O 0 3.174785467071478e-13
months O 0 1.2920398325994183e-14
of O 0 4.8851109838009575e-17
age O 0 7.104834776061608e-11
with O 0 2.5442070325509825e-11
severe O 0 3.7658992368960753e-06
hypertrophic B-Disease 1 0.9999804496765137
cardiomyopathy I-Disease 1 1.0
, O 0 0.0007131408783607185
hepatomegaly B-Disease 1 1.0
, O 0 1.3513289559341501e-05
encephalopathy B-Disease 0 0.0017794034210965037
, O 0 2.2509458186270592e-10
and O 0 5.185167850640937e-10
hypotonia B-Disease 1 0.6899648904800415
. O 0 9.251162613743702e-10

Biochemical O 0 0.00023005620460025966
studies O 0 2.8251097319298424e-06
indicated O 1 0.7666998505592346
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 4.830416742152011e-07
by O 0 3.536963202790261e-13
a O 0 4.4701239931832504e-10
stable O 0 2.457721137716362e-08
yet O 0 8.820241412244023e-12
inactive O 0 9.674994833064332e-11
enzyme O 0 3.156062078346622e-10
. O 0 2.481986187755081e-12

Molecular O 0 1.9961841246640688e-07
genetic O 0 9.368218911731674e-07
analysis O 0 8.170785575911665e-11
of O 0 7.70148240970478e-14
her O 0 7.990720973793941e-08
VLCAD O 0 0.0002986207837238908
gene O 0 3.9607530766261334e-07
revealed O 0 1.2989123110429546e-09
a O 0 4.4265917428960855e-13
T1372C O 0 1.1132755828313634e-09
( O 0 4.249708291975858e-14
F458L O 0 4.0062059225576263e-10
) O 0 1.9317923996564623e-13
missense O 0 4.5640707213578935e-08
mutation O 0 1.884303486576755e-07
and O 0 1.2443024388630874e-10
a O 0 2.097620133145739e-10
1668 O 0 0.003101919312030077
ACAG O 0 0.0013948797713965178
1669 O 0 7.75968871380428e-08
splice O 0 3.2504369755770313e-06
site O 0 1.7535082719177808e-08
mutation O 0 3.6927144009268886e-08
. O 0 2.1885255760412115e-11

After O 0 4.87306289070899e-12
initial O 0 1.2726354258613126e-13
treatment O 0 1.9822078006770383e-12
with O 0 8.706900692513446e-15
intravenous O 0 8.575106735797533e-10
glucose O 0 1.8027367332251742e-07
and O 0 1.337439325954648e-10
carnitine O 0 1.3137685073161265e-07
, O 0 1.4874488793448215e-11
the O 0 1.089058314016067e-12
patient O 0 1.2300700014122867e-08
has O 0 2.267837653779914e-11
thrived O 0 4.348365667539156e-09
on O 0 5.11220568915477e-13
a O 0 3.056401160807243e-13
low O 0 8.338653101347404e-10
- O 0 7.077051122905686e-08
fat O 0 3.080439796576684e-07
diet O 0 2.3706013152491323e-08
supplemented O 0 3.8898454769731305e-12
with O 0 6.950414229616245e-14
medium O 0 4.187425961532654e-09
- O 0 2.9254207944973132e-08
chain O 0 2.306869539836498e-08
triglyceride O 0 1.324666903945726e-10
oil O 0 5.655091737770401e-13
and O 0 5.086390157801532e-14
carnitine O 0 6.196072821484933e-11
and O 0 3.515801338211874e-14
avoidance O 0 3.3688407966026013e-12
of O 0 1.2281127525866548e-15
fasting O 0 1.017107370548942e-10
. O 0 1.242382715802015e-12

Her O 0 1.1991199244221207e-05
ventricular O 0 1.015902284962067e-06
hypertrophy O 0 1.1505509064591024e-05
resolved O 0 2.7684018633067353e-08
significantly O 0 1.131789506558789e-08
over O 0 3.022539774022448e-09
1 O 0 3.4235669854609796e-10
year O 0 4.51428608036486e-13
, O 0 1.2688459657961282e-11
and O 0 1.7758522430355583e-10
cognitively O 0 6.056334544979336e-09
, O 0 3.584903554565422e-11
she O 0 1.1694687174212959e-07
is O 0 4.4766144425016554e-15
in O 0 2.671160221418207e-16
the O 0 2.2585864605575165e-15
superior O 0 1.534543976264291e-13
range O 0 4.360477257048245e-12
for O 0 1.6797281339291092e-13
age O 0 2.531188036947185e-10
. O 0 8.291035392959945e-12

Clinical O 0 5.784814675280359e-06
recognition O 0 1.6474366315577527e-10
of O 0 1.743868272008342e-09
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.9344907620233442e-10
important O 0 2.384168383551266e-12
because O 0 4.710040690802941e-10
it O 0 1.4263025656380268e-11
is O 0 1.2700353565857619e-14
one O 0 5.0800661251140366e-15
of O 0 2.6487039552358417e-17
the O 0 1.960773394777543e-13
few O 0 1.1504910912840671e-10
directly O 0 3.4755906486161336e-10
treatable O 0 3.656602348200977e-05
causes O 0 3.8482050879196095e-11
of O 0 3.679252735810934e-11
cardiomyopathy B-Disease 1 1.0
in O 0 1.7321349332632963e-07
children O 0 6.4922462961192196e-09
. O 0 9.167853108615898e-13
. O 0 7.024415337592016e-12

Cloning O 0 4.759797889164474e-08
of O 0 1.640078047329685e-14
a O 0 3.073183797285689e-13
novel O 0 1.707584941501583e-11
member O 0 9.496738925850526e-14
of O 0 3.4592971149653435e-16
the O 0 1.6130641744202534e-12
low O 0 9.00523833280431e-09
- O 0 2.345717859952856e-07
density O 0 1.2814939387428836e-10
lipoprotein O 0 1.441271137991862e-06
receptor O 0 2.2839110158656695e-08
family O 0 3.435336237700426e-09
. O 0 3.245845259236546e-11

A O 0 1.2756939601898942e-11
gene O 0 2.509980071008222e-11
encoding O 0 1.5260451322746116e-12
a O 0 1.038031748230861e-12
novel O 0 2.2099404251019195e-10
transmembrane O 0 2.4557236244504566e-09
protein O 0 7.002540769462939e-09
was O 0 1.7889388971917275e-12
identified O 0 6.960032458138907e-14
by O 0 4.009471483986613e-17
DNA O 0 1.181065106825585e-10
sequence O 0 7.428068576897928e-12
analysis O 0 1.2378431070957097e-13
within O 0 4.730450311519509e-14
the O 0 8.126548045606086e-12
insulin B-Disease 0 0.052423518151044846
- I-Disease 1 0.999995231628418
dependent I-Disease 1 0.9999834299087524
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 6.110343342413671e-10
IDDM B-Disease 0 2.7426390261098277e-06
) O 0 6.665538346967148e-13
locus O 0 4.192352368037611e-11
IDDM4 O 0 2.8603864166143467e-07
on O 0 2.1883263257027608e-10
chromosome O 0 5.4796660151623655e-06
11q13 O 0 7.670836055240216e-08
. O 0 6.235111732477705e-11

Based O 0 4.5901844825113614e-11
on O 0 2.5363029818731286e-12
its O 0 5.925488100405954e-14
chromosomal O 0 0.0001976575149456039
position O 0 2.785015951189962e-08
, O 0 4.206797941681134e-13
this O 0 7.649595204235055e-15
gene O 0 7.934788937014048e-11
is O 0 3.3827109899130106e-15
a O 0 4.0334970441398895e-16
candidate O 0 4.48944021538898e-15
for O 0 1.4641824761127637e-17
conferring O 0 1.2649217610849472e-11
susceptibility O 0 4.17145638493821e-05
to O 0 1.0714018117141677e-07
diabetes B-Disease 1 0.9984734654426575
. O 0 8.589643440970463e-10

The O 0 1.8663157824727605e-11
gene O 0 2.6730490043647137e-10
, O 0 1.221871047266468e-13
termed O 0 6.591559936763858e-11
low O 0 4.744072512608e-08
- O 0 2.676598285233922e-07
density O 0 1.4929464609014786e-10
lipoprotein O 0 1.0441682718465017e-07
receptor O 0 2.7602953256433693e-10
related O 0 3.657563973913369e-10
protein O 0 6.80860807733552e-08
5 O 0 1.1050829522296635e-11
( O 0 1.6464816164109275e-14
LRP5 O 0 9.352293162123715e-09
) O 0 6.974420583297442e-15
, O 0 7.068048561262278e-17
encodes O 0 6.828157475064411e-15
a O 0 2.256008727540785e-14
protein O 0 5.120144239145752e-11
of O 0 2.489558792746608e-15
1615 O 0 1.9423621044900585e-10
amino O 0 2.89675878770157e-12
acids O 0 8.060688618319323e-13
that O 0 1.8779133369189625e-15
contains O 0 2.36425318545278e-15
conserved O 0 9.566724148979411e-12
modules O 0 3.865412989689787e-10
which O 0 1.4807965617591456e-11
are O 0 7.840236062640633e-15
characteristic O 0 1.3851172812884283e-11
of O 0 1.0909242259549146e-14
the O 0 1.425691370515736e-10
low O 0 2.832998916346696e-06
- O 0 9.63299535214901e-05
density O 0 9.116291721511516e-09
lipoprotein O 0 4.772577085532248e-05
( O 0 1.7559589199356296e-11
LDL O 0 4.528924080204888e-07
) O 0 3.566650664046933e-12
receptor O 0 1.1913142694552903e-10
family O 0 3.2644359437838943e-10
. O 0 1.4666578715405443e-11

These O 0 8.047573024638766e-12
modules O 0 1.5640559593993464e-12
include O 0 8.534880159387359e-15
a O 0 2.006760388965261e-15
putative O 0 4.101353046244427e-13
signal O 0 8.104080557666538e-14
peptide O 0 4.7885672749097e-14
for O 0 1.2063533397482514e-17
protein O 0 9.462769109958025e-13
export O 0 4.807903380976697e-11
, O 0 3.6305786935836304e-12
four O 0 4.0391770332083576e-13
epidermal O 0 7.180506855775093e-09
growth O 0 1.0581040384149976e-11
factor O 0 2.2482819913519775e-13
( O 0 3.3838210265903874e-15
EGF O 0 7.26301074838176e-10
) O 0 2.2359391288885415e-14
repeats O 0 1.8322726669239842e-10
with O 0 3.3738209979667505e-14
associated O 0 5.251792403737632e-11
spacer O 0 2.911404635597137e-06
domains O 0 5.355066718948365e-07
, O 0 2.5427854266624195e-11
three O 0 1.7352753348826022e-12
LDL O 0 7.279021474460023e-08
- O 0 5.622690224527105e-08
receptor O 0 9.419915368569232e-12
( O 0 1.7313097637927828e-14
LDLR O 0 4.216663462841552e-09
) O 0 2.6665762696900797e-14
repeats O 0 2.7262744839440245e-10
, O 0 1.190632539934365e-14
a O 0 4.653592659468022e-15
single O 0 1.2021712835277865e-12
transmembrane O 0 3.279049254345523e-11
spanning O 0 9.964991332100936e-11
domain O 0 1.677976757541444e-09
, O 0 5.964056939283813e-12
and O 0 2.0765546671509122e-13
a O 0 4.727212273968745e-14
cytoplasmic O 0 5.6155091243681454e-08
domain O 0 2.8410884311824702e-08
. O 0 7.919276345802473e-11

The O 0 1.5234888003923253e-12
encoded O 0 8.276684459324057e-13
protein O 0 4.220171323510158e-09
has O 0 3.261577813384875e-11
a O 0 1.388681040276861e-14
unique O 0 7.224086509115962e-15
organization O 0 7.346437369028236e-14
of O 0 9.163746642065632e-16
EGF O 0 7.543085871475341e-07
and O 0 6.694315241029258e-11
LDLR O 0 6.965782972656598e-07
repeats O 0 1.3403806065070967e-07
; O 0 2.437100814125376e-13
therefore O 0 4.0555639358938467e-14
, O 0 1.109469842928458e-14
LRP5 O 0 5.666702307394189e-08
likely O 0 1.1917834340929856e-12
represents O 0 2.9210545284951307e-16
a O 0 4.595343474234764e-15
new O 0 4.969912285532341e-13
category O 0 5.932530855456974e-11
of O 0 1.2398998513224089e-15
the O 0 3.408141824312594e-12
LDLR O 0 2.1626210582326166e-05
family O 0 7.827480330568903e-10
. O 0 1.3890301235608415e-11

Both O 0 5.053254259479445e-09
human O 0 4.82120288136656e-10
and O 0 1.4709307383231618e-10
mouse O 0 1.1769623142754426e-06
LRP5 O 0 2.804403322897997e-07
cDNAs O 0 5.034129557657252e-09
have O 0 5.637159072868769e-10
been O 0 1.2191624446100668e-11
isolated O 0 1.2018891766274464e-06
and O 0 5.054685836558548e-11
the O 0 3.50867177719154e-15
encoded O 0 1.5045991254118707e-13
mature O 0 7.395450896639788e-13
proteins O 0 6.680803046194006e-12
are O 0 2.997546262313404e-14
95 O 0 2.269629102713555e-11
% O 0 1.4211869460672814e-14
identical O 0 5.245198164693932e-10
, O 0 4.9951748466725565e-12
indicating O 0 2.782335820072923e-11
a O 0 1.0665695757139382e-11
high O 0 1.8947551860826195e-11
degree O 0 9.592184631226214e-14
of O 0 1.6674606227225676e-17
evolutionary O 0 9.975478559506867e-13
conservation O 0 3.875387695213145e-13
. O 0 8.274150712728277e-15
. O 0 6.191942574992892e-13

The O 0 9.72179021313524e-12
APC B-Disease 0 2.7033100757911654e-10
variants O 0 1.3815401600503208e-10
I1307K O 0 1.231296953285721e-09
and O 0 1.3869036127878154e-12
E1317Q O 0 2.5019322724695314e-10
are O 0 1.4016355621721682e-13
associated O 0 3.1814772682992043e-07
with O 1 0.9210349917411804
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.3320836842467543e-05
but O 0 1.5088856741840573e-07
not O 0 2.1141333128582573e-09
always O 0 1.2628732781738705e-10
with O 0 1.2859304380607572e-14
a O 0 7.318847134243911e-13
family O 0 5.2511918424702486e-11
history O 0 5.17685408429891e-11
. O 0 8.556994522679329e-12

Classical O 0 0.13351982831954956
familial B-Disease 1 0.9999992847442627
adenomatous I-Disease 1 0.9999344348907471
polyposis I-Disease 1 0.9999992847442627
( O 0 2.1743022937670275e-09
FAP B-Disease 0 4.654416940752526e-08
) O 0 3.4679056501452088e-12
is O 0 5.552186789210649e-14
a O 0 1.8159430122816067e-12
high O 0 1.0951244888701694e-07
- O 1 0.9999567270278931
penetrance O 1 0.99997878074646
autosomal B-Disease 1 0.999998927116394
dominant I-Disease 1 0.9999064207077026
disease I-Disease 1 0.9999616146087646
that O 0 9.226350423680724e-14
predisposes O 0 6.006209418707442e-10
to O 0 1.5142430020921756e-14
hundreds O 0 2.7476395673796264e-15
or O 0 1.2018307390135406e-14
thousands O 0 6.158149077478692e-14
of O 0 2.9934086459570963e-11
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.7876967191696167
carcinoma I-Disease 1 1.0
and O 0 6.481857326434692e-06
that O 0 3.31999028269081e-09
results O 0 2.1834815899790527e-10
from O 0 2.593317787686418e-15
truncating O 0 4.302367244690686e-07
mutations O 0 2.3875685428720317e-07
in O 0 4.014451328326375e-14
the O 0 3.0300011767203996e-14
APC B-Disease 0 3.8998931861655706e-10
gene O 0 2.719067859757729e-09
. O 0 1.6052263684951384e-11

A O 0 4.5244707286284935e-11
variant O 0 2.8472986191019345e-09
of O 0 3.625149903570615e-14
FAP B-Disease 0 1.6419696180491883e-07
is O 0 3.4751995725557094e-10
attenuated B-Disease 1 0.9947298765182495
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999949932098389
coli I-Disease 1 1.0
, O 0 4.130882658159862e-08
which O 0 3.0968841380207834e-10
results O 0 1.0477213714665812e-11
from O 0 1.4551246763517406e-15
germ O 0 1.3932019101048354e-05
- O 0 2.201047209382523e-06
line O 0 5.880615390196908e-07
mutations O 0 4.2611169703832275e-08
in O 0 1.0740729459264228e-13
the O 0 1.3770427940290597e-12
5 O 0 1.164394691777204e-10
and O 0 3.784104696258339e-10
3 O 0 1.1167452379501341e-11
regions O 0 3.787393142162809e-12
of O 0 2.325991119038527e-16
the O 0 2.229385296162456e-14
APC B-Disease 0 4.086201169095638e-11
gene O 0 2.8468355450783633e-10
. O 0 4.656032937672139e-12

Attenuated B-Disease 1 0.9980162382125854
adenomatous I-Disease 1 0.9999939203262329
polyposis I-Disease 1 0.9999866485595703
coli I-Disease 1 0.9999998807907104
patients O 1 0.9821949601173401
have O 0 9.883554241696402e-08
" O 0 2.58861110324915e-09
multiple O 0 4.265380084689241e-06
" O 0 0.14743022620677948
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 9.95061325004265e-11
typically O 0 7.436016320923333e-13
fewer O 0 9.951870734827353e-14
than O 0 2.31218395260269e-14
100 O 0 1.2824896038817618e-13
) O 0 3.4905709372186e-14
without O 0 2.1467982285524462e-14
the O 0 1.0636263022406871e-14
florid O 0 6.55889849099367e-08
phenotype O 0 1.586713399559514e-10
of O 0 3.464156701802419e-16
classical O 0 5.824624810246704e-11
FAP B-Disease 0 7.302686899635091e-09
. O 0 1.0795949204056576e-11

Another O 0 3.4594875852889118e-09
group O 0 4.943031053916691e-11
of O 0 8.175883032385516e-15
patients O 0 3.373870974265891e-11
with O 0 4.920487845297417e-13
multiple O 0 4.377232798447039e-09
adenomas B-Disease 0 0.009914732538163662
has O 0 5.280701316223713e-06
no O 0 3.1997349214663018e-09
mutations O 0 2.0866881556003136e-08
in O 0 1.959744215865311e-14
the O 0 5.267662747107183e-15
APC B-Disease 0 2.130915756348717e-11
gene O 0 2.003053500843066e-09
, O 0 3.598712907532109e-12
and O 0 2.897477180061059e-12
their O 0 5.597846947265339e-14
phenotype O 0 2.6298260791257633e-10
probably O 0 8.120679129142161e-11
results O 0 4.543942262388856e-13
from O 0 1.8297908805563835e-16
variation O 0 1.356065482127633e-09
at O 0 9.770578790480045e-10
a O 0 1.0846345523118917e-12
locus O 0 1.5383794238488235e-10
, O 0 2.5288462296435554e-11
or O 0 1.5622900651109106e-13
loci O 0 1.625534965963779e-13
, O 0 4.694714669101208e-13
elsewhere O 0 5.770559811241194e-12
in O 0 1.9263274108434134e-14
the O 0 4.342810087779904e-14
genome O 0 5.075853626301807e-11
. O 0 1.7956426276444226e-12

Recently O 0 1.0407558193037403e-06
, O 0 3.72580308619086e-12
however O 0 1.0744602093899075e-13
, O 0 2.100453032601664e-15
a O 0 2.085315918559519e-15
missense O 0 2.4795814290712315e-09
variant O 0 9.307132842195642e-08
of O 0 2.5778239880701846e-14
APC B-Disease 0 1.8147279234881353e-08
( O 0 3.1964770999363956e-13
I1307K O 0 4.12608280875304e-10
) O 0 1.1816696438623348e-13
was O 0 8.265924836964311e-13
described O 0 2.4992909217896875e-13
that O 0 2.18654033681126e-14
confers O 0 1.1680770283309383e-12
an O 0 3.5492726074522803e-15
increased O 0 4.979106904556829e-09
risk O 0 1.2519162737589795e-05
of O 0 3.149852318529156e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.3440152990540355e-08
including O 0 6.534920174439129e-13
multiple O 0 1.660832860128636e-10
adenomas B-Disease 0 6.843122719146777e-06
, O 0 9.296387271096052e-11
in O 0 6.778484717973043e-11
Ashkenazim O 0 3.739178282557987e-05
. O 0 1.2859305287271638e-10

We O 0 1.9159469957230613e-06
have O 0 1.973286768361393e-12
studied O 0 9.086883264071421e-13
a O 0 1.8958503183682564e-15
set O 0 3.0471748713699343e-13
of O 0 1.0251122772735951e-17
164 O 0 2.8373853613872235e-11
patients O 0 1.5452976355120884e-12
with O 0 1.031969323363191e-12
multiple O 0 0.03808833286166191
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.014095802791416645
/ I-Disease 1 0.9999666213989258
or I-Disease 0 5.129163037054241e-05
carcinoma I-Disease 1 1.0
and O 0 2.9950322186778067e-06
analyzed O 0 4.827469410884078e-07
codons O 0 1.1516738140926464e-07
1263 O 0 5.6977206952524284e-08
- O 0 2.0927870991727104e-07
1377 O 0 1.7025750809196438e-09
( O 0 1.508938034743522e-14
exon O 0 2.956610650750591e-11
15G O 0 1.7496562421115414e-08
) O 0 3.1193102977998197e-14
of O 0 2.1774017539298707e-17
the O 0 1.2407136382264834e-15
APC B-Disease 0 1.9546467309311533e-12
gene O 0 6.741284180183937e-12
for O 0 4.709361838110837e-16
germ O 0 5.242642941993836e-07
- O 0 2.441839512812294e-07
line O 0 1.5664047836594364e-09
variants O 0 1.4553760419033779e-09
. O 0 5.0374482363224615e-11

Three O 0 1.1210444794684804e-09
patients O 0 3.784434571274531e-11
with O 0 2.345269398335622e-14
the O 0 4.919359326361131e-14
I1307K O 0 1.2265170823422267e-10
allele O 0 7.964890682762849e-14
were O 0 1.6342575757293323e-14
detected O 0 2.2500262070179744e-11
, O 0 5.60953710308028e-15
each O 0 6.27875877646459e-17
of O 0 5.970520839980789e-16
Ashkenazi O 0 4.182258180662757e-06
descent O 0 1.428836271522016e-09
. O 0 3.717386468093942e-11

Four O 0 2.9514752863946114e-09
patients O 0 5.398152480573515e-10
had O 0 4.2253218285326355e-11
a O 0 6.998970901537366e-14
germ O 0 3.621652285801247e-05
- O 0 9.269057045457885e-06
line O 0 1.6634370325618875e-08
E1317Q O 0 3.0263094114024724e-11
missense O 0 9.67588023592647e-11
variant O 0 4.4785276182013334e-11
of O 0 1.0757073584668299e-16
APC O 0 2.014681477202629e-10
that O 0 3.652689262167996e-11
was O 0 2.7095730104065296e-09
not O 0 2.6281799653249394e-11
present O 0 5.862444454581353e-14
in O 0 2.6084247473556407e-14
controls O 0 0.0032924520783126354
; O 0 2.6447644421723204e-11
one O 0 9.059656372540151e-14
of O 0 5.371962360825578e-17
these O 0 9.020585114375562e-14
individuals O 0 7.323499801519884e-16
had O 0 1.5176722378829055e-10
an O 0 2.6186359730567637e-16
unusually O 0 1.6926020860504737e-13
large O 0 1.6558714035358468e-12
number O 0 4.449875884438015e-11
of O 0 3.036498258239019e-14
metaplastic B-Disease 0 2.192921965615824e-05
polyps I-Disease 0 2.6029317723441636e-06
of I-Disease 0 1.941482947852161e-15
the I-Disease 0 6.019894326948771e-13
colorectum I-Disease 0 1.4311165159597294e-06
. O 0 3.087240185717377e-11

There O 0 8.96737240019263e-10
is O 0 5.8744851973331624e-15
increasing O 0 4.4218109872978285e-15
evidence O 0 3.238929957571912e-12
that O 0 9.052734690345732e-13
there O 0 2.8404054282227253e-12
exist O 0 3.195364806085621e-11
germ O 0 1.0248670889723144e-07
- O 0 3.175227858420726e-09
line O 0 3.066952247721133e-10
variants O 0 1.5179053760444594e-12
of O 0 1.413224974005945e-16
the O 0 2.7266939249016853e-15
APC B-Disease 0 5.947800411909565e-12
gene O 0 5.275936371812451e-12
that O 0 1.3565511324117267e-14
predispose O 0 2.5183900104197576e-12
to O 0 1.404852000382777e-14
the O 0 3.5063437071360115e-15
development O 0 3.0481110799458755e-13
of O 0 3.3431628098474706e-14
multiple O 0 0.30102041363716125
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9391099214553833
carcinoma I-Disease 1 1.0
, O 0 4.501855599414739e-08
but O 0 3.388001545978625e-10
without O 0 4.307173378809842e-14
the O 0 1.0194437084591872e-14
florid O 0 1.2415092953688145e-07
phenotype O 0 4.920598373203688e-10
of O 0 1.3929133886285828e-16
classical O 0 4.79462259825314e-12
FAP B-Disease 0 1.5343530612721423e-10
, O 0 4.273575579787775e-13
and O 0 1.7411327371194552e-13
possibly O 0 9.383019670483952e-14
with O 0 3.4594703861426162e-15
importance O 0 5.735897520842137e-11
for O 0 4.2064397121066577e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 2.880133251892403e-07
in O 0 4.257764591743783e-14
the O 0 1.1715751795354085e-13
general O 0 1.0521545657296572e-12
population O 0 1.3644169344698143e-13
. O 0 6.739015134772305e-14
. O 0 2.010173060992826e-12

Genomic O 0 5.224246137913724e-07
structure O 0 3.2398059790494926e-09
of O 0 2.3843430281924628e-14
the O 0 3.911451024185553e-12
human O 0 1.24316912319955e-07
congenital B-Disease 1 0.9999954700469971
chloride I-Disease 1 0.9999797344207764
diarrhea I-Disease 1 1.0
( O 0 2.44413200789495e-07
CLD B-Disease 1 0.5968381762504578
) O 0 1.6090889037867484e-11
gene O 0 6.784195871745169e-09
. O 0 3.828167990937992e-11

Congenital B-Disease 1 0.9999969005584717
chloride I-Disease 1 0.9999655485153198
diarrhea I-Disease 1 1.0
( O 0 3.4139050058001885e-06
CLD B-Disease 1 0.9993906021118164
) O 0 9.844544068826622e-10
is O 0 4.2570951104548005e-12
caused O 0 4.854307927848467e-11
by O 0 1.2917054578731602e-13
mutations O 0 1.631649979572103e-07
in O 0 7.933505740374824e-14
a O 0 3.994541242918759e-13
gene O 0 4.90911755690604e-09
which O 0 1.0289224306554365e-13
encodes O 0 9.372566091292445e-12
an O 0 2.849585530647486e-13
intestinal O 0 2.082513219647808e-06
anion O 0 1.213377953668271e-09
transporter O 0 1.1930706023122184e-06
. O 0 1.3989882863274516e-10

We O 0 8.730577974347398e-06
report O 0 1.0506395059506346e-10
here O 0 7.087881713843669e-13
the O 0 4.423616438024901e-15
complete O 0 2.3153460485675348e-12
genomic O 0 1.1950767042634425e-09
organization O 0 5.365215108125987e-13
of O 0 4.403964903071687e-16
the O 0 3.865849697651247e-13
human O 0 9.846904541754853e-11
CLD B-Disease 0 4.3824380554724485e-05
gene O 0 6.234645155700491e-08
which O 0 1.6220732439523045e-12
spans O 0 1.2712229879863202e-10
approximately O 0 7.71727896430735e-13
39kb O 0 6.781836532354646e-07
, O 0 8.752490399110968e-11
and O 0 2.8724037037797245e-11
comprises O 0 3.196376843761506e-11
21 O 0 5.913122769207746e-11
exons O 0 5.4289696294063106e-08
. O 0 6.325297230436178e-11

All O 0 6.325390298350664e-12
exon O 0 1.2203454913262135e-09
/ O 0 5.730521024815971e-06
intron O 0 3.6277469916967675e-05
boundaries O 0 2.814225297242956e-07
conform O 0 7.915705424466069e-09
to O 0 9.51467027453072e-14
the O 0 2.2331176621412374e-14
GT O 0 3.184816022017145e-10
/ O 0 1.0397259302408202e-06
AG O 0 2.816007508954499e-06
rule O 0 1.051929920947714e-08
. O 0 1.7772269766958004e-11

An O 0 2.125668890039234e-13
analysis O 0 2.0863538761212164e-12
of O 0 1.0350976211252535e-16
the O 0 1.9630575122934384e-15
putative O 0 9.610580560537318e-12
promoter O 0 4.0600611761476557e-10
region O 0 6.305758692981556e-11
sequence O 0 1.1561648305402628e-09
shows O 0 2.622891660808424e-11
a O 0 2.6022391706737036e-13
putative O 0 4.105100148699137e-10
TATA O 0 2.569853219114293e-09
box O 0 5.08269089039004e-08
and O 0 4.673966214063796e-10
predicts O 0 5.607756925485319e-09
multiple O 0 1.559766725500733e-11
transcription O 0 1.165228979971289e-08
factor O 0 3.344724150422529e-11
binding O 0 1.0965108682148283e-10
sites O 0 8.088334446654244e-09
. O 0 4.803066278036283e-10

The O 0 8.32021517654935e-12
genomic O 0 4.2913006481626326e-09
structure O 0 7.263190604511749e-10
was O 0 1.338389902377779e-12
determined O 0 3.725117070818747e-14
using O 0 3.998462649710708e-15
DNA O 0 4.9854001815674565e-08
from O 0 1.0495787743241988e-16
several O 0 1.654870371316694e-16
sources O 0 4.963749019698234e-15
including O 0 8.785740825177982e-15
multiple O 0 3.455967066343102e-12
large O 0 1.5101962735908359e-10
- O 0 2.3764792786096223e-05
insert O 0 7.673864388380025e-07
libaries O 0 4.350110316408973e-08
and O 0 1.8752881192352078e-13
genomic O 0 2.49731235690831e-10
DNA O 0 3.032548434589444e-08
from O 0 1.907290684167052e-14
Finnish O 0 3.550643896232941e-06
CLD B-Disease 1 0.9191722869873047
patients O 0 7.533610641985433e-07
and O 0 4.330704631710924e-12
controls O 0 0.00012825218436773866
. O 0 7.588564221450156e-10

Exon O 0 2.6110245077148875e-09
- O 0 3.6337798547947386e-08
specific O 0 4.173203015794824e-12
primers O 0 2.9233988243504427e-06
developed O 0 4.329837821615001e-08
in O 0 7.027744949568773e-14
this O 0 8.172362932863317e-14
study O 0 4.727133398260697e-13
will O 0 3.609515708243374e-14
facilitate O 0 2.8319528457844932e-14
mutation O 0 9.618993969395806e-13
screening O 0 3.123369271551546e-11
studies O 0 1.261674819523842e-13
of O 0 2.2083187873768976e-17
patients O 0 3.636858175726232e-12
with O 0 1.2741412471536234e-13
the O 0 3.629841704988479e-10
disease O 0 0.0007614215719513595
. O 0 3.972895797066389e-12

Genomic O 0 5.422353677175806e-09
sequencing O 0 1.7413147312961286e-10
of O 0 1.7244736361612012e-15
a O 0 4.259561995657857e-13
BAC O 0 6.26188602836919e-06
clone O 0 3.115582876489498e-05
H O 1 1.0
_ O 0 1.882411587716959e-10
RG364P16 O 0 8.196607281796275e-10
revealed O 0 5.864153607149092e-11
the O 0 2.278064194937866e-15
presence O 0 4.1075690483498295e-13
of O 0 9.14540877580427e-17
another O 0 1.0976857443834032e-12
, O 0 2.7490142595013728e-14
highly O 0 1.515175288905571e-15
homologous O 0 5.461067795892172e-13
gene O 0 5.438685057868042e-10
3 O 0 3.757095329293136e-12
of O 0 1.5551117276983088e-15
the O 0 3.845172878019776e-12
CLD B-Disease 0 0.00010287349141435698
gene O 0 5.2300559438833716e-09
, O 0 2.163627587368263e-14
with O 0 4.389708279778213e-16
a O 0 3.577082816693007e-15
similar O 0 3.3675461778934906e-14
genomic O 0 7.910591648396803e-08
structure O 0 6.674893171521035e-08
, O 0 1.5336405105939588e-12
recently O 0 1.358441276133604e-10
identified O 0 4.572689796256135e-11
as O 0 1.2094994276956594e-11
the O 0 8.278252039417566e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 3.1842668590797985e-07
( O 0 4.217199506273417e-14
PDS B-Disease 0 1.571358154706104e-08
) O 0 3.541112715554906e-14
. O 0 3.3133079477753666e-14
. O 0 3.976739510608285e-12

The O 0 4.067065781376833e-11
APCI1307K O 0 4.5064686560181144e-07
allele O 0 5.308611861210011e-08
and O 0 3.322691100038355e-07
cancer B-Disease 0 0.0010006912052631378
risk O 0 1.497211243872698e-08
in O 0 5.489033706729263e-13
a O 0 1.1338085331713543e-10
community O 0 1.3843031538771089e-12
- O 0 1.6157866156163436e-08
based O 0 1.249964351858826e-13
study O 0 1.573395717370269e-14
of O 0 3.1925833143594604e-17
Ashkenazi O 0 2.1299428887289196e-09
Jews O 0 6.37745715612037e-12
. O 0 6.948548724253212e-13

Mutations O 0 4.3850050133187324e-05
in O 0 4.273738481164191e-13
APC O 0 9.756072616440292e-10
are O 0 5.603479377551401e-13
classically O 0 1.3930305613030214e-05
associated O 0 3.1272184060071595e-06
with O 0 2.0557054085657e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999980926513672
polyposis I-Disease 1 1.0
( O 0 4.041032508617093e-10
FAP B-Disease 0 1.8248423216959964e-08
) O 0 2.8893191008141916e-13
, O 0 6.364690946589896e-14
a O 0 3.784050330024602e-12
highly O 0 1.3808863741360256e-06
penetrant O 1 0.9999691247940063
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 5.259516910882667e-06
by O 0 1.0093759595514173e-12
multiple O 0 7.00417288612698e-08
intestinal O 0 0.4722701907157898
polyps B-Disease 0 0.1334724873304367
and O 0 1.5293343258449e-09
, O 0 1.6200851424286178e-12
without O 0 6.303632068367301e-14
surgical O 0 6.619513470695892e-08
intervention O 0 6.696242865755764e-11
, O 0 8.872825976551091e-14
the O 0 3.730549262516078e-14
development O 0 2.2167583046961425e-10
of O 0 1.188167964016884e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.6567441862846977e-11
CRC B-Disease 0 7.119452220649691e-06
) O 0 4.720486588422057e-12
. O 0 5.627033995009301e-12

APC B-Disease 0 3.7947909703461846e-08
is O 0 1.724154846671766e-11
a O 0 4.527682048727222e-11
tumour O 1 0.9999998807907104
- O 0 5.58406441086845e-07
suppressor O 0 2.2183975545431167e-08
gene O 0 3.023209771413349e-08
, O 0 9.293027502035867e-13
and O 0 3.33979914036997e-13
somatic O 0 2.7214310666101582e-11
loss O 0 2.3799420212355926e-09
occurs O 0 2.6297056199275914e-10
in O 0 1.0722159965448341e-10
tumours B-Disease 1 1.0
. O 0 6.650034745092626e-09

The O 0 1.203709770747352e-10
germline O 0 7.15895751568496e-08
T O 0 4.423907012096606e-05
- O 0 1.9926484640109265e-07
to O 0 9.727651843760565e-12
- O 0 3.3318148240368828e-09
A O 0 1.621618529561164e-12
transversion O 0 1.0350435786232737e-10
responsible O 0 3.2243305247980913e-14
for O 0 3.212741705887378e-17
the O 0 3.2083831919781623e-16
APC O 0 1.9904026343775527e-12
I1307K O 0 6.303887533504193e-13
allele O 0 7.465412125019343e-15
converts O 0 4.79434073618148e-15
the O 0 1.1271128615934073e-15
wild O 0 1.8087873863634196e-12
- O 0 6.049216683123859e-11
type O 0 1.1626641871487209e-09
sequence O 0 1.2840138674530266e-10
to O 0 6.451521717028286e-13
a O 0 3.76405469293406e-11
homopolymer O 0 0.03462934494018555
tract O 1 0.9954311847686768
( O 0 5.0294123032923466e-11
A8 O 0 0.0014159568818286061
) O 0 3.01411395842166e-11
that O 0 3.454743435771235e-11
is O 0 3.4492651790341e-11
genetically O 0 3.898915679201309e-07
unstable O 0 0.2087172418832779
and O 0 4.0083961039272253e-08
prone O 0 3.5327423120179446e-06
to O 0 2.0565234899131563e-13
somatic O 0 7.535209955999989e-11
mutation O 0 3.5134641862555327e-09
. O 0 5.44129455035125e-12

The O 0 6.595366613959541e-12
I1307K O 0 7.223663889277532e-10
allele O 0 2.7184428319504406e-11
was O 0 7.080781100343714e-11
found O 0 2.3496194139632776e-12
in O 0 8.688457397119931e-14
6 O 0 1.630453883016969e-09
. O 0 2.3179366412384717e-11

1 O 0 1.5227320793176347e-10
% O 0 3.134853352381936e-14
of O 0 7.337873421239198e-16
unselected O 0 2.6357147362432443e-06
Ashkenazi O 0 4.479799827095121e-06
Jews O 0 6.75159816942994e-10
and O 0 1.7089695977801078e-11
higher O 0 1.383017100365161e-13
proportions O 0 4.3124678827943796e-10
of O 0 2.093405930238745e-15
Ashkenazim O 0 3.253409772696614e-07
with O 0 6.37943101122751e-11
family O 0 7.459339257387398e-10
or O 0 1.1173242235942848e-12
personal O 0 5.369555711523533e-13
histories O 0 1.2294243401100857e-09
of O 0 1.4974409177372604e-14
CRC B-Disease 0 8.839288057060912e-06
( O 0 1.8725858808455592e-13
ref O 0 3.4911890907096677e-06
. O 0 9.16865650242571e-13
2 O 0 3.0002263694262066e-12
) O 0 2.9978452988251025e-13
. O 0 1.315074026238261e-12

To O 0 2.232069043484053e-11
evaluate O 0 1.2760370884934424e-11
the O 0 6.3888184259825506e-15
role O 0 3.0896812885927716e-13
of O 0 2.0446316555534742e-15
I1307K O 0 5.076787878977029e-09
in O 0 2.5017772142116312e-12
cancer B-Disease 0 1.0850340004253667e-06
, O 0 5.887637382837041e-13
we O 0 4.586615809376582e-10
genotyped O 0 1.5797128583017184e-07
5 O 0 7.429768605904385e-12
, O 0 6.451546111577167e-13
081 O 0 4.389458467812801e-07
Ashkenazi O 0 5.273391820992401e-07
volunteers O 0 1.440543322649146e-12
in O 0 2.5843703669063342e-15
a O 0 7.735047276085857e-14
community O 0 2.1850029381306757e-13
survey O 0 5.702180394528966e-11
. O 0 1.6097019550631586e-12

Risk O 0 7.434034614561824e-07
of O 0 8.40243835880522e-13
developing O 0 1.9139347386953887e-06
colorectal B-Disease 1 1.0
, I-Disease 0 0.00023914857592899352
breast I-Disease 1 0.9998867511749268
and I-Disease 0 2.1738352984357334e-07
other I-Disease 0 2.1575741193657905e-10
cancers I-Disease 0 0.0037279832176864147
were O 0 8.15029359106656e-13
compared O 0 1.8310017130956924e-13
between O 0 1.1559712605538341e-12
genotyped O 0 7.127511025828426e-07
I1307K O 0 3.6070663123055624e-10
carriers O 0 1.1446593672914673e-11
and O 0 6.793764227401577e-13
non O 0 1.594447094971016e-13
- O 0 1.4680369808672822e-08
carriers O 0 1.3205202487043266e-09
and O 0 2.517633879151049e-10
their O 0 7.095776603013165e-14
first O 0 2.932855239050347e-13
- O 0 1.2591885867330177e-10
degree O 0 4.271554355887719e-13
relatives O 0 1.7495359544775213e-12
. O 0 6.181947315164749e-13

Sperm O 0 3.4588805153390467e-09
DNA O 0 5.934661650996986e-10
analysis O 0 1.7513188165299565e-12
in O 0 9.619405051425767e-15
a O 0 2.7724718354438238e-11
Friedreich B-Disease 1 0.999945878982544
ataxia I-Disease 1 0.99998939037323
premutation O 0 0.016948383301496506
carrier O 0 1.1621840911857362e-07
suggests O 0 4.188957236639368e-10
both O 0 3.976957652085389e-13
meiotic O 0 2.3009973926235716e-09
and O 0 5.447940709668586e-12
mitotic O 0 7.394883594358248e-10
expansion O 0 1.2744980071310863e-10
in O 0 6.264286507053074e-13
the O 0 2.7214959886362466e-13
FRDA B-Disease 0 1.0140017536741652e-07
gene O 0 5.272172032277922e-09
. O 0 9.939209177911579e-12

Friedreich B-Disease 1 0.9999123811721802
ataxia I-Disease 1 0.9999982118606567
is O 0 5.584475729847327e-05
usually O 0 2.5937433179024083e-07
caused O 0 1.6508337752352276e-10
by O 0 1.0426396421922752e-15
an O 0 4.2331842673617027e-16
expansion O 0 5.859580876066417e-11
of O 0 1.3972946030207847e-14
a O 0 1.0762236241079748e-10
GAA O 0 4.0477939222682835e-08
trinucleotide O 0 4.046878984809155e-06
repeat O 0 5.13886577735434e-09
in O 0 1.2750109128212284e-14
intron O 0 2.797783906771656e-07
1 O 0 3.582179854393769e-13
of O 0 1.4558067761022967e-16
the O 0 8.723744789702545e-14
FRDA B-Disease 0 1.579327317813295e-07
gene O 0 2.1491595170175515e-09
. O 0 6.665223928337127e-12

Occasionally O 0 1.467197489546379e-05
, O 0 1.265747142514817e-11
a O 0 2.443948092945708e-13
fully O 0 3.184294462225262e-13
expanded O 0 1.5349690919361225e-12
allele O 0 4.8005540514983736e-11
has O 0 1.282112471745478e-10
been O 0 7.244211740892181e-13
found O 0 1.6725542392043158e-13
to O 0 1.1443565042237262e-14
arise O 0 1.778920842012907e-13
from O 0 7.138605082279581e-18
a O 0 3.133823487373017e-15
premutation O 0 2.2580721736886744e-09
of O 0 1.9441650776796417e-16
100 O 0 2.341162135574386e-14
or O 0 9.681514758722726e-14
less O 0 1.0626717469311084e-13
triplet O 0 0.00011720554903149605
repeats O 0 1.62181313498877e-05
. O 0 6.360405258032387e-11

We O 0 1.0526182450121269e-06
have O 0 3.951975899307847e-12
examined O 0 5.903543626173402e-11
the O 0 9.871326202466352e-16
sperm O 0 4.0468632134596505e-14
DNA O 0 9.119478609764808e-12
of O 0 8.318634474368129e-18
a O 0 7.049870127777413e-14
premutation O 0 5.529587809860459e-08
carrier O 0 7.980417993103117e-10
. O 0 9.966963018803732e-12

This O 0 3.065348322395245e-11
mans O 0 6.759706572267987e-09
leucocyte O 0 4.352176574684563e-08
DNA O 0 9.6455607945245e-07
showed O 0 5.098201305564487e-10
one O 0 6.678792955695009e-15
normal O 0 6.691728876746794e-13
allele O 0 1.0318433390707482e-12
and O 0 3.1849203179293295e-13
one O 0 7.27738203391544e-16
allele O 0 1.1073261719455468e-14
of O 0 3.5910792288181066e-17
approximately O 0 1.411185350432692e-13
100 O 0 2.689842055689229e-12
repeats O 0 1.2173145478300285e-06
. O 0 1.1355853757333279e-10

His O 0 4.5487880129257974e-10
sperm O 0 3.010467153341523e-10
showed O 0 5.765333956769814e-12
an O 0 3.6525040067450693e-17
expanded O 0 1.7420015083202678e-11
allele O 0 3.2217964407443844e-11
in O 0 4.0809475482066204e-13
a O 0 1.9230155662297577e-11
tight O 0 9.447792876926542e-07
range O 0 1.3334676245146948e-11
centering O 0 3.453726670973878e-12
on O 0 1.1831496069328318e-12
a O 0 1.9147118786311257e-14
size O 0 3.214157726864203e-13
of O 0 3.988376393133041e-16
approximately O 0 1.7103384680750011e-12
320 O 0 1.6725543172668722e-09
trinucleotide O 0 8.512541535310447e-05
repeats O 0 3.1617641980119515e-06
. O 0 2.8736145407659563e-11

His O 0 5.314343187734494e-09
affected O 0 2.615625271928934e-09
son O 0 1.066599697452375e-08
has O 0 6.411904340808405e-11
repeat O 0 1.090860290986484e-09
sizes O 0 3.2389747134375924e-11
of O 0 2.0783037563056744e-15
1040 O 0 2.0724150173734301e-10
and O 0 1.1552372556830615e-12
540 O 0 3.6035091577346634e-11
. O 0 2.8155986656758225e-12

These O 0 3.106849846834514e-12
data O 0 5.728642928949645e-13
suggest O 0 3.045983604232916e-13
that O 0 1.506927517339919e-14
expansion O 0 2.3895278117302965e-11
occurs O 0 5.552743594788856e-12
in O 0 4.03694674463626e-15
two O 0 8.898575236046535e-13
stages O 0 1.9180858290557268e-10
, O 0 5.717353809353912e-14
the O 0 2.586895583880336e-15
first O 0 1.9343806612927283e-13
during O 0 1.3074320306136287e-14
meiosis O 0 4.971476789267237e-13
followed O 0 4.163173373205285e-14
by O 0 3.315357100469276e-17
a O 0 2.4597381508055733e-15
second O 0 1.2347940595361373e-13
mitotic O 0 2.3292034967425934e-10
expansion O 0 2.5939290715371044e-09
. O 0 1.2932802051501824e-10

We O 0 7.427493642353511e-07
also O 0 2.7959759507645288e-11
show O 0 9.860455507659793e-11
that O 0 3.14945443856407e-13
in O 0 1.0113020277701789e-14
all O 0 3.334423970930648e-15
informative O 0 5.205238150229885e-12
carrier O 0 5.740910524743015e-11
father O 0 2.1022371343715207e-11
to O 0 1.309746582023319e-13
affected O 0 1.880530280107262e-11
child O 0 2.6164560101848977e-11
transmissions O 0 4.044681922721338e-09
, O 0 6.642462187927967e-14
with O 0 3.681631669856132e-15
the O 0 2.580075698105518e-15
notable O 0 1.1836495156139059e-14
exception O 0 4.006627928737627e-13
of O 0 2.0054508230892465e-16
the O 0 5.5616305289461765e-14
premutation O 0 6.77039047047856e-09
carrier O 0 5.6459017148957624e-12
, O 0 3.5503557508335818e-15
the O 0 1.2856225045267388e-16
expansion O 0 7.546147409200066e-13
size O 0 7.658833636736695e-12
decreases O 0 1.0794930505042544e-09
. O 0 1.3586058276657265e-12
. O 0 3.0649139910049472e-12

The O 0 7.447617175748711e-12
R496H O 0 4.554569776882289e-10
mutation O 0 3.961880129521589e-11
of O 0 3.91492090185376e-16
arylsulfatase O 0 1.663593280909481e-07
A O 0 1.7584432521200455e-10
does O 0 2.0761390384649303e-09
not O 0 2.663846920825108e-10
cause O 0 3.7518681494930206e-08
metachromatic B-Disease 1 0.9999995231628418
leukodystrophy I-Disease 1 0.9999984502792358
. O 0 4.006460496697173e-09

Deficiency B-Disease 1 0.9997857213020325
of I-Disease 0 9.515182695582491e-13
arylsulfatase I-Disease 0 6.375526481861016e-06
A I-Disease 0 2.020250633449905e-09
( O 0 5.4398417194401194e-12
ARSA O 0 7.905779057182372e-05
) O 0 3.3855240659519392e-12
enzyme O 0 1.2167036267385356e-09
activity O 0 6.185158696325743e-08
causes O 0 2.6622235964168794e-05
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999997615814209
( O 0 1.5351245608030695e-08
MLD B-Disease 1 0.9999896287918091
) O 0 4.4630507622933635e-11
. O 0 1.5831998906312705e-11

A O 0 1.4496294442611912e-10
number O 0 1.2603165039370978e-12
of O 0 5.503980111303333e-14
ARSA O 0 0.07123394310474396
gene O 0 1.9172287579749536e-07
mutations O 0 6.261123530748591e-08
responsible O 0 8.905507407896973e-12
for O 0 2.510236213771472e-13
MLD B-Disease 1 1.0
have O 0 5.578667838790352e-08
been O 0 1.8253476855023543e-11
identified O 0 2.9131735912457657e-10
. O 0 1.5991625341646443e-12

Recently O 0 1.296171348030839e-07
, O 0 5.506555498038801e-13
the O 0 9.911100328570573e-15
R496H O 0 8.402591122891323e-11
mutation O 0 3.2774030885029948e-12
of O 0 6.004298263986025e-17
ARSA O 0 2.754886281763902e-06
was O 0 1.73431906856647e-12
proposed O 0 1.6341952341044144e-14
to O 0 6.210663764955743e-14
be O 0 2.0633195740621564e-14
a O 0 7.960789688045422e-14
cause O 0 3.4074805477235515e-11
of O 0 1.6990591876139827e-12
MLD B-Disease 1 1.0
( O 0 3.7266739694175044e-10
Draghia O 0 4.8063531721709296e-05
et O 0 1.4025035000031494e-07
al O 0 8.982667054624471e-08
. O 0 6.729721814535683e-12
, O 0 4.58751905820648e-13
1997 O 0 7.768910298064369e-13
) O 0 1.48745572066053e-13
. O 0 2.4565256512981692e-12

We O 0 2.915884920184908e-07
have O 0 5.852024051976323e-13
investigated O 0 5.936622179091022e-13
the O 0 6.954066910970513e-16
R496H O 0 7.408432894928652e-11
mutation O 0 1.3818899149975472e-11
and O 0 3.982997945676213e-14
found O 0 5.478728026266609e-14
this O 0 4.310094594274597e-16
mutation O 0 5.817624485447703e-13
at O 0 7.23249991797445e-14
a O 0 6.990985371372184e-16
relatively O 0 2.6770679585879503e-15
high O 0 7.854968167879048e-14
frequency O 0 1.1374507022030023e-12
in O 0 2.248366626884067e-14
an O 0 4.21650587099291e-15
African O 0 6.966872418594575e-14
American O 0 2.0361137228292955e-14
population O 0 1.3566520140357446e-14
( O 0 2.9586711769793994e-14
f O 0 2.223077217422542e-06
= O 0 3.1143324008553463e-07
0 O 0 2.9926151834391845e-11
. O 0 5.312556086234724e-14
09 O 0 4.022933028369202e-12
, O 0 3.0469948938093017e-13
n O 0 1.8301741988580034e-07
= O 0 1.4799906011830899e-06
61 O 0 4.5508183332820806e-10
subjects O 0 2.2860005555180862e-10
) O 0 1.6243178677100012e-12
. O 0 3.425307563628688e-12

The O 0 1.3906054086021413e-10
ARSA O 0 1.4397792256204411e-06
enzyme O 0 1.671396798741398e-09
activity O 0 3.3959854373044607e-10
in O 0 1.300927952602865e-13
subjects O 0 1.723581277701669e-09
with O 0 5.863773355763158e-11
and O 0 1.68900254893245e-10
without O 0 1.6113529578026288e-14
the O 0 2.318593874431037e-16
R496H O 0 5.5330367024208904e-12
mutation O 0 3.919703537441643e-12
was O 0 4.006331724704104e-12
determined O 0 6.472345576158389e-11
and O 0 9.335277342814585e-12
found O 0 8.259125328091699e-11
to O 0 3.901950377388497e-12
be O 0 2.5191022878789937e-11
normal O 0 2.795028375413011e-10
. O 0 1.4804012182789705e-11

It O 0 8.158258069101976e-09
is O 0 1.4360195975046675e-12
therefore O 0 5.950611639722603e-13
concluded O 0 8.444633881055097e-12
that O 0 1.323386319691637e-14
the O 0 8.372674197021108e-15
R496H O 0 2.984846814158004e-10
mutation O 0 1.1207226119358538e-11
of O 0 3.4017187268867524e-16
ARSA O 0 6.019338616169989e-05
does O 0 2.1178009346201065e-10
not O 0 2.6231427918471314e-14
negatively O 0 2.4081597311967698e-14
influence O 0 4.622006716161614e-14
the O 0 1.516494585072567e-14
activity O 0 5.985058802726595e-12
of O 0 4.707619067821861e-16
ARSA O 0 0.010916678234934807
and O 0 1.0561385793694811e-10
is O 0 1.185263231963038e-13
not O 0 2.028606097123284e-13
a O 0 2.2158998540158098e-14
cause O 0 4.2919487408532575e-12
of O 0 3.0130032583480792e-12
MLD B-Disease 1 0.9999994039535522

Down O 0 5.818025238113478e-05
- O 0 3.638406269601546e-07
regulation O 0 1.774813518373719e-09
of O 0 1.4165753598892501e-14
transmembrane O 0 3.2659448478966624e-09
carbonic O 0 4.064425684902062e-09
anhydrases O 0 3.63111297474461e-07
in O 0 4.114347751382752e-11
renal B-Disease 0 0.0009902097517624497
cell I-Disease 1 0.9210487604141235
carcinoma I-Disease 1 1.0
cell O 1 0.9992836117744446
lines O 0 3.720848690136336e-05
by O 0 2.0080702725633337e-11
wild O 0 4.8424039960082155e-06
- O 0 0.3116731643676758
type O 0 0.22467496991157532
von B-Disease 1 0.9996531009674072
Hippel I-Disease 1 0.99882572889328
- I-Disease 1 0.981974184513092
Lindau I-Disease 0 0.29430973529815674
transgenes O 0 2.8086105885449797e-05
. O 0 1.4486158939064353e-09

To O 0 4.2470021943685765e-10
discover O 0 3.5554403865489803e-10
genes O 0 5.822958781820375e-11
involved O 0 4.22101850000578e-12
in O 0 1.0193718785744821e-10
von B-Disease 1 0.9999932050704956
Hippel I-Disease 1 0.9999923706054688
- I-Disease 1 0.9999905824661255
Lindau I-Disease 1 0.9999517202377319
( O 0 2.340470595108002e-10
VHL B-Disease 0 2.230979225714691e-05
) O 0 3.90594154242585e-12
- O 0 2.426207501571298e-08
mediated O 0 3.462704256662619e-08
carcinogenesis O 0 3.3985813274739485e-07
, O 0 6.050324824480313e-11
we O 0 4.3268119642725367e-10
used O 0 1.8476474517026276e-10
renal B-Disease 0 1.5284276742022485e-05
cell I-Disease 1 0.5382450222969055
carcinoma I-Disease 1 1.0
cell O 1 0.9999891519546509
lines O 1 0.998227059841156
stably O 0 0.030882354825735092
transfected O 0 2.3628950657439418e-05
with O 0 2.7985969097699126e-10
wild O 0 4.075319282037526e-07
- O 0 0.012768350541591644
type O 0 0.003508077934384346
VHL O 0 0.01869182661175728
- O 0 3.781695113502792e-06
expressing O 0 1.4109337830026103e-11
transgenes O 0 9.842937487292147e-08
. O 0 3.148286839560477e-11

Large O 0 5.824080800964637e-11
- O 0 8.224298575498779e-09
scale O 0 5.139274561472007e-10
RNA O 0 2.190164716253662e-09
differential O 0 3.848946161788547e-11
display O 0 2.856917610469245e-12
technology O 0 7.985102856711279e-11
applied O 0 1.9892953603828367e-11
to O 0 4.5004532869472036e-13
these O 0 5.4665880112533816e-14
cell O 0 2.765852613606512e-08
lines O 0 1.3189959702231135e-07
identified O 0 2.437792467890887e-10
several O 0 4.372398642693391e-14
differentially O 0 2.1371904246336726e-09
expressed O 0 1.1525928831962375e-14
genes O 0 3.0034670497197657e-12
, O 0 6.478393324824995e-16
including O 0 4.203749740095718e-17
an O 0 1.2353057034351792e-16
alpha O 0 8.047380849803693e-14
carbonic O 0 4.443156346317645e-12
anhydrase O 0 1.478516267749974e-11
gene O 0 6.325130419426728e-10
, O 0 5.572581241938823e-13
termed O 0 5.570336414351118e-10
CA12 O 0 6.769295850972412e-06
. O 0 9.153027641373157e-11

The O 0 2.695301230468128e-12
deduced O 0 1.057488558525721e-11
protein O 0 1.9549610194569134e-11
sequence O 0 1.835630814017719e-10
was O 0 1.7115482479641148e-13
classified O 0 6.945885923717587e-13
as O 0 9.895389900278079e-14
a O 0 2.7335510157516785e-12
one O 0 1.7325363366182955e-09
- O 0 0.022766167297959328
pass O 0 1.611307851590027e-07
transmembrane O 0 9.07972896868614e-09
CA O 0 1.1037111669054411e-08
possessing O 0 7.27771894127021e-15
an O 0 3.1332616927707505e-15
apparently O 0 1.5524780072606603e-10
intact O 0 9.450616504647069e-12
catalytic O 0 8.450369744228414e-12
domain O 0 9.906093306755182e-11
in O 0 1.1391435754751211e-13
the O 0 1.0092291179196813e-13
extracellular O 0 4.012878918047136e-08
CA O 0 7.126463060558308e-06
module O 0 1.1124080323554608e-08
. O 0 1.3099452078613183e-11

Reintroduced O 0 1.3866529968709074e-07
wild O 0 2.6457024659976014e-07
- O 0 0.00020693265832960606
type O 0 3.290002132416703e-05
VHL B-Disease 0 0.000559710431843996
strongly O 0 3.148299954069955e-10
inhibited O 0 1.2306694552322028e-10
the O 0 1.2458222421621399e-14
overexpression O 0 5.264930852399985e-11
of O 0 3.385769096489954e-16
the O 0 7.48929049202221e-14
CA12 O 0 1.049056663759984e-08
gene O 0 4.6546679705050664e-11
in O 0 1.1259102442148956e-14
the O 0 3.706055102560557e-13
parental O 0 1.0556004781392403e-05
renal B-Disease 0 0.00183377624489367
cell I-Disease 1 0.6261326670646667
carcinoma I-Disease 1 1.0
cell O 1 0.9986203908920288
lines O 0 0.01411458756774664
. O 0 4.078279047803335e-09

Similar O 0 2.5864197450431448e-09
results O 0 1.519276787709245e-10
were O 0 5.705925640829557e-14
obtained O 0 2.1820377807141994e-13
with O 0 1.2167956089058612e-14
CA9 O 0 8.622875924402251e-08
, O 0 1.1150519933387712e-13
encoding O 0 1.421399781730004e-12
another O 0 5.687519899488791e-10
transmembrane O 0 1.392105673403421e-06
CA O 0 7.57396082917694e-06
with O 0 1.232238290083728e-14
an O 0 6.646333488485921e-16
intact O 0 9.725931171544744e-11
catalytic O 0 2.808826782274565e-10
domain O 0 5.61835600265681e-09
. O 0 3.4419637279237136e-11

Although O 0 3.815393334605233e-09
both O 0 1.67083957346853e-12
domains O 0 2.1712964759501574e-10
of O 0 1.2194722330191848e-14
the O 0 1.5500915438379503e-12
VHL B-Disease 0 2.3727375264570583e-06
protein O 0 3.6420888527288753e-10
contribute O 0 3.0549263748021194e-13
to O 0 9.05499227031939e-14
regulation O 0 2.739065085854975e-10
of O 0 1.6408844015196474e-15
CA12 O 0 2.5825818283919943e-07
expression O 0 1.2038026825367254e-12
, O 0 1.0625070329041853e-14
the O 0 4.830834833076576e-16
elongin O 0 5.111130962909272e-10
binding O 0 3.979038452894823e-12
domain O 0 4.4309320101909577e-10
alone O 0 2.2652490994090613e-10
could O 0 3.755327646071116e-11
effectively O 0 1.4339845977318078e-10
regulate O 0 2.686964428733063e-09
CA9 O 0 3.782040948863141e-05
expression O 0 1.2477903155172498e-08
. O 0 7.970251542088747e-11

We O 0 7.03220962350315e-07
mapped O 0 6.710770321660675e-07
CA12 O 0 7.014780749159399e-06
and O 0 7.811994801043554e-11
CA9 O 0 1.0663269449651125e-06
loci O 0 1.5000424513633703e-10
to O 0 2.28239519298179e-12
chromosome O 0 4.513539764161578e-08
bands O 0 1.3724947567350654e-10
15q22 O 0 1.3278656396664701e-08
and O 0 2.2395019866339183e-11
17q21 O 0 2.231191409407529e-08
. O 0 2.729972845005868e-11

2 O 0 6.853072775925284e-09
respectively O 0 5.72727247571958e-11
, O 0 2.7507586052716304e-12
regions O 0 2.3719388675402797e-09
prone O 0 2.8431322789401747e-06
to O 0 2.710963235581093e-13
amplification O 0 1.5873755435102943e-11
in O 0 1.1689362145069198e-14
some O 0 9.166465871936202e-14
human O 0 7.188861728124607e-10
cancers B-Disease 0 0.0016899132169783115
. O 0 4.119765986687618e-11

Additional O 0 8.502347263739107e-12
experiments O 0 1.4215999488698117e-09
are O 0 2.1829274024780417e-14
needed O 0 5.925049947202998e-13
to O 0 3.950824246207706e-15
define O 0 3.3002678281185416e-12
the O 0 7.497633258332897e-15
role O 0 4.94284951510493e-12
of O 0 2.4858590798879435e-14
CA O 0 1.788092777132988e-05
IX O 0 2.0826064428547397e-06
and O 0 2.5823988281103993e-08
CA O 0 2.3424076971423347e-06
XII O 0 9.79453629312843e-10
enzymes O 0 2.0940461864515925e-10
in O 0 9.214544478461893e-15
the O 0 1.1695606471956357e-14
regulation O 0 1.3018532085684598e-10
of O 0 9.14084392996306e-16
pH O 0 3.969846951168421e-10
in O 0 2.310376553699839e-14
the O 0 6.89309110550422e-14
extracellular O 0 1.9529167172294137e-09
microenvironment O 0 1.3188190450819093e-06
and O 0 3.0454857385953105e-12
its O 0 1.4935579493004572e-15
potential O 0 2.468292971814605e-14
impact O 0 4.3847109103267723e-13
on O 0 1.480966738132139e-10
cancer B-Disease 0 2.0441598280740436e-07
cell O 0 1.3952109689796544e-08
growth O 0 1.9091435377038835e-10
. O 0 2.0134165168439466e-11

A O 0 1.4024927920408548e-11
gene O 0 2.621426166415919e-11
encoding O 0 3.0166143021037595e-12
a O 0 2.9143920892045483e-13
transmembrane O 0 8.720180827426205e-11
protein O 0 2.331657089627015e-10
is O 0 2.325975512456474e-14
mutated O 0 4.750390303343011e-09
in O 0 3.407240115049781e-11
patients O 0 3.8807090163572866e-07
with O 0 0.003040857845917344
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.03601156547665596
optic B-Disease 1 0.9999969005584717
atrophy I-Disease 1 0.9999955892562866
( O 0 0.0002451931650284678
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 2.1774926306505904e-10
. O 0 3.3903269081037024e-11

Wolfram B-Disease 1 0.999997615814209
syndrome I-Disease 1 1.0
( O 0 9.486497809518823e-09
WFS B-Disease 0 0.0011906480649486184
; O 0 5.774198896801863e-10
OMIM O 0 0.00015918487042654306
222300 O 0 1.008972247973361e-07
) O 0 9.562888675374026e-13
is O 0 9.473333575926723e-13
an O 0 3.582825702785897e-11
autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 0.9999997615814209
neurodegenerative I-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999986886978149
defined O 0 1.0864360078244317e-08
by O 0 2.5291485485773313e-12
young O 0 2.236644203179594e-09
- O 0 9.753545600688085e-05
onset O 0 0.0001332061947323382
non O 0 2.6829516741599946e-07
- O 1 0.909550130367279
immune O 0 0.0024892278015613556
insulin B-Disease 0 0.016811620444059372
- I-Disease 1 0.9997169375419617
dependent I-Disease 1 0.9896132349967957
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 2.59751988807011e-08
progressive O 0 1.117028070041215e-08
optic B-Disease 1 0.7680332064628601
atrophy I-Disease 1 0.8390300273895264
. O 0 2.854106062599726e-09

Linkage O 0 1.8005939637077972e-06
to O 0 1.894140920499776e-11
markers O 0 2.9447073757182807e-07
on O 0 2.0868970440623968e-10
chromosome O 0 1.698641244729515e-05
4p O 0 5.102183422422968e-06
was O 0 5.384501733374236e-08
confirmed O 0 1.5818319099025757e-08
in O 0 3.423542374071664e-13
five O 0 2.8003951588195797e-11
families O 0 1.8625916781145335e-12
. O 0 5.794979513612519e-12

On O 0 2.757020826915646e-11
the O 0 2.8857146198697867e-15
basis O 0 3.81000755982552e-15
of O 0 6.752800765395459e-16
meiotic O 0 2.2470931071438827e-06
recombinants O 1 0.8782092928886414
and O 0 6.264325202209875e-05
disease O 1 0.9905468225479126
- O 0 1.408390835422324e-05
associated O 0 1.7110639305428776e-07
haplotypes O 0 1.8328499891140382e-06
, O 0 2.6717465045900113e-12
the O 0 5.343336924724766e-14
WFS B-Disease 0 1.6373700617577924e-08
gene O 0 1.6392213975091607e-10
was O 0 1.7788393913246991e-13
localized O 0 2.5803416695002745e-11
to O 0 9.461741286298508e-13
a O 0 3.746997503939475e-12
BAC O 0 1.3456435226544272e-05
/ O 0 1.0417110729576962e-08
P1 O 0 9.683658319659116e-10
contig O 0 3.975818008150611e-10
of O 0 8.303010025213737e-17
less O 0 2.919450195153472e-16
than O 0 1.2710768047702347e-15
250 O 0 2.826881252953467e-13
kb O 0 1.0922183264483465e-06
. O 0 6.276192066057007e-11

Mutations O 0 0.0001105083865695633
in O 0 2.631216913188267e-13
a O 0 9.982191803833626e-14
novel O 0 2.3769318110988813e-11
gene O 0 2.844616986408255e-09
( O 0 6.112720328825191e-14
WFS1 O 0 2.842111435086281e-09
) O 0 1.8106347804679743e-15
encoding O 0 2.3465939884585382e-14
a O 0 6.676897804178822e-14
putative O 0 1.1285521996085013e-11
transmembrane O 0 3.1934439901487588e-12
protein O 0 6.558167342518573e-10
were O 0 1.00613189654708e-11
found O 0 7.946905633549051e-11
in O 0 1.8209296104385736e-13
all O 0 1.6579919945650112e-12
affected O 0 5.6241403895151976e-11
individuals O 0 1.6243927759157246e-15
in O 0 1.0662512404035693e-13
six O 0 1.5222869839681685e-11
WFS B-Disease 0 5.419988724497671e-08
families O 0 3.845229527583288e-13
, O 0 1.377044637172753e-13
and O 0 1.4920967022699627e-12
these O 0 2.4002586078647817e-14
mutations O 0 6.389822004848611e-10
were O 0 1.0679242321183502e-13
associated O 0 1.7702611945780156e-11
with O 0 1.0659675399316004e-11
the O 0 2.0967599878574106e-10
disease O 0 2.2351403458742425e-05
phenotype O 0 7.965123671738183e-09
. O 0 1.157339675483815e-11

WFS1 O 0 3.1327822398452554e-06
appears O 0 1.220373468946434e-09
to O 0 4.535188414048208e-13
function O 0 1.1397141043423265e-11
in O 0 1.1189172418463178e-12
survival O 0 1.5619579585290921e-07
of O 0 7.29158571764971e-15
islet O 0 5.873363261343911e-05
beta O 0 8.432715636885746e-10
- O 0 1.9884802895830944e-05
cells O 0 6.540519681408341e-09
and O 0 1.4046685906446421e-12
neurons O 0 2.3236545066557257e-12
. O 0 7.356771848611096e-14
. O 0 2.5723195275217936e-13

Stable O 0 1.266094926677397e-07
interaction O 0 5.4002708554934387e-11
between O 0 2.7940341013055203e-12
the O 0 9.349559158561976e-14
products O 0 1.3880263258214676e-11
of O 0 1.1718733647789951e-15
the O 0 1.3781804473686488e-12
BRCA1 O 0 6.154245966172311e-07
and O 0 3.501367251690368e-10
BRCA2 O 0 1.1344413408664877e-08
tumor B-Disease 0 2.232095897003461e-10
suppressor O 0 4.7242539741310097e-11
genes O 0 1.6631246380072184e-10
in O 0 1.5191702605089896e-13
mitotic O 0 2.801457021917031e-08
and O 0 3.014650196142554e-10
meiotic O 0 5.660663191520143e-07
cells O 0 6.619955001951894e-07
. O 0 2.0327418914778406e-10

BRCA1 O 0 0.0026405274402350187
and O 0 1.2713503139138993e-08
BRCA2 O 0 5.3427623214474806e-08
account O 0 3.433115066103082e-13
for O 0 1.5695034792166494e-16
most O 0 1.294249190987389e-15
cases O 0 5.7508414263302e-14
of O 0 1.3673900359965446e-16
familial O 0 1.1231215069074096e-07
, O 0 2.744501024012913e-12
early O 0 6.555325032797654e-11
onset O 0 5.61396632292599e-07
breast B-Disease 1 0.6720581650733948
and I-Disease 0 0.0019107670523226261
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9999898672103882
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.090878243795393e-12
encode O 0 7.109548626899054e-12
products O 0 3.110675095285842e-08
that O 0 1.026132651071876e-11
each O 0 7.401662413705735e-16
interact O 0 4.8995543408016096e-14
with O 0 7.952139787588061e-14
hRAD51 O 0 1.4439821782730178e-08
. O 0 1.581377043202714e-11

Results O 0 6.705595012590493e-08
presented O 0 3.7531202104479355e-12
here O 0 3.328289250106864e-13
show O 0 6.473329684786311e-12
that O 0 1.657609379618341e-12
BRCA1 O 0 2.7894395770999836e-07
and O 0 1.5956246324222434e-09
BRCA2 O 0 1.2575628716149367e-07
coexist O 0 7.580250205307948e-09
in O 0 6.675684768295059e-15
a O 0 1.7884253648327297e-14
biochemical O 0 1.2453116315924717e-10
complex O 0 3.4300166873446614e-11
and O 0 2.6008672646127273e-11
colocalize O 0 1.1623326656717836e-07
in O 0 5.211255147026528e-13
subnuclear O 0 3.471466669680012e-08
foci O 0 5.885109621850404e-10
in O 0 7.111653896796268e-15
somatic O 0 2.46769293367477e-12
cells O 0 7.250249289825206e-10
and O 0 3.0100029998862687e-13
on O 0 1.086343556479458e-14
the O 0 1.2014718987993922e-16
axial O 0 8.479762709069985e-14
elements O 0 4.801639229452814e-13
of O 0 2.74333494594168e-15
developing O 0 1.0726148441664307e-10
synaptonemal O 0 1.488760119627841e-07
complexes O 0 1.6364856492145918e-07
. O 0 5.2307689429875737e-11

Like O 0 8.328265010959512e-08
BRCA1 O 0 4.153607733314857e-06
and O 0 9.232314218676763e-11
RAD51 O 0 1.4313268366095144e-06
, O 0 1.0370680009197386e-12
BRCA2 O 0 6.195791657503946e-10
relocates O 0 3.6406438974623256e-10
to O 0 2.1136936059935885e-13
PCNA O 0 4.2064236538408295e-08
+ O 0 3.9171547949745644e-12
replication O 0 5.4538696475647797e-11
sites O 0 6.87630291248964e-12
following O 0 6.6023418794582036e-15
exposure O 0 8.728009634473288e-13
of O 0 1.5031883433338242e-16
S O 0 6.950140907235891e-09
phase O 0 5.752479113711739e-13
cells O 0 4.3256668863164704e-13
to O 0 3.975148067837534e-15
hydroxyurea O 0 8.753976710185185e-11
or O 0 4.574200854244939e-14
UV O 0 1.5225665173090874e-10
irradiation O 0 1.4808593240545065e-10
. O 0 5.54379068692934e-12

Thus O 0 9.051315252861514e-10
, O 0 1.4426888503282775e-11
BRCA1 O 0 1.455563420904582e-07
and O 0 4.4396794574019793e-10
BRCA2 O 0 4.75490686824287e-08
participate O 0 1.047497050037094e-12
, O 0 8.938402101810183e-12
together O 0 1.5615618173536738e-11
, O 0 9.70046119168691e-14
in O 0 3.5481490182477475e-15
a O 0 7.442000981390182e-14
pathway O 0 8.865325140661184e-12
( O 0 2.8359854002397815e-14
s O 0 2.485239569693931e-09
) O 0 1.167291869446415e-14
associated O 0 8.012923549509388e-13
with O 0 8.015575270854062e-15
the O 0 1.4175018021753095e-15
activation O 0 9.851280320736632e-15
of O 0 1.4104296329311077e-16
double O 0 3.9493575076932075e-10
- O 0 4.231506167684529e-08
strand O 0 2.3404483727063052e-05
break O 0 1.6420069641753798e-06
repair O 0 2.3794541448296513e-06
and O 0 8.347620338022832e-12
/ O 0 2.125511100459221e-09
or O 0 2.5446883979867753e-14
homologous O 0 4.408234628022756e-12
recombination O 0 1.1285802153926383e-11
. O 0 5.766037820820191e-12

Dysfunction O 0 0.0005891051841899753
of O 0 9.362978870951916e-14
this O 0 2.5893070782108396e-13
pathway O 0 6.046589340336084e-10
may O 0 1.8114950511849415e-11
be O 0 3.5483063969693474e-14
a O 0 9.647775572961103e-15
general O 0 3.3366985932072046e-13
phenomenon O 0 1.557283191289116e-09
in O 0 2.69496068256575e-13
the O 0 2.4684105399876838e-14
majority O 0 1.6239235704849225e-13
of O 0 5.667001141710992e-17
cases O 0 2.982002665630201e-13
of O 0 1.3155242445785174e-14
hereditary B-Disease 1 0.9967561364173889
breast I-Disease 1 0.9999809265136719
and I-Disease 0 0.04655016213655472
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9999769926071167
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.956530841483287e-12
. O 0 1.1221022375162981e-11

A O 0 4.294123112646986e-10
novel O 0 1.2802235660469563e-10
Arg362Ser O 0 3.588617403238459e-07
mutation O 0 1.2288288164796768e-09
in O 0 1.1485505031587611e-14
the O 0 3.0173420999170947e-14
sterol O 0 1.3656072042067535e-06
27 O 0 8.140212059970509e-09
- O 0 2.922390995863111e-09
hydroxylase O 0 1.4507199352919997e-07
gene O 0 6.0530660483948395e-09
( O 0 6.0870044932498455e-15
CYP27 O 0 1.1425317358870757e-09
) O 0 9.414009726111967e-15
: O 0 2.0232404737452773e-15
its O 0 4.899764256741763e-16
effects O 0 1.045583238046266e-11
on O 0 7.12220755462456e-13
pre O 0 3.0927625044308016e-11
- O 0 2.1448124526424195e-11
mRNA O 0 8.769354464593579e-14
splicing O 0 3.5978157952865075e-11
and O 0 2.5112897872325846e-13
enzyme O 0 1.896808231316438e-12
activity O 0 3.89571838330105e-12
. O 0 1.962469249605636e-12

A O 0 4.6209935877783437e-10
novel O 0 5.447842177375151e-10
C O 0 4.0287852698384086e-07
to O 0 1.5483415331113415e-13
A O 0 2.1932464525087347e-12
mutation O 0 3.2120896220622086e-11
in O 0 9.538723469133901e-15
the O 0 4.328065954673638e-14
sterol O 0 9.288934847972996e-07
27 O 0 2.014237665548535e-08
- O 0 7.463213158587223e-09
hydroxylase O 0 1.5320318880185368e-07
gene O 0 4.272548981276714e-09
( O 0 9.637329115622616e-15
CYP27 O 0 1.0655356597055743e-09
) O 0 4.1295282928041025e-15
was O 0 2.275234342564384e-14
identified O 0 1.5085438256098697e-14
by O 0 3.6424302703731535e-17
sequencing O 0 1.0016474628893324e-11
amplified O 0 2.4105805893070986e-11
CYP27 O 0 2.040363877853224e-09
gene O 0 7.377611854764154e-10
products O 0 1.4996840574932335e-11
from O 0 1.886594365837135e-15
a O 0 5.62800023598542e-12
patient O 0 5.089365373578403e-08
with O 0 7.820198377750387e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 0.9999996423721313
( O 0 7.534516413554293e-12
CTX B-Disease 0 5.102876343698881e-07
) O 0 6.111187510898786e-12
. O 0 1.1182266050624445e-11

The O 0 9.572492104537034e-12
mutation O 0 5.0897362713353544e-11
changed O 0 7.368599545636012e-13
the O 0 1.443629221647638e-16
adrenodoxin O 0 2.709596089167654e-11
cofactor O 0 6.725278428772186e-13
binding O 0 1.479023175633698e-12
residue O 0 1.884470079982492e-10
362Arg O 0 2.137947735514345e-10
to O 0 3.139354553226281e-13
362Ser O 0 2.9343383278757074e-09
( O 0 7.376583610434195e-14
CGT O 0 1.2167430396559098e-09
362Arg O 0 5.247409728958985e-10
to O 0 1.7578270111208438e-13
AGT O 0 2.0293531299842016e-09
362Ser O 0 7.90314980125828e-10
) O 0 4.663128810498095e-14
, O 0 5.830018000481385e-14
and O 0 8.431400109337739e-13
was O 0 1.396031467509884e-11
responsible O 0 6.1278087638838574e-12
for O 0 3.295102092657626e-13
deficiency O 0 6.760765245417133e-07
in O 0 3.296481765333102e-15
the O 0 1.0651007663732906e-13
sterol O 0 4.005846221843967e-06
27 O 0 5.2800106509209854e-09
- O 0 1.1455255632952799e-09
hydroxylase O 0 4.672295261798354e-08
activity O 0 1.029175744626798e-09
, O 0 1.9756608119771667e-14
as O 0 1.5057947166520849e-15
confirmed O 0 1.43626538613717e-13
by O 0 1.946323224985017e-17
expression O 0 9.815302384543769e-16
of O 0 3.5239713892106596e-18
mutant O 0 5.835519567565228e-12
cDNA O 0 8.92703792831906e-12
into O 0 5.155429902425901e-12
COS O 0 6.593605803573155e-07
- O 0 2.801211174130458e-08
1 O 0 1.5702553190014013e-12
cells O 0 1.9876418219655356e-11
. O 0 9.467571041379963e-13

Quantitative O 0 2.402486209973631e-09
analysis O 0 4.684808443955468e-11
showed O 0 1.3198976633876924e-10
that O 0 2.3946980059726466e-14
the O 0 2.049394733574122e-15
expression O 0 2.8199007527911907e-14
of O 0 8.826109118424921e-17
CYP27 O 0 1.856632891872323e-08
gene O 0 1.0333288912034444e-11
mRNA O 0 2.076538675168868e-13
in O 0 2.5901541196284234e-15
the O 0 8.45648827655851e-14
patient O 0 1.687968653740768e-10
represented O 0 5.493376952869604e-14
52 O 0 5.465705665841369e-09
. O 0 3.710175222604306e-11

5 O 0 1.4156363858930376e-09
% O 0 1.3124774162452668e-13
of O 0 1.0511819694653348e-15
the O 0 2.270935609699487e-12
normal O 0 1.0989093190971744e-08
level O 0 9.436481457347767e-11
. O 0 6.035786453972847e-12

As O 0 2.335210800771814e-12
the O 0 1.5616449986995996e-15
mutation O 0 3.6261339525674174e-13
occurred O 0 1.1485801459237832e-12
at O 0 1.3563104903514117e-14
the O 0 5.826007093011855e-17
penultimate O 0 3.78601907853951e-13
nucleotide O 0 1.1629435749897082e-13
of O 0 2.1481629045095913e-17
exon O 0 6.915119171724271e-11
6 O 0 4.304110678976514e-10
( O 0 1.1434886512066283e-13
- O 0 3.839815931883095e-08
2 O 0 5.033238582863309e-12
position O 0 8.04172321181712e-13
of O 0 4.976561094474615e-17
exon O 0 3.2561855434209974e-09
6 O 0 1.8694823467058086e-08
- O 0 2.5574647111170634e-07
intron O 0 6.8739291236852296e-06
6 O 0 7.494531384377723e-11
splice O 0 3.564399975175547e-08
site O 0 8.316226041138464e-10
) O 0 9.30713703805805e-15
of O 0 3.309391432532513e-18
the O 0 1.754539176503111e-15
gene O 0 2.966440981744256e-10
, O 0 3.609387094760663e-13
we O 0 1.7218197082956993e-13
hypothesized O 0 5.1659861826681974e-14
that O 0 1.4244244753982768e-14
the O 0 2.2458893943265272e-14
mutation O 0 1.132838489681376e-09
may O 0 3.365085640694154e-11
partially O 0 2.117341635354819e-09
affect O 0 6.908435629116028e-11
the O 0 1.318636751846498e-14
normal O 0 1.6909501685154205e-13
splicing O 0 4.158780958496422e-12
efficiency O 0 2.638785728554388e-13
in O 0 2.9797353828941325e-16
exon O 0 4.296220323940503e-10
6 O 0 6.509228711593096e-10
and O 0 4.232948355980398e-13
cause O 0 2.8122091854103533e-14
alternative O 0 5.198988703875593e-15
splicing O 0 2.9304775273075734e-10
elsewhere O 0 2.625265282940603e-10
, O 0 3.6523651399285317e-13
which O 0 2.811373909280407e-13
resulted O 0 1.265431986627319e-13
in O 0 1.3815294563998982e-14
decreased O 0 9.231690079047894e-09
transcript O 0 4.953921006745077e-08
in O 0 3.506494140187444e-13
the O 0 1.3020853926321019e-12
patient O 0 1.9524439842655283e-09
. O 0 1.715428580434386e-12

Transfection O 0 2.3200823306979146e-06
of O 0 6.167320343655747e-13
constructed O 0 1.0666642014101058e-09
minigenes O 0 1.8303330762137193e-07
, O 0 5.150888830046663e-12
with O 0 3.3888625412814566e-13
or O 0 4.0262625590307966e-13
without O 0 9.164980514959897e-14
the O 0 6.2284784771991005e-15
mutation O 0 1.2579732394657483e-11
, O 0 2.3619510346054376e-14
into O 0 9.865995824129281e-13
COS O 0 1.0632385055941995e-05
- O 0 1.5186207846795696e-08
1 O 0 4.696989867360168e-13
cells O 0 8.043031518578658e-12
confirmed O 0 2.0483009385841022e-11
that O 0 4.021116122368551e-15
the O 0 1.0073011099954706e-15
mutant O 0 3.19115789348956e-10
minigene O 0 7.235388288506783e-09
was O 0 5.630835207826035e-12
responsible O 0 1.2712325529534111e-14
for O 0 2.5490808038017927e-17
a O 0 2.71331927466454e-15
mRNA O 0 7.035258335098826e-13
species O 0 1.1905871389683922e-14
alternatively O 0 5.968025010814892e-13
spliced O 0 4.123336111661047e-06
at O 0 9.425837887988564e-10
an O 0 1.3507082991415665e-14
activated O 0 2.3000408244655546e-09
cryptic O 0 6.951674791366713e-10
5 O 0 2.3942985181296672e-12
splice O 0 8.798297557177648e-08
site O 0 5.652878720674437e-10
88 O 0 1.6092575189086133e-11
bp O 0 2.7232834043378062e-12
upstream O 0 2.3872214968689853e-12
from O 0 8.406368426509055e-16
the O 0 8.812022563465388e-15
3 O 0 2.5560833831483887e-12
end O 0 1.5817010787060048e-13
of O 0 6.748857429979296e-17
exon O 0 7.57633333847707e-09
6 O 0 4.366692341051248e-09
. O 0 1.7822136127998434e-11

Our O 0 6.183062395415106e-11
data O 0 1.2825465516008716e-12
suggest O 0 4.562466398606857e-13
that O 0 3.225899229816406e-14
the O 0 8.66263983288762e-15
C O 0 1.6060121010852413e-09
to O 0 3.2825154625822995e-15
A O 0 1.338708332555838e-13
mutation O 0 8.374502805628958e-13
at O 0 2.2358463279588403e-13
the O 0 2.8826762597484264e-16
penultimate O 0 1.0778331352434556e-12
nucleotide O 0 2.7242990239466185e-14
of O 0 1.0199828475770926e-17
exon O 0 4.937415407080259e-11
6 O 0 2.5888454574518605e-11
of O 0 2.0406565564017894e-16
the O 0 3.792992192574486e-14
CYP27 O 0 1.6283475900991107e-08
gene O 0 1.2880324584685354e-09
not O 0 1.8343130833708976e-12
only O 0 3.0606479807168685e-13
causes O 0 3.681953613526856e-12
the O 0 1.909867403115939e-11
deficiency B-Disease 0 1.724768299027346e-05
in I-Disease 0 1.3848456750916935e-14
the I-Disease 0 2.903395297619571e-13
sterol I-Disease 0 5.071891791885719e-06
27 I-Disease 0 4.63351934598677e-09
- I-Disease 0 1.5830255162274653e-10
hydroxylase I-Disease 0 1.0729925392638506e-08
activity I-Disease 0 3.6594918206844795e-09
, O 0 1.3653418673431617e-12
but O 0 1.0490795732120972e-10
also O 0 1.9866308598182059e-10
partially O 0 5.9841323007958636e-09
leads O 0 1.6342692824022897e-11
to O 0 1.1171306841891338e-15
alternative O 0 1.439451517508926e-14
pre O 0 6.905178252109012e-12
- O 0 6.325510427951375e-12
mRNA O 0 8.184717416618789e-14
splicing O 0 2.001484698463396e-12
of O 0 2.1095018061678428e-16
the O 0 4.1230434085599236e-15
gene O 0 4.5113555252607185e-11
. O 0 1.2412221857965866e-12

To O 0 4.816830045939469e-09
our O 0 2.7166272703604832e-12
knowledge O 0 1.515560477138335e-14
, O 0 5.106706412448016e-14
this O 0 1.917539655773887e-15
is O 0 9.518113463461309e-15
the O 0 1.0228203417759455e-15
first O 0 1.0924364169349887e-13
report O 0 5.967794346802696e-14
regarding O 0 2.354766204685295e-15
effects O 0 1.8778886431980446e-11
on O 0 6.782888053308289e-13
pre O 0 2.008211999471321e-11
- O 0 8.780158024246365e-12
mRNA O 0 1.3576666748032606e-14
splicing O 0 4.5460228463578556e-13
of O 0 7.823881206387912e-18
a O 0 3.935976605675285e-15
mutation O 0 2.535113178409043e-12
at O 0 6.398996458580053e-13
the O 0 1.0171814698043194e-13
- O 0 2.0060672341060126e-06
2 O 0 3.856362729148799e-10
position O 0 6.808091590482235e-11
of O 0 1.932253809207776e-16
a O 0 1.5461045529789608e-13
5 O 0 1.4418159591592095e-12
splice O 0 1.0371160641398092e-07
site O 0 4.980151402378397e-09
. O 0 1.3289936859339768e-11

ATM O 0 1.313336611019622e-06
germline O 0 1.632314365451748e-06
mutations O 0 1.0744284736574627e-05
in O 0 4.454495453054541e-11
classical O 0 0.07904710620641708
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999246597290039
in O 0 8.788938327120022e-12
the O 0 3.2730801576008606e-12
Dutch O 0 6.714662390550075e-07
population O 0 5.225558484187043e-13
. O 0 8.877452809322173e-13

Germline O 0 8.515043009538203e-05
mutations O 0 9.482487803325057e-05
in O 0 8.991250127245165e-13
the O 0 4.095753955175169e-14
ATM O 0 5.652598944472231e-10
gene O 0 7.893594111685331e-11
are O 0 6.879109259698836e-16
responsible O 0 7.947181595528013e-14
for O 0 2.2439550760068594e-13
the O 0 0.00015737113426439464
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.15357303619384766
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 2.893040529361457e-10
. O 0 7.525984176137701e-12

In O 0 1.5193297731030952e-09
our O 0 1.921299751239669e-11
study O 0 1.0206543726506978e-13
, O 0 3.7607981643152447e-14
we O 0 1.7605490633051946e-12
have O 0 3.0415469134178336e-14
determined O 0 1.9393412250450284e-14
the O 0 1.919835909154334e-17
ATM O 0 4.041552682798599e-12
mutation O 0 4.166750223934951e-13
spectrum O 0 7.184457225645723e-15
in O 0 1.4160649378352347e-14
19 O 0 4.05586397800306e-11
classical O 0 6.668543051091547e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.949431051201827e-07
, O 0 1.770601885798368e-15
including O 0 3.5022112451445946e-16
some O 0 1.7613121578284748e-15
immigrant O 0 6.748108738463543e-10
populations O 0 1.648197134329621e-10
, O 0 1.8064168528521794e-14
as O 0 1.4121377542785848e-14
well O 0 5.499551823055088e-14
as O 0 8.12000138894313e-14
12 O 0 1.1410703382608994e-13
of O 0 9.83816393613906e-17
Dutch O 0 1.2887998224186958e-08
ethnic O 0 3.514398841386601e-11
origin O 0 7.083600199464524e-12
. O 0 3.11339907847763e-12

Both O 0 2.792788569849769e-11
the O 0 2.3031871074501338e-14
protein O 0 2.2051476963880212e-11
truncation O 0 4.497135108749717e-08
test O 0 1.2020060466966243e-06
( O 0 2.3141914206876828e-14
PTT O 0 2.8278995811703567e-10
) O 0 2.0405069439135247e-14
and O 0 1.540410306228408e-15
the O 0 1.2514891943347586e-16
restriction O 0 1.1546293435249488e-12
endonuclease O 0 1.1150222967160062e-09
fingerprinting O 0 7.776750354793194e-10
( O 0 7.232050948160758e-16
REF O 0 9.901138936507792e-12
) O 0 6.674376433263796e-18
method O 0 4.4226184214547987e-16
were O 0 3.1021716131395774e-16
used O 0 4.62916434785382e-13
and O 0 1.6181612256735423e-12
compared O 0 6.13149405177143e-15
for O 0 1.6314208597419997e-17
their O 0 8.248588423050444e-16
detection O 0 1.6916371461169616e-13
efficiency O 0 8.73467913801865e-15
, O 0 2.9227485943896393e-16
identifying O 0 1.061567165145912e-14
76 O 0 1.1244231934437465e-10
% O 0 1.0376367903200834e-14
and O 0 5.412426149625782e-12
60 O 0 1.3374131663246303e-11
% O 0 3.5291697627568572e-15
of O 0 1.0767789213195556e-16
the O 0 4.52974219548527e-13
mutations O 0 3.703542006405769e-08
, O 0 1.2259451266649624e-12
respectively O 0 7.859443131030819e-12
. O 0 1.041689651204436e-11

Most O 0 2.4754443286867378e-11
patients O 0 4.221747396115916e-10
were O 0 1.8278821923949085e-13
found O 0 1.8780094666881464e-12
to O 0 4.496572317508156e-14
be O 0 8.457778477143768e-14
compound O 0 6.811420316665817e-10
heterozygote O 0 1.9467332634803824e-08
. O 0 1.2502994299612435e-11

Seventeen O 0 7.653208733415795e-09
mutations O 0 1.465676149337014e-07
were O 0 1.3791376894667362e-12
distinct O 0 1.2126999166146846e-13
, O 0 6.188593040801216e-12
of O 0 1.092077546015896e-14
which O 0 5.071580932991537e-09
10 O 0 1.0798626749741747e-11
were O 0 1.3442151038101091e-12
not O 0 9.299237595239429e-12
reported O 0 1.7642484695379324e-10
previously O 0 2.931595521893371e-10
. O 0 1.7511426336769276e-11

Mutations O 0 6.108704837970436e-05
are O 0 3.0369456949230766e-13
small O 0 6.5459980101365e-13
deletions O 0 5.959485633866279e-07
or O 0 1.6109583000911698e-08
point O 0 1.3609822246962722e-07
mutations O 0 6.628776191064389e-06
frequently O 0 4.8930384188849985e-09
affecting O 0 1.0032603636744852e-09
splice O 0 0.00032540789106860757
sites O 0 6.738841307196708e-07
. O 0 3.361238509747011e-10

Moreover O 0 3.342280407991893e-08
, O 0 5.943910728195556e-12
a O 0 1.8827723668318752e-12
16 O 0 7.094597131995783e-11
. O 0 7.435226913321547e-12

7 O 0 6.9733512297887046e-09
- O 0 1.0642992265275097e-08
kb O 0 1.676156768937176e-09
genomic O 0 1.7452923550820287e-09
deletion O 0 2.4327968972670533e-08
of O 0 4.609511794343487e-15
the O 0 1.2864395963416153e-12
3 O 0 6.221569093245449e-11
end O 0 3.067440398907273e-12
of O 0 4.3999324968471644e-17
the O 0 6.045582464546742e-15
gene O 0 8.086070008017643e-12
, O 0 4.282938665046065e-15
most O 0 1.06547705334857e-16
likely O 0 3.546777333092964e-14
a O 0 1.1989681488166473e-15
result O 0 1.3502240504056212e-14
of O 0 1.3704696335529826e-18
recombination O 0 3.3856496436685674e-14
between O 0 3.345736881987804e-12
two O 0 1.8093885764680628e-11
LINE O 0 1.1418639189741953e-07
elements O 0 1.2587322850698968e-10
, O 0 1.7344292668752814e-11
was O 0 5.784792644902836e-10
identified O 0 3.920344937569098e-09
. O 0 3.0119243904502824e-11

The O 0 2.4976208601312777e-11
most O 0 9.014771080225609e-14
frequently O 0 1.3558527911516904e-10
found O 0 3.4250722917572585e-12
mutation O 0 2.2770166828445237e-12
, O 0 5.218561094187798e-15
identified O 0 4.817725732242373e-11
in O 0 3.439385752655559e-14
three O 0 1.7214067627932539e-12
unrelated O 0 2.6836506350491618e-09
Turkish O 0 0.0049704150296747684
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
individuals O 0 1.2863371826044023e-11
, O 0 7.013169992658996e-12
was O 0 3.7079558867780804e-10
previously O 0 8.875628530746749e-12
described O 0 1.7534780051564614e-12
to O 0 6.855617012664975e-14
be O 0 1.1532971572105616e-13
a O 0 5.46910444449572e-13
Turkish O 0 4.852963229495799e-06
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999986886978149
T I-Disease 1 0.9999998807907104
founder O 0 5.776702227677788e-09
mutation O 0 2.9286129077377154e-09
. O 0 9.242576322343599e-13

The O 0 1.1790412396406325e-11
presence O 0 3.0707947035885086e-12
of O 0 1.411070916281518e-15
a O 0 9.979774710615341e-14
founder O 0 9.562090702575077e-12
mutation O 0 2.520553904483691e-11
among O 0 2.068543395654463e-15
relatively O 0 3.302443225567525e-14
small O 0 4.593919645731748e-13
ethnic O 0 4.71536198975997e-10
population O 0 1.1189237470593527e-12
groups O 0 3.748852628066707e-14
in O 0 5.703746225056271e-15
Western O 0 1.3826058076205072e-09
Europe O 0 7.541655078213694e-10
could O 0 5.373605206637766e-12
indicate O 0 1.1838707606197287e-14
a O 0 1.2087446030938564e-16
high O 0 1.5641131468287803e-15
carrier O 0 3.920858592226101e-14
frequency O 0 2.9069360308643655e-13
in O 0 1.1264859725091444e-14
such O 0 4.665833894918446e-14
communities O 0 7.181073791162618e-11
. O 0 1.1509381989127654e-11

In O 0 2.2978999258960187e-10
patients O 0 4.1767825309513285e-10
of O 0 1.7849451182106986e-15
Dutch O 0 8.226261343224905e-07
ethnic O 0 2.5468152586860526e-10
origin O 0 1.8098581661130098e-11
, O 0 5.140014715937502e-12
however O 0 4.3259822807284465e-12
, O 0 2.971152038050602e-14
no O 0 2.91969275362583e-14
significant O 0 9.887455827364442e-16
founder O 0 6.179098031855457e-12
effect O 0 1.223701279196021e-10
could O 0 3.992652874984515e-09
be O 0 5.954040429093088e-13
identified O 0 6.120312590063293e-11
. O 0 7.310619991318656e-12

The O 0 5.3028120089448905e-12
observed O 0 6.085458525983967e-12
genetic O 0 1.6561627069755502e-11
heterogeneity O 0 2.281777197743473e-12
including O 0 1.5564040670417584e-13
the O 0 5.003172355577679e-13
relative O 0 1.2089973466800075e-10
high O 0 4.327627145528368e-11
percentage O 0 1.068222767186544e-11
of O 0 3.5399410042910573e-16
splice O 0 0.00021490432845894247
- O 0 1.2361825838524965e-06
site O 0 1.2016785788659945e-08
mutations O 0 3.709679106123076e-07
had O 0 1.6232054589337963e-09
no O 0 3.544518465629226e-14
reflection O 0 4.7894783435477664e-15
on O 0 1.142834470720805e-13
the O 0 1.2072695545085194e-13
phenotype O 0 7.886299946413544e-10
. O 0 2.2568934568423238e-12

All O 0 5.134278557861194e-10
patients O 0 5.019187149235549e-11
manifested O 0 2.187089051530755e-12
classical O 0 8.76304397934291e-08
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
and O 0 2.139682653279351e-09
increased O 0 1.207472815310806e-12
cellular O 0 1.0498222430266324e-10
radioresistant O 0 9.06193842187264e-10
DNA O 0 2.439834723144685e-10
synthesis O 0 9.884628705825182e-12
. O 0 1.629123919100195e-12

Determination O 0 8.468275858319885e-09
of O 0 2.1478373262204904e-15
the O 0 3.9492568117388115e-15
genomic O 0 1.6916107403730507e-10
structure O 0 1.8999484277526513e-11
of O 0 1.11183701943637e-16
the O 0 1.2702048478785075e-14
COL4A4 O 0 3.151144767343794e-08
gene O 0 7.99824650954406e-10
and O 0 2.9702865059037797e-13
of O 0 1.3919366537612802e-15
novel O 0 5.1728843430964844e-08
mutations O 0 0.0007452380959875882
causing O 0 2.0345323719084263e-05
autosomal B-Disease 1 0.9999971389770508
recessive I-Disease 1 0.9999990463256836
Alport I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999997615814209
. O 0 2.6402071640063696e-08

Autosomal B-Disease 1 0.9999889135360718
recessive I-Disease 1 0.9999951124191284
Alport I-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999997615814209
is O 0 2.3643403901374427e-10
a O 0 5.01920657813848e-11
progressive O 0 1.478234480600804e-06
hematuric B-Disease 1 0.9995778203010559
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.0005154190002940595
by O 0 7.134901003347238e-11
glomerular B-Disease 1 0.9998162388801575
basement I-Disease 1 0.9998788833618164
membrane I-Disease 1 0.9998819828033447
abnormalities I-Disease 1 0.9999983310699463
and O 0 6.221136494843904e-09
associated O 0 5.501412214670154e-09
with O 0 4.776141634965647e-11
mutations O 0 1.0060299473479972e-06
in O 0 4.616467256211843e-13
either O 0 2.5553973867498136e-11
the O 0 5.702599308564371e-13
COL4A3 O 0 5.561053058045218e-07
or O 0 1.024551971040566e-12
the O 0 2.173960881104997e-14
COL4A4 O 0 5.125494251245755e-09
gene O 0 3.165080142419896e-10
, O 0 1.013650257209852e-14
which O 0 2.589253723605492e-16
encode O 0 4.993455058081506e-14
the O 0 1.535070898520119e-13
alpha3 O 0 6.820292952625095e-08
and O 0 2.8378455835254002e-11
alpha4 O 0 1.1707402336469386e-06
type O 0 2.908158057834953e-05
IV O 0 6.706274234602461e-06
collagen O 0 0.003437519073486328
chains O 0 0.0030849312897771597
, O 0 3.782812951769188e-10
respectively O 0 2.4571546186624715e-11
. O 0 1.3181132400841289e-11

To O 0 3.0136542567005264e-11
date O 0 4.66127570569741e-12
, O 0 1.2794373375969899e-14
mutation O 0 2.8035771404075205e-13
screening O 0 2.460204262533239e-10
in O 0 2.167319973391934e-14
the O 0 1.2777138288372347e-13
two O 0 1.4902174980124805e-11
genes O 0 2.908740448503977e-08
has O 0 6.056704027201931e-09
been O 0 2.6600326108461303e-11
hampered O 0 5.967846306020874e-08
by O 0 3.2554261207313334e-14
the O 0 3.536679954972699e-13
lack O 0 9.851948900782559e-13
of O 0 5.697129706598133e-17
genomic O 0 2.9931661593707304e-09
structure O 0 9.67830371401135e-10
information O 0 6.583665904114078e-12
. O 0 1.1624900694839901e-11

We O 0 2.7774042337114224e-06
report O 0 6.966178328626782e-11
here O 0 2.6103023822304783e-13
the O 0 3.371308655893547e-16
complete O 0 7.325351669652466e-14
characterization O 0 5.3555583579001365e-11
of O 0 4.885001531262304e-16
the O 0 1.1819175195840192e-13
48 O 0 2.3418177119705064e-11
exons O 0 4.716153578776527e-10
of O 0 2.0451072645533575e-15
the O 0 1.3387517006427374e-13
COL4A4 O 0 9.407686718532204e-08
gene O 0 7.071903618260933e-10
, O 0 4.701665760279555e-14
a O 0 4.825643262263736e-15
comprehensive O 0 7.060544098165533e-13
gene O 0 2.265202914131237e-09
screen O 0 2.8339184154901886e-07
, O 0 8.352916136544764e-10
and O 0 9.456278642072657e-12
the O 0 1.7831756663838844e-15
subsequent O 0 3.102151443167521e-14
detection O 0 1.9971641528060413e-12
of O 0 2.1854331482821685e-16
10 O 0 3.1403127168962153e-13
novel O 0 1.0559587926284308e-11
mutations O 0 3.3610493943569963e-08
in O 0 1.7786469996491916e-12
eight O 0 4.21554524621115e-09
patients O 0 2.6778307349317743e-10
diagnosed O 0 3.241940760290163e-07
with O 0 2.8679993935298853e-09
autosomal B-Disease 1 0.9999983310699463
recessive I-Disease 1 0.9999994039535522
Alport I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999997615814209
. O 0 2.2939785182529704e-08

Furthermore O 0 3.6519011814561964e-07
, O 0 3.9035975840651105e-11
we O 0 4.344289251251299e-12
identified O 0 9.729454960064835e-15
a O 0 5.27340743043458e-17
glycine O 0 1.0287811455598345e-13
to O 0 1.591631156172484e-16
alanine O 0 5.040826154927014e-13
substitution O 0 1.324717177858363e-14
in O 0 7.260439786783578e-16
the O 0 4.705142025846734e-16
collagenous O 0 1.2418876593756067e-08
domain O 0 5.440179418059188e-10
that O 0 9.220360586148502e-12
is O 0 2.9470815978566156e-13
apparently O 0 1.2358562784253735e-10
silent O 0 9.430796421572296e-11
in O 0 1.444253177880321e-14
the O 0 7.649887430601857e-15
heterozygous O 0 3.7198973068530705e-11
carriers O 0 9.668662571959974e-12
, O 0 1.9001674420125042e-13
in O 0 3.1452279474451783e-13
11 O 0 1.3267427434460188e-10
. O 0 2.7724597791156658e-12

5 O 0 6.925428286397306e-11
% O 0 9.473450263185537e-15
of O 0 1.127249842702846e-16
all O 0 1.1256745996489695e-13
control O 0 4.0646608567840303e-07
individuals O 0 7.865477475062221e-14
, O 0 7.400378920774386e-12
and O 0 4.882443407905335e-11
in O 0 9.82280392008289e-14
one O 0 3.292051093534143e-12
control O 0 2.308038631326781e-07
individual O 0 1.0973841889015985e-16
homozygous O 0 7.414864586858996e-15
for O 0 6.5129533774949916e-18
this O 0 2.46000784477249e-17
glycine O 0 1.9639372593471816e-12
substitution O 0 7.665844413244638e-13
. O 0 8.604387276463232e-13

There O 0 2.0968739633531186e-08
has O 0 2.417073485805332e-10
been O 0 2.888439053910785e-12
no O 0 1.2059744479084311e-12
previous O 0 1.7511342311100908e-13
finding O 0 2.353679461413968e-15
of O 0 1.9554750013558177e-19
a O 0 7.513343707801214e-17
glycine O 0 1.588579257288253e-13
substitution O 0 2.2713579809845695e-14
that O 0 4.6624884535899705e-14
is O 0 1.5443296123786483e-14
not O 0 2.0981090129157387e-13
associated O 0 2.030860288965153e-12
with O 0 3.3101813797604615e-14
any O 0 6.961911516029096e-12
obvious O 0 9.610841983365148e-11
phenotype O 0 1.4595145925166975e-10
in O 0 1.8741644114460623e-14
homozygous O 0 2.1293283802847895e-10
individuals O 0 1.7999383721770817e-13
. O 0 4.385415641738888e-12

Founder O 0 3.598137539029267e-07
BRCA1 O 0 8.360830543097109e-05
and O 0 3.665017178633434e-09
BRCA2 O 0 5.42562474947772e-07
mutations O 0 1.4199996201114118e-07
in O 0 9.151486859981794e-12
French O 0 7.302509766304865e-05
Canadian O 0 0.03333934769034386
breast B-Disease 1 0.9999997615814209
and I-Disease 1 0.999998927116394
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.298569998897108e-11
. O 0 1.731708700047907e-11

We O 0 2.941712580195599e-07
have O 0 1.0055885161022737e-12
identified O 0 5.653197094473983e-12
four O 0 2.288255610655935e-14
mutations O 0 2.318904963882762e-11
in O 0 3.5663051694721434e-15
each O 0 1.5679424769041985e-15
of O 0 7.71850811075777e-15
the O 0 1.823457473904e-08
breast B-Disease 1 0.9826122522354126
cancer I-Disease 0 0.0010211938060820103
- O 0 2.022335365836625e-06
susceptibility O 0 1.420468652213458e-05
genes O 0 9.810153187572723e-07
, O 0 1.0281098195008553e-10
BRCA1 O 0 1.5671010942241992e-06
and O 0 2.465979420662734e-09
BRCA2 O 0 1.6869114105588778e-08
, O 0 5.816115276023603e-13
in O 0 3.5511180042531454e-13
French O 0 4.0525301869820396e-07
Canadian O 0 5.788848511656397e-07
breast B-Disease 1 0.946452260017395
cancer I-Disease 1 0.8627594113349915
and O 0 0.051554203033447266
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.533472208745337e-11
from O 0 1.1213415856666312e-13
Quebec O 0 1.8870528037950862e-06
. O 0 1.544624289584462e-10

To O 0 1.4554585314741075e-10
identify O 0 8.14372944080155e-11
founder O 0 1.073316852062689e-10
effects O 0 1.117480366019663e-07
, O 0 3.787194724491627e-10
we O 0 6.131907204220965e-10
examined O 0 1.2155392248303087e-09
independently O 0 2.1211836107037918e-11
ascertained O 0 1.762511381286913e-08
French O 0 3.899027660736465e-07
Canadian O 0 1.5046918377947804e-08
cancer B-Disease 0 1.2251233783899806e-05
families O 0 2.651346447891858e-14
for O 0 1.970672179670577e-16
the O 0 5.030332585616e-15
distribution O 0 4.2492342110234116e-12
of O 0 5.449571754617753e-16
these O 0 1.1629946680170866e-13
eight O 0 1.8447721648884308e-12
mutations O 0 1.6627979548822225e-10
. O 0 1.7170456679746482e-12

Mutations O 0 8.430120215052739e-05
were O 0 6.289302412199049e-11
found O 0 2.8047768101113757e-12
in O 0 1.1838436555654166e-14
41 O 0 2.484570049698931e-10
of O 0 1.3639263329867646e-15
97 O 0 1.9794764938296794e-08
families O 0 6.797604146235869e-12
. O 0 9.185675657608083e-12

Six O 0 3.9988770628163195e-10
of O 0 1.320098201317867e-15
eight O 0 2.1004244350752987e-12
mutations O 0 1.5727448510194364e-10
were O 0 2.151525621075026e-13
observed O 0 8.687571495524793e-12
at O 0 1.0058114931210671e-11
least O 0 1.4143199415436736e-12
twice O 0 3.0551716712068355e-09
. O 0 1.816976430424333e-11

The O 0 7.643091715081596e-11
BRCA1 O 0 1.5122413543622315e-08
C4446T O 0 7.173152072326161e-10
mutation O 0 3.584208208007311e-10
was O 0 9.92018966972097e-13
the O 0 1.5100398340254866e-15
most O 0 6.5961991965247154e-15
common O 0 4.485037016256632e-13
mutation O 0 2.611581229050586e-10
found O 0 7.319915507064678e-11
, O 0 1.6947051672145524e-13
followed O 0 2.92376799854166e-13
by O 0 2.4057851166807897e-15
the O 0 1.0895424102860818e-12
BRCA2 O 0 6.251434570003767e-08
8765delAG O 0 6.938220220575886e-09
mutation O 0 1.2355009237907666e-09
. O 0 6.09903056877914e-12

Together O 0 5.197698982328802e-08
, O 0 7.338668518361291e-13
these O 0 2.2133401204492073e-14
mutations O 0 9.10385863917007e-11
were O 0 2.8086955504436073e-12
found O 0 1.267148747041702e-10
in O 0 1.190166129712289e-12
28 O 0 1.280631933830989e-09
of O 0 7.564625200010358e-16
41 O 0 1.2835990048642998e-08
families O 0 3.736310441810123e-14
identified O 0 8.067295442781841e-11
to O 0 2.023678804825152e-13
have O 0 1.621822684830243e-12
a O 0 2.204817410459206e-13
mutation O 0 1.1016384332540596e-10
. O 0 2.258994857493035e-12

The O 0 5.720532988279237e-12
odds O 0 2.697606721335788e-11
of O 0 1.889293092216426e-17
detection O 0 6.870259569580206e-12
of O 0 5.424472778727179e-17
any O 0 1.263324297604007e-13
of O 0 1.1578363347770969e-15
the O 0 8.674420773693847e-13
four O 0 5.644383831854283e-12
BRCA1 O 0 4.704925338216981e-09
mutations O 0 2.349404581991621e-08
was O 0 2.2671997612633277e-09
18 O 0 7.475771390819119e-11
. O 0 3.69210174586132e-12

7x O 0 9.425935587614731e-08
greater O 0 1.3722767713830741e-11
if O 0 8.412003732471973e-11
one O 0 4.7692525520200493e-14
or O 0 3.7127021089108404e-15
more O 0 8.798984608824776e-16
cases O 0 8.444347998626256e-11
of O 0 2.0813775591932426e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 8.529042472282811e-10
also O 0 3.291296124530163e-09
present O 0 1.0834849727484053e-12
in O 0 1.3739364463846715e-12
the O 0 1.2171822794462828e-12
family O 0 5.798202473705771e-10
. O 0 6.458209834969697e-12

The O 0 1.0819551851670717e-11
odds O 0 3.677414622815789e-11
of O 0 5.034262897900599e-17
detection O 0 2.591918693561901e-11
of O 0 9.576448622538713e-17
any O 0 1.4174275089155058e-13
of O 0 8.955021841994411e-16
the O 0 2.9952975863500875e-12
four O 0 4.23325957621401e-11
BRCA2 O 0 1.0980963693896229e-08
mutations O 0 2.8382705075102876e-09
was O 0 1.6737247698905833e-10
5 O 0 1.2962108816849671e-11
. O 0 1.58755422002832e-11

3x O 0 1.8085048125726644e-08
greater O 0 3.3732728416113744e-11
if O 0 2.4100393902770634e-10
there O 0 6.191316990339368e-13
were O 0 3.527502590158424e-14
at O 0 7.774198494160667e-14
least O 0 8.277276264303645e-15
five O 0 1.2321490128110874e-14
cases O 0 1.5188630247183615e-13
of O 0 8.025312727734379e-13
breast B-Disease 1 0.999964714050293
cancer I-Disease 0 0.08725441992282867
in O 0 1.400973412800377e-12
the O 0 7.344610163106946e-12
family O 0 4.328712943646451e-09
. O 0 3.4344940086361575e-11

Interestingly O 0 2.1280028406067686e-08
, O 0 1.5710880946900874e-12
the O 0 3.026487684055189e-15
presence O 0 1.9580338869382152e-13
of O 0 1.5332345607366247e-15
a O 0 1.575446856305618e-10
breast B-Disease 0 3.069224476348609e-05
cancer I-Disease 0 2.643220966547233e-07
case O 0 5.46740690915426e-12
< O 0 7.250208211573295e-10
36 O 0 9.877910711608706e-10
years O 0 1.7887811186705765e-13
of O 0 2.0393024948262646e-16
age O 0 7.969244188166247e-12
was O 0 4.3120251835317147e-13
strongly O 0 1.0927276438029137e-14
predictive O 0 2.2924769179331894e-13
of O 0 4.068341266437522e-17
the O 0 4.362084153088086e-15
presence O 0 1.3846402865426433e-13
of O 0 2.0530859377221337e-17
any O 0 1.3203657154984335e-14
of O 0 5.518920261068484e-17
the O 0 2.5042952602047017e-14
eight O 0 1.7611436397765856e-12
mutations O 0 7.06251793158863e-11
screened O 0 8.471684687094694e-09
. O 0 8.988442802559948e-12

Carriers O 0 3.1088167595783034e-09
of O 0 6.088049731906757e-15
the O 0 8.148202842702193e-15
same O 0 1.0232971154461312e-14
mutation O 0 1.6886142007246918e-12
, O 0 3.1671135762660054e-15
from O 0 4.9907816526933817e-17
different O 0 2.34244420464335e-14
families O 0 3.7637135161944224e-13
, O 0 1.3496248931800514e-13
shared O 0 1.7464243213475422e-13
similar O 0 1.1883365724275376e-14
haplotypes O 0 7.431671250612837e-11
, O 0 9.257670313938399e-15
indicating O 0 4.624784645415429e-14
that O 0 2.8184690977037415e-15
the O 0 1.213697760601824e-16
mutant O 0 1.5618767130326505e-12
alleles O 0 3.945795581006446e-14
were O 0 1.5618678225748361e-12
likely O 0 1.5253562302142143e-11
to O 0 1.3929188748609822e-12
be O 0 2.379575052627314e-12
identical O 0 5.838551170311845e-11
by O 0 7.319038224876812e-14
descent O 0 4.810178297343093e-11
for O 0 5.5783391855670095e-15
a O 0 9.87676954111727e-12
mutation O 0 5.486302523394215e-09
in O 0 2.344805393687116e-13
the O 0 5.38565936639146e-13
founder O 0 2.409280830395488e-10
population O 0 9.86742588679479e-13
. O 0 1.1889930229616597e-12

The O 0 2.575810387466654e-13
identification O 0 1.4216919471104345e-13
of O 0 8.449707396650913e-16
common O 0 2.808759952052653e-12
BRCA1 O 0 1.853832259257615e-06
and O 0 3.5320828484231015e-09
BRCA2 O 0 7.732930384918291e-07
mutations O 0 2.8067628221606356e-08
will O 0 1.388745211492945e-13
facilitate O 0 5.946025600058261e-14
carrier O 0 1.4951364799009603e-12
detection O 0 2.9851032756766926e-10
in O 0 2.10412134764304e-12
French O 0 1.2579362191900145e-06
Canadian O 0 2.3457878342014737e-06
breast B-Disease 1 0.9641827940940857
cancer I-Disease 1 0.9846989512443542
and O 0 0.025007184594869614
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.965767909035577e-10
. O 0 7.651124525609454e-12

Are O 0 2.894977868539428e-10
Dp71 O 0 8.896983672457282e-06
and O 0 1.138763638941498e-09
Dp140 O 0 2.5286578875238774e-07
brain O 0 1.3108344631973523e-08
dystrophin O 0 1.844430164155142e-09
isoforms O 0 8.523488338740837e-12
related O 0 2.372931885707974e-11
to O 0 3.166019096195738e-12
cognitive B-Disease 0 8.719710820059845e-08
impairment I-Disease 0 1.0114786341830495e-08
in O 0 1.3135612042525224e-10
Duchenne B-Disease 1 0.9990878105163574
muscular I-Disease 0 0.1920674592256546
dystrophy I-Disease 1 0.9906850457191467
? O 0 6.033922090864507e-07

Molecular O 0 9.752653795658262e-07
study O 0 2.12052242432037e-09
and O 0 6.0436547259790085e-12
neuropsychological O 0 4.2414083356590027e-10
analysis O 0 9.38526166505138e-13
were O 0 7.372729271711009e-14
performed O 0 1.7290221338006617e-11
concurrently O 0 2.145761693328474e-11
on O 0 5.570759131767744e-11
49 O 0 3.6033159744874865e-07
patients O 0 4.2082712314872595e-11
with O 0 7.177620043458122e-12
Duchenne B-Disease 0 0.048646148294210434
muscular I-Disease 0 2.025908906944096e-05
dystrophy I-Disease 0 0.00023865432012826204
( O 0 2.995219350321321e-11
DMD B-Disease 1 1.0
) O 0 4.671578124337827e-10
in O 0 8.259211457112281e-13
order O 0 2.7545660197247912e-11
to O 0 2.640185433559067e-13
find O 0 5.3949503691459386e-14
a O 0 4.8575347674119097e-17
molecular O 0 6.289064456927243e-14
explanation O 0 3.310951502116105e-14
for O 0 4.571370641882455e-16
the O 0 2.3451767329311923e-13
cognitive B-Disease 0 7.820455394380588e-09
impairment I-Disease 0 5.7663127744911336e-12
observed O 0 1.2104774647914152e-12
in O 0 1.6666087455409484e-13
most O 0 4.099065878393482e-11
DMD B-Disease 1 1.0
patients O 0 1.2228588275320362e-05
. O 0 1.0478492205867607e-11

Complete O 0 8.934353812328766e-10
analysis O 0 3.472035809901075e-12
of O 0 4.730482075255031e-16
the O 0 6.2691682459193026e-15
dystrophin O 0 2.7812680158945113e-08
gene O 0 1.762417234374425e-08
was O 0 1.651374523237159e-11
performed O 0 7.107162081076979e-12
to O 0 1.110049276991851e-15
define O 0 6.158280808042649e-13
the O 0 7.785839500888843e-16
localization O 0 3.835809165957105e-13
of O 0 9.60978664820256e-17
deletions O 0 3.2909596825447807e-07
and O 0 6.264119889465292e-09
duplications O 0 7.908884640528413e-07
in O 0 2.6432855470409633e-12
relation O 0 1.5012780948953086e-11
to O 0 1.4530848854894807e-13
the O 0 8.797013139640042e-14
different O 0 7.615090849566464e-12
DMD B-Disease 1 0.999998927116394
promoters O 0 3.7958042042873785e-08
. O 0 1.6555248491534336e-11

Qualitative O 0 8.776183113567981e-10
analysis O 0 9.675322175384249e-12
of O 0 2.5712413032843333e-16
the O 0 1.555483342228093e-14
Dp71 O 0 2.199173998462811e-08
transcript O 0 4.790534635645827e-09
and O 0 1.892800369565628e-12
testing O 0 4.630126577281901e-13
for O 0 7.841296873799756e-19
the O 0 1.4074244857657026e-17
specific O 0 1.7017054699483444e-16
first O 0 4.023985446477375e-15
exon O 0 2.4135791022034114e-12
of O 0 5.069379957451476e-15
Dp140 O 0 1.2852257036399806e-08
were O 0 1.0129951738546694e-10
also O 0 2.005663551907233e-10
carried O 0 6.528529716831599e-09
out O 0 5.370209277266724e-10
. O 0 5.559695499118833e-12

Neuropsychological O 0 6.588457495126931e-07
analysis O 0 4.447262350049108e-11
assessed O 0 3.984339334156539e-12
verbal O 0 8.017261854398328e-10
and O 0 4.1402395400957914e-11
visuospatial O 0 2.3046493424772052e-07
intelligence O 0 1.7227594906188415e-09
, O 0 8.240930507441568e-12
verbal O 0 1.8898558273861e-09
memory O 0 6.774810401566356e-08
, O 0 2.2968218993391076e-10
and O 0 1.5332793368294517e-10
reading O 0 7.291325321290287e-10
skills O 0 9.387675081740099e-10
. O 0 4.315154136791399e-12

Comparison O 0 6.521892470523483e-10
of O 0 6.5421966109725175e-15
molecular O 0 9.200269018849738e-11
and O 0 4.778025631396732e-12
psychometric O 0 7.896270659557558e-08
findings O 0 1.0146344701922327e-11
demonstrated O 0 6.00261282194571e-14
that O 0 2.47789557257939e-15
deletions O 0 2.753859806858827e-09
and O 0 8.015923862181307e-12
duplications O 0 2.3316237829362763e-08
that O 0 5.1557272340296834e-11
were O 0 1.115627013513476e-12
localized O 0 8.865625567011648e-09
in O 0 1.7919178293968052e-11
the O 0 2.2622966596840682e-13
distal O 0 1.8711784899316797e-10
part O 0 2.4318330335559857e-11
of O 0 6.129806973898737e-16
the O 0 2.5080142430629164e-14
gene O 0 2.0434202940844415e-10
seemed O 0 3.670783295384172e-12
to O 0 7.952196877608706e-15
be O 0 5.60707689588498e-15
preferentially O 0 1.1660736395566196e-12
associated O 0 8.063356926601983e-11
with O 0 1.2053104174458706e-11
cognitive B-Disease 0 2.2301327362583834e-07
impairment I-Disease 0 4.2925346610545034e-10
. O 0 3.5091723363939176e-12

Two O 0 1.0929090965561272e-10
altered O 0 1.8081184549600948e-08
Dp71 O 0 3.1251920518116094e-07
transcripts O 0 2.14794351194314e-08
and O 0 2.0892129172500606e-12
two O 0 3.0837909452446e-15
deleted O 0 3.994309050181499e-11
Dp140 O 0 1.2591326419009174e-11
DNA O 0 3.3513544717145294e-10
sequences O 0 1.5490757981906356e-11
were O 0 1.0454511605376138e-12
found O 0 2.1363598824014618e-12
in O 0 3.161689050216847e-14
four O 0 3.640767201606998e-11
patients O 0 7.095703365156414e-12
with O 0 3.82294369771774e-11
severe O 0 0.0002537994587328285
cerebral B-Disease 0 0.20502987504005432
dysfunction I-Disease 0 0.0001403396890964359
. O 0 1.4384170243797456e-10

These O 0 3.3398665777450987e-11
findings O 0 3.331917641097304e-12
suggest O 0 3.109836335928734e-13
that O 0 3.4261500687613226e-16
some O 0 1.1813207202864164e-16
sequences O 0 4.918487284122364e-10
located O 0 6.375788785817349e-09
in O 0 3.722647190507189e-13
the O 0 1.8365236225227968e-14
distal O 0 1.1442845282427783e-10
part O 0 1.497249026150005e-11
of O 0 3.677589205115361e-15
the O 0 3.18899908650222e-13
gene O 0 1.03947819241057e-08
and O 0 2.5163940375882987e-11
, O 0 4.456629970660611e-14
in O 0 9.302517108605488e-16
particular O 0 1.500878008030629e-14
, O 0 1.2919012156576e-15
some O 0 3.423786793898924e-15
DMD B-Disease 1 0.9999996423721313
isoforms O 0 1.1529667498511031e-10
expressed O 0 5.686966332964574e-14
in O 0 1.3319836194029735e-14
the O 0 5.848999670016175e-13
brain O 0 3.0802635819782154e-07
may O 0 1.7516162131858692e-12
be O 0 8.076188630922224e-16
related O 0 4.682103026142949e-14
to O 0 4.330506439553794e-12
the O 0 9.771090186960762e-12
cognitive B-Disease 0 1.0708604492037921e-07
impairment I-Disease 0 6.291654003343083e-11
associated O 0 2.558544209829705e-10
with O 0 1.1378950004470312e-09
DMD B-Disease 1 1.0
. O 0 9.193817929187276e-10
. O 0 1.9995434127895173e-11

I1307K O 0 3.3251890840801934e-07
APC O 0 1.8618209196574753e-08
and O 0 1.306764141340011e-10
hMLH1 O 0 7.99988626454251e-08
mutations O 0 1.6086485175037524e-06
in O 0 2.469631758209717e-13
a O 0 4.1442882654264823e-13
non O 0 1.1618428441551032e-11
- O 0 2.8428557925508358e-06
Jewish O 0 4.3901280832869816e-08
family O 0 6.474299429903851e-10
with O 0 2.8279722313895306e-12
hereditary B-Disease 0 0.00016304891323670745
non I-Disease 0 2.778983514417632e-07
- I-Disease 1 0.9993523955345154
polyposis I-Disease 1 0.9999654293060303
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.495326747099853e-10

We O 0 8.72694450038125e-09
describe O 0 7.818330011177821e-11
a O 0 2.498944410775361e-12
French O 0 1.8296553605523513e-08
Canadian O 0 2.4562869072042304e-08
hereditary B-Disease 1 0.9219822883605957
non I-Disease 0 0.0004650505434256047
- I-Disease 1 0.999998927116394
polyposis I-Disease 1 0.9999997615814209
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.936857784214709e-10
HNPCC B-Disease 0 5.3616295190295205e-05
) O 0 3.796709040909674e-12
kindred O 0 1.1584672110487304e-09
which O 0 2.431363270438691e-12
carries O 0 7.094224838653795e-13
a O 0 4.5099113923615167e-14
novel O 0 4.0456884370376756e-11
truncating O 0 2.1060593269339734e-07
mutation O 0 2.878138971595945e-08
in O 0 2.458409994673949e-12
hMLH1 O 0 1.0386477242718684e-06
. O 0 7.25680349145108e-11

Interestingly O 0 5.21513365825399e-09
, O 0 4.4234521644551106e-13
the O 0 2.0253187961363078e-14
I1307K O 0 3.489205105400295e-11
APC O 0 3.795442259091342e-12
polymorphism O 0 5.776079267660883e-11
, O 0 3.560149611637857e-14
associated O 0 3.535371322950509e-13
with O 0 7.107314547007484e-15
an O 0 5.009803895106345e-15
increased O 0 4.776328665911933e-09
risk O 0 1.6225117178692017e-06
of O 0 6.951363218377082e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.5493254457155103e-09
is O 0 7.81176685837881e-12
also O 0 4.0275438539794095e-10
present O 0 2.6846843433243894e-13
in O 0 1.527363440801191e-13
this O 0 1.1603495941869824e-12
family O 0 5.513570849879912e-11
. O 0 8.312918929609392e-12

The O 0 3.360889041029158e-12
I1307K O 0 4.29404123369892e-10
polymorphism O 0 1.591752862850626e-08
has O 0 6.937157515096715e-10
previously O 0 4.5794458503056745e-11
only O 0 3.0142390319842782e-12
been O 0 1.9147404148323055e-11
identified O 0 2.252914077516266e-09
in O 0 1.8102981949857239e-13
individuals O 0 1.1878924730532921e-14
of O 0 9.91926996134684e-15
self O 0 6.18767273863341e-07
- O 0 4.044661545776762e-05
reported O 0 1.08259063935634e-08
Ashkenazi O 0 3.387242486496689e-08
Jewish O 0 2.3408620528075907e-11
origins O 0 3.6963734156847394e-11
. O 0 9.996282447632954e-12

In O 0 4.247986511163315e-12
addition O 0 9.511281736165889e-13
, O 0 9.4861174037425e-13
in O 0 7.327754532717237e-14
this O 0 7.276130110749068e-13
family O 0 1.2961120891830102e-11
, O 0 1.4811227602457705e-13
there O 0 2.4311021945555567e-13
appears O 0 8.870669823690669e-12
to O 0 2.203526667772862e-13
be O 0 5.492112298798035e-13
no O 0 6.786511456968736e-13
relationship O 0 5.479451527928836e-13
between O 0 3.845914980525524e-15
the O 0 2.4494744937650153e-16
I1307K O 0 7.094536004677299e-13
polymorphism O 0 9.115965794725955e-12
and O 0 5.848307949030129e-13
the O 0 3.462229595968297e-15
presence O 0 1.2637890733913082e-10
or O 0 7.305713325966856e-12
absence O 0 5.768523679561266e-12
of O 0 1.457246599763731e-15
cancer B-Disease 0 6.799277230129519e-08
. O 0 2.4389317605441607e-14
. O 0 2.298980450454735e-12

Identification O 0 5.77842995674871e-10
of O 0 2.3505392985202593e-15
a O 0 5.458305045468771e-14
novel O 0 5.932448976508908e-12
mutation O 0 1.845586183879533e-11
of O 0 2.7868855684412336e-16
the O 0 1.847137351927708e-13
CPO O 0 5.767258812738874e-07
gene O 0 1.1632719232324007e-09
in O 0 4.676293057751142e-14
a O 0 8.877316741949526e-13
Japanese O 0 1.0006468187384598e-07
hereditary B-Disease 0 0.00020158724510110915
coproporphyria I-Disease 0 0.00010969388677040115
family O 0 5.231582278497626e-09
. O 0 2.634790129130149e-11

Hereditary B-Disease 1 0.9985392093658447
coproporphyria I-Disease 0 0.011395104229450226
( O 0 3.552891592040197e-10
HCP B-Disease 0 0.00035675865365192294
) O 0 1.0761451625651564e-11
is O 0 1.9310492874874408e-12
an O 0 6.475812074080434e-12
autosomal B-Disease 1 0.999998927116394
dominant I-Disease 1 0.9999994039535522
disease I-Disease 1 0.9999997615814209
characterized O 0 1.2142021432737238e-07
by O 0 1.3432796541756886e-12
a O 0 4.7367101352335794e-09
deficiency B-Disease 0 0.0007513235323131084
of I-Disease 0 1.8203790474931878e-15
coproporphyrinogen I-Disease 0 5.456829512695549e-06
oxidase I-Disease 0 1.4715277529830928e-07
( O 0 1.9320946210120427e-13
CPO O 0 1.9504126314018322e-08
) O 0 6.879300053870205e-14
caused O 0 5.732872943725598e-13
by O 0 2.009141636808009e-16
a O 0 8.44720276257753e-14
mutation O 0 7.568858040318815e-11
in O 0 2.2087012598102744e-14
the O 0 1.1366736951635634e-13
CPO O 0 2.486673622570379e-07
gene O 0 2.4954900368356903e-09
. O 0 1.3263196096957586e-11

Only O 0 1.7093634951947934e-08
11 O 0 1.6677265471387592e-11
mutations O 0 2.5585200624789195e-10
of O 0 6.087535265270419e-16
the O 0 3.62081716063882e-14
gene O 0 1.9833652942224944e-08
have O 0 1.1550577855290456e-10
been O 0 7.0408327605686605e-12
reported O 0 7.990252903766759e-11
in O 0 3.4850778946743377e-13
HCP B-Disease 1 0.5370904803276062
patients O 0 1.320686449091113e-09
. O 0 1.3891910625313253e-12

We O 0 2.041880122760631e-07
report O 0 1.3956021668176666e-12
another O 0 2.5217907257302392e-14
mutation O 0 6.09400724327358e-12
in O 0 8.812218969230033e-16
a O 0 4.3530126335109e-13
Japanese O 0 1.700496454759559e-07
family O 0 4.5837647566493445e-10
. O 0 1.881470326758894e-11

Polymerase O 0 2.4452324964840955e-07
chain O 0 1.3970804069174392e-08
reaction O 0 1.7759122297733576e-11
- O 0 5.233286026751216e-10
single O 0 8.273050078116614e-14
strand O 0 6.604521790576356e-11
conformational O 0 9.75657339749754e-14
polymorphism O 0 1.840386133419858e-12
and O 0 1.9129634332214034e-14
direct O 0 3.439051344047983e-14
sequence O 0 1.8997572959200681e-10
analyses O 0 3.924328570437119e-11
demonstrated O 0 1.120049962066022e-14
a O 0 5.798077319776667e-15
C O 0 9.912613785356683e-11
to O 0 3.3980258114674894e-14
T O 0 5.608093850417717e-11
substitution O 0 7.464927622173514e-15
in O 0 7.276128822200197e-17
exon O 0 2.864813421210588e-12
1 O 0 9.40416161284742e-14
of O 0 4.228179030562369e-17
the O 0 8.80432811617253e-15
CPO O 0 7.937699386673103e-10
gene O 0 2.1428648785959403e-12
at O 0 2.419213341751849e-14
nucleotide O 0 3.253496918490667e-13
position O 0 2.977542691573465e-12
85 O 0 1.6762669377556882e-11
, O 0 2.8295383397436424e-11
which O 0 1.0742036427036084e-10
lies O 0 1.4544685456030493e-09
in O 0 3.2805331937274876e-14
the O 0 6.459641815317798e-15
putative O 0 1.495013748215035e-12
presequence O 0 1.7196815152442646e-11
for O 0 2.7406543447439713e-17
targeting O 0 6.168099885017764e-12
to O 0 4.554006911156039e-13
mitochondria O 0 9.914288057188969e-09
. O 0 1.549589970228915e-11

This O 0 1.541802926649516e-12
mutation O 0 1.5489103055710274e-11
changes O 0 8.661123982725213e-14
the O 0 1.9149727488970122e-16
codon O 0 6.163448793223072e-14
for O 0 1.5556729945593444e-18
glutamine O 0 6.491483054354508e-15
to O 0 2.1261199308484822e-16
a O 0 3.7285680948040975e-16
termination O 0 5.340983528384115e-14
codon O 0 1.941715668460353e-12
at O 0 2.483121401639782e-13
amino O 0 1.5219871803834328e-12
acid O 0 3.043581012218688e-12
position O 0 1.2573351214351103e-11
29 O 0 6.411589592580924e-10
. O 0 2.966737749562909e-12

MaeI O 0 1.1289262147329282e-06
restriction O 0 3.951936555779412e-09
analysis O 0 1.0096581209984024e-10
showed O 0 1.9758647495926596e-10
two O 0 2.5203276880720943e-15
other O 0 8.292093623408201e-16
carriers O 0 1.520553865111407e-12
in O 0 1.685241301976198e-13
the O 0 2.884673186084874e-12
family O 0 5.679075543163492e-10
. O 0 2.281708676166172e-11

The O 0 4.303308376307768e-09
C O 0 0.005359352100640535
- O 1 0.8075518012046814
T O 0 0.038168489933013916
mutation O 0 1.131645319674135e-07
is O 0 2.332045147268591e-13
located O 0 1.7176973819005292e-12
within O 0 3.540174203049348e-14
a O 0 1.9194654275311168e-14
recently O 0 9.659519711879838e-12
proposed O 0 2.0299906910601836e-14
putative O 0 1.0019101433916822e-13
alternative O 0 1.76790228591635e-15
translation O 0 2.7744247396992334e-14
initiation O 0 7.641661893651071e-15
codon O 0 1.7894482770564046e-11
( O 0 9.926954244244331e-15
TIC O 0 4.0941317003273525e-09
- O 0 4.916970386403818e-09
1 O 0 1.0260200214396928e-13
) O 0 9.157806823523011e-16
, O 0 3.961325866566883e-16
supporting O 0 1.746060334349448e-14
that O 0 3.0396925211270687e-13
TIC O 0 1.8677502211517094e-08
- O 0 4.052757573980159e-10
1 O 0 4.5616549410433874e-14
is O 0 2.062578801398135e-15
the O 0 6.623705532695615e-16
real O 0 7.440851049460989e-14
TIC O 0 2.3630137777064242e-11
rather O 0 3.5582586211710236e-16
than O 0 1.0075196842005316e-16
TIC O 0 6.073671565687278e-10
- O 0 7.46476214175118e-10
2 O 0 2.764210572676201e-13
. O 0 1.2232554209748014e-14
. O 0 1.9977879214209265e-13

Human B-Disease 0 4.7580797080115644e-09
complement I-Disease 0 9.196084782558955e-09
factor I-Disease 0 2.5368074147991138e-06
H I-Disease 1 1.0
deficiency I-Disease 1 0.999971866607666
associated O 0 5.8400539273861796e-05
with O 0 0.0004953035968355834
hemolytic B-Disease 1 0.999998927116394
uremic I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999996423721313
. O 0 8.473640455974873e-09

This O 0 1.998825584215158e-12
study O 0 6.612755048401864e-14
reports O 0 1.2282007550747098e-13
on O 0 5.443451136892541e-13
six O 0 3.4763012780880675e-13
cases O 0 2.6492198192118455e-13
of O 0 2.9249839312781023e-13
deficiency B-Disease 0 0.0013583570253103971
in I-Disease 0 1.2980156500422974e-13
the I-Disease 0 4.12306338159682e-13
human I-Disease 0 2.4786180052860374e-12
complement I-Disease 0 1.5533678943829843e-12
regulatory I-Disease 0 1.7027835304966876e-12
protein I-Disease 0 2.3211407795820094e-10
Factor I-Disease 0 3.208217247419043e-09
H I-Disease 1 0.9999998807907104
( O 0 1.857800751344646e-13
FH O 0 1.2338199439909658e-06
) O 0 5.895160848059166e-15
in O 0 1.900055836951374e-16
the O 0 1.6692244033991022e-16
context O 0 3.477227796607092e-14
of O 0 7.289941414940853e-16
an O 0 2.219380235146673e-11
acute B-Disease 0 0.4282280504703522
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.13062828386046e-09

Five O 0 4.0528171096898546e-11
of O 0 2.3674917629870477e-16
the O 0 1.763524078491111e-15
cases O 0 1.5718096312358765e-13
were O 0 1.3776909571928259e-13
observed O 0 7.6494314354969e-12
in O 0 4.913714359987449e-14
children O 0 1.3297816623888958e-12
presenting O 0 7.040295863652846e-12
with O 0 6.682523689960362e-08
idiopathic O 1 0.999998927116394
hemolytic B-Disease 1 0.9999998807907104
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.615641888809478e-08
HUS B-Disease 1 0.9999440908432007
) O 0 3.1985955217805895e-08
. O 0 1.6302454941552469e-09

Two O 0 3.4866970421987276e-11
of O 0 6.151806325363062e-15
the O 0 4.1644939992140084e-13
children O 0 6.887377495580493e-13
exhibited O 0 3.960081915166391e-11
a O 0 7.602841967102592e-12
homozygous O 0 1.42611770570511e-06
deficiency O 0 0.0008958810358308256
characterized O 0 1.0662359883895078e-11
by O 0 3.3741943700899e-14
the O 0 2.9508066996808413e-12
absence O 0 2.9743145446570196e-11
of O 0 3.676786389934931e-17
the O 0 7.421425280551954e-16
150 O 0 2.017729465632204e-15
- O 0 9.813445629031081e-13
kD O 0 4.482279478135176e-11
form O 0 2.283816988605733e-14
of O 0 4.740595251598553e-17
Factor O 0 5.090030064103246e-10
H O 1 1.0
and O 0 1.5227284710928046e-11
the O 0 1.2372964955590228e-15
presence O 0 2.0542732283041626e-13
, O 0 2.219942911679644e-15
upon O 0 2.1406208371204553e-17
immunoblotting O 0 1.4108503428034158e-11
, O 0 2.422555098487004e-15
of O 0 5.894477050933993e-18
the O 0 1.1565738321692143e-15
42 O 0 1.098649274854091e-12
- O 0 1.3911771040708842e-12
kD O 0 2.529244147453369e-09
Factor O 0 2.3620021494252796e-09
H O 1 0.9999990463256836
- O 0 2.189922243545084e-09
like O 0 5.541137427372833e-12
protein O 0 6.518071499206357e-11
1 O 0 2.6277748762224863e-14
( O 0 6.905875500832072e-16
FHL O 0 1.1763020557609138e-09
- O 0 2.336901783195344e-10
1 O 0 2.1417593989558198e-14
) O 0 1.5676912257562192e-15
and O 0 2.201194176205349e-14
other O 0 1.022169629890041e-14
FH O 0 4.93263105454389e-05
- O 0 9.916528709297268e-11
related O 0 1.9154881673866253e-12
protein O 0 1.6653339818262225e-10
( O 0 4.651196826776713e-15
FHR O 0 3.7961336851743965e-10
) O 0 7.944161923071052e-15
bands O 0 7.161808038974593e-13
. O 0 3.358011785303816e-12

Southern O 0 3.1666518296447066e-09
blot O 0 1.2967317388756783e-06
and O 0 7.189944305078036e-14
PCR O 0 4.845646887213784e-12
analysis O 0 1.4850135044450295e-15
of O 0 1.5656390733745364e-18
DNA O 0 2.0320789495542613e-10
of O 0 1.7463908585168675e-17
one O 0 7.528134474306392e-13
patient O 0 4.775905018683524e-11
with O 0 1.4941635439764261e-13
homozygous O 0 1.9530935446709918e-07
deficiency O 0 0.005975575651973486
ruled O 0 1.3371199258926936e-07
out O 0 3.092778655400252e-08
the O 0 6.902326475134724e-14
presence O 0 6.910945340304897e-13
of O 0 1.1861653351544047e-17
a O 0 3.5391982622754337e-16
large O 0 4.694673757409855e-15
deletion O 0 5.167009181628046e-11
of O 0 3.7493761208978895e-17
the O 0 1.1950737030834088e-14
FH O 0 2.1796154214825947e-06
gene O 0 5.680990053380519e-11
as O 0 5.566498935513815e-15
the O 0 5.309825082606186e-16
underlying O 0 1.4026517306583303e-13
defect O 0 3.609013643490755e-10
for O 0 2.760519973892049e-15
the O 0 1.314819503273057e-10
deficiency O 0 0.0007979398942552507
. O 0 1.1862504901982707e-11

The O 0 1.2897519857668627e-11
other O 0 2.6412428017277834e-13
four O 0 2.5205430190938793e-12
children O 0 1.3936196489351682e-13
presented O 0 2.0534338525347515e-14
with O 0 8.485709530881014e-12
heterozygous O 0 6.933850090717897e-05
deficiency O 0 0.1388552337884903
and O 0 1.547979973370861e-11
exhibited O 0 5.742555875265509e-10
a O 0 6.725230615456379e-12
normal O 0 2.9075573060310944e-09
immunoblotting O 0 1.1262234522746439e-07
pattern O 0 1.886161982156409e-08
of O 0 2.946796124459985e-16
proteins O 0 5.908714489910594e-11
of O 0 9.137393329494183e-16
the O 0 2.05552068421877e-12
FH O 0 0.24472922086715698
family O 0 1.950931499683506e-10
. O 0 2.37677195633057e-12

Factor B-Disease 0 0.030012190341949463
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999350309371948
is O 0 5.381379803576225e-12
the O 0 1.88917544802214e-12
only O 0 4.1350571677867265e-07
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 4.800385422498721e-09
with O 0 2.8345619254577237e-11
HUS B-Disease 1 0.9998703002929688
. O 0 3.902328238325481e-09

These O 0 2.2804817062516136e-11
observations O 0 4.749966045491938e-12
suggest O 0 6.896158448975453e-13
a O 0 5.495017189820314e-16
role O 0 2.7592105033072412e-14
for O 0 6.660647815898927e-16
FH O 0 0.00035001689684577286
and O 0 2.048250111186256e-11
/ O 0 8.243163307497525e-08
or O 0 3.1756213869464645e-13
FH O 0 5.861523459316231e-05
receptors O 0 3.292264464521688e-12
in O 0 1.9434243473672678e-15
the O 0 1.1539566909446117e-14
pathogenesis O 0 6.214126990755631e-09
of O 0 1.782482751081383e-14
idiopathic O 1 0.8234179019927979
HUS B-Disease 1 0.9999654293060303
. O 0 3.4220477562740825e-09
. O 0 3.153787231369165e-10

Further O 0 6.696192211830265e-11
evidence O 0 1.7539128786478453e-12
for O 0 4.2307767085580304e-17
a O 0 1.8420620321517138e-15
major O 0 6.281931761885004e-14
ancient O 0 3.104168658230044e-11
mutation O 0 7.173007361416239e-07
underlying O 0 4.881174930915222e-08
myotonic B-Disease 1 0.9999986886978149
dystrophy I-Disease 1 0.9999996423721313
from O 0 1.9188964653360507e-12
linkage O 0 8.214696208597161e-06
disequilibrium O 0 1.0212843903900648e-07
studies O 0 3.2873920252640687e-10
in O 0 9.318078162637734e-15
the O 0 2.0374461056553266e-14
Japanese O 0 1.2643779356835694e-09
population O 0 1.8448345065133487e-13
. O 0 1.0521646488098613e-12

The O 0 2.6699384036987794e-08
myotonic B-Disease 1 0.9999886751174927
dystrophy I-Disease 1 0.9999992847442627
( O 0 2.5365018530010275e-08
DM B-Disease 1 1.0
) O 0 5.466661567865572e-10
mutation O 0 1.4713924301190673e-08
is O 0 1.8377965436359306e-13
an O 0 5.694941317569563e-15
unstable O 0 3.277033783888328e-06
( O 0 1.0326303343227011e-13
CTG O 0 3.2250091486218935e-09
) O 0 5.318912899097278e-14
n O 0 2.2546454980787445e-10
repeat O 0 1.4241129386860507e-09
, O 0 2.788272271490172e-13
present O 0 6.01281177625701e-14
at O 0 2.918074039782309e-13
a O 0 1.1423495020068545e-15
copy O 0 3.545788315739706e-11
number O 0 8.485899157840981e-13
of O 0 2.4251533720527066e-15
5 O 0 1.412512329324045e-10
- O 0 1.7813708552694152e-07
37 O 0 7.546072655628677e-10
repeats O 0 1.3264582321426133e-08
on O 0 6.0649714417326805e-12
normal O 0 2.883612966464444e-11
chromosomes O 0 6.6533102811849876e-12
but O 0 1.1943034960244705e-14
amplified O 0 1.4335668069298535e-13
to O 0 5.711652938805711e-14
50 O 0 4.71118132840901e-14
- O 0 1.0548677382982152e-11
3000 O 0 4.690254871227324e-14
copies O 0 3.345652476848676e-13
on O 0 8.75919281551063e-10
DM B-Disease 1 0.9999996423721313
chromosomes O 0 4.108365828869864e-06
. O 0 3.232815057319094e-11

Previous O 0 1.7025239884560506e-08
findings O 0 2.762791939669995e-10
in O 0 2.8933116753143695e-13
Caucasian O 0 1.4914083294570446e-05
populations O 0 8.135850215751361e-09
of O 0 8.2297975265112e-15
a O 0 1.2788915482175867e-09
DM B-Disease 1 1.0
founder O 0 5.714764483855106e-07
chromosome O 0 2.1874993763049133e-05
raise O 0 1.270562322887303e-12
a O 0 4.1192489550661085e-14
question O 0 1.3933273209244118e-13
about O 0 1.8765671898075386e-15
the O 0 1.1911180592197312e-15
molecular O 0 3.1450079086142724e-12
events O 0 1.7885217233008094e-13
involved O 0 6.214704450927325e-14
in O 0 7.258837729842964e-15
the O 0 6.7087702987312856e-15
expansion O 0 4.315970844603889e-11
mutation O 0 2.741908644576796e-10
. O 0 1.79110014580236e-12

To O 0 3.065184564499113e-11
investigate O 0 3.6069335018762416e-11
whether O 0 4.190757170539211e-13
a O 0 2.4682082685198795e-14
founder O 0 1.6287325221159277e-12
chromosome O 0 3.1988747206668222e-09
for O 0 1.8063297355135543e-15
the O 0 1.090906553459503e-12
DM B-Disease 1 1.0
mutation O 0 3.6768631161976373e-07
exists O 0 3.762753563590904e-12
in O 0 1.7004279589754277e-15
the O 0 3.1405809891712697e-14
Japanese O 0 8.18158518711698e-09
population O 0 2.1783617932483873e-13
, O 0 2.484301013603446e-13
we O 0 1.149376167158822e-11
genotyped O 0 3.2333576788223795e-11
families O 0 1.0656111889567016e-16
using O 0 4.595691604776086e-16
polymorphic O 0 4.460402099754068e-12
markers O 0 2.090393564913029e-07
near O 0 3.432718287399439e-08
the O 0 1.0103134556174384e-13
( O 0 2.8221013443881574e-14
CTG O 0 3.217881738848405e-09
) O 0 4.763845568023228e-13
n O 0 1.612483124802111e-08
repeat O 0 4.940710027767636e-07
region O 0 1.3442614132941344e-08
and O 0 1.3152308409036806e-10
constructed O 0 9.824069024944038e-08
haplotypes O 0 5.958804081274138e-07
. O 0 1.5615118920120352e-10

Six O 0 5.651916434867843e-11
different O 0 1.7166869258045635e-14
haplotypes O 0 1.847964559154036e-10
were O 0 1.2187619620115941e-12
found O 0 3.9187988791489214e-12
and O 0 1.7630173709815011e-10
DM B-Disease 1 1.0
alleles O 0 5.2896274027602885e-09
were O 0 1.6587108422894126e-11
always O 0 9.50920071851602e-12
haplotype O 0 3.517492130900024e-10
A O 0 1.9608951615235348e-11
. O 0 1.1597748802993912e-11

To O 0 1.6603704522388796e-10
find O 0 1.0292252076646302e-12
an O 0 1.3682144372822395e-16
origin O 0 1.053868652094907e-14
of O 0 1.674696765633957e-16
the O 0 6.802655769418131e-14
( O 0 1.3017953016353592e-15
CTG O 0 7.421444014887868e-11
) O 0 8.760072338744387e-15
n O 0 1.2967920140494194e-11
repeat O 0 1.3352396965871094e-10
mutation O 0 2.547897656746123e-11
and O 0 7.601166603695558e-14
to O 0 2.420024375798845e-15
investigate O 0 4.574517305754033e-13
the O 0 9.960562817525487e-15
mechanism O 0 4.3948004957439224e-13
of O 0 6.274590117049567e-18
the O 0 9.088412590528019e-16
expansion O 0 9.782012439646381e-13
mutation O 0 1.928855295971199e-12
in O 0 1.6605432950715909e-15
the O 0 4.026519345539086e-15
Japanese O 0 2.1854869025617063e-09
population O 0 8.173797467862787e-14
we O 0 4.383977122296434e-12
have O 0 1.9261327626721343e-14
studied O 0 3.9810101287555966e-13
90 O 0 1.2490635153787621e-13
Japanese O 0 2.6952180487427313e-09
DM B-Disease 1 0.9999998807907104
families O 0 9.043747521697565e-12
comprising O 0 5.65364405681959e-14
190 O 0 3.009953180796443e-12
affected O 0 1.4274735560260154e-10
and O 0 2.5065724235801e-12
130 O 0 1.607560330511848e-12
unaffected O 0 1.8349174402132462e-09
members O 0 1.1941349364679669e-14
. O 0 1.298489310866402e-12

The O 0 1.9750632240800314e-09
results O 0 1.756432083110937e-10
suggest O 0 5.812780378561255e-12
that O 0 3.1972989929457754e-14
a O 0 2.355090914765625e-14
few O 0 1.8544870229297156e-13
common O 0 3.8294403591080176e-14
ancestral O 0 3.468226539293795e-10
mutations O 0 7.303553672954877e-08
in O 0 2.469622271440708e-13
both O 0 3.81057295092968e-12
Caucasian O 0 3.2923027902143076e-05
and O 0 4.542391796036327e-09
Japanese O 0 2.5381575596838957e-07
populations O 0 3.201523712803578e-09
have O 0 2.389243046029693e-13
originated O 0 1.1003741490309572e-14
by O 0 1.3648767552387819e-18
expansion O 0 1.641811161443062e-15
of O 0 4.636289430716841e-19
an O 0 4.565181676539333e-17
ancestral O 0 1.905088753417772e-09
n O 0 1.9799207962023502e-07
= O 0 3.1621027574146865e-08
5 O 0 3.1923460186086827e-13
repeat O 0 1.776045283063965e-10
to O 0 1.6378288699228638e-12
n O 0 1.663829607423395e-06
= O 0 1.111502388084773e-05
19 O 0 2.6282512277653325e-10
- O 0 2.821037625722056e-09
37 O 0 6.626448955521225e-12
copies O 0 1.200709345318407e-12
. O 0 8.666717517258338e-12

These O 0 3.779554252035522e-13
data O 0 3.425428004937524e-14
support O 0 2.342026246823439e-16
multistep O 0 3.716576525703008e-12
models O 0 2.193255820015505e-11
of O 0 5.504607085090891e-15
triplet O 0 5.566530489886645e-06
repeat O 0 7.716003125324278e-08
expansion O 0 2.152459634141568e-11
that O 0 3.850374066891732e-13
have O 0 5.461418738582878e-14
been O 0 4.786260783018503e-16
proposed O 0 7.472730595562739e-16
for O 0 3.657580910472675e-16
both O 0 2.3948812377661e-10
DM B-Disease 1 1.0
and O 0 3.186014964740025e-06
Friedreichs B-Disease 0 0.12733349204063416
ataxia I-Disease 1 0.9996227025985718
. O 0 2.1496708579871182e-10
. O 0 4.8181850870188114e-11

The O 0 5.161005628938342e-13
molecular O 0 4.151418792064376e-12
basis O 0 6.482779265661043e-13
of O 0 9.036918782734382e-12
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 6.959106685008876e-13
the O 0 3.8371777001493246e-13
western O 0 1.3351238337122595e-08
Cape O 0 2.9775815146848572e-09
, O 0 1.307797620198059e-12
South O 0 7.997258855141354e-09
Africa O 0 1.0484035167790395e-10
. O 0 8.711012597015233e-13

Deficiency B-Disease 1 0.999933123588562
of I-Disease 0 1.9112173595039333e-13
the I-Disease 0 2.513639036499926e-12
sixth I-Disease 0 8.574534415828339e-10
component I-Disease 0 3.134965897988451e-11
of I-Disease 0 4.976376163359428e-15
human I-Disease 0 9.495466912756712e-11
complement I-Disease 0 3.5210498405824353e-10
( O 0 1.098533427851961e-13
C6 O 0 3.758436051271019e-08
) O 0 2.1561895064553527e-12
has O 0 4.2165645974812094e-10
been O 0 4.209989301617867e-11
reported O 0 7.394964501861168e-11
in O 0 2.9068165399264963e-15
a O 0 6.665938807203951e-15
number O 0 1.3771077919493002e-13
of O 0 5.305813719856447e-17
families O 0 3.508256942805622e-15
from O 0 2.7856511502695084e-17
the O 0 2.7852277661447793e-16
western O 0 1.1222505563734941e-10
Cape O 0 3.823643485167949e-11
, O 0 7.962495138062742e-13
South O 0 7.269406410159718e-08
Africa O 0 7.494002640662245e-11
. O 0 2.1091670619234615e-13

Meningococcal B-Disease 1 0.9984365105628967
disease I-Disease 1 0.9998583793640137
is O 0 1.6376299621922996e-11
endemic O 0 3.0563898079094542e-09
in O 0 1.84102421350342e-13
the O 0 1.3178920628409418e-11
Cape O 0 4.0110883503530204e-08
and O 0 4.731925788703517e-12
almost O 0 8.77136227149175e-14
all O 0 1.622056066124134e-14
pedigrees O 0 5.786102499905077e-11
of O 0 8.242427634787709e-15
total O 0 1.488305798602596e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.2223145632743746e-12
C6Q0 O 0 3.63840308637009e-06
) O 0 1.861398405203496e-12
have O 0 6.952887918187933e-12
been O 0 1.3777494770050858e-12
ascertained O 0 1.3555451205959912e-10
because O 0 5.396250395313384e-13
of O 0 1.0913903481857886e-14
recurrent O 1 0.9973440766334534
disease O 1 0.9993295669555664
. O 0 8.073528651175721e-11

We O 0 5.965069931335165e-07
have O 0 2.735167778031289e-12
sequenced O 0 7.690774232738118e-12
the O 0 2.7187900487126186e-15
expressed O 0 3.2251576207073496e-16
exons O 0 3.700034376108441e-11
of O 0 5.805134480655835e-16
the O 0 2.0011886909415168e-14
C6 O 0 3.478953236601967e-10
gene O 0 9.591901925509738e-12
from O 0 1.1131526998314724e-16
selected O 0 2.408210214360426e-14
cases O 0 2.027771613816176e-12
and O 0 2.2508868102733004e-09
have O 0 1.3951098942754925e-08
found O 0 2.180430974663139e-10
three O 0 6.432820313755083e-13
molecular O 0 1.0996263455353983e-08
defects O 0 0.004558958578854799
leading O 0 1.7412624675472443e-09
to O 0 4.154076249651695e-10
total O 0 5.570615524419509e-09
deficiency O 0 0.02033628709614277
879delG O 0 4.2641579511837335e-07
, O 0 3.6562039507082034e-10
which O 0 3.0672547834953434e-11
is O 0 8.091692870219533e-14
the O 0 3.6652648757328106e-15
common O 0 9.351556123438423e-14
defect O 0 5.129139335480204e-10
in O 0 8.252778377403156e-15
the O 0 5.737018932833182e-13
Cape O 0 1.9218588942493398e-09
and O 0 1.1536365395956039e-12
hitherto O 0 5.738742814287434e-11
unreported O 0 7.703727239460889e-11
, O 0 1.6749876225602423e-12
and O 0 3.853570023845676e-13
1195delC O 0 2.4929687203467665e-09
and O 0 3.070829831738897e-12
1936delG O 0 1.2124803383528615e-09
, O 0 1.398389325342475e-12
which O 0 8.383868686095974e-13
have O 0 8.190863785839664e-12
been O 0 2.1114425312329654e-12
previously O 0 3.955220179152619e-11
reported O 0 9.021635660744209e-10
in O 0 4.2162448662605434e-13
African O 0 7.362646950448415e-12
- O 0 1.2087725487219814e-08
Americans O 0 4.293316136633196e-12
. O 0 3.577427525221222e-13

We O 0 2.05770831485097e-07
also O 0 2.4577208757731173e-12
show O 0 8.809548576738102e-12
that O 0 1.7803761801415616e-14
the O 0 9.652635000979501e-15
879delG O 0 8.683596064429366e-08
and O 0 1.5691492549763097e-10
1195delC O 0 4.838854238187196e-06
defects O 0 0.0003738898376468569
are O 0 2.803628021676662e-15
associated O 0 3.634042936365156e-12
with O 0 2.88337496240354e-12
characteristic O 0 4.809699305496906e-08
C6 O 0 4.994819391868077e-05
/ O 0 0.000163577264174819
C7 O 0 3.051504791073967e-07
region O 0 1.4381385859962847e-08
DNA O 0 8.490309483022429e-06
marker O 0 2.1911436220989344e-08
haplotypes O 0 5.105015077333519e-09
, O 0 8.918557624186529e-13
although O 0 7.798974682206306e-13
small O 0 3.4197959134646405e-13
variations O 0 2.8156512676957846e-09
were O 0 4.773000050750653e-11
observed O 0 1.3836393142341308e-10
. O 0 1.5111205689533058e-11

The O 0 9.14947978492009e-12
1936delG O 0 5.716081385997995e-09
defect O 0 3.516214519549976e-08
was O 0 2.5392121131423417e-12
observed O 0 3.255857822931363e-12
only O 0 6.431866324263513e-12
once O 0 8.398846618185019e-10
in O 0 9.278728908259856e-14
the O 0 3.1879546745494647e-12
Cape O 0 4.350446114465001e-10
, O 0 6.43373700669192e-14
but O 0 6.971178734098415e-14
its O 0 1.0126482701728094e-16
associated O 0 7.59189694617135e-13
haplotype O 0 1.0016637519427718e-09
could O 0 1.4788636981677428e-10
be O 0 1.212207417777833e-13
deduced O 0 6.469691449240145e-11
. O 0 3.821133947451427e-12

The O 0 3.812412191495085e-12
data O 0 1.3107218218774697e-12
from O 0 8.422096769548383e-16
the O 0 2.176731314117229e-15
haplotypes O 0 9.744193008032198e-09
indicate O 0 4.758767269130715e-10
that O 0 1.5535486308851376e-12
these O 0 2.1707619764763965e-14
three O 0 7.742693611907311e-14
molecular O 0 1.9180539378993444e-09
defects O 0 0.0009268607245758176
account O 0 8.000309399333605e-13
for O 0 1.0780402449634546e-13
the O 0 3.6217311372155336e-09
defects O 1 0.9991623163223267
in O 0 4.2593368068666315e-12
all O 0 3.4100797272756944e-12
the O 0 1.6237564678250882e-13
38 O 0 2.124885822851752e-10
unrelated O 0 2.7451830739155803e-11
C6Q0 O 0 1.4910320942362887e-06
individuals O 0 3.5978601283133405e-13
we O 0 9.485656010665977e-11
have O 0 6.44052682279711e-14
studied O 0 7.152333738290328e-13
from O 0 5.647039619168862e-17
the O 0 5.6704235253948135e-15
Cape O 0 6.957760062542562e-11
. O 0 9.074498964756206e-13

We O 0 1.2613623994184309e-06
have O 0 6.362404093157581e-12
also O 0 1.6942396379067415e-13
observed O 0 1.1420370400229418e-13
the O 0 1.811919941207196e-15
879delG O 0 5.663133961775202e-09
defect O 0 1.492612078379807e-08
in O 0 1.061017118890624e-13
two O 0 4.810116749354165e-10
Dutch O 1 0.9992783665657043
C6 B-Disease 1 1.0
- I-Disease 1 0.999998927116394
deficient I-Disease 1 1.0
kindreds O 0 0.004812293220311403
, O 0 1.6260359378406086e-11
but O 0 1.8136436363141994e-13
the O 0 8.134067980394887e-16
879delG O 0 2.0441452697195217e-10
defect O 0 2.9947638813254684e-10
in O 0 9.766225295579855e-16
the O 0 8.62425992301458e-15
Cape O 0 1.3577515847740251e-11
probably O 0 3.1141370732123974e-11
did O 0 6.890239490076056e-10
not O 0 4.146098883054533e-13
come O 0 1.8218286173274714e-14
from O 0 3.510783814140849e-17
The O 0 2.175827572314156e-14
Netherlands O 0 1.4001861359247414e-07
. O 0 2.0340613958794163e-13
. O 0 4.3779669017633693e-13

Complement B-Disease 1 0.9985874891281128
C7 I-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
: O 0 1.2866041565473552e-08
seven O 0 1.2237659670344403e-11
further O 0 9.092886166239822e-12
molecular O 0 4.43674389316584e-06
defects O 1 0.9999688863754272
and O 0 1.298684382255999e-09
their O 0 1.3804903400971291e-12
associated O 0 7.499511567310435e-10
marker O 0 2.589489668025635e-06
haplotypes O 0 8.454015187453479e-06
. O 0 3.7376293726687493e-10

Seven O 0 1.1856901571682954e-10
further O 0 3.5428509626879434e-13
molecular O 0 5.5687617711575044e-11
bases O 0 8.092378607216233e-07
of O 0 6.5754681699559114e-09
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 2.0164718853021846e-11
described O 0 3.2627864299250575e-10
. O 0 9.328621208837262e-12

All O 0 2.169978953470153e-11
these O 0 2.814978305521517e-14
new O 0 9.349523244365013e-14
molecular O 0 7.831826853710311e-10
defects O 0 3.1836884772928897e-06
involve O 0 1.2199480791882933e-12
single O 0 2.120770919988857e-11
- O 0 8.271777041102268e-09
nucleotide O 0 3.454758146226311e-10
events O 0 7.234104266139185e-13
, O 0 3.583701532142852e-14
deletions O 0 4.025569877441626e-10
and O 0 5.990598208466258e-12
substitutions O 0 1.1838945622455466e-12
, O 0 1.3495340573667879e-14
some O 0 2.138173739083503e-16
of O 0 6.179789594022825e-17
which O 0 6.940389560804172e-13
alter O 0 7.322659811848098e-09
splice O 0 3.582605927476834e-07
sites O 0 2.1409572781294628e-08
, O 0 1.1493630699965784e-11
and O 0 1.2202553420839757e-12
others O 0 5.6527597544226565e-14
codons O 0 3.129889125652596e-10
. O 0 1.9397907759233224e-12

They O 0 3.352494060138156e-09
are O 0 2.7944347495836375e-15
distributed O 0 4.7338956180324656e-15
along O 0 3.228273898203682e-11
the O 0 3.0364867385909364e-14
C7 O 0 4.3547465633508864e-10
gene O 0 7.0628489723389976e-09
, O 0 1.0628913114235639e-12
but O 0 7.76130868558253e-14
predominantly O 0 1.6565045572757876e-14
towards O 0 3.409438733398794e-14
the O 0 3.019437998241781e-14
3 O 0 2.1032477842686248e-11
end O 0 5.019950601037326e-12
. O 0 3.748841948675308e-12

All O 0 1.4519621616138068e-10
were O 0 1.5179053760444594e-12
found O 0 1.9505490972404615e-13
in O 0 1.7505146053333506e-15
compound O 0 2.697186363143089e-10
heterozygous O 0 2.179205482732982e-09
individuals O 0 7.393345376020821e-14
. O 0 6.914201741529957e-13

The O 0 1.5874527248271875e-09
C6 O 0 2.8121992727392353e-05
/ O 0 0.0003525819047354162
C7 O 0 2.647666178745567e-06
marker O 0 3.508150257403031e-06
haplotypes O 0 3.12119368572894e-06
associated O 0 5.3507271502439835e-08
with O 0 9.864575128970543e-11
most O 0 1.2535332494234552e-10
C7 B-Disease 1 0.9481773972511292
defects I-Disease 1 0.9999948740005493
are O 0 6.585040845941137e-10
tabulated O 0 1.0902329449891113e-05
. O 0 4.028061738325928e-12
. O 0 2.699222789726008e-11

A O 0 1.6562782256812625e-09
genome O 0 5.683474801898569e-10
- O 0 7.730409379291814e-08
wide O 0 2.8834865051230452e-11
search O 0 2.755957571529133e-12
for O 0 2.852725862947784e-15
chromosomal O 0 7.605127393617295e-06
loci O 0 1.4899426137304772e-10
linked O 0 1.9619474187493324e-06
to O 0 5.903234789883527e-09
mental O 0 0.004130189307034016
health O 0 2.018899358802173e-08
wellness O 0 1.8255768452490884e-08
in O 0 8.295708548268846e-14
relatives O 0 1.7241275681451063e-12
at O 0 1.9104713470941004e-12
high O 0 9.049028019958438e-12
risk O 0 3.1787576043607046e-11
for O 0 1.8338422550249686e-14
bipolar B-Disease 1 0.9995912909507751
affective I-Disease 0 0.02853136509656906
disorder I-Disease 1 0.873935878276825
among O 0 1.3708593823633358e-14
the O 0 5.2076757890793385e-14
Old O 0 1.456656491427566e-06
Order O 0 4.132657410726992e-11
Amish O 0 4.5823446725989925e-07
. O 0 2.5177767856709998e-11

Bipolar B-Disease 1 0.9998648166656494
affective I-Disease 1 0.9978712797164917
disorder I-Disease 1 0.9998677968978882
( O 0 5.237595601670364e-08
BPAD B-Disease 1 0.9999998807907104
; O 0 5.01516587974038e-05
manic B-Disease 1 0.9999860525131226
- I-Disease 1 0.9999995231628418
depressive I-Disease 1 1.0
illness I-Disease 1 0.9999992847442627
) O 0 3.807521572335437e-12
is O 0 3.543416645171438e-14
characterized O 0 3.5507068205792303e-12
by O 0 1.91172583338217e-15
episodes O 0 6.453417800145189e-09
of O 0 5.50038089890386e-14
mania B-Disease 0 0.0005998753476887941
and O 0 4.533294628572548e-09
/ O 0 4.492649168241769e-05
or O 0 1.3568584623924185e-11
hypomania B-Disease 0 3.011139233422e-05
interspersed O 0 1.3323862049219315e-06
with O 0 9.545034901359273e-12
periods O 0 8.925208350163416e-10
of O 0 7.365841877410295e-14
depression B-Disease 0 9.196825345725301e-08
. O 0 2.649807239948898e-12

Compelling O 0 1.7284162989739116e-10
evidence O 0 1.2534081411663678e-11
supports O 0 7.69891637421305e-13
a O 0 5.571108912329247e-15
significant O 0 3.0753678378588663e-15
genetic O 0 7.226609588517618e-11
component O 0 1.0607930549591527e-12
in O 0 2.6019400325180513e-14
the O 0 1.0073924794394909e-13
susceptibility O 0 5.720817952692414e-08
to O 0 5.5963185474627863e-11
develop O 0 2.759061885626579e-07
BPAD B-Disease 1 0.9999988079071045
. O 0 2.08690620340235e-09

To O 0 3.202547949054946e-10
date O 0 4.935120645477298e-10
, O 0 2.5638861693433324e-12
however O 0 1.2685887496727277e-12
, O 0 1.457197365973672e-14
linkage O 0 2.926185516116675e-08
studies O 0 3.8257810114350477e-11
have O 0 6.301182449083842e-13
attempted O 0 9.320016980396417e-11
only O 0 4.449234492116816e-13
to O 0 1.712910141418028e-13
identify O 0 2.4986882354860462e-11
chromosomal O 0 2.706731356738601e-05
loci O 0 2.363816260786411e-11
that O 0 9.29794713444565e-11
cause O 0 1.0596924449046696e-09
or O 0 9.030803015119826e-12
increase O 0 3.475999696411769e-11
the O 0 5.2474871670149525e-11
risk O 0 6.294177401500178e-10
of O 0 3.849467013189835e-15
developing O 0 5.780077927397542e-08
BPAD B-Disease 1 0.9999996423721313
. O 0 1.7136684293816984e-09

To O 0 6.529615390049592e-12
determine O 0 5.575600744989195e-13
whether O 0 2.9447086858768595e-14
there O 0 3.3735134911255793e-13
could O 0 5.340560892824753e-12
be O 0 1.4513272158909627e-15
protective O 0 9.358234673295662e-13
alleles O 0 2.2117038560830193e-13
that O 0 9.877669428920433e-13
prevent O 0 3.6687922144729157e-10
or O 0 1.3676726418054841e-11
reduce O 0 3.4793330438986914e-09
the O 0 1.8026028586470844e-11
risk O 0 1.8851603611480527e-10
of O 0 4.415134355970215e-16
developing O 0 8.255164551940197e-09
BPAD B-Disease 1 0.9999998807907104
, O 0 6.784880816901318e-13
similar O 0 6.391182918454811e-15
to O 0 8.724855249896395e-15
what O 0 4.6549775583367824e-15
is O 0 1.1039430164750948e-15
observed O 0 1.1823369702994996e-13
in O 0 5.53393898902136e-14
other O 0 5.761868759890376e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 4.05928242408482e-12
we O 0 1.2633172286058425e-09
used O 0 2.110120966847262e-09
mental O 0 3.109277895418927e-05
health O 0 3.825128214174356e-09
wellness O 0 1.0922557969195168e-08
( O 0 6.635282736667039e-14
absence O 0 9.088980653174095e-13
of O 0 9.96873075623586e-16
any O 0 7.266058865695868e-10
psychiatric B-Disease 0 0.07512453943490982
disorder I-Disease 0 2.94724623017828e-06
) O 0 1.6772102564955953e-15
as O 0 7.195404618269216e-14
the O 0 1.7672305676133537e-12
phenotype O 0 2.1708478925575037e-07
in O 0 3.143558330309659e-11
our O 0 6.496202187289413e-11
genome O 0 2.147470118396555e-10
- O 0 1.5147760379363717e-08
wide O 0 9.526179151064795e-11
linkage O 0 1.9646327586997359e-07
scan O 0 5.0468997869757e-07
of O 0 1.515504784722053e-15
several O 0 2.394825907947682e-14
large O 0 4.505841012802936e-12
multigeneration O 0 1.3005970913582132e-06
Old O 0 1.5600420510963886e-06
Order O 0 4.987054606081509e-12
Amish O 0 2.738994808737516e-08
pedigrees O 0 2.731416759438332e-10
exhibiting O 0 9.040603552237791e-13
an O 0 1.4061488078250233e-15
extremely O 0 1.2035140245503229e-11
high O 0 1.2304182672728814e-10
incidence O 0 0.00044651771895587444
of O 0 6.524017437392615e-11
BPAD B-Disease 1 0.9999998807907104
. O 0 1.0020426266521554e-08

We O 0 3.115707659162581e-05
have O 0 4.414437912436675e-11
found O 0 9.590519703265091e-14
strong O 0 6.386695655537613e-16
evidence O 0 1.755129177302521e-14
for O 0 3.257812130487432e-17
a O 0 1.5732156381656828e-14
locus O 0 3.811716220436523e-11
on O 0 1.0395609928437466e-09
chromosome O 0 1.0082975677505601e-05
4p O 0 2.4673967757848914e-08
at O 0 3.4447267087400757e-12
D4S2949 O 0 1.6140099673433994e-11
( O 0 1.017768425520284e-15
maximum O 0 1.20249108589922e-14
GENEHUNTER O 0 5.289778837180847e-09
- O 0 1.5593162316918097e-09
PLUS O 0 8.085665383766871e-13
nonparametric O 0 7.208441621386896e-10
linkage O 0 4.6603602754657913e-07
score O 0 2.3334566279231694e-08
= O 0 2.6502509076209435e-09
4 O 0 8.636944241399713e-13
. O 0 4.63624805051039e-14
05 O 0 5.279366721566703e-09
, O 0 3.742098211162448e-12
P O 0 2.049181148322532e-06
= O 0 6.071509073279913e-09
5 O 0 1.8014666906644716e-13
. O 0 7.446497879307155e-15
22 O 0 9.748746948590181e-13
x O 0 7.825827985641354e-09
10 O 0 8.600880424536328e-12
( O 0 1.0195413713580057e-13
- O 0 7.195796314363179e-08
4 O 0 6.15324718261645e-12
) O 0 6.1818001855418105e-15
; O 0 4.316826759199815e-15
SIBPAL O 0 6.890604059561767e-11
Pempirical O 0 3.734214326645002e-11
value O 0 7.919350633980079e-15
< O 0 1.2837439444801646e-11
3 O 0 1.6507501745741116e-12
x O 0 4.6253365582060724e-08
10 O 0 1.3002123683270028e-11
( O 0 2.3839532236301364e-13
- O 0 8.855709410227064e-08
5 O 0 4.869550943031875e-12
) O 0 6.758860439100116e-15
) O 0 1.4600677488736799e-15
and O 0 1.0225010738823016e-14
suggestive O 0 3.598261966164529e-11
evidence O 0 3.520553802909693e-13
for O 0 3.99007906170592e-17
a O 0 9.608550324206704e-15
locus O 0 2.3324476031150176e-11
on O 0 1.946464989188712e-09
chromosome O 0 0.00011980220006080344
4q O 0 3.828002718364587e-06
at O 0 2.1283325796206398e-11
D4S397 O 0 2.6803125691143848e-11
( O 0 1.4205440268844917e-15
maximum O 0 5.0234102088545646e-15
GENEHUNTER O 0 8.872561352291086e-09
- O 0 5.168125372101429e-10
PLUS O 0 5.661955821724407e-13
nonparametric O 0 7.146004343816514e-10
linkage O 0 1.1896491969309864e-07
score O 0 2.373691465606953e-08
= O 0 1.2208064559260379e-09
3 O 0 1.7474074216674435e-13
. O 0 2.1255219467635443e-14
29 O 0 6.354281684162189e-11
, O 0 2.1933301529164506e-12
P O 0 4.991155492461985e-06
= O 0 1.9335140155618546e-09
2 O 0 2.6236345452949894e-13
. O 0 6.4833655141044964e-15
57 O 0 6.0050584296811316e-12
x O 0 1.5325381852449027e-08
10 O 0 3.720384677413646e-12
( O 0 2.5097464254400514e-14
- O 0 1.6587639706244772e-08
3 O 0 1.2912109532622895e-12
) O 0 2.8842837694636374e-15
; O 0 1.5404866450727792e-15
SIBPAL O 0 7.237092175538251e-11
Pempirical O 0 5.279744003106046e-11
value O 0 2.063759141810134e-15
< O 0 2.9847697664148187e-12
1 O 0 5.22561811530653e-13
x O 0 1.0782243720086626e-07
10 O 0 1.206886240251448e-11
( O 0 4.112994124970404e-13
- O 0 5.13303973548318e-07
3 O 0 3.561126393769598e-11
) O 0 1.1436668499980717e-14
) O 0 6.245129450876226e-16
that O 0 9.097158417466656e-15
are O 0 5.3285364639275076e-15
linked O 0 1.528742998857524e-08
to O 0 1.9199232481614814e-10
mental O 0 4.510038252192317e-06
health O 0 7.027598503128729e-10
wellness O 0 4.478013337916309e-08
. O 0 2.651728663038977e-12

These O 0 2.8214774960844125e-10
findings O 0 2.7764526788764954e-10
are O 0 4.2612662259477324e-14
consistent O 0 1.3970829701448473e-12
with O 0 3.7285272254643925e-15
the O 0 2.2813428477184506e-15
hypothesis O 0 1.6613443476823364e-12
that O 0 3.0884629142838586e-16
certain O 0 5.653357823210889e-16
alleles O 0 1.8616884292846358e-13
could O 0 8.946184071323415e-11
prevent O 0 1.551666087284964e-11
or O 0 4.476166345131899e-13
modify O 0 5.8975881955802834e-08
the O 0 9.236959287728386e-12
clinical O 0 8.447964994218182e-09
manifestations O 0 1.2594456033632184e-10
of O 0 4.3065182496471177e-13
BPAD B-Disease 1 1.0
and O 0 1.0472148703755124e-09
perhaps O 0 9.171310222768139e-14
other O 0 3.3961467535773004e-14
related O 0 1.9189065891822565e-09
affective B-Disease 0 0.0004476466274354607
disorders I-Disease 0 0.0768483430147171
. O 0 3.746249144231939e-11

Segregation O 0 2.2737654944648966e-05
distortion O 0 9.318729325968889e-07
in O 0 1.4786474267225458e-09
myotonic B-Disease 1 0.9999951124191284
dystrophy I-Disease 1 0.9999983310699463
. O 0 6.324265555690545e-09

Myotonic B-Disease 1 0.9999951124191284
dystrophy I-Disease 1 0.9999995231628418
( O 0 7.6248433344972e-08
DM B-Disease 1 1.0
) O 0 4.851905988090266e-09
is O 0 7.760621138774848e-12
an O 0 2.9850317096596912e-12
autosomal B-Disease 1 0.9999972581863403
dominant I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
which O 0 1.077060929333129e-07
, O 0 3.917276572562578e-11
in O 0 1.3096616076780504e-13
the O 0 1.8889149142400918e-13
typical O 0 4.112543292023041e-11
pedigree O 0 1.818462158631462e-09
, O 0 9.660665720352419e-15
shows O 0 8.650458143853387e-14
a O 0 2.3556286959838368e-15
three O 0 1.4060610552116878e-14
generation O 0 1.9856353703200796e-13
anticipation O 0 6.25722550487949e-14
cascade O 0 8.68426663913624e-10
. O 0 6.89226037353663e-11

This O 0 2.1814584860724295e-10
results O 0 8.340625967662163e-10
in O 0 4.935174491293992e-11
infertility B-Disease 1 0.9999009370803833
and O 0 8.618339779786766e-05
congenital B-Disease 1 0.9999994039535522
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.3304889412424359e-09
CDM B-Disease 0 4.043666592679074e-07
) O 0 1.9333625954527645e-13
with O 0 2.564250115683845e-14
the O 0 9.31264681797335e-14
disappearance O 0 2.5194748509704823e-09
of O 0 2.6353452840105485e-13
DM B-Disease 1 1.0
in O 0 4.662451327797079e-11
that O 0 1.896121801236994e-11
pedigree O 0 7.3138939349348675e-09
. O 0 7.744277766806584e-13

The O 0 4.887031534658859e-13
concept O 0 7.636361839093511e-14
of O 0 3.079745357069836e-16
segregation O 0 2.0370665154700873e-09
distortion O 0 8.85615261680961e-11
, O 0 1.1038957562718027e-13
where O 0 3.241808405919644e-13
there O 0 1.8284591065352834e-15
is O 0 9.73208100042934e-17
preferential O 0 1.1346938064713333e-13
transmission O 0 4.4333578474997637e-10
of O 0 5.653934583164798e-18
the O 0 1.0882421225972134e-16
larger O 0 2.7290042072653214e-15
allele O 0 2.2869304106692967e-13
at O 0 1.656762184040761e-12
the O 0 6.196704390934449e-13
DM B-Disease 1 0.9999998807907104
locus O 0 5.988973317272439e-09
, O 0 1.482300671096226e-10
has O 0 1.716000563867226e-09
been O 0 4.5519619323863836e-11
put O 0 2.458310444097833e-09
forward O 0 1.5864401806120476e-11
to O 0 2.691708889199923e-13
explain O 0 1.0583386250706539e-10
partially O 0 3.578429219608381e-10
the O 0 4.488838927875548e-16
maintenance O 0 2.419420046251286e-11
of O 0 1.2623650497319006e-14
DM B-Disease 1 1.0
in O 0 4.823233132333904e-11
the O 0 2.376734605565728e-13
population O 0 2.1997976899258698e-13
. O 0 1.879973173662952e-12

In O 0 3.642807843567963e-12
a O 0 2.6279266306453164e-13
survey O 0 6.8840584274698635e-12
of O 0 1.2066673606698337e-15
DM B-Disease 1 1.0
in O 0 2.940684917795977e-10
Northern O 0 0.0001234914525412023
Ireland O 0 3.068751937007619e-07
, O 0 4.3499166942073675e-13
59 O 0 9.749328080954633e-12
pedigrees O 0 5.341959513627259e-11
were O 0 6.49340607325466e-14
ascertained O 0 2.0565384117876562e-10
. O 0 1.3546571633535343e-12

Sibships O 0 1.9034063143408275e-06
where O 0 1.2020395789846816e-10
the O 0 8.450002375874795e-15
status O 0 9.904699131181582e-14
of O 0 2.7184670115223595e-16
all O 0 1.3351562151882324e-13
the O 0 5.4403524362616005e-15
members O 0 2.0398782125326015e-16
had O 0 3.797389919873995e-12
been O 0 9.274920139909233e-15
identified O 0 1.5722925077784472e-13
were O 0 1.5971117505087949e-15
examined O 0 4.0511843012180915e-12
to O 0 1.631758574425048e-15
determine O 0 3.810954373253961e-14
the O 0 3.4300207446324787e-16
transmission O 0 1.1111075393088754e-09
of O 0 6.52586343346929e-17
the O 0 6.270059883621559e-13
DM B-Disease 1 0.9999998807907104
expansion O 0 7.21721848950807e-10
from O 0 2.6791074445183492e-14
affected O 0 3.570130649444003e-11
parents O 0 1.7783823458988879e-12
to O 0 5.748133631404417e-14
their O 0 4.201174998164081e-14
offspring O 0 2.6892622243673836e-12
. O 0 4.220203288392288e-13

Where O 0 7.57582385713107e-10
the O 0 6.33342391118813e-14
transmitting O 0 2.5539965697873868e-09
parent O 0 1.1808158895121323e-09
was O 0 1.2261036630434319e-09
male O 0 6.376681821462782e-11
, O 0 5.288083339272109e-13
58 O 0 1.782568981312238e-09
. O 0 7.665380483135031e-12

3 O 0 1.7301975130390446e-10
% O 0 2.5870449581405844e-14
of O 0 2.33040495478711e-16
the O 0 2.7907301578151966e-13
offspring O 0 9.305749747168246e-12
were O 0 5.428823623282453e-12
affected O 0 1.43988834744313e-10
, O 0 1.8443087335118236e-11
and O 0 8.387839901813354e-12
in O 0 3.5678975914129815e-15
the O 0 1.7194746594647431e-15
case O 0 2.413485806606469e-13
of O 0 4.557784200321271e-18
a O 0 2.435785676890151e-13
female O 0 3.9321861738939035e-12
transmitting O 0 1.2217382661106058e-09
parent O 0 3.959925165553102e-10
, O 0 1.5783386967185842e-12
68 O 0 1.0001523165215076e-08
. O 0 1.195697967720788e-11

7 O 0 9.041277060362063e-09
% O 0 9.230878865104652e-13
were O 0 3.008202627968748e-12
affected O 0 2.1467125299601264e-10
. O 0 5.503883807045362e-11

Studies O 0 1.608225219662529e-09
on O 0 6.165814928939251e-13
meiotic O 0 1.7747221470187924e-09
drive O 0 1.01189163714821e-08
in O 0 2.347339553634975e-12
DM B-Disease 1 1.0
have O 0 1.5540498665700397e-08
shown O 0 2.5541279703202024e-13
increased O 0 2.3123250682917026e-14
transmission O 0 1.512327263419877e-09
of O 0 2.254013898775552e-17
the O 0 1.7956046308052e-16
larger O 0 5.821836170430677e-15
allele O 0 1.444182230400659e-13
at O 0 3.0626349980383827e-12
the O 0 6.282054412255766e-13
DM B-Disease 1 0.9999995231628418
locus O 0 4.781241624840504e-09
in O 0 5.897306514651701e-12
non O 0 6.706612487583641e-10
- O 0 0.0014007262652739882
DM O 1 0.9999990463256836
heterozygotes O 0 1.983875996813822e-08
for O 0 1.3848092865562794e-13
CTGn O 0 2.404450185622409e-07
. O 0 6.634441260255919e-12

This O 0 1.8601429424558447e-11
study O 0 1.844961222642258e-13
provides O 0 1.809419499946901e-15
further O 0 3.7718593134635544e-15
evidence O 0 5.407766655264254e-14
that O 0 2.550411969017962e-14
the O 0 2.150545231260556e-13
DM B-Disease 1 1.0
expansion O 0 3.466310571909048e-09
tends O 0 1.2044859554194431e-10
to O 0 1.6772526293187817e-14
be O 0 1.9731490204753788e-14
transmitted O 0 1.0568741715122343e-10
preferentially O 0 8.007920715424888e-11
. O 0 5.646407820469879e-12

Diagnosis O 1 0.8345025181770325
of O 0 2.37991348850386e-10
hemochromatosis B-Disease 1 0.9999996423721313
. O 0 1.1680887723741762e-07

If O 0 2.7084277007816127e-06
untreated O 0 2.0571369532262906e-05
, O 0 1.3528975162380164e-10
hemochromatosis B-Disease 1 1.0
can O 0 0.0017047874862328172
cause O 0 7.496771559090121e-07
serious O 0 1.0059214218927082e-05
illness O 1 0.9827750325202942
and O 0 2.093139828129864e-10
early B-Disease 0 6.697409293821011e-10
death I-Disease 0 3.846484464276045e-09
, O 0 1.4636257483768844e-11
but O 0 1.3305219148662673e-09
the O 0 3.2142101480392427e-11
disease O 0 0.00014072466001380235
is O 0 7.708923018164004e-13
still O 0 2.7879362707317057e-10
substantially O 0 1.441041348471117e-07
under O 0 5.325464069727559e-09
- O 1 0.9141883850097656
diagnosed O 0 0.0015745763666927814
. O 0 1.0051478746553322e-11

The O 0 4.168499313089713e-13
cornerstone O 0 2.318641697911239e-13
of O 0 1.907207673614732e-17
screening O 0 1.7624112239045253e-11
and O 0 4.064343178282253e-15
case O 0 7.580459528047211e-15
detection O 0 6.120003050343048e-13
is O 0 3.0221367934424987e-16
the O 0 3.8595056241642195e-17
measurement O 0 4.066037870981143e-13
of O 0 7.953978187896782e-17
serum O 0 1.3945703966622425e-11
transferrin O 0 5.421911183911554e-12
saturation O 0 2.164415001393305e-11
and O 0 9.145780487107569e-12
the O 0 2.423999857174147e-13
serum O 0 2.8758315173682547e-10
ferritin O 0 2.172748736484209e-08
level O 0 3.3828098655597216e-10
. O 0 1.4619794957981824e-11

Once O 0 2.9866413342460874e-07
the O 0 9.63237844521514e-13
diagnosis O 0 5.78856145239115e-07
is O 0 5.372070145768116e-15
suspected O 0 4.3484407186156204e-09
, O 0 3.911508703741129e-13
physicians O 0 6.891122329884258e-13
must O 0 1.6594179101572099e-13
use O 0 8.254738581049692e-13
serum O 0 6.370767913210784e-09
ferritin O 0 2.212088475062046e-06
levels O 0 1.3879827065466088e-07
and O 0 6.528965812435672e-09
hepatic O 0 0.00035177412792108953
iron O 0 0.018333300948143005
stores O 0 4.965172138327034e-06
on O 0 1.87468476298136e-08
liver O 0 1.8263087042669213e-07
biopsy O 0 1.1152641263834084e-06
specimens O 0 2.2760612838901295e-12
to O 0 2.1030760818810737e-14
assess O 0 7.965769016626822e-11
patients O 0 1.314903481236529e-12
for O 0 2.375895487876668e-17
the O 0 4.015674359198916e-15
presence O 0 1.802265801875702e-11
of O 0 4.297244119788948e-14
iron B-Disease 0 0.0006009571952745318
overload I-Disease 0 1.5120334865059704e-05
. O 0 4.962585550827292e-11

Liver O 1 0.9984979629516602
biopsy O 1 0.9981826543807983
is O 0 4.833114464197763e-11
also O 0 4.686459120079034e-12
used O 0 5.682276264101782e-12
to O 0 3.6057607095442423e-13
establish O 0 1.96239170746626e-11
the O 0 7.840703455420928e-14
presence O 0 2.353317540837452e-10
or O 0 7.306050903155281e-11
absence O 0 1.815459067799896e-11
of O 0 5.373484267273557e-15
cirrhosis B-Disease 0 4.73397558380384e-05
, O 0 1.6252823739626443e-11
which O 0 4.662462638194143e-10
can O 0 1.615765121698587e-08
affect O 0 3.2538721939090465e-07
prognosis O 0 2.5797959096962586e-05
and O 0 7.907725689537681e-12
management O 0 7.646853289466904e-11
. O 0 1.0808223890532154e-12

A O 0 1.0402065493686496e-11
DNA O 0 3.4019578265542805e-09
- O 0 5.286112172986357e-11
based O 0 3.4906376834148434e-14
test O 0 1.1475291203377758e-12
for O 0 5.819362847459584e-18
the O 0 4.574335786593437e-16
HFE O 0 8.303328691283696e-09
gene O 0 2.908121521372209e-10
is O 0 3.4698986322727375e-15
commercially O 0 1.5643885384157563e-14
available O 0 2.8760135007029064e-13
, O 0 1.4975545109541244e-11
but O 0 2.595560988361001e-10
its O 0 8.045078953066234e-14
place O 0 4.5550041516406736e-10
in O 0 5.574757506749545e-14
the O 0 1.2934409945007663e-13
diagnosis O 0 6.891835369060573e-07
of O 0 8.04133184871417e-15
hemochromatosis B-Disease 1 1.0
is O 0 4.89109126533549e-08
still O 0 7.569421478503813e-11
being O 0 2.4262894211118935e-13
evaluated O 0 1.8251039568539795e-11
. O 0 3.133456222357417e-13

Currently O 0 5.149462189990572e-09
, O 0 8.167878808203188e-13
the O 0 1.625118047876811e-15
most O 0 1.7865918362869447e-17
useful O 0 1.4445003420943299e-15
role O 0 2.475421601098697e-14
for O 0 1.7388069688759609e-16
this O 0 7.75800441005529e-15
test O 0 2.5959559155075418e-11
is O 0 5.4163674013408945e-17
in O 0 1.367478031470108e-17
the O 0 1.782915183900269e-17
detection O 0 8.242514201554918e-13
of O 0 3.8002099297246295e-15
hemochromatosis B-Disease 1 1.0
in O 0 2.5778308376800396e-09
the O 0 1.3402451023991624e-11
family O 0 6.967703324034513e-12
members O 0 8.990649238896009e-17
of O 0 1.0936766992216868e-17
patients O 0 8.749923528783565e-14
with O 0 5.565367775952316e-17
a O 0 1.3780555201733241e-14
proven O 0 9.229223288387267e-13
case O 0 2.1371168452532369e-13
of O 0 7.182837275134099e-16
the O 0 1.1457106097179093e-10
disease O 0 1.1935159818676766e-05
. O 0 2.160198886089204e-12

It O 0 1.0087265051028638e-10
is O 0 2.96246554576992e-14
crucial O 0 2.264318290159939e-12
to O 0 1.4217476154709807e-11
diagnose O 1 0.9992183446884155
hemochromatosis B-Disease 1 1.0
before O 0 0.00038555459468625486
hepatic B-Disease 1 0.9997934699058533
cirrhosis I-Disease 1 0.9996156692504883
develops O 0 8.182077181118075e-06
because O 0 1.946334066138533e-10
phlebotomy O 0 0.009270746260881424
therapy O 0 5.7533128710929304e-05
can O 0 2.8523659878487706e-08
avert O 0 1.297341555073217e-06
serious O 0 0.00018964217451866716
chronic O 1 0.9999992847442627
disease O 1 0.9999997615814209
and O 0 1.0671312367094288e-07
can O 0 3.4340121146669844e-07
even O 0 1.1500358887417406e-08
lead O 0 5.109789526613895e-06
to O 0 5.2706079084474666e-11
normal O 0 7.13179248990059e-09
life O 0 2.0260802757743335e-10
expectancy O 0 4.926839380914316e-08
. O 0 4.555681325886171e-14
. O 0 6.026224441332828e-13

Prevalence O 0 0.002845810493454337
of O 0 7.729177676574564e-14
the O 0 1.349678967763404e-13
I1307K O 0 8.975363785523882e-10
APC B-Disease 0 6.562982102220616e-11
gene O 0 8.10005881812792e-11
variant O 0 1.8401817847291113e-09
in O 0 6.644743078248333e-14
Israeli O 0 4.285615862187342e-09
Jews O 0 3.094778990367364e-12
of O 0 1.8203007697374607e-17
differing O 0 1.0018943716382043e-14
ethnic O 0 4.7125250750290615e-12
origin O 0 1.452584038295901e-12
and O 0 4.085118354701933e-11
risk O 0 1.6151710177658707e-11
for O 0 3.2677966235739042e-12
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.728683000720935e-10

BACKGROUND O 0 0.0001259396376553923
& O 0 1.1606725820456631e-06
AIMS O 0 4.297449895940275e-10
Israeli O 0 1.743964750389182e-09
Jews O 0 8.201295198517755e-11
of O 0 5.220654027897169e-14
European O 0 4.0648364674211734e-09
birth O 0 7.268245033609233e-11
, O 0 2.376808168683131e-12
i O 0 9.654469224074091e-09
. O 0 1.850916067549363e-15
e O 0 2.662480018357158e-14
. O 0 1.415038100969102e-15
, O 0 3.353263889501715e-15
Ashkenazim O 0 2.6018399240657075e-11
, O 0 6.381490659252559e-14
have O 0 4.505875273591586e-12
the O 0 3.2017509303539082e-12
highest O 0 5.687730890713283e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.20849256217479706
of O 0 1.1537013952143092e-14
any O 0 5.422461785142829e-11
Israeli O 0 8.400396473007277e-05
ethnic O 0 5.819025545861223e-07
group O 0 1.0046108833705603e-08
. O 0 9.196491658480799e-12

The O 0 1.8031151224895403e-11
I1307K O 0 1.2141280203437077e-09
APC B-Disease 0 6.814392800036373e-11
gene O 0 5.218972476406236e-10
variant O 0 2.523165676393546e-06
was O 0 9.532881506402191e-08
found O 0 7.358554876546464e-10
in O 0 4.112235291869881e-12
6 O 0 7.981429916981142e-08
. O 0 2.875908122756954e-10

1 O 0 3.444912410888179e-11
% O 0 1.3058395239694959e-14
of O 0 1.8799755643605062e-17
American O 0 1.4467793011795765e-13
Jews O 0 5.881445070549107e-12
, O 0 1.067254791486949e-12
28 O 0 1.9871101292201487e-12
% O 0 7.945608443586725e-17
of O 0 9.408973665254287e-17
their O 0 2.2038255664824646e-09
familial O 1 0.9999890327453613
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 3.9979133248380094e-07
, O 0 5.716808693101427e-10
but O 0 3.216140598283346e-08
not O 0 8.752679137025154e-10
in O 0 1.3864559186057418e-13
non O 0 7.169520185867917e-12
- O 0 3.0599785816320946e-08
Jews O 0 8.677689122826848e-11
. O 0 9.439411058353997e-12

We O 0 5.388906654246739e-09
assessed O 0 1.7239862966020314e-12
the O 0 4.81838012414762e-14
I1307K O 0 7.486505859688464e-10
prevalence O 0 7.437225946205217e-08
in O 0 1.4190336189087716e-14
Israeli O 0 6.337496638586515e-10
Jews O 0 7.447343523120376e-13
of O 0 2.9081668560282075e-17
differing O 0 1.4637715274904914e-14
ethnic O 0 4.7709405870399735e-12
origin O 0 4.574101080540016e-12
and O 0 3.032295248228678e-11
risk O 0 1.0404882684611483e-11
for O 0 3.838109517706467e-12
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.157808181608601e-10

METHODS O 0 5.440926598154761e-10
DNA O 0 2.0849089121810493e-09
samples O 0 7.791823284676591e-13
from O 0 8.842854397309322e-18
500 O 0 2.6700294324336223e-16
unrelated O 0 2.388413631367742e-13
Jews O 0 7.435272536548965e-11
of O 0 9.786953419996941e-14
European O 0 1.917217318236908e-08
or O 0 7.855906029863302e-12
non O 0 7.650277980553177e-12
- O 0 2.505445593214972e-07
European O 0 9.242780846241416e-11
origin O 0 1.7721503043775962e-14
, O 0 2.414336295448148e-14
with O 0 5.5627842725236316e-15
or O 0 1.6278426564065966e-14
without O 0 1.196911870458069e-15
a O 0 6.03573972994141e-16
personal O 0 1.1287921552333158e-13
and O 0 3.045616536745399e-10
/ O 0 1.6742917068768293e-05
or O 0 6.987536937952399e-11
family O 0 3.733275910633438e-10
history O 0 5.261706001458144e-12
of O 0 8.077232069634123e-17
neoplasia B-Disease 0 5.809341896423348e-09
, O 0 4.836060480024884e-13
were O 0 9.781131254330694e-14
examined O 0 1.0978899733782299e-10
for O 0 1.2619976968366323e-16
the O 0 9.563785479977261e-16
I1307K O 0 9.880160925512804e-12
variant O 0 1.6422686127670616e-11
by O 0 3.1387393489615257e-16
the O 0 1.343923332299999e-15
allele O 0 1.0491966453626822e-12
- O 0 3.392638114885216e-10
specific O 0 1.8188747762711704e-13
oligonucleotide O 0 3.484606159176451e-09
( O 0 6.051426178731167e-13
ASO O 0 3.5640812257042853e-07
) O 0 3.329970441100574e-14
method O 0 3.748449033807999e-12
. O 0 2.1604133412789217e-12

RESULTS O 0 7.484442932081947e-08
In O 0 3.43503268093303e-14
persons O 0 9.686792451610478e-15
at O 0 2.4821329887292354e-12
average O 0 2.601052151440797e-10
risk O 0 9.95850335527848e-09
for O 0 2.4846958268653907e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 5.7023871735673026e-11
I1307K O 0 5.83122261588187e-09
was O 0 3.4355704392474706e-10
found O 0 3.3805941986736476e-12
in O 0 5.103181738947901e-14
5 O 0 3.8180465733450575e-11
. O 0 5.072269861072787e-12

0 O 0 9.008949142241818e-09
% O 0 8.477594982351372e-14
of O 0 4.121421975740642e-16
120 O 0 7.237700022644233e-11
European O 0 5.057052998580502e-09
and O 0 2.8554006381575903e-10
1 O 0 2.7099836263921873e-11
. O 0 4.908735744268977e-12

6 O 0 6.057859547325961e-09
% O 0 9.408054576273e-14
of O 0 6.002354985116566e-16
188 O 0 1.6068162425608712e-11
non O 0 2.5925811844573765e-11
- O 0 3.2288012334902305e-06
European O 0 3.2177083220119584e-10
Jews O 0 4.0687411773099313e-11
( O 0 1.1131634893371545e-12
P O 0 5.648741534969304e-06
= O 0 2.2779158115326936e-08
0 O 0 2.8163023128857656e-12
. O 0 2.0286127378615904e-14
08 O 0 1.0791065306950398e-12
) O 0 1.1358668623999858e-14
. O 0 3.5368282196197864e-13

It O 0 9.973343262359435e-10
occurred O 0 1.6120456081125667e-09
in O 0 1.6689850456524935e-13
15 O 0 1.929923408583445e-11
. O 0 3.0718843267718565e-12

4 O 0 1.1919717435304733e-09
% O 0 3.84734765205251e-14
of O 0 6.803894851565022e-16
52 O 0 2.073859306506165e-09
Ashkenazi O 0 3.1136364668782335e-06
Israelis O 0 1.9119046612559032e-07
with O 0 6.991510148601776e-11
familial O 0 0.0012763742124661803
cancer B-Disease 0 0.06480009108781815
( O 0 1.4364203403116615e-11
P O 0 0.2499246597290039
= O 0 9.507885988568887e-05
0 O 0 4.090018101976511e-09
. O 0 2.2072378647042257e-12
02 O 0 5.04631725295468e-10
) O 0 2.6777842096481486e-14
and O 0 6.076257661087603e-13
was O 0 3.585478094980665e-11
not O 0 8.127215046782599e-12
detected O 0 2.2330008064841422e-08
in O 0 6.455731674064047e-13
51 O 0 2.797452403058287e-08
non O 0 2.076620125857076e-11
- O 0 4.323343603118701e-07
European O 0 1.4194877911988257e-11
Jews O 0 3.8099826570568707e-13
at O 0 7.981775505296052e-13
increased O 0 2.140594819455277e-11
cancer B-Disease 0 1.8573446780578706e-08
risk O 0 1.6873691680019398e-11
. O 0 9.877255263690543e-13

Colorectal B-Disease 0 0.009486107155680656
neoplasia I-Disease 0 0.0006610850687138736
occurred O 0 3.1780459721630905e-06
personally O 0 8.770334147811809e-08
or O 0 5.560676918925367e-10
in O 0 8.794874550854814e-12
the O 0 1.2500394816483684e-11
families O 0 5.042672551226757e-13
of O 0 8.480643686862601e-16
13 O 0 4.152883766039839e-12
of O 0 1.7424721069085098e-16
20 O 0 9.746180642047908e-13
Ashkenazi O 0 3.9848599420189146e-10
I1307K O 0 8.927769981625922e-12
carriers O 0 2.450324014871552e-13
, O 0 3.7764608199495134e-14
8 O 0 4.1600007943606854e-13
of O 0 3.654888933887182e-16
whom O 0 5.497738375659367e-10
also O 0 2.942196886124293e-08
had O 0 1.7110116345975257e-07
a O 0 1.2295021771524528e-12
personal O 0 2.4243582835703492e-11
or O 0 2.390741771218785e-10
family O 0 1.835021717910834e-10
history O 0 2.4945249858798757e-12
of O 0 1.2000623883295577e-14
noncolonic O 0 7.705656571488362e-06
neoplasia B-Disease 0 5.984311428619549e-06
. O 0 1.7379933603400843e-10

CONCLUSIONS O 0 1.6465964591816373e-08
The O 0 1.4291557303910962e-12
I1307K O 0 5.941411806986707e-10
APC O 0 8.174869808863505e-11
variant O 0 3.314487173611269e-08
may O 0 2.413741428952676e-11
represent O 0 9.379412877139602e-16
a O 0 6.082295582986175e-14
susceptibility O 0 2.917729391427315e-09
gene O 0 3.4067969778561746e-08
for O 0 7.171106156805829e-12
colorectal B-Disease 1 1.0
, I-Disease 0 3.251297187034652e-08
or I-Disease 0 2.6083951665256677e-10
other I-Disease 0 4.42260672528505e-10
, I-Disease 0 4.020133914650614e-08
cancers I-Disease 0 0.05686688423156738
in O 0 7.711584734497456e-13
Ashkenazi O 0 2.914188144131913e-06
Jews O 0 7.555552627991347e-09
, O 0 1.6438153060960303e-09
and O 0 8.258893013923796e-10
partially O 0 4.507053219526824e-08
explains O 0 7.264673307361136e-10
the O 0 2.8136577811567476e-14
higher O 0 1.5663837414636728e-13
incidence O 0 5.308110121404752e-05
of O 0 1.358093584258313e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.2201858407289166e-10
European O 0 9.697724845381117e-10
Israelis O 0 2.3121907943846054e-08
. O 0 1.2302440316469543e-11

Systematic O 0 2.381354224922916e-09
analysis O 0 9.43203241204893e-12
of O 0 4.847081666158742e-15
coproporphyrinogen O 0 4.843198553317052e-07
oxidase O 0 5.911648258916102e-06
gene O 0 0.0005529209156520665
defects O 1 0.9811210036277771
in O 0 2.6203064024121758e-11
hereditary B-Disease 1 0.8964624404907227
coproporphyria I-Disease 0 0.00932223442941904
and O 0 1.6260004453982901e-09
mutation O 0 1.7303840138538362e-08
update O 0 1.7640374494476418e-07
. O 0 1.3511826379986047e-10

Hereditary B-Disease 1 0.9988928437232971
coproporphyria I-Disease 0 0.0100979283452034
( O 0 5.346638409786664e-11
HC B-Disease 0 0.002707365434616804
) O 0 1.6050068218920188e-10
is O 0 2.4674965196092025e-11
an O 0 3.812559642990543e-11
acute O 1 0.9604111909866333
hepatic B-Disease 1 0.9999945163726807
porphyria I-Disease 1 0.9999991655349731
with O 0 2.7204470825381577e-05
autosomal O 1 0.9999877214431763
dominant O 1 0.9957922697067261
inheritance O 0 0.00011931334302062169
caused O 0 2.734813961069449e-06
by O 0 4.653873315364765e-13
deficient B-Disease 0 3.6338121844892157e-06
activity I-Disease 0 1.6910009503767753e-10
of I-Disease 0 8.615743006729938e-15
coproporphyrinogen I-Disease 0 2.953853027065634e-06
III I-Disease 0 1.5496934224756842e-07
oxidase I-Disease 0 2.0421315749530322e-09
( O 0 1.086607339479892e-13
CPO O 0 1.1184693171628624e-08
) O 0 8.316657367120339e-13
. O 0 1.6418449716101846e-12

Clinical O 0 2.056023004115559e-05
manifestations O 0 3.0499681002993384e-08
of O 0 3.7695760683915946e-13
the O 0 6.044514333503059e-10
disease O 0 0.020040413364768028
are O 0 2.1368262790710107e-14
characterized O 0 1.47880180323412e-10
by O 0 1.5799400633273453e-13
acute O 0 2.0895474790449953e-06
attacks O 0 0.0012885425239801407
of O 0 4.710678513930588e-10
neurological B-Disease 1 0.9999977350234985
dysfunction I-Disease 0 0.0002621705934870988
often O 0 1.7764305651479795e-11
precipitated O 0 2.639637857251853e-12
by O 0 6.076770005906409e-16
drugs O 0 2.8714545931979307e-12
, O 0 6.695939104833099e-14
fasting O 0 2.0377290133044568e-11
, O 0 2.1295931598025453e-13
cyclical O 0 1.5812170772733225e-07
hormonal O 0 1.7449437450522964e-08
changes O 0 2.4525301234312735e-10
, O 0 1.5598560637597458e-11
or O 0 5.991758200707409e-10
infectious B-Disease 0 0.0032746754586696625
diseases I-Disease 0 0.008729925379157066
. O 0 1.2001563631791612e-10

Skin O 1 0.9999899864196777
photosensitivity O 1 0.9998152852058411
may O 0 2.2466376321972348e-05
also O 0 7.149235647929686e-10
be O 0 1.2714908336278197e-12
present O 0 1.8702381223562048e-12
. O 0 6.521031631345764e-11

The O 0 3.1846743991925663e-11
seven O 0 9.217151645873542e-14
exons O 0 1.0078893449005921e-11
, O 0 4.5095220960189586e-15
the O 0 2.5310882358153353e-16
exon O 0 1.5041624890077543e-10
/ O 0 2.4565131298004417e-06
intron O 0 4.4071734009776264e-05
boundaries O 0 2.1037716578575782e-05
and O 0 1.7025351961574842e-10
part O 0 3.485888877899357e-13
of O 0 1.0471876797234388e-15
3 O 0 7.857339995656631e-13
noncoding O 0 1.8915506938554927e-09
sequence O 0 2.329412218671223e-10
of O 0 3.428293856211264e-16
the O 0 1.879075169661064e-14
CPO O 0 9.174867976469159e-09
gene O 0 3.868385611838221e-10
were O 0 2.878384108753046e-13
systematically O 0 2.832812318054323e-10
analyzed O 0 1.9713068254590543e-13
by O 0 6.497443741009622e-18
an O 0 2.775107203078387e-18
exon O 0 1.892175652273842e-12
- O 0 9.706681014520768e-10
by O 0 2.0095653385700935e-14
- O 0 9.705237724588756e-10
exon O 0 8.615473667816786e-09
denaturing O 0 6.225177912710933e-06
gradient O 0 1.589016740410898e-08
gel O 0 4.602719343438366e-07
electrophoresis O 0 5.432405192351553e-09
( O 0 1.0109302988909469e-13
DGGE O 0 7.923238176665848e-10
) O 0 3.8854814141510777e-14
strategy O 0 3.6652546774561257e-13
followed O 0 1.3271012579675287e-15
by O 0 1.957453850025592e-18
direct O 0 6.447649205213216e-16
sequencing O 0 1.9232906933730476e-11
in O 0 4.5485096673283584e-14
seven O 0 6.414588912123653e-13
unrelated O 0 2.468089621565639e-11
heterozygous O 0 1.4370794554352528e-09
HC B-Disease 0 1.2924974726047367e-05
patients O 0 1.0758167690028131e-07
from O 0 2.185853359209719e-13
France O 0 1.5044850442791358e-05
, O 0 7.340118096665904e-11
Holland O 0 6.680906153633259e-06
, O 0 3.907426118776591e-11
and O 0 1.9888410363044784e-10
Czech O 0 0.005727324169129133
Republic O 0 8.45046486119827e-07
. O 0 3.170602946855894e-10

Seven O 0 1.1490989271223384e-09
novel O 0 1.6747019049301315e-10
mutations O 0 8.478138369127919e-08
and O 0 3.1855173880657173e-12
two O 0 7.928236856629724e-15
new O 0 3.792637455176176e-14
polymorphisms O 0 4.948901288770458e-10
were O 0 1.2988830930954487e-12
detected O 0 9.237290932162523e-09
. O 0 2.7054750800781235e-11

Among O 0 7.69211361273392e-11
these O 0 1.3935221249497531e-12
mutations O 0 1.6281944681395544e-09
two O 0 4.122795854710759e-13
are O 0 6.490050467530817e-14
missense O 0 1.0420792051490935e-07
( O 0 8.961489997337882e-14
G197W O 0 1.4502461731513705e-10
, O 0 1.4062468095370206e-13
W427R O 0 6.682578101990799e-11
) O 0 2.0811967126337268e-14
, O 0 1.6302849912067097e-14
two O 0 6.080289131340719e-14
are O 0 7.877474172100773e-14
nonsense O 0 5.374105604971646e-09
( O 0 2.137783045136582e-15
Q306X O 0 8.040791990571172e-12
, O 0 1.980206668398491e-14
Q385X O 0 1.382082295831033e-11
) O 0 5.089182317208861e-15
, O 0 2.1500027235984986e-14
two O 0 3.413317127857682e-14
are O 0 2.337689385193938e-15
small O 0 7.429009528858374e-14
deletions O 0 2.700153700629926e-08
( O 0 7.746061414905595e-14
662de14bp O 0 1.289265048887156e-11
; O 0 1.003424282547535e-14
1168del3bp O 0 7.035355804874133e-12
removing O 0 3.3556732154278734e-13
a O 0 1.1706184219401668e-14
glycine O 0 3.7364495178437984e-12
at O 0 6.0667764215094344e-12
position O 0 1.0906298650650847e-12
390 O 0 1.1654105415079274e-13
) O 0 1.431585834035451e-13
, O 0 1.5591711949314302e-12
and O 0 3.3510950091242275e-12
one O 0 4.6240084244225654e-14
is O 0 1.3085915763667725e-15
a O 0 6.725037672362423e-16
splicing O 0 1.4687673299818016e-09
mutation O 0 6.822547388152245e-11
( O 0 4.0091386529779015e-15
IVS1 O 0 2.246421937357468e-09
- O 0 5.981633410812037e-09
15c O 0 2.271189070146562e-10
- O 0 2.4034807477590903e-09
- O 0 7.3695702873521896e-09
> O 0 1.6366658028843517e-10
g O 0 1.826910889235478e-08
) O 0 1.962864007616638e-14
which O 0 5.497598310968835e-15
creates O 0 1.3715341288091185e-14
a O 0 3.965939125634985e-15
new O 0 4.520159474583757e-14
acceptor O 0 3.8641247319948224e-13
splice O 0 6.851948342045944e-09
site O 0 1.4614930377021551e-09
. O 0 2.620761246907577e-11

The O 0 4.026850033977958e-11
pathological O 0 4.887821813959192e-10
significance O 0 7.52095814012671e-13
of O 0 5.976539961983097e-15
the O 0 1.9961805917002168e-13
point O 0 3.152228131297896e-11
mutations O 0 5.4266213050935264e-11
G197W O 0 1.3253485982300806e-11
, O 0 3.365746190528928e-15
W427R O 0 3.5838762513229483e-12
, O 0 4.327868087777159e-14
and O 0 8.111101444359739e-14
the O 0 1.7507349397787551e-15
in O 0 1.566914898884237e-14
- O 0 4.434992817436978e-09
frame O 0 1.7007000252533544e-08
deletion O 0 1.7908149962941877e-10
390delGly O 0 5.641588238236572e-11
were O 0 1.4796057919998738e-14
assessed O 0 5.323213285370488e-15
by O 0 1.9543826243641335e-15
their O 0 3.943134610061988e-13
respective O 0 3.2362560981741284e-12
expression O 0 1.1590926243983113e-13
in O 0 1.1092111378905429e-15
a O 0 1.0809319900343924e-15
prokaryotic O 0 2.2447929948796012e-14
system O 0 1.2067002467240108e-14
using O 0 1.818331768859674e-15
site O 0 1.3967539624903935e-10
- O 0 2.2589995651856043e-08
directed O 0 2.441404411968051e-09
mutagenesis O 0 5.550133685972014e-10
. O 0 3.556596857301475e-12

These O 0 6.924542883535167e-11
mutations O 0 5.940281599947639e-09
resulted O 0 1.2678541376487384e-11
in O 0 7.196392597498893e-14
the O 0 7.639046188147314e-13
absence O 0 5.773433380679149e-12
or O 0 2.2302740031307153e-14
a O 0 1.4903602305179828e-14
dramatic O 0 2.295165446586367e-11
decrease O 0 2.760651776623213e-11
of O 0 7.79116151477556e-15
CPO O 0 2.8117941837990656e-05
activity O 0 6.220329140660397e-09
. O 0 8.345518720531686e-12

The O 0 2.8153571054317927e-12
two O 0 1.3723479580648405e-14
polymorphisms O 0 6.928677770412506e-11
were O 0 3.0151516049528593e-13
localized O 0 1.3061767223376819e-09
in O 0 4.93511319050316e-13
noncoding O 0 1.2185712421342032e-06
part O 0 1.479909944590574e-11
of O 0 1.350841579775817e-15
the O 0 1.4622201019443004e-14
gene O 0 9.673845058344455e-12
1 O 0 2.5026992383738378e-15
) O 0 1.8826392513690495e-16
a O 0 6.211015622442032e-15
C O 0 1.2998672360708952e-08
/ O 0 4.6661060792985154e-08
G O 0 9.022323443907965e-10
polymorphism O 0 9.269809919665306e-11
in O 0 5.763967319931396e-13
the O 0 2.373572529929674e-13
promotor O 0 2.5852276763771442e-08
region O 0 6.501110760837037e-11
, O 0 3.5271725861221737e-14
142 O 0 1.6598864210209952e-13
bp O 0 3.124635153482075e-13
upstream O 0 7.670711396796925e-14
from O 0 5.075893326487229e-18
the O 0 3.718762910889853e-18
transcriptional O 0 1.4298222775579496e-14
initiation O 0 8.488605796566791e-16
site O 0 1.0217320696101484e-12
( O 0 1.620061049423466e-15
- O 0 4.134196873728513e-10
142C O 0 3.368015311089323e-10
/ O 0 7.944852775665368e-09
G O 0 9.427132408035277e-10
) O 0 5.713327438239138e-15
, O 0 3.455733149724388e-14
and O 0 8.153963073319337e-13
2 O 0 6.227245959557551e-14
) O 0 3.14336441355133e-16
a O 0 4.811083612933382e-16
6 O 0 5.582812451264754e-14
bp O 0 9.698296175473728e-14
deletion O 0 3.211645359380011e-13
polymorphism O 0 1.3243571820795164e-12
in O 0 6.806052879756389e-15
the O 0 5.8618597477378635e-15
3 O 0 1.741428317736729e-13
noncoding O 0 4.2340548844777e-09
part O 0 6.707817352784307e-13
of O 0 1.1500712661122615e-15
the O 0 3.9306675725684845e-14
CPO O 0 3.5260314668050796e-09
gene O 0 8.212514002181592e-12
, O 0 1.7918763888180806e-15
574 O 0 3.110452027237434e-14
bp O 0 2.5844715365215543e-13
downstream O 0 4.0342799630457837e-13
of O 0 1.7890879365033847e-17
the O 0 4.7129044475336095e-15
last O 0 1.756811384735768e-13
base O 0 1.050778713172773e-12
of O 0 2.3256791726859212e-17
the O 0 6.1220750453979626e-15
normal O 0 5.269540012675655e-12
termination O 0 1.1210791409782539e-12
codon O 0 4.223202690334382e-11
( O 0 2.2020676365805576e-14
+ O 0 8.151665974176492e-12
574 O 0 1.7928167631020564e-11
delATTCTT O 0 5.219389920263495e-10
) O 0 1.1374593758203821e-12
. O 0 1.4641860857436684e-12

Five O 0 8.468384882220903e-10
intragenic O 0 6.215303471890365e-08
dimorphisms O 0 4.925495886709541e-07
are O 0 2.6541319055745083e-12
now O 0 5.1149612323442284e-11
well O 0 4.3311651465836876e-13
characterized O 0 1.0495559282786004e-10
and O 0 1.4446080616459245e-11
the O 0 4.540794891244766e-14
high O 0 4.107944995453139e-13
degree O 0 6.88192077380901e-15
of O 0 2.1328041457679517e-17
allelic O 0 3.5811878462688185e-10
heterogeneity O 0 1.0487909207768098e-07
in O 0 2.3074545746348818e-12
HC B-Disease 0 3.704766641021706e-05
is O 0 1.7834071025513154e-11
demonstrated O 0 4.3528716872284767e-13
with O 0 1.1901103441223828e-14
seven O 0 1.559925013596905e-14
new O 0 1.7276077639451605e-15
different O 0 6.361165553111776e-16
mutations O 0 9.395349949425924e-12
making O 0 4.9159424801552016e-15
a O 0 3.98500405850849e-14
total O 0 3.9219356793218293e-14
of O 0 1.206446496828837e-15
nineteen O 0 2.5983561968700997e-09
CPO O 0 7.510275463573635e-05
gene B-Disease 0 1.1291090231679846e-05
defects I-Disease 0 0.07724612951278687
reported O 0 2.8860753786830173e-09
so O 0 5.41235372492066e-12
far O 0 6.749029286823305e-12
. O 0 1.1794228788053474e-12
. O 0 1.820316813949674e-11

Coincidence O 0 1.4513178436814655e-09
of O 0 2.5542725757849577e-14
two O 0 2.9983256003875136e-13
novel O 0 1.6942738878533703e-11
arylsulfatase O 0 7.660978518231332e-09
A O 0 3.944565594299343e-12
alleles O 0 5.261725950778118e-12
and O 0 3.660947239803036e-11
mutation O 0 2.9727620365349594e-10
459 O 0 3.6423860455547796e-11
+ O 0 6.646020539458064e-11
1G O 0 1.5242191864217602e-07
> O 0 1.8673538271229972e-09
A O 0 8.595194694871466e-11
within O 0 1.8039535793976103e-12
a O 0 5.817241827132946e-11
family O 0 3.941737958257363e-08
with O 0 2.3306195373606897e-07
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999992847442627
: O 0 5.160916724360198e-13
molecular O 0 2.931138133859673e-13
basis O 0 4.3326641577311024e-15
of O 0 4.249849905296727e-16
phenotypic O 0 4.3954023754011473e-10
heterogeneity O 0 6.038520496076671e-06
. O 0 2.105260632490058e-09

In O 0 1.4899248501620832e-11
a O 0 7.171407131328911e-12
family O 0 1.3031650758499325e-10
with O 0 1.4640779907870716e-11
three O 0 3.218819377703852e-10
siblings O 0 1.0931723304352658e-09
, O 0 4.517321575397276e-15
one O 0 2.98420739921828e-15
developed O 0 3.1509701532012047e-12
classical O 0 1.987507269873845e-09
late O 0 8.313884904964652e-07
infantile O 1 0.9998340606689453
metachromatic B-Disease 1 0.9999997615814209
leukodystrophy I-Disease 1 0.9999994039535522
( O 0 2.268116805481668e-09
MLD B-Disease 1 0.9999970197677612
) O 0 2.365357259018208e-12
, O 0 1.4751176354629164e-13
fatal O 0 7.352708220054183e-09
at O 0 9.11872244380163e-10
age O 0 3.3700264800984314e-10
5 O 0 1.425709637153938e-11
years O 0 3.7292849472576883e-13
, O 0 2.0862134177297709e-13
with O 0 7.251026493647339e-13
deficient O 0 3.724567534391099e-07
arylsulfatase O 0 1.7593844603425168e-08
A O 0 2.2164950430614283e-11
( O 0 4.374642602377257e-14
ARSA O 0 2.40491118574937e-07
) O 0 2.506421651715489e-14
activity O 0 1.616810678395364e-11
and O 0 8.387994617463368e-13
increased O 0 1.9713614421434933e-11
galactosylsulfatide O 0 4.4990838432568125e-06
( O 0 3.131738618433744e-11
GS O 1 0.9999984502792358
) O 0 2.3589910407018078e-12
excretion O 0 1.1612179967590563e-11
. O 0 2.0122445376635767e-12

The O 0 8.926003686182682e-11
two O 0 5.630466795927824e-13
other O 0 1.2206457632862877e-13
siblings O 0 2.9139750612472426e-09
, O 0 6.578907991300342e-12
apparently O 0 1.5110535045437246e-08
healthy O 0 8.202542811641678e-12
at O 0 1.3624151719987543e-12
12 O 0 7.406979895966184e-14
( O 0 5.510151551005381e-16
1 O 0 1.1348106970180544e-13
/ O 0 1.3095799999973678e-08
2 O 0 2.413901327089074e-12
) O 0 1.0278965043497221e-13
and O 0 6.434700862423259e-12
15 O 0 7.901163447468496e-13
years O 0 1.3744514796860518e-14
, O 0 1.3784577761199752e-14
respectively O 0 7.032977715829003e-13
, O 0 2.606384726100419e-11
and O 0 2.6056314883504683e-09
their O 0 1.907570108816703e-11
father O 0 5.203407149600991e-10
, O 0 1.392613455108993e-12
apparently O 0 1.8493681586129185e-10
healthy O 0 9.233968638008329e-15
as O 0 1.6427375507895622e-16
well O 0 1.5926804552935866e-14
, O 0 9.84211542424734e-15
presented O 0 4.3479759723186184e-13
ARSA O 0 2.0168143237242475e-05
and O 0 1.4885891630456172e-08
GS O 1 0.9999997615814209
values O 0 4.392966893029815e-12
within O 0 5.219758205852153e-14
the O 0 6.5782077932085604e-15
range O 0 3.0463630749932857e-12
of O 0 2.342083504133091e-13
MLD B-Disease 1 0.9999990463256836
patients O 0 6.357188198080621e-08
. O 0 1.864198032053288e-12

Mutation O 0 9.715095394824402e-09
screening O 0 2.010022592813243e-09
and O 0 2.0166928836520132e-13
sequence O 0 3.0581986595890065e-12
analysis O 0 1.5329846224897137e-13
disclosed O 0 2.0808734509797366e-12
the O 0 1.4421383907209113e-15
involvement O 0 1.6049133593279419e-12
of O 0 8.327597009392365e-16
three O 0 2.2664916818349035e-12
different O 0 1.66536624985128e-13
ARSA O 0 0.00016442702326457947
mutations O 0 2.262492238003233e-08
being O 0 3.562975652363076e-14
the O 0 9.250529535025469e-17
molecular O 0 1.3237056849940698e-12
basis O 0 4.33554322271882e-14
of O 0 1.0598919880861271e-14
intrafamilial O 0 2.657526920302189e-06
phenotypic O 0 1.1833280133544122e-08
heterogeneity O 0 2.09530048778106e-06
. O 0 3.028795436677001e-09

The O 0 5.087292809236033e-10
late O 0 2.56390952912966e-09
infantile O 0 0.018490320071578026
patient O 0 0.00019916451128665358
inherited O 0 4.903286389890127e-05
from O 0 2.606646886185726e-12
his O 0 2.325325043628368e-09
mother O 0 4.898807333120203e-07
the O 0 2.6158632212918385e-14
frequent O 0 1.9366945547272252e-10
0 O 0 3.5247721408282473e-10
- O 0 3.1411595102781575e-08
type O 0 5.887068610377355e-08
mutation O 0 5.75852587836323e-10
459 O 0 4.160026489952173e-12
+ O 0 1.4924268418314846e-12
1G O 0 7.863154016796159e-10
> O 0 3.313679539096448e-11
A O 0 4.2225847818322393e-10
, O 0 1.4672200954191084e-11
and O 0 5.211767475921114e-11
from O 0 2.733970446138368e-14
his O 0 1.7159660845034175e-11
father O 0 2.664501085047899e-11
a O 0 7.349362682014873e-15
novel O 0 1.6187322749577904e-12
, O 0 3.81252477233817e-14
single O 0 3.1264235449655897e-13
basepair O 0 4.581684753812709e-10
microdeletion O 0 4.00007284240278e-11
of O 0 4.910745641856221e-17
guanine O 0 1.1927778209575024e-11
at O 0 3.327527598080693e-13
nucleotide O 0 3.116863104418721e-12
7 O 0 1.3558197533430905e-13
in O 0 3.0207421007552853e-16
exon O 0 2.1746786316167999e-10
1 O 0 1.3306651787392543e-11
( O 0 7.468819399752968e-14
7delG O 0 4.183832835735757e-09
) O 0 7.796521132689971e-13
. O 0 2.494629719809738e-12

The O 0 9.243789622637166e-10
two O 0 6.870301549888325e-11
clinically O 0 4.338584460583661e-07
unaffected O 0 4.766993697558064e-06
siblings O 0 1.278270929105929e-07
carried O 0 4.860325475419813e-09
the O 0 5.185466314151788e-13
maternal O 0 8.134981577256895e-09
mutation O 0 8.63240728898873e-11
459 O 0 5.354922668482365e-12
+ O 0 6.154608940545092e-12
1G O 0 1.3180021518621743e-08
> O 0 7.624603171052513e-10
A O 0 6.7100445200196646e-09
and O 0 7.546864244645235e-10
, O 0 1.534471551559169e-12
on O 0 9.108596689400006e-12
their O 0 6.978349376216691e-14
paternal O 0 4.201884500065756e-12
allele O 0 7.163577016462957e-15
, O 0 4.986920770640678e-16
a O 0 8.96304853796083e-17
novel O 0 2.6734309685190298e-14
cytosine O 0 1.1828073243069781e-11
to O 0 2.5539692956381933e-15
thymidine O 0 6.513314887435229e-10
transition O 0 7.046986258418819e-12
at O 0 1.856447667033384e-13
nucleotide O 0 1.0957973244074548e-11
2435 O 0 1.6056007912101933e-10
in O 0 2.9111554661988065e-15
exon O 0 1.0860557592140552e-10
8 O 0 1.493288270815185e-10
, O 0 2.9817511307261846e-14
resulting O 0 1.0801534397009236e-14
in O 0 6.941266125555132e-16
substitution O 0 4.902788990220584e-14
of O 0 1.944031537641551e-16
alanine O 0 4.2639602959582135e-09
464 O 0 1.2476908395342434e-11
by O 0 1.4882844576961235e-13
valine O 0 5.529764894163236e-05
( O 0 4.5219381082477195e-13
A464V O 0 3.346844745788502e-10
) O 0 6.543676191184122e-13
. O 0 1.5321114602701025e-12

The O 0 8.817470364963498e-11
fathers O 0 3.524588954029184e-11
genotype O 0 1.8757622191611922e-11
thus O 0 2.475455821229766e-13
was O 0 1.625694717732884e-11
7delG O 0 3.307982581191027e-07
/ O 0 2.006770773732569e-05
A464V O 0 1.8770646192933782e-07
. O 0 8.945381935188124e-11

Mutation O 0 6.058335770831036e-07
A464V O 0 8.375749871447624e-09
was O 0 1.227483531485163e-10
not O 0 1.5452947081662227e-12
found O 0 6.527196860263429e-13
in O 0 2.4993994097695718e-14
18 O 0 7.103859167578719e-11
unrelated O 0 9.25261378625919e-09
MLD B-Disease 1 1.0
patients O 0 3.418664846321917e-06
and O 0 2.3819321081502975e-12
50 O 0 2.7209105194631045e-12
controls O 0 0.0001167681475635618
. O 0 9.886731433539353e-10

A464V O 0 8.050936628478667e-08
, O 0 5.985515902362515e-12
although O 0 1.7925799733475856e-12
clearly O 0 6.812972928871286e-12
modifying O 0 1.4262033776191174e-09
ARSA O 0 0.04102351889014244
and O 0 1.70489840911614e-06
GS O 1 1.0
levels O 0 5.164633307686017e-07
, O 0 5.357425874458199e-12
apparently O 0 1.0557020813095619e-09
bears O 0 1.0866441774171065e-10
little O 0 1.771238727519761e-13
significance O 0 1.1596940855534976e-13
for O 0 7.03332960719661e-16
clinical O 0 8.420379844775727e-12
manifestation O 0 5.72263590681299e-13
of O 0 3.301530124050385e-14
MLD B-Disease 1 0.9999995231628418
, O 0 1.9045990912874844e-12
mimicking O 0 7.484503294907796e-11
the O 0 7.498508920993768e-14
frequent O 0 1.3854754010722559e-09
ARSA O 0 0.00019270720076747239
pseudodeficiency O 0 2.663039992967242e-07
allele O 0 3.3139166966122957e-09
. O 0 9.939857964491594e-11

Our O 0 3.215355448560331e-08
results O 0 9.027448927279025e-11
demonstrate O 0 1.9086891355629687e-13
that O 0 3.617094959055406e-15
in O 0 7.710057580680369e-16
certain O 0 2.306995740275486e-13
genetic O 0 1.1104412322993085e-07
conditions O 0 1.446841650931674e-07
MLD B-Disease 1 0.9999966621398926
- O 0 1.3438842643154203e-06
like O 0 2.5585797924776443e-09
ARSA O 0 0.002999398158863187
and O 0 9.148746471510094e-08
GS O 1 0.9999997615814209
values O 0 2.2425795595526488e-11
need O 0 1.7339940789652675e-13
not O 0 1.4401709872943237e-14
be O 0 1.2642142761804784e-16
paralleled O 0 5.277647242840633e-12
by O 0 1.5512797209987772e-13
clinical O 0 2.9299721973075066e-06
disease O 0 0.04872652888298035
, O 0 1.8559413446188333e-13
a O 0 2.3892701510840053e-13
finding O 0 3.4973055267756292e-12
with O 0 5.694156517827009e-12
serious O 0 4.967766129015949e-11
diagnostic O 0 2.3905576540528273e-07
and O 0 5.12050540857345e-11
prognostic O 0 6.769824722141493e-06
implications O 0 1.2575912755607987e-08
. O 0 1.1867896942963085e-10

Moreover O 0 1.0847236886490919e-08
, O 0 8.352446338733e-12
further O 0 1.1549955436507275e-11
ARSA O 0 9.089040395338088e-05
alleles O 0 2.1246861908741366e-11
functionally O 0 1.8817034735940652e-11
similar O 0 3.3991166543782814e-13
to O 0 1.383540309228548e-12
A464V O 0 5.666000291171258e-08
might O 0 3.7825206078423435e-08
exist O 0 8.297297071635512e-09
which O 0 1.2565877505199552e-10
, O 0 2.332348723876887e-12
together O 0 2.621655063178574e-12
with O 0 1.0361624752652787e-12
0 O 0 1.1306217073681069e-09
- O 0 9.006187440263602e-08
type O 0 6.182682454891619e-07
mutations O 0 8.260049639829958e-07
, O 0 1.3904402802744631e-11
may O 0 1.9813584800632e-11
cause O 0 9.369258840985495e-12
pathological O 0 2.884861487473245e-07
ARSA O 1 0.8118289113044739
and O 0 2.6762285415316e-05
GS O 1 1.0
levels O 0 4.475998593989061e-07
, O 0 8.405307699854703e-13
but O 0 6.593316604491806e-12
not O 0 1.249006974235467e-12
clinical O 0 2.743744953459526e-10
outbreak O 0 1.1535919997029964e-09
of O 0 2.8803145730728038e-15
the O 0 1.1057945670245317e-09
disease O 0 0.009181266650557518
. O 0 4.759755957428613e-14
. O 0 3.2075451236041053e-12

Human O 0 9.981612674891949e-05
MLH1 O 1 0.9941648840904236
deficiency O 1 0.9777822494506836
predisposes O 0 5.811381561215967e-05
to O 0 4.575887668778478e-09
hematological B-Disease 1 0.9952539205551147
malignancy I-Disease 1 0.9995529055595398
and O 0 5.279933361634903e-07
neurofibromatosis B-Disease 1 0.9998348951339722
type I-Disease 0 0.3823280334472656
1 I-Disease 0 3.5707760304148906e-08
. O 0 4.905436612467895e-10

Heterozygous O 0 5.181406663723465e-07
germ O 0 0.0005096857203170657
- O 0 0.0029326307121664286
line O 0 2.906982217609766e-06
mutations O 0 2.3935260440310913e-09
in O 0 1.1263865308411367e-15
the O 0 3.2818518122681257e-15
DNA O 0 6.740406899297113e-09
mismatch O 0 5.30231751838528e-08
repair O 0 4.915369231639488e-07
genes O 0 2.5893731603332526e-08
lead O 0 1.9401319661938032e-07
to O 0 1.1321747706016794e-10
hereditary B-Disease 1 0.9998648166656494
nonpolyposis I-Disease 1 0.9999948740005493
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.939336418705807e-08

The O 0 3.538171311490146e-09
disease O 0 3.429866410442628e-05
susceptibility O 0 6.809543151575781e-08
of O 0 3.5803676104624593e-14
individuals O 0 1.0889300745831054e-11
who O 0 3.7313472489586275e-07
constitutionally O 0 5.871974281035364e-06
lack O 0 2.0700496872194663e-09
both O 0 1.2001906413150465e-10
wild O 0 7.215284369976871e-08
- O 0 3.676028882182436e-06
type O 0 1.5778398676502547e-07
alleles O 0 2.017941543031032e-11
is O 0 2.5728310541067723e-12
unknown O 0 3.676145499120764e-11
. O 0 9.19850914188336e-12

We O 0 9.749818445925484e-07
have O 0 5.436128543839791e-12
identified O 0 1.0924688237379243e-11
three O 0 1.5369252908108838e-13
offspring O 0 2.6484871695937884e-13
in O 0 8.94355492171272e-15
a O 0 1.0083647805636531e-10
hereditary B-Disease 1 0.9998670816421509
nonpolyposis I-Disease 1 0.9999982118606567
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.3282808140502311e-05
who O 0 2.5197556396960863e-07
developed O 0 6.090719040230397e-08
hematological B-Disease 0 0.0007356818532571197
malignancy I-Disease 0 0.06290983408689499
at O 0 4.1247216753248495e-10
a O 0 2.28139745593256e-13
very O 0 1.2908686706364358e-12
early O 0 1.0656692889243757e-10
age O 0 3.046790320038184e-10
, O 0 6.053515436317547e-13
and O 0 3.448394998370463e-12
at O 0 1.924017022092439e-11
least O 0 3.5900595647328504e-13
two O 0 1.5799431804085912e-13
of O 0 9.807624427923603e-17
them O 0 1.500895897366475e-13
displayed O 0 8.005244037101455e-12
signs O 0 1.0905180404530146e-11
of O 0 3.4763905045387313e-15
neurofibromatosis B-Disease 1 0.6909341216087341
type I-Disease 0 0.0001244737795786932
1 I-Disease 0 2.6728655400098944e-10
( O 0 1.259485137711236e-12
NF1 B-Disease 0 1.0551093510002829e-05
) O 0 1.1226567418753941e-11
. O 0 8.14271566840219e-12

DNA O 0 1.5047895374209475e-08
sequence O 0 3.992770350458308e-11
analysis O 0 1.0197014673613003e-12
and O 0 7.816076988919046e-15
allele O 0 5.817244066010432e-14
- O 0 3.166890361061547e-11
specific O 0 4.117316703506832e-14
amplification O 0 2.3043770017161513e-11
in O 0 2.837284985950095e-13
two O 0 1.19186127980897e-11
siblings O 0 2.620219152760228e-09
revealed O 0 1.5217471380224445e-11
a O 0 9.931505352269929e-14
homozygous O 0 1.5332918268384788e-09
MLH1 O 0 1.3875985132472124e-05
mutation O 0 2.658696152124662e-09
( O 0 7.526292279290067e-14
C676T O 0 1.054701881386677e-09
- O 0 4.497024747251999e-06
- O 0 1.2359065294731408e-05
> O 0 1.7860232182087543e-09
Arg226Stop O 0 7.817745029115031e-08
) O 0 1.2196728273617535e-13
. O 0 2.1590444276159415e-13

Thus O 0 2.7846625005878423e-10
, O 0 8.002259065890277e-14
a O 0 2.2337907145211257e-14
homozygous O 0 1.2943907057305637e-10
germ O 0 2.509149635443464e-05
- O 0 5.4853848268976435e-05
line O 0 9.40258985338005e-07
MLH1 O 0 4.1527575376676396e-05
mutation O 0 1.9093967296157643e-08
and O 0 9.408674360444902e-12
consequent O 0 2.228295237216571e-08
mismatch O 1 0.8665851950645447
repair O 1 0.9998372793197632
deficiency O 1 0.9995868802070618
results O 0 6.816748832072506e-10
in O 0 1.358076520165119e-13
a O 0 9.06603195294231e-11
mutator O 0 0.05446514114737511
phenotype O 0 1.2979046459804522e-06
characterized O 0 1.6615021580790312e-09
by O 0 1.9818790705783407e-12
leukemia B-Disease 1 0.9994463324546814
and O 0 2.182248681492638e-05
/ O 1 0.9999997615814209
or O 1 0.9301713705062866
lymphoma B-Disease 1 1.0
associated O 0 0.00012092215183656663
with O 0 1.1879323302821376e-08
neurofibromatosis B-Disease 1 0.9998966455459595
type I-Disease 0 0.07068134844303131
1 I-Disease 0 4.187000468558466e-10
. O 0 2.1687322077079685e-12
. O 0 8.616709776254616e-12

Missense O 0 9.282016253564507e-05
mutations O 0 0.00012261119263712317
in O 0 6.699442433102942e-13
the O 0 6.873656696859123e-15
most O 0 5.937788310525331e-17
ancient O 0 7.228718085271549e-15
residues O 0 3.1145069856464147e-10
of O 0 9.236143209811947e-17
the O 0 5.900428122441667e-14
PAX6 O 0 1.8839224935618404e-07
paired O 0 4.26043811341259e-10
domain O 0 7.03042008290411e-12
underlie O 0 1.2187858361434323e-11
a O 0 2.579889901428538e-14
spectrum O 0 3.4766410670489245e-12
of O 0 1.33593060658993e-13
human O 0 4.35283436672762e-06
congenital B-Disease 1 0.9999939203262329
eye I-Disease 1 0.9998553991317749
malformations I-Disease 1 0.9995182752609253
. O 0 3.751360111436952e-08

Mutations O 0 8.508976861776318e-06
of O 0 1.794250918630766e-14
the O 0 1.6788633471712805e-13
human O 0 1.1887191751769333e-11
PAX6 O 0 2.382333332207054e-05
gene O 0 1.917307781695854e-05
underlie O 0 0.023520492017269135
aniridia B-Disease 1 0.9999998807907104
( O 0 9.516893584304853e-08
congenital B-Disease 1 0.9999692440032959
absence I-Disease 0 1.9528993533413086e-08
of I-Disease 0 1.446607590660509e-14
the I-Disease 0 6.824873565597356e-12
iris I-Disease 0 3.4407364637445426e-06
) O 0 2.4340963272750926e-12
, O 0 1.2245072848488664e-13
a O 0 3.699628494183149e-13
rare O 0 1.1369687413775864e-09
dominant O 1 0.5462085008621216
malformation B-Disease 1 0.9998165965080261
of I-Disease 0 4.700986778669036e-13
the I-Disease 0 8.12982320352873e-11
eye I-Disease 0 0.0035261064767837524
. O 0 4.2755304852093445e-10

The O 0 1.2898596036745036e-12
spectrum O 0 1.5684592296824618e-12
of O 0 2.41381130442744e-14
PAX6 O 0 2.133465386577882e-05
mutations O 0 7.648936843906995e-06
in O 0 3.2673433403296315e-11
aniridia B-Disease 1 1.0
patients O 0 5.045562261329906e-07
is O 0 7.17142392968632e-15
highly O 0 5.548690491314267e-15
biased O 0 8.883669799786276e-09
, O 0 4.461714678272166e-11
with O 0 6.165453564355161e-12
92 O 0 5.6141997717418235e-09
% O 0 3.209731403732395e-15
of O 0 3.742630959310887e-17
all O 0 3.240874636798591e-13
reported O 0 3.4261343762054253e-10
mutations O 0 6.599504498439046e-09
leading O 0 1.8309860572163217e-11
to O 0 4.942422881550057e-13
premature O 0 7.54239552758218e-12
truncation O 0 8.997457223713923e-10
of O 0 2.557217031716203e-14
the O 0 1.273039074330129e-12
protein O 0 1.085238343634387e-09
( O 0 1.6915298778645213e-14
nonsense O 0 5.1764398323328464e-11
, O 0 2.494424679391229e-16
splicing O 0 8.872069203434696e-13
, O 0 1.925338499877494e-15
insertions O 0 1.2599182114270135e-11
and O 0 5.51968952315629e-13
deletions O 0 5.611263120819387e-10
) O 0 1.1008328580294768e-12
and O 0 1.5279455478633963e-10
just O 0 1.260017978843564e-09
2 O 0 9.678344280519835e-13
% O 0 9.754009227595876e-17
leading O 0 5.5167581962357274e-15
to O 0 6.239958711779932e-17
substitution O 0 1.4407033051500257e-15
of O 0 1.5252351882002e-17
one O 0 4.3511509906181065e-14
amino O 0 5.244627093183539e-14
acid O 0 6.624593858499048e-15
by O 0 2.941213052371946e-17
another O 0 3.421524944879212e-13
( O 0 1.0902257964679266e-13
missense O 0 3.8986776473848295e-08
) O 0 1.2537908211651683e-11
. O 0 7.474285079744902e-12

The O 0 2.5722768099561977e-12
extraordinary O 0 2.7900157363461645e-14
conservation O 0 7.036261357633647e-14
of O 0 3.0128690618594546e-17
the O 0 1.2947232118004962e-15
PAX6 O 0 2.5770233169630785e-10
protein O 0 1.0312148357449757e-10
at O 0 5.994469786003986e-13
the O 0 2.3640367685347566e-15
amino O 0 9.542122300643108e-12
acid O 0 1.345133986835334e-11
level O 0 3.7183895285758384e-13
amongst O 0 2.2261728390066994e-14
vertebrates O 0 4.415636190024941e-10
predicts O 0 4.9332808060853495e-08
that O 0 5.696340101002395e-12
pathological O 0 2.8750280378631032e-08
missense O 0 4.438258656591643e-06
mutations O 0 0.0008906509028747678
should O 0 1.6841684713497784e-09
in O 0 3.6078501026558935e-14
fact O 0 3.768370164525248e-12
be O 0 1.9743557917034638e-12
common O 0 5.289926754015878e-14
even O 0 7.0394098536374905e-12
though O 0 1.2713660679786187e-10
they O 0 9.152050645111487e-11
are O 0 9.929875660879411e-14
hardly O 0 2.3670825716193278e-11
ever O 0 2.5785643151948756e-12
seen O 0 1.6879260142377284e-11
in O 0 1.1203358553368847e-11
aniridia B-Disease 1 0.9999998807907104
patients O 0 1.2099933144327224e-07
. O 0 2.104454631390862e-12

This O 0 4.0795120753722713e-11
indicates O 0 3.603942144714267e-11
that O 0 1.052075703574136e-13
there O 0 4.4442792138501067e-14
is O 0 1.9938714856535862e-16
a O 0 1.7899908934774925e-15
heavy O 0 9.234344400255168e-10
ascertainment O 0 2.3412676242173802e-08
bias O 0 3.016367600139347e-07
in O 0 5.340494282153781e-14
the O 0 6.597105098261804e-15
selection O 0 3.533116301016352e-15
of O 0 5.2738094402122806e-17
patients O 0 7.387439184686206e-14
for O 0 8.188479259344135e-18
PAX6 O 0 6.739188762594495e-08
mutation O 0 1.3830113443358272e-10
analysis O 0 2.8207158830895196e-12
and O 0 5.065557890683581e-13
that O 0 5.851454845835768e-13
the O 0 3.589402267165781e-13
missing O 0 1.5510639439497709e-09
PAX6 O 0 6.642850166826975e-06
missense O 0 1.994212198042078e-06
mutations O 0 5.192038770474028e-06
frequently O 0 2.1063581101543605e-08
may O 0 5.2396056243741995e-11
underlie O 0 1.4090404931721423e-07
phenotypes O 0 3.160336348173587e-07
distinct O 0 1.336454297923284e-11
from O 0 1.0695086309631119e-12
textbook O 0 0.008729570545256138
aniridia B-Disease 1 0.9999992847442627
. O 0 1.0333481625934837e-08

Here O 0 8.113879346183239e-08
we O 0 1.391430581865194e-10
present O 0 2.2992236708833415e-14
four O 0 7.174765474663239e-14
novel O 0 4.0538839646275804e-11
PAX6 O 0 3.63966250915837e-07
missense O 0 2.382792445132509e-06
mutations O 0 3.445303809712641e-05
, O 0 6.061043333893679e-11
two O 0 4.906093435154413e-13
in O 0 1.5012080120668791e-13
association O 0 4.79047682598599e-14
with O 0 2.9119249871610575e-13
atypical O 0 8.185270417016e-07
phenotypes O 0 8.36160950257181e-07
ectopia B-Disease 0 4.925373559672153e-06
pupillae I-Disease 0 2.6162560970988125e-06
( O 0 3.173243568951878e-12
displaced B-Disease 0 3.2922065074103557e-09
pupils I-Disease 0 3.745233101426493e-08
) O 0 2.726525449858741e-09
and O 0 5.078737785879639e-07
congenital B-Disease 1 0.9999450445175171
nystagmus I-Disease 0 1.0849164027604274e-05
( O 0 4.643146978011714e-12
searching B-Disease 0 9.97815718939421e-10
gaze I-Disease 0 1.3050123470748076e-07
) O 0 1.4012514022374023e-12
, O 0 4.144561083219145e-11
and O 0 1.1604087690741949e-09
two O 0 4.510391712897466e-11
in O 0 2.0395748891871568e-12
association O 0 4.934561534885272e-15
with O 0 3.988285072393415e-16
more O 0 4.56880974364555e-15
recognizable O 0 2.2246352671118075e-07
aniridia B-Disease 1 0.9999991655349731
phenotypes O 0 3.0527491617249325e-05
. O 0 1.6868743901721217e-10

Strikingly O 0 2.4365304440721047e-08
, O 0 1.6645274047988323e-10
all O 0 1.0286402805925743e-12
four O 0 6.532527340244454e-13
mutations O 0 1.3233712736759884e-10
are O 0 3.656592105385874e-15
located O 0 9.584477309032557e-12
within O 0 4.564007049893959e-13
the O 0 5.737355306557196e-14
PAX6 O 0 1.054803320243991e-07
paired O 0 3.957744798555041e-09
domain O 0 2.9417282498833686e-10
and O 0 4.7558790239321524e-11
affect O 0 6.789628859138475e-10
amino O 0 4.51116838329213e-10
acids O 0 9.37994348859661e-10
which O 0 1.450396877253346e-12
are O 0 3.5358668287543233e-15
highly O 0 1.2767971359003982e-14
conserved O 0 1.4098315570532094e-10
in O 0 1.2317859406085763e-12
all O 0 1.0473131693486404e-12
known O 0 9.107501211524927e-12
paired O 0 4.075899173727748e-09
domain O 0 2.8026087006693956e-10
proteins O 0 3.2225928592310993e-09
. O 0 6.172881650279294e-11

Our O 0 2.1820557805085627e-08
results O 0 4.247769844201166e-11
support O 0 8.394901188590008e-15
the O 0 3.8785045731711335e-15
hypothesis O 0 3.3011681496025735e-12
that O 0 1.5826961391311213e-14
the O 0 1.9446034172298458e-15
under O 0 1.790087412881832e-14
- O 0 2.451378336432164e-11
representation O 0 1.3802422204299558e-13
of O 0 1.4268221292104222e-15
missense O 0 7.690509278290847e-07
mutations O 0 4.982938150988048e-08
is O 0 1.1648320010642938e-14
caused O 0 1.1607407472257608e-13
by O 0 8.788585161814862e-16
ascertainment O 0 1.6368016275691843e-08
bias O 0 2.8208401090523694e-06
and O 0 3.150659247386223e-11
suggest O 0 2.1391988874741585e-11
that O 0 6.567476309283322e-15
a O 0 1.309605263046399e-15
substantial O 0 1.0367511157297754e-13
burden O 0 5.200331276711267e-10
of O 0 6.797205620622318e-15
PAX6 B-Disease 1 0.5283921957015991
- I-Disease 0 0.02578187920153141
related I-Disease 0 6.279217632254586e-05
disease I-Disease 1 0.9998400211334229
remains O 0 1.0792295945805108e-09
to O 0 1.4103304028095787e-12
be O 0 6.536017387037685e-13
uncovered O 0 1.9102492032629925e-08
. O 0 5.286177853953966e-13
. O 0 1.1779615911172714e-12

The O 0 8.628090429618762e-12
chromosomal O 0 2.2664829884888604e-05
order O 0 7.211243407967416e-11
of O 0 8.053211485799412e-15
genes O 0 1.8558928616130288e-08
controlling O 0 2.671469928827719e-06
the O 0 9.221328561848097e-12
major O 0 4.940917033152692e-12
histocompatibility O 0 4.085977667322993e-10
complex O 0 2.911028362806434e-11
, O 0 1.4106740135830936e-13
properdin O 0 1.7823513775994115e-09
factor O 0 1.07168843244132e-10
B O 0 0.0001621371484361589
, O 0 6.583166650697692e-11
and O 0 2.354738803944656e-08
deficiency B-Disease 0 6.402475719369249e-06
of I-Disease 0 1.4899210280529637e-16
the I-Disease 0 1.3811139189766342e-13
second I-Disease 0 3.4386614649467573e-12
component I-Disease 0 8.719905765335045e-13
of I-Disease 0 2.390015269027046e-15
complement I-Disease 0 1.0528045102375927e-09
. O 0 1.2825862767684715e-11

The O 0 3.407240115049781e-11
relationship O 0 3.445870108351179e-12
of O 0 1.1668365892372658e-16
the O 0 4.573951974789212e-16
genes O 0 6.493641209600817e-14
coding O 0 8.627498021551716e-12
for O 0 2.1412413880159925e-17
HLA O 0 1.4862470976151343e-10
to O 0 1.4444893306660156e-15
those O 0 4.698897407792e-17
coding O 0 1.993496166752262e-11
for O 0 1.5363778735341058e-16
properdin O 0 1.907181912397249e-10
Factor O 0 7.310145544447977e-12
B O 0 4.7648029521951685e-08
allotypes O 0 1.1951314382585565e-09
and O 0 2.165678747445554e-11
for O 0 8.134433475111627e-14
deficiency B-Disease 0 1.9300964027024747e-07
of I-Disease 0 6.348217463372912e-17
the I-Disease 0 3.6678001131065785e-13
second I-Disease 0 5.9436500859932906e-12
component I-Disease 0 2.1592146473570217e-12
of I-Disease 0 1.7365077508801983e-15
complement I-Disease 0 1.6952582670981542e-09
( O 0 2.249308378443615e-12
C2 O 0 3.450310259722755e-08
) O 0 2.1538126100326127e-13
was O 0 2.6928771712508848e-11
studied O 0 2.5204302533943235e-10
in O 0 8.025293618671089e-14
families O 0 3.7797395150817453e-14
of O 0 7.158656072676765e-16
patients O 0 1.0570435499124287e-10
with O 0 1.0998853217092375e-10
connective O 1 0.9999933242797852
tissue O 1 0.9999737739562988
disorders O 1 0.9989591836929321
. O 0 7.730663331706467e-11

Patients O 0 7.911648026492912e-06
were O 0 4.074361941580618e-12
selected O 0 4.349900160124237e-13
because O 0 2.0335230895007772e-12
they O 0 4.24529497927012e-13
were O 0 1.572978638347041e-14
heterozygous O 0 2.242899442561619e-12
or O 0 1.6238826079715933e-14
homozygous O 0 3.7712069578255125e-10
for O 0 4.967894096097325e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.6205688180281896e-10

12 O 0 4.419834720437166e-09
families O 0 1.6153827407661137e-12
with O 0 7.134590363161789e-14
15 O 0 1.22724833767629e-12
matings O 0 3.934662373694664e-08
informative O 0 1.1865304259117693e-06
for O 0 1.7770012163964566e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 8.816881946760446e-11
found O 0 1.0030321712095613e-10
. O 0 1.9770247938755148e-11

Of O 0 1.0261639628306174e-11
57 O 0 8.248896565810071e-10
informative O 0 1.9716858701279705e-10
meioses O 0 5.05955995322438e-07
, O 0 2.616224023446051e-13
two O 0 7.606583506448192e-16
crossovers O 0 1.0952744787517954e-12
were O 0 1.1795011039920922e-13
noted O 0 5.866599740722567e-12
between O 0 2.274100872889928e-11
the O 0 1.133211213755203e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
gene O 0 9.032155579014045e-10
and O 0 7.777109034892704e-13
the O 0 3.7629435293640504e-14
HLA O 0 3.449965879553929e-05
- O 0 9.620439413993154e-06
B O 0 8.810370104583853e-07
gene O 0 3.335232090506679e-11
, O 0 7.474840236996994e-16
with O 0 2.6894594748885744e-18
a O 0 2.6927444158961756e-18
recombinant O 0 1.3237996294182498e-15
fraction O 0 1.1168075199439326e-14
of O 0 1.7028630092921944e-14
0 O 0 1.6834843519220044e-09
. O 0 3.0907912947769622e-12

035 O 0 0.002085769781842828
. O 0 3.0903258618764085e-08

A O 0 1.2904294299787011e-10
lod O 0 2.4237659090431407e-05
score O 0 2.050567182720897e-08
of O 0 2.607491666448857e-16
13 O 0 6.824674831339139e-13
was O 0 4.188868964693192e-14
calculated O 0 5.564314945762615e-14
for O 0 1.6847704490663136e-15
linkage O 0 0.0001959168293979019
between O 0 0.0005632556276395917
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 3.8529695926825536e-12
HLA O 0 3.785274202527944e-06
- O 0 4.482996700971853e-06
B O 0 5.186844873605878e-07
at O 0 5.129097050782325e-15
a O 0 1.3509587383290565e-17
maximum O 0 1.796734394085825e-17
likelihood O 0 6.736643082530991e-16
value O 0 1.5241707721879668e-17
of O 0 4.0191147245484835e-19
the O 0 1.5948940528167606e-17
recombinant O 0 4.0836610351938085e-15
fraction O 0 6.814704050763171e-15
of O 0 1.0790251071118862e-14
0 O 0 6.896787030363782e-10
. O 0 1.7456760863232557e-12

04 O 0 0.0003751972399186343
. O 0 5.953121107182824e-09

18 O 0 1.0434813901838424e-07
families O 0 3.3406419991388603e-12
with O 0 1.5954693620943983e-13
21 O 0 2.4923420532257934e-12
informative O 0 3.5582795390731725e-12
matings O 0 9.629783637166156e-10
for O 0 2.1468227925079165e-14
both O 0 4.866214852947137e-13
properdin O 0 5.380211121064349e-08
Factor O 0 5.497591271108604e-10
B O 0 2.4892906935747305e-07
allotype O 0 1.3821470634667321e-09
and O 0 9.944518299109806e-12
HLA O 0 2.007691546168644e-05
- O 0 8.345106471097097e-05
B O 0 8.272616105386987e-05
were O 0 8.855028797889741e-13
found O 0 1.5437245665800292e-12
. O 0 6.156589994754658e-13

Of O 0 2.9198365947280536e-11
72 O 0 2.3761693057622324e-08
informative O 0 5.874197794852876e-10
meioses O 0 1.6562891005378333e-06
, O 0 1.8554512093427178e-11
three O 0 3.43312184236666e-13
recombinants O 0 4.053588753549775e-08
were O 0 7.2461498606957164e-12
found O 0 8.683938984566097e-13
, O 0 7.328082779160122e-16
giving O 0 1.63161987939738e-17
a O 0 1.4417903660587082e-17
recombinant O 0 3.2773354325933658e-15
fraction O 0 1.481441312396574e-14
of O 0 4.986067490825438e-15
0 O 0 1.6036305616751179e-09
. O 0 4.25016619121088e-12

042 O 0 0.00014674551493953913
. O 0 1.2108170466262891e-08

A O 0 2.6646751472014785e-10
lod O 0 8.49092521093553e-06
score O 0 4.8184474188417425e-09
of O 0 1.3049716487177832e-16
16 O 0 1.1297419840990489e-13
between O 0 2.980505992293721e-14
HLA O 0 4.79776099382434e-06
- O 0 4.2213032429572195e-06
B O 0 1.9680658169818344e-06
and O 0 3.2496146615615396e-13
Factor O 0 1.8429997111768515e-12
B O 0 1.0051814935962966e-09
allotypes O 0 9.996510563770045e-12
was O 0 1.7876520576332044e-13
calculated O 0 6.069567896514142e-15
at O 0 2.6204662524371026e-15
a O 0 8.383467567291055e-17
maximum O 0 1.1599311531347752e-16
likelihood O 0 3.916655784148414e-15
value O 0 5.79924416060107e-17
of O 0 8.010943345628257e-19
the O 0 1.491080073527273e-17
recombinant O 0 4.532578121084984e-16
fraction O 0 2.0564037194544145e-15
of O 0 5.637854685056412e-15
0 O 0 2.2269641686278874e-09
. O 0 2.2719319914960012e-12

04 O 0 0.0005450209719128907
. O 0 3.3646911923312928e-09

A O 0 1.7336444779747495e-12
crossover O 0 9.91661288675394e-13
was O 0 1.4291462457904913e-10
shown O 0 1.5889276927614354e-13
to O 0 3.0468422245908885e-14
have O 0 7.103390683819988e-13
occurred O 0 5.66337428342667e-12
between O 0 7.88633572491583e-16
genes O 0 7.404917878959388e-14
for O 0 2.5507146509477075e-17
Factor O 0 2.174551988129436e-12
B O 0 4.6075150805791054e-08
and O 0 4.481436922942894e-13
HLA O 0 1.6448235840016423e-07
- O 0 1.8696931647355086e-07
D O 0 3.3531737386738314e-08
, O 0 2.7328494827359717e-14
in O 0 1.4420338880310438e-15
which O 0 2.0973487161422832e-13
HLA O 0 4.071682369044538e-08
- O 0 1.3906201523639083e-08
D O 0 4.226089755920981e-10
segregared O 0 4.238931428091064e-11
with O 0 8.919501727109539e-15
HLA O 0 2.1736564548291426e-08
- O 0 9.74211200599484e-09
A O 0 9.395372674303459e-11
and O 0 1.134479177267167e-10
B O 0 4.796754637936829e-07
. O 0 1.5236166278284613e-12

These O 0 1.0559311758306933e-10
studies O 0 3.5639646615848175e-12
suggest O 0 1.0888458781528956e-13
that O 0 7.318863884320443e-16
the O 0 2.8254309276716736e-17
genes O 0 2.175118097517536e-14
for O 0 2.237916368485229e-16
Factor O 0 4.623740323950187e-08
B O 1 0.9999915361404419
and O 1 0.9790478348731995
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 2.0330605417489406e-13
located O 0 5.800876792805276e-11
outside O 0 2.4181283711510737e-11
those O 0 3.6024830054405587e-16
for O 0 1.005618442649803e-17
HLA O 0 1.5081907944747286e-09
, O 0 3.7766122694404825e-14
that O 0 1.168708786160582e-14
the O 0 1.6121514557620054e-15
order O 0 6.398724730410574e-14
of O 0 2.9691929328999196e-17
genese O 0 6.527107188070147e-10
is O 0 9.638174454503975e-15
HLA O 0 1.870105625911833e-09
- O 0 1.2146214034558511e-09
A O 0 9.871156843310747e-12
, O 0 1.3070121157240933e-12
- O 0 1.7310146205318233e-08
B O 0 5.560576710195164e-08
, O 0 8.484660422977599e-15
- O 0 4.5777492040099954e-12
D O 0 9.244591203660946e-12
, O 0 1.6921259773011515e-15
Factor O 0 2.7833907054186646e-12
B O 0 1.1696281632112004e-07
allotype O 0 4.110420945835358e-07
, O 0 1.2579098438436631e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 2.418990572086721e-15
that O 0 5.975283282726727e-16
the O 0 1.8200378255643423e-16
genes O 0 2.5445902329668257e-11
coding O 0 4.996546522306744e-06
for O 0 6.893844606281618e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.000609248236195e-10
Factor O 0 1.6172503336520094e-09
B O 0 2.847315408871509e-05
allotypes O 0 2.898631334957713e-09
are O 0 8.063559856722607e-14
approximately O 0 1.4694122654757003e-12
3 O 0 8.244204624530127e-11
- O 0 2.9059510353590667e-08
- O 0 1.7818660325019664e-08
5 O 0 9.908554147531126e-14
centimorgans O 0 5.149120713143773e-12
from O 0 1.8057906983043005e-17
the O 0 2.3320934620279024e-17
HLA O 0 2.109040546371954e-11
- O 0 3.3122181213041113e-12
A O 0 3.0803373632197484e-13
and O 0 4.3422904161261044e-13
HLA O 0 3.2458757459608023e-07
- O 0 5.152451620915599e-08
B O 0 3.6058556140972087e-10
loci O 0 1.9562774370671413e-15
, O 0 2.5125135973754365e-15
and O 0 6.739628132516233e-15
that O 0 5.9387457753930836e-15
the O 0 1.6611515706068379e-15
apparent O 0 3.058617270047803e-13
lack O 0 1.3895182476419271e-14
of O 0 8.797392550843408e-19
recombinants O 0 5.950549775146641e-11
between O 0 2.277673289232708e-15
the O 0 5.853700702873436e-16
Factor O 0 2.1906469693799835e-11
B O 0 6.320768079604022e-06
gene O 0 2.22129856410902e-05
and O 1 0.6451438665390015
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 2.1067886279979575e-07
suggests O 0 2.687439715209905e-10
that O 0 5.326529690409532e-13
these O 0 2.381040514493754e-13
two O 0 1.4546807335091838e-11
genes O 0 6.983682965255866e-08
lie O 0 5.013988811697345e-06
in O 0 1.1319398651905843e-13
close O 0 2.461288395316785e-10
proximity O 0 3.199704501355427e-09
to O 0 7.2186154623232746e-12
one O 0 5.004279325995786e-13
another O 0 2.8540310306052197e-12
. O 0 1.3893348277393969e-11

Distribution O 0 2.919627650754819e-09
of O 0 1.5168626717101258e-13
emerin O 0 2.5502799871901516e-06
and O 0 2.258462999948918e-10
lamins O 0 3.538060263963416e-05
in O 0 5.9749987076085365e-12
the O 0 9.612854783014324e-12
heart O 0 2.2060890003672284e-08
and O 0 3.4556160558897597e-13
implications O 0 2.7443021813344792e-12
for O 0 1.3315542584020103e-14
Emery B-Disease 0 0.0682542622089386
- I-Disease 1 0.9996650218963623
Dreifuss I-Disease 1 0.9999526739120483
muscular I-Disease 0 0.0007670983322896063
dystrophy I-Disease 0 0.004968059249222279
. O 0 5.351943888065591e-11

Emerin O 0 1.672692633292172e-05
is O 0 4.798126305993744e-12
a O 0 2.940657971035182e-13
nuclear O 0 1.3712682100930351e-09
membrane O 0 9.304505965701537e-08
protein O 0 3.393392944417428e-07
which O 0 1.121935946923891e-10
is O 0 1.6059513744878795e-12
missing O 0 3.11299666599929e-11
or O 0 7.855298171915298e-14
defective O 0 1.4058902930713657e-09
in O 0 3.05290827340432e-11
Emery B-Disease 1 0.999411940574646
- I-Disease 1 0.9999880790710449
Dreifuss I-Disease 1 0.9999911785125732
muscular I-Disease 1 0.6404772400856018
dystrophy I-Disease 0 0.41338425874710083
( O 0 2.0514492882206525e-10
EDMD B-Disease 1 0.9999991655349731
) O 0 2.9733729367542594e-11
. O 0 5.661635656822872e-12

It O 0 1.3986161562229427e-08
is O 0 1.914231793909149e-12
one O 0 7.723518818860547e-14
member O 0 3.203529640250836e-15
of O 0 1.0836232784056153e-16
a O 0 6.063305673514874e-12
family O 0 1.1487083506622753e-10
of O 0 2.7743280932399517e-15
lamina O 0 2.60692868323531e-05
- O 0 3.1440085876965895e-05
associated O 0 7.024827386459265e-09
proteins O 0 5.2472022282756825e-09
which O 0 4.682811213449489e-13
includes O 0 7.517125349921702e-14
LAP1 O 0 2.9148663927003327e-08
, O 0 5.116273615705935e-13
LAP2 O 0 8.754606994898495e-08
and O 0 4.6926601493524345e-11
lamin O 0 0.0006085022469051182
B O 0 0.0019911685958504677
receptor O 0 9.759626440342117e-10
( O 0 2.327012063943479e-12
LBR O 0 3.402069705771282e-05
) O 0 8.703360081241396e-12
. O 0 7.2611747344020205e-12

A O 0 1.82104453738674e-09
panel O 0 2.3060532650109877e-10
of O 0 4.853797790397522e-15
16 O 0 3.878658678957425e-12
monoclonal O 0 1.4929495140147964e-10
antibodies O 0 1.2038803287595101e-09
( O 0 3.002072128757173e-14
mAbs O 0 3.6812691783794094e-10
) O 0 1.281023464388964e-12
has O 0 8.046472516065606e-11
been O 0 8.304044951668033e-12
mapped O 0 1.4493848787822117e-08
to O 0 2.583003255729466e-13
six O 0 2.142119049145224e-14
specific O 0 4.448676331285893e-16
sites O 0 2.558351317252794e-12
throughout O 0 8.058547454553935e-14
the O 0 1.1987807427770673e-15
emerin O 0 5.189891918999656e-12
molecule O 0 3.224890244169637e-14
using O 0 2.089828655992606e-14
phage O 0 6.0707354941624825e-12
- O 0 3.4496072665035626e-11
displayed O 0 7.51520427919733e-14
peptide O 0 1.8171330054810725e-14
libraries O 0 6.080277611692636e-14
and O 0 6.885049713516167e-14
has O 0 2.843980544228915e-14
been O 0 1.3282914451375393e-15
used O 0 1.9534521163199273e-14
to O 0 2.8765604806989253e-14
localize O 0 5.1347239349297524e-08
emerin O 0 2.3543357201560866e-06
in O 0 1.1560468728133433e-11
human O 0 7.614201713579405e-09
and O 0 6.2923199983799805e-09
rabbit O 1 0.9354600310325623
heart O 0 0.00018207590619567782
. O 0 1.0688204488129571e-10

Several O 0 3.133469612254247e-12
mAbs O 0 3.809094706319627e-10
against O 0 3.9994738207024816e-13
different O 0 1.8485777483951728e-14
emerin O 0 2.2573198421582674e-08
epitopes O 0 1.9570045139971626e-08
did O 0 5.724703555642918e-08
not O 0 5.463008084100052e-12
recognize O 0 7.166125874126517e-13
intercalated O 0 2.9849947513760355e-10
discs O 0 1.0699341146391816e-06
in O 0 2.584643055136837e-10
the O 0 5.506469724636531e-10
heart O 0 4.572500813537772e-07
, O 0 2.5930399320805986e-12
though O 0 1.1382194665954248e-11
they O 0 1.530560509062362e-12
recognized O 0 5.6663502286547623e-14
cardiomyocyte O 0 7.007196212160949e-11
nuclei O 0 6.643175050856376e-13
strongly O 0 7.43231951677581e-12
, O 0 5.025197922711722e-13
both O 0 2.6611933143239064e-12
at O 0 2.0412009860137914e-09
the O 0 3.826750114704902e-12
rim O 0 7.04922331351554e-06
and O 0 1.7330056278908046e-09
in O 0 3.967625273465503e-12
intranuclear O 0 3.207251211279072e-06
spots O 0 7.725412842773949e-08
or O 0 1.2471721572149264e-11
channels O 0 8.829512232466641e-09
. O 0 9.578615678407232e-11

A O 0 3.5218086780197666e-10
polyclonal O 0 1.6251368606390315e-07
rabbit O 0 2.146245606127195e-06
antiserum O 0 1.3256038755571353e-07
against O 0 7.895254450218658e-10
emerin O 0 1.3381599046624615e-06
did O 0 2.6016701681896848e-08
recognize O 0 9.591755341376018e-12
both O 0 8.827642393113844e-13
nuclear O 0 4.303146639017541e-08
membrane O 0 1.6698011862104067e-08
and O 0 4.929865543568113e-12
intercalated O 0 1.9521290833823812e-11
discs O 0 6.856576639791001e-09
but O 0 3.57769203152003e-10
, O 0 2.4266062453154845e-15
after O 0 3.0876369248113877e-17
affinity O 0 1.0117866457595496e-17
purification O 0 6.207439025822251e-15
against O 0 1.7134255101444555e-14
a O 0 8.300639127054813e-16
pure O 0 4.274010937782005e-15
- O 0 1.5003458198048492e-10
emerin O 0 3.526668401754307e-10
band O 0 4.4751993045566776e-14
on O 0 5.9581923813126214e-15
a O 0 6.888802492988977e-15
western O 0 3.3482956407482334e-09
blot O 1 0.8203811645507812
, O 0 6.976700328564789e-10
it O 0 7.255917394699551e-11
stained O 0 8.53157260394255e-08
only O 0 2.3914323212664845e-12
the O 0 1.1666419410659868e-14
nuclear O 0 4.0895015152031533e-10
membrane O 0 3.5898202188633377e-09
. O 0 1.2865137774542568e-11

These O 0 1.2369151536351097e-10
results O 0 1.864611590129961e-11
would O 0 2.0181098545762888e-12
not O 0 3.6273997586037943e-13
be O 0 2.1838145847869958e-14
expected O 0 1.922573428583818e-13
if O 0 7.641469922103905e-12
immunostaining O 0 2.7264853486030916e-08
at O 0 4.338112334634214e-12
intercalated O 0 3.4384053763936162e-12
discs O 0 1.3364792827985639e-08
were O 0 8.776027127233021e-11
due O 0 4.723438437256866e-13
to O 0 2.4462428068437736e-13
a O 0 1.361458553316916e-13
product O 0 9.637302891482569e-13
of O 0 1.2318798522102295e-16
the O 0 1.853638228153931e-13
emerin O 0 5.777211953272854e-08
gene O 0 1.5283821142020315e-07
and O 0 5.5489980665957006e-11
, O 0 1.8576589919105935e-13
therefore O 0 3.5263387668888965e-14
, O 0 2.2072261942842784e-15
cast O 0 1.7752635570345704e-13
some O 0 8.120798150484964e-16
doubt O 0 1.5956084787856553e-14
upon O 0 8.349568547735774e-18
the O 0 4.610157471677311e-17
hypothesis O 0 5.30940048870665e-12
that O 0 5.361859502402144e-13
cardiac B-Disease 0 5.192721800995059e-06
defects I-Disease 0 0.38728195428848267
in O 0 9.730092287441039e-10
EDMD B-Disease 1 1.0
are O 0 1.4864980357742752e-08
caused O 0 5.5098130502528875e-09
by O 0 3.9194975796864526e-14
absence O 0 7.831310253059165e-12
of O 0 1.1125504594059745e-15
emerin O 0 7.77705224663805e-07
from O 0 4.945749146052607e-14
intercalated O 0 1.4118530788920225e-09
discs O 0 3.2022404639064916e-07
. O 0 8.371162096842966e-10

Although O 0 1.268075422444781e-09
emerin O 0 5.6477659882148146e-08
was O 0 4.831381475445262e-11
abundant O 0 3.74430744927174e-14
in O 0 1.932874975525689e-14
the O 0 9.36258584766439e-14
membranes O 0 2.2211776240510517e-07
of O 0 1.909772363647565e-15
cardiomyocyte O 0 2.8261768036941248e-08
nuclei O 0 2.87434936963038e-11
, O 0 3.623466977853429e-12
it O 0 2.4738724957451552e-11
was O 0 1.1209926736865938e-10
absent O 0 2.4068902253204794e-12
from O 0 9.989667293109619e-16
many O 0 4.996577899151443e-15
non O 0 1.6999441134271653e-12
- O 0 4.086862048779949e-08
myocyte O 0 4.2412554535076197e-07
cells O 0 5.783173495643723e-09
in O 0 6.299413166663617e-14
the O 0 3.9874237267069346e-13
heart O 0 1.3450641489498594e-08
. O 0 1.944228198574871e-12

This O 0 7.240356860067909e-13
distribution O 0 1.27440441012594e-12
of O 0 2.9767585914801256e-16
emerin O 0 4.043657853003424e-08
was O 0 3.262330336428754e-11
similar O 0 8.905595987214465e-15
to O 0 1.032803738907663e-13
that O 0 3.9662159190614887e-13
of O 0 5.93926373604033e-16
lamin O 0 6.420972567866556e-06
A O 0 1.4125777214601953e-09
, O 0 3.877530146468612e-14
a O 0 4.115595024338243e-15
candidate O 0 7.203932545982172e-14
gene O 0 1.436006608762641e-11
for O 0 5.221106851710771e-16
an O 0 3.432642015142699e-14
autosomal O 0 0.00027989724185317755
form O 0 7.563775028529562e-08
of O 0 2.9431945769431422e-09
EDMD B-Disease 1 1.0
. O 0 5.159571969670651e-08

In O 0 9.355901470220473e-12
contrast O 0 4.2375897929547435e-11
, O 0 6.8385032879481056e-12
lamin O 0 0.0008335376041941345
B1 O 0 0.188032329082489
was O 0 7.613239483283962e-10
absent O 0 1.549137727818728e-11
from O 0 3.004161377873223e-15
cardiomyocyte O 0 1.7028121135354013e-09
nuclei O 0 1.7915315064787052e-11
, O 0 1.0511435472038144e-12
showing O 0 1.36331071431961e-10
that O 0 2.6460006061213015e-11
lamin O 0 0.00047133787302300334
B1 O 0 0.00018514452676754445
is O 0 1.1134857277753443e-13
not O 0 1.5295375372075676e-14
essential O 0 4.818228335843472e-16
for O 0 8.999016997972596e-18
localization O 0 1.9253294705062762e-13
of O 0 6.561209191915926e-17
emerin O 0 6.355575266070446e-08
to O 0 8.560027144575988e-13
the O 0 1.579708179587705e-13
nuclear O 0 4.837638289956203e-09
lamina O 0 4.326907188101359e-08
. O 0 1.5458651025923587e-10

Lamin O 1 0.8760731220245361
B1 O 1 0.9992703795433044
is O 0 9.7241077412491e-08
also O 0 6.528495077873231e-08
almost O 0 1.311974417994577e-09
completely O 0 3.2854698019946227e-06
absent O 0 8.184500299712738e-10
from O 0 3.5652460394748967e-14
skeletal O 0 0.00013008390669710934
muscle O 0 7.583217325191072e-07
nuclei O 0 1.8562601455940353e-09
. O 0 3.6553374910264225e-11

In O 0 6.285288400853517e-10
EDMD B-Disease 1 0.9999963045120239
, O 0 1.1245957507247106e-12
the O 0 9.400080481052606e-16
additional O 0 1.0181956477630554e-15
absence O 0 9.370321630165074e-14
of O 0 1.7943183848050147e-15
lamin O 0 0.04743356257677078
B1 O 0 0.3494182229042053
from O 0 1.430838520583011e-12
heart O 0 1.2811673286705627e-06
and O 0 2.1750778955720307e-09
skeletal O 1 0.7045401334762573
muscle O 0 6.020120963512454e-06
nuclei O 0 3.096330525309554e-09
which O 0 1.3694150258203308e-09
already O 0 1.8381297595126966e-09
lack O 0 1.3981446209121451e-11
emerin O 0 8.456656246380589e-07
may O 0 6.969484451363472e-12
offer O 0 8.303932497032856e-16
an O 0 5.408498514891739e-18
alternative O 0 1.1822641932286715e-14
explanation O 0 9.86808508171566e-13
of O 0 2.2928417434939013e-15
why O 0 5.9115532025089124e-08
these O 0 2.5179097088573466e-12
tissues O 0 7.518417000085265e-10
are O 0 2.5777650345770557e-14
particularly O 0 3.1627581413215533e-13
affected O 0 9.463405753473708e-12
. O 0 1.201822251743409e-13
. O 0 1.6111025274295754e-12

Genetic O 0 1.415280053151946e-06
mapping O 0 4.025193511836278e-10
of O 0 1.7117661726007843e-14
the O 0 2.196771627452354e-12
copper B-Disease 0 2.063869075641378e-08
toxicosis I-Disease 0 6.474740075645968e-06
locus O 0 6.290409304554601e-10
in O 0 9.754921479962486e-13
Bedlington O 0 6.286318239290267e-05
terriers O 0 1.4195722542353906e-05
to O 0 1.7166339530416685e-11
dog O 0 6.619014243369747e-07
chromosome O 0 6.216018391569378e-06
10 O 0 7.270196163838838e-12
, O 0 2.1334309644426008e-13
in O 0 5.286648736510004e-14
a O 0 7.137605610718634e-12
region O 0 9.50774659003173e-09
syntenic O 0 9.618733201932628e-06
to O 0 2.1367359270829667e-11
human O 0 1.8096658893629325e-10
chromosome O 0 1.3168485565984156e-05
region O 0 1.4300039374859352e-08
2p13 O 0 2.1489228174687014e-08
- O 0 1.5748655712854998e-08
p16 O 0 1.2259586679164158e-09
. O 0 4.742081727293623e-12

Abnormal O 1 0.9988901019096375
hepatic B-Disease 1 0.9966155886650085
copper I-Disease 0 3.952655242756009e-05
accumulation I-Disease 0 8.258820116679999e-07
is O 0 3.7788500627244925e-12
recognized O 0 5.775643635227978e-13
as O 0 3.1269875577777384e-11
an O 0 6.554309806006131e-08
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.358187451394599e-10
man O 0 4.322448887705832e-07
, O 0 3.955580654690927e-12
mouse O 0 1.2938322413447167e-07
, O 0 3.669341306494767e-12
rat O 0 7.89959176472621e-06
and O 0 1.9616629154395326e-10
dog O 0 1.6287862081298954e-07
. O 0 1.2259760914790085e-11

The O 0 1.9934240022556615e-11
major O 0 2.404427525137809e-11
cause O 0 4.2444514569695e-10
of O 0 7.27152441992035e-13
hepatic B-Disease 1 0.8658730983734131
copper I-Disease 0 0.0007577650831080973
accumulation I-Disease 0 5.610762400465319e-06
in O 0 1.6048781747990404e-10
man O 0 3.523197165122838e-07
is O 0 1.703656611401136e-13
a O 0 9.278444982815937e-14
dysfunctional O 0 5.202717900942844e-08
ATP7B O 0 5.540555889638199e-07
gene O 0 3.8965364268506164e-08
, O 0 5.874673143779763e-12
causing O 0 2.501690188339012e-09
Wilson B-Disease 0 0.00021015622769482434
disease I-Disease 0 0.080051489174366
( O 0 4.760006191290023e-12
WD B-Disease 1 0.9999963045120239
) O 0 8.336840662259704e-10
. O 0 3.205553184004728e-11

Mutations O 0 9.432364458916709e-05
in O 0 4.663407247168516e-13
the O 0 1.0346254696079818e-13
ATP7B O 0 3.809971076407237e-07
genes O 0 1.2625180900727173e-08
have O 0 4.3519232661992646e-10
also O 0 1.0420737189820173e-10
been O 0 1.6019628332197833e-11
demonstrated O 0 2.1089860001606564e-13
in O 0 3.8481912968679755e-14
mouse O 0 2.000425638470915e-06
and O 0 4.234319839202527e-10
rat O 0 7.355751222348772e-06
. O 0 9.2898414655318e-12

The O 0 3.263799300268211e-11
ATP7B O 0 1.5321677437896142e-07
gene O 0 1.0675424988448867e-07
has O 0 5.291461158130062e-10
been O 0 1.010780435045655e-12
excluded O 0 1.0592590173053029e-11
in O 0 1.468928031139315e-15
the O 0 6.0448183349492e-16
much O 0 8.811988682147498e-15
rarer O 0 9.964615799162857e-10
human O 0 5.7180327139860765e-09
copper B-Disease 0 3.986882802564651e-06
overload I-Disease 1 0.5175948739051819
disease O 1 0.9952049255371094
non B-Disease 0 5.461974428300209e-09
- I-Disease 1 0.8156311511993408
Indian I-Disease 0 0.09830256551504135
childhood I-Disease 0 0.2187795490026474
cirrhosis I-Disease 0 0.007548443973064423
, O 0 1.8280286952134656e-13
indicating O 0 5.203520773988668e-12
genetic O 0 8.316511368455792e-10
heterogeneity O 0 4.565985989302135e-08
. O 0 2.1181524589852785e-10

By O 0 5.704252174776325e-13
investigating O 0 9.413915827427566e-12
the O 0 8.969085782233044e-13
common O 0 4.582766111038694e-11
autosomal O 0 0.00018548536172602326
recessive O 0 0.007959531620144844
copper B-Disease 0 3.144368383800611e-05
toxicosis I-Disease 0 0.0004823259951081127
( O 0 4.675673476867148e-12
CT B-Disease 0 0.00032254072721116245
) O 0 1.049697568450414e-11
in O 0 6.115522042764165e-13
Bedlington O 0 0.000923365296330303
terriers O 0 0.014221711084246635
, O 0 7.014086533807529e-10
we O 0 1.6546007619577807e-10
have O 0 1.439640914075932e-14
identified O 0 1.1451993020062442e-14
a O 0 5.268460890371513e-17
new O 0 3.7663523287569806e-15
locus O 0 5.541369880318614e-12
involved O 0 1.0857900516192398e-11
in O 0 1.011499439762531e-09
progressive O 1 0.9708715677261353
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.676125154810194e-10

We O 0 4.5423309558145775e-09
examined O 0 4.98967325790467e-11
whether O 0 2.497637242426104e-13
the O 0 4.793574933693867e-14
WD B-Disease 1 0.9996252059936523
gene O 0 2.144366106904272e-07
ATP7B O 0 5.168121219867317e-07
was O 0 7.17330882193945e-12
also O 0 3.819650691116831e-14
causative O 0 2.1868219041154546e-12
for O 0 4.596741263886191e-17
CT B-Disease 0 1.36218986312997e-07
by O 0 1.0828469197698976e-15
investigating O 0 4.911018423522928e-13
the O 0 4.121897796498762e-14
chromosomal O 0 8.3739789261017e-05
co O 0 9.413301995664369e-07
- O 0 2.3422088712976574e-09
localization O 0 1.322193049491105e-10
of O 0 3.614101544619809e-15
ATP7B O 0 6.563679448845505e-07
and O 0 1.9506197059069447e-13
C04107 O 0 3.2603989495207097e-13
, O 0 2.166448724566811e-17
using O 0 1.6042789131745422e-17
fluorescence O 0 5.760969123994812e-16
in O 0 1.4852902724605448e-16
situ O 0 1.2017310974457573e-12
hybridization O 0 2.909099014198474e-13
( O 0 2.8061974537705106e-14
FISH O 0 7.149481007218128e-10
) O 0 3.2812855622725567e-13
. O 0 1.3308117628729743e-12

C04107 O 0 4.7278672354877926e-07
is O 0 6.398532420050229e-13
an O 0 6.257577658827312e-16
anonymous O 0 2.0166581891824936e-13
microsatellite O 0 6.848475919696284e-08
marker O 0 1.4712190932186786e-07
closely O 0 1.998153031923522e-10
linked O 0 7.109220323542331e-09
to O 0 7.642358967885343e-12
CT B-Disease 0 0.0027977325953543186
. O 0 7.249830596967044e-11

However O 0 5.1493640462751955e-09
, O 0 4.876819434396218e-12
BAC O 0 1.6336537100869464e-07
clones O 0 2.051743885900237e-09
containing O 0 1.3149267265311071e-11
ATP7B O 0 2.694127715585637e-06
and O 0 4.4224780088031324e-11
C04107 O 0 1.0872210909340652e-09
mapped O 0 4.338995829300529e-09
to O 0 4.298459917000119e-13
the O 0 9.182127849944113e-14
canine O 0 1.277792307519121e-06
chromosome O 0 0.0001186729350592941
regions O 0 2.2465479787570075e-07
CFA22q11 O 0 0.0008218078874051571
and O 0 1.1707911307112795e-09
CFA10q26 O 0 1.5157030475165811e-06
, O 0 8.834311862777888e-13
respectively O 0 8.566801104224406e-14
, O 0 2.764988284447052e-15
demonstrating O 0 3.9323772238692226e-14
that O 0 1.3053379991495584e-12
WD B-Disease 1 0.9999926090240479
cannot O 0 1.863945797708766e-08
be O 0 1.0336224470731611e-15
homologous O 0 9.688700986247231e-14
to O 0 9.507178437518846e-14
CT B-Disease 0 0.000423076911829412
. O 0 9.383498839055093e-11

The O 0 1.59973465030383e-10
copper O 0 1.3908819651575755e-09
transport O 0 1.5500281613789468e-10
genes O 0 1.8685072933344316e-10
CTR1 O 0 2.0155333402271935e-07
and O 0 3.201978265865435e-11
CTR2 O 0 1.8250774473926867e-06
were O 0 6.018132520102526e-11
also O 0 2.916752950277157e-11
excluded O 0 4.082576724601106e-12
as O 0 1.31304006635081e-14
candidate O 0 1.0234107533863349e-13
genes O 0 1.2615045726777074e-12
for O 0 4.191758003493863e-16
CT B-Disease 0 0.012587805278599262
since O 0 9.632508124468586e-09
they O 0 1.3863621188547892e-11
both O 0 2.685063271983673e-13
mapped O 0 1.4948422233374004e-07
to O 0 3.673199765186208e-12
canine O 0 2.111268440785352e-05
chromosome O 0 0.008043180219829082
region O 0 1.5399991752929054e-06
CFA11q22 O 0 0.00022970332065597177
. O 0 1.7167035848419943e-10

2 O 0 1.682001311564818e-07
- O 0 0.0001801832258934155
22 O 0 4.679615361879996e-09
. O 0 1.642058884698816e-11

5 O 0 2.655494490966248e-08
. O 0 4.492209937367875e-10

A O 0 1.3518495350917092e-11
transcribed O 0 2.87256940456615e-10
sequence O 0 3.7970748767435225e-10
identified O 0 2.7844644992502943e-11
from O 0 9.037383090620683e-16
the O 0 2.655572464672299e-14
C04107 O 0 4.175430667885394e-09
- O 0 2.983351565788439e-09
containing O 0 1.6804659877175943e-12
BAC O 0 1.7124204987339908e-07
was O 0 1.2793685381928821e-11
found O 0 7.131991666079612e-14
to O 0 5.050673234811365e-16
be O 0 3.328677752356034e-16
homologous O 0 2.9952030303681196e-14
to O 0 4.16789041498525e-15
a O 0 2.6638415391165744e-14
gene O 0 1.229578994177416e-09
expressed O 0 2.6220423266420587e-14
from O 0 3.896537481101704e-15
human O 0 5.48196340752205e-12
chromosome O 0 3.0351847613019345e-07
2p13 O 0 5.601158981072274e-10
- O 0 8.662644490620153e-10
p16 O 0 2.214382323340036e-11
, O 0 1.319928460150402e-13
a O 0 6.123946564694921e-14
region O 0 1.0305462733173343e-10
devoid O 0 7.782707638070985e-12
of O 0 6.486104501018562e-17
any O 0 1.0835169228311757e-14
positional O 0 6.027130461383479e-10
candidate O 0 1.2528592052696297e-10
genes O 0 3.1602198635738432e-09
. O 0 3.959915728657393e-11

Molecular O 0 4.0870236084344924e-09
analysis O 0 5.87042012223371e-11
of O 0 1.9235252140956593e-15
the O 0 7.985209139694995e-15
APC B-Disease 0 1.953186917758032e-11
gene O 0 8.424030917275616e-11
in O 0 1.9128758500146573e-14
205 O 0 2.684158234220191e-12
families O 0 1.2758435800896972e-13
: O 0 7.978057640521327e-14
extended O 0 4.288334271018712e-11
genotype O 0 1.8354487374416806e-10
- O 0 7.93511816254977e-08
phenotype O 0 2.4195516701297493e-09
correlations O 0 3.4588311381700265e-11
in O 0 1.1691145149423168e-14
FAP B-Disease 0 3.504538673149149e-11
and O 0 3.886415183272131e-14
evidence O 0 5.789449865692409e-14
for O 0 2.891893566401329e-17
the O 0 1.7876426534499076e-16
role O 0 5.3139823203113105e-15
of O 0 5.401776431643827e-18
APC B-Disease 0 8.286731218755394e-13
amino O 0 1.3317886832404924e-13
acid O 0 2.872745715355035e-13
changes O 0 1.0187571272690654e-11
in O 0 9.266075551295216e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.003283114405348897
. O 0 1.1189781740084115e-10

BACKGROUND O 0 2.5076067231566412e-06
/ O 0 3.193560769432224e-05
AIMS O 0 5.759305810038029e-10
The O 0 1.0173871294039127e-13
development O 0 4.2016763332486384e-12
of O 0 3.303437384749586e-11
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 9.247306913262587e-12
a O 0 6.367262284507876e-15
variable O 0 1.12476954833296e-12
range O 0 1.2845227485847044e-11
of O 0 6.475262627524472e-14
extracolonic O 0 0.035668887197971344
manifestations O 0 5.833536488353275e-05
in O 0 1.9378852300633298e-07
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.9999573230743408
polyposis I-Disease 1 0.9999995231628418
( O 0 1.3468265391836098e-10
FAP B-Disease 0 5.06188824189735e-09
) O 0 4.309100819221978e-12
is O 0 1.8793915534075223e-13
the O 0 5.033195472274425e-14
result O 0 1.8501422182487515e-12
of O 0 3.640209588213469e-16
the O 0 8.412476986720263e-13
dominant O 0 4.364838162018714e-07
inheritance O 0 7.457141038003101e-08
of O 0 1.091193246871569e-09
adenomatous B-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999876022338867
coli I-Disease 1 0.9999997615814209
( O 0 3.209284921146249e-11
APC B-Disease 0 1.1713987557726568e-09
) O 0 1.1375591224202508e-12
gene O 0 9.258687150293099e-09
mutations O 0 3.068441856157733e-07
. O 0 3.581240512473549e-11

In O 0 9.835755127030055e-11
this O 0 4.318105186027106e-14
study O 0 1.7692456589948717e-14
, O 0 1.2740080946331062e-16
direct O 0 1.219411077240393e-15
mutation O 0 2.591700075035841e-12
analysis O 0 3.000120564846699e-14
of O 0 6.457857772024978e-18
the O 0 3.433387065323104e-15
APC B-Disease 0 2.8901709150930266e-11
gene O 0 4.4554746003733214e-10
was O 0 4.876057023428526e-12
performed O 0 1.3739286401290296e-12
to O 0 2.3898522998879942e-14
determine O 0 3.1418960315388045e-12
genotype O 0 1.7925433706822425e-11
- O 0 5.796361790544324e-08
phenotype O 0 5.887489384903688e-10
correlations O 0 3.3389110920545306e-11
for O 0 5.0492630096574814e-14
nine O 0 1.376944391839885e-10
extracolonic O 0 2.191371777371387e-07
manifestations O 0 1.5755587945420757e-09
and O 0 1.895679793695315e-12
to O 0 9.904750122565007e-15
investigate O 0 3.63671245895425e-12
the O 0 6.484506806297627e-14
incidence O 0 1.8375791910330008e-07
of O 0 1.0030033918760443e-14
APC B-Disease 0 7.816507263669337e-08
mutations O 0 7.163450277403172e-07
in O 0 3.5212004752954718e-12
non O 0 5.676370928853203e-09
- O 1 0.8214417695999146
FAP O 1 0.9724742770195007
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.510170292792992e-10

METHODS O 0 1.1704389457634079e-08
The O 0 3.2495715645251833e-13
APC B-Disease 0 3.744284743367743e-11
gene O 0 4.805815745356767e-10
was O 0 3.780464656599758e-12
analysed O 0 1.1341627290106793e-11
in O 0 5.968335494976873e-16
190 O 0 7.958455942869147e-13
unrelated O 0 3.4729247255782525e-11
FAP B-Disease 0 1.9487094604642152e-08
and O 0 8.146607277659257e-10
15 O 0 1.138059438354766e-10
non O 0 6.153358933502773e-10
- O 1 0.6599776148796082
FAP O 1 0.7849721312522888
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
patients O 0 6.096916721487489e-11
using O 0 3.1457668636875394e-14
denaturing O 0 5.773884481641289e-07
gradient O 0 3.841000406623607e-09
gel O 0 1.0212653478447464e-06
electrophoresis O 0 5.118177437424265e-09
, O 0 2.724009440322611e-13
the O 0 1.3629797736682079e-15
protein O 0 1.0098540059733097e-11
truncation O 0 2.458405568006583e-08
test O 0 2.9613672722916817e-06
, O 0 2.7663718280630974e-14
and O 0 2.0536756380895452e-15
direct O 0 7.888915893152285e-14
sequencing O 0 4.549412513377149e-10
. O 0 1.0867701703831667e-11

RESULTS O 0 3.430460537856561e-07
Chain O 0 1.5223532656705174e-08
terminating O 0 5.5862509062976073e-11
signals O 0 2.927688647069715e-11
were O 0 7.282947574009657e-13
only O 0 1.733825485527446e-13
identified O 0 5.155199045425718e-10
in O 0 8.178791845170341e-13
patients O 0 3.993651763456452e-12
belonging O 0 4.177668681912966e-13
to O 0 3.697873604546764e-12
the O 0 9.864879773517979e-14
FAP B-Disease 0 4.28911572925017e-09
group O 0 1.4862087255318457e-12
( O 0 1.255046706243447e-15
105 O 0 6.737479064239382e-12
patients O 0 1.4817883031703616e-11
) O 0 4.3471297525229935e-13
. O 0 1.3505713040984357e-11

Amino O 0 3.968600115200616e-09
acid O 0 6.754608677939089e-11
changes O 0 9.995095029413648e-13
were O 0 6.861268416489055e-14
identified O 0 7.47819254437454e-12
in O 0 1.2856047877738558e-13
four O 0 1.3367329465552302e-10
patients O 0 2.8314873015689024e-11
, O 0 1.5463375209207736e-13
three O 0 4.316007729161797e-13
of O 0 1.335429815300525e-15
whom O 0 1.8062519535622101e-10
belonged O 0 4.9060377982357295e-09
to O 0 3.0786003087091007e-12
the O 0 3.906458693309599e-14
non O 0 5.945211228701452e-13
- O 0 2.2349639916541264e-09
FAP O 0 1.425526141574096e-09
group O 0 7.092756937332467e-11
of O 0 2.91951914033195e-11
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.004475956913666e-08
. O 0 8.4825332521965e-13

Genotype O 0 1.4443931831920054e-05
- O 0 0.00016578914073761553
phenotype O 0 7.70632482272049e-08
correlations O 0 1.5733515601468184e-09
identified O 0 9.429829139762091e-10
significant O 0 6.5988646838488485e-12
differences O 0 3.5754794680542545e-07
in O 0 2.7038706343351926e-11
the O 0 7.432088798553504e-13
nature O 0 5.786000151219994e-12
of O 0 1.7067633154346367e-16
certain O 0 9.591531128366748e-13
extracolonic O 0 2.6134978270420106e-07
manifestations O 0 1.825292972323922e-10
in O 0 2.216897489421086e-14
FAP B-Disease 0 4.5138190407634227e-10
patients O 0 4.278373228611132e-12
belonging O 0 2.959771642184472e-14
to O 0 3.7634408393480423e-13
three O 0 3.2300893730574654e-12
mutation O 0 1.2136602833834331e-09
subgroups O 0 1.519461001464606e-08
. O 0 9.123397176624692e-11

CONCLUSIONS O 0 3.258454839283331e-08
Extended O 0 1.7314164546533561e-09
genotype O 0 1.7747999736528186e-09
- O 0 1.3864496395399328e-06
phenotype O 0 5.0767226866810233e-08
correlations O 0 2.0377866505327802e-08
made O 0 1.1027589258416626e-10
in O 0 2.1806273692130673e-13
this O 0 7.499381703742619e-14
study O 0 1.9128522550648785e-12
may O 0 5.194940072734966e-13
have O 0 4.048222193120225e-14
the O 0 1.5968613199239832e-16
potential O 0 7.17289734349807e-16
to O 0 1.670607634671748e-15
determine O 0 6.794771586745088e-14
the O 0 2.5077139976763833e-17
most O 0 4.645160942786473e-18
appropriate O 0 9.454486466045934e-17
surveillance O 0 8.032457338158494e-11
and O 0 2.0445350937974872e-14
prophylactic O 0 2.191663794892662e-10
treatment O 0 1.6423273331567234e-12
regimens O 0 4.166903801172683e-12
for O 0 2.079086705916513e-17
those O 0 6.454740035652037e-15
patients O 0 2.9765816547677737e-13
with O 0 2.3235235214807623e-14
mutations O 0 1.7311968747435458e-07
associated O 0 2.3684952665803394e-08
with O 0 3.0713132037618607e-10
life O 0 1.335261412549471e-08
threatening O 0 5.895591584703652e-06
conditions O 0 2.3809857907508558e-07
. O 0 1.2997883151733003e-11

This O 0 5.776461774187336e-12
study O 0 1.1878369381851384e-12
also O 0 3.875045968240905e-14
provided O 0 1.4540980724196684e-15
evidence O 0 4.808419016687909e-14
for O 0 1.3768856194424002e-15
the O 0 9.318936545826481e-14
pathological O 0 1.1727831150665224e-08
nature O 0 6.498327809016657e-13
of O 0 6.177031442988328e-17
amino O 0 2.484041618233679e-12
acid O 0 6.359573241285221e-13
changes O 0 9.484954325861966e-14
in O 0 2.373298226780035e-15
APC O 0 8.05141578408275e-11
associated O 0 2.8214005784454876e-11
with O 0 4.1023601345373945e-14
both O 0 2.384736722330083e-12
FAP B-Disease 0 1.4792404634533796e-08
and O 0 2.2263600685246132e-10
non O 0 8.075324409162477e-09
- O 1 0.9930163621902466
FAP O 1 0.9991051554679871
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.3099102602609491e-07
. O 0 1.1155434079734503e-13
. O 0 1.7654416340287526e-12

Inherited B-Disease 1 0.9993745684623718
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.9999868869781494
and O 0 0.10848883539438248
cancer B-Disease 1 0.916884183883667
risk O 0 9.77300640414569e-09
of O 0 2.1346458468581887e-15
the O 0 1.970171665784462e-13
APC O 0 2.1063490951434005e-09
I1307K O 0 8.23388413007109e-10
polymorphism O 0 1.4540830761688994e-09
. O 0 1.189721758609874e-11

Germ O 0 0.012611943297088146
- O 0 0.008555988781154156
line O 0 8.027665899135172e-06
and O 0 2.4410796734680718e-12
somatic O 0 5.954565833465875e-12
truncating O 0 6.413990227827071e-09
mutations O 0 3.7975134148382494e-08
of O 0 4.144898287967183e-16
the O 0 2.416611044779647e-15
APC B-Disease 0 1.5150453808177033e-11
gene O 0 4.082757742995824e-11
are O 0 8.166095566679993e-15
thought O 0 1.8884837270360944e-12
to O 0 1.3329779174984374e-13
initiate O 0 2.73709375164799e-08
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.5855837464332581
formation O 0 3.756893462991684e-09
in O 0 4.841776330977154e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 1.8450559764460195e-06
sporadic O 1 0.9987162351608276
colorectal O 1 1.0
carcinogenesis O 1 0.9992235898971558
, O 0 2.6193360369575203e-08
respectively O 0 2.473511617751001e-09
. O 0 1.7155775411392682e-10

Recently O 0 1.2416619199484558e-07
, O 0 4.3761806786841995e-13
an O 0 3.863074173971002e-15
isoleucine O 0 0.0002329101407667622
- O 0 2.8613981157832313e-06
- O 0 1.0454396459635973e-07
> O 0 2.22048959080956e-11
lysine O 0 1.9858227909286263e-11
polymorphism O 0 2.113067013032044e-11
at O 0 1.3746939784425871e-12
codon O 0 1.0919985055091175e-10
1307 O 0 3.366793302483906e-11
( O 0 9.322949449117393e-15
I1307K O 0 2.109337227454433e-12
) O 0 1.0613074013168127e-15
of O 0 6.348625677005207e-18
the O 0 3.4818718664986507e-15
APC B-Disease 0 1.0335738515054871e-10
gene O 0 1.3609011695336903e-08
has O 0 2.0175731918481432e-10
been O 0 2.8826270797449594e-12
identified O 0 4.20784587729095e-11
in O 0 1.2001546132768548e-13
6 O 0 7.572457660920406e-10
% O 0 8.208496680766827e-14
- O 0 1.4011638427291473e-07
7 O 0 3.5970079692582146e-10
% O 0 1.5241490735861383e-15
of O 0 3.3509589540335583e-17
the O 0 6.618206552450392e-14
Ashkenazi O 0 1.0095877911453499e-08
Jewish O 0 6.707155664198439e-12
population O 0 3.7991338590684376e-13
. O 0 2.923918431593092e-13

To O 0 4.2065538552460424e-11
assess O 0 1.8435042381526046e-10
the O 0 1.345145376379156e-13
risk O 0 2.2893308342791796e-13
of O 0 1.5612494326588707e-18
this O 0 6.085028047746546e-16
common O 0 3.2448317714402555e-14
APC B-Disease 0 2.337257297424511e-11
allelic O 0 2.4025079148337625e-10
variant O 0 4.6842815208947286e-05
in O 0 1.8076016772283765e-07
colorectal O 1 1.0
carcinogenesis O 1 0.999715268611908
, O 0 5.062952936896181e-07
we O 0 3.130394077288656e-07
have O 0 2.4196681984445245e-12
analyzed O 0 1.9230073262932468e-12
a O 0 1.3904879097841201e-15
large O 0 4.3238331616296186e-14
cohort O 0 1.863838944293761e-12
of O 0 8.722482578262238e-17
unselected O 0 7.226564093798515e-07
Ashkenazi O 0 2.8195876211611903e-07
Jewish O 0 7.229352533277833e-11
subjects O 0 6.033246124914626e-11
with O 0 2.7822373311475745e-13
adenomatous B-Disease 0 1.040509687300073e-06
polyps I-Disease 0 0.001143539440818131
and O 0 1.0306921982561335e-09
. O 0 6.988593592716086e-10
or O 0 0.00041245826287195086
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.6699665738792446e-12
for O 0 8.516954401124616e-16
the O 0 4.571982729065964e-15
APC O 0 5.836137684234188e-10
I1307K O 0 3.979384044505707e-10
polymorphism O 0 1.6041934447486028e-09
. O 0 2.48518029072331e-11

The O 0 2.4971682707763954e-11
APC O 0 3.8718622752398346e-10
I1307K O 0 2.5218918620062425e-10
allele O 0 8.092118121416636e-12
was O 0 1.6123945928425698e-11
identified O 0 1.593731223381578e-11
in O 0 3.8655968074945146e-14
48 O 0 2.302077417581927e-09
( O 0 1.2836789736649784e-13
10 O 0 4.223021400889121e-13
. O 0 5.157076751315798e-14
1 O 0 1.3330187106051772e-13
% O 0 7.418877828963086e-16
) O 0 1.765811967421204e-16
of O 0 4.484711561316704e-17
476 O 0 1.8961082703938814e-10
patients O 0 6.918140366130032e-11
. O 0 1.367311971110785e-12

Compared O 0 1.2378419469993851e-11
with O 0 2.046275068877737e-14
the O 0 1.7250459127961899e-15
frequency O 0 2.0810835693607643e-12
in O 0 7.096805917450669e-14
two O 0 1.3948563170381595e-13
separate O 0 6.211069527618795e-13
population O 0 6.863336532133071e-14
control O 0 6.0728750916894114e-09
groups O 0 1.7963817824755146e-13
, O 0 2.276084933050017e-14
the O 0 1.40966124169905e-15
APC O 0 1.5393207541958276e-11
I1307K O 0 3.103469911613921e-11
allele O 0 1.8678283746076385e-12
is O 0 5.171251000655151e-14
associated O 0 5.879871784776614e-13
with O 0 6.492498646858266e-15
an O 0 1.3686484357885889e-15
estimated O 0 5.703537035023354e-12
relative O 0 8.979271548525958e-09
risk O 0 4.693855526483048e-09
of O 0 3.2326360216590987e-15
1 O 0 3.4247885083438234e-10
. O 0 6.314086753445025e-11

5 O 0 7.492597831060266e-08
- O 0 1.5397057723021135e-05
1 O 0 2.773647422849024e-10
. O 0 2.962848716370203e-11

7 O 0 2.7497395471698383e-09
for O 0 2.274637726437656e-12
colorectal B-Disease 1 0.9999997615814209
neoplasia I-Disease 1 0.9741371870040894
( O 0 7.438457849673341e-09
both O 0 8.603012133789889e-07
P O 1 0.9999873638153076
= O 1 0.9625491499900818
. O 0 6.213211611871827e-10
01 O 0 4.8086352677501054e-08
) O 0 1.696345646416686e-12
. O 0 3.635679214283871e-12

Furthermore O 0 4.333206238271714e-09
, O 0 1.1337296119268148e-12
compared O 0 3.024280587245187e-13
with O 0 4.2020426309526127e-13
noncarriers O 0 2.1012145623444667e-07
, O 0 2.5874707107811923e-13
APC O 0 2.6617378440230155e-11
I1307K O 0 1.6357255827603723e-11
carriers O 0 4.005904115367276e-12
had O 0 2.1741632799665567e-11
increased O 0 8.050819803569545e-14
numbers O 0 1.2359209792742187e-12
of O 0 5.154084522726327e-15
adenomas B-Disease 1 0.5628210306167603
and O 0 0.0385061614215374
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.999997615814209
per O 0 1.9359623279480154e-11
patient O 0 2.925431999756256e-06
( O 0 7.82860054560075e-10
P O 1 0.9999802112579346
= O 1 0.7878446578979492
. O 0 6.523725115670231e-09
03 O 0 7.747561880933063e-08
) O 0 1.0986360882451682e-13
, O 0 4.608617496957776e-14
as O 0 3.694682838210721e-14
well O 0 1.2445972800544797e-13
as O 0 1.3848615146078071e-14
a O 0 2.587658006706489e-13
younger O 0 1.5516046780739146e-10
age O 0 1.2680517443366957e-12
at O 0 2.1985445148448024e-12
diagnosis O 0 6.155301690569104e-08
. O 0 1.920939752750317e-12

We O 0 2.227160678103246e-08
conclude O 0 1.365360689092876e-11
that O 0 5.246785502539732e-15
the O 0 1.8821374902269197e-15
APC O 0 3.5628926892128376e-11
I1307K O 0 2.907077703562244e-11
variant O 0 8.214798619121666e-09
leads O 0 6.062367496895149e-09
to O 0 1.893150566867341e-12
increased O 0 1.674965410813911e-08
adenoma B-Disease 1 1.0
formation O 0 1.2572344587624684e-07
and O 0 2.232010687386321e-10
directly O 0 4.070748187319506e-13
contributes O 0 7.962001891126391e-11
to O 0 5.1813462374761254e-12
3 O 0 1.7839684590681415e-11
% O 0 2.1702652763561266e-14
- O 0 7.011735636552885e-09
4 O 0 9.323213208400905e-12
% O 0 3.8093083341275615e-16
of O 0 4.3624790821997434e-17
all O 0 6.375021495939881e-13
Ashkenazi O 0 1.5517978681600653e-05
Jewish O 0 6.203505472512916e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 9.301282660745258e-11

The O 0 3.652192697572998e-12
estimated O 0 2.1778881324242827e-13
relative O 0 7.712015054339716e-12
risk O 0 4.346974603192111e-12
for O 0 4.746895456190451e-16
carriers O 0 6.897125925942049e-11
may O 0 7.816547431017951e-13
justify O 0 1.9824309294841358e-12
specific O 0 1.0377199689555038e-14
clinical O 0 2.5074668903724007e-12
screening O 0 1.0017099996706413e-12
for O 0 4.0291580516931303e-17
the O 0 1.4663463805952024e-16
360 O 0 1.0347518469237121e-13
, O 0 3.518294918505296e-15
000 O 0 2.098339050123554e-15
Americans O 0 4.223701839396309e-15
expected O 0 3.0939714342376494e-15
to O 0 6.841193735639128e-15
harbor O 0 4.768565750601361e-12
this O 0 4.2687767241542264e-17
allele O 0 5.285476273504414e-15
, O 0 1.3634848594146556e-14
and O 0 1.0655274676907994e-13
genetic O 0 6.249780554190565e-11
testing O 0 4.9163839666022113e-11
in O 0 1.6123360030653885e-15
the O 0 3.0301804088920387e-14
setting O 0 3.335060352882557e-11
of O 0 7.564802124017216e-15
long O 0 8.97430241231234e-10
- O 0 2.3511169899848028e-08
term O 0 7.954878943061683e-12
- O 0 4.902284689300984e-10
outcome O 0 1.0492787194671394e-12
studies O 0 1.7116494853419706e-13
may O 0 2.41937808966009e-15
impact O 0 3.357872172251252e-15
significantly O 0 1.0289603835644812e-08
on O 0 0.00175257190130651
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 9.516505087958649e-06
in O 0 1.0512747831005302e-14
this O 0 7.386931642544212e-14
population O 0 1.092553673399943e-12
. O 0 6.789013795582832e-12

Localization O 0 3.5830087341537364e-08
of O 0 4.0865849929277304e-14
human O 0 2.0776462147931163e-11
BRCA1 O 0 1.4727788766322192e-06
and O 0 1.4892671540422953e-09
its O 0 3.5637404485755475e-12
loss O 0 1.9792574690313813e-08
in O 0 4.082055006515706e-12
high O 0 4.4818651012690225e-09
- O 0 4.1822062485152856e-05
grade O 0 5.797151629849395e-07
, O 0 5.308998726749614e-11
non B-Disease 0 4.149898558125642e-08
- I-Disease 1 0.9697192907333374
inherited I-Disease 1 0.9978312849998474
breast I-Disease 1 0.9996949434280396
carcinomas I-Disease 1 0.9999998807907104
. O 0 7.936314005974054e-08

Although O 0 2.2078633366007239e-10
the O 0 1.743604447022179e-14
link O 0 9.670825945606865e-11
between O 0 1.802471258187388e-12
the O 0 4.801815629146278e-12
BRCA1 O 0 6.270948506426066e-05
tumour B-Disease 1 0.9999997615814209
- O 0 3.5909792472921254e-08
suppressor O 0 2.0207291839824393e-08
gene O 0 4.140927558182739e-06
and O 0 6.11197492617066e-07
hereditary B-Disease 1 0.9999974966049194
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 6.756786102846135e-11
established O 0 3.898855630707354e-12
, O 0 1.0096989840361822e-13
the O 0 1.0882967297525317e-15
role O 0 1.0201683248167726e-12
, O 0 3.4503143072663056e-13
if O 0 6.70707521639724e-13
any O 0 1.4813867211231234e-15
, O 0 2.087637381758059e-14
of O 0 4.149248860942518e-16
BRCA1 O 0 1.0082411705525374e-07
in O 0 3.38336962613095e-11
non B-Disease 0 4.932227071208217e-08
- I-Disease 1 0.9450395703315735
familial I-Disease 1 0.9769435524940491
cancers I-Disease 1 0.9999208450317383
is O 0 1.0035981594380683e-11
unclear O 0 9.225765984499645e-11
. O 0 1.1271625126318963e-11

BRCA1 O 0 7.070154242683202e-05
mutations O 0 4.25706912210444e-06
are O 0 1.3169064363299787e-12
rare O 0 4.872080169859849e-11
in O 0 1.1155999735112943e-11
sporadic B-Disease 1 0.9785875678062439
cancers I-Disease 1 0.9999988079071045
, O 0 1.050031528393447e-08
but O 0 4.562275446318154e-09
loss O 0 6.243704164798913e-11
of O 0 1.1566620294748472e-15
BRCA1 O 0 4.502963335539789e-08
resulting O 0 3.569044474023564e-13
from O 0 4.016900015873593e-15
reduced O 0 4.644035156431414e-11
expression O 0 1.2247070545201577e-11
or O 0 8.703389571540487e-13
incorrect O 0 4.4573872370889944e-10
subcellular O 0 2.9936478540548705e-07
localization O 0 1.8692138947784542e-09
is O 0 1.719784017072904e-14
postulated O 0 5.285867663712418e-12
to O 0 1.2381859860327582e-12
be O 0 2.5239380897768005e-13
important O 0 4.7610542895301644e-14
in O 0 6.115464037947937e-13
non B-Disease 0 2.1268655725492636e-09
- I-Disease 1 0.9029473066329956
familial I-Disease 1 0.9999188184738159
breast I-Disease 1 0.9999992847442627
and I-Disease 1 0.9999881982803345
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 4.4252645992060025e-10

Epigenetic O 0 0.00010997047502314672
loss O 0 2.141453251169878e-06
, O 0 4.441438536395559e-11
however O 0 1.5723840632309027e-11
, O 0 3.64899690324938e-12
has O 0 1.3258877329391794e-10
not O 0 3.7294486617857336e-13
received O 0 1.0444863196010774e-16
general O 0 9.31178894300437e-15
acceptance O 0 1.1828083271939877e-13
due O 0 5.910768700661748e-14
to O 0 6.683992467441729e-15
controversy O 0 4.814245925738661e-14
regarding O 0 3.2141010773006906e-14
the O 0 1.6916814967620798e-14
subcellular O 0 2.409737298592063e-09
localization O 0 3.42333661418337e-11
of O 0 8.484138227165617e-16
BRCA1 O 0 1.400791926897682e-08
proteins O 0 1.802996640876131e-09
, O 0 1.592174742742758e-12
reports O 0 1.7792586848308645e-11
of O 0 3.984652201022201e-15
which O 0 5.850102069437924e-10
have O 0 4.988988389076354e-11
ranged O 0 3.6227897851764945e-12
from O 0 2.1036435145463953e-16
exclusively O 0 7.424306801935218e-14
nuclear O 0 2.7246018774462755e-09
, O 0 9.586430905822105e-16
to O 0 2.837822159422167e-16
conditionally O 0 3.5846404512242247e-13
nuclear O 0 8.532357459456463e-11
, O 0 1.0768533146351261e-15
to O 0 3.743576883354733e-15
the O 0 3.8387936357247784e-14
ER O 0 0.0004475544556044042
/ O 0 6.833248988868945e-08
golgi O 0 2.8136435403780524e-09
, O 0 2.3528234075658253e-14
to O 0 1.121974336218889e-14
cytoplasmic O 0 1.63598945501775e-09
invaginations O 0 1.6798157531638935e-08
into O 0 4.2483730292378064e-13
the O 0 1.758406347775448e-14
nucleus O 0 1.1269727555676678e-12
. O 0 1.5341934537019264e-12

In O 0 1.4014038410628538e-12
an O 0 9.207552221482309e-15
attempt O 0 3.677149973402294e-10
to O 0 7.1265463148784125e-12
resolve O 0 3.099435638698189e-11
this O 0 3.8549794189072714e-14
issue O 0 1.202096235053407e-11
, O 0 1.2620667011464803e-10
we O 0 3.796787328980145e-09
have O 0 1.2220492846826136e-11
comprehensively O 0 2.3412853877857742e-08
characterized O 0 1.1702920750533696e-11
19 O 0 6.6652113515919265e-12
anti O 0 8.13679290612157e-10
- O 0 4.40926305600442e-06
BRCA1 O 0 2.0885333924525185e-06
antibodies O 0 1.8819925617918898e-09
. O 0 6.771077188522101e-12

These O 0 1.4066641081111886e-11
reagents O 0 6.908251054538184e-11
detect O 0 1.0973771197297921e-10
a O 0 5.437074418755726e-15
220 O 0 3.380373509321438e-13
- O 0 5.365509703203486e-10
kD O 0 2.2890047191026497e-08
protein O 0 4.982065801573121e-11
localized O 0 4.040059259358131e-11
in O 0 2.3617741317744035e-15
discrete O 0 6.746918128353041e-12
nuclear O 0 2.857087793017854e-07
foci O 0 6.381470463168171e-09
in O 0 5.352622641993654e-13
all O 0 4.248340774223175e-13
epithelial O 0 1.6003742331349713e-08
cell O 0 3.866483166348189e-05
lines O 0 1.7920626760314917e-06
, O 0 1.4763194735711166e-13
including O 0 3.989367209923092e-15
those O 0 2.9733215435384045e-15
derived O 0 1.6498421349258642e-14
from O 0 1.5065056949321864e-13
breast B-Disease 0 7.591765097458847e-06
malignancies I-Disease 0 0.00044297004933469
. O 0 4.848360601883428e-10

Immunohistochemical O 0 1.7199445210280828e-05
staining O 0 7.747989343442896e-07
of O 0 2.92039179297654e-12
human O 0 1.161188833975757e-08
breast O 0 0.059752557426691055
specimens O 0 6.296296106711452e-08
also O 0 4.796230079762154e-09
revealed O 0 1.2695014817154515e-08
BRCA1 O 0 1.8587222427868255e-07
nuclear O 0 3.154163508156671e-08
foci O 0 2.5546849968804963e-08
in O 0 1.293745839625604e-11
benign O 0 0.02758089266717434
breast O 0 0.2086138278245926
, O 0 1.4201527731572128e-09
invasive B-Disease 0 0.001873054658062756
lobular I-Disease 1 0.9999943971633911
cancers I-Disease 1 0.9999998807907104
and O 0 3.6587167414836586e-05
low B-Disease 0 0.10536555200815201
- I-Disease 1 0.9995689988136292
grade I-Disease 0 0.00022447716037277132
ductal I-Disease 1 0.9981339573860168
carcinomas I-Disease 1 1.0
. O 0 2.5091233055718476e-06

Conversely O 0 1.2772931157201128e-08
, O 0 4.929968759614933e-12
BRCA1 O 0 4.4375059182755194e-09
expression O 0 1.066130256993647e-11
was O 0 5.68883273821541e-10
reduced O 0 1.2282985739631158e-10
or O 0 6.503715621608563e-11
undetectable O 0 9.859002148004947e-08
in O 0 2.2324871308153013e-14
the O 0 1.610419696901344e-13
majority O 0 2.4067905654567845e-11
of O 0 3.3711836761821795e-14
high O 0 7.113968081284838e-09
- O 0 3.963287781516556e-06
grade O 0 1.7114711425847418e-08
, O 0 1.406395746389455e-11
ductal B-Disease 0 0.000138533185236156
carcinomas I-Disease 1 1.0
, O 0 8.719225341735637e-09
suggesting O 0 7.432734983048306e-11
that O 0 1.1409403153153641e-12
absence O 0 2.5519950735963803e-13
of O 0 1.7668225836063969e-16
BRCA1 O 0 9.383046517541516e-08
may O 0 8.153702539537289e-12
contribute O 0 7.721570981895041e-15
to O 0 5.49169067967821e-14
the O 0 2.6289881662161334e-14
pathogenesis O 0 3.366135370441725e-09
of O 0 5.0512101742905855e-17
a O 0 1.0847824747576684e-14
significant O 0 6.302835264473819e-15
percentage O 0 1.1432847724091033e-11
of O 0 6.249973547598278e-14
sporadic B-Disease 1 0.9957029223442078
breast I-Disease 1 0.9999815225601196
cancers I-Disease 1 0.9995973706245422
. O 0 2.2628773854727058e-11
. O 0 4.566327524435643e-11

